Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac...
Transcript of Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac...
![Page 1: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/1.jpg)
![Page 2: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/2.jpg)
1.1
1.2
1.3
1.4
1.5
2.1
2.1.1
2.1.2
2.1.3
2.1.4
2.1.5
2.1.6
2.1.7
2.1.8
2.1.9
2.1.10
2.1.11
2.1.12
2.2
2.2.1
2.2.1.1
2.2.1.2
2.2.2
2.2.2.1
2.2.2.2
2.2.2.3
2.2.2.4
2.2.2.5
2.2.2.6
2.2.2.7
2.2.2.8
2.2.2.9
2.2.3
2.2.3.1
TableofContentsAboutPartOne
DownloadPartOne
HowtoPass
TheSAQ
TheViva
Curriculum
ResearchMethodsandStatistics
Evidence-BasedMedicine
StudyTypes
ClinicalTrialDesign
DataTypes
BiasandConfounding
FrequencyDistributions
SampleSizeCalculation
StatisticalTests
StatisticalTerms
RiskandOdds
SignificanceTesting
DrugDevelopment
Pharmacology
Pharmaceutics
Additives
Isomerism
Pharmacokinetics
Modeling
Absorption
Distribution
MetabolismandClearance
Elimination
BolusandInfusionKinetics
DrugMonitoring
EpiduralandIntrathecal
TIVAandTCI
Pharmacodynamics
ReceptorTheory
2
![Page 3: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/3.jpg)
2.2.3.2
2.2.3.3
2.2.3.4
2.2.4
2.2.4.1
2.2.4.2
2.2.4.3
2.2.4.4
2.2.4.5
2.2.5
2.2.5.1
2.2.5.2
2.2.5.3
2.3
2.3.1
2.3.2
2.3.3
2.3.4
2.3.5
2.3.6
2.4
2.4.1
2.4.1.1
2.4.1.2
2.4.1.3
2.4.2
2.4.3
2.4.3.1
2.4.3.2
2.4.3.3
2.4.3.4
2.4.3.5
2.4.3.6
2.4.3.7
2.4.3.8
2.4.4
2.4.4.1
2.4.4.2
2.4.5
2.4.5.1
ReceptorTypes
Dose-ResponseCurves
MechanismsofAction
VariabilityinDrugResponse
AdverseEffects
DrugInteractions
AlterationstoResponse
Pharmacogenetics
DrugsinPregnancy
Toxicology
GeneralManagement
TCAOverdose
Organophosphates
CellularPhysiology
TheCellMembrane
Organelles
ExcitableCells
TransportAcrossMembranes
FluidCompartments
CellHomeostasis
RespiratorySystem
RespiratoryAnatomy
AirwayandAlveolus
ChestWallandDiaphragm
VariationsinAnatomy
ControlofBreathing
MechanicsofBreathing
Respiration
Compliance
Time-Constants
Resistance
Surfactant
VolumesandCapacities
Spirometry
WorkofBreathing
DiffusionofGases
OxygenCascade
DiffusingCapacityandLimitation
V\QRelationships
West'sZones
3
![Page 4: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/4.jpg)
2.4.5.2
2.4.5.3
2.4.5.4
2.4.6
2.4.6.1
2.4.6.2
2.4.7
2.4.7.1
2.4.7.2
2.4.7.3
2.4.7.4
2.4.7.5
2.4.7.6
2.4.7.7
2.4.7.8
2.4.7.9
2.4.7.10
2.4.8
2.4.8.1
2.5
2.5.1
2.5.1.1
2.5.1.2
2.5.1.3
2.5.2
2.5.2.1
2.5.3
2.5.3.1
2.5.3.2
2.5.3.3
2.5.3.4
2.5.3.5
2.5.4
2.5.4.1
2.5.4.2
2.5.4.3
2.5.4.4
2.5.4.5
2.5.5
2.5.5.1
BasicsofV\QMatching
DeadSpace
Shunt
GasTransport
OxygenStorage
CarbonDioxide
AppliedRespiratoryPhysiology
PositivePressureVentilation
Hypoxia
HypoandHypercapnea
PositionandVentilation
Humidification
CoughReflex
Non-RespiratoryFunctions
AltitudePhysiology
RespiratoryChangeswithObesity
NeonatesandChildren
RespiratoryPharmacology
Anti-AsthmaDrugs
CardiovascularSystem
StructureandFunction
CardiacAnatomy
CoronaryCirculation
CardiacCycle
ElectricalProperties
CardiacActionPotential
CardiacOutput
DeterminantsofCardiacOutput
VenousReturn
MyocardialOxygenSupplyandDemand
Pressure-VolumeRelationships
CardiacReflexes
PeripheralCirculation
StarlingForces
VariationsinBloodPressure
PulmonaryCirculation
CerebralBloodFlow
HepaticBloodFlow
CirculatoryControl
Baroreceptors
4
![Page 5: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/5.jpg)
2.5.5.2
2.5.5.3
2.5.5.4
2.5.6
2.5.6.1
2.5.6.2
2.5.6.3
2.6
2.6.1
2.6.1.1
2.6.1.2
2.6.1.3
2.6.1.4
2.6.1.5
2.6.1.6
2.6.1.7
2.6.2
2.6.2.1
2.6.2.2
2.7
2.7.1
2.7.2
2.7.3
2.8
2.8.1
2.8.2
2.8.3
2.8.4
2.8.5
2.8.6
2.8.7
2.8.8
2.8.9
2.8.9.1
2.8.9.2
2.8.9.3
2.8.9.4
2.8.9.5
2.8.9.6
2.8.9.7
ValsalvaManoeuvre
CVSChangeswithObesity
CVSEffectsofAgeing
CardiovascularPharmacology
Inotropes
Adrenoreceptors
Antiarrhythmics
RenalSystem
RenalPhysiology
FunctionalAnatomyandControlofBloodFlow
GlomerularFiltrationandTubularFunction
HandlingofOrganicSubstances
MeasurementofGFR
EndocrineFunctionsoftheKidney
Acid-BaseBalance
Dialysis
FluidsandElectrolytes
SodiumandWater
Potassium
Acid-BasePhysiology
PrinciplesofAcid-BasePhysiology
Compensation
Buffers
NervousSystem
Blood-BrainBarrier
CSF
SpinalCordAnatomy
IntracranialPressure
IntraocularPressure
Sleep
Pain
AutonomicNervousSystem
Neuropharmacology
Neurotransmitters
Anticonvulsants
LocalAnaesthetics
NeuraxialBlockade
AcetylcholineReceptors
Opioids
InhalationalAnaesthetics
5
![Page 6: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/6.jpg)
2.9
2.9.1
2.9.2
2.9.3
2.9.4
2.9.5
2.9.6
2.9.7
2.9.8
2.9.9
2.10
2.10.1
2.10.2
2.10.3
2.11
2.11.1
2.11.2
2.11.3
2.11.4
2.11.5
2.11.6
2.12
2.12.1
2.13
2.13.1
2.13.2
2.13.3
2.13.4
2.14
2.14.1
2.14.2
2.14.3
2.15
2.15.1
2.15.2
2.15.3
2.15.4
2.16
2.16.1
2.16.2
Endocrine
ABriefOverviewofHormones
Insulin,Glucagon,andSomatostatin
ControlofBloodGlucose
HypothalamusandPituitary
Thyroid
AdrenalHormones
CalciumHomeostasis
Histamine
Prostanoids
MusculoskeletalSystem
SkeletalMuscleStructure
SkeletalMuscleInnervation
NeuromuscularBlockers
Nutrition&Metabolism
BasalMetabolicRate
FatMetabolism
CarbohydrateMetabolism
ProteinMetabolism
RequirementsandStarvation
AnaerobicMetabolism
Thermoregulation
RegulationofBodyTemperature
Immunology
Inflammation
InnateImmunity
AdaptiveImmunity
Hypersensitivity
Microbiology
ClassificationofMicroorganisms
AntimicrobialResistance
Antiseptics
Obstetrics&Neonates
RespiratoryChanges
CardiovascularChanges
FoetalCirculation
ThePlacenta
GastrointestinalSystem
Oesophagus
GastricSecretions
6
![Page 7: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/7.jpg)
2.16.3
2.16.4
2.16.5
2.16.6
2.16.6.1
2.16.6.2
2.16.6.3
2.17
2.17.1
2.17.2
2.17.3
2.17.4
2.17.5
2.17.6
2.17.7
2.18
2.18.1
2.18.2
2.18.3
2.18.4
2.18.5
2.18.6
2.18.7
2.18.8
2.18.9
2.18.10
2.18.11
2.18.12
2.18.13
2.18.14
2.18.15
2.18.16
2.18.17
2.18.18
2.18.19
2.18.20
2.18.21
2.18.22
2.18.23
2.18.24
ControlofGastricEmptying
Swallowing
PhysiologyofVomiting
LiverPhysiology
FunctionsoftheLiver
LaboratoryAssessmentofLiverFunction
Bile
Haematology
Erythrocytes
IronHomeostasis
Platelets
Transfusion
Haemostasis
HaemostaticRegulation
CoagulopathyTesting
EquipmentandMeasurement
SIUnits
ElectricalSafety
WheatstoneBridge
NeuromuscularMonitoring
PressureTransduction
PressureWaveformAnalysis
Non-InvasiveBloodPressure
CardiacOutputMeasurement
PulseOximetry
OxygenAnalysis
End-TidalGasAnalysis
BloodGasAnalysis
GasFlow
PrinciplesofUltrasound
TemperatureandHumidity
Electrocardiography
Humidifiers
SupplementalOxygen
BispectralIndex
MedicalGasSupply
Vapourisers
BreathingSystems
CircleSystem
Scavenging
7
![Page 8: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/8.jpg)
2.18.25
2.18.26
2.19
2.19.1
2.19.2
2.19.3
2.19.4
2.19.5
3.1
3.1.1
3.1.1.1
3.1.2
3.1.2.1
3.1.2.2
3.2
3.2.1
3.2.2
3.2.3
3.2.3.1
3.2.3.2
3.2.3.3
3.2.3.4
3.2.4
3.2.5
3.3
3.3.1
3.3.2
3.3.3
3.3.3.1
3.3.3.2
3.3.3.3
3.3.3.4
3.3.3.5
3.3.3.6
3.3.3.7
3.3.4
3.3.4.1
Diathermy
Lasers
ProceduralAnatomy
SubclavianVein
InternalJugularVein
IntercostalCatheter
AntecubitalFossa
Tracheostomy
Pharmacopoeia
Toxicology
RecreationalDrugs
ToxicAlcohols
Antidotes
Naloxone
Flumazenil
Respiratory
Oxygen
Helium
Bronchodilators
BetaAgonists
Antimuscarinics
PhosphodiesteraseInhibitors
LeukotrieneAntagonists
Corticosteroids
PulmonaryVasodilators
CardiovascularPharmacology
AdrenergicVasoactives
Non-adrenergicVasoactives
Antihypertensives
CentrallyActingAgents
CalciumChannelBlockers
DirectVasodilators
ACEInhibitors
AngiotensinReceptorBlockers
NeprilysinInhibitors
PotassiumChannelActivators
Antiarrhythmics
SodiumChannelBlockers
8
![Page 9: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/9.jpg)
3.3.4.2
3.3.4.3
3.3.4.4
3.3.4.5
3.3.4.6
3.3.4.7
3.3.4.8
3.4
3.4.1
3.4.2
3.5
3.5.1
3.5.2
3.5.3
3.5.4
3.5.5
3.5.6
3.5.7
3.5.8
3.5.9
3.5.10
3.5.11
3.5.12
3.6
3.6.1
3.6.2
3.6.3
3.6.4
3.7
3.7.1
3.7.2
3.8
3.8.1
3.8.2
3.8.3
3.8.4
3.9
3.9.1
3.9.2
3.9.3
Beta-Blockers
Amiodarone
Sotalol
Digoxin
Adenosine
Magnesium
Atropine
Renal
Diuretics
IntravenousFluids
Neuropharmacology
Propofol
Barbiturates
Ketamine
Dexmedetomidine
LocalAnaesthetics
Benzodiazepines
Antidepressants
Antipsychotics
Anticonvulsants
GABAAnalogues
InhalationalAnaestheticAgents
NitrousOxide
Analgesics
Opioids
COXInhibitors
Tramadol
Paracetamol
Autonomic
Anticholinesterases
Antimuscarinics
Neuromuscular
DepolarisingNMBs
Non-DepolarisingNMBs
Dantrolene
Sugammadex
Haematological
Anticoagulants
DirectThrombinInhibitors
Antifibrinolytics
9
![Page 10: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/10.jpg)
3.9.4
3.10
3.10.1
3.10.2
3.10.3
3.10.4
3.10.5
3.10.6
3.11
3.11.1
3.11.1.1
3.11.1.2
3.12
3.12.1
3.12.2
3.13
3.13.1
3.13.2
3.14
3.14.1
4.1
4.2
4.3
4.4
Antiplatelets
Antimicrobials
Penicillins
Glycopeptides
Aminoglycosides
Lincosamides
Metronidazole
Antifungals
Endocrine
Hypoglycaemics
Insulin
OralHypoglycaemics
Obstetric
Oxytocics
Tocolytics
Gastrointestinal
AcidSuppression
Antiemetics
OtherDrugs
IVContrast
Appendices
Definitions
KeyGraphs
LawsandEquations
StructuresforSAQs
10
![Page 11: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/11.jpg)
PartOnePartOneisareferencefortraineespreparingfortheCICMandANZCAPrimaryExams.
PartOneis:DesignedtocovertheassessedsectionsoftheCICMandANZCAcurriculainenoughdetailtopassAroughguidefortheexpecteddepthofknowledgerequiredonatopicAtooltocorrectyourwrittenanswersAsourceofinformationyoumightfinddifficulttofindelsewhere
PartOneisnot:AtextbookThedefinitiveguidetotheprimaryexamAcompletereferenceTherewillbebothomissionsanderrors.Ifyoufindany,pleaseletmeknow.
Layout
Thebookisdividedintothreesections:
CurriculumCoversstatistics,physiology,equipmentandmeasurement,andanatomy.
Pagesarelaidoutusingthesectiontitle,topictitles,andorderfromtheCICMcurriculumAgreyblockindicatesatopicisfromtheCICMcurriculumORbothcurricula
WhenatopicisonlyexaminableintheANZCAcurriculum,ithasbeenslottedinsomewheresensibleApurpleblockindicatesatopicisONLYfromtheANZCAcurriculum
Topicscoveredbythepagearelistedatthebeginningofeachpage
PharmacopoeiaCoversdrugs.
Forthesakeofconsistency,thegeneralprinciplesofpharmacologyarecoveredinthecurriculum,whilstthespecificsofdifferentagentswillbefoundinthepharmacopoeia.Iflost,usethesearchbox.
AppendicesIncludesthekeydefinitions,graphs,andequationsyoushouldknow,aswellassamplestructuresforSAQs.
Acknowledgements+TechnicalStuff
PartOneisbuiltwithanumberofopen-sourcetools:
WritteninJohnGruber'selegantMarkdownBuiltandmadeprettybytheGitBooktoolchainWithpluginsfrom:
BenLauforautomatictimestampsMichaelJergerforcollapsiblechaptersRishabhGargfortopnavigation
EquationswritteninLATEXGraphshavebeen:
WritteninPGF/Tikzusingtexworks
AboutPartOne
11
![Page 12: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/12.jpg)
ConvertedtovectorgraphicswithdvisvgmRefinedwithsvgo(Somegraphshavebeentakenfromopen-sourcesitessuchasWikimediaCommons.Thesehavebeencreditedwhereused.)
Additionally,chemicalstructureshavebeenbuiltinMarvinSketch
AbouttheAuthor
JakeBarlowisanAnaestheticandIntensiveCareRegistrarfromMelbourne,Australia.Interestedinallthingscriticalcare(withaparticularfascinationforphysiology),aswellasbiotech,physicalcomputing,teaching,analytics,andoutcomepredictioninintensivecare.Sendallcomments,criticism,andcomplaintsaboutPartOnetohimhere.
Copyright+Legal
Copyright©2015-2019C.JakeBarlow
ThisworkislicensedunderaCreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
Lastupdated2019-11-09
AboutPartOne
12
![Page 13: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/13.jpg)
DownloadPartOne
PartOneisalsoprovidedwith:
APDFversionforofflineuseNotethat:
TheimagequalityofgraphsisreducedinthePDFversionThePDFversionisautomaticallybuiltwheneverthesiteisupdatedTherefore:
ThedownloadlinkwillalwayslinktothemostrecentversionThispagewillappearinthePDFversion
Acompanionsetofflashcards,madeinAnki
Lastupdated2018-07-16
DownloadPartOne
13
![Page 14: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/14.jpg)
HowtoPassThefirstpartexamis:
PainfulTheknowledgedemandedishuge,andcannotbeavoided.EminentlyachievableRemember,itisnotimpossible-everybodybeforeyouhascompletedit.
PlanforSuccess
Thisisnotanexamyouwanttohavetositmorethanonce-trytogiveyourselfthebestchanceofsuccessthefirsttimeround:
CommityourselfearlyDecidewhenyouaregoingtosit:
Pickadate~9monthsinadvance6monthsisprobablypushingit9monthsisachievable12monthsisalmosttoolong-youwilllosemotivationandknowledgewillfade.
AcceptthatthetimebetweennowandtheexamisnotgoingtobethebesttimeofyourlifeConsiderpayingthemoneyassoonaspossible-lockyourselfinYourfamilyandfriendswillforgiveyou,eventually
Don'tlosefaithTherewillbetimesthatyouquestionwhyyouhavetolearnthisThoseareverylegitimatefeelingsAcceptthatpartofthisexamisanacademichazingyoumustpassthroughonyourpathtofellowship
BeStrategicThecurriculumprovidedisoverwhelming,andprobablynotachievableformostofus.Haveaplanabouthowyouwillapproachit:
HaveatimetableContenttocovereachweek
Ifoundsettingaweeklygoalwouldallowmetoplanaroundday-to-dayvariations(finishinglate,gooddays,baddays,etc)Adailytimetablewasoftenmangledbylife,creatingunnecessarystress
TimetostartvivapracticeAimtostartbeforethewritten.
Topicsthatyoucan'texplain,youprobablydon'tunderstandfullyThismaynotbeapparentuntilyoutryandexplainit.
KnowtheenemySyllabusReadthroughitsoyouappreciatethebreadthofknowledgerequired.KnowthestyleThisallowsyoutogiveanswersefficiently-thekeymetricforboththevivasandtheSAQsismarksperunittime.
StyleofexamquestionsIncludingthestyleofanswers-seetheSAQ.
HowtoPass
14
![Page 15: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/15.jpg)
StyleofvivasDopracticevivas
Recordyourself,soyouknowyourticsDoadressrehearsalMakesureyoursuitstillfitsbeforetheday.
GraphsBeabletodrawthemwhiletalkingaboutthem.
DopastquestionsIcannotstressthisenough.Thisisthekeytopreparingforthisexam.
Pastquestions:TeachyouappropriatestructureTeachyoutowritetotimeEnsureyoulearnthecontentinthewayitwillberecalledEnsureyoudon'twastetimelearningthingsthatareunlikelytobeexaminedWhenIsattheCICMexam,Ihaddonealmostallthepastquestions,whichcovered~60%ofthecurriculum.Therewas1(outof24)oftheSAQsonatopicIhadnotansweredanSAQonbefore.
DoquestionstotimeKeepingtotimeisvital.
Itisalmostimpossibletowriteaperfectanswerin10minutesInmanycasesyouwillneedtomoveontothenextquestiondespitestillhavingthingstosayRememberthatthemarkingfollowsasigmoiddistribution
Thefirst30%ofmarksforaquestionareeasytogetThelast30%ofmarksareverydifficulttogetTherefore,themostefficientuseofyourtimeistoaimtoget~60-70%ofmarksforeachquestion.
Rememberthepassmarkis50%YouarenotexpectedtoknoweverythingBreadthtendstoberewardedoverdepthItisnormaltosittheexamandhaveaquestionyouhavenotthoughtaboutbefore
SuggestedApproach
Therearemanyequallyvalidwaystoapproachtheseexams.ThisishowIwoulddoit,ifIhadtodoitagain:
1. ReadageneralphysiologyandpharmacologytextbookThiswillhelpyouunderstandthescopeoftheundertaking.Iwouldrecommendspending2-3weeksreading:
ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.Inmyopinion,thisisthegeneralphysiologytext.Ibelievethatifyoukneweverythinginthisbook,youwouldpassthephysiologycomponentofbothexams.PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.Thefirstfewchaptersareagoodintroductiontopharmaceuticsandpharmacokinetics,whichwillhelpyouputlaterinformationfrommorecompletetextsintocontext.
2. Startdoingpracticequestions:Thisisthekeytotheexam.Isuggest:
StartdoingonequestionatatimeInthebeginning,youwillnotknowenoughtowritefor10minutes.
Afterdoingthequestion,checkyouransweragainstavailablepastanswersThisforcesactivelearning,andisfarmoreefficientthanreading.Lookat:
StructureHowdidyoustructureyouranswer?Whatwastheexamplestructure?
HowtoPass
15
![Page 16: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/16.jpg)
ContentWhatdidyoumiss?Arethenumbers/graphsyouusedcorrect?
Thenstudythecurriculumareasthatquestioncovered,andmakenotesThiswouldtakeme~1-2hoursforanewcurriculumarea.
Onceyoustartdoingquestionswhichyouknowsomethingabout(havingansweredonesimilarpreviously),moveuptothreequestionsin24minutes.Thisteachesyoutokeeptime,whichisvitalforsuccessintheSAQ.
Stillcheckeachanswerafterwards,lookoverthatareaofthecurriculum,andreviseandrefineyournotesWhenyoufindyourselfrunningoutoftimebeforeyourunoutofthingstowrite,giveyourself9minutesperquestionIwouldsuggestnotgoingbeyondthis-youneedtoallocateyourtimestrategicallyontheday,andwritingtotimeiscritical.Asthisgetseasier,startdoing6ormorequestionsatatimetotrainyourwritinghandDooneortwofullexamstotimebeforegameday
3. DoalotofflashcardsFlashcardsarelessdemandingthandoingquestions,andasimpleformofrevision.
Theyaretheabsolutebestwayofrotelearningfacts(inmyopinion)Iusedanki,butusewhateverworksforyouMyankideckisavailablehere
4. DopracticevivasStartbeforethewritten.Thereisalotofcrossoverofskillsbetweenthevivaandthewritten.Bothrequireastructuredapproach,andgoodcontentknowledge.
Remembertotakeabreakafterthewrittenexams,itisexhausting
TheBottomLine
Pickadate,andcommittoitWorkoutwhichtimesworkbestforyouwithrespecttostudyDifferenttimeswillbebetterfordifferentthings.Ifound:
Daysoff(includingweekends)werebestforlearningnewcontentWorkdayswereforrevisingPostnightshiftwasawrite-off
MaintainapositiveattitudeStudygroupsaregoodforthis-sharethesuffering!SplitlargetopicsintomanageablechunksDon'tloseyourheadSetasidetimeforrelaxation,anddon'tfeelguiltyaboutit.Youdon'thavetoknoweverythingThepassmarkis50%
ReferencesThisisbasedonatalkIgaveatthe2016VPECCCourse,stillrawfromtheCICMprimary
Lastupdated2019-08-01
HowtoPass
16
![Page 17: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/17.jpg)
HowtoPass
17
![Page 18: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/18.jpg)
TheSAQAgoodresponsetoashort-answerquestionisconstructedfromtwothings:
StructureDevelopingastructuredapproachtoansweringSAQsisessentialtosucceedinginthissectionoftheexam.Astructuredapproach:
IseasilydigestedbytheexaminerReducestheamountoffilleryouneedtowrite,meaningyoucanwritemorefactsTypicallylendsitselftobulletpointsratherthanparagraphsAllowsyoutorecallmoreinformationthanyouwouldotherwiseEspeciallyifyoulearntitinthesameformat.Thisisparticularlyimportantforpharmacology.
KnowledgeObviously.
Additionally,agoodresponsewill:
AnswerthequestionThisisstatedrepeatedlyinexaminerreports.Ifthequestionasksforadiscussionoftherespiratorychangesofpregnancy,nomarkswillbeawardedforcardiovascularchanges.BelegibleNotbeperfectThisisoften-overlooked.
Examinerreports(andsomemodelanswers),assumeaperfectresponseThisnotfeasiblegiventhetimeallowedItisalsonotactuallyexpected-rememberthatthepassmarkis50%
Thebottomline:
AgoodresponsewillcoverthemajorpointsinreasonabledetailWillgenerallyfocusonprinciplesratherthanspecificsMarksbecomeprogressivelyhardertoacquire:
ThefirstoneortwomarksonaquestionshouldbeeasyGoingfroman8/10toa10/10willrequiretimewhichyoulikelycannotspare
AnsweringtheQuestion
Youhaveexactly10minutesperSAQYoushouldpracticeto8-9minutesperSAQInmanycases,thelastquestion(orquestions)goesunanswered.Thisdemonstratespoortimemanagement,aseasymarkswerethrownawaybycandidatesreachingforhardermarksonearlierquestions.
Duringreadingtime,youshouldevaluateeachquestionto:
DecidewhatpartofthecurriculumitisassessingWorkoutthecontext,ifanyDecidewhatstructurewouldbemostappropriate
Lastupdated2017-08-14
TheSAQ
18
![Page 19: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/19.jpg)
TheSAQ
19
![Page 20: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/20.jpg)
TheVivaThevivaisthepartoftheexammostcandidatesseemmoststressedabout.However:
Ifyoumakeitthroughthewritten,youwillmostlikelypassVeryfewpeoplesucceedinthewrittenexamstofailattheviva.
TheknowledgeisthereExaminerswantyoutopassTheywillredirectyouifyou'reofftrack.
Thismakesiteasiertomakeupmarksthanonthewritten,whereyoucaneasilygooffdowntherabbithole,haemorrhagingtimeandmarks
UnderstandingtheViva
Todowellattheviva:
UnderstandthevivaisaperformancepieceThevivaisaritualisedconversation.Successrequiresyoutoknowandunderstandthelanguageandstructureused,justliketheSAQ.StructureyouranswerAswiththeSAQ,categoriseyouranswer.
HaveagoodopeningstatementDon'tanswermorethanisasked.StartbroadOftenthevivawillgointodepthononlyoneortwoareasofatopic.Ifyoustartgoingintodetailononlypartsofatopic,itmakesithardfortheexaminertoredirectyouandscoresyounomarks.
BeconfidentEnjoyitifyoucan.LearntothinkonyourfeetThevivaassessesknowledgeinadifferentwaytotheSAQs.
Theknowledgewillbethere,butitmayrequireadifferentapproachtoaccessitThisrequirespractice.Thisisalsoimportantfordeliveringasoundanswerbasedonincompleteknowledge
It'sokaytosay"Idon'tknow"Butprobablynotonthefirstquestion.
Ifyoudon'tknowimmediately,canyouworkitoutfromfirstprinciples?Don'tgetangry
WithyourselfWiththeexaminerDon'targue.
Don'tapologiseApologies:
MakeyouloseconfidenceDon'tgetyoumarksRemember,marksperunit-time.
Don'ttalkovertheexaminerTheyareinterruptingyoubecausewhatyouaresayingisgainingnomarks.Ifyoukeeptalking,youwill:
NotbegettingmarksIrritatethem
TheViva
20
![Page 21: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/21.jpg)
Potentiallylosingfuturemarks.
Lastupdated2019-11-02
TheViva
21
![Page 22: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/22.jpg)
Evidence-BasedMedicineDescribethefeaturesofevidence-basedmedicine,includinglevelsofevidence(e.g.NHMRC),meta-analysis,andsystematicreview
WhatisEvidence-BasedMedicine?
Evidence-basedmedicine(EBM)is"theconscientious,explicit,andjudicioususeandappraisalofcurrentbestevidenceinmakingdecisionsaboutthecareofindividualpatients."ThepurposeofEBMistoprovideaframeworkforacquiringknowledgeandmakingoptimaldecisionsaroundmedicalcare.Itmeansintegratingindividualclinicalexpertisewiththebestavailableexternalclinicalevidencefromsystematicresearch."
TherearefivestagesofEBM:
1. Askananswerablequestion2. Search3. Criticallyappraisetheevidence4. Integratetheevidencewiththepatientsuniquecircumstancesandvalues5. Evaluatetheresult
LevelsofEvidence
Levelsofevidencegradestudiesonlikelihoodofbiasandinternalvalidity.TheNHMRCdefines6levelsofevidence,gradedfromI-IV(withthreelevelIIIsubtypes).
Ingeneral:
LevelIisevidencefromasystematicreviewofRCTsLevelIIisevidencefromatleastonegoodRCTLevelIII-1isevidencefromapseudo-RCTLevelIII-2isevidencefromacomparativestudywithconcurrentcontrols,suchasacohortorcase-controlstudyLevelIII-3isevidencefromacomparativestudywithoutconcurrentcontrols,suchasacohortstudywithhistoricalcontrolsLevelIVisevidencefromacase-series
NotethatexpertopinionisnotpartofNHMRClevelsofevidence,thoughitisincludedontheOxfordCentreforEvidenceBasedMedicinesystem,usedbytheNHS.
Level Intervention DiagnosticAccuracy Prognostic Aetiology Screening
IAsystematicreviewoflevelIIstudies
AsystematicreviewoflevelIIstudies
AsystematicreviewoflevelIIstudies
AsystematicreviewoflevelIIstudies
AsystematicreviewoflevelIIstudies
II Arandomisedcontrolledtrial
Astudyoftestaccuracywith:anindependent,blindedcomparisonwithavalidreferencestandard,amongconsecutivepersonswithadefinedclinicalpresentation
Aprospectivecohortstudy
Aprospectivecohortstudy
Arandomisedcontrolledtrial
Astudyoftestaccuracy
ResearchMethodsandStatistics
22
![Page 23: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/23.jpg)
III-1Apseudorandomisedcontrolledtrial
with:anindependent,blindedcomparisonwithavalidreferencestandard,amongnon-consecutivepersonswithadefinedclinicalpresentation
Allornone AllornoneApseudorandomisedcontrolledtrial
III-2
Acomparativestudywithconcurrentcontrols
AcomparisonwithreferencestandardthatdoesnotmeetthecriteriarequiredforLevelIIandIII-1evidence
Analysisofprognosticfactorsamongstpersonsinasinglearmofarandomisedcontrolledtrial
Aretrospectivecohortstudy
Acomparativestudywithconcurrentcontrols
III-3
Acomparativestudywithoutconcurrentcontrols
Diagnosticcase-controlstudy
Aretrospectivecohortstudy
Acase-controlstudy
Acomparativestudywithoutconcurrentcontrols
IV
Caseserieswitheitherpost-testorpre-test/post-testoutcomes
Studyofdiagnosticyield(noreferencestandard)
Caseseries,orcohortstudyofpersonsatdifferentstagesofdisease
Across-sectionalstudyorcaseseries
Caseseries
Gradesofevidence
Evidenceisgradedto"indicatethestrengthofthebodyofevidenceunderpinningarecommendation"(e.g.inaclinicalguideline).TheNHMRCgradesrecommendationsfromAtoDasfollows:
A:BodyofevidencecanbetrustedtoguidepracticeB:Bodyofevidencecanbetrustedtoguidepractice,inmostsituationsC:Bodyofevidenceprovidessomesupport,butcareshouldbetakeninitsapplicationD:Bodyofevidenceisweakandrecommendationmustbeappliedwithcaution
Studytypes:SystematicReviewsandMeta-analyses
SystematicReview
Processofevaluatingallofthe(quality)literaturetoansweraspecificclinicalquestion.Doesnotnecessarilyinvolvestatisticalanalysis.Ifitinvolvesquantitativeanalysisofmultipletrials,itisknownasameta-analysis.
Meta-analysis
Mathematicaltechniqueofcombiningtheresultsofdifferenttrialstoderiveasinglepooledestimateofeffect.Canbedoneby:
PoolingtheresultsofeachtrialPoolingalloftherawdataandconductingareanalysis
Meta-analysesusuallyuserandom-effectsmodels,whichassumestherewillbeavarietyofsimilartreatmenteffectsIndividualtrialsaresummarisedwithanoddsratio,andweighted,usuallybysamplesize
Stagesofa[meta-analysis]andsystematicreview:
1. Inclusionandexclusioncriteriaarepredefined2. Search:includingonlinedatabases,referencelists,citations,andexperts3. Validationofpotentiallyeligibletrials(critiqueofintervalvalidity,i.e.trialquality)
ResearchMethodsandStatistics
23
![Page 24: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/24.jpg)
4. [HeterogeneityAnalysis]5. [Meta-analysis]6. Reliabilityofresultdetermined
i.e.Consistencyacrossstudies,statisticalsignificance,largeeffectsize,biologicalplausibility.7. Sensitivityanalysis
Repeatingtheanalysiswithanalternativemodel,excludingborderlinetrialsoroutliers.Iftheresultisunchanged,thenthefindingsarerobust.
Heterogeneity
Forthepoolingofresultstobevalid,thetrialsneedtobesimilar.Differencesbetweentrialsiscalledheterogeneity,andisimportantbecause:
Heterogeneityanalysisaffectsthetypeofmodelthatcanbeused(fixedormixedeffects)Highlyheterogenousdataisnotappropriateformeta-analysis.
Heterogeneityisdividedinto:
StatisticalHeterogeneityTheeffectsoftheinterventionaremoredifferentthanwouldbeexpectedtooccurthroughchancealone.ClinicalHeterogeneityDuetotrialdesignitwouldbeinappropriatetopooltheresults.
E.g.,conductingameta-analysisontheeffectsofthesamedruginapaediatricandadultpopulationmaybeinappropriate,asthesetwotrialshaddifferentinclusioncriteria.
MethodologicalHetreogeneityWherethemethodsusedindifferenttrialsaretoodifferenttoallowpoolingofthedata.
ForestPlots
Resultsofmeta-analysesarepresentedinablobbogram,ormoreboringly,aForestPlot.
Where:
Thex-axisplotstheoddsratio,rememberingthatanORof1indicatesnodifferenceThey-axisliststhestudiesincluded,andtheoverallsummarystatisticThedot(orsquare)indicatesthepointestimate(fromitsx-location)andtheweightgiventothestudy(byitssize)ThehorizontallineindicatestheupperandlowerboundsoftheconfidenceintervalThediamondindicatestheoverallpointestimateand(byitswidth)theconfidenceintervalforthepointestimateTheresultoftheheterogeneitytestshouldalsobedisplayedP<0.1indicatessignificantheterogeneity.
FunnelPlots
ResearchMethodsandStatistics
24
![Page 25: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/25.jpg)
Funnelplotsareagraphicaltooltodetectpublicationbias.
Duetostatisticalpower,largerstudiesshouldbeacloserrepresentationofthetrueeffectTherefore,whenevaluatingannumberofstudies,onewouldexpectthatlargestudiesclusteraroundthe'trueeffect',andsmallerstudiestoscatterfurtherAgraphisthenplottedofORonthex-axis,andstandarderroronthey-axis
PublicationbiasissuggestedwhenresultsclusterononesideofthefunnelplotNoevidenceofpublicationbiaswouldhavestudiesclusteredaroundthetrueeffect
Strengthsandweaknessesofmeta-analyses
Strengths Weaknesses
Enhancedprecisionofestimatesofeffect Publicationbias
Usefulwhenlargetrialshavenotbeendoneorarenotfeasible Duplicatepublication
Generateclinicallyrelevantmeasures(NNT,NNH) Heterogeneity
Inclusionofoutdatedstudies
Becauseoftheseweaknesses:
Positivemeta-analysesshouldbeconsideredlargelyhypothesis-generating,andshouldbeconfirmedby(alarge)RCTNegativemeta-analysescanprobablybeaccepted
References
1. SacketDL,RichardsonWS,RosenbergW,HaynesRB.Evidence-basedMedicine:HowtopracticeandteachEBM.ChurchillLivingstone,London1997.
2. SackettDavidL,RosenbergWilliamMC,GrayJAMuir,HaynesRBrian,RichardsonWScott.Evidencebasedmedicine:whatitisandwhatitisn'tBMJ1996;312:71.
3. NHMRC.NHMRCadditionallevelsofevidenceandgradesforrecommendationsfordevelopersofguidelines.NationalHealth&MedicalResearchCouncil.2009.
4. MylesPS,GinT.Statisticalmethodsforanaesthesiaandintensivecare.1sted.Oxford:Butterworth-Heinemann,2001.5. LalkhenAG,McCluskeyA.StatisticsV:Introductiontoclinicaltrialsandsystematicreviews.CEACP2008.
Lastupdated2019-07-18
ResearchMethodsandStatistics
25
![Page 26: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/26.jpg)
StudyTypesDescribethefeaturesofevidence-basedmedicine,includinglevelsofevidence(e.g.NHMRC),meta-analysis,andsystematicreview
RandomisedControlTrial
Aprospectiverandomisedcontrolledtrialisthegoldstandardofexperimentalresearch.
Itinvolvesallocatingpatientsrandomlytoeitheraninterventionorareference(control)group,andmeasuringtheoutcomeofinterest.Allocationcanbeperformedinthreeways:
SimpleIndividualsallocatedrandomly.Thismayleadtounevengroupsizes.BlockAllocationisperformedwithinblockssuchthatgroupsizeswillremaincloseinsizeStratifiedGroupsarerandomisedwithinacategory(i.e.menandwomenarerandomisedseparately).
Strengths
OnlystudydesignwhichcanestablishcausationEliminatesconfoundingRandomisationcontrolsforbothknownandunknownconfoundingfactors,astheseshouldberandomlyallocatedbetweengroups.BlindingcanbeperformedinastandardisedfashionDecreasesselectionbias
Weaknesses
CostlyTime-consumingNotappropriateforallstudydesigns
Ethicalconcernse.g.AdrenalineinALSPracticalconcernsSmallpatientpopulationoruncommondiseasemaycauserecruitmentdifficulties
SystematicReviewTheprocessofevaluatingallofthe(quality)literaturetoansweraspecificclinicalquestion.This:
DoesnotnecessarilyinvolvestatisticalanalysisIfitinvolvesstatisticalanalysisofmultipletrialstogenerateacombinedestimateofeffect,itisknownasameta-analysis.
Meta-analysis
StudyTypes
26
![Page 27: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/27.jpg)
Mathematicaltechniqueofcombiningtheresultsofdifferenttrialstoderiveasinglepooledestimateofeffect.Canbeperformedby:
PoolingtheresultsofeachtrialCombiningalloftherawdataandconductingareanalysis
Meta-analysesusuallyuserandom-effectsmodels,whichassumestherewillbeavarietyofsimilartreatmenteffectsIndividualtrialsaresummarisedwithanoddsratio,andweighted,usuallypredominantlybysamplesize
Stagesofa[meta-analysis]andsystematicreview:
1. Inclusionandexclusioncriteriaarepredefined2. Search:includingonlinedatabases,referencelists,citations,andexperts3. Validationofpotentiallyeligibletrials(critiqueofintervalvalidity,i.e.trialquality)4. [HeterogeneityAnalysis]5. [Meta-analysis]6. Reliabilityofresultdetermined
i.e.Consistencyacrossstudies,statisticalsignificance,largeeffectsize,biologicalplausibility.7. Sensitivityanalysis
Repeatingtheanalysiswithanalternativemodel,excludingborderlinetrialsoroutliers.Iftheresultisunchanged,thenthefindingsarerobust.
Heterogeneity
Forthepoolingofresultstobevalid,thetrialsneedtobesimilar.Differencesbetweentrialsisknownasheterogeneity.Heterogeneitycanbeeither:
Statistical;wheretheeffectsoftheinterventionaremoredifferentthanwouldbeexpectedtooccurthroughchancealone.Heterogeneityanalysisaffectsthetypeofmodelthatcanbeused(fixedormixedeffects)andhighlyheterogenousdataisnotappropriateformeta-analysis.Clinical;where,duetotrialdesign,itwouldbeinappropriatetopooltheresults.Forexample,conductingameta-analysisontheeffectsofthesamedruginapaediatricandadultpopulationwouldbeinappropriate,asthesearetwodifferentpopulations.Methodological;Wherethemethodsusedindifferenttrialsaretoodifferenttoallowpoolingofthedata.
ForestPlots
Resultsofmeta-analysesarepresentedinablobbogram,ormoreboringly,aForestPlot.
Where:
Thex-axisplotstheoddsratio,rememberingthatanORof1indicatesnodifferenceThey-axisliststhestudiesincluded,andtheoverallsummarystatistic
StudyTypes
27
![Page 28: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/28.jpg)
Thesquareindicatesthepointestimate(fromitsx-location)andtheweightgiventothestudy(byitssize)ThehorizontallineindicatestheupperandlowerboundsoftheconfidenceintervalThediamondindicatestheoverallpointestimateand(byitswidth)theconfidenceintervalforthepointestimateTheresultoftheheterogeneitytestshouldalsobedisplayed.P<0.1indicatessignificantheterogeneity.
FunnelPlots
Agraphicaltooltodetectpublicationbias.Duetostatisticalpower,largerstudiesshouldbeacloserrepresentationofthetrueeffect.Whenevaluatingannumberofstudies,onewouldexpectthatlargestudiesclusteraroundthe'trueeffect'andsmallerstudiestohavemorescatter.
Strengthsandweaknessesofmeta-analyses
Strengths Weaknesses
Enhancedprecisionofestimatesofeffect Publicationbias
Usefulwhenlargetrialshavenotbeendoneorarenotfeasible Duplicatepublication
Generateclinicallyrelevantmeasures(NNT,NNH) Heterogeneity
Inclusionofoutdatedstudies
Becauseoftheseweaknesses,positivemeta-analysesshouldbeconsideredlargelyhypothesis-generating,andshouldbeconfirmedby(alarge)RCT.Negativemeta-analysescanprobablybeaccepted.
References
1. MylesPS,GinT.Statisticalmethodsforanaesthesiaandintensivecare.1sted.Oxford:Butterworth-Heinemann,2001.
Lastupdated2019-07-18
StudyTypes
28
![Page 29: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/29.jpg)
ClinicalTrialDesignDescribethestagesindesignofaclinicaltrial
1. Determineresearchquestion2. Determinetargetpopulation3. Specifyoutcomes4. Determinerequirementforcontrolgroup5. Samplesizeestimation6. Controlforconfounding7. Controlforbias8. Datahandling9. Statisticalanalysisplan(pre-specified)
References
1. PSMyles,TGin.Statisticalmethodsforanaesthesiaandintensivecare.1sted.Oxford:Butterworth-Heinemann,2001.
Lastupdated2017-09-12
ClinicalTrialDesign
29
![Page 30: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/30.jpg)
DataTypesDescribethedifferenttypesofdata
Dataareaseriesofobservationsormeasurements.Canbeeitherqualitativeorquantitative.
QualitativeData
Usingwordsasdataratherthannumbers,evaluatingmeaningandprocess.Commoninthesocialsciences.
QuantitativeData
Usesnumbers,orcanbecodednumerically.Dividedintomultipletypes,eachwithmultiplesubtypes.
CategoricalDataexistindiscretecategorieswithoutintrinsicorder.
e.g.Medicalspecialty(intensivecare,emergencymedicine,orthopaedics,cardiology)Descriptivestatisticsforcategoricaldatacanbereportedusingtheabsolutenumberforeachcategory,percentages,orproportions
OrdinalDataexistsindiscretecategorieswithanintrinsicorder,e.g.agegroups(0-5,6-10,11-15...)
Descriptivestatisticsforordinaldataarethesameforcategoricaldata,buttheycanalsobesummarisedbythemedianandtherange(e.g.medianagegroup,agegrouprange).
NumericalDataisanactualnumber.Canbesubdividedintodiscreteorcontinuous:
DiscreteCanonlyberecordedasaninteger(wholenumber),e.g.numberofhospitaladmissions.
Dichotomousorbinarydata,whichoccurswhenthereareonlytwocategoriesContinuousWheredatacanassumeanyvalue(includingfractions),e.g.whitecellcount.
Continuousdatacanbefurthersubdividedintointervalorratiodata:RatiodataAreexpressedwithreferencetoarationalzero,whichiswherezeromeansnomeasurement.
e.g.Temperaturein°Kisaratiovariable,whilsttemperaturein°CisnotThisisbecause0°Kmeansnotemperature,whilst0°Cdoesnot;e.g.50°Kishalfthetemperatureof100°K,but50°Cisnothalfthetemperatureof100°C.Ratiovariablescan(unsurprisingly)beexpressedasratios,whilstintervalvariablescannot
IntervaldataDonothavearational0-thisisjustanotherpointontheline(e.g.temperaturein°C).
References
1. MylesPS,GinT.Statisticalmethodsforanaesthesiaandintensivecare.1sted.Oxford:Butterworth-Heinemann,2001.
Lastupdated2019-07-18
DataTypes
30
![Page 31: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/31.jpg)
DataTypes
31
![Page 32: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/32.jpg)
BiasandConfoundingDescribebias,typesoferror,confoundingfactorsandsamplesizecalculations,andthefactorsthatinfluencethem
Bias
Biasisasystematicdeviationfromtruth,andcausesastudytolackinternalvalidity.
Inaresearchstudy,anobserveddifferencebetweengroupsmaybedueto:
AtruedifferencebetweengroupsAnerrorErrorcanbedueto:
Normalrandomvariation,i.e.chanceAsystematicdifference,i.e.biasUnlikeerrorduetochance,theeffectofbiascannotbereducedbyincreasingthesamplesize.
TypesofBias
Typeofbias Description Prevention
Selection Wheresubjectallocationresultsintreatmentgroupsthataresystematicallydifferent,apartfromintheinterventionbeingstudied Randomisation
Detection Wheremeasurementsaretakendifferentlybetweentreatmentgroups Blinding
Observer Wherethedatacollectorisabletobesubjectiveabouttheoutcome Blinding,Hardoutcomes
Publication Whennegativestudiesarelesslikelytobesubmittedorpublishedthanpositiveones Clinicaltrialregistries
Recall Alteredreportingofsymptomsbypatientsdependingonwhichgrouptheyhavebeenallocatedto Blinding
Response Whenpatientswhoenrollforatrialdifferfromthepopulation,limitinggeneralisability Randomsampling
Hawthorneeffect Whentheprocessofactuallydoingthestudyimprovestheoutcome
Controlgroup,maskingstudyintentfrompatientsandobservers
ConfounderAconfounderis"avariablethat,ifremoved,resultsinachangeintheoutcomevariablebyaclinicallysignificantamount."Itisatypeofbiaswhichwillresultinadistortionofthemeasuredeffect.
Aconfoundingfactormustbe:
AssociatedwiththeexposurebutnotaconsequenceofitAconfoundingfactorcannotbeonthecausalpathwaybetweenexposureanddiseaseItmustbepresentunevenlybetweengroupstocausedistortionofthemeasuredeffect
AnindependentpredictorofoutcomeTheconfoundingfactormustalsobeariskfactorforthedisease,butindependentlyfromexposure.
BiasandConfounding
32
![Page 33: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/33.jpg)
Controllingforconfounding
ByDesign
RandomisationAllconfounders(knownandunknown)aredistributedevenlybetweengroups.RestrictionRestrictsparticipantstoremoveconfounders.
ResultsinreducedgeneralisabilityanddoesnotcontrolallfactorsMatchingPairingofsimilarsubjectsbetweengroups.
Mayintroduceadditionalconfounding,andmatchingbymultiplecharacteristicsisdifficult
ByAnalysis
StandardisationAdjustfordifferencesbytransformingdata.StratificationAnalysethedatainsubgroupsforeachpotentialconfoundingfactor.
References1. Sackett,D.L.(1979).Biasinanalyticresearch.JournalofChronicDiseases32(1–2):51–63.2. PSMyles,TGin.Statisticalmethodsforanaesthesiaandintensivecare.1sted.Oxford:Butterworth-Heinemann,2001.3. StatsnotesfrommyMPh(UniversityofSydney).ProbablyaTimothySchlublecture,circa2014.
Lastupdated2019-07-18
BiasandConfounding
33
![Page 34: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/34.jpg)
FrequencyDistributionsandMeasuresofCentralTendencyDescribefrequencydistributionsandmeasuresofcentraltendencyanddispersion
FrequencyDistributions
Frequencydistributionsareamethodoftabulatingorgraphicallydisplayinganumberofobservations.
TheNormalDistribution
Thenormaldistributionisagaussiandistribution,wherethemajorityofvaluesclusteraroundthemean,andwhilstmoreextremevaluesbecomeprogressivelylessfrequent.
Thenormaldistributioniscommoninmedicinefortworeasons.
MuchofthevariationinbiologyfollowsanormaldistributionWhenmultiplerandomsamplesaretakenfromapopulation,themeanofthesesamplesfollowsanormaldistribution,evenifthecharacteristicbeingmeasuredisnotnormallydistributedThisisknownasthecentrallimittheorem.
Itisusefulbecausemanystatisticaltestsareonlyvalidwhenthedatafollowanormaldistribution
Theformulaforthenormaldistributionisgivenby:
FrequencyDistributions
34
![Page 35: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/35.jpg)
Fromthis,itcanbetseenthetwovariableswhichwilldeterminetheshapeofthenormaldistributionare:
μ(mu):Themeanσ(sigma):Thestandarddeviation
TheStandardNormalDistribution
Thestandardnormaldistributionisanormaldistributionwithameanof0andastandarddeviationof1.Theequationforthestandardnormaldistributionismuchsimpler,whichiswhyitisused.
Anynormaldistributioncanbetransformedtofitastandardnormaldistributionusingaztransformation:
Thevalueofzthengivesastandardisedscore,i.e.thenumberofstandarddeviationsformthemeaninastandardisedcurve.Thiscanthenbeusedtodetermineprobability.
Binomialdistribution
Whereobservationsbelongtooneoftwomutuallyexclusivecategories,i.e.:
If then
Ifthenumberofobservationsisverylargeandtheprobabilityofaneventissmall,aPoissondistributioncanbeusedtoapproximateabinomialdistribution.
MeasuresofCentralTendencyAsnotedaboveinthenormaldistribution,resultstendtoclusteraroundacentralvalue.Quantificationofthedegreeofclusteringcanbedoneusingmeasuresofcentraltendency,ofwhichtherearethree:
ModeThemostcommonvalueinthesample.MedianThemiddlevaluewhenthesampleisrankedfromlowesttohighest.
ThemedianisthebestmeasureofcentraltendencywhenthedataisskewedArithmeticmean
Theaverage,i.e:Themeaniscommonandreliable,thoughinaccurateifthedistributionisskewed.
MeasuresofDispersion
Measuresofvariabilitydescribethedegreeofdispersionaroundthecentralvalue.
BasicMeasuresofDeviation
FrequencyDistributions
35
![Page 36: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/36.jpg)
Range:ThelowestandhighestvaluesinthesampleHighlyinfluencedbyoutliersPercentiles:Rankobservationsinto100equalparts,sothatthemedianbecomesthe50%percentile.Bettermeasureofspreadthanrange.Interquartilerange:The25thto75thcentileAbox-and-whiskerplotgraphicallydemonstratesthemean,25thcentile,75thcentile,and(usually),the10thand90thcentiles.
OutliersarerepresentedbydotsOccasionallytherangeisplottedbythewhiskers,andtherearenooutliersplotted
VarianceandStandardDeviation
Varianceisabettermeasureofvariabilitythantheabovemethods.Variance:
Evaluateshowfareachobservationisfromthemean,andpenalisesobservationsmorethefurthertheyliefromthemeanSumsthesquaresofeachdifferenceanddividesbythenumberofobservationsi.e:
isused(insteadof )becausethemeanofthesampleisknownandthereforethelastobservationcalculatedmusttakenonaknownquantity
Thisisknownasadegreesoffreedom,whichisamathematicalrestrictionusedwhenusingonestatisticaltestinordertoestimateanotherItisaconfusingtopicbestillustratedwithanexample:
Youhavebeengivenasampleoftwoobservations(say,agesoftwoindividuals),andyouknownothingaboutthemThedegreesoffreedomistwo,sincethoseobservationscantakeonanyvalue.Alternatively,imagineyouhavebeengiventhesamesample,butthistimeItellyouthatthemeanageofthesampleis20Thedegreesoffreedomisone,sinceifItellyouthevalueofoneoftheobservationsis30,youknowthattheothermustbe10Therefore,onlyoneoftheobservationsisfreetovary-assoonasitsvalueisknownthenthevalueoftheotherobservationisknownaswell.
Differentstatisticaltestsmayresultinadditionallossesindegreesoffreedom.
StandardDeviation
Thestandarddeviationisthepositivesquarerootofthevariance.
Inasampleofnormaldistribution:
1SDeithersideofthemeanshouldinclude~68%ofresults2SDeithersideofthemeanshouldinclude~95%ofresults3SDeithersideofthemeanshouldinclude~99.7%ofresults
FrequencyDistributions
36
![Page 37: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/37.jpg)
StandarderrorandConfidenceIntervals
Standarderrorofthemeanis:
AmeasureoftheprecisionoftheestimateofthemeanCalculatedfromthestandarddeviationandthesamplesizeAsthesamplesizegrows,theSEMdecreases(astheestimatebecomesmoreprecise).Givenbytheformula:
Usedtocalculatetheconfidenceinterval
ConfidenceInterval
Theconfidenceinterval:
GivesarangeinwhichthetruepopulationparameterislikelytolieThewidthoftheintervalisrelatedtothestandarderror,andthedegreeofconfidence(typically95%):
Isafunctionofthesamplestatistic(inthiscasethemean),ratherthantheactualobservationsHasseveralbenefitsoverthep-value:
IndicatesmagnitudeofthedifferenceinameaningfulwayIndicatestheprecisionoftheestimateThesmallertheconfidenceinterval,themoreprecisetheestimate.AllowsstatisticalsignificancetobecalculatedIftheconfidenceintervalcrosses1,thentheresultisinsignificant.
References
1. "Normaldistribution".LicensedunderAttribution3.0Unported(CCBY3.0)viaSubSurfWiki.2. MylesPS,GinT.Statisticalmethodsforanaesthesiaandintensivecare.1sted.Oxford:Butterworth-Heinemann,20013. Coursenotesfrom"IntroductiontoBiostats",UniversityofSydney,SchoolofPublicHealth,circa2013.
Lastupdated2019-07-18
FrequencyDistributions
37
![Page 38: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/38.jpg)
SampleSizeCalculationDescribebias,typesoferror,confoundingfactorsandsamplesizecalculations,andthefactorsthatinfluencethem
Samples
Asampleisasubsetofapopulationthatwewishtoinvestigate.Wetakemeasurementsonoursamplewiththeaimtomakeinferencesonthegeneralpopulation.Anoptimalsample(inquantitativeresearch)willberepresentative,thatis,ithasthesamecharacteristicsofthepopulationitisdrawnfrom.
SamplingError
Duetochance,thesamplemeanwillnotequalthepopulationmean.Thisiscalledsamplingerror,andisaformofrandomerror.Alargersamplewillmorecloselyapproximatethepopulationmean,reducingrandomerrorleadingtomoreaccuratepointestimatesandnarrowerconfidenceintervals.
Thisiswhylargesamplesizesaredesirableinresearch.However,largerstudiesarealsomorecostlyandtimeconsumingtorun.Sample-sizecalculationsareperformedtofindahappymedium.
SampleSizeCalculation
Allsamplesizecalculationsdependon:
AcceptableriskofTypeIerror(α),typicallysetat0.05Asmallerα(lowerfalsepositiverisk)requiresalargersamplesize.AcceptableriskofTypeIIerror(β),typicallysetat0.20Asmallerβ(lowerfalsenegativerisk)requiresalargersamplesize.ExpectedeffectsizeAsmallereffectsizerequiresalargersamplesize,asthedifferencebetweengroupswillbesmallerandhardertodetect.PopulationvarianceAlargerpopulationvariancerequiresalargersamplesize,asthereismore'noise'inthesample.StudydesignCertaintrialdesigns(e.g.multiplearms)requirealargersamplesizeforagiveneffectsizeandpower.Practicalconsiderations
CostIncreasingsamplesizeincreasesthecostofastudy.ParticipantavailabilitySamplesizeislimitedwhenthenumberofeligibleparticipantsforastudyissmall(e.g.rarediseases)
Differentformulasforsamplesizecalculationsexistfordifferentstudies,andcanbeadjustedforparticularstudydesigns,suchasmultipleorunequalgroups.
References
1. MylesPS,GinT.Statisticalmethodsforanaesthesiaandintensivecare.1sted.Oxford:Butterworth-Heinemann,2001.2. Coursenotesfrom"IntroductiontoBiostats",UniversityofSydney,SchoolofPublicHealth,circa2013.
SampleSizeCalculation
38
![Page 39: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/39.jpg)
Lastupdated2017-09-22
SampleSizeCalculation
39
![Page 40: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/40.jpg)
StatisticalTestsDescribetheappropriateselectionofnon-parametricandparametrictestsandteststhatexaminerelationships(e.g.correlation,regression)
ParametricTests
Parametrictestsareusedwhendatais:
ContinuousandnumericalNormallydistributed
Rememberthatduetothecentrallimittheorem-largedatasets(n>100)aretypicallyamenabletoparametricanalysis,assamplemeanswillfollowanormaldistributionNon-normaldatacanbetransformedsothattheyfollowanormaldistribution
SamplesaretakenrandomlySampleshavethesamevarianceObservationswithinthegroupareindependentIndependentresultsarethosewhenonevalueisnotexpectedtoinfluenceanothervalue.
Acommonexampleisrepeatedmeasures:whenserialmeasuresaretakenfromapatientorahospital,theresultscannotbetreatedasindependentPairedtestsareusedwhentwodependentsamplesarecomparedUnpairedtestareusedwhentwoindependentsamplesarecompared
Testsmaybeone-tailedortwo-tailed:
Atwo-tailedtestevaluateswhetherthesamplemeanissignificantlygreaterorlessthanthepopulationmeanAone-tailedtestonlyevaluatestherelationshipinonedirectionThisdoublesthepowerofthetesttodetectadifference,butshouldonlybeperformedifthereisaverygoodreasonthattheeffectcouldonlyoccurinonedirection.
Commonparametrictestsinclude:
Ztest
Usedtotestwhetherthemeanofaparticularsample(x̄)differsfromthepopulationmean(μ)byrandomvariation.
Assumptions:
Largesamplen>100.DataisnormallydistributedPopulationstandarddeviationisknown
Student'sTTest
ThisisavariantoftheZtest,usedwhenthepopulationstandarddeviationisnotknown.
TheresultsfromTtestapproximatetheresultsoftheZtestwhenn>100
FTest
StatisticalTests
40
![Page 41: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/41.jpg)
Comparestheratioofvariances( )fortwosamples.IfFdeviatessignificantlyfrom1,thenthereisasignificantdifferenceingroupvariances.
AnalysisofVariance(ANOVA)
ANOVAtestsforsignificantdifferencesbetweenmeansofmultiplegroups,inamoreefficientmannerthanmultiplecomparisons(doinglotsofTtests).
ThereareseveraltypesofANOVAtestsusedindifferentsituations.
Non-ParametricTests
Non-parametrictestsareusedwhentheassumptionsforparametrictestsarenotmet.Non-parametrictests:
DonotassumethedatafollowsanyparticulardistributionThisisrequiredwhen:
Non-normalityisobviouse.g.Multipleobservationsof0Possiblenon-normalityTypicallysmallsamplesizes.Dataisordinal
Arenotaspowerfulasparametrictests(alargersamplesizeisrequiredtoachievethesameerrorrate)Aremorebroadlyapplicablethanparametrictestsastheydonotrequirethesameassumptions
Non-parametrictestsstillrequirethatdata:
IscontinuousorordinalWithin-groupobservationsareindependentSamplesaretakenrandomly
Ingeneral,non-parametrictests;
TakeeachresultandrankthemCalculationsarethenperformedoneachranktofindtheteststatistic
Commonnon-parametrictestsinclude:
Mann-WhitneyUTest/WilcoxonRankSumTest
AlternativetotheunpairedT-testfornon-parametricdata.
Process:
Datafrombothgroupsarecombined,ordered,andgivenranksTieddataaregivenidenticalranks,wherethatrankisequaltotheaveragerankofthetiedobservations
ThedataarethenseparatedintotheiroriginalgroupRanksineachgroupareaddedtogiveateststatisticforeachgroupAstatisticaltestisperformedtoseeifthesumofranksinonegroupisdifferenttoanother
WilcoxonSignedRanksTest
AlternativetothepairedT-testfornon-parametricdata.
Process:
StatisticalTests
41
![Page 42: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/42.jpg)
Asabove(fortheWilcoxonRankSumTest),exceptabsolutedifferencebetweenpairedobservationsarerankedThesign(i.e.positiveornegative)ispreserved.ThesumofpositiveranksisthencomparedwiththesumofnegativeranksIfthereisnodifferencebetweengroups,wewouldexpectthenetvaluetobe0
References1. MylesPS,GinT.Statisticalmethodsforanaesthesiaandintensivecare.1sted.Oxford:Butterworth-Heinemann,2001.
Lastupdated2017-09-22
StatisticalTests
42
![Page 43: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/43.jpg)
StatisticaltermsUnderstandthetermssensitivity,specificity,positiveandnegativepredictivevalueandhowtheseareaffectedbytheprevalenceofthediseaseinquestion
Describebias,typesoferror,confoundingfactorsandsamplesizecalculations,andthefactorsthatinfluencethem
Allthesetermsrefertocharacteristicsofdiagnostictests.Theeasiestwaytoapproachthisisviaa2x2table,andhasbeenrecommendedinpreviousexamsasanapproachtoquestionsonthistopic.
TypesofErrorDrawa2x2tableofdiseasestateversustestoutcome:
DiseasePositive DiseaseNegative Total
TestPositive TruePositives FalsePositives AllTestPositives
TestNegative FalseNegatives TrueNegatives AllTestNegatives
Total AllDiseasePositives AllDiseaseNegatives
TrueorfalsereferstowhetherthetestwascorrectPositiveornegativereferstothetestresult
ATypeIerrorisafalsepositive,whenweincorrectlyrejectthenullhypothesisThetypeIerrorratecanbedecreasedbydecreasingα
ATypeIIerrorisafalsenegative,whenweincorrectlyacceptthenullhypothesisThetypeIIerrorratecanbedecreasedbydecreasingβ,usuallyexpressedasincreasingpowerPoweristhechanceofdetectingadifferenceifitexists.Powerisequalto1-β.
SensitivityandSpecificity
Sensitivity
Sensitivityistheprobabilitythosewiththediseasetestpositive,i.e.thetruepositiverate,andexpressedmathematicallyas:
ItreferstotheabilityofatesttodetecttheconditionAhighlysensitivetestwilllikelybepositiveiftheconditionispresentTherefore,anegativeresultonasensitivetestgivesahighlikelihoodthediseaseisnotpresent
ThemnemonicforthisisSNOUT-Sensitive,Negative,ruleOUT
Specificity
Specificityistheprobabilitythosewithoutthediseasetestnegative,i.e.thetruenegativerate,andexpressedmathematicallyas:
ItreferstotheabilityofatesttodetectabsenceoftheconditionAhighlyspecifictestwilllikelybenegativeiftheconditionisnotpresent
StatisticalTerms
43
![Page 44: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/44.jpg)
ThereforeapositiveresultonaspecifictestgivesahighlikelihoodthediseaseispresentThemnemonicforthisisSPIN-Sensitive,Positive,ruleIN
PositiveandNegativePredictiveValues
PositiveandnegativepredictivevaluesdescribetheproportionoftestresultswhicharetrueAhighvalueindicatesaccuracyofthetestBecauseofhowtheyarederived,theyaredependentonpopulationprevalenceofthedisease
PositivePredictiveValue(PPV)istheprobabilitythatthediseaseispresentwhenthetestispositive:
NegativePredictiveValue(NPV)istheprobabilitythatthediseaseisabsentwhenthetestisnegative:
RememberingtheDifference
RotelearningtheseformulasishardRememberthat:
SensitivityandspecificityarethesameforanygivenprevalenceofdiseaseThereforetheylookatcolumns(diseasepositiveordiseasenegative).PPVandNPVarenotThereforetheylookatrows(testpositiveortestnegative).
LikelihoodRatiosTheweaknessofPPVandNPVastoolsofevaluatingtheutilityofatestinclinicalpracticeisthattheydonottakeintoaccountthepopulationprevalence,i.e.thepriorprobability,ofacondition.
AclassicexampleistheurinebHCG,whichhasahighpositivepredictivevalueforpregnancy.Testedonanexclusivelymalegrouphowever,thetruepositiveratewillbe0(sincetherearenopregnancies),andsoalltestpositiveswillbefalsepositives.
Therefore:
TheactualutilityofatestindecisionmakingisdependentuponthepriorprobabilityofthediseasebeingpresentLikelihoodRatiosrelatethepre-testoddstothepost-testoddsTheyareusefulbecause(unliketheabovevalues)theydonotassumethatthepatientyouareapplyingthemtoisidenticaltothesamplefromwhichthestatisticwasderived.Thelikelihoodratiomultipliedbythepre-testoddsgivesthepost-testoddsofthediseasebeingpresent
Apositivelikelihoodratioisusedwhenthetestispositive:
Anegativelikelihoodratioisusedwhenthetestisnegative:
References
StatisticalTerms
44
![Page 45: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/45.jpg)
1. MylesPS,GinT.Statisticalmethodsforanaesthesiaandintensivecare.1sted.Oxford:Butterworth-Heinemann,2001.2. Coursenotesfrom"IntroductiontoBiostats",UniversityofSydney,SchoolofPublicHealth,circa2013.
Lastupdated2019-11-02
StatisticalTerms
45
![Page 46: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/46.jpg)
RiskandOddsUnderstandtheconceptsofriskandOddsRatio
Risk
AbsoluteRiskistheriskofaneventoccurringintheexposedgroupRelativeRisk(orriskratio)istheriskofaneventoccurringintheexposedgrouprelativetotheunexposedgroup.
AbsoluteRiskReductionisthedecreaseinriskprovidedbyanexposure:
Isaclinicalusefulmeasureofthevalueofanintervention,howeverisbetterexpressedas:NumberNeededtoTreat(NNT)isthenumberofindividualswhomustreceiveatreatmenttopreventoneevent:
RelativeRiskReductionisthedecreaseinincidenceprovidedbytreatment.Itisnotasusefulameasureofthevalueofanintervention,butdrugcompanieslikeitbecausethenumbersarebiggerthanabsoluteriskreduction.
Odds
Oddsaretheprobabilityofaneventhappeningcomparedtotheprobabilityofitnothappening,usuallyexpressedasafractionTheOddsRatioistheratiooftheoddsoftheoutcomeoccurringintheexposedcomparedtotheoddsofitoccurringintheunexposed
AnOR<1suggeststheriskislowerintheexposedgroupAnOR>1suggeststheriskishigherintheexposedgroupAnOR=1suggeststhatthegroupsareequivalent
Ingeneral,theORoverstatesriskcomparedtotheRR.ItisapproximatelyequaltotheRRwhentheoutcomeisrare(<10%)Itisusedwhen:
Thedenominatorisuncertain,i.e.:Inretrospectivedesigns,suchascase-controlstudieswhenpatientswiththediseasewereidentified,andthenexposuresascertained
Whenitstatisticallyappropriate(ORsaremucheasiertouseinstatisticaltests),i.e.:MultivariateregressionSystematicReviews
RiskversusOdds
RiskandOdds
46
![Page 47: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/47.jpg)
RelativeRiskandOddsRatiosarebothmethodsofcomparingthelikelihoodofanoutcomeoccurringbetweentwogroups.Thedifference,andparticularlytheconceptofoddsratios,arecommonlyconfused.Relativerisktendsbemuchmoreintuitivethanoddsratios.Imagineatrialhasbeenperformed,wheregroupAwasexposedgroup:
IngroupA,themortalitywas50%IngroupB,themortalitywas25%
Therelativeriskisintuitive:
Theoddsratioisnot:
ARRof2isintuitive,buttheORof3isnot.Now,imagineanothertrialwhere:
IngroupA,themortalitywas90%IngroupB,themortalitywas10%
Therelativeriskis9,buttheORis81!
Sowhyuseoddsratiosatall?Oddsratiosare:
RequiredwhenresearchsubjectsareselectedonthebasisofoutcomeratherthanthebasisofexposureUsedbymanystatisticaltestsbecausethelogoddsratioisnormallydistributed,whichisamathematicallyusefulproperty
RelativeRiskhasaweaknessaswell-itisdependentonhowthequestionisframed.Usingthefirsttrialabove,wecalculatedthatRRfordeathwas2andtheORwas3.Ratherthancalculatingmortality,analternativemethodcouldbetolookatsurvival:
IngroupA,thesurvivalwas50%IngroupB,thesurvivalwas75%
Notethattherelativeriskisnot0.5(asyoumayinitiallyassume),howevertheoddsratioisjusttheinverseofthepreviousvalue.
References
1. MylesPS,GinT.Statisticalmethodsforanaesthesiaandintensivecare.1sted.Oxford:Butterworth-Heinemann,2001.2. Coursenotesfrom"IntroductiontoBiostats",UniversityofSydney,SchoolofPublicHealth,circa2013.3. SimonS.Oddsratiovs.relativerisk."Steve'sAttempttoTeachStatistics(StATS)".Children'sMercyHospital,2006.4. BlandJM,AltmanD.BlandJMartin,AltmanDouglasG.Theoddsratio.BMJ2000;320:1468.
Lastupdated2019-07-18
RiskandOdds
47
![Page 48: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/48.jpg)
RiskandOdds
48
![Page 49: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/49.jpg)
SignificanceTesting'Understandconceptofsignificanceandtestingofsignificance
Significancetestingis:
Theprocessofdeterminingwhetheradifferencebetweengroupsinastudyisduetoarealdifference,orchancealonePerformedusingp-valuesDoesnotimplyclinicalsignificanceForaresulttobestatisticallysignificant,theremustbea'real'differencebetweengroups.
Thisdifferencedoesnothavetobeclinicallymeaningfule.g.Adrugmayreliablycausea5mmHgdecreaseinSBP-thisisunlikelytocauseameaningfuldropincardiovascularmortalitybutmaybestatisticallysignificant
PValuesThep-valueistheprobabilityofobtainingasummarystatistic(e.g.amean)equaltoormoreextremethantheobservedresult,providedthenullhypothesisistrue.
Thep-valueiscommonly(mis)usedinfrequentistsignificancetesting.
Priortoperforminganexperiment,asignificancethreshold(α)isselectedTraditionally0.05(5%)or0.01(1%)Thesevaluesdefinethe"false-positiverate".
Whenmultipletestsarebeingperformedononesetofdata,thechanceofafalse-positivewillincreaseToreducethechanceofafalsepositiveoccurring,thesignificancethresholdforeachtestcanbereduced.OnemethodofthisistheBonferronicorrection,whereαisdividedbythenumberoftestsbeingperformed.
Thentheexperimentisperformed,andavalueforpiscalculatedIfp<α,itsuggeststhattheresultsareinconsistentwiththenullhypothesis(atthatsignificancelevel),anditshouldberejected.
ProblemswithP-values
P-valuesare,whenemployedcorrectly,areuseful.However,theydohaveseveralweaknesses:
AssumethenullhypothesisistrueThep-valueassumesthatthereisnorealdifferencebetweengroups.
ThismaynotbethecaseNotallhypothesesarecreatedequalTheremaybesignificantpriorevidencesupporting(orrefuting)H -thiswillbeignoredwheninterpretingap-value.
Anystudywithsignificantresultsmustthereforebeinterpretedinthecontextof:BiologicalplausibilityofthoseresultsThepreviousevidenceonthetopic
Itisacommonmisconceptionthatthep-valueestimatesthechancethattheresultistrueThisisnotthecase.Thep-valuemeasureshowinconsistenttheobservedresultsarewiththenullhypothesis.
Athresholdof0.05isnotalwaysappropriateThecostofbeingwrongmustbeincludedwheninterpretingap-value.Ifthisisatrueresult,whatarethepotentialbenefits?Ifthisisafalsepositive,whatarethepotentialharms?
VulnerabletomultiplecomparisonsConductingrepeatedanalyseswilleventuallyfinda'significant'result.Atanαof0.05,wewouldexpect1/20analysestobe
A
SignificanceTesting
49
![Page 50: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/50.jpg)
afalsepositive.Conducting20analyseswouldthereforegenerateonefalsepositiveresult.
DoesnotquantifyeffectsizeAsignificantp-valuesimplysuggestsadifferenceexists,itdoesnotmeasurehowbigthisdifferenceis.
Aresultmaybestatisticallysignificantbutclinicallyunimportant,e.g.anantihypertensivemedicationcausingadecreaseinSBPby2mmHgmaybestatisticallysignificant,butclinicallyunimportant.
Relatedtosamplesizep-valuesareaffectedbysamplesize:Alargeeffectsizemaybehiddenbyaninsignificantp-valueifsamplesizeissmallSimilarly,atinyeffectsizemaybedetected(i.e.asignificantp-value)ifsamplesizeislarge
DoesnotaccountforbiasLikeotherstatisticaltest,thep-valuecannotaccountforbiasorconfounding.
References
1. WassersteinRL,LazarNA.TheASA'sStatementonp-Values:Context,Process,andPurpose.TheAmericanStatistician.2016vol:70(2)pp:129-133.
Lastupdated2019-07-18
SignificanceTesting
50
![Page 51: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/51.jpg)
DrugApprovalandDevelopmentDescribetheprocessesbywhichnewdrugsareapprovedforresearchandclinicaluseinAustralia,andtooutlinethephasesofhumandrugtrials(PhaseI-IV)
DrugApproval
TheTherapeuticGoodsAdministration(TGA)approvesmedicineforbothresearchandclinicaluseinAustralia.
Research
Drugtrialsareapprovedforresearchpurposesundertwoschemes:
1. ClinicalTrialsExemptionDrugsmustbeevaluatedbyanexpertcommitteetoevaluateallaspectsofpharmacology,toxicology,mutagenicity,teratogenicity,organdysfunction,andotherside-effects.
2. ClinicalTrialsNotificationAdrugwhichhasbeenapprovedinanothernationwithsimilarlystringentrequirements(NewZealand,Netherlands,UK,Sweden,US)maybeusedinatrialwithoversightbyalocalethicscommittee.
ClinicalUse
TheTGAclassifiesmedicinesinto:
RegisteredMedicinesAssessedbytheTGAforquality,safety,andefficacy.
Allprescription(high-risk)medicines.Assessedon:Quality
CompositionofdrugsubstanceBatchconsistencyStabilitydataSterilitydata(ifapplicable)Impurities
Non-clinicalPharmacologydataToxicologydata
ClinicalEfficacy:resultsofclinicaltrials
MostOTC(low-risk)medicinesSomecomplementarymedicines
ListedMedicinesAssessedbytheTGAforquality,safety,butnotefficacy.
SomeOTCmedicinesMostcomplementarymedicines
PhasesofDrugDevelopment"Phase0"
Pre-clinicalR&D
DrugDevelopment
51
![Page 52: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/52.jpg)
InvitroandanimaltestingPhaseI
FirstadministrationinhumansBasicpharmacokineticandtoxicologydata20-100humansubjects
PhaseIIAdministrationtoselectpatientgroupsAimtoestablishdose-responsecurveEvidenceofefficacy
PhaseIIIFull-scaleevaluationofbenefits,potentialrisksandcostsanalysis2000-3000patients,usuallytreatedingroupsofseveralhundredforrelativelyshortdurations(3-6months),regardlessofthelengthoftimethedrugwillbeusedinpracticeMaynotrevealuncommonorlong-termrisks
PhaseIVPost-marketingsurveillance
References1. PSMyles,TGin.Statisticalmethodsforanaesthesiaandintensivecare.1sted.Oxford:Butterworth-Heinemann,2001.2. MedicinesandTGAclassifications.TherapeuticGoodsAdministration.Availableat:https://www.tga.gov.au/medicines-and-
tga-classifications3. ChrisAnderson.PharmaceuticalAspectsandDrugDevelopment.ICUPrimaryPrep.
Lastupdated2017-09-16
3
DrugDevelopment
52
![Page 53: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/53.jpg)
AdditivesDescribethemechanismsofactionandpotentialadverseeffectsofbuffers,anti-oxidants,anti-microbialandsolubilizingagentsaddedtodrugs
Additivesarecomponentsofadrugpreparationwhichdonotexertthepharmacologicaleffect.
Additivesinclude:
PreservativesBenzylalcohol
Antimicrobialwhen>2%Canbeusedasasolventwhen>5%Toxic
AntioxidantsSulfites
HypersensitivityNeurotoxicifgivenintrathecally
SolventsWaterAppropriatefordissolvingpolarmolecules.Non-aqueoussolventsUsedtodissolvenon-polarmolecules,ortoproducemorestablepreparationsofsemi-polarmolecules.Examplesinclude:
PropyleneglycolHypotensionArrhythmiaWithrapidinjection.PainoninjectionThrombophlebitis
MannitolDiuresis
SoybeanoilPainoninjectionAllergy
EmulsionFormedwhendropsofaliquidaredispersedthroughoutanotherliquidinwhichitisimmiscible.Emulsionsare:
UnstableEmulsifiersareusedtoenhancestability.PronetocontaminationDuetothewatercomponent.PronetorancidityDuetotheoilcomponent.
BuffersMaintainpHinaparticularrangeinorderto:
MaximisestabilityPreserveshelflife.Maintainsolubility
Pharmacology
53
![Page 54: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/54.jpg)
Maximisepreservativefunction
References1. MacPhersonRD.Pharmaceuticsfortheanaesthetist.Anaesthesia.2001Oct;56(10):965-79.2. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.
Lastupdated2019-07-18
Pharmacology
54
![Page 55: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/55.jpg)
IsomerismDescribeisomerismandprovideexamples
Isomerismdescribesgroupsofcompoundswhichhavethesamechemicalformulabutdifferentchemicalstructures.Isomerismisrelevantbecausedifferentisomersmayhavedifferentenzymaticandreceptoraffinities,alteringtheirpharmacokineticandpharmacodynamicproperties.
TypesofIsomerism
Isomerscanbedividedinto:
StructuralIsomersIdenticalchemicalformulabutdifferentarrangementofatoms.Structuralisomerismissubdividedinto:
StaticFurthersubdividedinto:
ChainisomerThecarbonskeletonvaries,butpositionoffunctionalgroupsisstatic.PositionisomerThecarbonskeletonisstatic,butthepositionoffunctionalgroupsvaries.
e.g.Isofluranevs.enfluraneDynamic(alsoknownastautomer)Themoleculeexistsinadifferentmolecularstructuresdependingontheenvironment.
e.g.MidazolamhaspHdependentimidazoleringopening.WhenthepHislessthan4theringremainsopen,maintainingwatersolubility.MidazolamissuppliedatpHof3.5,andsoiswatersolubleoninjectionbut(duetoitspKaof6.5)becomes89%unionisedatphysiologicalpHthereforeabletocrosslipidmembranes.
StereoisomersAtomsareconnectedinthesameorderineachisomer,butdifferentorientationoffunctionalgroups.Stereoisomersarenotsuper-imposable,meaningthedifferentisomerscan'tberotatedsothattheylookthesame.Stereoisomersaredividedinto:
GeometricIsomersHaveachemicalstructure(e.g.acarbon-carbondouble-bond)preventsfreerotationofgroups,sodifferentlocationsofchemicalgroupswillcreateanisomer.Geometricisomersareknownascis-ortrans-dependingonwhetherthesubgroupsareonthesameoroppositesides(respectively)ofthechemicalstructure.
e.g.AtracuriumOpticalIsomersOpticalisomersarechiral.Thismeanstheyhavenoplaneofsymmetry.Opticalisomers:
Wereinitiallynamedbasedonhowtheyrotatedunderpolarisedlight:(NotethisisdifferentfromD-andL-molecules,wheretheD-isomerreferstothemoleculesynthesisedfrom(+)glyceraldehyde).
Dextrorotatory(d-or(+)isomers)moleculesrotateclockwiseunderpolarisedlight.Levorotatory(l-or(-)isomers)moleculesrotatecounter-clockwiseunderpolarisedlight.
Unfortunately,differentmoleculeswerefoundtorotateindifferentdirectionsdependingonthetemperature.Therefore,adifferentclassificationscheme(R/S)isalsoused:
Basedonchemicalstructure"Priority"isassignedtoeachatominthestructureHighestpriorityisusuallythosewiththehighestmolecularweight,butotherrulesexistforambiguousorvery
Isomerism
55
![Page 56: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/56.jpg)
largemoleculesThemoleculeisarrangedinspacesuchthatthelowestpriorityatomisfacing"away"Anarrowisthendrawnfromthehighestprioritytothelowerpriorityatoms:
IfthisarrowtravelsclockwiseitistheR(Rectus)isomerIfthisarrowtravelscounter-clockwiseitistheS(Sinister)isomer
Opticalisomersaredividedinto:EnantiomersPossessonechiralcentre.
e.g.levobupivacaineislesscardiotoxicthanracemicbupivacaine.DiastereoisomersPossessmultiplechiralcentres,andmayhavemultiplestereoisomers.Sincenotallaremirrorimages,thesearenotenantiomers.
Foramoleculewithnchiralcentresupton isomersarepossible,thoughsomeofthesemaybeduplicates.
Preparations
Drugscanbeprovidedas:
RacemicsolutionsAracemicsolutionisonewhichwherethedifferentenantiomersarepresentinequalproportions.
EnantiopurepreparationsAdrugproducedwithasingleisomer,whichmaybemoreefficaciousorlesstoxic(anddefinitelymoreexpensive)thantheracemicpreparation.
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. CICM.TheMockExam.3. ChemGuide.Geometricisomerism4. ChEBI.Misoprostol.EuropeanMolecularBiologyLaboratory.5. ANZCAJuly/August20006. DayJ,ThomsonA,McAllisterT.GetThroughPrimaryFRCA:MTFs.2014.Taylor&FrancisLtd.
Lastupdated2019-07-18
2
Isomerism
56
![Page 57: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/57.jpg)
ModelingExplaintheconceptofpharmacokineticmodelingofsingleandmultiplecompartmentmodels.
Pharmacokineticsdescribeswhatthebodydoestoadrug.Pharmacokineticmodelsaremathematicalconceptsusedtopredictplasmaconcentrationsofdrugsatdifferenttimepoints.
BasicPharmacokineticTerms
Keyconceptsinpharmacokineticsinclude:
Volumeofdistribution,VThevolumeofdistributionisdefinedasthetheoreticalvolumeintowhichanamountofdrugwouldbedistributetoproducetheobservedplasmaconcentration.
Unitsareml.kg
Itisawaytodescribewhatproportionofadrugisconfinedtoplasma,andwhatproportiondistributestoothertissuesItdoesnotcorrespondtoanyparticularvolume,howeveraV of:
Lessthan40ml.kg indicatesadrugisconfinedtoplasmaUpto200ml.kg indicatesadrugisconfinedtotheECFUpto600ml.kg indicatesadrugisdissolvedintotheTBWGreaterthan1L.kg indicatesadrugishighlyproteinboundorlipophilicAgentswhichcrossthebloodbrainbarriertypicallyhaveaV of1-2L.kg .
SubtypesofthevolumeofdistributionareusedtodescribedrugdistributionatdifferenttimesorwithdifferentmodelsTheseinclude:
VVolumeofcentralcompartment.V ssVolumeofdistributionatsteadystate.V peVolumeofdistributionatpeakeffect.
Whichvolumetousedependsonthepharmacologicalquestione.g.IntubatingdoseforopioidshoulduseavolumebetweenV (verysmall)andV ss(verylarge)-V peisidealasitwillallowatargetconcentrationtobeselectedforthetimeatwhichintubationwilloccurrelativetodrugadministration
Half-life(t )Thetimeittakesforaprocesstobe50%complete.Withrespecttodrugclearance,itisthetimeittakesforconcentration(typicallyinplasma)tofallby50%.
Aprocessisconsideredtobecompleteafter4-5half-livesConcentrationwilldecreaseby50%aftereachhalf-life,soafter5half-livesconcentrationwillbe3.125%ofitsstartingvalue.
Thisalsoappliestowashin-itwilltake~4-5eliminationhalf-livesofadrugforaconstant-rateinfusiontoreachitsfinalconcentration
Half-lifeismathematicallyrelatedtomanyotherkeypharmacokineticterms:
,where:isthetimeconstant
D
-1
D-1
-1-1
-1
D-1
1
D
D
1 D D
1/2
Pharmacokinetics
57
![Page 58: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/58.jpg)
istherateconstantforelimination
isthevolumeofdistribution
istheclearanceVarioustypesofhalf-lifearedescribed:
t αdescribestherapidityofthedistributionphasefollowingdrugadministrationt βdescribestherapidityoftheeliminationphaseoccurringafterdrugdistributionequilibriumThisonlyevaluatesclearancefromplasma,andsoisacompositeofbothexcretionfromthebody(e.g.renalandhepaticclearance)andongoingdistributiontoperipheraltissues.
Theeliminationhalf-lifeisgenerallynotusefultopredictdrugoffset,asthisisaffectedbymanyfactorsHowever,itdoessetanupperlimitonhowlongitwilltakeplasmaconcentrationtofallby50%.
Time-constant( )Thetimetakenforaprocesstocompleteifitcontinuedatitsinitialrateofchange.Timeconstantsarerelatedtohalf-life,butarebettersuitedwhenmodelingchangeinexponentialprocesses.
TimeconstantsarediscussedinmoredetailunderrespiratorytimeconstantsEliminationwillbevirtuallycompleteafterthreetimeconstants
Atimeconstantistheinverseoftherateconstantforelimination,i.e.Illustrationoftherelationshipbetweenhalf-lifeandtimeconstant:
ClearanceTheclearanceisvolumeofplasmacompletelyclearedofadrugperunittime.
Inaonecompartmentmodel,thiscanbeexpressedas: inml.min .
Asthetimeconstantistheinverseofk,clearancecanalsobeexpressedas:
Since and areconstants,clearanceisalsoaconstantTotalclearanceisasumoftheclearanceofeachindividualclearanceorgan
RateofeliminationAmountofdrugremovedbythebodyperunittime.
Rateofeliminationistheproductoftheclearanceandthecurrentconcentration:
,inmg.minThisisnottherateconstantforelimination
CompartmentalModeling
Thesimplestmodelimaginesthebodyasingle,well-stirredcompartment.
1/21/2
-1
-1
Pharmacokinetics
58
![Page 59: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/59.jpg)
Inaonecompartmentmodel,theconcentrationofadrug( )attime isgivenbytheequation:
Where:
istheconcentrationattime0Asdrugcanonlybeeliminatedfromthecompartment,thisisalsothepeakconcentration.kistherateconstantforeliminationThisisthefractionoftheVdfromwhichthedrugisremovedperunittime.Therateconstantdeterminestheslopeofthecurve.
Ahighrateconstantforeliminationresultsinasteepcurveandthereforeashorttimeconstant
Steadystate
Atsteadystate,inputisequaltooutput.Thereforeconcentrationatsteadystateis:
ProportionaltotheconcentrationoftheinfusionandinfusionrateInverselyproportionaltotheclearance:
ConcentrationofdrugcanthereforebedeterminedbytheamountinfusedandtheclearanceNotesteadystaterequiresperipheralcompartmentstobesaturated,andsowillonlyoccurafteraninfusionofmanyhours
MultipleCompartmentModels
ModelswithmultiplecompartmentshaveabetterfitwithexperimentaldatathansinglecompartmentmodelsThree-compartmentmodelsaretypicallyused,asadditionalcompartmentstypicallyoffernoextrafidelitybutaremathematicallymorecomplexAthree-compartmentmodelcanbeconceptualisedasaplasma(orcentral)compartment,awell-perfusedcompartment,andapoorly-perfusedcompartmentThisdoesn'tmeanthattheyshouldbethoughtofinthisway-theyareamathematicaltechniqueusedtocalculateplasmaconcentrationatagiventime.
Pharmacokinetics
59
![Page 60: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/60.jpg)
Plasmaconcentrationinmulti-compartmentmodelsis:
PredictedthroughtheneteffectofseveralnegativeexponentialequationsxThisiscoveredundertwo-compartmentmodelsbelow.Dependentontheeffectsof:
DistributionDistributiondescribesthemovementofdrugfromthecentralcompartment(V )totheperipheralcompartment(s).
RapidfallinplasmaconcentrationofadrugafteradministrationisgenerallyduetodistributionDistributionisanimportantmethodfordrugoffsetinshort-actingdrugs.
RedistributionRedistributionreferstothemovementofdrugfromtheperipheralcompartment(s)backintoplasma.
DrugswhichhavealargeV inaperipheralcompartmenttendtodistributequicklyalongthisconcentrationgradient,andredistributeslowlybackintoplasmaDrugswhichtendtodistributeslowlytendtoredistributequicklyonceadministrationhasceased
ExcretionExcretionistheremovalofdrugfromthebody.
ClearanceinTwo-CompartmentModels
Removalofdrugintwo-compartmentmodelsisvia:
DistributionfromthecentraltotheperipheralcompartmentEliminationfromthecentralcompartmentThisproducesabi-exponentialfallinplasmaconcentrationConsistsoftwophases:
PhaseαDistributionphase:Arapiddeclineinplasmaconcentrationduetodistributiontoperipheraltissues.PhaseβEliminationphase:Slowdeclineinplasmaconcentrationdueto:
EliminationfromthebodyRedistributionintoplasma
1
D
Pharmacokinetics
60
![Page 61: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/61.jpg)
Thiscurveisgivenbytheequation ,where:
istheconcentrationofdruginplasma
isthey-interceptofthedistributionexponentUsedtocalculatedistributionhalf-life.
isthey-interceptoftheeliminationexponentUsedtocalculateeliminationhalf-life.istherateconstantfordistribution
Thevalueof isdependentontheratioofrateconstantsfordistributionandredistribution(i.e. ).Ifdistributiongreatlyexceedsredistribution,thegradientof willbeverysteepandplasmaconcentrationwillfallrapidlyafteradministration
istherateconstantforelimination
Notethatthedistributionandeliminationcurvesappearstraightbecausethey-axisislog-transformedIfplasmaconcentrationwasplottedonthey-axis,theneachofthesecurveswouldbeanegativeexponential(wash-outcurve)
EffectSite
Pharmacokineticmodelstypicallydisplaytheplasmaconcentration.
Clinicallyhowever,weareinterestedindrugconcentrationsatthesiteofaction(e.g.thebrain)Concentrationattheeffectsite(alsoknownasbiophase)isgivenbyCe
Thiscannotbemeasured,andsoisacalculatedvalueEffectsiteconcentrationbedifferentfromplasmaconcentration(Cp)priortoreachingsteadystateThedelaybetweenplasmaandeffectsiteconcentrationsisanexampleofhysteresis.
Theeffectsitecanbemodeledasanadditionalcompartmentinthree-compartmentmodelsTheeffectsiteismodeledasacompartmentofnegligiblevolumecontainedwithinV ,butdoeshaverateconstants
EffectsitevolumechangesasV changesThek istherateconstantfordrugdiffusionfromplasmaintotheeffectsiteThek istherateconstantforeliminationofdrugfromtheeffectsiteThisisatheoreticaleliminationpathway-drugisnotusuallymetabolisedattheeffectsite.
Thet ke0describestheeffect-siteequilibrationtimeItdescribeshowrapidlytheeffectsitereachesequilibriumwithplasma.
Alargeke0(rapiddrugflow)givesashortt ke0Afteronet ke0,50%ofthefinaleffectsiteconcentrationwillbereachedprovidedplasmaconcentrationremainsconstant
Ashortert ke0indicatesthatthattheeffectsiteconcentrationwillreachequilibriumwithplasmamorerapidly,andthereforeamorerapidclinicaleffectfollowingadministrationisseenNotethat:
Thet ke0isnotthetimetopeakeffectNeitherisk
Foraninfusionrunatconstantplasmaconcentrationthepeakeffectwillbeseenat3-5xthet ke0Thetimetopeakeffectisafunctionofbothplasmakineticsandthet ke0
e.g.adenosinehassuchashorteliminationt
11
e1e0
1/2
1/21/2
1/2
1/2e0
1/21/2
1/2theeffectsiteconcentrationwillreachitspeakrapidlyregardlessoftheke0
Pharmacokinetics
61
![Page 62: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/62.jpg)
Non-CompartmentalModels
Compartmentmodelsarenotappropriatefordescribingthebehavioursofalldrugs.Non-compartmentalmodelsareusedwhendrug:
Clearanceisorgan-independentEliminationdoesnotoccursolelyfromthecentralcompartment
ThesemodelsuseAUC,whichiscalculatedbymeasuringtheplasmaconcentrationofadrugatdifferenttimeintervals,andplottingtheareaunderthecurve(AUC).Thiscanbeusedto:
Determineclearance
DetermineBioavailabilityDifferencebetweentheAUCofthesamedoseofdrugadministeredIVandviaanotherroute.
Footnotes
Theformulaforhalf-lifecanbederivedfromtheequationforawash-inexponentialasfollows:
Washinexponentialisgivenby:
canthenbesubstitutedandtheequationsolvedfor asfollows:
References
Pharmacokinetics
62
![Page 63: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/63.jpg)
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. PlasmaVolume.Mosby'sMedicalDictionary,8thedition.2009.3. StanskiRD,ShaferSL.TheBiophaseConceptandIntravenousAnesthesia.4. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.
Lastupdated2019-07-18
Pharmacokinetics
63
![Page 64: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/64.jpg)
AbsorptionDescribeabsorptionandfactorsthatwillinfluenceit.
Absorptionisdependentontherouteofadministration.Routesofadministrationareselectedbasedon:
EffectsiteofthedrugDrugfactors
BioavailabilityAvailablepreparations
PatientfactorsAbilitytotakeorabsorboralmedicationsPreference
KeyConceptsBioavailabilityistheproportionofdruggivenwhichreachesthesystemiccirculationunchanged,comparedtotheIVform.Itisaffectedby:
FormulationPhysicochemicalInteractionsInteractionswithotherdrugsandfood.PatientFactors
MalabsorptionsyndromeGastricstasis
First-passmetabolism
First-pass(pre-systemic)metabolismistheextenttowhichdrugconcentrationisreducedafteritsfirstpassagethroughanorgan,priortoreachingthesystemiccirculation.Firstpassmetabolismis:
Typicallyusedwhenreferringtopassageoforally-administereddrugsthroughtheliverMayalsorefertometabolismbythe:
LungsFirstpassofintravenouslyinjecteddrugspriortoenteringthearterialsideofthecirculation,e.g.fentanyl.Vascularendothelium
Relevantin:UnderstandingdifferencesbetweenPOandIVdosing
AlternativeroutesofadministrationfordrugswithlowPObioavailabilityDeliveryofprodrugsviaPOmechanismsIncreasesactivedrugconcentration.UnderstandingenzymeinteractionsUnderstandingtheeffectsofhepaticdisease
Porto-systemicshuntsdecreasefirstpassmetabolismAlteredbioavailabilityofdrugswithhighhepaticextractionratios
Routesofadministration
Intravenous
RapidOnset
Absorption
64
![Page 65: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/65.jpg)
100%bioavailabilitySomedrugsmaystillundergometabolisminthepulmonarycirculation,suchasfentanyl,lignocaine,propofol,andcatecholamines.
Oral
Absorptionisthroughgutmucosa,througheither:TransportmechanismsUnionised(lipidsoluble)
AcidicdrugsareabsorbedmorerapidlyinthestomachThesmallbowelabsorbsbothacid(despitebeingionised)andalkalinedrugsduetohighsurfacearea
Lowestbioavailabilityofanyroutedueto:First-passmetabolismGutmetabolismofdrugsBacterialmetabolismofdrugs
Drugsmustbelipidsolubleenoughtocrosscell-membranesandwatersolubleenoughtocrossinterstitium
FactorsaffectingGITAbsorption
DrugFactorsMolecularWeightConcentrationGradientLipidSolubility
pHandpKaPharmaceuticalPreparationPhysiochemicalInteractions
FoodOtherdrugs
PatientFactorsGITbloodflowSurfaceArea
SmallbowelhasthelargestsurfaceareaofanyGITorganpHMotilityDigestiveEnzymesGITbacteriaandsubsequentmetabolismDisease
CriticalIllnessBowelObstructionEmesis/Diarrhoea
Epidural
MaybeviabolusorinfusionOnsetdeterminedbyproportionofunioniseddrugavailableLignocainehasamorerapidepiduralonsetthanbupivacaineasithasapKaof7.9(comparedto8.4)andthereforeagreaterunionisedportionatphysiologicpH.
Additionalfactorsincludeadditivesandintrinsicvasoactivepropertiesofthedelivereddrug
Subarachnoid/Intrathecal
Absorption
65
![Page 66: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/66.jpg)
VerysmalldosingMinimalsystemicspreadExtentofsubarachnoidspreadisdependentonvolumeandtypeofsolutionAppropriatepositioningofthepatient,withhigher-specificgravitysolutions,isrequiredtoavoidsuperiorspreadoftheblockAdditionalfactorsincludeadditivesandintrinsicvasoactivepropertiesofthedelivereddrug
Inhalation
SystemicabsorptiondependentonparticlesizeLargeparticlesreachthebronchioles<1microndiameterparticlesmayreachthealveolus
Rapiddiffusiontocirculationduetohighsurfaceareaandnofirst-passmetabolism
Transdermal
Systemicabsorptiondependenton:Doserequirement
LargedoserequirementscannotbeeffectivelygiventransdermallyFickPrinciple
AmountofdruggivenAmountofdruginskin
RegionalbloodflowHistaminerelease
SurfaceAreaSkinthicknessLipidsolubility
pHofskinandemulsionpKaofdrug
MolecularweightAdvantages
ConvenientPainlessNofirstpassmetabolismSteadyplasmaconcentrationonceestablished
DisadvantagesSlowonsetVariableplasmaconcentrationinitiallyOverdoseandabusepotentials
Subcutaneous
Absorptiondependentonregionalbloodflow
Sublingual
RapidonsetBypassportalcirculation(drainsintoSVC)
Rectal
Variableabsorption
Absorption
66
![Page 67: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/67.jpg)
DistalrectalabsorptionbypassesportalcirculationProximalrectalabsorptiondoesnotandmayresultinhepaticfirstpassmetabolismSmallsurfaceareaforabsorption
Intramuscular
Bioavailabilitycloseto1AbsorptiondependentonregionalbloodflowPotentiallocalcomplications:
AbscessHaematoma
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. ChongCA,DennyNM.Localanaestheticandadditivedrugs.3. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.
Lastupdated2019-07-18
Absorption
67
![Page 68: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/68.jpg)
DistributionDescribefactorsinfluencingthedistributionofdrugs.
Drugdistributionisdependentonmanyfactors,allofwhichcanberelatedtoFick'sLawofDiffusion:
Concentrationgradient
Tissuemass
MolecularWeightLargermoleculesarelessabletocrosscellmembranes,andsoagreaterportionwillremaininthecompartmenttheyaredeliveredto.
LipidSolubility
IonisationIoniseddrugsarepolar,andsoarelesslipidsoluble.
Ionisationisafunctionof:pKaThepKaisthepHatwhichaweakacidorweakbasewillbe50%ionised.
AssolventpHchanges,theproportionofionisedvs.unioniseddrugwilldifferHowdependsonwhetherthedrugisanacidorbase:
BasesareionisedBelowtheirpKaAcidsareionisedAbovetheirpKa
pHIncombinationwithpKa,affectstheionisedportion.
Unioniseddrugs:CrosscellmembranesmorereadilythantheionisedformAretypicallyhepaticmetabolisedAretypicallynotrenallyeliminated
Ioniseddrugs:AretypicallyrenallyexcretedwithoutundergoingmetabolismArepoorlylipidsolubleanddonotcrosscellmembranesreadilyMaybeiontrappedThisoccurswhenanunioniseddrugmovesacrossamembraneandbecomesionisedduetoachangeinpH.Thenow-insolubledrugistrappedinthenewcompartment.Thisisrelevantin:
PlacentaFoetalpHislowerthanmaternalpH,whichcantrapbasicdrugs(e.g.LA,opioids)infoetus.
ThisbecomesmoresignificantwithagreaterdivergenceofpH(e.g.placentalinsufficiency)RenaleliminationUrinaryalkalinisationisusedtoaccelerateeliminationofacidicdrugs,astheybecomeionisedandtrappedinurine.
Distribution
68
![Page 69: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/69.jpg)
ProteinbindingProteinsanddrugsmaybeboundtogetherbyweakbonds.Theseincludeionicbonds,vanderWaal'sforces,andhydrogenbonds.
Drugsmaybindtoproteinsin:Plasma
AlbuminBindsacidandneutraldrugs.
HighcapacityTwomajorbindingsites(sixtotal)
SiteI(warfarin)SiteII(diazepam)
α1-acidglycoproteinBindsbasicdrugs.
SinglebindingsiteLowcapacityTypicallyresultsinlowertotalbinding(comparedtoalbumin)ofalkalinedrugs,despiteitsincreasedaffinity.
LipoproteinForlipidsolubledrugs.
TissueReceptor
Proteinbindingisimportantas:Onlyunbounddrugsareableto:
CrosscellmembranesInteractwithreceptorsUndergometabolismReducedproteinbindingincreasesclearanceofdrugswithlowextractionratios.Befilteredbythekidney
Highlytissuebounddrugs:HavealongdurationofactionHaveahighvolumeofdistribution,prolongingtheireliminationMaybuildupintissues,leadingtoadverseeffectse.g.Cornealdeposition,lungfibrosis.
Proteinbindingisaffectedby:Affinityofdrugforprotein
IoniseddrugsdonotbindtoproteinpH.Competitionbetweendrugsforbindingsites
AmountofproteinDisease
Distribution
69
![Page 70: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/70.jpg)
Dueto:HypoalbuminaemiaNegativeacutephasereactant.Increasedα1-acidglycoproteinAcutephasereactant.
CompetitionSourceofpharmacokineticinteractions.
Proteinbindingtypically:CorrelateswithlipidsolubilityIsimportantonlywhenitisveryhighResultsinadecreasedV whenplasmabindingishighResultsinanincreasedV whentissuebindingishighIsimportantindurationofactionasitalsorelatestoaffinityfortissueproteins
RegionalbloodflowAffectsconcentrationgradientsbetweenbloodandtissue,andisaffectedbycardiacoutput.Regionsinclude:
VesselRichGroupBrainHeartLiverKidneys
VesselPoorGroupConnectivetissue
BonesLigamentTeethHair
MusclegroupsFat
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.
Lastupdated2019-07-18
DssDss
Distribution
70
![Page 71: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/71.jpg)
MetabolismDescribethemechanismsofdrugclearanceandmetabolism.
Removalofdrugfromthebodyrequireseither:
MetabolismofactivedrugtoaninactivesubstanceTypicallybytheliver,butotherorgans(kidney,lungs)alsometabolisesomesubstances.ExcretionofactivedrugOftenbythekidneys,butmayalsobeinbile,orexhaled.
Removalofdrugsfromthebodyisachievedpredominantlythroughrenalexcretionofwater-solublecompoundsAsmanydrugsarelipophilic,metabolismtowatersolublecompoundsisrequiredtocleardrugsfromthebody
ClearanceClearancedescribestheeliminationofdrugfromthebody.Clearanceis:
ThevolumeofplasmacompletelyclearedofadrugperunittimeMeasuredinml.min .
DiscussedfurtherinmodelingDoesnotincluderedistributionIscalculatedfromtheareaundertheconcentrationtimecurve:
Totalclearanceisthesumofclearancesfromindividualorgans,e.g.:
,where:
,where:
isurineconcentrationinmmol.LFunctionofglomerularfiltration,reabsorption,andsecretion.
istheurineflowinml.min
istheplasmaconcentrationinmmol.L
,where:
isthehepaticbloodflowinml.min
istheextractionratio
Kinetics
Drugclearancecanfolloweitherfirstorderorzero-orderkinetics:
First-orderKineticsAconstantproportionofthedruginthebodyiseliminatedperunittime.
Mostdrugsareeliminatedbyfirstorderkinetics,asthecapacityoftheeliminationsystemexceedstheconcentrationofdrug
-1
-1
-1
-1
-1
MetabolismandClearance
71
![Page 72: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/72.jpg)
Zero-orderkineticsAconstantamountofdrugiseliminatedperunittime,independentofhowmuchdrugisinthebody.
OccurswhenthereissaturationofenzymesystemsItisalsoknownassaturationkineticsforthisreason.
e.g.Phenytoinfollowsfirstorderkineticsatlowerdoses,butzero-orderkineticsatdoseswithinthetherapeuticrangeThisisclinicallyrelevantasthenarrowtherapeuticindexmeansthattoxiclevelsmayoccurrapidlywithasmallincreaseindose.e.g.Ethanolalsofollowszero-orderkineticswithinthe"therapeuticrange",asitisaveryweak(dosesareingrams)positiveallostericmodulatoroftheGABA receptor
Zero-orderkineticsisconcerningas:PlasmaconcentrationswillrapidlyincreasewithonlymodestdoseincreaseThereisessentiallynosteadystate:ifdruginputexceedsoutput,plasmalevelswillcontinuetorise
Michaelis-Menten
TheMichaelis-Mentenequationdescribesthetransitionfromfirstordertozeroorderkineticsasdrugconcentrationincreases:
Metabolismincreasesproportionallywithconcentrationaslongastheconcentrationofdrugleavingtheorganofmetabolism(e.g.inthehepaticvein)islessthanhalfofthemaximalconcentrationofdrugthatorgancanmetabolise
A
rd
MetabolismandClearance
72
![Page 73: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/73.jpg)
Thisis~1/3 ofthemaximalrateofmetabolism
HepaticMetabolism
Theprincipleorganofdrugmetabolismistheliver.Hepaticmetabolism:
Usuallydecreasesthefunctionofadrug,though:ProdrugshaveincreasedpharmacologicallyactivityafterlivermetabolismSomedrugshaveactiveortoxicmetabolites
Canbedividedintotwophases
PhaseI
Phaseonereactions:
OccurintheendoplasmicreticulumImprovewatersolubilitybyexposingafunctionalchemicalgroupTypicallyoccurpriortophaseIIreactionsformostdrugsInclude:
OxidationLossofelectrons.
MainphaseIreactionCYP450driven
ReductionGainofelectrons.
CYP450drivenHydrolysisAdditionofawatermolecule,whichmayresultintwonewcompounds.
EsterasedrivenThereforerapid,highcapacity,organ-independentelimination.
ButylcholinesteraseNon-specificplasmacholinesteraseRBCesterase
CYP450System
CYP450enzymesare:
AsuperfamilyofenzymesvitalindrugmetabolismNamedafterthewavelengthoflighttheyabsorbwhen:
ReducedCombinedwithCO
Locatedin:LiverEndoplasmicreticulumofhepatocytes.LungsKidneyGutBrain
Over1000enzymes,with~50functionallyactiveClassifiedbythedegreeofsharedamino-acidsequenceinto:
Families
rd
MetabolismandClearance
73
![Page 74: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/74.jpg)
CYP1,CYP2,CYP3...SubfamiliesCYP1A,CYP1B...IsoformsCYP1A1,CYP1A2...
CYP2B6 CYP2C9 CYP2C19 CYP2D6 CYP2E1 CYP3A4 CYP3A5
PropofolPropofol,Parecoxib,Warfarin
Diazepam,Omeprazole,Clopidogrel,Phenytoin
Codeine,Metoprolol,Flecainide
Volatileanaestheticagents,paracetamol
Commonbenzodiazepines,Fentanyl,Alfentanil,Lignocaine,Vecuronium
Diazepam
KeyCYPenzymesinclude:
CYP2E1Metabolisesvolatilesandparacetamol.CYP3A4Responsiblefor60%ofmetabolicactivity.CYP2D6
Importantbecausegeneticpolymorphismleadstosignificantinter-patientvariabilityMayresultinsignificantover-orunder-metabolismofdrugs,andthereforesignificantinter-individualvariabilityinresponse.
5-10%ofthepopulationarepoormetabolisers2-10%areintermediatemetabolisers1-2%areultra-rapidmetabolisersBulkofthepopulation(70-90%)areextensivemetabolisers
ClinicaleffectwilldependonthetypeofdrugPro-drugs
Extensive/ultra-rapidmetaboliserswillconvertmoredrugtotheactiveform,andseeagreatereffectMayleadtooverdose.Poormetaboliserswillexcretemorepro-drugpriortometabolism,andseeareducedclinicaleffect
ActivedrugExtensive/ultra-rapidmetaboliserswillinactivatemoredrug,andseeareducedeffectPoormetaboliserswillseeaprolongedclinicaleffect
Clinicaleffectmaybealteredbyenzymeinteractionse.g.Oxycodoneusebyanultra-fastmetaboliser,incombinationwithaCYP3A4inhibitor(e.g.diltiazem)willresultinasignificantincreaseintheclinicaleffectofoxycodone
DrugsmetabolisedbyCYP2D6include:Analgesics
Codeine(prodrug)Oxycodone(metabolisedtothesignificantlymorepotentoxymorphone)MethadoneTramadol(metabolisedtoformwithgreaterMOPselectivity)
PsychiatricdrugsSSRIsTCAsHaloperidol
CardiovasculardrugsAmiodaroneFlecainideMexiletine
MetabolismandClearance
74
![Page 75: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/75.jpg)
PhaseII
PhaseIIreactions:
Involveconjugationwithanothercompound,producingahighlypolarmetaboliteThisincreaseswatersolubilityandthereforerenalelimination.TypicallyoccurinthehepaticendoplasmicreticulumInclude:
GlucuronidationAdditionofglucuronicacid.SulfationAdditionofasulfagroup.AcetylationAdditionofanacetylgroup.
Alsooccursinthelungandspleen.MethylationAdditionofamethylgroup.
ExtractionRatio
Extractionratioistheproportionofadrugthatisclearedfromcirculationduringeachpassthroughtheorgan,typicallytheliver:
Extractionratioisdependenton:
BloodflowHepatocyteuptakeEnzymecapacityDescribedbytheMichaelisConstant:Theconcentrationofasubstratewhichcausesanenzymetoworkat50%ofitsmaximumcapacity.
Drugscanhaveeitherahighorlowextractionratio:
HighextractionratioThesedrugshavearapiduptakeandhighcapacity,soeliminationisperfusiondependent.
Freedrugisrapidlyremovedfromplasma,bounddrugisreleasedfromplasmaproteinsandaconcentrationgradientismaintainedMetabolismofdrugswithahighextractionratiois:
IndependentofproteinbindingDependentonliverflowTypicallydoublingliverbloodflowwilldoublehepaticclearance.
ThereisahighvariabilityinplasmaconcentrationbetweenindividualsduetothevariationinliverbloodflowDrugswithhighextractionratiosaregenerallyindependentofenzymeactivity-decreasingenzymeactivityfrom99%to95%hasaminimaleffectonhepaticclearance
Thekeyexceptionisfirstpassmetabolism,astheabovechangewillresultinafive-folddifferenceindosereachingthesystemiccirculationThereforedrugswithahighextractionratiohavelowPObioavailability.
LowextractionratioEliminationiscapacity-dependent.
AmountoffreedrugavailableformetabolismisgreatlyaffectedbythedegreeofproteinbindingMetabolismis:
Largelyindependentofflow
MetabolismandClearance
75
![Page 76: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/76.jpg)
DrugshavegoodPObioavailability.Dependentonhepatocytefunctionandproteinbinding
FactorsAffectingHepaticMetabolism
DrugFactors PatientFactors
Lipidsolubility Age
Ionisation Obesity
Proteinbinding Pregnancy
Enzymecompetition Genetics:Slowvs.fastacetylators
Hepaticflow/ExtractionRatio
EnzymeInhibition/Induction
Hepaticdisease
Smoking,ETOH
OrganIndependentMetabolism
Mechanismsoforganindependentmetabolisminclude:
HofmannDegradationSpontaneousdegradationormetabolismofsubstancesoccurringinplasma.
e.g.CisatracuriumundergoesHofmanndegradationPlasmaEsterasesPlasmaesterasesarenon-microsomalenzymeswhichhydrolyseesterbonds.They:
AretypicallysynthesisedintheliveranderythrocytesHaveahighcapacityThis,combinedwiththeorgan-independentelimination,meansdrugsmetabolisedbyplasmaesteraseshaveareliableoffset.e.g.Suxamethoniumishydrolysedbyplasmaesterases
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. EssentialpharmacologyfortheANZCAprimaryexam3. Birkett,DJ.Pharmacokineticsmadeeasy9:Non-linearpharmacokinetics.1994.AustralianPrescriber.
Lastupdated2019-07-18
MetabolismandClearance
76
![Page 77: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/77.jpg)
EliminationDescribethemechanismsofdrugclearanceandmetabolism.
Drugscanbeeliminatedin:
UrineBileSweatBreastmilkTearsExhaledgas
RenalEliminationDrugscanbe:
FilteredattheglomerulusFiltereddrugsare:
NotproteinboundOnlyfreedrugpresentinfilteredplasmawillbeexcreted.
ConcentrationoffiltereddrugwillbethesameasinunfilteredplasmaHighlyproteinbounddrugsarepoorlyfilteredThereisonlyaweakconcentrationgradientfavouringdissociationfromplasmaproteins.
SmallSubstanceslessthan7,000DaarefreelyfilteredSubstancesgreaterthan70,000Daareessentiallyimpermeable
Hydrophilic/lipophobicLipophilicdrugsmaybefilteredattheglomerulusbutwillbefreelyreabsorbedduringtheirpassagedownthetubule,suchthatonlytrivialamountsareeliminatedinurine.
SecretedinthetubulesActiveprocessallowssecretionagainstconcentrationgradientsSeparatemechanismsforacidicandalkalinedrugs
SaturatableprocessSaturationmayoccurofabasictransporterwhilststillallowingexcretionofacidicdrugs,andviceversa.
ReabsorbedinthetubulesPassivediffusiondownaconcentrationgradient.
HydrophilicmoleculescanonlybereabsorbedbyaspecialisedtransportmechanismAcidicdrugswillbebecomeionisedinanalkalineurine(andviceversa),reducingtheirsolubilityThisisthephysiologicaljustificationforurinaryalkalinisation.
HepaticElimination
Biliaryeliminationoccursfordrugsunabletobefilteredbytheglomerulus.Thesearetypically:
LargeGreaterthan30,000dalton.Lipidsoluble
Elimination
77
![Page 78: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/78.jpg)
Enterohepaticrecirculation
Drugsexcretedinbilemay:
BehydrolysedinthesmallbowelbybacteriaandthenreabsorbedThenpassthroughtheportalcirculationandgetmetabolisedagainThisprocessmayoccurmanytimes
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.
Lastupdated2019-07-18
Elimination
78
![Page 79: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/79.jpg)
BolusandInfusionKineticsExplaintheconceptsofintravenousbolusandinfusionkinetics.Todescribetheconceptsofeffect-siteandcontextsensitivehalftime.
ContinuousInfusions
PlasmaconcentrationsofanIVinfusionareinfluencedby:
DistributionMetabolismElimination
OnsetofContinuousRateInfusions
Withoutaloadingdose,theconcentrationofdruginfusedataconstantincreasesinanegativeexponentialfashion:
PlasmaconcentrationinitiallyrisesrapidlyDistributionintoperipheralcompartmentsisthemainmethodfordrugstoleaveplasmaThisisbecauseatthestartofaninfusionthereisalargeconcentrationgradientbetweenplasmaandperipheralcompartments.EliminationbecomesmoreimportantinprolongedinfusionsAsperipheralcompartmentsfilltheconcentrationgradientbetweenplasmaandcompartmentsfalls,andredistributionbecomesrelativelylessimportant.Steadystateisachievedwhenconcentrationsincompartmentsareequal,andinputisequivalenttoclearance
Concentrationatsteadystateisdeterminedbytheratioofinfusionratetoclearance:Therefore,atsteadystatewithdrugswith100%bioavailability:
Fordrugsgivenbyaroutewithlessthan100%bioavailability:
Ifthedosingisgivenintermittently,then:
VolumeofdistributionatsteadystateistermedV ssandistheapparentvolumeintowhichadrugwilldisperseduringaprolongedinfusion,andisthesumofallcompartmentvolumesinthemodel.
ContinuousRateInfusionswithBolusDosing
Asseen,abovestartinganinfusionattheraterequiredtomaintainsteadystateisinefficient:
Foranydesiredplasmaconcentration,itwilltakethreetimeconstants(4-5half-lives)foracontinuousinfusiontoreachthisconcentration
Ifthehalf-lifeislong,thenachievingatherapeuticlevelwilltakesometimeAbolusdoseaimedtofilltheV willallowsteady-statetobereachedimmediately:
D
D
BolusandInfusionKinetics
79
![Page 80: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/80.jpg)
StoppinganInfusion
Forabi-exponentialmodel(i.e.onlyoneperipheralcompartment),declineinplasmaconcentrationcanbemodeledbythe
equation .Inthismodel:
isthetime-constantforredistribution
isthetime-constantforterminalelimination(Providedtheinfusionhasreachedsteady-state).
Neither or correspondtoanyindividualrateconstant
Factorsaffectingrateofoffsetofaninfusioncanbeclassifiedintopharmacokinetic,pharmacodynamic,andotherdrugfactors:
PharmacokineticfactorsDistribution
VHighV willdecreaseclearancefromcentralcompartment.FactorsaffectingV include:
IonisationIontrappingcancausedrugtobesequestered.ProteinbindingLipidsolubilityAffectedbybodyfat.
SpeedofdistributionCOAffectsorganbloodflow.
RedistributionDuringaninfusion,peripheralcompartmentsbecomesaturatedwithdrug.Whenaninfusionceases,drugisredistributedcentralcompartment.
Thisisrelatedtocontext-sensitivehalftime(seebelow)Metabolism
RouteofclearanceOrgan-dependent
OrganfailuresExtractionratioOrganbloodflow
Organ-independentSaturatablekineticsZero-orderkinetics.
PresenceofactivemetabolitesEliminationRouteofexcretionofactivedrugoractivemetabolites.
DD D
BolusandInfusionKinetics
80
![Page 81: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/81.jpg)
OrganfailuresPharmacodynamicFactors
AgeSensitivityDoserequiredforeffectanddoserequiredforrecovery.
OrganfailuresPregnancy
OtherdrugfactorsPharmacokineticinteractions
Enzymeinhibition/inductionPharmacodynamicinteraction
DrugtolerancesTachyphylaxis
DrugactionDrugswhichaltergeneorreceptorexpression,orbindirreversibly(e.g.clopidogrel)mayshowongoingeffectsevenafterthedrughasleftthesystem.
Context-SensitiveHalf-Time
Context-sensitivehalftimeis:
DefinedasthetimeforplasmaconcentrationtofalltohalfofitsvalueatthetimeofstoppinganinfusionAmethodtodescribethevariabilityinplasmaconcentrationsafterceasinganinfusionThe"context"isthedurationofinfusion.Usedbecauseterminaleliminationhalf-lifehaslittleclinicalutilityforpredictingdrugoffsetHalf-livesareoftenmisleadingwhendiscussingdruginfusions.Dependenton:
DurationofinfusionDuringaninfusion,drugsdistributeoutofplasmaintotissues.Whentheinfusionceases,drugisclearedfromplasmaandtissuedrugredistributesbackintoplasma.
Thelongeraninfusion,themoredrughasdistributedoutoftissues,andthelongertheredistributionphaseThelongestcontext-sensitivehalftimeoccurswhenaninfusionisatsteady-state
RedistributionThemaximalCSHTreacheddependsonthe:
V ssDrugswithalargerV sshavealongerCSHT,asonlyasmallproportionofthedruginthebodywillbeinplasmaandabletobecleared.RateconstantforeliminationDrugswithasmallerrateconstantforeliminationhavealongerCSHT.
Drugswithlongercontext-sensitivehalf-timeswillwearofflesspredictably.
DD
BolusandInfusionKinetics
81
![Page 82: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/82.jpg)
RemifentanilhaslittleredistributionandasmallVd,andsohasaveryshortcontext-insensitivehalftimeItwearsoffreliablyandquicklyfollowingcessationofinfusion.
Context-SensitiveDecrementTime
DescribethetimeittakesforadrugleveltofalltoaparticularpercentageofitsstartingvaluefollowingcessationofaninfusionTheyareusedbecausethehalf-timesdonotdescribemono-exponentialdecayi.e.Thetimetakenfordrugconcentrationtoreach25%ofitsstartingvalueisnottwicethecontextsensitivehalf-time.Thecontext-sensitivehalf-timecouldalsobedescribedasthe50%context-sensitivedecrementtime
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. HillSA.PharmacokineticsofDrugInfusions.ContinEducAnaesthCritCarePain(2004)4(3):76-80.
Lastupdated2019-07-18
BolusandInfusionKinetics
82
![Page 83: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/83.jpg)
DrugMonitoringExplainclinicaldrugmonitoringwithregardtopeakandtroughconcentrations,minimumtherapeuticconcentrationandtoxicity
Drugmonitoring:
DescribestheindividualisationofdosingbymaintainingplasmadruglevelswithinatargetrangeIsimportantinadjustingdosetoaccountforinter-patientvariabilityinresponseVariabilitycanbe:
PharmacokineticAdjustingdrugdosebymonitoringplasmalevelsreducespharmacokineticvariability.PharmacodynamicDrugdoseisadjustedbyevaluatingtheclinicaleffect.
Druglevelsaremeasuredtoensuretheconcentrationisabovetheminimumtherapeuticconcentrationbutbelowtoxiclevels:
MinimumtherapeuticconcentrationTheED ,i.e.thedoserequiredtohaveaneffectin50%ofthepopulation.
DeterminesdesiredtroughlevelsMinimumtoxicconcentrationTheLD ,orthedosewhichislethalin50%ofthepopulation.
Determinestheacceptablepeaklevels
Fromtheselevelstworelatedtermsarederived:
Therapeuticrange(alsoknownasthetherapeuticwindow)Differencebetweentheselevels.TherapeuticindexRatiobetweentheselevels,i.e.
Ahighertherapeuticindexgivesagreatermarginforsafety
IndicationsDrugsaremonitoredinorderto:
AvoidtoxicityAdjustdosingforefficacyMonitorcomplianceordeterminefailureoftherapy
50
50
DrugMonitoring
83
![Page 84: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/84.jpg)
Drugsthattypicallyrequiremonitoringhavea:
NarrowtargetrangeSignificantpharmacokineticvariabilityRelationshipbetweentheconcentrationinplasmaandclinicaleffectsDeterminedconcentrationrangeValidatedmonitoringassay
Drugswheretheeffectcanbemeasuredclinically(e.g.antihypertensives)tendtobeadjustedbasedonobservedeffects.Thisisnotpossiblewhen:
Theclinicalresponseistheabsenceofacondition,e.g.antiepilepticsThedrughasanarrowtherapeuticrange
DrugscommonlymonitoredintheICUsettinginclude:
Drug TherapeuticRange
Digoxin 0.8-2microgram/L
Vancomycin 10-20mg/L*
Tacrolimus 5-20microgram/L
Serolimus 5-15microgram/L
Phenytoin 10-20mg/L
*Trough
Timingofsamples
SamplingfortoxicityshouldoccurattimesofpeakconcentrationThisrequiresaccountingforabsorptionanddistribution
e.g.Digoxinlevelsshouldbeperformed>6hoursfollowingadosetoallowtimefordistributiontooccurIfsymptomatic,samplestakenatthistimemaydemonstratetoxicconcentrations
Samplingformonitoringshouldideallyoccuratsteadystatei.e.after4-5eliminationhalf-livesFordrugswithverylonghalf-lives(suchasamiodarone),samplingtendstooccurearliertoensuretoxiclevelshavenotbeenreached,assteadystatemaytakemonthstoachieve
Fordrugswithshorthalf-lives,troughlevels(i.e.pre-doselevels)shouldbetakenThisistheleastvariablepointinthedosinginterval.Fordrugswithlonghalflives,timingofsamplingislessimportant
InterpretationInterpretationofdruglevelsisdependenton:
TimingofsampleDurationoftreatmentatthecurrentdoseanddosingscheduleIndividualcharacteristicsthatmayaffectthepharmacokinetics
AgePhysiologyComorbidities(hepatic,renal,cardiac)
DrugMonitoring
84
![Page 85: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/85.jpg)
DruginteractionsGeneticsEnvironmental
ProteinbindingAssaysmeasureboundandunbounddrugOnlyunbounddrugispharmacologicallyactive.Ifbindingischangedbydiseaseordisplacementbyotherdrug,theproportionofunbounddrugmaychangeandtargetedlevelsmayneedtobeadjustedaccordingly
ActivemetabolitesActivemetabolitesarenotmeasuredbutwillcontributetotheresponse.
References1. BirkettDJ.Therapeuticdrugmonitoring.AustPrescr1997;20:9-11.2. GhiculescuRA.Therapeuticdrugmonitoring,whichdrugs,why,when,andhowtodoit.AustPrescr2008;31:42-4.
Lastupdated2018-09-21
DrugMonitoring
85
![Page 86: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/86.jpg)
EpiduralandIntrathecalDescribethepharmacokineticsofdrugsintheepiduralandsubarachnoidspace
Inbothspaces,speedofonsetisdeterminedbyFick'sLaw.
EpiduralSpace
Factorsimportanttoepiduraladministration:
DosegivenVolumegivenIncreasedvolumeincreasesareaofsubarachnoidthatthedrugisincontactwith,increasingrateofdiffusion.SolubilityAffectedby:
pKaandpHDeterminesunionisedportionavailabletocrossintoCSF.ProteinbindingDeterminesfreedrugportionabletocrossintoCSF.Lipidsolubility
CSFflowAltersconcentrationgradientbetweenepiduralandsubarachnoidspace.
IntrathecalFactorsimportanttointrathecaladministration:
DoseMuchsmallerdosesrequired.VolumeAffectsextentofspread.BaricityAffectsdirectionofspread:
Hyperbaricsolutionswillsinkwithgravitye.g.Heavybupivacaine(0.5%bupivacainewith8%dextrose)Hypobaricsolutionswillriseagainstgravity
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. ANZCAFebruary/April20073. Factorsinfluencingdistributionofbupivacaineafterepiduralinjection-DiazNotes.
Lastupdated2017-09-17
EpiduralandIntrathecal
86
![Page 87: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/87.jpg)
EpiduralandIntrathecal
87
![Page 88: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/88.jpg)
TotalIntravenousAnaesthesiaandTarget-ControlledInfusion
Describethepharmacologicalprinciplesofandsourcesoferrorwithtargetcontrolledinfusion
TotalintravenousanaesthesiainvolvesusingIVagentsalonetoachievehypnosis,analgesia,andmusclerelaxation.TIVA:
AdvantagesAvoidsadverseeffectsofanaestheticagents
Nausea/vomitingPollutionIncreasedcerebralbloodflow
DisadvantagesDrugmustbemetabolisedPotentialincreasedlikelihoodofawareness
LikelyrelatedtopoorapplicationoftechniqueratherthanthetechniqueitselfMostlyrelatedtodisconnectionofinfusionwithoutEEGmonitoring
Variableplasmaconcentration
TargetControlledInfusionTCIistheuseofpharmacokineticmodels(typicallycombinedwithmicroprocessor-controlledinfusionpumps)toachieveatargetconcentrationofdruginaparticularbodycompartment.
TCI-systems:
Areopen-loopEffectsofdrugarenotmeasured(unlikewithend-tidalgasmonitoring),whichintroducesavulnerabilitythatcanleadtoawareness.
e.g.Comparedtoinhalationalanaesthetics,wheretheloopisclosedbyusingend-tidaldrugmonitoringFollowstheBET(Bolus,Elimination,Transfer)principle:Aloadingdoseisgiventosaturatethevolumeofdistributiontoachievetargetconcentration
Infusionrateisthensettomaintainatargetplasmaconcentration:
Ratecompensatesfor:DrugeliminationDrugdistribution(transfer)
Target canbeadjusted:Forahigherconcentration:
AsmallbolusisgivenInfusionrateisincreased
Foralowerconcentration:InfusionispauseduntildesiredlevelisreachedInfusionraterestartsatalowerrate
Modelscantargeteither:
Plasmaconcentration,
TIVAandTCI
88
![Page 89: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/89.jpg)
Willnotapproximate untilsteadstateisreached.Therefore:
Increase duringinduction,sothat willrisemorequickly
shouldbeadjustedtothelevelofthesurgicalstimulus
Effect-siteconcentration,Over-pressureoccursautomatically,sothereisnorequirementtoincreasetargetduringinduction.
TCIModelsforPropofol
TheBristolModel:
FirstpharmacokineticmodelBasedonthree-compartmentmodelofhealthpatientsAssumes:
PremedicationwithtemazepamFentanyl3μg.kg oninductionInhaledN O
Atargetplasmaconcentration( )of3μg.mlThemodel:
1mg.kg inductionbolus10-8-6maintenance:
10mg.kg .hr for10minutes8mg.kg .hr for10minutes6mg.kg .hr thereafter
MarshandSchniderModels:
ThesearecomputercontrolledmodelsBothwerederivedonverysmallgroupsofpatients(18and24respectively)Themodelsdiffermostlyinthefirst10minutesafterinduction,andprogressivelyconverge
-1
2-1
-1
-1 -1-1 -1-1 -1
TIVAandTCI
89
![Page 90: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/90.jpg)
Theinitialbehaviourofthemodeliskeyindecidingwhichmodeltoapplytoanyparticularpatient.
Property Marsh Schnider
Targets
Typicallytargetplasmaconcentration,butcantargeteffectsite.
EffectsitetargetingisusuallydonewiththemodifiedMarshmodel,duetothelargebolusdosinggivenbythestandardMarshmodel.
Typicallyeffectsite,butcantargetplasmaconcentration.
Plasmatargetinggivesinconsistentresults,asthefixedsizeofV meansanyincreaseindesiredplasmaconcentrationresultsinthesamesizebolusbeinggiven,irrespectiveofpatientparameters.
Requiredvariables
TBW(overestimatesinduction(butnotmaintenance)inobesepatients,considerusingIBW),Age(butnotusedincalculation)
Age,height(tocalculateleanbodymass),TBW
Values VariablecompartmentsizesbutbiggerV FixedV (4.27L)andV ,variableV andK
Other
The'modifiedMarsh'modelusesak of1.2L.min
insteadof0.26L.min ,whichdecreasesthe
requiredtoachievethetarget quickly.ThemodifiedMarshisthereforepreferableinpatientsathigherriskofoverdose.
LimitsBMIto<42formalesand<35forfemales,topreventabsurdcompartmentsizesbeingcalculatedfromthemethodusedtocalculateleanbodymass
Overall FasterinductionduetolargerV ,whichresultsinalargerloadingdose
Reducedrateofadverseevents.Overalllesspropofolused.
References
1. AbsalomAR,ManiV,DeSmetT,StruysMM.Pharmacokineticmodelsforpropofol--definingandilluminatingthedevilinthedetail.BrJAnaesth.2009Jul;103(1):26-37.
2. NaidooD.TargetControlledInfusions.DepartmentofAnaesthetics,UniversityofKwazulu-Natal.2011.3. EngbersFH,SutcliffeN,KennyG,SchraagS.Pharmacokineticmodelsforpropofol:Definingandilluminatingthedevilin
thedetail.BrJAnaesth.2010Feb;104(2):261-2;authorreply262-4.4. FRCA-TargetControlledInfusionsinAnaestheticPractice
Lastupdated2019-07-20
1
1 1 3 2eo
eo-1
-1
1
TIVAandTCI
90
![Page 91: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/91.jpg)
ReceptortheoryToexplaintheconceptofdrugactionwithrespectto:receptortheory
Todefineandexplaindose-effectrelationshipsofdrugs,includingdose-responsecurveswithreferenceto:therapeuticindex,potencyandefficacy,competitiveandnon-competitiveantagonists,partialagonists,mixedagonist-antagonistsandinverseagonists
ToexplaintheLawofMassActionanddescribeaffinityanddissociationconstants
Areceptorisacomponentofacellwhichinteractswithadrugandinitiatesasequenceofeventsleadingtoanobservedchangeinfunction.
Existenceofreceptorsisinferredfromtheresponseoftissuestodrugs,genomesequencing,andmolecularbiology.Adrugbindstoareceptorformingareceptor-drugcomplex,whichinitiatesacascadeofeventstoexertapharmacologicaleffect.
DissociationConstantsInteractionbetweenareceptorandadrugisbaseduponthelawofmassaction,whichstatestherateofachemicalreactionisproportionaltothemassesofreactingsubstances.Thiscanbeexpressedas:
Theratiooftherateconstantfortheforwardsreaction(K )andthebackwardsreaction(K )isthedissociationconstant.Thisistheconcentrationofdrugwhen50%ofreceptorsareoccupied:
AlowK valueindicatesthatalowerconcentrationofdrugisrequiredtooccupy50%ofthereceptor,indicatingthatthedrughasahighaffinityforthereceptor.
PhysiologicalfactorswhichaffectthedissociationconstantaredeterminedbytheArrheniusequation:
,where:
isaconstant
istemperatureinkelvin
istheactivationenergyrequired,whichmaybeloweredbyacatalyst
isthegasconstant
PropertiesofDrugs
Keypropertiesofdrugsinclude:
PotencyTheamountofdrugrequiredtohaveaneffect.
Givenbythe(typicallytheE 50)ThisrelatestoBowman'sprinciple,whichstatesthattheleastpotentanaestheticagentshavethequickestonsetThisisbecausetheyareadministeredinhigherdoses(astheyarelesspotent,moreisrequiredtogetaneffect),which
association dissociation
D
D
Pharmacodynamics
91
![Page 92: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/92.jpg)
resultsinahighconcentrationgradientandarapiddistributionintotissues.
EfficacyThemaximaleffectthatadrugcangenerate.
IntrinsicactivityThesizeofeffectadrughaswhenbound,whichisgradedfrom0to1.
Thisisalsoknownasactivity
Drug-ReceptorInteractionsDrugscanbeclassifiedbythewaytheyinteractwithreceptorsinto:
AgonistsPartialagonistsInverseagonists
AntagonistsIndirectantagonists
AllostericModulatorsMixedAgonist-Antagonists
Agonists
Anagonistwillgenerateamaximalresponseatthereceptorsite.Anagonisthashighaffinityandanactivityof1.Agonistscanbecomparedby:
Relativepotencyimpliesthatiftwoagonistsareequallyefficacious,asmallerdoseofoneisrequiredtogetaneffectRelativeefficacyimpliesthatthemaximaleffectofoneagonistisgreaterthantheother
Partialagonist
Apartialagonistgeneratesasubmaximalresponseatthereceptor.Apartialagonisthasahighaffinityandanactivitybetween0and1.Apartialagonistcanactasaneffectiveantagonistinthepresenceofafullagonist,asitwillpreventmaximalbindingatareceptor,evenwithahighagonistconcentration.
Inverseagonist
Adrugwhichhasanegativeactivity(between0and-1)producingtheoppositeresponse(comparedtotheendogenousagonist)atreceptor.
Occursduetolossofconstitutiveactivityatthatreceptor
Pharmacodynamics
92
![Page 93: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/93.jpg)
Antagonist
Anantagonistproducesnoresponseatthereceptorsite,andpreventsotherligandsbinding.Antagonistshavehighaffinityandanactivityof0.
Antagonistswiththesepropertiesarealsoknownasdirectantagonists,whichcanbeeither:
CompetitiveantagonistsDisplaceotherligandsfromabindingsite.Competitiveantagonistscanbe:
ReversibleTheeffectcanbeoverriddenbyincreasingthedoseofagonist.IrreversibleDrugcannotbeoverriddenbyincreasingdoseofagonist.Dose-responsecurveappearssimilartothatofthenon-competitiveantagonist.
Non-competitiveantagonistsCreateaconformationalchangeinthereceptor.Theycannotbeoverriddenbyincreasingthedoseofagonist.
IndirectAntagonist
Indirectantagonistsreducetheclinicaleffectofadrug,butdosoviameansotherthanreceptorinteraction.Theyinclude:
ChemicalantagonistsWherethedrugbindsdirectlytoanother.Examplesincludeprotamineandheparin,andsugammadexandrocuronium.PhysiologicantagonistsAcounteringeffectisproducedbyagonismofotherpathways.
AllostericModulator
Adrugwhichbindstoanallostericsiteonthereceptorandproducesconformationalchangethatalterstheaffinityofthereceptorfortheendogenousagonist.
Allostericmodulatorscanbe:
PositiveIncreasesaffinityforendogenousagonist.
e.g.BenzodiazepinesarepositiveallostericmodulatorsattheGABA receptorNegativeDecreasesaffinityforendogenousagonist.
A
Pharmacodynamics
93
![Page 94: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/94.jpg)
MixedAgonist-Antagonist
Adrugwhichhasdifferenteffectsondifferentreceptors.
References
1. PinnockC,LinT,SmithT.FundamentalsofAnaesthesia.2ndEd.CambridgeUniversiyPress.2003.2. EncyclopaediaBritannica.Availableat:https://www.britannica.com/science/law-of-mass-action3. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.
Lastupdated2019-07-20
Pharmacodynamics
94
![Page 95: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/95.jpg)
ReceptorTypesToexplaintheconceptofdrugactionwithrespectto:receptortheory,enzymeinteractions,andphysicochemicalinteractions.
Toexplainreceptoractivitywithregardto:ionicfluxes,secondmessengersandGproteins,nucleicacidsynthesis,evidenceforthepresenceofreceptors,regulationofreceptornumberandactivity,structuralrelationships.
ReceptorTypes
Areceptorisaprotein,usuallyinthecellularmembrane,towhichaligandmaybindtogeneratearesponse.
IntracellularreceptorsMaybeeithercytoplasmicorintra-nuclear.
Intranuclearreceptorsareactivatedbylipidsolublemolecules(suchassteroidsandthyroxine)toalterDNAandRNAexpressionThisresultsinanalterationofproductionofcellularproteins,sotheeffectstendtobeslowacting.
Enzyme-linkedreceptorsAreactivatedbyaligandandcauseenzymaticactivityontheintracellularside.Theycanbeeither:
MonomersDimersWheretwoproteinsjoin,ordiamerise,onbindingofaligand.
Ion-channelreceptors(inotropic)Createachannelthroughthemembranethatallowselectrolytestoflowdowntheirelectricalandconcentrationgradients.Theycanbeeither:
Ligand-gatedchannelsUndergoconformationalchangewhenaligandisbound.Therearethreeimportantfamiliesofligandchannels:
PentamericfamilyConsistoffivemembranespanningsubunits.Include:
NicotinicAChreceptorGABA receptor5-HT receptor
InotropicglutamatereceptorsBindglutamate,aCNSexcitatoryneurotransmitter.Include:NMDAreceptor
1
A3
2+
ReceptorTypes
95
![Page 96: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/96.jpg)
HighCa permeabilityInotropicpurinergicreceptorsFormcationicchannelsthatarepermeabletoCa ,Na ,andKActivatedbyATP
Voltage-gatedchannelsOpenwhenthethresholdvoltageisreached,facilitatingelectricalconductioninexcitabletissues.
Intheirnormalphysiologicalstate,voltagegatedchannelsdonotgenerallybehaveasreceptorsforaligand,howeversomedrugs(e.g.localanaesthetics)willbindtovoltagegatedchannelstoexerttheireffectHaveacommon4-subunitstructure(eachwith6transmembranesegments)surroundingacentralporeThisporeisselectivefortheparticularion,whichinclude:
NaLocatedinmyocytesandneuronsImportantingeneratingandtransmittinganactionpotentialbypermittingsodiuminfluxintocellsInhibitedbylocalanaesthetics,anti-epileptics,andsomeanti-arrhythmics
CaDividedintosubtypes,including:
LMuscularcontraction.TCardiacpacemaker.N/P/QNeurotransmitterrelease.KLocatedinmyocytesandimportantinrepolarisationfollowinganactionpotential.
UndergoaconformationalchangewhenthethresholdpotentialisreachedThisissensedbytheS4helix,whichactstoopenandclosethechannel.Existinoneofthreefunctionalstates:
RestingPoreisclosed.ActivePoreisopen,andionscanpass.InactiveTransientrefractoryperiodwheretheporeisopen,butionscannotpass.Thiscreatestheabsoluterefractoryperiodofacell.
G-proteincoupled(metabotropic)receptors:G-proteinsareagroupofheterotrimeric(containingthreeunits;α,β,γ)proteinswhichbindGDP.Whenstimulated,theGDPisreplacedbyGTPandtheα-GTPsubunitdissociatestoactivateorinhibitaneffectorprotein.Theeffectdependsonthetypeofα-subunit:
G proteinsArestimulatorly.These
IncreasecAMP,leadingtoabiochemicaleffectG proteinsAreinhibitory.These:
Inhibitadenylylcyclase,reducingcAMPG proteinsHaveavariableeffect,dependingonthecell.These:
ActivatephospholipaseCThisaffectstheproductionof:
Inositoltriphosphate(IP )
2+
2+ + +
+
2+
+
s
i
q
3
2+
ReceptorTypes
96
![Page 97: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/97.jpg)
StimulatesCa fromtheSR,affectingenzymaticfunctionorcausingmembranedepolarisation.Diacylglycerol(DAG)ActivatesproteinkinaseC,whichhascell-specificeffects.
ActivateintracellularsecondmessengerproteinswhenstimulatedSecondmessengersystems:
Resultinbothtransmissionandamplificationofastimulus,asasingleactivatedreceptorcanactivatemultipleproteinsandeachactivatedproteinmayactivateseveralotherintermediateproteins
ThisisknownasaG-proteincascade
Enzymeinteraction
Drugscaninteractwithenzymesbyantagonismorbybeingafalsesubstrate.
Enzymeantagonism
Mostdrugswhichinteractwithenzymesinhibittheiractivity.Thisresultsin:
IncreasedconcentrationofenzymaticsubstrateDecreasedconcentrationoftheproductofthereaction
Drugscanbecompetitive,non-competitive,orirreversibleinhibitorsofenzymaticactivity.Examplesinclude:
Ramiprilisacompetitiveinhibitorofangiotensin-convertingenzyme.Aspirinisanirreversibleinhibitorofcyclo-oxygenase.
Falsesubstrates
Falsesubstratescompetewiththeenzymaticbindingsite,andproduceaproduct.Examplesinclude:
Methyldopaisafalsesubstrateoftheenzymedopaminedecarboxylase.
PhysicochemicalDrugswhosemechanismofactionisduetotheirphysicochemicalproperties.Examplesinclude:
MannitolreducesICPbecauseitincreasestonicityoftheextracellularcompartment(andisunabletocrosstheBBB),drawingfreewaterfromtheintracellularcompartmentasaconsequence.Aluminiumhydroxidereactswithstomachacidtoformaluminiumchlorideandwater,reducingstomachpH.
References
1. Anderson,C.Pharmacodynamics2.ICUPrimaryPrep.2. LawofMassAction.EncyclopaediaBritannica.3. ANZCAAugust/September20014. CatterallWA.StructureandFunctionofVoltage-GatedIonChannels.Annu.Rev.Biochem.1995.64:493-531.
Lastupdated2019-07-18
2+
ReceptorTypes
97
![Page 98: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/98.jpg)
ReceptorTypes
98
![Page 99: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/99.jpg)
Dose-ResponseCurvesTodefineandexplaindose-effectrelationshipsofdrugs,includingdose-responsecurveswithreferenceto:gradedandquantalresponse.
StandardDose-ResponseCurves
Adose-responsecurveisagraphofconcentrationagainstthefractionofreceptorsoccupiedbyadrug.
Log-DoseResponseCurves
Itisdifficulttocomparedrugsusingstandarddose-responsecurves.Therefore,doseiscommonlylog-transformedtoproducealog-doseresponsecurve.
Thiscurve:
Compareslog-doseversusclinicaleffectDemonstratesthatthebluedrughasgreaterpotencythanthereddrug,thoughbotharefullagonists
Responsescanbeeithergradedorquantal:
GradedresponsesdemonstrateacontinuousincreaseineffectwithdoseE.g.Bloodpressureandnoradrenalinedose
QuantalresponsesdemonstratearesponseonceacertainproportionofreceptorsareoccupiedExamplesinclude:
EDMediandoseofneuromuscularblockerrequiredtoproducea95%lossoftwitchheight.MACMeanalveolarconcentrationofagentrequiredtopreventmovementinresponsetoasurgicalstimulus.
95
Dose-ResponseCurves
99
![Page 100: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/100.jpg)
References
1. AndersonC.Pharmacodynamics1.ICUPrimaryPrep.Availableat:https://icuprimaryprep.files.wordpress.com/2012/05/pharmacodynamics-1.pdf
Lastupdated2017-10-04
Dose-ResponseCurves
100
![Page 101: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/101.jpg)
MechanismsofActionDrugscanactinfourways:
ReceptorsGPCRIntracellular
CytoplasmicIntranucleare.g.Steroids,whichalterRNAexpression.
IonChannelsBlockadeAllostericmodulation
EnzymeinteractionAnenzymeisabiologicalcatalyst,increasingthespeedofreaction.Enzymeinteractioncanbe:
Irreversibleinhibitione.g.Aspirin,whichirreversiblyinhibitsplateletthromboxaneproduction.
ReversibleinhibitionCompetitiveantagonism
e.g.ACE-I.Non-competitiveantagonism
PhysicochemicalOsmotic
e.g.mannitol.Acid-base
e.g.antacids.ChelationRedoxreactions
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.
Lastupdated2019-07-18
MechanismsofAction
101
![Page 102: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/102.jpg)
AdverseeffectsClassifyanddescribeadversedrugeffects.
Anadverseeffectis:
Anoxiousorunintendedeffectassociatedwithadministrationofadrugatthenormaldosei.e.,notanoverdoseOccur:
Mainlyinyoungandmiddle-agedindividualsTwiceascommoninwomenMaybeexacerbatedbyasthmaandpregnancy.
Distinctfromanadverseevent,whichisanuntowardoccurrenceduringtreatmentthatdoesnotnecessarilyhaveacausalrelationshiptodrugadministration
Adverseeffectscanbeclassifiedbymechanismasfollows:
TypeAAdverseReactions
Thesearerelatedtothepharmacologicalactionofthedrug.Theyare:
CommonRelatedtodose(dose-responserelationship)TemporallyassociatedwithdrugadministrationReproduciblePharmacologicallypredictablebasedonunderstandingofthedruginquestion
e.ghypokalaemiasecondarytodiureticuse
Theytypicallyresultin:
Organ-selectiveinjuryMorepronouncedwithlong-termuseandinriskgroups:
ExtremesofagePregnancyRenalfailure
HighmorbiditybutlowmortalityTreatmentistodecreasedose.
TypeBAdverseReactions
Thesearepatient-specificoridiosyncraticreactions.Theyare:
RarePotentiallygenetic,butpoorlyunderstood.Independentofdose
OccurwithlowdosesDonothaveadose-responserelationship
NotpharmacologicallypredictableImportantcausesinclude:
AcetylatorstatusCYP450variants
VariabilityinDrugResponse
102
![Page 103: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/103.jpg)
ReceptorabnormalitiesEnzymealterations/deficiencies
e.g.SuxamethoniumapnoeaNotnecessarilyreproducible
Theytypicallyresultin:
Immuno-allergicreactionsPseudo-allergyIdiosyncraticreactionLowmorbiditybuthighmortality
e.g.Stevens-JohnsonSyndromeoranaphylaxisfollowingpenicillinadministration
Treatmentistoceasethemedication.
TypeCAdverseReactions
Theseare'statisticaleffects'associatedwithmonitoring.Theyare:
TypicallyanincreasedfrequencyofbackgrounddiseasethatisdetectedduetoincreasedscreeningAtypicalforadrugreactionandnotpharmacologicalpredictableNoidentifiabletemporalrelationshipNotreproducible
References
1. RHBMeyboom,MLindquist,ACGEgberts.AnABCofDrug-RelatedProblems.DrugSafety2000;22:415-23.2. PirmohamedM,BreckenridgeAM,KitteringhamNR,ParkBK.Adversedrugreactions.BMJ.1998Apr25;316(7140):1295-
8.OpenAccessReview.3. LazarouJ,PomeranzBH,CoreyPN.Incidenceofadversedrugreactionsinhospitalizedpatients—ameta-analysisof
prospectivestudies.JAMA1998;279:1200-5.
Lastupdated2019-07-18
VariabilityinDrugResponse
103
![Page 104: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/104.jpg)
DrugInteractionsClassifyanddescribemechanismsofdruginteraction.
Druginteractionsoccur"whentheactionofonedrugmodifiesthatofanother".
MechanismsofDrugInteraction
Druginteractionsarebestclassifiedintothreecategories:
PhysicochemicalPharmacokineticPharmacodynamic
Physicochemical
Physicochemicalinteractionsoccurbecauseofanincompatibilitybetweenchemicalstructures.
e.g.Thiopentoneandsuxamethoniumprecipitateoutofsolutionifpreparedtogetherordeliveredtogetherinthesameline
Pharmacokinetic
Pharmacokineticinteractionscanbesub-classifiedintothoseaffectingabsorption,distribution,metabolism,orelimination.
Absorption
Fororalmedications,absorptionmaybeaffectedbydrugswhichalter:
GastricpHGastricemptyingtime
Metoclopramideresolvesgastricstasisandimprovesabsorptionoforallyadministereddrugs
Distribution
Distributionmaybeaffectedby:
CompetitionforplasmaproteinbindingLossofalbuminandα1-acidglycoproteinMedicationswhichaltercardiacoutputDisplacementfromtissuebindingsitesThistypicallyoccursduetoalterationofmetaboliccapacityofonedrugbytheother.ChelationofdrugfromtissuesChelatingagentsbindtoxicelementsandpreventtissuedamage
Phenytoinisusuallyhighly(90%)proteinbound.Areductioninproteinbindingto80%willdoublethefreephenytoinlevel.Fordrugswithfirst-orderkinetics,metabolismwillincreaseproportionallyhoweverphenytoinrapidlysaturatestheenzymesystem,leadingtozero-orderkineticsandahighplasmalevel.
β-blockersreducecardiacoutputandwillprolongthetimetofasciculationofsuxamethonium.
Metabolism
MetabolismmaybeaffectedbychangestotheCYP450enzymes:
DrugInteractions
104
![Page 105: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/105.jpg)
EnzymeinductionBarbituratesPhenytoinCarbamazepine
EnzymeinhibitionAmiodaroneAmiodaroneinhibitsmetabolismofS-warfarinbyCYP2C9,enhancingit'seffect.DiltiazemVerapamilCiprofloxacinMacrolidesMetronidazoleGrapefruitjuice
Elimination
Renaleliminationcanbeaffectedby:
ChangesinurinarypHCompetitionforactivetubulartransportmechanisms
SodiumbicarbonateincreasesurinarypHandenhancesexcretionofweakacidssuchasaspirin.
Pharmacodynamic
Pharmacodynamicinteractionscanbedirect,duetointeractiononthesamereceptorsystem;oraindirect,whentheyactondifferentreceptorsystem.Theseinteractionscanbeclassifiedaseither:
AdditiveWhentheeffectssummate.
e.g.Administeringmidazolamwithpropofolreducestheamountofpropofolrequiredtogenerateaneffect.AntagonisticWhentheeffectsopposeeachother.
e.g.NeostigmineindirectlyantagonisestheeffectofNDMRsbyincreasingthelevelofAChattheNMJ.SynergisticWhenthecombinedeffectisgreaterthanwouldbeexpectedfromsummationalone.
e.g.Co-administrationofremifentanilandpropofolhasasynergisticeffectinmaintenanceofanaesthesia.
Thesethreeinteractionscanbegraphicallydemonstratedusinganisobologram,whichdrawsalineofequalactivityversusconcentrationoftwodrugs.
DrugInteractions
105
![Page 106: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/106.jpg)
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. KhanS,StannardN,GreijnJ.Precipitationofthiopentalwithmusclerelaxants:apotentialhazard.JRSMShortReports.
2011;2(7):58.
Lastupdated2019-07-18
DrugInteractions
106
![Page 107: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/107.jpg)
AlterationstoDrugResponseDefinetachyphylaxis,tolerance,addiction,dependenceandidiosyncrasy
Therearefourmechanismswhichresultinvariableresponsetodrug:
AlterationindrugthatreachesthereceptorThisistypicallyduetopharmacokineticfactors.RelativedifferenceinpresenceofexogenousandendogenousligandsAntagonistswillhaveagreatereffectinthepresenceofhighendogenousligandconcentration.VariationinreceptorfunctionandnumberUp-regulationanddown-regulationofreceptorsmayoccurasaconsequenceofprolongedstimulus.Alterationinfunctiondistaltothereceptor
KeyTermsTachyphylaxisistherapiddecreaseinresponsetorepeateddosingoverashorttimeperiod,usuallyduetodepletionoftransmitter
Desensitisationisthelossinresponseoveralongtimeperiod,usuallyduetochangeinreceptormorphologyorlossinreceptornumbers
Withdrawalisapathologicalresponsewhenadrugisceased
Duringadministrationreceptorsmaybe:Up-regulatedinthecontinuedpresenceofanantagonistDown-regulatedinthecontinuedpresenceofanagonist
LossofreceptornumbersmayprecipitatewithdrawalwhentheagonistorantagonistisceasedAddictionisabehaviouralpatterncharacterisedbycompulsiveuseandfixationonacquiringandusingadrug
IdiosyncrasyisanindividualpatientresponsetoadrugTypicallymediatedbyareactivemetaboliteratherthanthedrugitself.
Tolerance
Toleranceistherequirementforalargerdosetoachievethesameeffect,duetoalteredsensitivityofthereceptorstothestimulant.Mechanismscanbeclassifiedinto:
PharmacokineticAltereddrugmetabolismMetabolismmaybeincreasedordecreased:
EnzymaticinductionandincreaseddrugmetabolismIncreasedhepaticenzymepathwaycapacityincreasesmetabolismandlowersplasmaconcentration.DecreasedmetabolismDecreasedmetabolismofaprodrugcanresultinareducedeffect.
PharmacodynamicChangeinreceptormorphologyCanoccurwithion-channelreceptorsandGPCRs:
Ion-channelreceptorsbindtheligandbutdonotopenthechannelGPCRbecome'uncoupled'-phosphorylationofthereceptormakesitunabletoactivatesecondmessengercascade,thoughitcanstillbindtheligand.
AlterationstoResponse
107
![Page 108: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/108.jpg)
Receptordown-regulationProlongedexposuretoagonistscausestransmembrane(typicallyhormone)receptorstobecomeinternalised.Thisoccursmoreslowlythanuncoupling.Receptorup-regulationProlongedexposuretoantagonistscausesanup-regulationofreceptor.
Canleadtoreboundeffectswhenadrugisceased(e.g.hypertensionwithcessationofclonidine)ExhaustionofmediatorsSimilartotachyphylaxis-depletionofamediatingsubstancedecreasestheeffect.PhysiologicaladaptationActionsofadrugmaybecounteredbyacompensatoryhomeostaticresponse.Activeremovalofthedrugfromthecell
AlterationsinDrugResponse:PatientFactors
Pharmacokineticsandpharmacodynamicsareaffectedinpregnancyandatextremesofage.
Pregnancy
AbsorptionDecreasedgastricemptyingNauseaandvomitingIncreasedcardiacoutput
IncreasesIMandSCabsorptionVolatiles:
IncreasedonsetduetoincreasedMVandreducedFRCDecreasedonsetduetoincreasedCO
DistributionIncreasedV dueto:
IncreasedTBWIncreasedplasmavolumeIncreasedfatmass
Decreasedalbuminandα -glycoprotein
MetabolismNochangetoHBFProgesteroneinducesenzymesOestrogencompetesforenzymesDecreasedplasmacholinesteraseactivity
EliminationIncreasedRBFIncreasedGFR
PharmacodynamicDecreasedMACIncreasedLAsensitivityduetodecreasedα -glycoprotein
Foetus
Drugsthatcrosstheplacentacanbeteratogenictothefoetus,besidesexertingtheirusualpharmacologicaleffects.
Pharmacokineticfactorspredominantlyaffectplacentaltransfer,andinclude:
D
1
1
AlterationstoResponse
108
![Page 109: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/109.jpg)
LipidsolubilityLipidsolubledrugsdiffusemorerapidly.MolecularsizeDrugswithamolecularweight>1000daltoncrosstheplacentaslowly.ProteinbindingPlacentaltransportersSomemedicationsareactivelyremovedfromfoetalcirculation.PlacentalmetabolismTheplacentacanmetabolisesomemedications,althoughinsomecasesresultsintoxicmetabolites.
Maternalpharmacodynamicfactorspredominantlyaffecttheuterusandbreast,butmajororgansystemsarenotsignificantlyaffected.
Drugsthatcrosstheplacentacanhavedramaticeffectsinthefoetus.Theseinclude:
TeratogenesisAdrugwhichadverselyaffectsfoetaldevelopmentcausingapermanentabnormality.Multifactorialmechanismsthatarenotwellunderstood.
Neonates
At<1yearofage,pharmacokineticsaresignificantlyaltered:
AbsorptionDelayedgastricemptying,increasingabsorptionofdrugsmetabolisedinthestomachDecreasedsecretionofpancreaticenzymesandbilesaltsimpairsabsorptionoflipidsolublemedicationsSmallermusclemassandhigherrelativemusclebloodflowincreasesIMonsetIncreasedV :FRCratioincreasesonsetofvolatiles
DistributionTBWis70-75%(comparedto50-60%foranadult),andextracellularwateris40%(comparedto20%),whichtypicallyincreasesVPreterminfantshavereducedbodyfatGreaterproportionofcardiacoutputgoestohead,increasingonsetofcentrallyacting(e.g.anaesthetic)drugsDecreasedalbuminandα -glycoproteinImmatureBBBincreasesuptakeofpartiallyioniseddrugs
MetabolismEnzymaticcapacityofallpathwaysisreduced,whichprolongseliminationhalf-livesandreducesclearance.
HepaticallymetaboliseddrugsmustbedoseadjustedaccordinglyTheglucuronidepathwaymaynotmatureuntilage4
ExcretionGFRisproportionallyloweranddosenotreachadultequivalenceuntil6-12months
GFRisfurtherreducedinpre-terminfantsGFRisincreasedin1-3yearolds
PharmacodynamicSmallerAChreservesincreasesensitivitytoNMBsIncreasedMACbutmorerapidonsetNSAIDscauseclosuresofductusarteriosus
Geriatric
A
D
1
AlterationstoResponse
109
![Page 110: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/110.jpg)
Thoughthereisalineardecreaseinfunctionalcapacityofmajorsystemsbeginningat45,alterationsarepredominantlyaconsequenceofpolypharmacyanddruginteractions.
AbsorptionLaxativesandprokineticincreasegastricemptyingandreduceabsorptionoforalagents
DistributionThereisaproportionalincreaseinfatThereisaproportionaldecreasein:
LeanbodymassTotalbodywaterAlbumin
Metabolism↓Hepaticbloodflow↓EnzymaticactivityPhaseI>PhaseII.
EliminationLossofnephronnumberwithagereducesrenalclearance
PharmacodynamicIncreasedsensitivitytosedatives,opioids,andhypnoticsDecreasedsensitivitytoβ-agonistsandantagonistsDecreasedMACPolypharmacyincreasespotentialfordruginteractions
AlterationsinDrugResponse:DiseaseFactors
CardiacDisease
AbsorptionDecreasedcardiacoutputdecreasesPOabsorptionduetodecreasedgradient
DistributionDecreasedCOprolongsarm-braincirculationtimeIncreasedα -glycoproteinincreasingbindingofbasicdrugsDecreasedV
MetabolismLow-cardiacoutputstatesreducehepaticflowandwillreducemetabolismofdrugswithahighextractionratioHigh-outputstateshavetheoppositeeffect
EliminationDecreasedrenalbloodflow
HepaticDisease
AbsorptionPorto-cavalshuntingDecreasedfirstpassmetabolism.
DistributionImpairedsyntheticfunctionreducesplasmaproteinsandincreasesunboundfractionIncreasedV duetofluidretention
1D
D
AlterationstoResponse
110
![Page 111: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/111.jpg)
Metabolicacidosischangesionisedfraction
MetabolismImpairedphaseIandIIreactionsReducedplasmaesteraselevels
EliminationReducedbiliaryexcretion
PharmacodynamicsHepaticencephalopathyincreasessensitivitytosedativesandhypnotics
RenalDisease
AbsorptionUraemiaprolongsgastricemptying
DistributionIncreasedV duetofluidretentionMetabolicacidosisadjustsionisedfraction
MetabolismBuildupoftoxicmetabolitesmayinhibitdrugtransportersUraemictoxinsinhibitenzymesanddrugtransporters
EliminationReducedclearanceofactivemetabolites/activedrugclearedrenally
Obesity
Absorption:DelayedgastricemptyingDecreasedsubcutaneousbloodflowPracticaldifficultywithIMadministration
Distribution:IncreasedV oflipidsolubledrugs
Dosingoflipid-solubledrugsbyactualbodyweightDosingofwater-solubledrugsbyleanbodyweight
IncreasedCOIncreasedα -glycoproteinIncreasedbloodvolumeGreaterlipidbindingtoplasmaproteins,increasingfreedrugfractions
Metabolism:IncreasedplasmaandtissueesteraselevelsNormalorincreasedhepaticenzymes
EliminationIncreasedrenalclearanceduetoincreasedCO
Non-SpecificAlterationstoDrugResponse
Absorption:
Siteofadministration
D
D
1
AlterationstoResponse
111
![Page 112: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/112.jpg)
Drugsgivencentrallywillactfasterthanthosegivenintoperipheralveins.RateofadministrationFasterrateofadministrationwillincreaserateofonset.
Pharmacodynamic
DrugtoleranceIncreaserequirementofdrug.e.g.inductionanaestheticagentsinpatientstoleranttoCNSdepressants.
DruginteractionMaybe:SynergisticAdditiveAntagonistic
References
1. AndersonC.VariabilityinDrugResponse1.ICUPrimaryPrep.2. RangHP,DaleMM,RitterJM,FlowerRJ.RangandDale'sPharmacology.SixthEdition.ChurchillLivingstone.3. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.4. CICMExaminerReport:Sep/Nov20125. AlfredAnaestheticDepartmentPrimaryExamTutorialSeries
Lastupdated2019-07-18
AlterationstoResponse
112
![Page 113: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/113.jpg)
PharmacogeneticsOutlinegeneticvariability.
Explainthemechanismsandsignificanceofpharmacogeneticdisorders(egmalignanthyperpyrexia,porphyria,atypicalcholinesteraseanddisturbanceofcytochromefunction).
Geneticpolymorphismoccurswhenseveralfunctionallydistinctgenesexistwithinapopulation.Geneticpolymorphismis:
CommonImportantindetermininganindividualssusceptibilitytoadversedrugreactionsAgoalofpersonalisedmedicineAimstoadjustdrugtherapiesforinterpatientvariability.
Pharmacogeneticdisorders
Pseudocholinesterase
Aconditionwhereplasmacholinesteraseisunabletobreakdownsuxamethonium,prolongingitsdurationofaction.Thisdisease:
MaybecongenitaloracquiredCongenitalisautosomalrecessiveHasfouralleles
UsualAtypical(dibucaine-resistant)Silent(absent)Fluoride-resistance
AcquiredisduetoalossofplasmacholinesterasePregnancyOrganfailure
HepaticRenalCardiac
MalnutritionHyperthyroidismBurnsMalignancyDrugs
OCPKetamineLignocaineandesterlocalanaestheticsMetoclopramideLithium
HasbeentraditionallymeasuredusingthedibucainenumberDibucaineis:
AnamidelocalanaestheticwhichinhibitsplasmacholinesteraseDifferentformsareinhibitedtodifferentextents,withgreaterinhibitionindicatingalessseveremutation.
Percentageinhibitioncorrelateswithdifferentgenotypes,e.g.:Normal(Eu:Eu)hasadibucainenumberof80(80%inhibited)
Pharmacogenetics
113
![Page 114: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/114.jpg)
Dibucaineresistant(Ea:Ea)hasadibucainenumberof20(20%inhibited)Notethatacquireddiseasewillhaveanormaldibucainenumber,astheenzymeitselfisworkingcorrectly,howeverdoesnotexistinalargeenoughquantitytometabolisesuxamethoniumrapidly
G6PD
Acommonx-linkedrecessiveconditionthatmaycausehaemolysisfollowingadministrationofoxidativedrugs.Theseinclude:
AspirinSulfonamidesSomeantibiotics
MalignantHyperthermia
Autosomaldominantdeficiencyintheskeletalmuscleryanodinereceptorgeneresultinginadefectofintracellularcalciumregulation.Thismutation:
Causesmassivecalciumreleasefromsarcoplasmicreticuluminthepresenceofvolatileanaestheticagents(andpotentiallysuxamethonium)Leadsto:
IncreasedmuscleactivityRapidincreaseinbodytemperatureandlacticacidosisHighmortalityfromhyperthermia,hyperkalaemia/rhabdomyolysis,leadingtoventriculararrhythmiaandcardiacarrest
Mutationpresentin1:5,000-1:50,000Presentswith:
Initially:TachycardiaMasseterspasmHypercapneaArrhythmia
Intermediate:HyperthermiaSweatingCombinedmetabolicandrespiratoryacidosisHyperkalaemiaMusclerigidity
Late:Rhabdomyolysis
MyoglobinuriaElevatedCK
CoagulopathyCardiacarrest
Managementconsistsof:Ceaseadministrationofvolatile
StartTIVAGivedantrolene
2.5mg.kg incrementsupto10mg.kg20mgvialsreconstitutedwith60mlsterilewater
3gmannitolasadditiveHighlyalkaline
-1 -1
Pharmacogenetics
114
![Page 115: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/115.jpg)
Damagingifextravasationoccurs.Treatcomplications:
HyperkalaemiaHyperthermiaAcidosisArrhythmiasRenalfailure
Porphyria
Autosomaldominantdeficiencyinthefirststepofhaemesynthesis.Thesemutations:
ResultinapartialdeficiencyofenzymesLeadtoaccumulationofporphyrinprecursorsMaybeprecipitatedbymanydrugs:
KetamineClonidineKetorolacDiclofenacPhenytoinErythromycinBarbiturates
References
1. RangHP,DaleMM,RitterJM,FlowerRJ.RangandDale'sPharmacology.SixthEdition.ChurchillLivingstone.2. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.3. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.
Lastupdated2019-07-18
Pharmacogenetics
115
![Page 116: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/116.jpg)
DrugsinPregnancyTheTherapeuticGoodsAdministrationclassifiesdrugsforsuitabilityinpregnancybasedonthepotentialofadrugtocause:
BirthdefectsDetrimentaleffectsatbirthProblemsinlaterlife
Theclassificationsystemis:
ValidonlyforthedoseandrouteofadministrationlistedDoesnotapplyinoverdose
Nothierarchical'B'drugsarenotsaferthan'C'drugs
Categories
CategoryATakenbylargenumberofwomenwithoutdetrimentaleffects.
CategoryBSubclassifiedinto:
CategoryB1TakenbyalimitednumberofwomenwithoutdetrimentaleffectAnimalstudiesshownoevidenceofdetrimentaleffecttothefoetus
CategoryB2TakenbyalimitednumberofwomenwithoutdetrimentaleffectAnimalstudiesareinadequateorlacking,butavailabledatashowsnoevidenceofdetrimentaleffecttothefoetus
CategoryB3TakenbyalimitednumberofwomenwithoutdetrimentaleffectAnimalstudiesshowevidenceoffoetaldamage,butthesignificanceofthisinhumansisunknown
CategoryCDrugswhichhavecaused(orasuspectedtocause)detrimentalfoetaleffects,butwithoutmalformationsTheseeffectsmaybereversible
CategoryD
Drugswhichhavecaused(oraresuspectedtocause)anincreasedincidenceoffoetalmalformationsordamageMayalsohavedetrimentaleffects
CategoryX
DrugswhichhaveahighriskofcausingpermanentdamageShouldnotbeusedinpregnancy,orwhenpregnancyispossible
References
1. Australiancategorisationsystemforprescribingmedicinesinpregnancy.TherapeuticGoodsAdministration.
Lastupdated2017-09-23
DrugsinPregnancy
116
![Page 117: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/117.jpg)
DrugsinPregnancy
117
![Page 118: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/118.jpg)
GeneralManagementofPoisoningUnderstandingofthegeneralprinciplesofpoisoninganditsmanagement.
Principlesofmanagementofpoisoning:
"Recognition-Resus-RSI-DEAD"
RecognitionDegreeofemergencyGettingseniorhelpApplicationof100%oxygenearly
ResuscitationA:ControlinanypatientwithsignificantlyimpairedconsciousstateB:Oxygenifnotpreviouslyapplied.Mechanicalventilationifrequired.C:Intravenousaccessisalwaysrequired.Centralvenousaccessmayberequired.D:Glucoselevel.Controlseizures.E:Controlhypothermia
RiskassessmentHistoryincludingtiming,amount,co-administereddrugs,currentpatientstatus.
SupportivecareInvestigations
ECGInvasivemonitoringmayberequiredifhaemodynamicsareunstable.Druglevels
DecontaminationActivatedcharcoalmaybeappropriateifrecentingestion(<1hour)andtheairwayissecured
EnhancedEliminationUsedinseverepoisoningwhensupportivecareislikelytobeinadequate.Includes:
UrinaryalkalinisationFiltration
AntidotesE.g.naloxoneforopiates
Disposition
FootnotesLITFLhasafantasticsectionontheapproachtothepoisonedpatientifyouwantmoreinformation.
References1. Nickson,C.ApproachtotheAcutePoisoning.LITFL.2. LeslieRA,JohnsonEK,GoodwinAPL.DrPodcastScriptsforthePrimaryFRCA.CambridgeUniversityPress.2011.
1
Toxicology
118
![Page 119: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/119.jpg)
Lastupdated2019-07-18
Toxicology
119
![Page 120: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/120.jpg)
TricyclicAntidepressantOverdoseTricyclicantidepressantsareweakbasestypicallyusedfordepressionandasanadjunctforanalgesia.Theyhaveacomplexmechanismofaction,competitivelyinhibitingnoradrenalineandserotoninreuptake,andalsoblockingmuscarinicreceptors,histaminergicreceptors,α-adrenoreceptors,GABA-areceptors,andfastsodiumchannels.
Toxicity
Inoverdose,toxicityispredominantlyduetocardiacandcentraleffects,thoughthereareeffectsonmostofthemajororgansystems.
Cardiactoxicity
Cardiactoxicityisduetoantagonismofα-adrenoreceptorsuse-dependentblockadeoffastsodiumchannels.
α-antagonismresultsinvasodilatationandsubsequenthypotension.Hypotensionmayalsobeduetomyocardialdepressionfromsodiumchannelblockade.
BlockadeoffastsodiumchannelsoccursintheHis-Purkinjesystem,aswellastheatrialandventricularmyocardium.Thisresultsindecreasedmyocardialimpulseconduction.Theyblockchannelsintheinactivatedstate,resultinginause-dependentblockadesuchthattheeffectisgreateratfasterheartrates.Thisresultsinanincreaseddepolarisationandrepolarisationtime.ECGfindingsareconsistentwiththisandareessentiallypathognomonic:
WidenedQRSRightaxisdeviationoftheterminalQRS⩾3mmterminalRwaveinaVR.
AdditionalECGfindingsinclude:
TachycardiaAnydegreeofheartblockVentriculararrhythmias
Centraltoxicity
Centraltoxicityispredominantlyduetoanticholinergiceffects,thoughantihistaminiceffectscontribute.
Anti-cholinergiceffectstendtooccurpriortocardiaceffects,andinclude:
ConfusionAgitationSeizuresPupillarydilatationandblurredvision
Antihistaminiceffectsincludeobtundation.
Management
Standardmanagementofpoisoningapplies.TCAsarenotdialysableandastheyareweakbasesarenotamenabletourinaryalkalinisation.
TCAOverdose
120
![Page 121: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/121.jpg)
Cardiactoxicity
NaHCO andhyperventilationtoapH>7.5isusedtomanagecardiactoxicity.Thereareanumberofproposedmechanismsofactionforthebenefitofalkalinisation:
PlasmaalkalosisresultsinlessioniseddrugandincreasesdistributionintotissuesPlasmaalkalosisincreasesproteinbindingofdrugIntracellularalkalosisresultsinlessboundintracellulardrug,favouringitsmovementoutofcellsExtracellularalkalosisresultsinreducedH /K exchange,increasingintracellularpotassiumandhypopolarisingthecell.
Inadditiontothealkalinisingeffects,sodiumloadfromtheNaHCO improvesthesodiumconcentrationgradientintocells
α-adrenoreceptorantagonismcanbecounteredwithuseofanα-agonistsuchasnoradrenaline.
Arrhythmiasshouldbemanagedwithdrugsthatdonotprolongtheactionpotential-soamiodaroneandbeta-blockersarecontraindicated.InitialmanagementshouldbeusingNaHCO ,thoughMgSO andlignocainecanbeconsideredinrefractorycases.
Centraltoxicity
Seizuresshouldbemanagedwithbenzodiazepines,phenytoin,propofol,andphenobarbital.AvoidagentswhichresultinQRSprolongation.
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. RangHP,DaleMM,RitterJM,FlowerRJ.RangandDale'sPharmacology.6thEd.ChurchillLivingstone.3. CICMJuly/September20074. SalhanickSD,TraubSJ,GrayzelJ.TricyclicAntidepressantPoisoning.In:UpToDate,Post,TW(Ed),UpToDate,Waltham,
MA,2017.5. Nickson,C.ToxicologyConundrum22.LITFL.6. Nickson,C.TricyclicAntidepressantToxicity.LITFL.7. UpToDate.Tricyclicantidepressantpoisoning
Lastupdated2019-07-20
3
+ +
3
3 4
TCAOverdose
121
![Page 122: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/122.jpg)
OrganophosphatePoisoningOrganophosphatesaresubstancesbindirreversiblytoacetylcholinesterase,causingcholinergicexcess.Examplesincludefertilisersandsaringas.
Toxicity
Effects(asexpected)aresignsofmuscarinicandnicotinicover-activation.Thiscanberememberedby'BLUDGES'forthemuscariniceffects:
Bradycardia(andsubsequenthypotension)LacrimationUrinationDefecationGITupsetEmesisSweatingandSalivation
and'M'forthenicotiniceffects:
Muscularspasm
Management
ManagementisaimedatreducingAChburden:
AtropineCompetitiveantagonisesAChatthemuscarinicreceptor.
AtropineispreferredoverglycopyrrolateasitwillcrossthebloodbrainbarrierandtreatcentralAChtoxicityPralidoximeReactivatesacetylcholinesterasebyluringtheorganophosphateawayfromtheenzymewithatantalisingoximegroup.
PralidoximemustbeusedwithinthefirstfewhoursofpoisoningAfterwhichtheorganophosphate-enzymegroup'ages'andisnolongersusceptible.Doesnotcrosstheblood-brainbarrierandsocannottreatcentraleffects
References
1. CICMMarch/May20092. RangHP,DaleMM,RitterJM,FlowerRJ.RangandDale'sPharmacology.6thEd.ChurchillLivingstone.
Lastupdated2019-07-18
Organophosphates
122
![Page 123: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/123.jpg)
TheCellMembraneDescribethecellmembraneandcellularorganellesandtheirproperties.
Cellmembranesare:
FormedbyaphospholipidbilayerSeparatestheintracellularandextracellularfluid.Semi-permeableLeadstodifferentionicconcentrations(andthereforeelectricalcharge)oneithersideofthemembrane.
Alterationinchargemeansthemembraneactsasacapacitor,withmostcellshavingarestingpotential70-80mVlowerthanextracellularfluid
IonPermeabilityAtrest,thecellis:
PermeabletopotassiumPotassiumflowsoutdownitsconcentrationgradientThismakestherestingpotentialbecomesmorenegative.
Thisnegativechargeopposesthefurthermovementofpotassiumandsoanequilibriumisestablishedbetweenopposingelectricalandchemicalgradients
ImpermeabletoothercationsThemembraneisnotperfectlyimpermeabletosodium,andNa willleakindownitsconcentrationgradient.
The3Na -2K ATPasepumpsthreesodiumionsoutsideinexchangefortwopotassiumionsinordertomaintainthesegradientsAsthereisanunequalexchangeofcharge,thispumpiselectrogenic.
Ion [Intracellular] [Extracellular]
Na 15 140
K 150 4.5
Cl 10 100
References
1. BarrettKE,BarmanSM,BoitanoS,BrooksHL.Ganong'sReviewofMedicalPhysiology.24thEd.McGrawHill.2012.2. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2018-06-25
++ +
+
+
-
CellularPhysiology
123
![Page 124: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/124.jpg)
OrganellesDescribethecellmembraneandcellularorganellesandtheirproperties
Organellesarespecialisedfunctionalsubunitswithinacell,typicallycontainedwithintheirownlipidbilayer.
Keyorganellesinclude:
MitochondriaEndoplasmicreticulumGolgiapparatus
Mitochondria
Mitochondria:
ProduceATPviaaerobicmetabolismOnlymethodofaerobicmetabolisminthebody.
MitochondriaexistingreaternumbersinmoremetabolicallyactivecellsConsistoftwomembranes(outerandinner),whichcreatethreespaces,
CytoplasmOutsidetheoutermembrane.IntermembranespaceBetweenthemembranes.
Outermembraneseparatesmitochondriafromcytoplasm,butcontainsporesallowingsomesubstances(pyruvate,aminoacids,fattyacids)topassInnermembrane:
Isolatestheelectrontransportchainfromtheintermembrane(spacebetweeninnerandoutermembranes)space.ProteinsontheinnermembraneconducttheredoxreactionsimportantforATPproductionElectrontransportchainpumpshydrogenionsintotheintermembranespace
InnermitochondrialmatrixContentsimportantinmanymetabolicprocesses:
CitricacidcycleFattyacidmetabolismUreacycleHaemesynthesis
References
1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2019-07-18
Organelles
124
![Page 125: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/125.jpg)
ExcitableCellsExplainthebasicelectro-physiologyofneuraltissue,includingconductionofnerveimpulsesandsynapticfunction.
MembranePotential
Atrest,membranesare:
PermeabletopotassiumImpermeabletoothercations
Generationofmembranepotential:
IntracellularpotassiumconcentrationismuchhigherthanextracellularpotassiumconcentrationDuetotheactionoftheNa -K pump.Asthemembraneispermeabletopotassium,potassiumwillattempttodiffusedownthisgradient,generatinganegativeintracellularchargewhichopposesfurtherdiffusionAtsomepoint,anelectrochemicalequilibriumisreachedbetween:
TheconcentrationgradientdraggingpotassiumoutofthecellNegativeelectricalchargepullingitin
ThisequilibriumistherestingmembranepotentialRMPisdeterminedby:
PermeabilityofthemembranetodifferentionsRelativeionicconcentrationsoneithersideofthemembrane
ImpermeableionsdonotcontributetotherestingmembranepotentialAlteringmembranepermeabilitycausesaflowofionsandachangeinvoltage.
NernstEquation
ThepotentialdifferencegeneratedbyapermeableioninelectrochemicalequilibriumwhentherearedifferentconcentrationsoneithersideofthecellcanbecalculatedviatheNernstEquation:
,where:
istheequilibriumpotentialfortheion
isthegasconstant(8.314J.deg .mol )
isthetemperatureinKelvin
isFaraday'sConstantistheionicvalency(e.g.+2forMg ,-1forCl )
Goldman-Hodgkin-KatzEquation
TheNernstequationdescribestheequilibriumpotentialforasingleion,andassumesthatthemembraneiscompletelypermeabletothation.
However,calculationofmembranepotentialrequiresexaminingtheeffectsofmanydifferentionswithdifferentpermeability.ThiscanbeperformedwiththeGoldman-Hodgkin-Katzequation:
+ +
-1 -1
+2 -
ExcitableCells
125
![Page 126: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/126.jpg)
,where:
isthepermeabilityconstantfortheion,
Ifthemembraneisimpermeableto ,then .
Notethat:
ThismodeldoesnotconsidervalencyTheconcentrationsofnegativeionsarereversedrelativetopositiveions
ActionPotential
Excitablecellscanrespondtoastimulusbyachangingtheirmembranepotential.Thismaybemediated:
Chemicallye.g.AChreceptorscausingNa channelstoopen.PhysicallyPressurereceptorsphysicallydeformingandopeningNa channels.
StimulatinganexcitablecellincreasesNa permeabilityThisincreases(i.e.makeslessnegative)membranepotentialIfseveralstimuli,oralargeenoughstimuliraisesthemembranepotentialabovethethresholdpotential,thenanactionpotentialwillbegeneratedThisisduetofastNa channels
Alsoknownasvoltage-gatedNa channelsOpenwhenmembranepotentialexceedsthresholdpotentialThresholdpotentialistypically-55mV.Fastsodiumchannelsgeneratetheall-or-nothingresponse:
StimulibelowthethresholdpotentialdonotgenerateanactionpotentialStimuliabovethresholdpotentialgenerateanactionpotentialThesizeofthestimulusdoesnotaffectthemagnitudeoftheactionpotential,asthisisdeterminedbythefastsodiumchannels.
KeyPlayersintheActionPotential
FastNa channelsareresponsiblefordepolarisation.Theyexistinthreestates:
ClosedImpermeabletoNa .OpenPermeabletoNa .Occurswhenthemembranepotentialreachesthresholdpotential.
Differentvoltage-gatedchannelsmayhaveslightlydifferentopening(threshold)potentialsInactivatedImpermeabletoNa .Occursshortlyaftertheopenstate,andlastsuntilthemembranepotentialfallsbelow-50mV.
Voltage-gatedK channels:
ArevitalforrepolarisationOpenslowlywithdepolarisationThisincreasespotassiumpermeabilityandreducesmembranepotential.
PhasesoftheActionPotential
+
+
+
++
+
+
+
+
+
ExcitableCells
126
![Page 127: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/127.jpg)
Thisdescribestheperipheralnerveactionpotential.Theheartiscoveredunderthecardiacactionpotential.
1. RisingPhaseAstimuluswhichrisesabovethethresholdpotentialopensfastNa channels,increasingNa influx.
AdditionalNa hasapositivefeedbackeffect,causingadditionalNa channelstoopenandfurtherdepolarisationThisdrivesthemembranepotentialtowardstheNernstequilibriumforNa
2. PeakPhaseInactivationoffast-channelsanddelayedactivationofK channelsslowsdepolarisation.
Membranepotentialpeaksat30mV3. FallingPhase
Aspotassiumexitsthecell,membranepotentialcontinuestofall.Voltage-gatedK channelsstarttocloseat-50mVInactivationoffastsodiumchannelsdefinestheabsoluterefractoryperiodNoNa canbeconducted,regardlessoftheintensityofthestimulus,andsoanactionpotentialcannotbegenerated
Theabsoluterefractoryperiodlasts~1ms4. Hyperpolarisation
Aspotassiumchannelscloseslowly,themembranepotentialslightlyundershootsrestingpotential,causingslighthyperpolarisationofthecell.
ThisistherelativerefractoryperiodAlargeenoughstimulusmayovercometheadditionalhyperpolarisationandgenerateasecondactionpotential.
Therelativerefractoryperiodlasts10-15ms5. Resting
Cellisstableatrestingmembranepotential.
PropagationoftheActionPotential
AnincreaseinNa inoneregionwilldiffusedownthecell,raisingthemembranepotentialabovetherestingpotentialintheadjacentmembraneThiscauseslocalfastNa channelstoopen,andthecelldepolarisesThisresultsinapropagatingwaveofdepolarisationandrepolarisation
RegionsofanervecellcoveredbyamyelinsheathdonothaveionchannelsInthesecells,propagationissaltatoryThisdescribesthe"jumping"oftheactionpotentialbetweengapsinthemyelinsheath.
ThesegapsareknownasnodesofRanvierIonchannelsgenerateanactionpotentialatthenodesintheusualmanner.Betweennodes,conductionisvialocalelectricalcurrents
Myelination:IncreasesconductingvelocityReducesenergyexpenditureViareductionintotalionflux.
ClassificationofNerveFibres
Classifiedontheirdiameterandconductionvelocity:
TypeAMyelinated,12-20μmindiameter,conductat70-120m.s .Subdividedinto:
AαMotorfibres.AβTouchfibres.
+ ++ +
+
+
+
+
+
+
-1
ExcitableCells
127
![Page 128: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/128.jpg)
AγIntrafusal(proprioceptive)musclefibre.AδPainfibres.
TypeBMyelinated,<3μm,conductat4-30m.s .Innervatepre-ganglionicneurons.TypeCUnmyelinated,1μm,conductat0.5-2m.s .Painfibres.
References1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2019-07-18
-1
-1
ExcitableCells
128
![Page 129: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/129.jpg)
TransportAcrossCellMembranesExplainmechanismsoftransportofsubstancesacrosscellmembranes,includinganunderstandingoftheGibbs-Donnaneffect.
Substancescancrosscellmembranesbydiffusion,activetransport,andexo-orendocytosis.
Diffusion
Thereareseveraltypesofdiffusion:
SimplediffusionMoleculespassthroughthecellmembraneorviaachannel.Thisprocessispassive,andoccursdownaconcentrationgradient.
Onlylipidsolublemolecules(gases,steroids)canpassdirectlythroughthelipidbilayerwithoutaspecialisedchannelVoltage-gatedandligand-gatedchannelsfacilitatesimplediffusion
Facilitateddiffusion(uniporters)Moleculesbindtoacarrierprotein,andmovetogetherthroughthelipidbilayer,beforeseparatingontheotherside.Facilitateddiffusionisconcentrationgradient-dependent,andlimitedbytheamountofcarrierproteinavailable..
Therateandextentofdiffusionisaffectedby:
HydrostaticpressuregradientsConcentrationgradientsElectricalgradients
ActiveTransport
Substancesthataremovedagainstaconcentrationgradientrequireactivetransport,andrequiresenergyintheformofATP.Activetransportmechanismsmaybe:
PrimaryactivetransportThesubstanceitselfismoved.SecondaryactivetransportThesubstancemovesagainstaconcentrationgradientwithanothermoleculethathadagradientestablishedbyactivetransport.
Thismoleculeistypicallysodium
Co-transporters(symporters)Usescarrierproteinsandmovestwosubstances(e.g.sodiumandanaminoacid)acrossamembrane.
Thisprocesswillbepassiveiftheenergygainedmovingonesubstancedownitsconcentrationgradientisgreaterthantheenergyrequiredtomovetheothersubstanceupitsconcentrationgradient
Counter-transporters(antiporters)Usecarrierproteinsandmovestwosubstancesinoppositedirectionsacrossthemembrane.
Maybeactiveorpassive
Keytransportersinclude:
TheNa -K ATP-asepumpThismovesthreesodiumionsoutofacellandtwopotassiumionsin,cleavingoneATPintheprocess.Thispumphasmanyfunctions:
+ +
TransportAcrossMembranes
129
![Page 130: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/130.jpg)
Maintenanceofcellularvolume(whichwouldotherwiseburstfromtheinfluxofwaterwithchangingECFtonicities)bynetlossofosmolesMaintenanceofthepotentialdifferenceacrossthemembraneEstablishmentofchemicalgradientstobeusedinsecondaryactivetransportmechanism
e.g.ReabsorptionofglucoseinthekidneyviatheS-GLUTtransporter
Exo-andEndocytosis
Theseprocessesdescribetheformationofavesicle(typicallyfrommembranephospholipid)totransportsubstances:
ExocytosisVesiclecontainingasubstancetobesecretedfuseswiththecellmembranewhenactivatedbycalcium,depositingthesubstanceoutsidethecell.
EndocytosisThecellmembraneinvaginatesaroundthesubstance,absorbingthesubstanceintothecell.Avesicle(orvacuole)mayormaynotbecreated.Endocytosismaybesubdividedinto:
Phagocytosis,whereleukocytesengulfbacteriaintoavacuolePinocytosis,wheresubstancesareendocytosedbutnotintoavacuole
Gibbs-DonnanEffectDescribesthetendencyofdiffusableionstodistributethemselvessuchthattheratiosoftheconcentrationsareequalwhentheyareinthepresenceofnon-diffusableions.
TheGibbs-DonnanEffect:
Occurswhen:Asemi-permeablemembraneseparatestwosolutionsAtleastoneofthosesolutionscontainsanon-diffusableion
Thedistributionofpermeablechargedionswillbeinfluencedbyboththeirvalenceandthedistributionofnon-diffusableions,suchthatatequilibriumtheproductsoftheconcentrationsofpairedionsoneachsideofthemembranewillbeequal:
Alterstonicityoneithersideofthecellmembrane,causingmovementofwaterwhichthenupsetstheGibbs-DonnaneffectThisresultsinno'steady'stablestate.
ThetwomaincontributorstotheGibbs-Donnaneffectinthebodyaresodiumandprotein.Thisoccursbecausecellmembranes:
AreimpermeabletoproteinIntracellularproteinconcentrationishigh.EffectivelyimpermeabletosodiumDuetotheNa -K ATP-asepump.
ChangingGibbs-Donnanequilibriumsalsochangethetonicityoneachsideofthecellmembrane,causingmovementofwaterwhichthenupsetstheGibbs-Donnaneffect-thereforethereisnostablestate.
TheGibbs-DonnanEffectisimportantfor:
MaintenanceofcellvolumeNa actsasaneffectiveosmole,reducingcellularswelling.PlasmaoncoticpressureIncreasedplasmaionconcentrationincreasesoncoticpressure.
+ +
+
TransportAcrossMembranes
130
![Page 131: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/131.jpg)
RestingMembranePotential
References1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. EatonDC,PoolerJP.Vander'sRenalPhysiology.6thEd(Revised).McGraw-HillEducation-Europe.2004.
Lastupdated2018-09-21
TransportAcrossMembranes
131
![Page 132: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/132.jpg)
FluidCompartmentsTodescribethecompositionandcontrolofintracellularfluid~andthemechanismsbywhichcellsmaintaintheirhomeostasisandintegrity~
Onaverage,thehumanbodyis~60%water.Distributionofwatercontentcanbedividedconceptuallyinto:
IntracellularfluidComposes2/3 oftotalbodywater.ICFis:
NotacontiguousfluidspaceUsefulasthecompositionofcellularcontentsisrelativelyuniform:
PotassiumisthedominantintracellularcationSodiumconcentrationsarelow.ThedominantanionisproteinChlorideconcentrationisrelativelylow.Lowinmagnesium
ExtracellularfluidComposestheremaining1/3 oftotalbodywater,andisfurtherdividedinto:
IntravascularfluidComposes~20%ofECF.Thisreferssolelytoplasmavolume(asthevolumeofbloodfromcellularcomponentsisICF).TheICFis:
Vitalfortransportingnutrients,waste,andchemicalmessengersbetweentheplasmaandcellsTranscellularfluidComposes~7%ofECF,anddescribesthevolumeofCSF,urine,synovialfluid,gastricsecretions,andaqueoushumor.InterstitialfluidComposesthebulkofECFvolume,anddescribesthefluidthatoccupiesthevolumebetweencells.
VariationsActualtotalbodywatercontentvariespredominantlywithfatcontent.Thisleadstodifferencesconcentrationsin:
Neonates~75-80%.Elderly~50%bytheageof60,duetoincreasedadiposity.WomenTypically~55%.
MeasuringVolumesofFluidCompartments
Allmethodsrelyontheindicator-dilutionmethod:
Aknownamount(i.e.knownvolumeofaknownconcentration)ofindicatorwithaffinitytoaparticularcompartmentisgivenandallowedtoequilibrateTheconcentrationoftheindicatoristhenmeasuredThedifferencebetweenthemeasuredconcentrationandtheinitialconcentrationisproportionaltothevolumeofthecompartment
Indicatorsusedforcalculationof:
rds
rd
FluidCompartments
132
![Page 133: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/133.jpg)
PlasmavolumeAcolloidthatwillberetainedinthevascularcompartment;e.g.radio-labeledalbumin.ECFvolumeAsubstancewhichcanentertheinterstitiumbutnotcells;e.g.thiosulfate.Totalbodywater
Asubstancewhichcanenterallcompartmentsfreely;e.g.heavywater( ).ICFvolumeCanbemeasuredbythedifferencebetweencalculatedECFvolumeandTVW.
References1. Brandis,K.FluidCompartments.AnaesthesiaMCQ.2. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2019-07-18
FluidCompartments
133
![Page 134: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/134.jpg)
CellHomeostasisTodescribethe~compositionandcontrolofintracellularfluidandthe~mechanismsbywhichcellsmaintaintheirhomeostasisandintegrity
CellularrespirationdescribestheproductionofATPthroughaseriesofredoxreactions.Oxygenisusedastheoxidisingagent,whilstthecatabolicfuelmaybeglucose,fat,orprotein.
Cellularrespirationcanbebrokendowninto:
Glycolysis/Lipolysis/ProteolysisCitricAcidCycleElectronTransportChain
Glycolysis
Glycolysis,ortheEmbden-Meyerhofpathway,describestheproductionofpyruvatefromglucose.Glycolysis:
OccursinthecytoplasmBeginswiththephosphorylationofglucosetoglucose-6-phosphateProduces:
2ATP2Pyruvate2NADH
NotethatoxygenisnotconsumedandcarbondioxideisnotproducedInaerobicconditions:NADHexchangeselectronsacrossthemitochondrialwall,regeneratingNAD andallowingglycolysistocontinueInanaerobicconditions:NAD isregeneratedthroughtheproductionoflactate
Whenaerobicconditionsarerestored,lactatecanbeoxidisedbacktopyruvateandentertheCACTransportedtotheliverandconvertedbacktopyruvate(andentertheCAC),orproduceglucose(Coricycle)
CitricAcidCycle/Kreb'sCycle
TakesplaceinthemitochondriaComplicatedCantakemanyvarioussubstrates:
AcetylCoAProducedbyβ-oxidationoffattyacidsandpyruvate.PyruvateKetoacids
Doesnotconsumeoxygenbutalsodoesn'tfunctionunderanaerobicconditions,duetoitsrequirementonfreshNADfromtheETCProduces:
NADHFADHCO
+
+
+
22
CellHomeostasis
134
![Page 135: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/135.jpg)
ElectronTransportChain
Finalstageofcarbohydrate,fat,andproteincatabolismETCconsistsoffiveproteincomplexesElectronsarepassedalongthechainandcombinewithoxygen,releasingenergywhichstimulatesthemovementofhydrogenionsEachtimeahydrogenioncrossesthemitochondrialmatrix,anATPisproduced
ThisiscalledcoupledphosphorylationUncoupledphosphorylationallowshydrogenionstotraveldowntheirgradientwithoutgeneratingATP,whichproducesexcessheatinstead
36-38ATPareproducedbyaerobicglycolysisSourcesdisagreeonexactlyhowmuchATPisproduced.
2fromtheEmbden-Meyerhofpathway34-36fromtheCACandETC
References
1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2019-07-18
CellHomeostasis
135
![Page 136: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/136.jpg)
AirwayandAlveolarAnatomyDescribethefunctionandstructureoftheupper,lowerairwayandalveolus.
UpperAirway
Theupperairwayconsistsofthe:
MouthNasalcavity
HairsfilterlargeparticlesOlfactoryreceptorsdetectharmfulgasespriortoinhalation
PharynxLarynx
Breathingcanbeoralornasal.Nasalbreathingoffers:
Goodhumidificationandfiltrationofinhaledparticlesbecausetheseptumandturbinateshave:HighmucosalsurfaceareaHighmucosalbloodflowGenerateturbulentflow
HighresistancetoflowAtahighminuteventilation,oralbreathingisfavoured.
Structures
PharyngealdilatormusclesIncludinggenioglossusandlevatorpalati.Preventpharyngealcollapseduringnegative-pressureventilationandduringsleep.
LarynxImportantforairwayprotection,speech,andeffortclosure.
PreventsaspirationduringswallowingbyelevatingtheepiglottisandoccludingofthearyepiglotticfoldsPhonationisachievedbyadjustingtension(andthereforeresonance)ofthevocalcordsbyactionofthecricothyroidDuringinspiration,cricoarytenoidmusclesrotatethearytenoidcartilageandabductthevocalcordstoreduceresistancetoairflowDuringexpiration,thethyroarytenoidmusclesadductthecordsandincreaseresistance,providingintrinsicPEEP
3-4cmH OofPEEPisgeneratedMaintainspatencyofsmallairwaysPreventsalveolarcollapseandthereforemaintainsFRC.
Effortclosureistighterocclusionofthelaryngealinlet,inwhichthearyepiglotticmusclescontractstronglytoactasasphincter,allowingtheairwaytowithstandupto120cmH Oofpressure.
LowerAirwayThelowerairwayconsistsofthetracheobronchialtree:
Fromtracheatoalveolus,theairwaysofthelungsdivide23timesThetracheobronchialtreeisdividedintotwozones,basedonwhethertheycontainalveoliandthereforeareabletoparticipateingasexchange:
Theconductingzoneisthefirst16divisions
2
2
RespiratorySystem
136
![Page 137: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/137.jpg)
Therespiratoryzoneisthelast7divisions
ConductingZone
Thefirst16divisionsconstitutetheconductingzone:
Anatomically,theconductingzoneconsistsof:Trachea
Meandiameterof1.8cmandalengthof11cmD-shapedcrosssectionCurvedcartilagesanteriorlyandlongitudinalmuscle(trachealis)posteriorly.Externalpressureof40cmH Oissufficienttooccludetheextrathoracictrachea.Flowistypicallyturbulentinthetracheaandlargeairways
BronchiComprisethefirstfourdivisionsofthetracheaRightmainbronchusiswideranddeviateslessfromtheaxisofthetrachea(theleftmainbronchushasatighterturnovertheheart),whichiswhyforeignbodieswilltendtotherightsideThetwomainbronchidivideintoatotalof5lobarbronchi,whichinturndivideintoatotalof18segmentalbronchi
Cross-sectionalareaoftherespiratorytractislowestatthethirddivisionThesebronchiwillcollapsewhenintrathoracicpressureexceedsintraluminalpressureby~5cmH O.SegmentalbronchitravelwithbranchesofthepulmonaryarteryandlymphaticsThesearethebronchithatdemonstrateperibronchialcuffingandperihilarhazeinearlypulmonaryoedema.Flowistypicallytransitionalinthesmallerbronchiandbronchioles
BronchiolesEmbeddedinthelungparenchymaDonothavecartilageintheirwallstomaintainpatency-areheldopenbylungvolumeResistancetoflowtendstobenegligibleduetolargecrosssectionalarea,unlessthereisspasmofhelicalmusclebandsinbronchialwall
TerminalbronchiolesFlowmaybecomelaminarinthesmallestbronchiolesasflowdecreases
FlowintheconductingzoneduringinspirationisfastandturbulentNogasexchangeoccursintheconductingzoneThevolumeoftheconductingzonethereforecontributestoanatomicdeadspace.Bloodsupplytotheconductingzoneisviathebronchialcirculation
MucousissecretedbygobletcellsinthebronchialwallstotrapinhaledparticlesCiliainthebronchialwallsmoverhythmicallytodrivethemucociliaryelevator,drivingmucousuptotheepiglottis,whereitisthenswallowedorexpectorated
RespiratoryZone
Theremaining7divisionsmakeuptherespiratoryzone.Thisregion:
MakesupthemajorityoflungvolumeAllnon-anatomicaldeadspacevolumeisintherespiratoryzone,andis~30ml.kg (FRC)atrestBloodsupplyisviathepulmonarycirculation
2
2
-1
RespiratorySystem
137
![Page 138: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/138.jpg)
Gasflowintheterminalrespiratoryzoneisslowduetotheexponentialincreaseincross-sectionalareawitheachairwaydivision
Diffusionisthepredominantmechanismofgasmovement
Alveolus
Thealveolusisoptimisedforgasexchange:
SphericalshapemaximisessurfaceareatovolumeratioTotalsurfaceareaoflungalveoliis50-100mAlveolarwallsareextremelythin(0.2-0.3μm)Consequently,theyarefragileandcanbedamagedbyincreasesincapillarypressureAlveolarwallscontainadensemeshofcapillaries7to10μmthick,whichisjustlargeenoughforanerythrocytetopassthroughThealveolar-capillarybarrierconsistsofthreelayers:
TypeIpneumocytesExtracellularmatrixPulmonarycapillaryendothelium
Alveoliarecomposedofthreetypesofcells:
TypeIpneumocytesThin-walledepithelialcellsoptimisedforgasexchange.
Form~90%ofthealveolarsurfacearea
TypeIIpneumocytesSpecialisedsecretorycells.
SecretesurfactantAlveoliareinherentlyunstable,andsurfacetensionofalveolarfluidfavourscollapseofthealveoli.Surfactantreducessurfacetension,allowingthealveolitoexpand.Form~10%ofalveolarsurfacearea
AlveolarmacrophagesAlveolihavenocilia-inhaledparticlesarephagocytosedbyalveolarmacrophagesinalveolarseptaandlunginterstitium.
References1. LumbA.Nunn'sAppliedRespiratoryPhysiology.7thEdition.Elsevier.2010.2. WestJ.RespiratoryPhysiology:TheEssentials.9thEdition.LippincottWilliamsandWilkins.2011.3. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2019-07-18
2
RespiratorySystem
138
![Page 139: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/139.jpg)
ChestWallandDiaphragmDescribethestructureofthechestwallanddiaphragmandtorelatethesetorespiratorymechanics.
Thechestwallisformedbytheribsandintercostalmuscles:
RibsSlopeantero-inferiorly,andareconnectedbytheexternal,internal,andinnermostintercostalmuscles.Intercostalmuscles
Externalintercostalsslopeantero-inferiorlyInternalandinnermostintercostalsslopeinfero-posteriorly
DiaphragmComplexdome-shapedmembranousstructure,consistingofacentraltendonandperipheralmuscles
PerformsthemajorityofinspiratoryworkofbreathingAbletodramaticallyincreaseintraabdominalpressure,soisessentialin:
CoughingVomitingSneezing
RoleinmaintainingloweroesophagealsphinctertoneIthasthreeperforations:
T8forthevenacava(eightletters)T10fortheoesophagus(tenletters)T12fortheaorta,thoracicduct,andazygosvein
Inspiration
Duringinspiration,thediaphragmandexternalintercostalmusclescontractDiaphragmpushestheintraabdominalcontentsdown,increasingthoracicvolumeandgeneratinganegativeintrathoracicpressure
DiaphragmissuppliedbythephrenicnervesfromC3/4/5.Externalintercostalspulltheribsantero-superiorly,whichincreasesthecross-sectionalareaofthechest,furtherincreasingthoracicvolume(andnegativepressure)
IntercostalmusclesaresuppliedbyintercostalnervesfromthesamespinallevelParalysisoftheexternalintercostalsdoesnothaveadramaticeffectoninspiratoryfunctionprovidedthediaphragmisintact
Accessorymusclesincludesternocleidomastoidandthescalene,whichelevatethesternumandfirsttworibsrespectively.Theyareactiveinhyperventilation.
ChestWallandDiaphragm
139
![Page 140: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/140.jpg)
Expiration
ExpirationispassiveduringquietbreathingaselasticrecoilofthelungwillreturnthemtoFRCWhenminuteventilationishigh,expirationbecomesananactiveprocess:
Abdominalwallmuscles(rectusabdominis,internaloblique,externaloblique,transversusabdominis)contract,raisingintraabdominalpressureandforcingthediaphragmupInternalandinnermostintercostalscontract,pullingtheribsdownwardsandinwards,furtherdecreasingthoracicvolume
RespiratoryMechanicsinSpinalInjury
Paralysisoftheabdominalwallmuscles(e.g.spinalinjury)hassignificantaffectonrespiratorymechanics:Intheinitialphasesofinjury,spinalshockresultsinaflaccidparalysisoftheabdominalwall
Intraabdominalpressureislow,andsothediaphragmmovesinferiorlyThisresultsinahigherFRCbutlimitstidalvolumes,ascontractionofthediaphragmonlyincreasethoracicvolumebyasmallfraction.Nursinginasupinepositioncausestheabdominalcontentstopushthediaphragmsuperiorly,causing:
LowerFRCGreaterproportionalexpansionwithrespiration,improvingtidalvolumes
Oncespasticparalysisensues,theabdominalwallisrigidandthepatientcanbesatup
References
1. WestJ.RespiratoryPhysiology:TheEssentials.9thEdition.LippincottWilliamsandWilkins.2011.
Lastupdated2019-07-18
ChestWallandDiaphragm
140
![Page 141: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/141.jpg)
VariationsinUpperAirwayAnatomyUnderstandthedifferencesencounteredintheupperairwayforneonates,childrenandadults.
NeonatesandChildren
Changesaremostobviousbelow1yearofage.Theytypicallyresolveby~8yearsofage.
HeadandneckchangesObligatenosebreathersNasalobstructionmaysignificantlyimpairrespiration.ProportionallyenlargedheadandocciputOptimalintubatingpositionisneutralratherthanramped.ProportionallyshortneckFavoursairwayobstructionwhenflexed.
LaryngealchangesDisproportionatelylargetonguethatcomplicateslaryngoscopyEpiglottisisu-shaped,longer,andstifferLarynxliesatC4(ratherthanC6inadults)NarrowestpartoftheupperairwayisthetransversediameterofthevocalcordsNotatthecricoid.
IntrathoracicchangesIntrathoracictracheaisalsoshorterMaybeonly4cmlong,sothereislittlemarginforerrorintubeplacement.Leftandrightbronchiariseatsimilarangles,soendobronchialintubationmayoccuroneithersideAirwaysthemselvesarenarrower,andhaveahigherresistancetoflow.
References
1. Nickson,C.PaediatricAirway.LITFL.2. Anderson,C.AnatomyoftheRespiratorysystem..ICUPrimaryPrep.3. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.4. TobiasJD.Pediatricairwayanatomymaynotbewhatwethought:implicationsforclinicalpracticeandtheuseofcuffed
endotrachealtubes.PaediatrAnaesth.2015Jan;25(1):9-19.
Lastupdated2019-11-02
VariationsinAnatomy
141
![Page 142: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/142.jpg)
ControlofBreathingDescribethecontrolofbreathing
Ventilationiscontrolledbyafeedbackloopinvolving:
InputsIntegrationandcontrolcentresEffectors
InputsInputstotherespiratorycentrecomesfromanumberofsensors:
ChemoreceptorsChemoreceptorsactsynergistically.Chemoreceptorsaredividedinto:
PeripheralCentral
MechanoreceptorsOthereffects
PeripheralChemoreceptors
Peripheralchemoreceptorsaredividedinto:
ThecarotidbodyLocatedatthebifurcationofthecommoncarotidartery,andareinnervatedbytheglossopharyngealnerve(CNIX).TheaorticbodyLocatedintheaorticarch,andinnervatedbythevagus(CNX).
Peripheralchemoreceptorsarestimulatedby:
LowPaOPeripheralchemoreceptorsarestimulatedbylowO tension
HighPaCOPeripheralreceptorshavearapid(~1-3s)butweaker(~20%ofresponse)tochangesinCO ,comparedtocentralchemoreceptors
22
22
ControlofBreathing
142
![Page 143: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/143.jpg)
Acidaemia(Carotidbodiesonly)Hypotension
CentralChemoreceptors
Centralchemoreceptorsarelocatedontheventralmedulla,andarestimulatedbyafallinCSFpHH andHCO areionised,andcannotcrosstheBBBbydiffusionBecauseofthis,centralchemoreceptorsrespondindirectlytochangesinarterialPaCO
CarbondioxideislipidsolubleandfreelydiffusesintoCSFInCSF,carbondioxidecombineswithwater(catalysedbycarbonicanhydrase)toformH andHCO
Thisgivesthecentralchemoreceptorsanumberofspecialproperties:IncreasedsensitivityIncreasedrelativetoplasmaduetominimalbuffering(asthereislessproteininCSF)RespondtorespiratoryacidosisFixedaciddoesnotcrossthebloodbrainbarrierandsohaveaminimalresponseonCSFpH.CerebralhypoxiaincreasesCSFlactate,whichwillstimulaterespiration.
MechanismofCO Retention
Prolongedrespiratoryacidosis(i.e.prolongedCSFacidosis)stimulatesactivesecretionofbicarbonateintotheCSFWhenpHnormalises,thestimulationofcentralchemoreceptorsceases
Similarly,renalabsorptionofbicarbonateincreases,whichnormalisesarterialpHandreducesperipheralchemoreceptorstimulation
Mechanoreceptors
Stretchreceptorsinbronchialmusclearestimulatedbyoverinflation,andstimulatetheapneusticcentretoreduceinspiratoryvolumes.ThisistheHering-Breuerreflex.
OtherStimulants
Otherinputswhichstimulaterespirationinclude:
Juxtacapillaryreceptors(J-receptors)Receptorsinalveolarwalls,potentiallystimulatedbyoedemaandemboli.IrritantreceptorsInhalationofnoxiousgasesstimulatesrespiration.PainreceptorsThalamus
+3-
2
+3-
2
ControlofBreathing
143
![Page 144: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/144.jpg)
Increasedcoretemperaturestimulatesrespiration.LimbicsystemEmotionalresponses.CerebralcortexConsciouscontrolofbreathing.MusclespindlesVentilatoryresponsetoexercise.
IntegrationandControl
Therespiratorycentreislocatedinthemedullaandthepons.Itconsistsoffourgroups:
DorsalRespiratoryGroup(DRG)Controlsthediaphragm,andissoonlyinvolvedwithinspiration.VentralRespiratoryGroup(VRG)Controlstheintercostalmuscles,andsoisinvolvedininspirationandexpiration.ApneusticCentreModulatesDRGfunctiontopreventover-expansion.Lossofthisareacausesapneusis-long,deepbreaths.PneumotaxicCentreAlsomodulatestheDRG,increasingRRanddecreasingV tomaintainMV.
References
1. CICMFebruary/April20152. CICMMarch/May20093. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.4. BrandisK.ThePhysiologyViva:Questions&Answers.2003.
Lastupdated2019-07-18
T
ControlofBreathing
144
![Page 145: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/145.jpg)
RespirationDescribetheinspiratoryandexpiratoryprocessinvolvingthechestwall,diaphragm,pleuraandlungparenchyma
Explainthesignificanceoftheverticalgradientofpleuralpressureandtheeffectofpositioning
Changeinlungvolumeoccursduetochangeinintrapleuralpressures.Therefore,respirationreliesonthethoraciccavitybeingairtight,withthetracheabeingtheonlymethodgascanenterorexitthechest.
Intrapleuralpressure(P )Intrapleuralpressureisthepressureinthespacebetweenthevisceralandparietalpleura,or(physiologically)betweenthelungsandthechestwall.
Usuallynegative,typically-5cmH OatrestBalancebetweenthe:
OutwardsrecoilofthechestwallInwardsrecoilofthelungs(P )
VarieswithverticaldistanceinthelungGravitypullsthelungparenchymainferiorlyIntrapleuralpressureistherefore:
MorenegativeintheapexTypically-10cmH OatFRCLessnegativeinthebaseTypically-3cmH OatFRC
ThischangesthedegreeofinflationatFRCApicalalveoliaremaximallyinflatedBasalalveoliarerelativelydeflated
Duringinspiration,thepleuralpressurechangesevenlythroughoutthelung,howeverthebasalalveoliarebetterventilatedbecausetheircomplianceisincreased(duetolowerrestingvolume)
Inspiration
Diaphragmaticandexternalintercostal/accessorymusclecontractioncausesanincreaseinthevolumeofthethoraxIntrapleuralpressurebecomesmorenegative,typicallyto-8cmH OWhenP >P ,thelungsexpandsAlveolarpressure(P )becomessub-atmospheric,andinspirationoccursAtendinspiration:
P =PP =P
Expiration
MuscularrelaxationcausesthechestwalltopassivelyreturntotheirrestingpositionThoracicvolumefallsP fallsto-5cmH OTheelasticrecoilofthelungcausesittocollapseuntilP =P
Pl
2
el
2
2
2pl el
A
pl elA atmospheric
pl 2A atmospheric
MechanicsofBreathing
145
![Page 146: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/146.jpg)
References1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2019-07-18
MechanicsofBreathing
146
![Page 147: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/147.jpg)
ComplianceDefinecompliance(static,dynamicandspecific),itsmeasurement,andrelatethistotheelasticpropertiesoftherespiratorysystem.
ComplianceisthechangeinvolumeforagivenachangeinpressureComplianceismeasuredinml.cmH O .ItoccursduetothetendencyofatissuetoresumeitsoriginalpositionafterremovalofanappliedforceItistheinverseofelastance,whichistheforceatwhichthelungrecoilsforagivendistensionAdecreasedcompliancemeansthetranspulmonarypressuremustchangebyagreateramountforagivenvolume,whichincreaseselasticworkofbreathing
ComplianceoftheRespiratorySystem
Complianceoftherespiratorysystemisafunctionofbothlungandchestwallcompliance:
.
ThecurveisnotlinearascompliancevarieswithlungvolumeInthenormalrangehowever,(-5to-10cmH O)complianceofthelungandchestwallindependentlyistypicallystatedas~200ml.cmH O .
Complianceoftherespiratorysystemasawholeistherefore~100ml.cmH O
MeasurementofLungandChestWallCompliance
Lungcomplianceiscalculatedformthealveolar-intrapleuralpressuregradientChest-wallcomplianceiscalculatedfromtheintrapleural-ambientpressuregradientTotalcomplianceiscalculatedfromthealveolar-ambientgradient
Measuringambientandalveolarpressureisstraightforward,asiscalculatingcomplianceoftherespiratorysystemAlveolarpressureismeasuredbytakingaplateaupressure
SeparatinglungandchestwallcompliancerequiresmeasurementofintrapleuralpressureThisisperformedbymeasuringoesophagealpressure(usingaballoon)withanopenglottis,asoesophagealpressureapproximatesintrapleuralpressure.
Measurementofcomplianceofeachsystemindividuallydetermineswhatproportionofplateaupressureisdistributedtoeach
Ifthelungissignificantlylesscompliantthanthechestwall,agreaterpressureisrequiredtodistendthelungTherefore,thealveolar-intrapleuralgradientwillbemuchgreaterthantheintrapleural-ambientgradientThiscanbeexpressedbytheequation:
StaticCompliance
StaticcomplianceisthecomplianceofthesystematagivenvolumewhenthereisnoflowThereforethereisnopressurecomponentduetoresistanceAstaticcompliancecurveismadebymeasuringthepressureacrossarangeoflungvolumes,withpatienttakingincrementalbreathsStaticcomplianceisafunctionof:
2-1
22
-1
2-1
Compliance
147
![Page 148: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/148.jpg)
ElasticrecoilofthelungSurfacetensionofalveoli
DynamicCompliance
Dynamiccomplianceisthecompliancemeasuredduringrespiration,usingcontinuouspressureandvolumemeasurementsTherefore,dynamiccomplianceincludesthepressurerequiredtogenerateflowbyovercomingresistanceforces
ThismeansitisalsoabitofmisnomerDynamiccomplianceisalwayslessthanstaticcompliance,astherewillalwaysbeadegreeofairwayresistanceDynamiccomplianceisafunctionofrespiratoryrateInnormallungsatnormalrespiratoryratesitapproximatesstaticcompliance.Reducedininlungunitswithunequaltimeconstantsathighrespiratoryrates
Duetoincompletefillingofalveoli-theportionofpressurethatisusedtoovercomeairwaysresistanceisthereforeproportionallygreater
SpecificComplianceSpecificcomplianceisthecomplianceperunitvolumeoflung,expressedas:
Specificcomplianceisusedtocomparedifferentlungs
Hysteresis
Ingeneral,hysteresisreferstoanyprocesswherethefuturestateofasystemisdependentonitscurrentandpreviousstateSpecifictothelung,itmeansthecomplianceofthelungisdifferentininspirationandexpiration
Compliance
148
![Page 149: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/149.jpg)
Thereishysteresisinbothstaticanddynamiccurves:Indynamiccompliancecurves:Airwaysresistanceisafunctionofflowrate.Flowrate(thereforeresistance)ismaximalatthebeginningofinspirationandend-expiration.Instaticcompliancecurves:Thereisnoresistivecomponent.Hysteresisisduetoviscousresistanceofsurfactantandthelung.
ChangesinCompliance
Respiratorysystemcompliancecanbeaffectedbychangestoeitherlungorchestwallcompliance,andcanbeincreasedordecreased.
IncreasedLungCompliance
NormalageingAsthmaattackEmphysema
DecreasedLungCompliance
AlterationsinlungvolumeandconsolidationComplianceisreducedatextremesoflungvolume.ItishighestatFRC.
ChildrenPneumonectomy/lobectomyAtelectasis/collapsePneumoniaARDS
Increasedpulmonarybloodvolume/venouscongestionAPO
IncreasedsurfacetensionReducedsurfactant
HyalineMembraneDiseaseImpairedparenchymalcompliance
Pulmonaryfibrosis
IncreasedChestWallCompliance
Collagendisorders
DecreasedChestWallCompliance
Chestwallrestriction/structuralabnormalitiesObesitySpasticparalysisofchestwallmusculatureOssificationofcostalcartilagesKyphosis/scoliosisScarring/constriction(e.g.circumferentialburns)
PositionProne(60%reducedcompliance)/supineThisisduetotheeffectofpositiononlungvolume.
Compliance
149
![Page 150: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/150.jpg)
References1. BarrettKE,BarmanSM,BoitanoS,BrooksHL.Ganong'sReviewofMedicalPhysiology.24thEd.McGrawHill.2012.2. KennyJE.Heart-LungInteractionLectureSeries.Fromheart-lung.org.
Lastupdated2019-07-20
Compliance
150
![Page 151: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/151.jpg)
Time-ConstantsExplaintheconceptsoftimeconstants
ARefresheronTimeConstants
Thetime-constantis:
ThetimethataprocesswouldtaketocompleteifitsinitialrateofchangeremainedconstantRelevantwhenmodelingaprocessusingexponentialfunctions
Rememberanexponentialfunctionisacurvewheretherateofchangeisproportionaltothecurrentvalue
Foraquantitythatdecreases overtime,thegeneralcaseis:
,where:
isthevalueof at
istherateconstant( plotsacurvethatgrows)
istime
Importantly:
isthereciprocalofthetimeconstant,
Inanegativeexponential,time-constantisthetimeitwouldtakefor toreach0iftheoriginalrateofchangewasmaintained.Otherfunfactsaboutthetimeconstant(foranexponentialdecay)include:
After1 , willbe37%( )ofitsinitialvalue
After2 , willbe13.5%( )ofitsinitialvalue
After3 , willbe5%( )ofitsinitialvalue
After5 , willbe1%( )ofitsinitialvalue
PhysiologicalSignificance
Thetime-constantisusedinrespiratoryphysiologyin:
TiminginspirationandexpirationEliminationofinhalationalanaestheticsThechangeinPaO andPaCO afterchangesinventilation
Inventilation:
Thetimeconstantisaffectedby:ComplianceResistanceInflationpressureAtaconstantinflationpressure,thetimeconstantisequaltotheproductofresistanceandcompliance,i.e.
1
2 2
Time-Constants
151
![Page 152: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/152.jpg)
.
FortwolungunitsofequalcomplianceandresistanceInflationwilloccuraspertheexponentialgrowthfunctionTime-constantsofeachlungunitwillbeequalNoredistributionofgaswilloccuratend-inspirationasthepressureandvolumeofeachunitisthesame
Fortwolungunits,whereonehashalfthecompliancebuttwicetheresistanceThetimeconstantsareequal,thereforebothreachpeakfillingatthesametime
However,thepoorlycompliantunitwillonlyreachhalfthevolumeNoredistributionofgaswilloccuratend-inspirationasthepressureandvolumeofeachunitisthesame
Fortwolungunits,whereonehastwicetheresistanceoftheotherThetime-constantsareunequalTheresistantunitwillfillathalftherateoftheother
IfinspirationisprolongedbothwillreachthesamevolumeIfinspirationhishaltedearly,andexpirationprevented,therewillbeapressuregradientbetweentheunits(ascomplianceisthesame),andgaswillredistributefromthelow-resistantunittothehigh-resistantunit
FortwolungunitswhereonehashalfthecomplianceThetimeconstantsareunequalThepoorlycompliantunitwillfillathalftherateoftheother
IfinspirationisprolongedtheywillbothreachthesamepressureThevolumeinthepoorlycompliantunitwillbehalfthatofthemorecompliantunit.
Duringinspiration,thepressurerisesmorerapidlyinthepoorlycompliantunit,andifinspirationisstoppedandexpirationprevented,thiswillresultinredistributionintothemorecompliantunituntilpressuresareequal
Ingeneral:
RateoffillingisdeterminedbytimeconstantsHigh-resistancelungunitshavelongertimeconstantsandtakelongertofill
Finalvolume(assuminganindefiniteinspiration)isafunctionofcompliancePoorlycompliantunitswithemptyandfillrapidlyThiscreatestheconceptoffastandslowalveoli,dependingontheirtimeconstants.
Atasustainedinflationpressure:Alow-resistanceunitshowsinitialgreatervolumechangebutrapidlyapproachesequilibriumvolumeAhigh-complianceunittakesagreateroverallvolumeoveralongerperiod
Atend-inspiration:Pressureinunitswithashortertime-constantrisesmorerapidlyandifabreathisheldwillresultinredistributiontothoseunitswithalongertime-constant.
ClinicalSignificance
Iftime-constantsareequal:
ThepressureineachunitisidenticalthroughoutinspirationanddistributionTherefore,dynamiccompliancewillbeindependentofrespiratoryrate.
Iftime-constantsareunequal:
Long-timeconstantunitsmaystillbeinhalingwhilsttherestofthelunghasstopped,orbegunexhalationThisiscalledpendelluft.Inpendelluft,distributionofinspiredgasisdependentonrespiratoryrate
Asrespiratoryrateincreases,theproportionofthetidalvolumethatisdeliveredtotheregionwithalongtime-constantdecreasesFastalveoliarepreferentiallyinflated,causingV/Qscatterorshuntintheunventilatedslowalveoli.
Time-Constants
152
![Page 153: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/153.jpg)
Dynamiccompliancewilldecreaseasrespiratoryraterisesandbemarkedlydifferentfromstaticcompliance
Footnotes
.Foracurvethatgrowsovertime,thetimeconstantisthetimeitwouldtakefor toreach63%ofitsfinalvalue,i.e.
.↩
References1. LumbA.Nunn'sAppliedRespiratoryPhysiology.7thEdition.Elsevier.2010.
Lastupdated2019-07-18
1
Time-Constants
153
![Page 154: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/154.jpg)
ResistanceExplaintherelationshipbetweenresistanceandrespiratorygasflow
Describethefactorsaffectingairwayresistance,anditsmeasurement
Resistance(measuredincmH O.L .sec )comprisestheenergylostasfrictionalandinertialimpedancetogasflow,whereenergyislostasheat.Flowisafunctionofpressuregradient,resistance,andtypeofflow.
TypesofFlowFlowcanbeeitherlaminarorturbulent.Inlaminarconditionsflowisproportionaltodrivingpressure,whilstinturbulentconditionsflowisproportionaltothesquarerootofdrivingpressure.
Reynolds'Number
TypeofflowcanbepredictedbyReynolds'sNumber,adimensionlessindexwhere:
,where:
=Radius
=Gasdensity=Velocity
=Gasviscosity
AReynolds'Numberof<2000ispredominantlylaminarflow,whilst>4000ispredominantlyturbulent.
LaminarFlow
Inlaminarflow:
GasmovesinaseriesofconcentriccylinderswhichslideoveroneanotherGasinthecentremovestwiceasfastcomparedtotheoutside,whereitisalmoststationary
Gasappearsincross-sectionasanadvancingconeGasmayreachtheendofthetubewhenthevolumeofflowislessthanthevolumeofthetube.
Thisisthemechanismofalveolarventilationwhentidalvolumesarelessthananatomicaldeadspacevolume
Inastraightunbranchedtube,flowcanbequantifiedbytheHagen-PoiseuilleEquation:
,where:
=Flow
=Drivingpressure=Radius
=Length
=Viscosity
However,asinlaminarconditionsflowisproportionaltothedrivingpressureandinverselyproportionaltoresistance,flowcanbesubstitutedandtheequationsolvedforresistance:
2-1 -1
Resistance
154
![Page 155: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/155.jpg)
Thiscanbeusedtodescribethefactorsaffectingresistance:
LengthFixedconstant.ViscosityVarieswiththeparticulargasmixturebeingused.RadiusMaindeterminant.Maybedividedinto:
ExtraluminalfactorsCompression:
Haemorrhage,tumour,dynamichyperinflation,atelectasiscompressingairways,etc.Lungvolume:
Airwayradiusincreaseswhenlungvolumeexpandsduetoradialtractiononairways(untildynamichyperinflationoccurs,atwhichpointairwaysarecompressedagain)
LuminalconstrictionBronchospasm,bronchoconstriction.IntraluminalobstructionSputumplugging,aspiration.
Notethatairwayresistance:
Peaksatthe5 generationRapidlydecreaseswitheachairwaydivisionthereafterThisisduetothetotalcross-sectionalareaincreasingdramatically.
Reduceswithincreasinglungvolume,asradialtensiondistendsairways,increasingtheircrosssectionalarea
TurbulentFlow
th
Resistance
155
![Page 156: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/156.jpg)
Highflowratesandbranchingofairwaysdisruptdisciplinedlaminarflow.Turbulentflow:is:
Dominantintheupperairway(wherevelocityishigh)Dominantinearly-generationairwaysduetoregularbranching,changesindiameter,andsharpanglesReducesafterthe11thgenerationbronchiolesProportionaltothesquarerootofthedrivingpressureTherefore,resistanceishigherinturbulentflowthaninlaminarflow.
Drivingpressureisproportionaltogasdensity,andindependentofviscosity
Resistanceinturbulentflowismanagedbymakingflowlessturbulent:
AchievedbyreducingReynoldsnumberHeliummixturesreducegasdensityOfgreaterbenefitinupperairwaythanlowerairwaydisease.
TransitionalFlow
Transitionalflowoccursatbranchesandanglesintheairways,asoccurinmostofthebronchialtree.
References
1. LumbA.Nunn'sAppliedRespiratoryPhysiology.7thEdition.Elsevier.2010.
Lastupdated2018-04-24
Resistance
156
![Page 157: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/157.jpg)
SurfactantDescribetheproperties,productionandregulationof,surfactantandrelatethesetoitsroleininfluencingrespiratorymechanics
SurfaceTension
SurfacetensiondescribesthetendencyofafluidtominimiseitssurfaceareaItisrelatedtotheattractionbetweenparticlesinthefluidrelativetoparticlesoutsidethefluidSurfacetensioniswhy:
WaterscatteredonasurfaceformsroundeddropletsWhymultipledropletswilltendtocoalesceintoasinglelargerdroplet
ThisrelationshipisdescribedbyLaPlace'sLaw
,where:
ispressure
issurfacetensionisradius
AlveoliobeyLaplace'sLawHighsurfacetensioncausesthreeproblemswithalveoli
CompliancefallswhenthealveolusisemptyAstheradiusfalls,thepressurerequiredtoopenit(atagivensurfacetension)willbeincreased.Thisincreasesworkofbreathing.SmalleralveoliwillpreferentiallyemptyintobiggeralveoliSmalleralveolirequiregreatertransmuralpressurestoremaininflated.Thiscausessmalleralveolitoemptyintolargerones.FluidtransudationSurfacetensiondrawsfluidfrominterstitialspacesandcontributestopulmonaryoedema.
Overall,highsurfacetensionisdetrimentaltothelungs
Surfactant
SurfactantisasubstancewhichsubstantiallyreducesworkofbreathingbyreducingalveolarsurfacetensionSurfactantisproducedbytypeIIalveolarcellsinresponsetolunginflationandrespirationItiscomposedof:
85%phospholipid5%neutrallipid10%protein
SurfactantisamphipathicEachcomponenthasahydrophobicandhydrophilicend.
Thiscausesthemoleculestoorientthemselvesalongtheair-liquidinterface,disruptingtheattractivebondsbetweenwatermoleculesSurfacetensionisreducedinproportiontotheconcentrationofmolecules
TheconcentrationofsurfactantchangesthroughouttherespiratorycycleDuringexpirationalveolicollapseThedecreaseinalveolarradiusisoffsetbytheincreaseinsurfactantconcentration,sothefallinradiusismitigatedby
Surfactant
157
![Page 158: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/158.jpg)
thedropinsurfacetension.
References1. CICMSeptember/November20122. LumbA.Nunn'sAppliedRespiratoryPhysiology.7thEdition.Elsevier.2010.
Lastupdated2019-07-18
Surfactant
158
![Page 159: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/159.jpg)
VolumesandCapacitiesExplainthemeasurementoflungvolumesandcapacities,andfactorsthatinfluencethem
Statethenormalvaluesoflungvolumesandcapacities
Defineclosingcapacityanditsclinicalsignificanceandmeasurement
Thelunghasfourvolumesandfour(main)capacities:
AvolumeismeasureddirectlyAcapacityisasumofvolumes
Volumes
Tidalvolume(V )Volumeofairduringnormal,quietbreathing.
Normalis7ml.kg ,or500ml
Inspiratoryreservevolume(IRV)Volumeofairthatcanbeinspiredabovetidalvolume.
Normalis45ml.kg ,or2500ml
Expiratoryreservevolume(ERV)Volumeofairthatcanbeexpiredfollowingtidalexpiration.
Normalis15ml.kg ,or1500ml
Residualvolume(RV)Volumeofairinthelungsfollowingamaximalexpiration.
Normalis15-20ml.kg ,or1500ml
Capacities
FunctionalResidualCapacity(FRC)FRC=RV+ERV.
Normalis30ml.kg or3000mlFRCdecreases20%whensupine,andafurther20%undergeneralanaesthesia
VitalCapacity(VC)VC=ERV+V +IRV.
Normalis4500ml
T
-1
-1
-1
-1
-1
T
VolumesandCapacities
159
![Page 160: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/160.jpg)
InspiratoryCapacity(IC)IC=V +IRV.
Normalis3000ml
TotalLungCapacity(TLC)TLC=RV+ERV+V +IRV.
Normalis6000ml
FunctionalResidualCapacity
TheFRChasmanyimportantphysiologicalfunctions:
GasexchangeTheFRCallowsbloodinthepulmonarycirculationtobecomeoxygenatedthroughouttherespiratorycycle(iftherewasnoFRC,thenatexpirationthelungswouldbeemptyandnooxygenationwouldoccur).
OxygenReserveFRCistheonlyclinicallymodifiableoxygenstoreinthebody,andallowscontinualoxygenationofbloodduringapneicperiods.
MinimiseWorkofBreathingWorkofbreathingisafunctionoflungresistanceandcompliance.
ThelungsitsonthesteepestpartofthecomplianceoccursatFRCComplianceisoptimisedas:
AlveoliareopenandminimallydistendedBelowFRC,somealveolicollapseandthevolumeoflungavailabletoreceivethetidalvolumedecreasesRe-expansionofcollapsedalveolirequiresmoreworkthanexpandingopenalveoli.AboveFRC,somealveoliwillbecomeoverdistendedandtheircompliancewillfall
Airwayresistancedecreasesasairwayradiusincreasesaslungvolumeincreases
MinimiseRVAfterloadPVRisminimalatFRC.
AboveFRC,compressionofintra-alveolarvesselsoccursandPVRincreasesBelowFRC,extra-alveolarvesselscollapseandPVRincreases
MaintainlungvolumeaboveclosingcapacityIfclosingcapacity(seebelow)exceedsFRC,thenshuntwilloccur.
FactorsaffectingFRC:
FRCisreducedby:SupinepositioningFallsby~20%.AnaesthesiaFallsby~20%.Raisedintra-abdominalpressureImpairedlungandchestwallcompliance
FRCisincreasedby:PEEP
ExtrinsicIntrinsic(gastrapping)
PEEPEmphysemaAcuteasthmaAge
T
T
VolumesandCapacities
160
![Page 161: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/161.jpg)
Mayincreaseslightly.
MeasurementofLungVolumesandCapacities
ERV,V ,andIRVcanallbemeasureddirectlyusingspirometryAspirometerisaflowmeter
ThepatientexhalesasfastaspossiblethroughtheflowmeterAflow-timecurveisproducedThiscurvecanbeintegratedtofindvolume
Anycapacitywhichisasumofthese(IC,VC)canthereforebecalculated
RVcannotbemeasuredbyspirometry,asitcan'tbeexhaledThereforeFRCandTLCcannotbecalculated
RVcanbemeasuredusing:GasdilutionBodyplethysmography
GasDilution
Gasdilutionreliesontwoprinciples:ConservationofMassHeliumhaspoorsolubilityandwillnotdiffuseintocirculation
Limitationsofgasdilution:Onlygascommunicatinggascanbemeasured-willunderestimateFRCingas-trapping
Method:Patienttakesseveralbreathsfromagasmixturecontainingaknownconcentrationofhelium(givingtimeforequilibration)TheconcentrationofexpiredheliumisthenmeasuredFromthelawofconservationofmass:
isequaltothevolumeofthegasmixturethepatientwasbreathingfrom( )andthepatientsFRCTherefore:
BodyPlethysmography
Bodyplethysmographyrelieson:Boyle'slaw
Pressureandvolumeareinverselyproportionalataconstanttemperature,i.e.( ).
Method:Patientisplacedinaclosedbox,withamouthpiecethatexitstheboxThepatientinhalesagainstaclosedmouthpiece:
Whenthepatientinhales,thevolumeofgasintheboxdecreases(thepatienttakesupmorespace)andthereforethepressureincreasesThechangeinvolumeoftheboxisgivenby:
T
VolumesandCapacities
161
![Page 162: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/162.jpg)
,where:
isthechangeinboxvolume,orTherefore:
As istheonlyunknownvalue,itcanbecalculated.
Thechangeinvolumeofthelungmustbethesameasthevolumeofthebox( )
Inthecaseofthelung,theinitialvolume( )isFRCTherefore:
ClosingCapacity
ClosingcapacityisvolumeatwhichsmallairwaysbegintocloseClosingcapacityisthesumofresidualvolumeandclosingvolume.
Becausedependentlungiscompressedbygravity,dependent(typicallybasal)airwaysareofsmallercalibrethannon-dependent(typicallyapical)airwaysDuringexpiration,theseairwaysarecompressedfirstAlveoliconnectedtotheseairwaysareisolated,andV/Qscatterorshuntoccurs.IfclosingcapacityexceedsFRC,thenairwayclosureoccursduringnormaltidalbreathingThisoccurswhen:
FRCisdecreasedCCisincreased
IncreaseswithageCCexceedsFRCinthesupinepatientat44CCexceedsFRCintheerectpatientat66
Thisisclinicallyrelevantduringpreoxygenation,asitwilllimitthedenitrogenationthatcanoccur
MeasurementofClosingCapacity
ClosingcapacityismeasuredusingFowler'sMethod,andiscoveredunderDeadSpace.
References
VolumesandCapacities
162
![Page 163: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/163.jpg)
1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2019-07-18
VolumesandCapacities
163
![Page 164: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/164.jpg)
SpirometryDescribethepressureandflow-volumerelationshipsofthelung,chestwallandthetotalrespiratorysystem
Describethemeasurementandinterpretationofpulmonaryfunctiontests,includingdiffusioncapacity.
Pulmonaryfunctiontestsareperformedwithaspirometer,whichmeasureseithervolumeorflow(integratedfortime)toquantifylungfunction.
Basicspirometrycanbeusedtoquantify:
LungvolumesandcapacitiesAllexceptresidualvolume(andthereforeFRCandTLC).Dynamicmeasurements
FEVVolumeofairforciblyexhaledinonesecond.FVCForcedvitalcapacity.PEFRPeakexpiratoryflowrate.Flow-volumeloop
Additionaltestingcanbeperformedtomeasure:
ResidualvolumeFRCandTLCcanthereforebecalculated.Diffusioncapacity
BasicSpirometry
Basicspirometryincludes:
ForcedspirometryPatientforciblyexhalesavitalcapacitybreath,producingaexponential(wash-in)curve.Thiscalculates:
PEFRfromthegradientattime0(assumingmaximaleffort)FEV isthevolumeexpiredin1sNormalis>80%ofpredicted.FVCisthetotalvolumeexhaled.TheFEV /FVCratioNormalis>0.7.Thesevaluesalsoquantifydiseaseseverity:
Inobstructiveairwaysdisease:FEV <80%predictedFEV /FVCratio
Restrictivedisease:FEV <80%predictedFVCFEV/FVCratio>0.7TheratioisnormalastheFEV andFVCfallproportionally.
1
1
1
11
1
1
Spirometry
164
![Page 165: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/165.jpg)
Volume-TimeGraph(alsoknownasaspirographorspirogram)Quantifiesstaticlungvolumesbyhavingapatientperform:
NormaltidalbreathingVitalcapacitybreathVitalcapacityexhalation
Flow-VolumeLoopsNormal
Peakexpiratoryflowof~8L.sInitialflowishighestastheincreasedlungvolumeincreasesthecalibreoflungairways,reducingairwaysresistance.
ThisiscalledtheeffortdependentpartofthecurveFlowtailsofflaterinexpiration
Lungscollapse,andairwaycalibrefallsSmallairwaysarecompressedAnyincreaseinexpiratorypressurewillincreaseairwayresistanceproportionally.
Thisiscalleddynamicairwayscompression,andresultsinauniformflowratethatisindependentofexpiratoryeffort*Thisisthereforelabeledtheeffortindependent**partofthecurve.
-1
Spirometry
165
![Page 166: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/166.jpg)
ObstructivelungdiseaseRVandTLCareincreasedduetogastrappingPeakflowislimitedEffort-independentportionbecomesconcave
RestrictivelungdiseaseTLCisreduced,butresidualvolumeisunchangedPeakflowmaybereduced(asseenhere)However,thisreductionisproportionaltothedecreaseinvolume,suchthattheFEV :FVCratioisnormal.Ifpeakflowispreserved,theFEV :FVCratiowillbeincreased.Effortindependentpartislinear
FixedupperairwayobstructionDescribesanupperairwayobstructionthatdoesnotchangecalibreduringtherespiratorycycle.
Peakinspiratoryandexpiratoryflowratesarelimitedbythestenosis
VariableextrathoracicobstructionVariableastheobstructionchangesduringtherespiratorycycle:
During(negativepressure)inspirationthelesionispulledintotrachea,reducinginspiratoryflowDuringexpirationthelesionispushedoutofthetracheaThewaytorememberthisisanextrathoracicobstructionimpedesinspirationThereverseeffectoccursinpositivepressureventilation
11
Spirometry
166
![Page 167: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/167.jpg)
VariableintrathoracicobstructionTheoppositetoextrathoracicobstruction.
DuringinspirationtheairwaycalibreincreasesandinspiratoryflowisunimpededDuringexpirationtheairwaycalibrefallsandexpiratoryflowisreduced
References1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2019-07-18
Spirometry
167
![Page 168: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/168.jpg)
WorkofBreathingDescribetheworkofbreathinganditscomponents
Workofbreathingistheenergyusedbythemusclesforrespiration.Itisdefinedas:
,measuredinJoules.
ThisgivestheworkforasinglerespiratorycycleEnergyexpenditureovertimeisbetterdescribedasthe"powerofbreathing".ItdoesnottakeintoaccountrespiratoryrateorflowrateThesefactorshaveasignificanteffectonenergyrequirement.
Thiswouldbegivenbytherateofwork,orpower,where:
,measuredinWatts.Tidalbreathingisefficientanduses<2%ofBMR
Theoxygenrequirementofbreathingatrestis~2-5%ofVO ,or~3ml.min
DeterminantsofWorkofBreathingWorkofbreathingisdividedinto:
ElasticworkAbout65%oftotalwork,andisstoredaselasticpotentialenergy.Energyrequiredtoovercomeelasticforces:
LungelasticrecoilSurfacetensionofalveoli
ResistiveworkAbout35%oftotalwork,andislostasheat.Thisisduetotheenergyrequiredtoovercomefrictionalforces:
BetweentissuesIncreasedwithincreasedinterstitiallungtissue
BetweengasmoleculesIncreasedathighflowratesIncreasedwithturbulentflow
HighrespiratoryratesUpperairwayobstructionIncreasedairwaydensity
HyperbaricDiving
IncreasedwithdecreasedairwayradiusLowlungvolume
InadequatePEEPDecreasedrespiratorymuscletone
BronchoconstrictionDynamicairwaycompressionEffort-independentexpiration.Apparatus
EndotrachealTubeHMEfilters
Airwayresistancevariesdependingonairwaydivision:Resistancepeaksatthe3rdairwaydivision(lobarbronchi)
2-1
WorkofBreathing
168
![Page 169: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/169.jpg)
Fallswithincreasingairwaydivisionsduetoincreasedcross-sectionalarea
GraphingWorkofBreathing
Workofbreathingcanbeevaluatedwithadynamiclungcompliancecurve:
Iftherewerenoresistiveforces,thenthiscurvewouldbeastraightlineThetriangularareaistheelasticworkdone
Theresistiveworkofbreathingcausesthedeviationoftheinspiratoryandexpiratorylines:TheareabetweenthecompliancelineandtheinspiratorylineisadditionalresistiveinspiratoryworkdoneTheareabetweenthecompliancelineandexpiratorylineisadditionalresistiveexpiratoryworkdone
ThisworkistypicallydonebyelasticrecoilofthelungsIfthisareafallswithintheareaofelasticworkofbreathing,itisapurelypassiveprocess,usingthestoredelasticpotentialenergyofinspirationIfpartofthisareafallsoutsidetheareaofelasticworkofbreathing,itdemonstratesadditionalactiveworkofexpirationwhichmayoccurinobstructivelungdiseaseorwhenminuteventilationishigh
Activeexpiratorywork:
MinimisingWorkofBreathing
WorkofBreathing
169
![Page 170: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/170.jpg)
Workofbreathingcanbeminimisedbyoptimisingthedeterminants:
ElasticworkPEEPKeeplungvolumeatFRCandmaximisenumberofventilatedalveoli.PositioningOptimiselungvolume.SurfactantMinimisingsurfacetension.OptimiserespiratoryrateElasticworkofbreathingtypicallydecreaseswithincreasedrespiratoryrate.
ResistiveworkDecreaserespiratoryrateRespiratoryrateisdirectlyproportionaltoresistivework.IncreaselaminarflowLaminarflowismoreefficientthanturbulentflow.Laminarflowcanbeincreasedby:
ReducinggasdensityHeliox.
IncreaseRadiusIncreaselungvolumeBronchodilators
Derivation
Workisdefinedas:
,where:
=WorkinJoules
=ForceinNewtons
=DistanceinMetres
Additionally,pressureisdefinedas:
,where:
=PressureinPascal
=AreainMeterssquared
Therefore:
Substituting:
,where:
=Volume
Therefore:
WorkofBreathing
170
![Page 171: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/171.jpg)
References
1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.2. LumbA.Nunn'sAppliedRespiratoryPhysiology.7thEdition.Elsevier.2010.
Lastupdated2019-07-18
WorkofBreathing
171
![Page 172: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/172.jpg)
OxygenCascadeDescribeandexplaintheoxygencascade
Theoxygencascadedescribesthetransferofoxygenfromairtomitochondria.
IneachstepofthecascadethePaO fallsItdemonstratesthatoxygendeliverytotissuesreliesonthepassivetransferofgasdownpartialpressuregradients.Thestepsofthecascadeare:
DryatmosphericgasHumidifiedtrachealgasAlveolargasArterialbloodMitochondriaVenousblood
Remember:
PartialpressuredeterminesrateandextentofgastransferOxygencontentiswhatisimportantforcellularfunction
AtmosphericGas
AtmosphericpartialpressureofoxygenisafunctionofbarometricpressureandtheFiO :
,where:
is760mmHg
is0.21
Therefore, =160mmHg
2
2
DiffusionofGases
172
![Page 173: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/173.jpg)
HumidifiedTrachealGas
GasishumidifiedduringinspirationGasintheproximaltracheaisheatedto37°Candhas100%relativehumidityThesaturatedvapourpressureofwaterat37°Cis47mmHgTherefore:
,where:
and areasabove
is149mmHg
AlveolarGas
IdealalveolarPO iscalculatedusingthealveolargasequation:
,where:
isthealveolarpartialpressureofoxygen
istheinspiredpartialpressureofoxygen
isthearterialpartialpressureofcarbondioxide
istherespiratoryquotient,whereRisusedinthealveolargasequationtocorrectforthechangeininspiredrelativetoexpiredvolumeAsgenerallylessCO isproducedthanO consumed,expiredvolumesaretypicallylessthaninspiredvolumesRisdependentonthemetabolicsubstratesusedformetabolism:
Purefat≈0.7Pureprotein≈0.9Purecarbohydrate≈1ThenormalvalueforaWesterndietisquotedas0.8
isacorrectionfactor,usuallyequalto~2mmHg,andisgivenby
Alveolaroxygenisthereforedependenton:
PiO ,whichisafunctionof:FiOAirpressure
Alveolarventilation
As .
ArterialBloodThedifferenceinpartialpressureofoxygenbetweenalveolarandarterialbloodiscalledtheA-agradient:
AnormalA-agradientis
2
2 2
22
DiffusionofGases
173
![Page 174: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/174.jpg)
NormalarterialPO is100mmHgItoccursdueto:
Shunt/VQscatterAsmallshuntisnormalduetobloodfromthebronchialcirculationandthebesianveins.Diffusionabnormality
Mitochondria
PO varieswithmetabolicactivity,buttypicallyquotedas5mmHgThePasteurpointisthepartialpressureofoxygenatwhichoxidativephosphorylationceases,andis~1mmHg
VenousBlood
PO isgreaterthanmitochondrialPOMixedvenousbloodtypicallyquotedas40mmHg.Higherthanmitochondriaasnotallarterialbloodtravelsthroughcapillarybeds
References1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.2. BrandisK.ThePhysiologyViva:Questions&Answers.2003.
Lastupdated2019-07-18
2
2
2 2
DiffusionofGases
174
![Page 175: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/175.jpg)
DiffusingCapacityandLimitationExplainperfusion-limitedanddiffusion-limitedtransferofgases
Definediffusingcapacityanditsmeasurement
Describethephysiologicalfactorsthatalterdiffusingcapacity
RateofdiffusionofgasesisgivenbyFick'sLaw:
,where:
isthepressuregradientacrossthemembrane
istheareaofthemembraneisthesolubilityofthesubstance
isthethicknessofthemembrane
isthemolecularweightofthesubstance
Thesecanbedividedintopressure,lungfactors,andsubstancefactors:
PressuregradientInthelung,thisisafunctionof:
PartialpressureofthegasinthealveolusThisisaffectedby:
AtmosphericpressureVentilationAlveolarhypoventilationwill:
IncreasePACODecreasePAO
PartialpressureofthegasinbloodThisisaffectedby:
SolubilityofthegasinbloodCO is~20timesassolubleasO inblood.Bindingofgastoprotein:
ParticularlyhaemoglobinAffectstherateofuptakeofO andCO,andiswhycalculatedDL iscorrectedforhaemoglobin.
Theshapeoftheoxy-haemoglobindissociationcurveallowsalargevolumeofoxygentobeboundbeforePaO beginstorisesubstantially.
FormationofcarbaminocompoundsAnaestheticagentstoplasmacontentse.g.albumin,cholesterol.
LungfactorsSurfaceAreaAffectedby:
ParenchymavolumeBodysizePathologyManylungdiseaseswillreducesurfaceareaforgasexchange.
V/QmismatchBothshuntanddeadspacereducethesurfaceareaavailableforgasexchange.
22
2 2
2 CO
2
DiffusingCapacityandLimitation
175
![Page 176: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/176.jpg)
PulmonarybloodvolumeVasculardistensionandrecruitmentalsoaffectssurfacearea.Factorsaffectingpulmonarybloodvolumeinclude:
CardiacoutputIncreasedrecruitmentofvasculatureinhighoutputstatesDecreasedrecruitmentandincreasedV/Qmismatchinshockstates.
PostureIncreasedsurfaceareawhensupinerelativetosittingorstanding.
ThicknessIncreasingalveolar-capillarymembranethicknessimpedesgasexchange.Causesofthisinclude:
Pathologye.g.Pulmonaryoedemaandcardiacfailure.
SubstancefactorsSolubilityMoresolublesubstanceswilldiffusemorequickly.MolecularweightSmallersubstanceswilldiffusemorequickly.
DiffusionandPerfusionLimitation
Limitationreferstowhatprocesslimitsgasuptakeintoblood:
Gaseswhicharediffusionlimitedfailtoequilibrate,i.e.thepartialpressureofasubstanceinthealveolusdoesnotequalthatinthepulmonarycapillary
e.g.CarbonMonoxideGaseswhichareperfusionlimitedhaveequalalveolarandpulmonarycapillarypartialpressures,sotheamountofgascontenttransferredisdependentonbloodflow
e.g.Oxygen
Oxygen
Oxygendiffusiontakes~0.25sPulmonarycapillarytransittimeis0.75sTherefore,undernormalconditionsoxygenisaperfusionlimitedgasHowever,oxygenmaybecomediffusionlimitedincertaincircumstances:
Alveolar-capillarybarrierdiseaseDecreasestherateofdiffusion.
DecreasedsurfaceareaIncreasedthickness
Highcardiacoutput
DiffusingCapacityandLimitation
176
![Page 177: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/177.jpg)
Decreasespulmonarytransittime.AltitudeDecreasesPAO .
CarbonDioxide
Carbondioxideisventilationlimited,ratherthandiffusionorperfusionlimitedThisisbecauseitis:
20xmoresolubleinbloodthanoxygenRapidlyproducedfrombicarbonateandcarbaminocompoundsPresentinfargreateramountsthanoxygen1.8L.kg existinthebody(though1.6L ofthisareinboneandotherrelativelyinaccessiblecompartments).
Impairmentofdiffusioncapacitycausestype1respiratoryfailureasoxygenisaffectedtoamuchgreaterextentthancarbondioxide
OtherGases
CarbonmonoxideDiffusionlimiteddueto:
HighaffinityforhaemoglobinContinualuptakeintoHbresultsinalowpartialpressuresinblood.
NitrousoxidePerfusionlimitedasequilibriumbetweenalveolusandbloodisrapidlyreachedasitis:NotboundtohaemoglobinRelativelyinsoluble
DiffusionCapacity
MeasurementoftheabilityofthelungtotransfergasesMeasuredasDL ordiffusingcapacityofthelungforcarbonmonoxideCarbonmonoxideisusedasitisadiffusionlimitedgas.Process:
Vitalcapacitybreathof0.3%COHeldfor10sandexhaledInspiredandexpiredCOaremeasuredDifferenceistheamountofCOwhichisnowboundtoHbDL iscorrectedfor:
AgeSexHb
DL isdecreasedin:Thickenedalveolar-capillarybarrier
InterstitiallungdiseaseReducedsurfacearea
EmphysemaPELobectomy/pneumonectomy
DL isincreasedin:ExerciseRecruitmentandcapillarydistension.Alveolarhaemorrhage
2
-1 -1
CO
CO
CO
CO
DiffusingCapacityandLimitation
177
![Page 178: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/178.jpg)
HbpresentwithinthelungbindsCO.Asthma(maybenormal)Potentiallyduetoincreasedapicalbloodflow.Obesity(maybenormal)Potentiallyduetoincreasedcardiacoutput.
References1. BrandisK.ThePhysiologyViva:Questions&Answers.2003.2. LumbA.Nunn'sAppliedRespiratoryPhysiology.7thEdition.Elsevier.2010.3. ANZCAMarch/April19994. DerangedPhysiology-CarbonDioxideStorageandTransport
Lastupdated2017-10-04
DiffusingCapacityandLimitation
178
![Page 179: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/179.jpg)
West'sZonesDescribeWest'szonesofthelungandexplainthemechanismsresponsibleforthem
West'sZonestakeintoaccounttheeffectofalveolarpressureonpulmonarybloodflow.Thelungisdividedintofourzones:
WestZone1:P >P >PAlveolarpressureexceedsarterialpressure.
Thealveoluscompressesthecapillary,andnobloodflowoccursAsthereisventilationbutnoperfusion,thiscanalsobethoughtofasdeadspaceThisoccurswhen:
AlveolarpressureishighPEEP
ArterialpressureislowShock
Hypovolaemia
WestZone2:P >P >PArterialpressureexceedsalveolarpressure,whichexceedsvenouspressure.
BloodflowoccursintermittentlyduringthecardiaccycleAlveolarpressureactsasaStarlingresistorFlowisproportionaltotheP -P gradient.
WhenP fallsbelowP (e.g.indiastole),thennobloodflowwilloccur
WestZone3:P >P >PArterialpressureexceedsvenouspressurewhichexceedsalveolarpressure.
BloodflowoccursthroughoutthecardiaccycleFlowisproportionaltotheP -P gradient.ForanaccuratemeasureofPCWP,aPACmustbeplacedinWestZone3(sothereisacontinualcolumnofblood)Thistendstohappennaturallyasthemajorityofpulmonaryflowistothisregion
WestZone4:P >P >P >PInterstitialpressureactsasaStarlingresistorforpulmonarybloodflow.
Itisseenwheninterstitialpressureishigh(e.gduetopulmonaryoedema).
References1. BrandisK.ThePhysiologyViva:Questions&Answers.2003.2. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2018-07-09
A a v
a A v
a Aa A
a v A
a v
a i v A
V\QRelationships
179
![Page 180: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/180.jpg)
BasicsofV/QMatchingOptimalgasexchangeoccurswhenregionsoflungareventilatedinproportiontotheirperfusion,i.e.V/Q=1
Unevendistributionofventilationandperfusioncausesinefficientgasexchange:ExcessiveventilationcausesexcessiveworkInadequateventilationcausesinadequategasexchange
DistributionofVentilation
TherightlungisslightlybetterventilatedthantheleftInanerectpatientthebasesofthelungarebetterventilatedTheweightoflungabovecompressesthelungbelow,improvingthecomplianceofdependentlungwhilststretchingthenon-dependentlung.
ThisisonlysignificantatlowinspiratoryflowratesTheV/Qratiointhebasesis~0.6TheV/Qratiointheapicesis>3
Inalateralposition:ThedependentlungisbetterventilatedinaspontaneouslybreathingpatientThenon-dependentlungisbetterventilatedinaventilatedpatient
DistributionofPerfusion
ThepulmonarycirculationisalowpressurecirculationGravitythereforehasasubstantialeffectonfluidpressureConsequently,thedistributionofbloodthroughoutthelungsisuneven:
ThebasesperfusedbetterthantheapicesThisisaffectedbylungvolume,withtheeffect:
BecomingmorepronouncedatTLC(withapicalperfusionfallingprecipitously)ReversingslightlyatRV
V/QRatios
TheglobalV/Qratiofornormalrestinglungis0.9TheglobalV/Qratioimprovesto1.0duringexercise
BasicsofV\QMatching
180
![Page 181: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/181.jpg)
V/QMismatchandEtymology
V/QmismatchoccurswhenV/Q≠1:V/Q>1(DeadSpace)Ventilationinexcessofperfusion.
However,pulmonarybloodispassingventilatedalveoliandPaO isnormal
V/Q0to1(V/Qscatter)Perfusioninexcessofventilation.
IncreasinginPAO willincreasePaOThisiscommonlyreferredtobythegeneraltermofV/Qmismatch
V/Q=0(Shunt)Mixedvenousbloodenteringthesystemiccirculationwithoutbeingoxygenatedviapassagethroughthelungs.PaOfalls.
References
1. WestJ.RespiratoryPhysiology:TheEssentials.9thEdition.LippincottWilliamsandWilkins.2011.2. LumbA.Nunn'sAppliedRespiratoryPhysiology.7thEdition.Elsevier.2010.
Lastupdated2017-10-04
2
2 2
2
BasicsofV\QMatching
181
![Page 182: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/182.jpg)
DeadSpaceDeadspaceistheproportionofminuteventilationwhichdoesnotparticipateingasexchange.
TypesofDeadSpace
Deadspacecanbedividedinto:
ApparatusdeadspaceDeadspacefromequipment,suchastubesventilatorcircuitry.Someapparatusdeadspacemayactuallyreducetotaldeadspace,asanETTbypassesthemajorityofanatomicaldeadspaceofthepatient(nasopharynx).
PhysiologicaldeadspaceDeadspacefromthepatient.Physiologicaldeadspaceisdividedinto:
AnatomicaldeadspaceThevolumeoftheconductingzoneofthelung.Anatomicaldeadspaceisaffectedby:
SizeandAge3.3ml.kg intheinfant,fallsto2.2ml.kg intheadultPostureDecreaseswhensupine.PositionoftheneckandjawIncreasedwithneckextension.LungvolumesIncreasesby~20mlperlitreofadditionallungvolume.AirwaycalibreBronchodilationincreasesairwaydiameterandthereforeV .
Pathological/AlveolarDeadSpaceDeadspacecausedbydisease.Causesofpathologicaldeadspaceinclude:
ErectpostureDecreasedpulmonaryarterypressure/impairedpulmonarybloodflow
HypovolaemiaRVfailure/IncreasedRVafterload:
HPVMI
PEIncreasedalveolarpressureIncreasesWestZone1physiology.
PEEPCOAD
CalculationofDeadSpaceTwomethodsexisttoallowdeadspacevolumestobecalculated:
PhysiologicaldeadspacemaybemeasuredwithBohr'smethodAnatomicaldeadspacemaybemeasuredbyFowler'smethodPathologicaldeadspacemaybecalculatedbysubtractinganatomicaldeadspace(Fowler'smethod)fromphysiologicaldeadspace(Bohr'sMethod)
-1 -1
D
DeadSpace
182
![Page 183: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/183.jpg)
Fowler'sMethod
Fowler'sMethodisasingle-breathnitrogenwashouttest,usedtocalculateanatomicaldeadspaceandclosingcapacity.
Method:
Attheendofanormaltidalbreath(atFRC)avital-capacitybreathof100%oxygenistakenThepatientthenexhalestoRVExpirednitrogenconcentrationandvolumeismeasured.Aplotofexpirednitrogenconcentrationbyvolumeisgenerated,producingagraphwithfourphases:
Phase1(PureDeadSpace)Gasfromtheanatomicaldeadspaceisexpired.Thiscontains100%oxygen-nonitrogenispresent.Phase2Amixofanatomicaldeadspaceandalveolar(lungunitswithshorttimeconstants)isexpired.Themidpointofphase2(whenareaA=areaB)isthevolumeoftheanatomicaldeadspace.Phase3Expirednitrogenreachesaplateauasjustalveolargasisexhaled(lungunitswithvariabletimeconstants).Phase4Suddenincreaseinnitrogenconcentration,whichindicatesclosingcapacity.Thisincreaseoccursbecause:
BasalalveoliaremorecompliantthanapicalalveoliTherefore,duringinspirationbasalalveoliinflatemorethanapicalalveoliThesingle100%oxygenbreaththereforepreferentiallyinflatesthebasalalveoli.Attheendofthevitalcapacitybreath,theoxygenconcentrationinbasalalveoliisgreaterthanthatofapicalalveoli.Inexpiration,theprocessisreversed:
BasalalveolipreferentiallyexhaleAtclosingcapacity,smallbasalairwayscloseandnowonlyapicalalveoli(withahigherconcentrationofnitrogen)canexhaleMeasuredexpirednitrogenconcentrationincreases
Bohr'sMethod
PhysiologicaldeadspaceismeasuredusingtheBohrequation.Thiscalculatesdeadspaceasaratio,orproportionoftidalvolume:
TheBohrequationisbasedontheprinciplethatallCO exhaledmustcomefromventilatedalveoli.
Notethat:
2
DeadSpace
183
![Page 184: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/184.jpg)
isthemixed-expiredcarbondioxidePartialpressureofCO inanexpiredtidalbreath.TheBohrequationrequiresalveolarPCO tobemeasuredAsthisisimpractical,theEnghoffmodificationistypicallyused,whichassumesthatPACO ≈PaCO .Theequationthenbecomes:
Anormalvalueforphysiologicaldeadspaceduringnormaltidalbreathingis0.2-0.35
PhysiologicalConsequencesofIncreasedDeadSpace
Indeadspace:
TheV/QratioapproachesinfinityasalveolarperfusionfallsThisresultsinariseinPaCOInaspontaneously-ventilatingindividual,thisstimulatestherespiratorycentretoincreaseminuteventilationtoreturnalveolarventilation(andthereforeCO )tonormalThereisminimaleffectonPaO ,asinpuredeadspaceallbloodispassingthroughventilatedalveoliandthereforeundergoesgasexchange
RelationshipbetweenAlveolarVentilationandPaCO
AtmosphericaircontainsnegligibleCO .AsMVincreases,PaCO willfall,aswillthegradientforfurtherCO diffusion.Thiscanbeexpressedbytheequation:
Notethatthisgraph:
DescribesthechangeinPaCO forachangeinalveolarventilationAdoublingofalveolarventilationwillhalvePaCO .DoesnotdescribethechangeinventilatorydriveforagivenchangeinPaCOThisiscoveredunderremovalofCO .
Footnotes
NotethatWestZone1(wherePA>Pa>Pv)physiologyisincreaseddeadspace.
22
2 2
2
22
2
2 2 2
22
22
DeadSpace
184
![Page 185: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/185.jpg)
ThePaCO -ETCO differenceisaconsequenceofdeadspace,asdeadspacegasdilutesalveolargas.
References1. LumbA.Nunn'sAppliedRespiratoryPhysiology.7thEdition.Elsevier.2010.2. WestJ.RespiratoryPhysiology:TheEssentials.9thEdition.LippincottWilliamsandWilkins.2011.
Lastupdated2019-07-18
2 2
DeadSpace
185
![Page 186: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/186.jpg)
ShuntExplaintheconceptofshuntanditsmeasurement
Shuntisbloodreachingthesystemiccirculationwithoutbeingoxygenatedviapassagethroughthelungs.
FactorsContributingtoShunt
NormalshuntAnatomicalshunt
Thebesianveins,whichdraindirectlyintotheleftcardiacchambersBronchialcirculations,whichdrainintothepulmonaryveins
FunctionalshuntBlooddrainingthroughalveoliwithaV/Qbetween0and1.
Thismaynotbetrueshunt,asbloodmayhavesomeoxygencontentbutnotbemaximallyoxygenatedPathologicalshuntPathologicalshuntingcanbeanatomical(e.gcongenitalcardiacmalformations),orphysiological(e.g.pneumoniacausingalveolarconsolidation).
Intra-cardiace.g.VSDExtra-cardiace.g.PulmonaryAVM,PDA
CalculationofShunt
ShuntcannotbedirectlymeasuredThisisbecausewecannotseparatetrueshunt(V=0)fromV/Qscatter(V/Q<1)whensamplingbloodenteringtheleftheartVenousadmixtureisusedinsteadVenousadmixtureistheamountofmixedvenousbloodthatmustbeaddedtopulmonaryend-capillarybloodtogivetheobservedarterialoxygencontent.Venousadmixture:
Isacalculated,theoreticalvalueAssumesthatalveolihaveeithercompleteshunt(noventilationatall,i.e.V/Q=0)ornoshunt(V/Q=1)Isexpressedasaratio,orshuntfraction:
,where:
=Shuntbloodflow
=Cardiacoutput
=Pulmonaryend-capillaryoxygencontent,assumedtohaveanoxygentensionequaltoPAO (withthecorrespondingoxygensaturation)
=Arterialoxygencontent
=Mixedvenousoxygencontent
PhysiologicalConsequencesofShunt
EffectonCarbonDioxide
2
Shunt
186
![Page 187: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/187.jpg)
NoCO candiffusefromshuntedbloodThereforePaCO mightbeexpectedtorise,however:
InaspontaneouslybreathingpatienttheincreasedPaCO increasesrespiratorydrive,andalveolarventilationincreasesTherefore,shuntdoesnottendtoincreasePaCO unless:
TheshuntfractionislargeandThepatientisunabletoincreasetheiralveolarventilationtocompensate
Additionally,thesteepnessoftheCO dissociationcurveatthearterialpointmeansthatalthoughCO contentincreases,theincreaseinPaCO issmall
EffectonOxygen
PaO fallsproportionallytoshuntfractionAsshuntedalveoliareperfusedbutnotventilated,trueshuntissaidtobeunresponsivetoanincreaseinFiOThisiswheretechnicaldefinitionsbecomeimportanttoavoidconfusion.
ForanalveoliwithaV/Qbetween0-1(V/QmismatchorV/Qscatter,butnottrueshunt):Thereisperfusion,butrelativelylessventilationThereforebloodpassingthroughthisalveoliwillbepartiallyoxygenatedIncreasingPAO willimproveoxygenation(assumingnodiffusionlimitation):
AdministrationofsupplementaloxygenHyperventilationAsperthealveolargasequation
ForanalveoliwithaV/Qof0(trueshunt)Thereisnoventilation.RegardlessoftheincreaseinPAO ,PaO willnotimprove.
TheIsoshuntDiagram
IsoshuntdiagramplotstherelationshipbetweenFiO andPaO againstasetof'virtualshuntlines'These'shuntfractions'arecalculatedfromtheaboveequationandsoareactuallyV/Qadmixturefractions
References
1. LumbA.Nunn'sAppliedRespiratoryPhysiology.7thEdition.Elsevier.2010.2. WestJ.RespiratoryPhysiology:TheEssentials.9thEdition.LippincottWilliamsandWilkins.2011.3. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2019-07-18
22
22
2 22
22
2
2 2
2 2
Shunt
187
![Page 188: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/188.jpg)
Shunt
188
![Page 189: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/189.jpg)
OxygenStorageDescribetheoxygenandcarbondioxidestoresinthebody
Thestandardtextbook70kgmalecontains~1.5Lofoxygen,splitbetween:
~850mlinbloodThereis20.4mlofoxygenper100mlofblood,dividedupas:
20.1mlboundtohaemoglobin0.3mldissolved
~250mlboundtomyoglobin~450mlcontainedinFRC(21%of2.4L)Thisiswhypreoxygenationincreasessafeapnoeatimes,asthenitrogenwashoutincreasesthevolumeofoxygenstored.
Oxygen-HaemoglobinDissociationCurveThesigmoidshapeoftheoxygen-haemoglobindissociationcurveoffersmanyphysiologicaladvantages:
BufferingincaseoflowPaOTheplateauallowsoxygencontenttoremainhigh,evenifthePaO fallsMaintenanceofdiffusiongradienttotissuesThesteepsectionallowsalargeamountofoxygentobedeliveredwithonlyasmalldropinPaO ,whichallowstherateofoxygendeliverytobemaintained(astheblood-tissuepartialpressuregradientissteep)withanincreaseinoxygendemand.
ThesigmoidshapeexistsduetocooperativebindingEachoxygenwhichbindstoHbcausesconformationalchangeswhichallowitbindadditionaloxygenmoleculesmoreeasily.
Whenthefourthoxygenmoleculehasbound,Hbissaidtobeintherelaxedconformation(Rstate)Whennooxygenisbound,Hbissaidtobeinthetensestate(Tstate)
Thecurvecanberightorleft-shiftedbychangesintemperature,pH,CO ,and2-3DPG
22
2
2
GasTransport
189
![Page 190: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/190.jpg)
Notethatthemixedvenouspointisnotonthearterialcurve(unlikehowitisdisplayedabove),asthevenousdissociationcurveisright-shiftedrelativetothearterialcurve
HaemoglobinSpecies
Haemoglobinisafour-tetramermolecule,anditsspeciescanbephysiologicalorpathological:
PhysiologicalHbA
Mostcommon2alphaand2betasubunits(α β )
HbALesscommon2alphaand2deltasubunits(α δ )
HbFFoetalHbHigheraffinityforoxygenduetolackof2,3-DPG2alphaand2gammasubunits(α γ )
PathologicalHbSSickle-celldisease.
AbnormalbetasubunitUnabletodeformastheypassthroughcapillaries
Increasesbloodviscosity,thrombus,andischaemiathroughcapillaryocclusionOftencausessplenicinfarction
Reducedredcelllifespanto10-20days
MetHbMethaemoglobinaemia.
Ferrousiron(Fe )isoxidisedtoferriciron(Fe )Cannotbindoxygen,andleft-shiftstheoxyHbcurvefornormalHbwhichreducesoxygenoffloadingattissuesNormallypreventedby:
GlutathioneinredcellreducesoxidisingagentsMethaemoglobinreductaseenzymeusesNADHtoreduceMetHb
Occursdueto:Oxidisingagentsoverwhelmcapacityofglutathionesystem,e.g.:
SNPNOAmidelocalanaesthetics
2 22
2 2
2 2
2+ 3+
GasTransport
190
![Page 191: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/191.jpg)
SulfonamidesFailureofthemethaemoglobinaemiareductaseenzyme
G6PD
COHbCarboxyhaemoglobin.
Haemoglobinbindscarbonmonoxidewithgreateraffinitythanoxygen
CyanoHbHaemoglobinirreversiblybindscyanidemolecules,causingafunctionalanaemiaCyanideinhibitscytochromeoxidaseintheelectrontransportchain,preventingoxidativephosphorylationoccurring
OxygenSaturation
OxygenSaturationcanbedefinedintwoways:
FunctionalSaturation
However,additionalhaemoglobinspeciesexistinvaryingamounts,andthisdefinitionmaydeceptivelyimplygoodoxygendeliverywhenthisisnotthecase.
FractionalSaturation
Fractionalsaturationincludescarboxy-andmet-haemoglobin,andsoisamoreaccurateestimatorofoxygensaturation.
Notethatpulseoximetrydoesn'tmeasureeitheroftheseandisdependentonthecalibration,butwilltypicallymeasurefunctionalsaturation.
Myoglobin
MuscleishighlymetabolicallyactiveandhasalargeO demand.MyoglobinservesasanO storeformuscle.ItissimilartoHbinthatitisalargeO -bindingiron-containingproteinmyoglobin,andisdifferentbecauseit:
Containsoneglobinchainandonehaemegroup(bindingoneO molecule),andsodoesnotexhibitcooperativebindingThemyoglobindissociationcurvethereforehasarapidupstrokeandanearlyplateau.HasaP of2.7mmHgThisallowsittotakeupoxygenfromhaemoglobin(asthepartialpressuregradientfavoursdiffusionintothecell),andunloaditintothecell(soitcanactuallybeused).Isfoundinskeletalandcardiacmuscle
References
1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.2. BrandisK.ThePhysiologyViva:Questions&Answers.2003.
Lastupdated2019-07-18
2 22
2
50
GasTransport
191
![Page 192: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/192.jpg)
GasTransport
192
![Page 193: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/193.jpg)
CarbonDioxideDescribetheoxygenandcarbondioxidestoresinthebody
DescribethecarbondioxidecarriageinbloodincludingtheHaldaneeffectandthechlorideshift
Explainthecarbondioxidedissociationcurve
Describethemovementofcarbondioxidefrombloodtotheatmosphere
CO isproducedinthemitochondriaduringthecitric-acidcycleasaproductofmetabolism.
Thereis~120LofcarbondioxideinthebodyAtotalof1.8L.kg ,1.6L.kg ofwhichisinrelativelyinaccessiblecompartments.Normalelimination(and,atsteadystate,production)ofcarbondioxideis200ml.min
CarbonDioxideinBlood
Inblood,CO isstoredas:
Bicarbonate(90%)DissolvedgasCarbaminocompounds
Form ArterialBlood AdditionalCO invenousblood
Bicarbonate 90% 60%
Dissolved 5% 10%
Carbaminocompounds 5% 30%
Bicarbonate
CO diffusesfreelyintoerythrocytes,whereitcanbecatalysedbycarbonicanhydrasetoproducebicarbonate:
Tomaintainbicarbonateproduction,theproducts(H andHCO )arethenremoved:H ionsarebufferedtohaemoglobin
IntracellularHCO isthenexchangedwithextracellularCl-viatheBAND3membraneproteinThisiscalledtheHamburger,orChlorideShiftChlorideenteringthecelldrawswaterinalongitsosmoticgradient,increasingthehaematocritofvenousbloodrelativetoarterialblood
DissolvedGas
AsperHenry'sLaw,theamountofcarbondioxidedissolvedinbloodisproportionaltothePaCOAscarbondioxideis20xassolubleasoxygeninwater,dissolvedcarbondioxidecontributesmuchgreaterproportionofcarbondioxidecontentthandissolvedoxygendoestooxygencontent
CarbaminoCompounds
2
-1 -1-1
2
2
2
+3-
+
3-
2
+
CarbonDioxide
193
![Page 194: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/194.jpg)
CO canbinddirectlytoproteins(predominantlyhaemoglobin),whichdisplacesaH ion:
TheH ionisthenbufferedbyanotherplasmaprotein(alsopredominantlyhaemoglobin)
BoundCO doesnotcontributetothepartialpressuregradientCarbaminocompoundsareonlyasmallcontributortooverallCO carriage,butcontributeaboutonethirdofthearterio-venousCO differenceduetotheHaldaneeffectTheHaldaneeffectstatesthatdeoxyHbbindsCO moreeffectivelythanoxyHb.Thisisbecause:
DeoxyHbisabetterbufferofHpKaofdeoxyHbis8.2,comparedtothatofoxyHbwhichis6.6.
Enhancedbufferingcontributes~30%oftheHaldaneeffectDeoxyHbformscarbaminocompoundsmoreeasilyDeoxy-Hbhas3.5xtheaffinityforCO thanOxy-Hb.
Thisforms~70%oftheHaldaneeffect
CO DissociationCurve
ThiscurveplotsPCO againstbloodCO contentinml.100ml .
Keypoints:
MixedvenousCO contentis52ml.100ml ,ataPCO of46mmHgArterialCO contentis48ml.100ml ,ataPCO of40mmHgApproximately50%ofthearterial-mixedvenousdifferenceoccursduetotheupwardsshiftofthecurve,whichisduetotheHaldaneeffectThisisthemechanismforchangesinPO affectingtheCO dissociationcurve.
RemovalofCO
CO dissolvesfrompulmonaryarterialbloodintothealveolusdownaconcentrationgradient.AsinspiredCO isnegligible,PACO isafunctionofalveolarventilationandCO output,givenbytheequation:
Simplified,PaCO isinverselyproportionaltoalveolarventilation:
2+
+
22
22
+
2
2
2 2-1
2-1
22
-12
2 2
22 2
2 2
2
CarbonDioxide
194
![Page 195: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/195.jpg)
DistributionofCarbonDioxide
CO inthebodycanbeconsideredasathree-compartmentmodel:
Well-perfused(blood,brain,kidneys)Moderately-perfused(restingmuscle)Poorly-perfused(bone,fat))
Eachofthesetissueshasadifferenttime-constant,suchthatamismatchofventilationwithmetabolicactivitymaytake20-30minutestoequilibrateacrosscompartments
ThereforehypoventilationandhyperventilationhavedifferenteffectsonPCO :HyperventilationcausesarapiddecreaseinPCO inblood,subsequent(slower)redistributionfromperipheralcompartmentsHypoventilationcausesariseinPaCO ,therateofwhichisdeterminedbothbyproductionanddistributionintoplasma
Withnoventilation,PCO risesat3-6mmHg.minDuetotheHaldaneeffectthePaCO willrapidlyincreaseduringpassagethroughthepulmonarycapillary(despitethefactthatcarbondioxidecontentisunchanged)astheproportionofOxyHbincreases
Therefore:PaO ismoresensitiveatdetectingearlyhypoventilationprovidedPAO isnormalSteady-statePCO givesthebestindicationofadequacyofventilation
Inacutehypoventilation,producedCO ispreferentiallystoredintissues,decreasingCO eliminationInacutehyperventilation,CO ismobilisedfromtissuesresultinginincreasedCO elimination
CO Cascade
Region Value(mmHg)
MixedVenous 46
Alveolar 40
(Arterial) 40
Mixed-expired 27
VenousCO diffusesintothealveolus,reachingequilibriumwitharterialPCOAlveolarCO isthendilutedbydeadspacegas,resultinginalowerME'CO
References
2
22
2
2-1
2
2 22
2 22 2
2
2 22 2
CarbonDioxide
195
![Page 196: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/196.jpg)
1. LumbA.Nunn'sAppliedRespiratoryPhysiology.7thEdition.Elsevier.2010.2. FRCA:AnaesthesiaTutorialoftheWeek-RespiratoryPhysiology
Lastupdated2018-04-24
CarbonDioxide
196
![Page 197: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/197.jpg)
PositivePressureVentilationDescribethephysiologicalconsequencesofintermittentpositivepressureventilationandpositiveend-expiratorypressure.
Physiologicaleffectsofpositivepressureventilationaremostlyrelatedtotheincreasedmeanairwaypressure.Thisisafunctionof:
VentilationmodeTidalvolumeandpeak(andplateau)airwaypressureRespiratoryrateI:EratioPEEPPEEPhasamuchlargereffectthantheotherfactors.
PEEPisdefinedasapositiveairwaypressureattheendofexpirationPEEPisdistinctfrompositiveairwaypressure(whichisnotconfinedtoaphaseoftherespiratorycycle)andCPAP(whichisamodeofventilation)iPEEPreferstointrinsicPEEP,autoPEEPordynamichyperinflationiPEEPisPEEPgeneratedbythepatient,andoccurswhenexpirationstopsbeforethelungvolumereachesFRC.
ApplicationofexternalPEEPmaylimitthegenerationofiPEEPbymaintainingairwaypatencyinlateexpiration
RespiratoryEffectsDecreasedworkofbreathing
DecreasedVOMoreimportantwhenworkofbreathingishigh.
Alterationinanatomical/apparatusdeadspaceIntubationtypicallyreducesdeadspace,astheadditionalapparatusdeadspaceisofsmallervolumethantheanatomicaldeadspaceitreplacesNon-invasiveventilationmaskscausealargeincreaseindeadspace
Increaseslungvolume(andFRC,forPEEP)byanamountproportionaltothecomplianceofthesystemImprovesoxygenationviaalveolarrecruitmentImproveslungcomplianceviaalveolarrecruitment,reducingworkofbreathingElevatedairwaypressuresmayincreasetheproportionofWestZone1physiologyandalveolardeadspace
Inhealthylungsanincreaseinthe ratioisseenwhenPEEPexceeds10-15cmH O.ReducesairwayresistanceAirwayresistancedecreasesaslungvolumeincreases.
CardiovascularEffectsAlterationincardiacoutput
PEEPandIPPVgenerallydecreaseCOviadecreasingVRduetotheincreaseinintrathoracicpressure.LeadstoreductioninRVfillingpressure,LVfilling,andCO.
ThisisthepredominantreasonwhyCOfallswiththeapplicationofPEEPInawellpatient,COfallsby:
10%withIPPVandZEEP18%withIPPVand9cmH OofPEEP36%withIPPVand16cmH OofPEEP
2
2
22
AppliedRespiratoryPhysiology
197
![Page 198: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/198.jpg)
Thesechangesare:MoremarkedinhypovolaemiaChangesarereversedwithvolumeexpansion.LessseverewithpoorlungcomplianceReducedcompliancegreatlyreducestheeffectofPEEPandIPPVonthevasculature,asthechangeinintrapleuralpressureisreduced.
LVpreloadmayalsobereducedduetoincreasedRVafterloadIncreasedRVafterloadmayincreaseRVEDV,displacingtheinterventricularseptumintotheLVThebulgingseptumdecreasesLVEDV,causingLVdiastolicfunctionandreducedLVfillingThisisanexampleofventricularinterdependence.
ReducedLVafterloadduetoreducedLVtransmuralpressureInsomecases,IPPVaugmentscirculatoryfunctionbyreducingLVafterloadtoagreaterextentthanpreload.
Effectsinawellpatientareminimal,asPEEPisrelativelysmallinmagnitudecomparedtosystemicarterialpressuresInpatientsgeneratinghighlynegativeintrathoracicpressures,theLVtransmuralpressurecanincreasemarkedly,increasingLVafterloadandreducingcardiacoutput
ReductioninMAPMAPdecreasesasPEEPincreases.
ChangestooxygenfluxPEEPwilltendtoimprovePO whilstreducingCO.
ChangestopulmonaryvascularresistanceandRVafterloadIflungvolumeislowerthanFRC,thenPVRwillreduceasPEEPstretchesopenextra-alveolarvessels
Alveolarrecruitmentwillreducehypoxic-pulmonaryvasoconstriction,furtherreducingPVRIflungvolumeishigherthanFRC,thenPVRwillincreaseasPEEPcompressesalveolarvesselsTherefore,PEEPhasvariableeffectsonRVafterloaddependingonhowitchangeslungvolumewithrespecttoFRC
End-OrganEffects
Reducedurineoutputdueto:ReducedCOandrenalbloodflowADHreleaseasaconsequenceofreducedatrialstretchandANPreleaseMayworsenoedemainpatientswithprolongedperiodsofventilation.
Reducedhepaticbloodflowdueto:IncreasedCVPanddecreasedCOloweringthepressuregradientforhepaticflow
Mayresultincirculationonlyintermittentlythroughoutthecardiaccycle
References
1. LumbA.Nunn'sAppliedRespiratoryPhysiology.7thEdition.Elsevier.2010.2. LueckeT,PelosiP.Clinicalreview:Positiveend-expiratorypressureandcardiacoutput.CriticalCare.2005;9(6):607-621.
doi:10.1186/cc3877.3. Yartsev,A.PositiveEnd-ExpiratoryPressureandit'sconsequences.DerangedPhysiology.4. Yartsev,A.PositivePressureandPEEP.DerangedPhysiology.5. Yartsev,A.IndicationsandContraindicationsforPEEP.DerangedPhysiology.6. Yartsev,A.EffectsofPositivePressureandPEEPonAlveolarVolume.DerangedPhysiology.7. Yartsev,A.[PEEPandIntrinsicPEEP}(http://www.derangedphysiology.com/main/core-topics-intensive-care/mechanical-
2
AppliedRespiratoryPhysiology
198
![Page 199: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/199.jpg)
ventilation-0/Chapter%202.1.6/peep-and-intrinsic-peep).DerangedPhysiology.
Lastupdated2017-09-22
AppliedRespiratoryPhysiology
199
![Page 200: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/200.jpg)
HypoxiaExplainthephysiologicaleffectsofhyperoxia,hypoxaemia,hypercapnia,hypocapnia,andcarbonmonoxidepoisoning.
HypoxaemiaisalowpartialpressureofoxygeninbloodHypoxiaisanoxygendeficiencyatthetissues,dueto:
ImpairedoxygendeliveryImpairedoxygenextraction
Oxygendeliveryisgivenbytheequation:
,where:
1.34isHüfner'sconstantThisistheoxygencarryingcapacityofhaemoglobin,inml.g (ofHb).
Thetheoreticalmaximumis1.39Invivoitis1.34duetotheeffectofcarboxyhaemoglobinandmethaemoglobincompounds,whichlimitO binding
0.03isthesolubilitycoefficientofO inwaterat37ºC,inmls.mmHgCanalsobeexpressedas0.003mls.dL .mmHg (mlsperdeciliterpermmHg).Differenttextsusedifferentvalues,dependingonwhetherhaemoglobinisreporteding.L org.100ml .
ClassificationsandCausesofHypoxia
Hypoxiacanbecategorisedintofourtypes:
HypoxichypoxiaAnaemichypoxiaIschaemichypoxiaHistotoxichypoxia
HypoxicHypoxia
Hypoxichypoxia,orhypoxaemia,ishypoxiaduetolowPaO (andthereforelowSpO ),typicallydefinedasaPaO <60.
CausesofhypoxaemiacanbefurtherclassifiedbasedontheirA-agradient:
CausesofhypoxaemiawithanormalA-agradient:LowPiODecreasedalveolarventilation
CausesofhypoxaemiawitharaisedA-agradient:DiffusionlimitationShunt(Increasedoxygenextraction)
LowFiO
HypoxaemiaoccursathighaltitudeswhenthePO isdecreased.
Decreasedalveolarventilation
-1
22
-1-1 -1
-1 -1
2 2 2
2
2
2
Hypoxia
200
![Page 201: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/201.jpg)
Afallinalveolarventilation( )causesariseinPACO ,andthereforedecreasesPAO .DecreasedV canoccurwith:
Respiratorycentredepression:DrugsHeadinjury(RaisedICP,closedheadinjury)EncephalopathyFatigue
Nervedysfunction:SpinalcordinjuryGBSMND
NMJdysfunction:ParalysisMG
Musculardysfunction:MyopathyFatigueMalnutritionDystrophy
Chestwallabnormalities:KyphoscoliosisAnkylosingSpondylitisPleuralfibrosis
DiffusionLimitation
ImpaireddiffusionofO acrossthemembraneresultsinaloweredPaO .Diffusionlimitationoccursdueto:
DecreasedalveolarsurfaceareaIncreasedalveolarcapillarybarrierthickness
PulmonaryfibrosisARDS
Shunt
Shuntoccurswhenbloodreachesthesystemiccirculationwithoutbeingoxygenatedviapassagethroughthelung.Asthealveolusisperfusedbutnotventilated,thustheV/Qratiois0.
Administrationof100%O haslesseffectonPaO asshuntfractionincreasesOxygencontentofshuntedalveoliisidenticaltomixedvenouscontentOxygencontentofnon-shuntedalveolidoesnotincreaseappreciablyathighpartialpartialpressuresashaemoglobinisalreadyfullysaturated
Shuntphysiologyisexploredinmoredetailundershunt.
IncreasedOxygenExtraction
Increasedoxygenextraction(VO )willnottypicallycausehypoxiaThisisbecause:
NormalVO is250ml.minNormalDO is1L.min
22 A
2 2
2 2
2
2-1
2-1
Hypoxia
201
![Page 202: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/202.jpg)
Maximaloxygenextractionratiois~70%(thoughitvariesbetweenorgans)ThereforeVO canincreaseuntilitreaches70%oftheDO ,apointcalledcriticalDO .
However,itmayworsenhypoxiainthepresenceofasupply-side(DO )pathology
AnaemicHypoxia
ImpairedoxygendeliveryduetolowHbTypicallyasymptomaticatrestbutlimitsexercisetolerance
Compensationoccursbyincreasinglevelsof2,3-DPG,causingaright-shiftintheHb-O dissociationcurvetofavouroxygenoff-loadingattissues
CarbonMonoxidePoisoning
COpoisoningisclassifiedasasubsetofanaemichypoxiaascarboxyhaemoglobinreducestheeffectiveamountofhaemoglobininsolutionCOhas210timestheaffinityforHbthanO
COrapidlydisplacesO fromHbandisliberatedslowlyCOpoisoningcausesheadacheandnausea,butnoincreasedrespiratorydrivesincethePaO isunchanged
IschaemicHypoxia
Ischaemichypoxiaisduetoimpairedcardiacoutputresultinginimpairedoxygendelivery
HistotoxicHypoxia
Histotoxichypoxiaisduetoimpairedtissueoxidativeprocesses,preventingutilisationofdeliveredoxygenMostcommoncauseofhistotoxichypoxiaiscyanidepoisoning,whichinhibitscytochromeoxidaseandpreventsoxidativephosphorylationManagedbyusingmethyleneblueornitrites,whichformmethaemoglobin,inturnreactingwithcyanidetoformthenon-toxiccyanmethaemoglobin
EffectsofHypoxia
WithanormalPaCO ,PaO mustfallto50mmHgbeforeanincreaseinventilationoccursWitharisingPaCO ,afallinPaO below100mmHgwillstimulateventilationviaactiononcarotidandaorticbodychemoreceptors
Theeffectsofeachstimuliaresynergistic,andgreaterthanwhatisseenwitheithereffectalone
Prolongedhypoxaemiawillalsoleadtocerebralacidosis(viaanaerobicmetabolism),whichwillstimulatecentralpHreceptorsandstimulateventilation
Acid-BaseChanges
Hypoxiaresultsinbothfixedandvolatileacid-basedisturbancesAnaerobicmetabolismresultsinlactateproductionProductionoffixedacidresultsinabasedeficit,andalowbicarbonateHypoxiaandmetabolicacidosisstimulateventilationandhypocarbia
CO retention
InchronichypercarbiatheCSFpHnormalises(asbicarbonateissecretedintoCSF),witharaisedCO
2 2 22
2
22
2
2 22 2
2
2
Hypoxia
202
![Page 203: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/203.jpg)
FallinPaO becomesthepredominantstimulusforventilation
References1. WestJ.RespiratoryPhysiology:TheEssentials.9thEdition.LippincottWilliamsandWilkins.2011.2. BarrettKE,BarmanSM,BoitanoS,BrooksHL.Ganong'sReviewofMedicalPhysiology.24thEd.McGrawHill.2012.3. CICMJuly/September20074. ICUBasicBook.
Lastupdated2019-07-18
2
Hypoxia
203
![Page 204: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/204.jpg)
HypoandHypercapneaExplainthephysiologicaleffectsofhyperoxia,hypoxaemia,hypercapnia,hypocapnia,andcarbonmonoxidepoisoning
Carbondioxideislipidsolubleandcanrapidlycrossmembranes,allowingitaffectacid-basestatusinanycompartment.
Hypercapnea
RespiratoryEffects
IncreasedrespiratorydriveviachemoreceptorstimulationCVSeffects
PeripheralvasodilationMaycausetachycardiafromsympatheticstimulation
PulmonaryvasoconstrictionMyocardialdepressionIntracellularacidosis.Arrhythmogenic
CNSeffectsIncreasedCBFIncreasedICPsecondarytoincreasedCBFSNSactivationCNSdepressionWhenPaCO >100mmHg
HypocapneaRespiratoryEffects
Left-shiftofoxyhaemoglobindissociationcurveRespiratorydepression
CVSeffectsMyocardialdepressionIntracellularalkalosis.
CNSeffects
DecreasedcerebralbloodflowElectrolyteeffects
DecreasedserumKDecreasedserumCaLeadstoparesthesiasandtwitches.
Ca bindstoH bindingsiteonalbumin
References
2
+2+
2+ +
HypoandHypercapnea
204
![Page 205: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/205.jpg)
1. BrandisK.ThePhysiologyViva:Questions&Answers.2003.
Lastupdated2019-07-18
HypoandHypercapnea
205
![Page 206: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/206.jpg)
PositionandventilationExplaintheeffectofchangesinpostureonventilatoryfunction
AlteredpatientpositioncancausesignificantchangestoV/Qmatching.
LateralDecubitus
Inthelateralpositioninaspontaneouslyventilatingpatient:
Dependentlungventilationimprovesby~10%Duetoimpairedcomplianceofthenon-dependentlung(ithyperinflates)andimprovedcomplianceofthedependentlung(itislessexpanded).
DependentlungcorrespondsmoretoWestZone3Non-dependentlungcorrespondsmoretoWestZone2
Dependentlungperfusionimprovesby~10%Duetotheeffectofgravity.
Inthelateralpositioninapositive-pressureventilatedpatient:
Themajority(~55%)ofthetidalvolumeisdeliveredtothenon-dependentlungThemajorityofpulmonarybloodflowisdeliveredtothedependentlungThecomplianceofthedependentlungfallsduetocompressionfromthe:
MediastinumAbdominalorgansThesemovecephaladinaparalysedpatient.
ThedependentlungtypicallyreceivesgreaterbloodflowduetotheeffectofgravityThismayworsenV/QmatchingBloodflowisalsoaffectedby:
HPVAnatomicalfactorsBloodflowisgreaterincentralthanperipheralportions.LungvolumeAlterationsisextra-alveolarandintra-alveolarpressuresatFRCmayalterregionalbloodflow.
Whenbothlungsarebeingventilated,V/QmatchingcanbeimprovedwithselectiveapplicationofPEEPtothedependentlung,whichimprovescompliance
ThoracotomyOpeningofanon-dependenthemithoraxcauses:
IncreasedcomplianceandFRCofthenon-dependentlungReducedcomplianceandFRCofthedependentlung
References1. Dunn,PF.PhysiologyoftheLateralDecubitusPositionandOne-LungVentilation.ThoracicAnaesthesia.Volume38(1),
Winter2000,pp25-53.
PositionandVentilation
206
![Page 207: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/207.jpg)
2. GraphfromBenumofJL,ed.Anesthesiaforthoracicsurgery.2nded.Philadelphia:WBSaundersCompany,1995.3. ANZCAAugust/September2015
Lastupdated2017-09-20
PositionandVentilation
207
![Page 208: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/208.jpg)
HumidificationDefinehumidityandgiveanoutlineoftheimportanceofhumidification
Humidificationdescribestheamountofwatervapourpresentinair:
AbsoluteHumidityistheamountofwatervapourinagivenvolumeofair(g.m )RelativeHumidityistheratiobetweentheamountofwatervapourinasampleofair(absolutehumidity)andtheamountofwaterrequiredtofullysaturatethatsampleatitscurrentpressureandtemperature
Moistureisthewaterproducedbycondensationwhenrelativehumidityexceeds100%.
Humidificationofinspiredairisimportanttoavoiddryingoutmucosaandsputum,whichleadstotissuedamageandfailureofthemucociliaryelevatorOptimalfunctionrequiresarelativehumidityofgreaterthan75%
MechanismThenoseis:
OptimisedforhumidificationTheseptumandturbinatesincreasecontactofairwithmucosalsurfacesby:
IncreasingsurfaceareaGeneratingturbulentflow
ThepreferredorificeforbreathingunlessairwaysresistancebecomesasignificantlylimitingfactorThisisrelevantin:
Airwayobstruction(e.g.polyps)Athighminuteventilations(>35L. )
Humidifiesinspiredgasto90%,comparedto60%forthemouth
Methodofhumidification:
FluidliningtheairwayactsasaheatandmoistureexchangerIninspiration:
RelativelydryairisevaporateswaterfromtheairwayliningRelativehumidityisincreasedto90%inthenasopharynxand100%BTPSbythesecondgenerationofbronchiThisgivesawatervapourpressureof47mmHgatBTPS,withanabsolutehumidityof44g.m .
Inexpiration:AircoolsintheupperairwayAscoolerairhasalowersaturatedvapourpressure,moisturecondensesontheairway.MoistureisreabsorbedThisreducespotentialwaterlossesfromtheairwayfrom300ml.day to150ml.day .
References1. LumbA.Nunn'sAppliedRespiratoryPhysiology.7thEdition.Elsevier.2010.2. WeatherFaqs.AbsoluteandRelativeHumidity.3. CICMSeptember/November2012
Lastupdated2018-09-21
-3
-1
-3
-1 -1
Humidification
208
![Page 209: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/209.jpg)
Humidification
209
![Page 210: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/210.jpg)
CoughReflexExplainthepathwaysandimportanceofthecoughreflex
Coughing:
IsanairwayprotectionreflexInvolvesdeepinspirationfollowedbyforcedexpirationagainstaclosedglottisThesuddenopeningofthecordscausesaviolentrushofairat>900km.h ,removingirritantsandsecretionsfromtheairways.
SensationVagusafferentshaveexquisitelysensitivelighttouchandcorrosivechemicalreceptorsinthelarynx,carina,terminalbronchioles,andalveoli.
IntegrationVagalafferentssynapseinthemedulla,whichcoordinatestheeffectorresponse.
EffectorAseriesofprocessesoccurinthreephases:
InspiratoryphaseAclosetovitalcapacitybreathistaken.CompressivephaseEffortclosureoftheepiglottistosealthelarynx,followedbyaviolentcontractionofabdominalmusculatureandinternalintercostals,causingarapidriseinintrapleuralpressureto>100mmHg.ExpulsivephaseWide-openingofthecordsandepiglottis,causingaviolentexpiration.
Compressionofthelungscausesnarrowingofthenoncartilaginousairwaysandincreasesturbulentflow,removingadherentmaterialfromthetracheobronchialtree
References
1. BarrettKE,BarmanSM,BoitanoS,BrooksHL.Ganong'sReviewofMedicalPhysiology.24thEd.McGrawHill.2012.
Lastupdated2019-07-18
-1
CoughReflex
210
![Page 211: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/211.jpg)
Non-RespiratoryFunctionsOutlinethenon-ventilatoryfunctionsofthelungs
Thelungsareauniqueorganas:
TheentirecardiacoutputpassesthoughthepulmonarycirculationTheyhaveahugecapillarybedwhichbloodisincontactwithTheyhavealargeinterfacewiththeexternalenvironment
Consequentlytheyareadaptedtoanumberofnon-respiratoryfunctions,whichinclude:
FiltrationImmunedefenceBloodresevoirMetabolismDrugDelivery
(Takingupdrugs)InhalationalAnaesthetics
SyntheticEndocrine
FiltrationTheentirecardiacoutputpassesthroughthe7μmpulmonarycapillaries,whichactasaneffectivesieveforparticulatematter.Thisfunctionmaybeimpairedbyintra-cardiacshunting(e.g.PFO)orpre-capillaryanastomoses.
Complementingthisrole,thelungsareabletoclearthrombimorerapidlythanotherorgansaspulmonaryendotheliumhasahighconcentrationofplasminactivatorandheparin.
Metabolism
Thepulmonaryendotheliumhasavarietyofeffectsondrugsandendogenoushormones:
Class Activated Inactivated
Amines 5-HT,Noradrenaline
Peptides AngiotensinI(viaACE) Bradykinin,ANP
Arachidonicacidderivatives Arachidonicacid Manyprostaglandins
OtherDrugs Lignocaine,fentanyl
BloodReservoir
Thehighlycompliantpulmonarycirculationcontainsaresevoirof~500mlofbloodwhichactsasavolumereservefortheLV.
Defence
Non-RespiratoryFunctions
211
![Page 212: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/212.jpg)
Thelargesurfacearearequiredforgasexchangeleavesthelungvulnerabletoinvasionbyairbornsubstances.Thisisattentuatedby:
MucousAmucouslayerprotectslargeairways,aslarge(>8μm)particlesimpactintothemucous.
MucousisexocytosedbygobletcellsinresponsetonoxiousstimuliincludingchemicalirritationaswellasinflammatoryandneuronalstimulationTheefficacyofthemucous-ciliasystemisenhancedbybronchoconstriction,whichreducesflowvelocityandcausesparticulatemattertosettle
CiliaCiliaareprojectionsfromepitheliumwhichbeatrhythmicallyat~12Hztopropelmucousoutoftheairwayatarateof~4mm.min .
Ciliaryfunctioncanbeimpededbypollutants,smoke,andinfectionCiliaryfunctionisstimulatedbyanaestheticagents
Inhaledparticleswhichreachtherespiratoryzonearenottrappedbymucous,butinsteadphagocytosedbyalveolarmacrophagesBronchoconstrictionreducesflowvelocityandcausesparticulateparticlestosettleinthemucous
DrugDelivery
Thesamepropertiesthatoptimisethelungforgasexchangeoptimiseitfordeliveryofinhaledagents.Drugsabsorbedinthepulmonarycirculationare:
LipophilicAlkaline(pKa>8)
EndocrineImportantendocrinefunctionsofthelunginclude:
Releaseofinflammatorymediatorssuchashistamine,endothelin,andeicosanoidsReleaseofnitricoxidetoregulatesmoothmuscleACEmetabolisesangiotensinItoangiotensinII
References
1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.2. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.
Lastupdated2019-07-18
-1
Non-RespiratoryFunctions
212
![Page 213: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/213.jpg)
AltitudePhysiologyAltitudecausesanumberofphysiologicaleffects,relatedto:
ReduceatmosphericpressureReducedtemperatureReducedrelativehumidityIncreasedsolarradiation
PressureEffects
ReducedairpressureresultsinaproportionaldecreaseinPO :
At3,000m,alveolarPO is60mmHgAt5,400m,consciousnessislostinunacclimatisedindividualsAt10,400m,airpressureis187mmHgWith47mmHgofwatervapourandanalveolarPCO of40,breathing100%O givesanalveolarPO of100mmHg.At14,000m,consciousnessislostdespite100%OAt19,200m,theambientpressureissolowthattheboilingpointofwateris37°CThisistheArmstronglimit.
Respiratory
FallinPaO iscompensatedbyincreasingminuteventilation,whichdecreasesPACO andthereforeincreasesPAOLimitsofcompensationarereachedon100%oxygenat13,700m
Effectivecompensationislimitedbytherespiratoryalkalosis,thisisknownasthebrakingeffect:PeripheralchemoreceptorsdetecthypocapneaCentralchemoreceptorsdetectalkalosis
ThesubsequentrespiratoryalkalosisgeneratesacompensatorymetabolicacidosisThisacidosisrelaxesthebrakingeffectandallowsfurtherhyperventilation,andisthereforeamimportantpartofacclimatisation.
Thereisaninitialleft-shiftoftheoxygen-haemoglobindissociationcurveduetoalkalosisThisstimulatesacompensatoryincreasein2,3-DPGtoright-shiftthecurveandimproveoxygenoffloadingatthetissues
Cardiovascular
PVRincreasesduetoHPVHeartrateincreasesduetoincreasedSNSoutflow
2
2
2 2 22
2 2 2
AltitudePhysiology
213
![Page 214: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/214.jpg)
Strokevolumefalls(cardiacoutputremainsthesame)duetodecreasedpreload:Plasmavolumefallsdueto:
PressurediuresisInsensiblelossesfromhyperventilationandreducerelativehumidity
MyocardialworkincreasesIncreasedHRIncreasedviscosityofbloodduetohighhaematocritIncreasedRVafterloadfromhighPVRIncreasedpulmonarycapillaryhydrostaticpressuresleadtofluidtransudationandpulmonaryoedema
Haematological
IncreasedriskofthromboticeventstodueincreasedhaematocritIncreasedredcellmassduetoEPOsecretion
References1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2019-07-18
AltitudePhysiology
214
![Page 215: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/215.jpg)
RespiratoryChangeswithObesityDiscusstheeffectofmorbidobesityonventilation
Obesityisamultisystemdisorderdefinedbyanelevatedbodymassindex(BMI):
Normal:BMI<25Overweight:BMI25-30Obese:BMI>30MorbidlyObese:
ObesityrelateddiseaseandaBMI>35BMI>40
Characteristicsofobesityinclude:
ComplexgeneticandenvironmentalcausesIncreasedcaloricintakeIncreasedmetabolicrate(normalforBSA)
Morbidobesitycausesseveralchangestotherespiratorysystem:
AirwayIncreasedriskofOSAIncreasedriskofGORDandaspirationIncreasedriskofdifficultbag-maskventilationIncreasedriskofdifficultylaryngoscopy
ChangestorespiratorypatternIncreasedminuteventilation
SecondarytoincreasedVO andVCODuetotheincreaseinLBWandadiposity.IncreasedairwayreactivityCentraladiposityincreasescirculatingcytokines,includingTNF-α,IL-6,leptin.
ChangestovolumesandcapacitiesReducedrespiratorysystemcompliance
DecreasedchestwallcomplianceDuetoabdominalandchestwallfat.
FatdistributionmaybemoreimportantthanabsoluteBMIDecreasedlungcomplianceBasalatelectasisduetoabdominalcompressionandreducedrespiratorycompliance.
DecreasedERVandFRCNotethatRVisgenerallyrelativelyunchanged
IncreasedairwayresistanceDuetodecreasedairwayradiusatlowerlungvolumes.IncreasedworkofbreathingDuetoreducedrespiratorycomplianceandincreasedairwayresistance.ClosingcapacityencroachesonFRCAsFRCfalls,closingcapacitybecomesclosertoFRC.
Ifclosingvolumeexceedsexpiratoryreservevolume,thensmallairwayswillcollapseduringnormaltidalbreathing,causingshunt
Changestobloodgases
2 2
RespiratoryChangeswithObesity
215
![Page 216: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/216.jpg)
IncreasedA-agradientOccurswhenclosingcapacityexceedsFRC.
ChangestorespiratorycirculationPVRincreasesduetoreducedFRCcausingincreasedHPVMayleadtosecondaryPHTNandrightheartdysfunction.
References
1. AlvarezA,BrodskyJ,LemmensH,MortonJ.MorbidObesity:Peri-operativeManagement.Cambridge:CambridgeUniversityPress.2010.
2. LotiaS,BellamyMC.Anaesthesiaandmorbidobesity.ContinEducAnaesthCritCarePain2008;8(5):151-156.
Lastupdated2017-09-21
RespiratoryChangeswithObesity
216
![Page 217: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/217.jpg)
RespiratoryChangesinNeonatesandChildren
TransitionatBirth
Transitionfromplacentalgasexchangetopulmonarygasexchangeoccurswithin20safterbirth:
CompressionofthethoraxthroughthevaginalcanalexpelsfoetallungwaterElasticrecoil,combinedwithcoolingoftheskinandmechanicalstimulation(whichstimulatetherespiratorycentre),facilitatefirstbreath
Therapiddropinpulmonaryvascularresistancewithspontaneousbreathingdrivesthechangesinthecardiaccirculation
ThefirstthreebreathsestablishfunctionalresidualcapacityLargechangesinintrathoracicpressureinthefirstthreebreathspressuredrivealveolaramnioticfluidintothecirculation,andestablishFRC.
NeonatesandChildrenComplianceNeonatalchestwallsarehighlycompliantrelativetotheirlungs(duetobothareducedlungcomplianceandincreasedchestwallcompliance),ascomparedtoadultswherelungandchestcomplianceisequal.Thereforeelasticworkofbreathingislargelydeterminedbythelungs.
OxygenationO consumptionis~10ml.kg .min inneonates,and6ml.kg .min inchildrenThereisa~10%shuntafterbirthwhichcontributestoagreaterA-agradient
VentilationObligatenosebreathersIncreasedCO productionduetohighermetabolicrateIncreasedminuteventilation,whichisduetoincreasedrespiratoryrate(25-40breathsperminute)
NeurologicalcontrolofbreathingRespiratorypatternschangefollowingbirth,andcompletechangetoadultrespiratorypatternsmaytakesomeweeks.Patternsinclude:
PeriodicbreathingisaslowlyoscillatingrespiratoryrateandVPeriodicapnoeaisintermittentapnoeainterspersedwithnormalbreathing.
Volumesandcapacities
2-1 -1 -1 -1
2
T
NeonatesandChildren
217
![Page 218: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/218.jpg)
Closingcapacityisincreasedrelativetoadults,causingshuntFunctionalresidualcapacityisunchangedTidalvolumeanddeadspaceareunchanged
LaryngealanatomyLargeheadLargetongueLarge,stiff,U-shapedepiglottisElevatedlarynxGlottisisatC-3C4(C6inadults).Upperairwayisnarrowestatthecricoidring(ratherthantheglottis).Tracheaisshorterandnarrower4-5cmlong,6mmdiameterintheneonate.
SmallairwaysReducedbronchialsmoothmusclesobronchospasmisuncommonBronchiolescontribute50%ofairwaysresistanceBronchiolitismuchmoredistressinginneonatesandchildren.
References1. LumbA.Nunn'sAppliedRespiratoryPhysiology.7thEdition.Elsevier.2010.2. CICMMarch/May2013
Lastupdated2018-07-14
NeonatesandChildren
218
![Page 219: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/219.jpg)
Anti-AsthmaDrugsDescribethepharmacologyofanti-asthmadrugs.
OxygenIncreasesFiO andimprovessaturation.HelioxReducesspecificgravityofinhaledgasmixtures,improvinglaminarflow.β -agonistsActsonaG-proteincoupledreceptorto↑cellularlevelsofadenylylcyclase,↑cAMP,whichresultsinsmoothmusclerelaxationandbronchodilatation.CorticosteroidsGlucocorticoidsaresteroidhormonesthatbindtospecificintracellularreceptorsandtranslocateintothenucleus,wheretheyregulategeneexpressioninatissue-specificmanner.Theyareusedinasthmaastheycause:
BronchodilatationbyincreasingbronchialsmoothmuscleresponsetocirculatingcatecholaminesDecreasedairwayoedemabydecreasinginflammatoryresponsesandtransudateproduction
MuscarinicantagonistsAnti-muscarinicsaresyntheticquaternaryammoniumcompoundswhichcompetitivelyinhibitM3muscarinicreceptorsonbronchialsmoothmuscle,antagonisingthebronchoconstrictoractionofvagalimpulses.MethylxanthinesMethylxanthinesarephosphodiesteraseinhibitors,reducinglevelsofcAMPhydrolysisandincreasedintracellularlevelsofcAMP(viaadifferentmechanism,sotheyaresynergisticwithβ agonists)andcausingsmoothmusclerelaxation.KetamineIncreasessympatheticoutflowandrelaxesbronchialsmoothmuscle.VolatileAnaestheticAgentsVolatileanaestheticagentsreducesbronchialsmoothmuscleconstrictionwherethisispreexisting(suchasasthma).LeukotrieneAntagonistsSelectivelyinhibitsthecysteinylleukotrienereceptor,increasedactivityofwhichisinvolvedinairwayoedemaandbronchialsmoothmuscleconstriction.
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.
Lastupdated2019-07-18
2
2
2
RespiratoryPharmacology
219
![Page 220: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/220.jpg)
CardiacAnatomyDescribetheanatomyoftheheart,thepericardiumandcoronarycirculation
EchocardiographicAnatomy
Theleftventricleis:
DividedintofourpartsFrombasetoapex,inequalthirdsalongthelongaxisoftheventricle:
BasalMid-cavityIdentifiedbypresenceofthepapillarymuscles.ApicalApexTipoftheventricle,beyondwherethecavityends.
EachpartisdividedintosegmentsTotalofseventeensegmentsbetween:
6basalandmid-cavitysegmentsInferiorMid-cavitycontainsthepostero-medialpapillarymuscle.InferoseptalInferolateralAnteriorAntero-septalAntero-lateralMid-cavitycontainstheanterolateralpapillarymuscle.
4apicalsegmentsInferiorAnteriorLateralSeptal
Apicalcap
CoronarySupply
Thesegmentsofthebasalandmid-cavitypartsaresuppliedbyallthreevessels:
CardiovascularSystem
220
![Page 221: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/221.jpg)
Intheapicalpart,the:
LADSupplies:
AnteriorSeptal
LCxSupplies:
LateralRCASupplies:
Inferior
TheapicalcapissuppliedbytheLAD.
References
1. AlfredAnaestheticDepartmentPrimaryExamTutorialSeries2. AHA17SegmentModel.PMOD.
Lastupdated2018-08-01
CardiovascularSystem
221
![Page 222: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/222.jpg)
CardiovascularSystem
222
![Page 223: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/223.jpg)
CoronaryCirculationDescribetheanatomyoftheheart,thepericardiumandcoronarycirculation
VascularAnatomy
CoronaryArteryAnatomy
Theleftmaincoronaryartery:
ArisesfromtheposterioraorticsinussuperiortotheleftcoronarycuspoftheaorticvalveEddycurrentsproducedinthesinusesofValsalva(outpouchingsoftheaorticwall)preventthevalvesoccludingtheosoftheLMandRCAduringsystole,sotheyremainpatentthroughoutthecardiaccycle.Theleftmainis5-10mmlong,andbifurcatestoformtheLADandLCx
TheLAD:
CoursesalongtheanteriorinterventriculargroovetotheapexoftheheartHere,itanastomoseswiththeposteriordescendingarteryfromtheRCA.Suppliestheanterolateralmyocardiumandanterior2/3oftheinterventricularseptumBranchesoftheLADinclude:
DiagonalvesselsBranchesarenamedsuccessivelyfromproximaltodistal,i.e.LADD ,LADD ,etc.1 2
CoronaryCirculation
223
![Page 224: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/224.jpg)
Septalperforators
TheLCx:
CoursesalongtheleftatrioventriculargroovebetweentheLAandLVintheepicardialfatpadSuppliestheinferolateralwalloftheLVGivesoffthreeobtusemarginalbranches(OM ,OM )whichfollowtheleftmarginoftheheartRunsincloseapproximationwiththecoronarysinusformuchofitscourse
TheRCA:
Arisesfromtheanterioraorticsinus,superiortotherightcoronarycuspoftheaorticvalveCoursesverticallydownwardsintherightatrioventriculargrooveSuppliestheRAandRV
Theposteriordescendingartery:
ArisesfromeithertheLCxorRCAThesevesselstravelinoppositedirectionsaroundtheatrioventriculargroove.DescendsintheposteriorinterventriculargroovebeforecoursingalongthebasetoanastomosewiththeLADattheapexoftheheartIsalsoknownastheposteriorinterventricularartery
CoronaryDominance
CoronarydominancereferstowhichvesselgivesrisetothePDA:
Inaright-dominantcirculationthePDAissuppliedbytheRCAInaleft-dominantcirculationthePDAissuppliedbytheLCx
Additionally:
TheSAnodeissuppliedbytheRCAin60%ofindividualsTheAVnodeissuppliedbytheRCAin90%ofindividuals
VenousAnatomy
85%ofvenousdrainageoccursviathecoronarysinus,whichisformedfromthecardiacveins:ThegreatcardiacveinrunswiththeLADThemiddlecardiacveinfollowsthePDAThesmallcardiacveinrunswiththeRCATheobliqueveinfollowstheposteriorpartoftheLA
MostoftheremainderisviaanteriorcardiacveinswhichdraindirectlyintotheRAAsmallproportionofbloodfromtheheartisdrainedviathethebesianveinsdirectlyintofourthecardiacchambersMostintotherightatrium,andleastintotheleftventricle.Theportionofblooddrainingintotheleftsideofthecirculationcontributestophysiologicalshunt.
CoronaryBloodFlowCoronaryBloodFlow:
Normalis~250ml.min (~5%ofrestingCO)Mayincrease4xduringstrenuousexerciseMyocardialworkmayincreaseupto9x,thoughasmyocardialoxygenextractionisunchangedefficiencyisactuallyimprovedduringexercise.
1 2
-1
CoronaryCirculation
224
![Page 225: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/225.jpg)
CBFisdependenton:
CoronaryvascularresistanceCoronaryperfusionpressureThedifferencebetweenaorticrootpressureandthegreaterofRAPorintracavitypressure:i.e.
NotethatthepressuregradientisusuallyAorta-CavityratherthanAorta-RAThisisbecausethepressureintheventricleactsasaStarlingresistor-coronaryflowisindependentofRAPwhilst
HeartrateLVCBFisaffectedinsystoleduetothechangesinperfusionpressure,andcompressionofintramuscularvessels(causinganincreaseinCVR).
RVCBFislessaffected,astheforceofcontractionissignificantlysmallerandapressuregradientismaintainedTachycardiareducesdiastolictimeandsubsequentlyLVCBF
ControlofCoronaryBloodFlow
CBFisautoregulated:
MyogenicautoregulationThisiscommontomanyorgansystems,andoccurswithinthecoronaries.
Increasingtransmuralpressureincreasestheleakinessofsmoothmusclemembranes,depolarisingthemResistanceincreasesproportionallytopressure,suchthatflowremainsconstant
MetabolicautoregulationAnaerobicmetabolismresultsinproductionofvasoactivemediatessuchaslactateandadenosine,whichstimulatevasodilationandthereforeincreaseflow(andoxygendelivery).
ThisisthepredominantmeansforautoregulationintheheartTypicalmyocardialoxygenextractionis70%andraisingthisfurtherisdifficultTherefore,increasingoxygensupplyrequiresanincreaseinbloodflow.
CoronaryCirculation
225
![Page 226: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/226.jpg)
Autonomicmechanismsalsocontrolsomeaspectsofcoronarybloodflow:
Directeffectsinclude:Parasympatheticandsympatheticinnervationofcoronaryvessels,withreleaseofAChorNAandAdecreasingorincreasingcoronarybloodflow
IndirecteffectsAremoreimportantthandirecteffectsArerelatedtoautoregulationoccurringwithchanginglevelsofmyocardialworkinresponsetoparasympatheticorsympatheticstimuli
References
1. Hall,JE,andGuytonAC.GuytonandHallTextbookofMedicalPhysiology.11thEdition.Philadelphia,PA:SaundersElsevier.2011.
2. CICMJuly/September20073. McMinn,RMH.Last'sAnatomy:RegionalandApplied.9thEd.Elsevier.2003.4. CoronaryArteryGraphbasedonCoronaryArterialCirculation-es.2/3/2013.(Image).ByAddicted04(Ownwork)CCBY
3.0,viaWikimediaCommons.
Lastupdated2019-07-18
CoronaryCirculation
226
![Page 227: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/227.jpg)
CardiacCycleDescribethenormalpressureandflowpatterns(includingvelocityprofiles)ofthecardiaccycle
Thecardiaccycle:
DescribessequenceofeventsthatoccurintheheartoveronebeatConsistsoftwophasesdividedintosixstagesTypicallyisdescriedasbeginninginlatediastolewhenthemyocardiumisrelaxedandtheventriclesarepassivelyfilling
Phasesofthecardiaccycle:
DiastoleIsovolumetricVentricularRelaxationRapidVentricularFillingSlowVentricularFilling(Thecyclebeginshere).AtrialContraction
SystoleIsovolumetricVentricularContractionEjection
PhasesoftheCardiacCycleEventsduringeachphaseofthecardiaccyclearerepresentedonWigger'sDiagram:
CardiacCycle
227
![Page 228: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/228.jpg)
SlowVentricularFilling(Diastasis)
Inslowventricularfilling:
TheAVvalvesareopenandthesemi-lunarvalvesareclosedTheventricleisrelaxedcompletelyandfillsslowlyTheventricleshavebeenmostlyfilledduringrapidventricularfillingandsothepressuregradientisreducing.
ThepressureineachventricleisalmostzeroArterialpressureisfalling,asitisend-diastoleCVPisslowlyrisingastheventricleandatriafillThisperiodoccursaftertheydescent.TheECGwillshowthebeginningsofaP-waveattheendofthisphase
AtrialContraction
Theatriacontract,andremainingbloodintheatriaisejectedintotheventricle.Thissupplies10%oftheventricularfillingatrest,butupto40%intachycardia.
Inatrialcontraction:
ArterialpressureisstillfallingTheCVPwaveformdemonstratestheawaveasatrialcontractionalsocausesbloodtorefluxintotheSVCTheECGwillshowthePRinterval
IsovolumetricVentricularContraction
CardiacCycle
228
![Page 229: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/229.jpg)
OncetheactionpotentialpassesthroughtheAVnodeandbundleofHis,ventricularcontractionbegins.
Inisovolumetriccontraction:
Ventricularpressurerises,andtheAVvalvescloseThisgivesrisetothefirstheartsound,S .
Asventricularpressureisstilllessthansystemicvascularpressure,thesemilunarvalvesremainclosedArterialpressureisstillfallingTheCVPwaveformshowstheC(closure)wave,asthetricuspidvalveherniatesbackintotheRAduringventricularcontractionThereisasimilarspikeinLApressureasthemitralvalvealsobulgesbackintotheLA.TheECGwillshowtheremainderoftheQRSorthestartoftheQTinterval
Atrialrepolarisationoccursatthisstage,butistypicallymaskedbyventriculardepolarisation
Ejection
Whenventricularpressureexceedsarterialpressure,thesemilunarvalvesopenandejectionoccurs.Initialejectionisrapid,butasventricularpressurefallsandsystemicpressurerisesthegradientfallsejectionbecomesslower.
Duringejection:
Arterialpressurerisesrapidly,andisslightlylessthanventricularpressureduringthisstageTheCVPwaveformshowsthexdescent,astheshorteningRVpullstheRAdown,rapidlyloweringCVPTheSTsegmentshowsontheECGastheventriclesarefullydepolarised,thoughtheTwavemayappearinlateejection
IsovolumetricRelaxation
Whencontractioniscomplete,theventriclesbegintorelax.Inertiameansthatejectioncontinuesforashorttime.
Duringisovolumetricrelaxation:
ThesemilunarvalvescloseThisgivesrisetothesecondheartsound,S ,andmarksthebeginningofisovolumetricrelaxation.
ThisoccurswhenventricularpressurefallsbelowvascularpressureArterialpressurebeginstofall,interruptedbythedicroticnotchwhichisabriefincreaseinarterialpressureasthesemilunarvalvescloseThevwaveisvisibleontheCVPwaveformDuetoatriafillingagainstclosedAVvalves.TheendoftheTwaveisvisibleontheECGasventricularrepolarisationoccurs
RapidVentricularFilling
Mostofventricularfillingoccursinthisphase.Thisisbecauseinearlyventriculardiastoletheventricleisstillrelaxingandsoapressuregradientismaintainedbetweentheatriaandventricle.
Duringrapidventricularfilling:
TheAVvalvesopenandventricularfillingoccursThisoccurswhenatrialpressureexceedsventricularpressure.ArterialpressureisfallingTheydescentoccurswhentheAVvalvesopen,causingarapiddropinCVPastheventriclesfillNoelectricalactivityisproduced-theECGshowstheTPinterval
1
2
CardiacCycle
229
![Page 230: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/230.jpg)
References
1. Hall,JE,andGuytonAC.GuytonandHallTextbookofMedicalPhysiology.11thEdition.Philadelphia,PA:SaundersElsevier.2011.
2. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.3. Wigger'sDiagram(withsomemodifictions)fromWigger'sDiagram.21/3/2012.(Image).ByDanielChangMD(revised
originalworkofDestinyQx);RedrawnasSVGbyxavax.CCBY3.0,viaWikimediaCommons.
Lastupdated2019-07-18
CardiacCycle
230
![Page 231: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/231.jpg)
CardiacActionPotentialExplaintheionicbasisofspontaneouselectricalactivityofcardiacmusclecells
Describethenormalandabnormalprocessesofcardiacexcitationandelectricalactivity
Anactionpotentialisapropagatingchangeinthemembranepotentialofanexcitablecell,usedincellularcommunicationandtoinitiateintracellularprocesses.Itiscausedbyalteringthepermeabilityofamembranetodifferentions.
PacemakerPotentialThispatternofelectricalactivityisseenintheSAandAVnodes.Ithasnorestingstate,andiscontinuallydepolarising.
PhasesofthePacemakerPotential
Phase0Beginsatthethresholdpotentialof-40mV,withapeakmembranepotentialof20mV.Drivenpredominantlybythevoltage-gatedL-type(long-lasting)Ca channelscausinganinfluxofcalciumions.Phase3Repolarisationphase,whichoccursasK channelsopenandCa channelsclose.Thenadiriscalledthemaximumdiastolicpotentialandis-65mV.Phase4Phase4consistsof:
ThefunnycurrentAsteadyinfluxofNa /K whichgraduallydepolarisesthecell.
Sympatheticstimulationincreasesthefunnycurrent,increasingtherateofdepolarisation.ParasympatheticstimulationincreasesK permeability,hyperpolarisingthecellandflattensthegradientofphase4.
2+
+ 2+
+ +
+
ElectricalProperties
231
![Page 232: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/232.jpg)
CalciumcurrentInphase4,thisisthetransientcalciumcurrent,drivenbyT-typecalciumchannels.Theyopenwhenthemembranepotentialreaches~-50mV,alsocausingdepolarisation.
VentricularActionPotential
Topreventtetaniccontraction(whichwouldbebad)ventricularmusclehasalongplateaupriortorepolarisation,whichlengthenstheabsoluterefractoryperiodto250ms.Therelativerefractoryperiodis50ms.
PhasesoftheVentricularActionPotential
Phase0:DepolarisationAtthethresholdpotential,voltage-gatedfast-Na channelsopenbriefly,causingdepolarisation.Themembranepotentialpeaksat30mV.Phase1:PartialRepolarisationTheclosureofNa channelsresultsinK fleeingthecelldownitselectrochemicalgradient,causingaslightdropinvoltagecalledpartialrepolarisation.Phase2:PlateauL-typeCa channelsopen,causingaslowinwardCa currentwhichmaintainsdepolarisationandfacilitatesmusclecontraction.Phase3:RepolarisationMembranepermeabilitynormalises,andoutwardpotassiumcurrentreturnsthemembranepotentialtonormal.Phase4:RestingPotentialMembranepotentialreturnstoitsresting-85mV.
PropagationoftheCardiacActionPotentialPacemakercells:
+
+ +
2+ 2+
ElectricalProperties
232
![Page 233: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/233.jpg)
AreresponsibleforautomaticityandrhythmicityoftheheartThefastestpacemakeristhefocusformyocardialconductionThisistypicallytheSAnode.
ShouldtheSAnodefail,thenextfastestpacemakerwilltakeoverThisprovidesanelementofredundancy
Conductionpathway:
AtrialConductionFromtheSAnode,theimpulsetravelsat~1m.s ,depolarisingtheatria.
CurrenttravelsdownBachmann'sBundle,whichconnectstherightatriumtotheleftatrium
AVnodeTheAVnodeistheonly(normal)siteofconnectionbetweentheatriaandventricles.AVnodalcells:
Transmitswithadelayof0.1sThisallowstimeforatrialcontractiontofinishbeforeventricularcontractionbegins.Haveaprolongedrefractoryperiodandcannotconductmorethan220impulsesperminute
Thisperiodisprolongedbyvagalstimulation,whichincreasespotassiumpermeabilityandhyperpolarisesthecellConversely,sympatheticstimulationincreasescalciumpermeabilityandallowsmorerapidtransmission
Conductsviathreepathways:BachmannPathwayAlsoconductstotheLA.WenckebachpathwayThorelpathway
VentricularConductionFromtheAVnode,thesignalpropagates:
InitiallyviatheBundleofHistotherightandleftbundlesSecondlyviathePurkinjefibreswhichconductat1-4m.sPurkinjefibreshavealongrefractoryperiod,andspontaneouslydepolarisewithanintrinsicrateof30-40bpm.Lastly,ventricularmuscleisdepolarisedEndocardium,papillarymuscleandseptumcontractfirst,followedbyapex,followedbythechambers.
AutonomicControlParasympatheticInnervation
SAnodebytherightvagusThereiscontinualPNSinput("Vagaltone")viainhibitoryAChGPCR,reducingtheSAnodefromitsintrinsicrateof90-120bpmtoamoresedate60-100bpm.AVnodebytheleftvagusTheatriaareinnervatedbyparasympatheticneurons,whilsttheventriclesareonlyminimallyinnervatedPNSstimulationthereforehaslittleeffectoninotropy,butdoesaffectchronotropy.
PNSstimulationmayhavenodirecteffectoninotropy,insteadactingindirectlyviachangesinchronotropy
SympatheticInnervationSNSactivitycausesreleaseofnoradrenaline(atpost-ganglionicsynapse)andadrenalinefromadrenalmedullawhichstimulatecardiacβ receptorscausing:
PositivechronotropyattheSAnodePositiveinotropyatventricularmusclePositivelusitropyShorteractionpotentialduration(duetoopeningofrectifyingK channelsIncreasedAVconduction
-1
-1
1
+
ElectricalProperties
233
![Page 234: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/234.jpg)
CardiacTransplant
Thetransplantedhearthasnovagal/parasympatheticinnervationbutstillexpressesβ receptors,soit:
Defaultstoarestingheartrateof~100bpmBecomeshighlypreloaddependentasitcannotrespondquicklytochangesinSVRNotresponsivetoparasympatholytics(atropine,glycopyrrolate)orephedrine(asthisisindirectly-acting)toincreasechronotropy-isoprenalinemaybeusedGradualresponsetodemandsinexercise(lackslocalSNSinnervation,butwillstillrespondtocirculatingcatecholamines)Increasedsensitivitytocatecholaminesduetoincreasedexpressionofβ receptors
References1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.3. MatsuuraW,SugimachiM,KawadaT,SatoT,ShishidoT,MiyanoH,NakaharaT,IkedaY,AlexanderJJr,SunagawaK.
Vagalstimulationdecreasesleftventricularcontractilitymainlythroughnegativechronotropiceffect.AmJPhysiol.1997Aug;273.
Lastupdated2019-07-18
1
1
ElectricalProperties
234
![Page 235: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/235.jpg)
DeterminantsofCardiacOutputDefinethecomponentsanddeterminantsofcardiacoutput
CardiacoutputafunctionofHeartRate(HR)andStrokeVolume(SV):
.
Heartrateisfairlyintuitive
StrokevolumeisdefinedasthedifferencebetweenESVandEDV,i.e.Strokevolumeisafunctionofthreefactors:
PreloadAfterloadContractility
PreloadandafterloadhavealmostasmanydefinitionsastherearetextbooksForthepurposeoftheexam,it'sgoodtohavebothalaboratoryandaclinicaldefinitionThesedefinitionsarethosewhichhaveappearedinoldexaminerreports,orgiventomebycardiacanaesthetists
Preload
Preloadisdefinedasthemyocardialsarcomerelengthjustpriortocontraction.
Asthisisnotmeasurablewithoutremovingtheheartandcuttingitintotinypieces,clinicallyitisusuallyapproximatedbyEDVor,lessappropriately,byEDP
EDVistypicallycalculatedonechocardiographyEDPistypicallymeasuredusingaCVCorPAC
CVP≈RVEDPPCWP≈LVEDP
DeterminantsofPreload
Preloadisafunctionof:
VenousReturnIntrathoracicPressureMSFP
VenouscomplianceAdecreaseinvenouscompliancewillincreaseLVEDP.Volumestate
VentricularcomplianceReducedindiastolicdysfunction.PericardialcomplianceValvulardisease
AVvalvediseasewillimpairpreloadSemilunarvalvediseasewillincreasepreload
AtrialkickWallthicknessIncreasedventricularwallthicknessdecreasespreload.
HOCM/Hypertrophy
CardiacOutput
235
![Page 236: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/236.jpg)
PreloadandtheRespiratoryCycle
NegativeintrathoracicpressurecausesRAPandPCWPtofallThisincreasesRAfilling,soandRVEDPandRVEDVincreaserelativetothepleuralpressure(thoughabsolutepressureisstilllow)LVeffectsaremorevariableNegativeintrapleuralpressures:
IncreaseLVtransmuralpressureThisimpairsejection.CausebowingoftheinterventricularseptumintotheLVThisreducesLVEDV.
Frank-StarlingMechanism
TheFrank-StarlingLawoftheHeartstatesthatthestrengthofcardiaccontractionisdependentoninitialfibrelengthAtacellularlevel,additionalstretchincreases:
ThenumberofmyofilamentcrossbridgesthatcaninteractMyofilamentCa sensitivity
ThislawisrepresentedbytheventricularfunctioncurvePlotofpreloadagainststrokevolume(orcardiacoutput,assumingaconstantheartrate).
RightshiftofthecurvedemonstratesnegativeinotropyLeftshiftofthecurvedemonstratespositiveinotropy
Thefailingventricle:
Incardiacfailure,theventriclebecomesoverstretchedThisreducesthenumberofoverlappingcrossbridges,reducingcontractility.Thisislimitedintheacutesettingbyconstrictionofthepericardium,whichpreventsexcessiveventriculardilation
Afterload
2+
CardiacOutput
236
![Page 237: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/237.jpg)
Afterloadisthesumofforces,bothelasticandkinetic,opposingventricularejection
Thisdefinitionisabitwordybutavoidsusingthewords"resistance"and"impedance",whicharestrictlydefinedinphysics(andcrudelyappliedinmedicine),andmaybeleaptonbythecruelexaminer
DeterminantsofAfterload
Afterloadisequaltoventricularwallstress,whichisgivenbytheequation:
,where:
isventricularwallstress
isventriculartransmuralpressureisventricularchamberradius
isventricularwallthickness
Eachofthesefactorsareinturninfluencedby:
VentriculartransmuralsystolicpressureTransmuralpressureisthedifferencebetweenintrathoracicpressureandtheventricularcavitypressureduringejection.
IntrathoracicPressureNegativeintrathoracicpressurewillincreaseafterload,astheventriclehastogenerateagreaterchangeinpressuretoachieveejection.
PEEPreducesLVafterloadNegative-pressureventilationwithahighworkofbreathingincreasesafterloadThisiswhyAPOdeteriorates-increasedworkofbreathingincreasesLVafterloadandworsensLVfailure,increasedpulmonaryoedema,causingincreasedworkofbreathing...
VentricularcavitypressureTofacilitateejection,theventriclemustovercome:
OutflowtractimpedanceValvulardisease
e.g.aorticstenosisHOCM
SystemicarterialimpedanceDeterminedbyresistance(SVR),inertia,andcompliance:
DeterminantsofresistancearestatedinthePoiseuilleEquation:
,where:η=ViscosityAffectedbyhaematocrit(e.g.increasedinpolycythaemia)l=VessellengthEssentiallyfixed.r=Vesselradius
GreatestdeterminantFunctionofdegreeofvasoconstrictionofresistancevessels
InertiaGivenbythemassofbloodinthecolumnAffectedbyheartrate
ArterialcomplianceDecreasedarterialcomplianceincreasesafterload.
Duringejection,theaortaandlargearteriesdistend,reducingpeaksystolicpressure(impedanceto
CardiacOutput
237
![Page 238: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/238.jpg)
furtherejection)Decreasedarterialcomplianceincreasesthechangeinpressureforanygivenvolume,increasingafterloadduringejectionDecreasedarterialcomplianceincreasesthespeedofpropagationofreflectedpressureswavesreturningtotheaorticroot
WavearrivalindiastoleaugmentscoronarybloodflowWavearrivalduringsystolefurtherincreasesafterload
Indiastolethearteriesrecoilandbloodpressureandflowaremaintained-theWindkesseleffect.
VentricularchamberradiusEnd-DiastolicVolumeIncreasedEDVincreasesventricularradiusandthereforewalltension.
MyocardialwallthicknessIncreasingwallthickness(seenclinicallyasventricularhypertrophy)decreasesafterloadbysharingwalltension(theproductofpressureandradius)betweenalargernumberofsarcomeres.
ContractilityContractilitydescribesthefactorsotherthanheartrate,preload,andafterloadthatareresponsibleforforchangesinmyocardialperformance.
DeterminantsofContractility
ContractilityisprimarilydependentonintracellularCa .Determinantsinclude:
DrugsDisease
IschaemiaReducedATPproductionsecondarytohypoxia,whichimpairssarcoplasmicreticulumCa function.Furtherexacerbatedbyintracellularacidosisfromanaerobicmetabolism.HeartFailureImpairedcontractilityreserve,i.e.minimalincreaseincontractilitywithsympatheticstimulation.
ReducedpeakCa andsarcoplasmicreticulumuptakeofCaAutonomicToneBowditchEffectContractilityimprovesatfasterheartrates.Thisisbecausethemyocardiumdoesnothavetimetoremovecalcium,soitaccumulatesintracellularly.AnrepEffectContractilityincreasesasafterloadincreases.
MeasuringContractility
Aswiththeotherdeterminantsofcardiacoutput,therehasbeensomedifficultyindevelopingmeasurableindicesforcontractilityAllmeasuresofcontractilityareaffectedbypreloadorafterloadtosomeextent
dP/dt ( )TherateofriseofLVP,assumingaconstantpreloadandafterload
ThisindexispreloaddependentbutafterloadindependentTypically,thedP/dt inisovolumetricventricularcontractionisused
2+
2+
2+ 2+
max
max
CardiacOutput
238
![Page 239: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/239.jpg)
AgreaterrateofriseindicatesamoreforcefulcontractionMeasurementrequiresLVcatheterisation
End-SystolicPressure-VolumeRelationshipUsestheventricularPressure-VolumeRelationshipLineplottedatthetangenttothecurvefromtheend-systolicpoint(whenisovolumetricventricularrelaxationbegins)
Thesteeperthegradientthegreaterthecontractility
EjectionFractionMostcommonmethodusedclinicallyisejectionfraction:
FootnotesTheuseofwallstressforpreloadandafterloadcomesfromtheCardiovascularHaemodynamicstext,butisnotusedintheCICMtexts
Thissitehasaniceoverviewofwalltension,andtherelationshipofpressuretoradius
Thisarticlediscussesthewallstressdefinitionforpreloadandafterload
Changeswithventilationaredescribedwithprettygraphshere
References1. BrandisK.ThePhysiologyViva:Questions&Answers.2003.2. DerangedPhysiology-Haemodynamicchangesduringmechanicalventilation3. AnwaruddinS,MartinJM,StephensJC,AskariAT.Cardiovascularhemodynamics:anintroductoryguide,contemporary
cardiology.NewYork:Springer;2013.p.29–51.4. NortonJM.TowardConsistentDefinitionsforPreloadandAfterload.AdvancesinPhysiologyEducationMar2001,25(1)
53-61.5. ANZCAJuly/September2006
Lastupdated2019-07-18
CardiacOutput
239
![Page 240: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/240.jpg)
VenousReturnDefinethecomponentsanddeterminantsofcardiacoutput
Thevenoussystemhastwokeycardiovascularfunctions:
BloodreservoirContains65%ofbloodvolume.Conduitforreturnofbloodtotheheart
Venousreturnistherateatwhichbloodisreturnedtotheheart(inL.min ).Atsteadystate,venousreturnisequaltocardiacoutput,andcanbeexpressedas:
,where:
isvenousreturn
isthemeansystemicfillingpressureThisisthemeanpressureofthecirculationwhenthereisnoflow.Itisanindicatorofcirculatoryfilling,andisafunctionofcirculatingvolumeandvascularcompliance.
Normalmeansystemicfillingpressureis~7mmHg
istherightatrialpressureAnelevatedRAPreducesvenousreturn.
istheresistancetovenousreturn
Thisrelationshipcanbeexpressedgraphically:
Whenvenousreturnis0,themeasuredrightatrialpressureisanindicationofmeansystemicfillingpressure
Alterationstocirculatingvolumeandcomplianceaffectbothvenousreturnandmeansystemicfillingpressure
-1
VenousReturn
240
![Page 241: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/241.jpg)
Alterationstotheresistancetovenousreturnaffectvenousreturnbutmeansystemicfillingpressureisunchanged
FactorsAffectingVenousReturn
Venousreturnwillbealteredbyanyofthevariablesintheaboveequation:
MSFPVolumee.g.Haemorrhage,resuscitation.Compliance
RAPRespiratorypumpNegativeintrathoracicpressurereducesRAP,improvingvenousreturn.PositivepressureventilationPericardialcompliance
ConstrictionTamponade
ResistancetoVenousReturnPostureVascularcompression
ObesityPregnancyLaparoscopy
OtherfactorsaffectingvenousreturnSkeletalmusclepumpContractionoflegmusclesincombinationwithanintactvenoussystempropelsbloodbacktowardstheheart.
InteractionbetweenVenousReturnandCardiacFunctionCurves
Guyton'scurvecanbesuperimposedonStarling'scurvetoexaminetheinteractionbetweenvenousandcardiacfunctionoverarangeofconditions:
VenousReturn
241
![Page 242: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/242.jpg)
References1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.2. BrandisK.ThePhysiologyViva:Questions&Answers.2003.3. HendersonWR,GriesdaleDE,WalleyKR,SheelAW.Clinicalreview:Guyton-theroleofmeancirculatoryfillingpressure
andrightatrialpressureincontrollingcardiacoutput.CriticalCare.2010;14(6):243.doi:10.1186/cc9247.
Lastupdated2019-07-18
VenousReturn
242
![Page 243: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/243.jpg)
MyocardialOxygenSupplyandDemandDescribemyocardialoxygendemandandsupply,andtheconditionsthatmayaltereach
MyocardialoxygensupplyisafunctionofcoronarybloodflowMyocardialoxygendemandisdeterminedbymyocardialworkMyocardialischaemiaoccurswhendemandexceedssupply
MyocardialOxygenSupply
Myocardialoxygensupplyisdependenton:CoronaryarteryflowOxygencontentofbloodOxygenextraction
Functionally,coronaryarteryflowisthedeterminant.Thisisbecause:OxygencontentinindividualswithoutpulmonarydiseaseismaximalRestingmyocardialoxygenextractionisnear-maximal(~70%)ThishighERmakestheheartlesstolerantofanaemiathanorganswithalowER.
ThereforecoronarybloodflowisthelimitingfactorCoronarybloodflowisgivenbytheequation:
AorticrootpressureisthedrivingpressureforcoronaryflowCavity(ventricular)pressureactsasaStarlingresistorforcoronaryflow
NotethatifRAPexceedscavitypressure,RAPwillbethepressureopposingcoronaryflow(duetodownstreampressureatthecoronarysinus)
Notethatcavityandaorticrootpressurechangethroughoutthecardiaccycle,therefore:TheflowtoeachventricleisdifferentduringthecardiaccycleTheleftventricleisbestperfusedindiastoleThereforeheartrateisanimportantdeterminantofcoronarybloodflow,astachycardiawilldecreasecoronarybloodflow
Flowtoeachventricleisafunctionofhowrelationshipschangeoverthecardiaccycle
LeftVentricularCoronaryBloodFlow:
RightVentricularCoronaryBloodFlow:
MyocardialOxygenSupplyandDemand
243
![Page 244: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/244.jpg)
MyocardialOxygenDemand
Normalmyocardialoxygenconsumption(MVO )is21-27ml.min .Thethreemajordeterminantsare:
HeartrateAchangeinheartratewillchangethenumberoftension-generatingcycles,causingaproportionalchangeinMVO .
Contractility
Referstotherateoftensiondevelopmentaswellasitsmagnitude.Changing willchangeMVO .
VentricularwalltensionVentricularwalltensionispressurework,ortheworkdonebytheventricletogeneratepressurebutnottoejectvolume.
WalltensionisgivenbytheLawofLaPlace
,where:
=Pressureduringcontraction=Radius
Walltensionisthereforeafunctionof:AfterloadIncreasingafterloadwillincreasethepressureduringcontraction.PreloadIncreasingpreloadwillincreaseradius,buttoalesserextentthanincreasingafterload.
Thisisbecausevolumeandradiusarenotdirectlyproportional
Minordeterminantsofmyocardialworkare:
ExternalworkExternalworkcanalsobethoughtofasvolumework,ortheenergyexpendedtoejectbloodfromtheventricle.
Thisisencompassedbytheareaenclosedbythepressure-volumeloopConversely,internalworkisdefinedastheworkrequiredtochangetheshapeoftheventricleandprepareitforejectionOnthepressure-volumeloopinternalworkisrepresentedbyatrianglebetweenthepointof0pressureandvolume,theendsystolicpoint,andthebeginningofrapidventricularfilling.
Thisisaminordeterminantbecausethemajorityofventricularworkisgeneratingthepressurerequiredtoejectblood,notactuallymovevolumeExternalworkisofgreaterimportanceathighCOExternalworkisusedtocalculatecardiacefficiency,givenbytheequation:
Basaloxygenconsumption
2-1
2
2
-1 -1
MyocardialOxygenSupplyandDemand
244
![Page 245: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/245.jpg)
Basaloxygenconsumption(~8ml.min .100g )comprises~25%ofMVO .
References1. GrossmanW,BaimDS.Grossman'sCardiacCatheterization,Angiography,andIntervention.7thEd(revised).2006.
LippincottWilliamsandWilkins.2. LeslieRA,JohnsonEK,GoodwinAPL.DrPodcastScriptsforthePrimaryFRCA.CambridgeUniversityPress.2011.3. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.4. MillerRD,ErikssonLI,FleisherLA,Weiner-KronishJP,CohenNH,YoungWL.Miller'sAnaesthesia.8thEd(Revised).
ElsevierHealthSciences.
Lastupdated2017-10-04
-1 -12
MyocardialOxygenSupplyandDemand
245
![Page 246: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/246.jpg)
Pressure-VolumeRelationshipsDescribethepressure-volumerelationshipsoftheventriclesandtheirclinicalapplications
LeftVentricularP-VLoop:
PlotofleftventricularvolumeversuspressureTimeisnotdirectlydemonstratedonthisgraph,butthestagesofthecardiaccyclecanbeinferred:
A-BisisovolumetricrelaxationVentricularpressureislessthanaorticpressurebutgreaterthanatrialpressure,sobothmitralandaorticvalvesareclosed.B-Cisrapidandslowventricularfilling,followedbyatrialsystoleAtrialsystoleissometimesdemonstratedbyasharp'bump'towardsC,asventricularpressurewillbrieflyriseoutofproportiontoventricularvolumeC-DisisovolumetriccontractionTheventriclecontracts.Asventricularpressureisgreaterthanatrialpressurebutlessthanaorticpressure,themitralvalvecloses(pointC)andtheaorticvalveremainsclosed.Pressureincreaseswithoutachangeinvolume.
ThisslopeofthislineisknownasthedP/dt ( ),andisanindexofcontractilityD-AisventricularejectionWhenventricularpressureexceedsaorticpressure,bloodisejectedintotheaortaandventricularvolumedecreases.
TheslopeofthelineB-CgivestheelastanceoftheventricleThisisalsoknownastheEnd-DiastolicPressureVolumeRelationship(EDPVR),andisoften(erroneously)referredtoasventricularcompliance.
ElastanceoftheventricleincreasesasitisfilledThisisdemonstratedbythedashedline.
TheventricleonlyoverfillsathighfillingpressuresIncreasedelastance(suchasindiastolicdysfunction)isdemonstratedbyanincreasedslopeofthisline,suchthatventricularpressurewillbehigheratanygivenvolumeBothventricularandarterialelastancearelowinnormalcircumstances(astateknownasventricular-arterialcoupling),asthisallowstheventricletoachieveawiderangeofvolumetransfersinejectionwithminimalchangeinfillingpressure.
ThehorizontaldistancebetweenpointB(ESV)andC(EDV)givethestrokevolumeEjectionfractioncanthenbecalculated.PreloadisgivenbytheEDVAfterloadis:
Technicallygivenbythepressure-volumerelationshipthroughouttheentiretyofejectioni.e.theslopeD-A.
max
Pressure-VolumeRelationships
246
![Page 247: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/247.jpg)
ThiscomesfromLaPlace'slaw:
UsuallyassumedtogivenbytheslopeofalinedrawnfromtheEDV(onthex-axis)totheend-systolicpoint(pointA)Thisisalsoknownasthearterialelastanceline.
ThegradientofthearterialelastancelinecanbeworkedoutfromtheloopsThisisdifferentfromtheaboveformulabecauseitonlyconsidersthepressure-volumerelationshipatend-systole,notthroughouttheentiretyofejection
isagoodsubstituteforafterloadbecauseitisrelativelyindependentofpreloadandcontractility,andwillvarywithchangesinafterload
i.e.Foragivenstrokevolume,anincreasein leadstoanincreaseinSBP.Similarly,iftheventricleisunable
tomaintainagivenstrokevolumeas increases,thenSBPwillfall.Contractilityisgivenbytheslopeoftheend-systolicpressurevolume-relationship
Alsoknownaselastanceatend-systole,or ,andisgivenbythetangenttothecurveatend-systole.Thismeasurementisnotentirelyindependentofotherfactors,asitisinfluencedbyafterload
BasicPressure-VolumeLoops
Theseloops:
ShowisolatedchangestoonefactoronlyArenotaccurateofreal-worldphysiologyInreality:
ChangingonefactorwillinfluenceotherfactorsThesevalueschangebeat-to-beat
LeftVentricularP-VLoop-IncreasedPreload:
EDVisincreased,bydefinitionTheslopeoftheESPVRremainsunchanged(ascontractilityisunchanged)
Theslopeoftheafterloadline( )isunchanged(asafterloadisunchanged),butitisright-shiftedduetotheincreasedend-diastolicvolumeESVisincreased,thoughlessthanEDV,suchthatstrokevolumeincreases
LeftVentricularP-VLoop-IncreasedAfterload:
Pressure-VolumeRelationships
247
![Page 248: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/248.jpg)
EDVisunchanged(aspreloadisunchanged)TheslopeoftheESPVRremainsunchanged(ascontractilityisunchanged)
Theslopeoftheafterloadline( )hasincreased,butitsx-interceptisunchangedNotethatthepressure-volumerelationshipthroughoutejectionisalsosteeper,anddiastolicpressurehasincreased.ESVisincreased,causingareductioninstrokevolume
LeftVentricularP-VLoop-IncreasedContractility:
EDVisunchanged(aspreloadisunchanged)
Theslopeandx-interceptoftheafterloadline( )isunchanged(asafterloadisunchanged)TheslopeoftheESPVRhasincreased,thoughitsx-interceptisthesameESVisdecreased,causinganincreaseinstrokevolume
AdvancedPressureVolumeLoopsTheeasiestwaytoapproachmorecomplicatedpressure-volumeloopsistoaddresseachofthebasicfactorsbeforetryingtodrawthecurve:
Howispreloadchanged?Howisafterloadchanged?Howiscontractilitychanged?Howareisovolumetriccontractionandisovolumetricrelaxationchanged?
Theseshowtheloopfortheprimaryphysiologicalchange,withoutcompensatoryresponses:
LeftVentricularP-VLoop-AorticStenosis:
Pressure-VolumeRelationships
248
![Page 249: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/249.jpg)
PreloadisincreasedduetothehigherESV,astheventriclestartsfillingfromahigherpointOutflowtractimpedanceincreasesventricularwallstressandthereforeafterloadThisleadstothedecreaseinstrokevolume.Contractilityisunchanged
LeftVentricularP-VLoop-AorticRegurgitation:
PreloadisdramaticallyincreasedastheventriclefillsfromboththeaortaandatriaduringdiastoleAfterloadisincreasedduetothegreaterwallstressduringejectionContractilityisunchangedThereisnotrueisovolumetricrelaxation,astheventriclewillbegintofillfromtheaortaatthecompletionofejectionDiastolicpressureisdecreasedandsotheperiodofisovolumetriccontractionisbrief
LeftVentricularP-VLoop-MitralStenosis:
PreloadisreducedduetotheincreasedgradientacrossthemitralvalveTheeffectofthisisheartratedependent,andwillworsenasheartrateincreases.AfterloadisunchangedAfterloadmayfallduetothereductioninventricularwallstress.
Pressure-VolumeRelationships
249
![Page 250: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/250.jpg)
ContractilityisunchangedESVdecreases(duetothereducedpreload),thoughlessthanEDV,suchthatstrokevolumeisreduced
LeftVentricularP-VLoop-MitralRegurgitation:
PreloadisincreasedastheregurgitantvolumeincreasesleftatrialpressureandthereforeventricularfillingpressureAfterloadisreducedasbloodisejectedintothelow-pressureatrialsystemContractilityisunchangedThereisnotrueisovolumetriccontractionphaseasbloodisejectedintotheatriawhileventricularpressureexceedsatrialpressureThereisnotrueisovolumetricrelaxationphase,asonceatrialpressureexceedsventricularpressuretheventriclewillbegintofillApparentstrokevolumeisincreasedduetothelargedifferencebetweenEDVandESV,howevereffectivestrokevolumeisreducedasonlyaportionofthisisforwardflow
RightVentricularP-VLoop:
TherightventricularcurveisverydifferenttotheleftventricularcurveRVpreloadisincreasedrelativetoLVpreloadNotethatstrokevolumeisthesame(asbothsidesshouldhavethesamecardiacoutput).RVafterloadisdramaticallyreducedduetothelow-resistancepulmonarycirculation
MuchoftheRVejectionoccursaftersystolicpressureisreachedTherightventricleisverysensitivetochangesinafterload
ContractilityisreducedRightheartcontractilityispartiallydependentoncoordinatedcontractionwiththeLV(particularlytheseptum),andthereforeisdecreasedwithLVsystolicfailureorconductingsystemdisease(suchasbundlebrachblock).
Footnotes
Pressure-VolumeRelationships
250
![Page 251: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/251.jpg)
TheKhanAcademyseriesChangingthePressure-VolumeLoopisafantasticintroductiontothetopic.
References1. BrandisK.ThePhysiologyViva:Questions&Answers.2003.2. Klabunde,RE.[VentricularPressure-VolumeRelationship(http://www.cvphysiology.com/Cardiac%20Function/CF024).
CardiovascularPhysiologyConcepts.2015.3. Desai,R.Arterialelastance(Ea)andafterload.KhanAcademy.4. Redington,AN.CardiopulmonaryandRight–LeftHeartInteractions.ThoracicKey.5. BorlaugBA,KassDA.Ventricular-VascularInteractioninHeartFailure.Heartfailureclinics.2008;4(1):23-36.
Lastupdated2019-07-18
Pressure-VolumeRelationships
251
![Page 252: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/252.jpg)
CardiacReflexesDescribethecardiacreflexes
Cardiacreflexesarefast-actingreflexloopsbetweentheCVSandCNSwhichcontributetothemaintenanceofcardiovascularhaemostasis.
Theyinclude:
BaroreceptorreflexAorticarchandcarotidsinusreflexes.
BainbridgereflexAtrialstretchreceptorreflexes.
ChemoreceptorreflexDecreasedPaO <50mmHgordecreasedpHsensedbyperipheralchemoreceptorscausessubsequenttachycardiaandhypertension.
CushingreflexBrainstemcompressioncausesischaemiaofthevasomotorcentreleadingtoCushings'Triad:
HypertensionMayhaveawidepulsepressure.BradycardiaDuetobaroreceptorresponsefromhypertension.Irregularrespirations
Bezold-JarischreflexStimulationofCfibresofthevagusnerveinthecardiopulmonaryregion.
Thiscauses:SignificantbradycardiaHypotensionApnoea,followedbyrapidshallowbreathing.Thesefibrescanbestimulatedbyanumberofsubstances,including:
CapsaicinSerotoninThoseproducedinmyocardialischaemia
OculocardiacreflexPressureontheglobeortractiononocularmusclescausesadecreaseinheartrate.Thisismediatedbythe:
Trigeminalnerve(afferentlimb)Vagusnerve(efferentlimb)IncreasedvagaltonereducesSAnodalactivity.
References
1. CICMSeptember/November20132. BarrettKE,BarmanSM,BoitanoS,BrooksHL.Ganong'sReviewofMedicalPhysiology.24thEd.McGrawHill.2012.3. OpenAnaesthesia-Oculocardiacreflex:afferentpath
Lastupdated2019-07-18
2
CardiacReflexes
252
![Page 253: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/253.jpg)
CardiacReflexes
253
![Page 254: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/254.jpg)
StarlingForcesDescribetheessentialfeaturesofthemicro-circulationincludingfluidexchange(Starlingforces)andcontrolmechanismspresentinthepre-andpost-capillarysphincters
Interstitialfluidisanultrafiltrateofplasma,withthenetfiltrationpressuredeterminedbytheneteffectofopposinghydrostaticandoncoticpressures:
ThesefourvariablesareknownasStarling'sforces.
Actualfluidmovementis(ofcourse)morecomplicated.Hydrostaticpressurefallsalongthecapillary,andmovementofsoluteandwaterareaffectedbyotherfactors.Someofthesearedescribedbythe:
Reflectioncoefficient(σ)Thisdescribesthefactthatasmallamountofproteinleaksfromthecapillary,slightlyincreasinginterstitialoncoticpressureandslightlydecreasingcapillaryoncoticpressure.Itisdependentontheinterstitialproteincontent,andhasavaluebetween0and1.
Filtrationcoefficient(Kf)Encompassesmembranepermeability(towater)andmembranesurfacearea.Variesbetweentissues:
TheStarlingEquationbecomes:
TypicalValuesforPressures(mmHg)
Arteriolarend Venousend
Capillaryhydrostaticpressure 25 10
Interstitialhydrostaticpressure -6 -6
Capillaryoncoticpressure 25 25
Interstitialoncoticpressure 5 5
Organ-SpecificValues
Intheglomerulus:
Reflectioncoefficientiscloseto1duetotheimpermeabilityoftheglomerulustoproteinKfishighduetobothhighpermeabilityandalargesurfacearea.HydrostaticpressureishighGlomerularoncoticpressureisessentially0
Intheliver:
Reflectioncoefficientiscloseto0inhepaticsinusoidsastheyareverypermeabletoprotein
Inthelungs:
Reflectioncoefficientof~0.5inthelungsduetosignificantleakofproteinProteinleakdecreasesasinterstitialoncoticpressurerises,limitingfurtheroedemaformation
Theoncoticpressuregradientissmall,andfavoursreabsorption
PeripheralCirculation
254
![Page 255: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/255.jpg)
Hydrostaticpressuregradientissmall,butfavoursextravasationoffluidInterstitialhydrostaticpressurebecomesmorenegativeclosertothehilum,drawingfluidintothepulmonarylymphatics
CausesofOedema
Oedemacanbelocalisedorgeneralised,andinbothcasescausedby:
IncreasedFiltrationPressureOccurswhencapillaryhydrostaticpressureexceedsinterstitialhydrostaticpressure.Causes:
IncreasedVenouspressureThisincludesanincreaseinCVP:
CCFTRIncreasedvenoconstrictionIncreasedMSFP
ImpairedvenousreturnObstructionRespiratorymusclepumpSkeletalmusclepump
Positioning
DecreasedOncoticPressureGradientDecreasedplasmaprotein
HepaticfailureCriticalIllness
IncreasedinterstitialoncoticpressureMannitol/starchextravasation
Increasedcapillarypermeability
InflammatoryproteinsSubstancePHistamineKinins
InadequateLymphFlow
References
1. BarrettKE,BarmanSM,BoitanoS,BrooksHL.Ganong'sReviewofMedicalPhysiology.24thEd.McGrawHill.2012.2. Brandis,K.Starling'sHypothesis.AnaesthesiaMCQ.3. ANZCAAugust/September2001
Lastupdated2017-09-22
PeripheralCirculation
255
![Page 256: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/256.jpg)
VariationsinBloodPressureDescribethephysiologicalfactorsthatmaycontributetopulsevariationsinbloodpressure
Bloodpressureisnotuniformthroughoutthecirculation.Ventricularejectiongeneratestwowaves:
AbloodflowwaveTravelsat~20cm.s .AnarterialpressurewaveDistendstheelasticwallsofthelargearteriesduringsystole,whichthenrecoilduringdiastoletofacilitatecontinualbloodflow.ThisistheWindkesseleffect.
Thiswavetravelsat4m.sThisiswhatisfeltwhenpulsesarepalpated,andwhatisseenonthearteriallinewaveform
Keypressuresmeasuredare:
SystolicbloodpressureMaximalpressuregeneratedduringejection.
Determinedby:StrokevolumeSystolictimeArterialcomplianceReflectedpressurewave
Relevantfor:Bleeding
ClotdisruptionAneurysmalwallpressure
DiastolicpressurePressureexertedbythecirculationupontheaorticvalve.
Determinedby:CirculatorycomplianceCirculatingvolumeAorticvalve(in)competence
Relevantfor:Coronaryperfusion
MeanarterialpressureAveragepressureinthecirculationthroughoutthecardiaccycle,asmeasuredbytheareaunderthecurveofthearteriallinewaveform.
Determinedby:SystolicbloodpressureDiastolicbloodpressureHeartrateIncreasingHRwilltendtoincreaseMAP,asoverallsystolictime(andthereforetimespentathigherpressure)isincreased.Shapeofthearterialwaveform/diastolicrunoffTheslowdecreaseinpressureafterpeaksystolicpressurerepresentelasticrecoiloflargearteries,increasingthepressuredrivingbloodintotheperipheralcirculation.Alongerdiastolicrunoffperiodleadstoalargerareaunderthecurve,andahigherMAP.
Relevantfor:Organperfusion
-1
-1
VariationsinBloodPressure
256
![Page 257: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/257.jpg)
ChangesbySiteofMeasurement
Measuredpressurechangespredictablyatmoredistalsites:
AllgradientsareincreasedArterialupstrokeandfalloffarebothsteeper.TheSBPincreasesDBPdecreasesMAPisconstantThedicroticnotchoccurslaterandbecomeslesssharpThisoccursduetoreflectionsinarterialpressurewaves.
RespiratoryVariationVentilationcausesvariationinpeaksystolicpressureduetodynamicchangesincardiacloadingconditions:
Negativepressurerespiration(i.e.regularbreathing)generatesanegativeintrathoracicpressureduringinspirationLeadstoincreasedVR,butalsopoolingofbloodinthepulmonarycirculationandrelativeunderfillingoftheLV,leadingtoadecreaseinSVandpeaksystolicbloodpressure.PositivepressureventilationcausesthereverseIncreasedintrathoracicpressureduringinspirationresultsinadecreasedvenousreturnbutincreasesLVfillingviacompressionofthepulmonarycirculation.Whenthischangeis>10mmHg,itisknownaspulsusparadoxusThemagnitudeofthiseffectvarieswith:
MagnitudeofintrathoracicpressurechangeLargechangesinintrathoracicpressurecausecorrespondinglylargerchangesinventricularfilling.Otherfactorsaffectingcardiovascularfunction
PreloadVolumestate
CompliancePericardialcompliance
ConstrictionTamponade
CardiaccomplianceDiastolicdysfunction
AfterloadPERaisedintrathoracicpressure
PEEPTensionPTHx
Thesedifferencescanbemeasured:QualitativelyBylookingatrespiratoryswingonanarteriallineorplethysmograph;orbypalpation.QuantitativelyUsingpulsepressureorstrokevolumevariation.
PulsePressureVariation
Describesthevariationinpulsepressureoverthecourseofarespiratorycycle.Pulsepressurevariationis:
Mathematicallydefinedas:
VariationsinBloodPressure
257
![Page 258: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/258.jpg)
Therefore,itiscalculatedasapercentUsedasanindicatoroffluidresponsiveness
PatientshigherontheFrank-Starlingcurvewillhavelesschangeinstrokevolumewithanincreaseinpreload,andtherefore:
ReducedPPVBelessfluidresponsive
APPVof>12%suggestsvolumeresponsiveness.Notethatthisdoesnotnecessarilymeanafluidresponsivepatientneedsfluid.
Reliantonseveralassumptions:RegularsinusrhythmIrregularheartrates(particularlyAF)leadtosignificantalterationsinventricularfillingandthereforepulsepressure,independentoftherespiratorycycle.ControlledmechanicalventilationNospontaneousefforts.AdequatetidalvolumesMustbe>8ml.kg .NormalchestwallcomplianceRequiresaclosedchest.
StrokeVolumeVariation
SVVis:
Alternatelydefinedas:Thepercentchangeinstrokevolumeduringinspirationandexpirationovertheprevious20secondsVariationofbeat-to-beatSVfromthemeanvalueovertheprevious20seconds
CalculatedbyspecialiseddevicesfromaninvasivearterialwaveformCalculationincorporates:PulsepressureVascularcomplianceEstimatedfromnomogramsbasedonpatientage,gender,height,andweight.VascularresistanceEstimatedfromarterialwaveformshape.
AnalternativetoPPVinmeasuringfluidresponsivenessReliesonsimilarprinciples.ProbablylessspecificbutmoresensitivethanPPVforidentifyingfluidresponders
CirculatoryFactors
Changesincirculatoryfunction:
Inotropy
Therateofsystolicupstrokeisrelatedto ,andthereforecontractility.SVRThegradientbetweenthepeaksystolicpressureandthedicroticnotchgivesanindicationofSVR.E.g.,asteepdownstrokesuggestsalowSVR,asthepressureinthecirculationrapidlyfallswhenejectionceases.Preload
-1
VariationsinBloodPressure
258
![Page 259: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/259.jpg)
Abeat-to-beatvariationisseenwiththerespiratorycycle,duetothechangeinpreloadoccurringwithchangesinintrathoracicpressure.
PathologicalChanges
Somepathologicalcausesinclude:
AorticStenosisCausesareductionin:
PulsepressureDuetoreducedstrokevolume.GradientofupstrokeDuetoreducedstrokevolume.
AorticRegurgitationWidepulsepressureCombinationof:
IncreasedSBPduetotheincreasedforceofejectionduetoincreasedpreload(StarlingsLaw),whichoccursduetohighESVDecreasedDBPduetopartofthestrokevolumeflowingbackintotheventriclethroughtheincompetentvalve
References
1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.2. Buteler,BenjaminS.Therelationofsystolicupstroketimeandpulsepressureinaorticstenosis.BritishHeartJournal.1962.3. Mark,JonathanB.Atlasofcardiovascularmonitoring.NewYork;Edinburgh:ChurchillLivingstone,1998.4. MarikPE.Techniquesforassessmentofintravascularvolumeincriticallyillpatients.JIntensiveCareMed.2009;24(5):329-
37.5. SolimanRA,SamirS,elNaggarA,ElDehelyK.Strokevolumevariationcomparedwithpulsepressurevariationand
cardiacindexchangesforpredictionoffluidresponsivenessinmechanicallyventilatedpatients.EgyptJCritCareMed.2015;3(1):9-16.doi:10.1016/J.EJCCM.2015.02.002
Lastupdated2019-07-18
VariationsinBloodPressure
259
![Page 260: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/260.jpg)
PulmonaryCirculationOutlinetheanatomyofthepulmonaryandbronchialcirculations
Describethephysiologicalfeaturesofthepulmonarycirculationanditsresistance
Understandthedifferencesbetweenthepulmonaryandsystemiccirculation
Thepulmonarycirculationis:
Alow-pressure,high-flow,high-pulsatilitycirculationSuppliedbythepulmonarytrunk(pressure25/8mmHg),drivenbytheRV(pressure25/0mmHg)
Arteriesandveinsrunwiththebronchiasfarastheterminalbronchioles,dividingatthesamepointsBeyondthis,theyformacapillarybedsothinitisessentiallysheetofflowingbloodpunctuatedbyalveoli
Thebronchialcirculation:
Arisesfromthesystemiccirculation,andsuppliesbloodtotheconductingzoneofthelungAthirddrainsbacktothesystemiccirculationTheremainderdrainsintothepulmonaryvessels-thisisaphysiologicshunt
Supplytotumoursispredominantlyfromthebronchialcirculation(ratherthanthepulmonarycirculation)asthesevesselsrespondtoangiogenicfactors.
DifferencesbetweenPulmonaryandSystemicCirculations
BloodPressure
Pulmonaryarterialpressureis25/8mmHg(MAP15mmHg)comparedto120/80mmHg(MAP100mmHg)inthesystemiccirculation.Thisisbecausethesystemiccirculationmust:
RegulateflowtodifferentorgansatdifferenttimesItthereforecontainsresistancevesselswhichallowittoallocatecardiacoutputaccordingly.Maintainflowtoorgansfarabovetheheart
Conversely,thepulmonarycirculationmust:
Accepttheentiretyofcardiacoutput,withlittlecapacitytoregulateflow(hypoxicvasoconstrictionbeingtheexception)Minimiseextravasationoffluid
AsperStarlingsLaw,fluidmovementoutofthecapillaryisgivenbythedifferenceinhydrostaticgradientsandoncoticgradientsThenetoncoticgradientissmall(butfavoursreabsorption),howeverthepulmonaryinterstitiumhasnohydrostaticpressureIncreasedpulmonarycapillarypressurethereforecausesextravasationoflargevolumesoffluid
Consequently,pulmonaryvesselsarethinwalledandcontainminimalsmoothmuscleThismakesthepulmonarycirculationhighlycompliant-thevolumeofbloodisabletochangesubstantiallywithminimalchangeinpressure
PulmonaryVascularResistance
VascularresistancefollowsOhmslaw,i.e.:
th
PulmonaryCirculation
260
![Page 261: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/261.jpg)
Pulmonaryvascularresistanceis~1/10 thatofthesystemiccirculationThisisbecausethepressuredropacrossthepulmonarycirculationis10mmHg(MPAP-LAP),~1/10 thatofthesystemiccirculation,andflowisthesame
Determinantsofpulmonaryvascularresistanceare:
PulmonaryArteryPressureIncreasedPAPcausesadecreaseinPVR.Thisoccursbecause:
PreviouslyclosedpulmonarycapillariesarerecruitedwhentheircriticalopeningpressureisreachedThisismoreimportantwhenMPAPislow.VesselsdistendathigherpressuresThisismoreimportantwhenMPAPishigh.
LungvolumeLungvolumehasavariableeffectonPVR.
Atlargelungvolumes:Resistanceinlargeextra-alveolarvesselsdecreasesasthevesselsarepulledopeningbydistensionofelastictissuesResistanceinsmallintra-alveolarvesselsincreasesastheyarecompressedbythehighlungvolumes
Atsmalllungvolumes,thereverseoccurs
HypoxicPulmonaryVasoconstrictionLowPAO causesavasoconstrictioninthevesselssupplyingthatalveolus,increasingPVRanddirectingbloodtobetterventilatedalveoli.
LowalveolarPO istheprimarydeterminantLowmixedvenousPO alsocontributesConstrictionbeginswhenP O fallsbelow100mmHg,andbecomesdramaticbelow70mmHgThisisimportantin:
FoetalcirculationAlveolarconsolidation
PneumoniaCardiogenicpulmonaryoedema
thth
2
22
A 2
PulmonaryCirculation
261
![Page 262: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/262.jpg)
RaisedLVEDPincreasespulmonaryvenouspressures.Basalalveoliaremoreaffected.HPVcausesconstrictionofbasalvessels,increasingbloodflowtoapicalalveoliandresultinginupperlobediversionseenonchestx-ray.
HighaltitudeHPVisattenuatedby:
ElevatedLAPGreaterthan25mmHg.HighCO
MinorfactorswhichaffectPVR:IncreasePVR:
HypercarbiaHypothermiaAcidaemiaPain
DecreasePVR:BronchodilatorsVolatiles
ResponsetoSubstances
Oxygen:
ThepulmonarycirculationconstrictswhenPO falls,whilstthesystemiccirculationdilates
CarbonDioxide:
ThepulmonarycirculationconstrictionswhenPCO rises,whilstthesystemiccirculationdilates
DistributionofPulmonaryFlowGravityhasasignificanteffectonpulmonarybloodflow:
Intheuprightlung,flowdecreasesalmostlinearlywithheightInthesupinelung,flowtoposteriorregionsexceedsthatofanteriorregionsThisoccursduetothelowdrivingpressureofthepulmonarycirculation,whichmeansgravityhasamuchmoresignificantaffectonpulmonarybloodflowthansystemicbloodflow.
West'sZones
Thelungisdividedintofourzones,basedontherelationshipbetweenalveolarandvascularpressures:
West'sZone1InWest'sZone1,PA>Pa>Pv.
Thisshouldnotoccurinnormalconditions,becauseanormalpulmonaryarterypressureisnormally(just)sufficientThisisbecauseintheuprightlung,thehydrostaticpressuredifferencewillbeabout30cmH O.However,ifalveolarpressureisraised(e.g.IPPV),orarterialpressurefalls(shock),theremaybearegionwherealveolarpressureexceedsarterialpressure
West'sZone2InWest'sZone2,Pa>PA>Pv.
Here,flowisdeterminedbythearterial-alveolarpressuregradientratherthanthearterial-venousgradientAlveolarpressureactsasaStarlingResistor,whereflowisindependentofdownstreampressure.
2
2
2
PulmonaryCirculation
262
![Page 263: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/263.jpg)
West'sZone3Occurswhenalveolarpressurefallsbelowvenouspressure,i.e.Pa>Pv>PA.Flowisdependentonthearterial-venouspressuregradient.Capillarypressureincreasesalongtheirlength,increasingtransmuralpressureandmeanwidth.
West'sZone4Occursatlowlungvolumes,asextra-alveolarvesselscollapseandshuntoccurs.TheinterstitiumisactingasaStarlingresistor,whichcanbeexpressedas:Pa>Pint>Pv>PA.
HypoxicPulmonaryVasoconstriction
Asdiscussedabove,HPVallowsredirectionofbloodflowfrompoorlyventilatedregionsofthelung,andsoimproveV/Qmatching.HPVisrelevantindiseasestates,aswellasspecificphysiologiccircumstances:
Athighaltitude,thePAO isgloballyreduced,leadingtohighpulmonaryarterypressuresInutero,PAO isnegligible,andPVRisthereforeveryhighThisdivertsbloodfromthepulmonarycirculationintotheleftsideoftheheartviatheforamenovale.Whenthefirstbreathistaken,pulmonaryvesselsdilateandtheright-to-leftshuntisreversed.
References1. Dunn,PF.PhysiologyoftheLateralDecubitusPositionandOne-LungVentilation.ThoracicAnaesthesia.Volume38(1),
Winter2000,pp25-53.2. WestJ.RespiratoryPhysiology:TheEssentials.9thEdition.LippincottWilliamsandWilkins.2011.3. LumbA.Nunn'sAppliedRespiratoryPhysiology.7thEdition.Elsevier.2010.4. BrandisK.ThePhysiologyViva:Questions&Answers.2003.
Lastupdated2019-07-18
22
PulmonaryCirculation
263
![Page 264: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/264.jpg)
CerebralBloodFlowDescribethedistributionofbloodvolumeandflowinthevariousregionalcirculationsandexplainthefactorsthatinfluencethem,includingautoregulation.Theseinclude,butnotlimitedto,thecerebralandspinalcord,hepaticandsplanchnic,coronary,renalandutero-placentalcirculations
Withrespecttocerebralbloodflow:
Normalis~750ml.min or~15%ofrestingcardiacoutputNotethatthebrainmakesuponly~2%ofbodyweight.
Arelativelyhighbloodflowisrequiredduetothehighcerebralmetabolicrateforoxygen(CMRO )of50ml.minThebrainissensitivetointerruptionsinflowasithas:
AhighmetabolicrateNocapacitytostoreenergysubstrates
ThefactorsaffectingcerebralbloodflowcanbeclassifiedbythefactorsintheHagan-PoiseuilleEquation:
,where:
isthepressuredifferencedrivingflow,i.e.CPP
istheradiusofthebloodvessels
isthebloodviscosityThesearealsocalledrheologicfactors.
isthelengthofthetube,afixedquantity
FactorsAffectingPerfusionPressure{#cpp)
CerebralPerfusionPressureisthedifferencebetweenmeanarterialpressureandintracranialpressure:
AnormalCPPis~80mmHgInnormalindividuals,CBFisclassicallythoughttobeautoregulatedoveraCPPrangeof60-160mmHg
Thisoccursbymyogenicmeans,similartothekidneyInnormalcircumstances,thisisdependentonMAP(i.e.,withanormalICP<10mmHg,CBFisregulatedoveraMAPrangeof50-150mmHg).
NotethatmorerecentevidencewouldsuggestthatCBFisautoregulatedoveramuchnarrowerrangeofperfusionpressures,andhasagreatercapacitytobufferanincreasedratherthandecreasedperfusionpressure
Atthelowerlimit,thereducedperfusionpressuremeansflowcannotbemaintainedevenwithmaximalvasodilation
-1
2-1
CerebralBloodFlow
264
![Page 265: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/265.jpg)
Attheupperlimit,thehighperfusionpressureovercomesmaximalvasoconstrictionAdditionally,theincreasedCBFmayresultindamagetotheblood-brainbarrier
Thecurveisleft-shiftedinneonatesandchildren(duetolowernormalMAP)Thecurveisright-shiftedinchronichypertensionThecurveisprobablyinaccurateinthepathologicalconditionswhereitwouldotherwisebeuseful,suchasmalignancy,subarachnoidhaemorrhage,CVA,orTBI
Thismaybeduetodamagetoeitherthefeedbackmechanisms,ortheeffectors(vasculature)Flowmaybecomepressure-dependent,andsmallchangesinMAPcanhavelargechangesinCBF
FactorsAffectingVesselRadius
VasodilationandconstrictionaffectbothcerebralbloodflowandICP,asvasodilatationincreasescerebralbloodvolumeandthereforemayincreaseICPthroughtheMonroe-Kelliedoctrine.
Vesselcalibreisaffectedprimarilybyfourfactors:
CerebralmetabolismPaCOPaONeurohormonalfactorsTemperature
CerebralMetabolism
Cerebralmetabolism(typicallygivenbythecerebralmetabolicrequirementforoxygen,CMRO )hasalinearassociationwithcerebralbloodflow-thisisknownasflow-metabolismcoupling.Thisiscontrolledlocallythroughthereleaseofvasoactivemediators,suchasH ,adenosine,andNO.Determinantsofcerebralmetabolisminclude:
DrugsCerebralmetabolismmaybedecreasedbyuseofdrugssuchasbenzodiazepines,barbiturates,andpropofol.TemperatureCMRO decreaseslinearlyby~7%perdegreecentigrade,allowingprolongedperiodsofreducedCBFwithoutischaemiccomplications.
PaCO
Carbondioxideactsasacerebralvasodilator.
CBFisalmostlinearbetween20mmHgand80mmHgAbove80mmHg,thecirculationismaximallydilatedBelow20mmHg,thecirculationismaximallyconstrictedAdditionally,thealkalosiscausesaleft-shiftoftheoxyhaemoglobincurve.Thisreducesoffloadingofoxygen,causing
22
2
+
2
2
CerebralBloodFlow
265
![Page 266: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/266.jpg)
hypoxiaandsubsequentvasodilation.Thereisaright-shiftinchronichypercapneaThemechanismofactioniscomplex,butinvolveslocalincreaseinH ions.ChangestoCBFwithCO aredependentoncurrentarteriolartone-vasodilatoryeffectsofCO aresignificantlyreducedwhentheperfusingpressureislow.
PaO
CBFincreasesrapidlywhenPaO fallsbelow60mmHgsothatcerebraloxygendeliveryismaintainedHypoxiacausesareleaseofadenosineandreducedcalciumuptake,withsubsequentvasodilation
Neurohormonal
Autonomiccontrolofcerebrovasculartoneislimited,thoughisresponsiblefortheright-shiftintheautoregulationcurvewithsustainedhypertension
FactorsAffectingBloodViscosityBloodviscosityisdependentonhaematocritReducedhaematocritisassociatedwithincreasedCBF,butreducedO -carryingcapacityTheoptimalhaematocritis~0.3-0.35,whichprovidesthebestbalancebetweenreductionofviscositytoimprovecerebralbloodflow,withoutreducingDO .
References1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. HillL,GwinnuttC.CerebralBloodFlowandIntracranialPressure.FRCAWebsite.
+
2 2
2
2
2
2
CerebralBloodFlow
266
![Page 267: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/267.jpg)
3. WillieCK,TzengYC,FisherJA,AinsliePN.Integrativeregulationofhumanbrainbloodflow.JPhysiol.2014Mar1;592(5):841-59.
4. MuizelaarJP.CBFandmanagementofthehead-injuredpatient.In:NarayanRK,WilbergerJE,PovlishockJT,eds.Neurotrauma.NewYork:McGraw-Hill,1996:553–561.
Lastupdated2019-07-18
CerebralBloodFlow
267
![Page 268: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/268.jpg)
HepaticBloodFlowDescribethedistributionofbloodvolumeandflowinthevariousregionalcirculationsandexplainthefactorsthatinfluencethem,includingautoregulation.Theseinclude,butnotlimitedto,thecerebralandspinalcord,hepaticandsplanchnic,coronary,renalandutero-placentalcirculations
Theliverservesasabloodreservoir(30mlper100g,halfofwhichmaybemobilisedinhypovolaemia),andreceives25%ofcardiacoutputfromauniquedualbloodsupply:
Hepaticarterialsystem,whichsuppliesaboutone-thirdofblood,but40-50%ofOHepaticarterialbloodhasanSpO of~98%,aswouldbeexpected.Itisahigh-pressure,high-resistance,high-flowsystem(averagevelocity18cm.s ),withthecapacitytoautoregulate.
Portalvenoussystem,whichsuppliestheremainingtwo-thirdsofblood.Itisalow-resistance,low-pressure,low-velocitysystem(averageflow9cm.s ),withnocapacitytoautoregulate.TheSpO ofportalvenousbloodvariesdependingongutactivity:
Intherestinggut,SpO is~85%Intheactivegut,SpO is~75%
RegulationofFlow
Aswithotherorgans,bloodflowisautoregulatedviaintrinsicandextrinsicmechanisms,andmaybeaffectedbyexternalfactors.
IntrinsicAutoregulation
MyogenicautoregulationHepaticarterialbufferresponseThisisalsoknownasthe"hepaticartery-portalvenoussemi-reciprocalinterrelationship".
Hepaticarterialresistanceisproportionaltoportalvenousbloodflow,suchthatareductioninportalvenousflowcausesadecreaseinhepaticarterialresistanceandincreaseshepaticarterialflowThisisprobablymediatedbyadenosine.
ExtrinsicAutoregulation
AutonomicNervousSystemBoththehepaticandportalvasculaturehavesympatheticinnervation:
Thehepaticarteryhasdopaminereceptors,aswellasβ-andα-adrenoreceptorsTheportalveinhasonlyα-adrenoreceptorsActivationofthesereceptorscausesvenoconstriction,reducingthecomplianceofthehepaticvasculatureandmobilisingupto250mlofbloodintimesofsympatheticstress.
EndocrineandhormonaleffectsAnumberofsubstancesaffectportalflow:
Hormone PortalVeinEffect HepaticArteryEffect OverallEffectonFlow
Adrenaline Constriction Constriction(α),thendilation(β) Reduced
Glucagon Dilation - Increased
Secretin - Dilation Increased
AngiotensinII Constriction Constriction Reduced
22
-1
-1
222
HepaticBloodFlow
268
![Page 269: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/269.jpg)
Vasopressin Constriction Constriction Reduced
PCO Constriction - Reduced
ExternalFactors
Flowinthehepaticveinisdependentonvenousreturn:
Increasedvenousreturn(e.g.negative-intrathoracicpressure)increaseshepaticflowDecreasedvenousreturn(e.g.positive-pressureventilation,tamponade,haemorrhage),reduceshepaticflow,andinextremecasesflowmayonlyoccurintermittentlythroughoutthecardiaccycle
Exercisereducesbothportalveinandhepaticarterialflow
Microvasculature
Hepaticarteriolesandportalvenulesformthehepatictriadwithabilecanaliculi.Hepaticarteriolesandvenulesanastomosetoformsinusoids,whichcreateaspecialisedlow-pressure(~2mmHg)capillarysystemwhichdrainsintothecentralveinsofthehepaticacinus.
Thisarrangement:
OptimiseshepaticO extractionIncreasedhepaticO demandismetbyincreasingO extraction,ratherthanbyincreasingflow(asoccursintheheart).Preventsshuntingandretrogradeflow
References1. CICMMarch/May20132. LeslieRA,JohnsonEK,GoodwinAPL.DrPodcastScriptsforthePrimaryFRCA.CambridgeUniversityPress.2011.3. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.4. KogireM,InoueK,SumiS,DoiR,YunM,KajiH,TobeT.Effectsofgastricinhibitorypolypeptideandglucagononportal
venousandhepaticarterialflowinconsciousdogs.DigDisSci.1992Nov;37(11):1666-70.
Lastupdated2019-07-18
2
22 2
HepaticBloodFlow
269
![Page 270: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/270.jpg)
BaroreceptorsDescribethefunctionofbaroreceptorsandtorelatethisknowledgetocommonclinicalsituations.
Baroreceptorsarestretchreceptorswhichmonitorchangesinarterialpressure.Arterialpressureismonitoredbyreceptorsinthe:
AorticarchInnervatedbyCNX
CarotidsinusSmalldilationoftheICAatthelevelofthebifurcation.
InnervatedbyCNIXRememberthecarotidsinusisabaroreceptor,thecarotidbodyisachemoreceptor
Low-pressurestretchreceptors:
RespondtoincreasedvenousreturnAreinhibitedbypositivepressureventilationActbystretchandtypicallydescribedasvolumereceptorsArelocatedinthe:
AtrialwallsSVCandIVCPulmonarycirculation
BaroreceptorControlAfferentfibresfromCNIXandCNXtraveltotheNTSinthemedulla.EffectorneuronsfromtheRVLMareGABAergicandthereforeinhibitory,i.e.increasedbaroreceptordischargereducestonicsympathetictoneandincreasesvagaltone.
Increasedbaroreceptoractivitythereforeresultsin:
ArterialandvenousvasodilationHypotensionBradycardiaDecreasedcardiacoutputDecreasedrespiratoryrate
Conversely,increasedactivityoflow-pressurestretchreceptorsresultsinanincreaseratherthanadecreaseinheartrate.
BaroreceptorActivityBaroreceptorsare:
MoresensitivetopulsatilepressurethanconstantpressureAdecreaseinpulsepressurewithoutachangeinMAPwilldecreasebaroreceptorfiring.ActivethroughoutthecardiaccycleRapidcompensatoryresponsesarevitalintheshort-termcontrolofbloodpressure,e.g.withposture.Activeovertherangefrom50mmHgto200mmHg
CirculatoryControl
270
![Page 271: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/271.jpg)
Thiscurveisleft-shiftedinchildrenandneonates,andright-shiftedinchronichypertension,thoughthisisreversible
Hormonalcontrol
Activationofatrial/ventricularstretchreceptorsstimulatesANP/BNPreleaserespectively,whichacttoreducebloodpressureinthefollowingways:
IncreasedGFRActtoconstricttheefferentarterioleanddilatesoftheafferentarteriole.ThissubsequentlyinhibitsreninsecretionthroughincreasedhydrostaticpressureattheJGAandincreasedNa andCl deliverytothemaculadensa.DecreasedaldosteroneViainhibitionofaldosteronesecretion.VasodilationCausesvasodilationofperipheralsmoothmuscle.
References1. BarrettKE,BarmanSM,BoitanoS,BrooksHL.Ganong'sReviewofMedicalPhysiology.24thEd.McGrawHill.2012.2. CICMSeptember/November20143. ANZCAJuly/August2000
Lastupdated2018-06-25
+ -
CirculatoryControl
271
![Page 272: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/272.jpg)
ValsalvaManoeuvreExplaintheresponseofthecirculationtosituationssuchaschangesinposturehaemorrhage,hypovolaemia,anaemia,intermittentpositivepressureventilation,positiveend-expiratorypressure,andtheValsalvamanoeuvre.
AValsalvaisforcedexpirationagainstaclosedglottis.ThiscanbeachievedbyincreasingP to40mmHgfor15seconds.Thisincreaseinintrathoracicpressurealtersmanyhaemodynamicparameters.
Phases
AValsalvamanoeuvreconsistsoffourphases:
PhaseI
P isincreasedto40cmH O,withacorrespondingincreaseinPSBPandDBPincreasedueto:
CompressionoftheaortaIncreasedLVpreloadduetoejectionofbloodinthepulmonaryvasculature
PhaseII
VRfallsduetoincreasedPCOfallsduetodecreasedVRSBPandDBPfallduetodecreasedCO
BaroreceptorsareactivatedbythefallinBP,andSNSoutflowincreases,causing:
IncreasedHRIncreasedSVR
BPthereforestartstorecoverlateinPhaseII
PhaseIII
TheValsalvaceases,andP returnsto0cmH OPVRrapidlydropsasalveolarvesselsre-expandSBPandDBPrapidlyfalldueto:
DecreasedPVRcausingdecreasedLVpreloadLossofhighintrathoracicpressurecompressingtheaorta
PhaseIV
VRnormalisesCOnormalisesduetonormalVRandPVRSBPandDBPtransientlyincreaseduetoanormalCOenteringabaroreceptor-drivenhigh-SVRvascularbed
BaroreceptorsrespondtohighSBPanDBPbyincreasingvagaltone:
HRfalls(reflexbradycardia)BPfalls
AW
AW 2 Thoracic
Thoracic
AW 2
ValsalvaManoeuvre
272
![Page 273: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/273.jpg)
AbnormalResponses
Abnormalresponsesoccurincardiacfailureandautonomicneuropathy.
CCF
InCCFasquare-wavepattenisproduced:
IncreasingP resultinginasustainedincreaseinSBPandDBPThereisaslightdecreaseinSBPandDBPforthefewsecondsinphaseIIIwhenairwaypressureisreleased
Appearstobeduetotheincreasedcirculatingvolume,asthisdifferenceresolvesinvenesectedcardiacpatients,andisdemonstratedinnormalindividualswhoaretransfusedtoahighcirculatingvolume.
AutonomicNeuropathy
BaroreceptorresponsetotheValsalvaisminimalinbothphaseIIandIV:
InphaseII,thereisnocompensatoryincreaseinsympatheticoutflow,soBPcontinuestofalluntilP returnsto0mmHgInphaseIV,thereisnocompensatoryincreaseinvagaltoneandsoBPreturnstonormalwithoutovershooting
References
1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. JudsonWE,HatcherJD,WilkinsRW.BloodPressureResponsestotheValsalvaManeuverinCardiacPatientswithand
withoutCongestiveFailure.Circulation.1955;11:889-899.
Lastupdated2019-07-20
AW
AW
ValsalvaManoeuvre
273
![Page 274: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/274.jpg)
CVSChangeswithObesityDescribethecardiovascularchangesthatoccurwithmorbidobesity
Obesityisamultisystemdisorderdefinedbyanelevatedbodymassindex(BMI):
Normal:BMI<25Overweight:BMI25-30Obese:BMI>30MorbidlyObese:
ObesityrelateddiseaseandaBMI>35BMI>40
Characteristicsofobesityinclude:
ComplexgeneticandenvironmentalcausesIncreasedcaloricintakeIncreasedmetabolicrate(normalforBSA)
Theeffectofobesityonthecardiovascularsystemiscomplex,andcanbeclassifiedinto:
HormonalchangesAbdominalvisceralfatisresponsibleforsecretingalargenumberofhormoneswhichaffectcardiovascularparameters:
IncreasedleptinContributestocardiacremodellingandLVH.AngiotensinogenLeadstosystemichypertensionandLVremodelling.
Smallamountsareproducedinadipocytes,whichincreasesasfatvolumeincreasesPlasminogenactivatorinhibitor-1ReducesfibrinolysisandpredisposestoVTE.InflammatoryadipokinesImpairendothelialfunction,leadingtoincreasedSVR.CatecholaminesIncreasedcontractility,SVR,andworsenendothelialfunction.
Releasedwith:HypoxiaHypercapneaNegativeintrathoracicpressureFragmentedsleepDuetoOSA.
ChangesinkeycardiovascularparametersIncreasedVODuetoincreasedLBMandfatmass.IncreasedBloodVolumeDuetoincreasedangiotensinIIandaldosterone.IncreasedStrokeVolumeDueto:
Increasedpreload(majorfactor)Increasedcontractility(minorfactor)Duetoincreasedcirculatingadrenalhormones.
IncreasedCardiacOutput
2
CVSChangeswithObesity
274
![Page 275: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/275.jpg)
TomaintainDO .Initiallywithpreservedejectionfraction
CardiacchangesDiastolicdysfunctionDuetomyocardialfibrosisimpairingrelaxation.Fattyinfiltrationofmyocardiumandconductingsystem
PredisposestoarrhythmiasRiskisworsenedbychangeinmyocardialarchitecture,hypoxia,andincreasedcirculatingcatecholamines.
BiventricularhypertrophyasaresponsetoincreasedafterloadLVafterloadincreasedduetosystemichypertensionLVHismuchmorecommonthanRVH.
EccentrichypertrophyduetovolumeoverloadConcentrichypertrophyduetopressureoverloadorhormonalchanges
RVhypertrophydueto:LVdiastolicfailureIncreasedPVR
HypoxiaDueto:
EffectsofOSAIncreasedshuntthroughcollapsedlungbases
Acidosis
References
1. AlvarezA,BrodskyJ,LemmensH,MortonJ.MorbidObesity:Peri-operativeManagement.Cambridge:CambridgeUniversityPress.2010.
2. LotiaS,BellamyMC.Anaesthesiaandmorbidobesity.ContinEducAnaesthCritCarePain2008;8(5):151-156.
Lastupdated2019-07-18
2
CVSChangeswithObesity
275
![Page 276: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/276.jpg)
CardiovascularEffectsofAgeingDescribethecardiovascularchangesthatoccurwithageing.
CVSeffectsofageingcanbedividedintocardiac,vascular,andautonomicchanges:
CardiacchangesDecreasedreceptordensityandnumberDecreasedmaximumheartrateDuetofibrosisoftheSAnodecausingreducedpacemakercellnumberandfunction,andreductionincatecholaminereceptordensity.
DecreasedinotropyMinor.IncreasedrelianceonatrialkickReducedventricularcomplianceincreasestherelianceonatrialkicktoachieveadequatepreload.Decreaseddiastoliccompliance
Duetohypertrophyfromincreasedafterload
VascularchangesReducedcomplianceDuetolossofelastictissueinthelargearteries.IncreasedSVRReducedcomplianceresultsinincreasedvascularresistance.Reducedendothelialcellfunction(decreasedNO)Impairstheabilityofthevasculartreetoadapttochangesinpressure/volumeleadingto:
ElevatedSBPReducedDBPReducedelasticrecoilcausesdiastolicrunoffandafallindiastolicbloodpressure.
ReducedcatecholaminereceptordensityReducedresponsivenessto(andincreasednumberof)circulatingcatecholamines.
AutonomicImpairedautonomicfunctionDuetodecreasedcatecholamineresponsiveness.ImpairedbaroreceptorresponseDecreasedexercisetoleranceRelianceonpreloadtomaintaincardiacoutput.
References
1. ANZCAFebruary/April20162. CheitlinMD.Cardiovascularphysiology-changeswithageing.AmJGeriatrCardiol.2003Jan-Feb;12(1):9-13.
Lastupdated2019-07-20
CVSEffectsofAgeing
276
![Page 277: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/277.jpg)
CVSEffectsofAgeing
277
![Page 278: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/278.jpg)
InotropesUnderstandthedetailedpharmacologyofinotropesandvasopressors
Inotropesareagentswhichaltermyocardialcontractility.
PositiveinotropesincreasecontractilityNegativeinotropesdecreasecontractility
ClassesofPositiveInotrope
Classes ClassI:IncreaseIntracellularCalcium
ClassII:CalciumSensitisers ClassIII:Metabolic/Endocrine
Examples Adrenaline,milrinone,glucagon,digoxin Levosimendan T3,Insulin
GeneralMechanismofAction
IncreaseintracellularCa byavarietyofdifferentpathways
IncreasesensitivityofactomyosintoCa
Variable.T3potentiatestheeffect(orincreasesexpressionof)cardiacβreceptors
References1. LeslieRA,JohnsonEK,GoodwinAPL.DrPodcastScriptsforthePrimaryFRCA.CambridgeUniversityPress.2011.2. TielensET,ForderJR,ChathamJC,MarrelliSP,LadensonPW.AcuteL-triiodothyronineadministrationpotentiates
inotropicresponsestoP-adrenergicstimulationintheisolatedperfusedratheart.CardiovascularResearch32(1996)306-310.
Lastupdated2017-09-18
2+
2+ 1
CardiovascularPharmacology
278
![Page 279: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/279.jpg)
AdrenoreceptorsUnderstandthepharmacologyofadrenoreceptorblockingdrugs.
Thiscoversthepharmacologyofadrenoreceptors.Theproductionandmetabolismofendogenouscatecholaminesiscoveredunderadrenalhormones.Detailedinformationonspecificsympathomimeticagents,includingstructure-activityrelationships,isinthepharmacopeia.
Adrenoreceptorsareclassifiedbytheirvaryingsensitivitytodifferentcatecholamines.Additionally:
AlladrenoreceptorsareGprotein-coupledreceptorsEachreceptorcontainsseventransmembraneα-helicalsubunits,threeextracellularloops,andthreeintracellularloops
AlphareceptorshavedifferentsubunitsandmechanismsofactionAllbetareceptorsare:
G coupledActivateadenylatecyclaseincreasingcAMP,leadingtoincreasedNa/K<sup+ATPaseactivityandhyperpolarisation
AdrenoreceptorSubtypes
α -receptors:
ArepresentinsmoothmuscleAgonismcausesvasoconstriction,relaxationofGITmuscle(viapresynapticreceptors),andcontractionofGUmuscle.Theyare:
G coupledPhospholipaseCactivatedincreasesIP ,increasecalcium
α -receptors:
ArepresentintheCNS,arterioles,pancreasAgonismcausessedation,analgesia,vasodilatation,andinhibitionofinsulinrelease.Theyare:
G coupledInhibitsadenylatecyclase,decreasingcAMP
β -receptors:
ArepresentincardiacmuscleandtheJGACardiacagonismincreasesinotropy,chronotropy,anddromotropyJGAagonismincreasesreninrelease
IncreaseincAMPincreasesintracellularcalcium
β -receptors:
Arepresentinskeletalvascularandbronchialsmoothmuscle,theliver,andoncellmembranesAgonismcauses:
VasodilationandbronchodilationHepaticglycogenolysisIncreasesactivityoftheNa -K ATPasepump,increasingintracellularpotassium
IncreaseincAMPincreasesNa /K ATPaseactivityandhyperpolarisation
β -receptors:
Arepresentinfat
s
1
q3
2
i
1
2
+ ++ +
3
Adrenoreceptors
279
![Page 280: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/280.jpg)
Agonismcauseslipolysisandthermogenesis.
References1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.2. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.3. BarrettKE,BarmanSM,BoitanoS,BrooksHL.Ganong'sReviewofMedicalPhysiology.24thEd.McGrawHill.2012.
Lastupdated2018-05-27
Adrenoreceptors
280
![Page 281: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/281.jpg)
AntiarrhythmicsUnderstandthepharmacologyofantiarrhythmicdrugs
AntiarrhythmicdrugsaretypicallyclassifiedusingtheVaughanWilliamsclassificationsystem,whichdividesdrugsintofourclassesbasedontheireffectonthecardiacactionpotential.Manydrugswillactviamultiplemechanisms.
ClassI:Blockvoltage-gatedNachannelsClassIa:IntermediatedissociationClassIb:FastdissociationClassIc:Slowdissociation
ClassII:β-BlockersClassIII:Prolongtheactionpotential(UsuallyviaK channelblockade)ClassIV:Ca antagonists
Thisclassificationisnotablyincomplete,assomedrugs(suchasamiodarone)fitintomultiplecategories,andothers(suchasdigoxin,adenosine,andmagnesium)fitintonone.
ClassINa -channelblockadeinhibitsactionpotentialprolongationbyblockingactiveandrefractorysodiumchannelsinause-dependentfashionThisinhibitstachyarrhythmiaswhilstallowingnormalconductionExtentofblockdependsontheheartrate,membranepotential,andthesubclassofdrugSodiumchannelblockadeincreasespacingthresholdanddefibrillationenergyrequirement
ClassIa
ClassIadrugshavemixedpropertiesofIbandIc,andalsohaveClassIIIeffectsAstheyprolongtheAVconductionandprolongtheactionpotentialtheyincreasebothQRSdurationandtheQTintervalExamplesincludeprocainamide
Pro-arrhythmiceffectsmayresultbecauseAVnodalconductionmaybeincreased,sodespitedecreasedatrialactivityincreasedventricularconductanceresultsinapotentiallyfatalshorteningofdiastolictime
+2+
+
Antiarrhythmics
281
![Page 282: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/282.jpg)
ClassIb
ClassIbdrugsbindtoopensodiumchannel,andwillassociateanddissociatefromasodiumchannelinthecourseofanormalbeatTachyarrhythmiasarepreventedbecausedissociationoccurstooslowlyforafurtheractionpotentialtobegeneratedClassIbdrugswillbindselectivelytorefractorychannels,suchasoccursinischaemiaAstheyhavelittleeffectonnormalcardiactissuetheyhavelittleeffectontheECGExamplesofclassIbagentsincludeincludephenytoinandlignocaine
ClassIc
ClassIcdrugsassociateanddissociateslowlycreatingasteady-statelevelofblockThiscausesindiscriminateblockadeandgeneralreductioninexcitabilityClassIcagentsareusedtosuppressunidirectionalorintermittentconductionpathwaysAstheymarkedlyslowconductionvelocitytheyincreaseQRSdurationExamplesofClassIcagentsincludeflecainide
Antiarrhythmics
282
![Page 283: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/283.jpg)
ClassII
Normalβ-adrenergicstimulationhasanumberofpro-arrhythmiceffects:
IncreasedpacemakerpotentialcurrentIncreasedslow-inwardCa currentIncreasedrepolarisingK andCl currentsIncreasedCa storedinthesarcoplasmicreticulum,whichmaybespontaneouslyreleasedcausingadelayed-after-depolarisationsReducedserum[K ]*
β-blockershaveanantiarrhythmiceffectbyantagonisingthesemechanisms.Theyareusefulfortreatmentofarrhythmiasoccurringwithsympatheticover-activation,suchaspostMI.
ClassIIIBlockingofoutwardK channelsslowscardiacrepolarisation,whichincreasesthecardiacrefractoryperiod.Thishasanumberofbeneficialeffects:
DecreasedautomaticityDecreasedectopyReduceddefibrillationenergyrequirementIncreasedinotropy
Duetotheprolongedrepolarisation,theywillalsocausealongQT(thoughinthecaseofamiodaronethisisnotassociatedwithanincreasedriskofTPD).
ClassIV
2++ -
2+
+
+
2+
Antiarrhythmics
283
![Page 284: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/284.jpg)
ClassIVdrugsinhibitL-typeCa channels,inhibitingtheslowinwardcalciumcurrent,which:
SlowsSAandAVnodalconductionAVblockadeslowstransmissionofsupra-ventriculararrhythmias.ReducesinotropyPreventsafter-depolarisationsThissuppressesectopybyreducingcalciumleakfromsarcoplasmicreticulum.
AlternativestoVaughanWilliamsAstheVaughanWilliamsclassificationsystemdoesnotneatlydivideagents,andsomeagentsdonotfitintoanycategory,theymayalsobeclassifiedbytheiruses:
Indication Examples
SVT Digoxin,adenosine,verapamil,β-blockers
VT Lignocaine,mexiletine
SVT/VT Amiodarone,flecainideprocainamide,sotalol
Digoxintoxicity Phenytoin
References
1. RangHP,DaleMM,RitterJM,FlowerRJ.RangandDale'sPharmacology.6thEd.ChurchillLivingstone.2. BruntonL,ChabnerBA,KnollmanB.GoodmanandGilman'sThePharmacologicalBasisofTherapeutics.12thEd.
McGraw-HillEducation-Europe.2011.3. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.
Lastupdated2019-07-18
2+
Antiarrhythmics
284
![Page 285: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/285.jpg)
FunctionalAnatomyandControlofRenalBloodFlowDescribethefunctionalanatomyofthekidneysandrenalbloodflow.
FunctionalAnatomy
Thefunctionalunitofthekidneyisthenephron.Nephrons:
Arecomposedoftheglomerulus,proximaltubule,loopofHenle,distaltubule,andcollectingductAredividedbytheirlocationinto:
SuperficialcorticalnephronsHaveshortloopsofHenle.JuxtamedullarynephronsHavelongloopsofHenle,andtheefferentarterioleformsthevasarectaforthekidney.Mid-corticalnephronsMayhaveeitherlongorshortloops.
ControlofRenalBloodflow
Thekidneys:
Receive22%ofcardiacoutputatrestExtractonly10%ofdeliveredOHaveahighrenalbloodflowexceedsthatrequiredformetabolismHighflowisinsteadneededtoproducethelargevolumeofglomerularfiltrate(125ml.min )requiredforexcretionofwaste.
Autoregulation
Renalbloodflowisautoregulatedoverawiderangeofmeanarterialpressures(60-160mmHg)via:
MyogenicautoregulationTubuloglomerularfeedback
Myogenicautoregulation:
DescribestheintrinsicconstrictionoftheafferentarterioleinresponsetoanincreasedtransmuralpressureThisincreasesvascularresistanceinproportiontotheincreaseinpressure,keepingflowconstant
2
-1
RenalSystem
285
![Page 286: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/286.jpg)
Tubuloglomerularfeedbackismorecomplicated,anddescribestheconstrictionordilationoftheafferentarterioleinresponsetoadenosineorNO(respectively)releasefromthemaculadensa:
ThemaculadensaliesinthewalloftheascendinglimboftheloopofHenleItdetectschangeintubularflowrate(probablyviachangingNa fluxacrossitsmembrane)
Increasedflowintheloopindicatesanincreasedperfusionpressure,promptingreleaseofadenosineandconstrictionoftheafferentarterioleDecreasedflowindicatesadecreasedperfusionpressure,reducingadenosinereleaseandpromptingthereleaseofNOandrenin,whichcausestheafferentarterioletodilate
Notably,flowtojuxtamedullarynephronsisnotautoregulated.Highbloodpressureincreasesjuxtamedullaryflow,increasingGFRandimpairingrenalconcentration,resultinginapressurediuresis.
NeuronalControl
Thekidneysareinnervatedbynoradrenergicsympatheticnerves,whichcauses:
AfferentandefferentarteriolarconstrictionThisincreasescapillaryhydrostaticpressure(increasingfiltration)andalsoincreasescapillaryoncoticpressure(decreasingfiltration).
ThisleadstoanoverallslightreductioninGFR
HormonalControl
Renin:
Isreleasedfromthejuxtaglomerularapparatusbyβ stimulationCatalysestheproductionofangiotensinIfromcirculatingangiotensinogenAngiotensinIisthenconvertedintoAngiotensinIIbycirculatingACE.
TheactionsoftheRAASaredescribedinmoredetailintheendocrinefunctionsofthekidney.
References
1. BarrettKE,BarmanSM,BoitanoS,BrooksHL.Ganong'sReviewofMedicalPhysiology.24thEd.McGrawHill.2012.2. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.3. Hall,JE,andGuytonAC.GuytonandHallTextbookofMedicalPhysiology.11thEdition.Philadelphia,PA:Saunders
Elsevier.2011.
Lastupdated2018-06-25
+
1
RenalSystem
286
![Page 287: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/287.jpg)
GlomerularFiltrationandTubularFunctionDescribeglomerularfiltrationandtubularfunction.
Glomerulus
TheglomerulusisasetofcapillarieswhichinvaginateBowman'scapsuleFluidfiltersoutofthecapillarybedintoBowman'sspacebasedonStarlingforces:
MembranepermeabilityHydrostaticpressuregradientsOncoticpressuregradient
Reflectioncoefficient
GlomerularFiltrationRate
GlomerularFiltrationRateis:
ThevolumeofplasmafilteredbytheglomeruluseachminuteNormalrenalbloodflowis1.1L.min ,howeverrenalplasmaflowisless(600ml.min foranormalhaematocrit).Therefore,thenormalfiltrationfraction(proportionofrenalbloodflowwhichisfiltered)is~20%.Typically125ml.min
Decreaseswithage(partiallyduetolossofnephronnumber)
GFRcanbeexpressedastheproductofNetFiltrationPressureandthecombinationofmembranepermeabilityandmembranesurfacearea,designatedK (thefiltrationcoefficient):
NetFiltrationPressureisgivenbyopposingStarlingForcesacrosstheglomerularmembrane:
Asproteinisnotfilteredinnormalstates,theoncoticpressureinBowman'sSpaceisusuallyassumedtobe0mmHg.TheaveragecapillaryNFPis~17mmHgHydrostaticpressureDeterminedbyrenalbloodflowandtherelativeconstrictionoftheafferentandefferentarterioles.Hydrostaticpressuredecreasesalongthecapillary.Affectedby:
MAPCatecholaminesLocalautoregulation
MyogenicTubuloglomerularFeedbackHormones
AngiotensinIIconstrictstheefferentarteriolemorethantheafferentarteriole,causinganincreaseinrenalresistancewithonlyasmalldecreaseinGFR.ProstaglandinE2dilatestheafferentarteriole,increasingGFR
OsmoticpressureIncreasesalongthecapillary,asproteinfree-fluidisfilteredleavingahigherconcentrationofproteinwithinthecapillary.Thischangeincapillaryoncoticpressureisproportionaltothefiltrationfraction-agreaterfiltrationfractionwillcauseahigheroncoticpressureoffluidinthecapillary.
-1 -1
-1
f
GlomerularFiltrationandTubularFunction
287
![Page 288: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/288.jpg)
MembranepermeabilityOverallpermeabilityis:
Afunctionof:Membranepermeability,inturnaffectedby:
CapillaryendotheliumBasementmembraneNegativelychargedmoleculeshavereducedfiltrationasthebasementmembraneisalsonegativelychargedwhichopposesmovementoutofthecapillary.FootprocessesofpodocytesMoleculeslessthan7000Daltonarefreelyfiltered,whilstlargermoleculesarefilteredless.
MembraneSurfaceAreaTypicallyveryhighforwaterandsolutes.Affectedby:
GlomerulonephritisChangeinbasementmembraneorpodocytefootprocesses
AngiotensinIIcausingcontractionofmesangialcells
TubularFunction
ProximalTubule
Theproximaltubulereabsorbs60%ofglomerularfiltrate.Itreabsorbsbasicallyeverything,includingprotein,andsecretesH ,organicions(suchasuricacidandsalicylates),ammonium,andupto60%offilteredureaload.
LoopofHenle
TheloopofHenleconsistsofathindescendinglimbandathickascendinglimb;
ThedescendinglimbreabsorbswateronlyThethickascendinglimb:
Reabsorbscommonions(Na ,K ,Cl )andHCOExcretesH
ThefunctionoftheloopistoconcentrateurineinstatesofwaterdeprivationThisisdoneviathecountercurrentmechanism.
CountercurrentMultiplier
Thecountercurrentconcentratingsystemis:
FormedfromtheloopofHenleandcollectingductsDrivenentirelybytheremovalofNaClfromtheascendinglimbMosteasilyunderstoodinstages:
NaClisactivelytransportedoutofthethickascendinglimb,increasinginterstitialosmolalityatthatlevelIncreasedinterstitialosmolalityresultsinwaterreabsorptionfromthedescendinglimb,increasingtubularosmolalityatthatlevelThismoreconcentratedtubularfluidthenflowstoadeeper,moreconcentratedlevel,andmorewaterisreabsorbedTheeffectisprogressiveconcentrationoftubularandinterstitialfluid,butwithalowandstableenergycostastherelativegradientsthateachtransportpumpworksagainstissmallTheendresultisadiluteurineleavingtheascendinglimb,butahighlyconcentratedmedullaryinterstitium
CountercurrentExchange
+
+ + -3-
+
GlomerularFiltrationandTubularFunction
288
![Page 289: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/289.jpg)
Thevasarectaareperitubularcapillariesthat:
SurroundtheloopofHenleofjuxtamedullarynephronsFollowtheloopintothemedullaHavetypicallylowbloodflowThisprevents"washout"ofthecountercurrentmultiplier,astheslowbloodflowallowssoluteconcentrationstoequaliseateachleveloftheloop.
Inhypovolaemicsituations,renalbloodflowfallsandvasarectaflowdecreases,furtherreducingwashoutWhenrenalbloodflowishigh,vasarectaflowincreasesThiswashesoutpartofthemedullaryconcentrationgradientandreducestheconcentratingabilityofthekidney.
Distaltubules
Fluidenteringthedistaltubulehasaboutone-thirdtheosmolarityofplasma.Thedistaltubule:
Reabsorbs:Na ,Cl ,HCO ,CaSecretes:K ,H
CollectingDucts
Thecollectingductslieintheinterstitium(concentratedbytheloopofHenle)Intheabsenceofaquaporins,thecollectingductsareimpermeabletowater
Osmolalitycanfallaslowas50mmol.L duetocontinuedreabsorptionofsoluteInthepresenceofaquaporins,waterflowsdowntheosmoticgradientintotheconcentratedinterstitium,resultinginahighlyconcentratedurineADHalsoincreasescollectingductpermeabilityofurea
Ureamovesviasolventdragwithwater
References1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. GregerR,WindhorstU.ComprehensiveHumanPhysiology:FromCellularMechanismstoIntegration.Springer-Verlag
BerlinHeidelberg.1996.3. CICMMarch/May2010
Lastupdated2019-07-18
+ -3- 2+
+ +
-1
GlomerularFiltrationandTubularFunction
289
![Page 290: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/290.jpg)
HandlingofOrganicSubstancesDescribetheroleofthekidneyinthehandlingofglucose,nitrogenousproductsanddrugs
Broadlyspeaking,thekidney:
ReabsorbsimportantsubstancesFiltersandsecreteswasteproducts
MethodsofReabsorptionReabsorptionfromtubuletobloodcanoccurviatwomechanisms:
TranscellularreabsorptionSubstanceisabsorbedintotubularepitheliumandthensecretedintoblood.Thisistypicallyachievedbysymporters,whichrelyonthelowintracellularsodiumconcentrationtomovesubstancesoutofthetubuleagainsttheirconcentrationgradient.ParacellularreabsorptionSubstancepassesthroughthematrixoftightjunctionsbetweenepithelialcells.
RateLimitation
Therearefunctionalupperlimitsontherateofreabsorptionofsubstancesfromthetubule.Therearetwolimits:
TubularMaximum(T )LimitedSaturationoftransportersoccur,soafurtherincreaseinsoluteconcentrationdoesnotincreasetherateofsubstancereabsorption.
ThemaximumsoluteconcentrationforaT systemisafunctionofthetransporter.
GradientLimitedLeaksinthetightjunctionswillresultinsolutemovingfromtheinterstitiumbackintothetubuleifthetubularconcentrationfallstoolow.
Themaximumsoluteconcentrationforagradientlimitedsystemisrelatedtothepermeabilityofthetightjunctions.
GlucoseGlucoseis:
FreelyfilteredattheglomerulusCompletelyreabsorbedviathetranscellularrouteintheproximalconvolutedtubuleundernormalcircumstancesActivelytransportedviatheSGLUT(Sodium-dependentGlucosesymporter)transmembraneprotein
Secondaryactivetransport(downtheestablishedSodiumgradient)TherearetwosubtypesoftheSGLUTprotein:
Low-affinity,high-capacityRapidlyreabsorbsglucose,butisineffectivewhenglucoseconcentrationislow.ItislocatedearlyinthePCT,andreabsorbs~90%offilteredglucose.High-affinity,low-capacitySlowlyreabsorbsglucose,butremainseffectiveevenwhenglucoseconcentrationislow.ItislocatedlateinthePCT,whereglucoseconcentrationislower(havingalreadybeenreabsorbedbythehigh-capacitytransporter),andreabsorbs~10%offilteredglucose.
max
max
HandlingofOrganicSubstances
290
![Page 291: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/291.jpg)
AsGFRincreases,glucosefiltrationandthereforeglucoseabsorptionincreaseAsglucoseisco-transportedwithNa ,absorptionofNa andH OalsoincreaseThisphenomenonisknownasglomerulo-tubularbalance
GlucosereabsorptionisaT system,andisoverwhelmedwhenfilteredglucoseexceeds300mg.min or16mmol.minThistypicallyoccurswhenplasma(andthereforefiltered)glucoseconcentrationsexceed12mmol.L
ConsequencesofGlycosuria
GlycosuriaoccurswhenfilteredglucoseexceedsthecapacityofthePCTtoreabsorbit,andcauses:
IncreasedurinevolumeGlucoseactsasanosmoticdiureticby:
ReducingNa reabsorptioninthePCTAssomeglucoseisnotabsorbed,thesodiumthatwouldnormallybereabsorbedwith(tubuloglomerularbalance)isremaininginthetubule.ReducingwaterandsaltreabsorptionintheLoopofHenleDuetohightubularflowrates.
Impairstheformationofthemedullaryconcentrationgradient,limitingconcentratingcapacityStimulatesADHrelease
ElectrolytederangementsHypokalaemiadueto:
ReducedK reabsorptionduetohightubularflowratesAldosteronereleaseduetohypovolaemia,increasingNa reabsorptionandK secretion
ADHreleaseinresponsetohypovolaemiaLossofsubstrateforATPgenerationIncreaseriskofurinaryinfections
NitrogenousProducts
Aminoacidsarereabsorbedbyamino-acidtransportersThesearenot(entirely)selective,andreabsorbseveralstructurallysimilaraminoacids.
ThesesharedpathwayscreatecompetitionforbindingsitesbetweenaminoacidsExcessofonesubstancewillleadtobothexcretionofthissubstanceinurine,aswellasinappropriateexcretionofrelatedsubstances
Largerproteins(suchasalbumin)areinfactfilteredattheglomerulus(thoughinverysmallamounts)Reuptakeoccursinseveralstages:
EndocytosisattheluminalmembraneThisisanenergy-dependentprocess,requiringproteintobindtomembranereceptors.Degradationofproteinintoindividualaminoacids
+ +2
max-1 -1-1
+
++ +
HandlingofOrganicSubstances
291
![Page 292: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/292.jpg)
Reuptakeacrossthebasolateralmembrane
Smallerproteinsandpeptides(e.g.insulin,angiotensinII)arecompletelyfilteredCatabolismoccursinthetubularlumenbymembrane-surfacepeptidasesAminoacidsarereabsorbedbystandardamino-acidtransporters
Urea
Ureaisasmall,watersolublemoleculeproducedintheliverfromammoniaasamethodforeliminatingnitrogenouswaste.
Ureaexcretioniscomplex,asithasanimportantroleinthecountercurrentmultiplier.Thismeansthatintheshortterm(hourstodays)eliminationmaynotmatchproduction,althoughoverweekstheywillbeequal.Ureais:
Freelyfiltered~50%offilteredloadisreabsorbedinthePCTbysolventdrag(withwaterreabsorption)Ureaconcentrationisslightlyincreasedasmorewaterisreabsorbedthanurea.TheureareabsorbedinthePCTisthensecretedintotheLoopofHenleviaUTuniporters
Luminalconcentrationofureaismuchhigherintheascendinglimbduetotheabsorptionofwater~50%isreabsorbed(again)inthemedullarycollectingductsHere,urinebecomessoconcentratedthatluminalconcentrationofureaexceedsmedullaryconcentration.
Overall,50%offilteredloadisexcreted
pHDependentDrugReabsorption
Manysubstances,suchasdrugs,areweakacidsorbasesReabsorptionofthesesubstancesispHdependent
WeakacidsareproportionallymoreionisedatapHabovetheirpKaWeakbasesareproportionallymoreionisedatapHbelowtheirpKaUnionisedsubstancesarelipidsoluble,andabletodiffuseintotubularcellsdownconcentrationgradientsIonisedsubstancesaretrappedwithinthelumen
References
1. EatonDC,PoolerJP.Vander'sRenalPhysiology.6thEd(Revised).McGraw-HillEducation-Europe.2004.
Lastupdated2019-07-18
HandlingofOrganicSubstances
292
![Page 293: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/293.jpg)
MeasurementofGFRDescribetheprinciplesofmeasurementofglomerularfiltrationrateandrenalbloodflow
Renalclearanceofasubstancequantifiestheeffectivenessofkidneysinexcretingsubstances.Thedefinitionofclearanceisthevolume(typicallyofplasma)clearedofadrugperunittime.Renalclearancecanthereforebeexpressedas:
,where:
=Clearance
=Urineconcentration
=Urineflowrate
=Plasmaconcentration
ClearanceandGFR
Astheeliminationofmostsubstancesisdependentonglomerularfiltration,clearanceofasubstancecanbeusedtoestimateGFR.Methodsinclude:
InulinInulinisanaturallyoccurringpolysaccharide.
InulinclearanceaccuratelymeasuresGFRasitis:FreelyfilteredbytheglomerulusNotsecretedatthetubulesNotreabsorbed
However,inulinisnotproducedbythebodyandsomustbegivenbyIVinfusionThislimitsitsclinicalutility.
CreatinineCreatinineisabyproductofmusclecatabolism.
Creatinineisusedclinicallytomeasurerenalfunctionbecauseitis:ProducedatarelativelyconstantrateFactorsaffectingcreatinineproductioninclude:
RaceMusclemass
AgeSex
DietNotmetabolisedFreelyfilteredbytheglomerulusMinimallysecretedAsGFRfallstheproportionofcreatininesecretedbyrenaltubulesincreases,soplasmacreatininewilloverestimateGFRwhenGFRislow.Notreabsorbed
GFRcanbeapproximatedbycreatinineclearance
Thisisgivenbytheequation:
MeasurementofGFR
293
![Page 294: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/294.jpg)
SerumCreatinine
ThisformulademonstratesthatGFRisinverselyproportionaltoserumcreatinineconcentration.
Thisisonlytruewhenbothcreatinineproductionandglomerularfiltrationareatsteady-stateAsuddendropinglomerularfiltration(e.g.aorticcross-clamp)willnotresultinanimmediateriseincreatinine.
DuringacutechangesinGFR,serumcreatininewillunderestimateGFRuntilanewsteadystateisreachedCreatininemustbeproducedandnoteliminatedforittorise.
EstimatingCreatinineClearance
Usingtheaboveformularequiresmeasurementofurinevolume.Thisis:
Typicallyperformedbytakinga24hoururinecollectionTedious,andsocreatinineclearanceisoftenestimatedAcommonmethodistheCockcroft-Gaultformula,whichhasacorrelationof~0.83withcreatinineclearance:
,where:
=Clearance
=Age
=Sexcoefficient(Male=1,Female=0.85)
=Creatinineinµmol.L
AlternativeformulasareMDRDandCKD-EPI.TheseequationshavetwoadvantagesofCockcroft-Gault:
TheyarebetterpredictorsofGFRTheydonotrequireweight,andsocanbecalculatedbythelaboratoryautomaticallyOtherrequireddata(e.g.age)canbetakenfromhospitalrecords.
Theseestimateshavesimilarweaknessestotheabove:
Dependentonserumcreatinine,whichcanbehighlyvariable.Formulasarederivedfromaveragevaluesofdependentvariables,andsowillbeunreliableatextremesof:
AgeMusclemassCriticallyillMalignancyDiet
References
-1
MeasurementofGFR
294
![Page 295: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/295.jpg)
1. Hall,JE,andGuytonAC.GuytonandHallTextbookofMedicalPhysiology.11thEdition.Philadelphia,PA:SaundersElsevier.2011.
2. CockcroftDW,GaultMH.PredictionofCreatinineClearancefromSerumCreatinine.Nephron1976;16:31-413. LeveyAS,StevensLA,SchmidCH,ZhangYL,CastroAF3rd,FeldmanHI,KusekJW,EggersP,VanLenteF,GreeneT,
CoreshJ;CKD-EPI(ChronicKidneyDiseaseEpidemiologyCollaboration).Anewequationtoestimateglomerularfiltrationrate.AnnInternMed.2009May5;150(9):604-12.
4. MDCalc-Cockcroft-GaultEquation.5. NIDDK.EstimatingGlomerularFiltrationRate(GFR)
Lastupdated2019-07-18
MeasurementofGFR
295
![Page 296: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/296.jpg)
EndocrineFunctionsoftheKidneyOutlinetheendocrinefunctionsofthekidney
Thekidneyisinvolvedinanumberofendocrineprocessesandproducesormetabolisesanumberofhormones:
RAASVitaminDEPOProstaglandins
Renin-Angiotensin-AldosteroneSystemTheRAASisasignalingpathwayinvolvedinbloodpressurecontrol.Itinvolvesanumberofhormones:
Angiotensinogenisproducedbytheliverinresponseto:GlucocorticoidsThyroidhormonesOestrogensAngiotensinIIVariousinflammatoryproteins
Reninisaproteaseproducedbythekidneysinresponsetoβ stimulationorhypotension,andexiststocleaveangiotensinogentoangiotensinI
ACEcleavesangiotensinItoangiotensinII,andalsocleavesbradykininintoinactivemetabolites
AngiotensinIIincreasesbloodpressureviaanumberofmechanisms:Simulatesaldosteronereleasefromtheadrenalcortex,increasingsodiumandwaterretentionVasoconstrictionofefferentgreaterthantheafferentarteriolesResultsinslightdecreaseinGFRatalowerperfusionpressure,butincreasesfiltrationfraction.
NB:Differentsourcesquotedifferentchanges(increaseordecrease)inGFRThefinaleffectmayvarydependingonthecontributionofotherautoregulatoryprocesses.
ReducesK throughconstrictionofglomerularmesangialcellsIncreasedSNSactivityandcentralandperipheralvasoconstrictionIncreasesthirstviahypothalamicstimulationStimulatesADHrelease,reducingrenalwaterexcretionStimulatesreleaseofangiotensinogen
Aldosteroneactsonthedistalconvolutedtubuleto:IncreasereabsorptionofNa andwaterIncreaseeliminationofK andH
VitaminDVitaminDhasacomplexmetabolicpathwaywhichmeandersthroughanumberoforgansystems:
VitaminD maybeabsorbedindietorproducedinskinbytheactionofUVlighton7-dehydrocholesterolVitaminD isthenhydrolysedintheliverbyCYP450enzymestoform25-hydroxycholecalciferol(25-OHD )25-OHD isthenconvertedintheproximaltubuletocalcitriol-theactiveform
1
f
++ +
33 3
3
EndocrineFunctionsoftheKidney
296
![Page 297: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/297.jpg)
Erythropoietin
ErythropoiesisisstimulatedbyEPOrelease:
Inadults,EPOisreleasedfromthe:Peritubularcapillaryfibroblasts(85%)Liver(15%)
EPOisreleasedinresponseto:HypoxiaHypotensionLowHct
Erythropoiesisisinhibitedby:HighredcellvolumeRenalfailureProductionofEPOisdecreasedinrenalfailure,whichiswhypatientswithend-stagerenaldiseaserequireexogenousEPO.
References1. BarrettKE,BarmanSM,BoitanoS,BrooksHL.Ganong'sReviewofMedicalPhysiology.24thEd.McGrawHill.2012.2. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.
Lastupdated2018-09-21
EndocrineFunctionsoftheKidney
297
![Page 298: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/298.jpg)
Acid-BaseBalanceDescribetheroleofthekidneysinthemaintenanceofacid/basebalance
Acidsproducedbythebodycanbe:
Volatile(CO )Bodyproducesandeliminates~13-20mol.dayRemovedbythelungs
Fixed(everythingelse)Includelactate,sulphate,phosphate,andketonesBodyproducesandeliminates10mmol.kg .dayEliminatedbythekidneyMechanismsforeliminationofacidinclude:
ReabsorptionofHCOThisisequivalenttotheremovalofthesameamountofH .
Asthereisusuallyanetproductionofacid,undernormalcircumstancesallfilteredHCO isreabsorbedNotethatremovalofanacidloadisassociatedwithgreaterHCO generationandreabsorption,notincreasedH secretion
BoundtofilteredbuffersAsammonium
TherateandextentofthesereactionsisdependentonECFpHandionconcentrations,whichgivesthekidneycontroloverionconcentrationsUrinarypHcanfallaslowas~4.4,beforetheactivetransportofH isinhibited
BicarbonateandtheKidneyBuffersystemsminimisechangesinpHuntilthekidneycaneliminateexcesshydrogen.
BicarbonateisthepredominantECFbuffersystem(seeAcid-Basephysiologyformoreonbuffers).ByadjustingthelevelofHCO thekidneyisabletoadjustpH,aspertheHenderson-Hasselbalchequation:
Where:
=6.1,thepKaofHCO
=24,thenormal[HCO ]inmmol.L
=1.2,thenormal[CO ]inmmol.L
Bicarbonateis:
Freelyfiltered4320mmol.day ofHCO isfiltered(24mmol.L x180L.day ,normalrangeis4-5mol.day )ReabsorbedinthePCT(90%),thickascendinglimb,DCT,andCT
2-1
-1 -1
3-
+
3-
3-
+
+
3-
3-
3- -1
2-1
-13- -1 -1 -1
-
Acid-BaseBalance
298
![Page 299: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/299.jpg)
Adjustingrateofabsorptionallowscorrectionofanacidosisoralkalosis.AllHCO reabsorptionisequivalenttoalossofH .
ReabsorptionofBicarbonate
Reabsorptionofbicarbonateinvolvesseveralsteps:
H issecretedintothelumeninoneofthreeways:PrimaryH ATPaseinthePCTandDCTH -Na antiporterinthePCTandascendinglimbH -K ATPaseintheCT
SecretedH combineswithfilteredHCO toformCO andH OCO andH OdiffuseintothetubularcellCO andH OareconvertedbackintoHCO andH inthetubularcellHCO isreabsorbedintothecapillaryviatheHCO -Cl antiporter,andtheH ionisavailabletobesecretedintothetubule(inexchangeforK inthecollectingductsandNa intheproximaltubule)
ThiscomplicatedprocessallowsHCO tobemovedfromthetubuletothetubularcellandthentothecapillary.ThereisnoeliminationofH bythismethod-thepurposeofH secretionistofacilitatethereabsorptionofHCO intothetubularcell.
AmmoniaGlutamineprovidesamechanismforeliminationofalargenumberofH ions:
Thisisimportantin:EliminationofexcessmetabolicacidRenalcompensationforacidosis
Thisoccursvia:FilteredglutamineisabsorbedintoproximaltubularcellsandmetabolisedtoNH (ammonium)andHCOHCO diffusesintoblood,andtheNH issecretedintothetubuleviatheNH -Na antiporterandeliminatedinurine
The reactionhasapKaof9.2meaning:AmmoniacannotactasaneffectiveurinarybufferAmmoniaisnotatitratableacid,asitwillnotreleaseH ionsasurinarypHincreasesThismeansfilteredammoniadoesnotcontributetothelowerlimitofurinarypH(4.4),whichiswhyitissoimportantintherenalcorrectionofseveremetabolicacidosis.
BoundtoFilteredBuffers
SecretedH mayalsocombinewithafilteredbuffer(e.g.PO ).TheseH ionsarenotreabsorbed.About36mmolofH iseliminatedwithfilteredPO eachday,witheachPO bindingtwoH ions.
References
1. CICMSep/Nov20142. ANZCAFeb/April20123. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.4. Acid-BaseOnlineTutorial,UniversityofConneticut5. Brandis,K.RenalRegulationofAcid-BaseBalance,in'Acid-basepHysiology'.
3-
+
++
+ ++ +
+3-
2 22 22 2 3
- +
3-
3- - +
+ +
3-
+ +3-
+
4+
3-
3-
4+
4+ +
+
+43- + +
43-
43- +
Acid-BaseBalance
299
![Page 300: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/300.jpg)
Lastupdated2019-07-18
Acid-BaseBalance
300
![Page 301: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/301.jpg)
DialysisDialysisistheseparationofparticlesinaliquidbasedontheirabilitytopassthroughamembrane.
Indications
Failureofnormalrenalfunctions,i.e.:
AcidElectrolytederangementParticularlyhyperkalaemia.IntoxicationsOverloadUreamia
PhysicalMechanisms
Fluidandelectrolytescanberemovedbyfourdifferentmechanisms:
DiffusionDiffusionisthespontaneousmovementofsubstancesfromahigherconcentrationtoalowerconcentration,whererateofmovementisproportionaltotheconcentrationgradient(asperFick'sLaw).
UltrafiltrationMovementofwater,asdeterminedbyStarling'sForces.
Whenasolventpassesthroughamembrane,theprocessiscalledosmosis.Thefrictionalforcesbetweensolutesandwatermoleculeswillpulldissolvedsubstancesalong,aprocessknownasbulkfloworsolventdrag.
Implementation
HaemodialysisUsesdiffusion.
Bloodispumpedthroughanextracorporealcircuitthatcontainsadialyser.Dialysateflowiscountercurrent,whichmaximisesthegradientfordiffusion.Solutesmoveacrossamembranebetweenbloodanddialysate,asperFick'sLaw:
ConcentrationgradientbetweenbloodanddialysateFlowrateofbloodanddialysate
SolubilityofthesoluteMassChargeProteinbinding
DialysismembranepermeabilityThicknessPorositySurfacearea
HaemofiltrationUsesultrafiltration.
Bothapositivehydrostaticpressureinbloodandanegativehydrostaticpressureindialysateisgenerated,causing
Dialysis
301
![Page 302: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/302.jpg)
ultrafiltrationandremovalofsolutesviasolventdrag.
Eliminationviabulkflowisindependentofsoluteconcentrationgradientsacrossthemembrane.TransportisdependentonStarlingForces:
ThetransmembranepressuregeneratedThisisafunctionof:
BloodflowtothemembraneDetermineshydrostaticpressure.Oncoticpressuregradient
PorosityofthemembraneAdditionally,ahighfiltrationfractionwillcauseexcessivehaemoconcentration,andclottingofthefilterThefilteredfluid(ultrafiltrate)isdiscarded,andreplacedwithanotherfluiddependingonthedesiredfluidbalance.
Differences
RenalReplacementTherapy(RTT)canbevia:Peritonealdialysis(PD)Intermittenthaemodialysis(IHD)IHDcausesgreatercardiovascularinstabilitycomparedtoCRRTasthefluidandelectrolyteshiftsoccurmorerapidly.ContinuousRenalReplacementTherapy(CRRT)
ContinuousVeno-VenousHaemofiltration(CVVH)ContinuousVeno-VenousHaemodiafiltration(CVVHDF)
Methodchosendependsdesiredeffect:
Smallmolecules(<500Da)andelectrolytescanberemovedbyfiltrationordialysisMedium-sizedmolecules(500-5000Da)arebestremovedbyfiltrationLowmolecularweightproteins(5000-50000Da)areremovedbyfiltrationThisincludesremovalofinflammatoryproteins,whichmaybebeneficialinsepsis.Waterisbestremovedbyfiltration
PharmacokineticsofRRTPharmacokineticsareunpredictable,butarebroadlyaffectedby:
DrugfactorsFreedruginplasmaDrugswithasmallproportionoffreedruginplasmaare(unsurprisingly)poorlyremovedbyRRT(butmayberemovedviaplasmapheresis).Theseinclude:
Highly(>80%)proteinboundsubstancesExamplesincludedphenytoin,warfarin,andmanyantibiotics.
NotthatthismaynotapplyinoverdoseOnceproteinbindingsitesaresaturated,bothfreedrugfractionandefficacyofdialysisisincreased.
DrugswithaV greaterthan1L.kgSize/MolecularWeight
Smallmolecules(<500Da)aremoreeasilyclearedbydiffusivemethodsofRTTMolecules>15kDaarepoorlydialysedThisincludesproteins,heparins,andmonoclonalantibodies.
VolumeofdistributionDrugswithhighvolumesofdistributionarepoorlydialysed,asremovalofdrugfromplasmaonlyremovesasmallproportionoftotal-bodydrugcontent.
Dialysisfactors
D-1
Dialysis
302
![Page 303: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/303.jpg)
Dose/FlowratesReducedflowrateswillreduceclearance.
Conventionalhigh-fluxhaemodialysishasmorerapidclearancecomparedtolower-fluxhaemoperfusionorCRRTMembranepermeabilityTimingDrugsgivenbetweenIHDorSLEDsessionswillnotbecleareduntilthenextsession.s
PatientfactorsResidualrenalfunctionPatientsresidualGFRwillalsoaffectpharmacokinetics.
AnIncompleteListofDrugs
DrugsRemovedonRRT DrugsnotremovedonRRT
Barbiturates Digoxin
Lithium TCAs
Aspirin Phenytoin
Sotalol/Atenolol Otherbeta-blockers
Theophylline Gliclazide
EthyleneGlycol Benzodiazepines
Methanol Warfarin
Aminoglycosides,metronidazole,carbapenems,cephalosporins,penicillins Macrolides,quinolones
References
1. JohnsonCA,SimmonsWD.DialysisofDrugs.NephrologyPharmacyAssociates.
Lastupdated2019-07-18
Dialysis
303
![Page 304: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/304.jpg)
SodiumandWaterDescribethefunction,distribution,regulationandphysiologicalimportanceofsodium,chloride,potassium,magnesium,calciumandphosphateions
NormaltotalbodyNa is60mmol.kg ,70%ofwhichisexchangeable.TotalbodyNa isdistributedas:
50%inECFSodiumisthedominantextracellularcation.
TypicalECF[Na ]of140mmol.L .45%inbone5%inICFAminorintracellularcation.
ICF[Na ]varieswithcelltype,butistypically12-20mmol.L .Concentrationiskeptlowbytheactionofthe2Na -3K ATPaseexchangepumpandthelowpermeabilityofthecellularmembranetoNa
FunctionofSodiumRegulationofECFvolumePrincipalECFcation.Changesinsodiumlevelscausecompensatoryfluidshifts.Lossofsodiumcontentwillresultinhypotension/hypovolaemia,withconsequentbaroreceptorstimulationandactivationoftheRAAS.Baroreceptorswillactivatewitha7-10%changeinvolume.
OsmolarityChangesinsodiumconcentrationaffectosmoreceptorsandwillaffectADHandthirstmechanisms.Osmoreceptorswillactivatewitha1-2%changeinosmolality.
Acid-BasebalanceNa -H exchangepumpsinthekidneyarestimulatedinacidosis.
RestingMembranePotentialAlterationsinsodiumconcentrationwillaffectintracellularpotassiumtoasimilardegree,whichwillaltertheRMP.
RegulationofSodiumandWater
Regulationofanysystemistypicallyabalancebetweeninputandoutput:
SodiumintakeisessentiallyunregulatedTherefore,sodiumconcentrationisafunctionof:
SodiumeliminationSodiumreabsorptionWaterhomeostasisControloftotalbodywaterisamajormechanismtoregulatesodiumconcentration.
SodiumElimination
Sodiumiseliminatedin:
SweatandGITObligatoryandnotamenabletoregulation.
+ -1 +
+ -1
+ -1+ +
+
+ +
FluidsandElectrolytes
304
![Page 305: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/305.jpg)
Acclimatisationtohotenvironmentsimprovestheefficiencyofsweatingbyreducingitstonicity,reducingsodiumlossGITUrine
AdjustrenaleliminationisthemainmechanismtoregulatesodiumconcentrationCanbeperformedintwoways:
ChangesinGFRChangesinGFRduetohyperorhypovolaemiawill(indirectly)adjustsodiumelimination.IncreasedplasmavolumeincreasesGFR,andviceversa.ChangesinsodiumreabsorptionThisisthemainmechanismforcontrollingsodiumineuvolaemia,andismediatedprimarilybyaldosterone.
SodiumReabsorption
Giventhat:
Normalglomerularfiltrateis~180L.dayThedominantosmoleinglomerularfiltrateissodiumNormalurineoutputis~1.5L
Themajorityoffilteredsodiummustbereabsorbed.ThisiscalledbulkreabsorptionandoccursinthePCTandLOH:
60%oftotalreabsorptionisbytheNa -K ATPasepumpinthePCT30%oftotalreabsorptionisbytheNa -K -2Cl co-transporterintheLOH
Theremaining10%ofsodiumreabsorptionoccursintheDCTandCT.Asitisundertheinfluenceofaldosterone,itisthecomponentwhichisimportantinregulation.AldosteroneincreasesNa reabsorptionbyincreasingthenumberoractivityofthesepumps:
Na -Cl pumpsintheDCTNa -K ATPasepumpsinprincipalcellsoftheDCTNa -H pumpsinintercalatedcellsoftheCT
WaterHomeostasis
Bodywaterhomeostasisinvolves:
SensorsOsmoreceptorspresentinthe:
MaculadensaCircumventricularorgansSubfornicalorganandthevascularorganofthelaminaterminalis.
Changeincellularvolumesecondarytochangesinosmolalityalterhormonesecretion.EffectorsPredominantlyhormonal:
ADHRAASNatriureticpeptides
References
1. BrandisK.ThePhysiologyViva:Questions&Answers.2003.2. CICMSeptember/November2014
-1
-1
+ ++ + -
+
+ -+ ++ +
FluidsandElectrolytes
305
![Page 306: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/306.jpg)
3. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.4. NationalResearchCouncil.RecommendedDietaryAllowances.10thEd.1989.NationalAcademiesPress.
Lastupdated2019-07-18
FluidsandElectrolytes
306
![Page 307: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/307.jpg)
PotassiumDescribethefunction,distribution,regulationandphysiologicalimportanceofsodium,chloride,potassium,magnesium,calciumandphosphateions.
Potassiumisthemajorintracellularcation,with90%oftotalbodypotassiumpresentintheICF.Afurther8%issequesteredinbone,with2%presentintheECF.
NormalECFconcentrationis3.5-5mmol.LNormalICFconcentrationis~150mmol.L
FunctionandDysfunctionPotassiumisimportantfor:
RegulationofintracellularpHControlofintracellularvolumeDNAandproteinsynthesisEnzymaticfunctionRestingmembranepotential
Therestingmembranepotentialisdeterminedbytheratioofintracellular:extracellularpotassium,aspertheNernstequation:
SmallchangesinextracellularionconcentrationproducelargechangesinvoltageThishassignificanteffectonexcitabletissues.RapidchangesinpotassiumconcentrationcausesymptomsatlowerlevelsthanchronicchangesSymptomsarerelatedtothechangeinactionpotentialgeneration.
VentricularActionPotentialinHyperkalaemia:
Hyperkalaemia
Hyperkalaemiacauses:
TherestingmembranepotentialtobecomelessnegativeAspertheNernstequation.
Thisresultsintherestingmembranepotentialbeingclosertothethresholdpotential,increasingirritabilitySeveralsymptoms,including:WeaknessParalysisParasthesiasECGfindingsarethoseofprolongeddepolarisationandrapidrepolarisation:
-1-1
Potassium
307
![Page 308: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/308.jpg)
Serum[K ](mmol/L) ECGFindings
5.5-6.5 TalltentedTwaves
6.5-7.5 LossofPwave,lengtheningPRinterval
7.5-8.5 WideningQRS
>8.5 Sine-waveQRS
Hypokalaemia
Hypokalaemia:
Causestherestingmembranepotentialtobecomemore-negativeThismakesitmoredifficultforastimulustoreachthethresholdpotential,andthereforeitishardertogenerateandpropagateactionpotential.ECGfindingsarethoseofrapiddepolarisationandprolongedrepolarisation,andinclude:
ProlongedPRLongQTFlatTwavesorTWIUwavesSTdepressionSeverehypokalaemiamayresultin:FrequentsupraventricularandventricularectopicsSupraventriculararrhythmiasVentriculararrhythmias
Regulation
Serumpotassiumisdependentonintake,sequestration,andelimination.
Intake
Dietaryintakemaybehighlyvariable.PotassiumiscompletelyabsorbedfromtheupperGItract.
Sequestration
Severalfactorsaffectpotassiumsequestration:
Insulinandβ -agonismresultsinincreaseactivityoftheNa -K ATPasepump,shiftingpotassiumintocellsfollowingamealandduringexerciseAcidosiscausesanextracellularshiftofpotassium,ashydrogenionsareexchangedforpotassiumionsThereverseoccursinalkalosis.CelllysismayreleasealargeamountofpotassiumintocirculationandcausesignificanthyperkalaemiaifalargenumberofcellsaredestroyedAldosteroneincreasesuptakeofpotassiumintocells
Elimination
Eliminationofpotassiumoccursviathekidneys,andisdependentonproductionoflargevolumesofglomerularfiltrateandsecretionbythedistalconvolutedtubuleandcollectingduct.
Innormalconditions:
+
2+ +
Potassium
308
![Page 309: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/309.jpg)
ThePCTandascendinglimbreabsorbthemajorityofabsorbedpotassiumThisisessentiallyfixed.
PCTabsorbs~55%Ascendinglimbabsorbs~30%
TheprincipalcellsoftheDCTandcollectingductsecretepotassiumAlteringpotassiumsecretionisthemainmethodbywhichthekidneyregulatesserumpotassium.
ThecollectingducthasamuchgreaterrolethantheDCTWithnormaldietaryintake,morepotassiumissecretedthanreabsorbedThischangesinconditionsofpotassiumdepletion.
ControlofTubularSecretion
Tubularpotassiumsecretionismainlyafunctionof:
Plasma[K ]Increasedplasma[K ]stimulatestheNa -K ATPasepumpintheprincipalcells,andalsostimulatesaldosteronereleasefromtheadrenalcortex.TubularflowrateMovementofpotassiumoutofprincipalcellsoccursdownapassiveconcentrationgradient.IncreasingtubularflowrateincreasestheconcentrationgradientforpotassiumAldosteroneAldosteroneincreasesproductionoftheNa -K ATPasepump,whichincreasespotassiumsecretionanduptakeintocells.
Minorcontributorsinclude:
SodiumandwatercontentHighsodiumcontentinhibitsaldosteronerelease,reducingpotassiumeliminationHighwatercontentinhibitsADHexcretionandreducessecretionofpotassium,howeverhighwatercontentalsoincreasesflowthroughtherenaltubule,whichindirectlyincreasestubularsecretionofpotassium.
AlkalosisAlkalosisincreaseseliminationofpotassiumastheNa -K ATPasepumpisstimulatedbylowH ionconcentration.
References
1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. Hall,JE,andGuytonAC.GuytonandHallTextbookofMedicalPhysiology.11thEdition.Philadelphia,PA:Saunders
Elsevier.2011.3. Nickson,C.Hyperkalaemia.LifeintheFastLane.4. ParhamWA,MehdiradAA,BiermannKM,FredmanCS.HyperkalemiaRevisited.TexasHeartInstituteJournal.
2006;33(1):40-47.
Lastupdated2017-10-04
++ + +
+ +
+ + +
Potassium
309
![Page 310: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/310.jpg)
PrinciplesofAcid-BasePhysiologyExplaintheprinciplesunderlyingacid-basechemistry
Therehavebeenseveraldifferenttheoriesofacid-basechemistry.TheonemostrelevantfortheprimaryexamistheBrønsted–Lowrydefinition,whichdefines:
AnacidasaprotondonorAbaseasaprotonacceptor
pHStandsforthepowerofhydrogenIsameasureofhydrogenionactivityinasolution
Activitycanbeapproximatedbyconcentration
Therefore,pHcanbeexpressedasafunctionofhydrogenionconcentration:UsingpHratherthanconcentrationmakesiteasiertocomparedifferentsolutions.
pKaStrongacids(andbases)dissociatecompletelyinsolutionWeakacids(andbases)onlypartiallydissociateTheyhaveadissociatedstate(A-)andanundissociatedstate(HA)Theratioofconcentrationsoneachsidecanbeusedtocalculatetheaciddissociationconstant,Ka
Thisequationdescribesthestrengthofanacidbyindicatinghowreadilytheacidgivesupitshydrogen.SimilartopH,thisvalueisoftenlogtransformedtopKaproduceanindex,whichallowseasycomparisonofdifferentsubstances:
pKahasseveralusefulproperties:Anacidofbasewillbe50%ionisedwhenthepHofitssolutionequalsitspKaAcidsaremoreionisedabovetheirpKaBasesaremoreionisedbelowtheirpKaAnincreaseinpHof1abovethepKawillresultinthatsubstancebeingeither90%(foranacid)or10%(forabase)ionised
Acid-BasePhysiology
310
![Page 311: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/311.jpg)
SystemicEffectsofAcid-BaseDisorders
pHdisturbanceaffectsmanyorgansystems:
Respiratory
IncreasedPeripheralandcentralchemoreceptorsincreaseventilationinresponsetoafallinpH.Oxyhaemoglobin-DissociationCurve
Acid-BasePhysiology
311
![Page 312: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/312.jpg)
Right-shiftedbyafallinpH.BronchoconstrictionHypercapneacausesparasympathetically-mediatedbronchoconstriction.
CardiovascularInotropyInotropyfallsinacidosisduetoadirectmyocardialdepressanteffect.MaybeoffsetbyincreasedSNStoneinlow-gradeacidosis.Alkalosismayincreaseinotropybyincreasingresponsivenesstocirculatingcatecholamines.DecreasedresponsetocatecholaminesWhenpH<7.2.ArrhythmiasSecondarytoalteredSNStoneandelectrolytes.VasodilationDirectlyduetohypercapnea.
CNSH ionscannotcrosstheBBB,howeverCO can.FluidandElectrolyte
PlasmaK increasesby0.6mmol.L forevery0.1unitfallinpHThisisduetoimpairmentoftheNa /K -ATPaseH ionsbindtothesamesiteonalbuminascalcium,soionisedcalciumwillincrease
MSKBonesChronicmetabolicacidosisconsumesbonephosphatetobufferH ions,causingosteoporosis.
CellularEnzymefunctionDenaturationandfunctionalimpairment.MolecularionisationChangeinionisationmaychangeamoleculesabilitytocrosscellmembranes(e.g.reducingdoseofthiopentoneinacidosis),oraffecttheirfunctionRestingmembranepotentialChangeinionpermeabilitywillalterRMP,andthereforehoweasyitistogenerateanactionpotential.
ChangewithTemperature
pHistemperaturedependent:
pHincreasesby0.015forevery1°CfallintemperatureDuetodecreasedionicdissociationofwater.GassolubilityalmostalwaysincreaseswhentemperaturefallsDissolvingistypically(notalways)anexothermicreaction.Asthekineticenergycontentofamoleculefalls,itsabilitytodissociatefromsolutiondecreases.
AsCO dissolves,PaCO fallsAsbloodgasmachinesoperateat37°C,ameasurementerrorwilloccurifapatientisnotcloseto37°C
AhypothermicpatientwillhaveahigherpHandCO thanmeasured
TherearetwocommonmethodsformanagingpHofsignificantlyhypothermicpatients(e.g.,thoseonCPB):pH-statandalpha-stat.
pH-stat
CO isaddedtothecircuitsothatpHandPaCO arenormalwhencorrectedfortemperatureThistheoreticallyimprovesoxygendeliverybypreventingtheleft-shiftintheoxyhaemoglobindissociationcurveTheincreasedCO alsocausescerebralvasodilation,which:
+2
+ -1+ +
+
+
2 2
2
2 2
2
Acid-BasePhysiology
312
![Page 313: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/313.jpg)
IncreasesspeedanduniformityofcerebralcoolingIncreasesriskofcerebralembolicevents
alpha-stat
pHandCO valuesaremaintainedat'normalfor37°C'Measuredvalueswillbedifferent,as:
pHwillbeincreasedCO willbedecreased
CellularautoregulationispreservedUnlikepH-stat,thisdoesnotcausecerebralvasodilation
References1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.2. ANZCAJuly/August19993. Chemlab.Solubility.FloridaStateUniversity.
Lastupdated2019-07-18
2
2
Acid-BasePhysiology
313
![Page 314: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/314.jpg)
CompensationExplaintheprinciplesunderlyingacid-basechemistry
MetabolicAcidosis
Compensationtometabolicacidosisincludes:
BufferingOccursoverminutestohours.Includes:
ECFbuffersBicarbonatePlasmaproteins
AlbuminICFbuffers
Includephosphate,proteinsLeadstohyperkalaemiaduetoH /K exchangeK increasesby0.6mmol.L per0.1unitfallinpH.
BoneExchangeofNa andCa inbone.
LeadstodemineralisationandreleaseofalkalinecompoundsRespiratorycompensationOccursinminutes.
RapidresponseCannotcompensatecompletely
RenalcompensationOccursoverdaystoweeks.Includes:
EliminationofH boundtofilteredbuffersIncludeammonium,phosphate
ReabsorptionofbicarbonateActivesecretionofH intheDCT/CTUndercontrolofaldosterone.
References
1. Diaz,A.Describehowthebodyhandlesmetabolicacidosis.PrimarySAQs.
Lastupdated2017-09-20
+ ++ -1
+ 2+
+
+
Compensation
314
![Page 315: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/315.jpg)
BuffersDescribethechemistryofbuffermechanismsandexplaintheirrelevantrolesinthebody
Abufferisasolutionwhichconsistsofaweakacidanditsconjugatebase,thatcanresistachangeinpHwhenastrongeracidorbaseisadded.
Buffering:
Isakeypartofacid-basehomeostasisAllowscompensationforlargechangesinacidoralkaliloadwithminimalchangeinhydrogenionconcentration
Inoneexperiment,dogswereinfusedwith14,000,000nmol.L ofH ,withacorrespondingriseinH ofonly36nmol.L
Efficacyofabuffersystemisdeterminedby:
pKaofthebuffer80%ofbufferingoccurswithin1pHunitofthepKaofthesystem.pHofthesolutionAmountofbufferWhetheritisanopenorclosedsystemAnopenbuffersystemcanhavetheamountofchemicalatone(orboth)endsadjustedbyphysiologicalmeans.
Thisalterstheconcentrationofreactantsateitherendoftheequation,thusalteringthespeedofthereactionviatheLawofMassAction
BufferSystems
Importantbuffersystemsinclude:
BicarbonatebuffersystemProteinbuffersystem
HaemoglobinbuffersystemPhosphatebuffersystem
AllbuffersystemsareinequilibriumwiththesameamountofH .Thisisknownastheisohydricprinciple.
BicarbonateBufferSystem
Thebicarbonatebuffersystemis:
ThemostimportantECFbuffersystemBicarbonateisformedintheerythrocyteandthensecretedintoplasmaBicarbonatediffusesintotheinterstitiumandisalsothedominantfluidbufferininterstitialspace
FormedintheerythrocyteAbufferpairconsistingofbicarbonateandcarbonicacidCarbonicacidisexceedinglyshortlivedinanyenvironmentevenremotelycompatiblewithlifeanditrapidlydissociatestoHCO andH .
Hydrogenionsareconsumedorreleasedbythefollowingreaction:
-1 + +-1
+
3- +
Buffers
315
![Page 316: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/316.jpg)
Carbonicanhydrase(presentinerythrocytes)isanenzymewhichallowsrapidconversionofH OandCO toH CO (andbackagain)EachstageofthereactionhasanindividualpKa:
AsthepKaofthe systemis6.1,thesesubstancespredominateatphysiologicalpHThepKaforthesecondstageofthereactionis9.3andsoessentiallynoCO existsinbloodClincicallythisreactioncanbeignored.
Inclinicalconditions,thereactionbecomes:
Additionofastrongaciddrivestheabovereactiontotheleft,forming(briefly)H CO beforeitdissociatestoCO andH O
CO isthenabletobeexhaled,whichpreventsequilibrationandallowsthesystemtobuffermoreacid
Bicarbonateisaneffectivebufferbecauseitis:
PresentinlargeamountsOpenatbothends
CO canbeadjustedbychangingventilationBicarbonatecanbeadjustedbychangingrenaleliminationThispreventsthebicarbonatebuffersystemfromequilibratingandallowsittoresistlargechangesinpHdespiteitslowpKaHowever,becauseitreliesheavilyonchangesinpulmonaryventilationitisunabletoeffectivelybufferrespiratoryacid-basedisturbances.
ProteinBufferSystem
AllproteinscontainpotentialbuffergroupsHowever,theusefuloneatphysiologicalpHistheimidazolegroupsofthehistidineresidues.Extracellularly,proteinshaveasmallcontributionwhichisentirelyduetotheirlowpKaIntracellularlyproteinshaveamuchgreatercontributionbecause:
IntracellularproteinconcentrationismuchgreaterthanextracellularconcentrationIntracellularpHismuchlower(~6.8)andclosertotheirpKa
HaemoglobinBufferSystem
Haemoglobinis:
AproteinbuffersystemQuantitativelythemostimportantnon-bicarbonatebuffersystemofbloodThisisbecausehaemoglobin:
Existsingreateramountsthanplasmaproteins(150g.L comparedto70g.L )Eachmoleculecontains38histidineresiduesThisresultsin1gofHb~3xthebufferingcapacityof1gofplasmaprotein.
Inthecell:
Haemoglobinexistsasaweakacid( )aswellasitspotassiumsalt( )Inacidosis:
AdditionalH ionsareboundtoHbmoleculesHCO diffusesdownitsconcentrationgradientintoplasmaElectroneutralityismaintainedthroughtheinwardsmovementofCl .DissolvedCO willalsoformcarbaminocompoundsbybindingtotheterminalaminogroups
2 2 2 3
32-
2 3 22
2
2
-1 -1
+
3-
-
2
Buffers
316
![Page 317: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/317.jpg)
ThepKaofHbisvariabledependingonwhetherithasboundoxygen:DeoxyhaemoglobinhasapKaof8.2BecauseofitshigherpKa,deoxyhaemoglobinwillmorereadilyacceptH ionswhichmakesitabetterbufferofacidicsolutions.OxyhaemoglobinhasapKaof6.6BothareessentiallyequidistantfromnormalpH,andareequallyeffectivebuffersQuantitatively,permmolofoxyhaemoglobinreduced,~0.7mmolofH canbebufferedTherefore0.7mmolofCO canenterbloodwithoutachangeinpH.
ThisisthemechanismbehindtheHaldaneeffect,andwhyvenousbloodisonlyslightlymoreacidicthanarterialblood
PhosphateBufferSystem
Phosphoricacidis:
TribasicandcanthereforepotentiallydonatethreehydrogenionsHowever,onlyoneofthesereactionsisrelevantatphysiologicalpH,withapKaof6.8:
ThequantitativeeffectislowdespitetheoptimalpKaduetothelowplasmaconcentrationofphosphateAthigherconcentrations,suchasintracellularlyandinurine,itisasignificantcontributorInprolongedacidosis,CaPO canbemobilisedfrombonesandcanbeconsideredasanalkalireserve
Footnotes
1. AlexYartsevoffersanexcellentdiscussiononbufferinginhisexcellenttrademarkproseatDerangedPhysiology2. Brandis'sanaesthesiaMCQisrequiredreading
References
1. BarrettKE,BarmanSM,BoitanoS,BrooksHL.Ganong'sReviewofMedicalPhysiology.24thEd.McGrawHill.2012.2. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.
Lastupdated2019-07-18
+
+
2
4
Buffers
317
![Page 318: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/318.jpg)
CerebrospinalFluidDescribethephysiologyofcerebrospinalfluid
CSFisatranscellularfluidintheventriclesandsubarachnoidspace.~150ml(2ml/kg)ofCSFexistinanormalindividual,dividedevenlybetweentheheadandspinalcolumn.
Functions
MechanicalProtectionDuetoitslowspecificgravity,CSFreducestheeffectiveweightofthebrain(byafactorof30)andthereforereducestraumacausedbytheaccelerationanddecelerationofthebrain.BufferingofICPCSFcanbedisplacedtothespinalsubarachnoidandhaveitsrateofreabsorptionincreasedinordertooffsetanincreaseinICPbyanotherspace-occupyinglesion.StableExtracellularEnvironmentNeuronsaresensitivetoionicchangesintheextracellularenvironment.IonicconcentrationsinCSFaretightlycontrolled,whichensuresstableneuronalactivity.Additionally,toxinsareactivelyremovedfromCSF.pHRegulationpHofextracellularfluidisimportantinthecontrolofrespiration,andisalsotightlyregulated.NutritionSupplyofO andsimplesugarsandaminoacids,andremovalofCO occursoccursinCSF.
Formation
CSFisproducedinthechoroidplexus(70%)andbraincapillaryendothelialcells(30%)atarateof0.4ml.min (500ml.day).Itisproducedbyacombinationofultrafiltrationandsecretionfromplasma:
Na isactivelytransportedDrivesflowofCl ionsandwater.Glucoseistransportedviafacilitateddiffusiondownitsconcentrationgradient
FactorsAffectingFormation
Formationisrelativelyconstantwithinnormalparameters(alteringtherateofabsorptionisthepredominantmeanstocontrolpressure),thoughitisreducedby:
DecreasedChoroidalBloodFlowCPP<70mmhgreduces=""CSFformation.
Contents
Content RelativeChange [CSF]
Na - 140mmol.L
Cl ↑ 124mmol.L
K ↓ 2.9mmol.L
Gluc ↓ 3.7mmol.L
2 2
-1 -1
+-
+ -1
- -1
+ -1
-1
NervousSystem
318
![Page 319: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/319.jpg)
pH ↓ 7.33
PCO ↑ 50mmHg
Protein ↓ Variable*
Ca ↓ 1.12mmol.L
Mg ↑ 1.2mmol.L
*CSF[protein]isvariable:
HighestinthelumbarsacLowestintheventriclesAlwayslowerthanplasma[protein]ThismeansCSFisapoorbuffersolution,whichincreasesitssensitivitytoderangementsinrespiratoryacid-basestatus.
Insummary:
[Na ]isunchanged[Mg ]and[Cl ]areincreasedConcentrationsofeverythingelseisless
Circulation
CSFflowisdrivenbyrespiratoryoscillations,arterialpulsations,andongoingproductioninthechoroidalplexus.
ProductioninthechoroidalplexusinthelateralventriclesTothethirdventricleviatheForamenofMunroTothefourthventricleviatheAqueductofSylviusTothecisternamagnaviathetwolateralForaminaofLuschkaandthemidlineForamenofMagendieItmaynowpasseither:
Cranially,tothebasilarcisternsandviatheSylvianfissuretothecorticalregionsCaudally,tothespinalsubarachnoidspaceviathecentralcanal
Reabsorption
ReabsorptionofCSF:
Occursinthearachnoidvilli,whicharelocatedintheduralwallsofthesagittalandsigmoidsinuses85%ofreabsorptionoccursinintracranialarachnoidvilliRemainderbyspinalarachnoidvilli
IspredominantlyviapinocytosisandopeningofextracellularfluidspacesIspressure-dependent
ReabsorptionoccurswhentheCSFpressureis1.5mmHggreaterthanvenouspressureTypicallyanICP<7mmHgresultsinminimalCSFreabsorption.Abovethis,CSFabsorptionincreasesinalinearfashionupto22.5mmHg.
References1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. Hall,JE,andGuytonAC.GuytonandHallTextbookofMedicalPhysiology.11thEdition.Philadelphia,PA:Saunders
Elsevier.2011.
2
2+ -1
2+ -1
+2+ -
NervousSystem
319
![Page 320: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/320.jpg)
Lastupdated2019-07-18
NervousSystem
320
![Page 321: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/321.jpg)
Blood-BrainBarrierTheblood-brainbarrierisaphysiologicalbarrierwhichpreventssubstancesintheECFofthebodymovingfreelyintotheECFofthebrain.ThefunctionsoftheBBBare:
MaintainastableextracellularmilieuOptimisesneuronalfunctionbypreventingfluctuationsinplasmaK ,Na ,andH affectingcerebralcells.ProtectionofthebrainIsolatesthebrainfromtoxins.ProtectionofthebodyIsolatestherestofthebodyfromCNSneurotransmitters.
Anatomy
TheBBBoccursinthreelayers:
CapillaryendothelialcellsJoinedwithtightjunctions,preventingfreemovementofsolventandsolute.
SubstancesmustmovethroughcapillaryendotheliumtoreachthebrainCapillaryendothelialcellscontainhighnumbersofmitochondria,duetothehigherenergycostoftheactivetransportmechanisms.
BasementmembraneAstrocytesGlialcellwhichextendsfootprocessesaroundthebasementmembrane,andreducepermeabilityofendothelialcells.
Duetotheirfunction,severalimportantCNSstructuresmustexistoutsideoftheBBB.Theseareknownasthecircumventricularorgans,andinclude:
SensingstructuresChemoreceptortriggerzone(AreaPostrema)Identifiestoxinsinthesystemiccirculation,triggeringvomiting.HypothalamusOsmoreceptorsdetectsystemicosmolarity.SubfornicalorganRoleinCVSandfluidbalance.Organumvasculosum
SecretingstructuresPituitarySecreteshormones.PinealglandSecretesmelatonin.ChoroidplexusProducesCSFviasecretionandultrafiltrationofplasma.
MovementofSubstances
Substancescanmovevia:
DiffusionForlipidsolublemoleculesonly;e.g:
+ + +
Blood-BrainBarrier
321
![Page 322: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/322.jpg)
COO
FacilitateddiffusionFormovementoflarger/lesssolublemoleculesdowntheirconcentrationgradient,e.g:
GlucoseWater
ActivetransportResponsibleformovementofmostsmallions;e.g:
NaClKMgCa
Othersubstancesarespecificallyexcluded:
CatecholaminesMetabolisedbyMAOincapillaryendothelium,preventingtheiractionasCNSneurotransmitters.AminoacidsPreventactionasneurotransmitters.AmmoniaMetabolisedinastrocytestoglutamine,limitingitsneurotoxiceffects.
References1. LawtherBK,KumarS,KrovvidiH.Blood–brainbarrier.ContinuingEducationinAnaesthesiaCriticalCare&Pain,Volume
11,Issue4,1August2011,Pages128–132.2. BrandisK.ThePhysiologyViva:Questions&Answers.2003.
Lastupdated2019-07-18
22
+-+2+2+
Blood-BrainBarrier
322
![Page 323: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/323.jpg)
SpinalCordAnatomyDescribethemajorsensoryandmotorpathways(includinganatomy)
SpinalCordAnatomy
Thespinalcordintransversesectionconsistsofacentralsectionofgreymattercontainingneuronalcellbodiesandsynapses,andaperipheralsectionofwhitemattercontainingmyelinatedascendinganddescendingpathways.Importantpathwaysare:
CorticospinaltractMotorfunction.Crossesatthebrainstem.DorsalcolumnLighttouchandproprioception.Crossesatthebrainstem.SpinothalamictractPainandtemperature.Crosseswithintwovertebralsegments.
SpinocerebellartractUnconsciousproprioception.Doesnotcross.
SpinalCordSyndromesLesionstocertainanatomicalregionsofthespinalcordproduceaparticularconstellationsoffindings.
CompleteTransection
Acompletetransectionresultsinlossofmovementandsensationbelowthelevelofthelesion.Initially,paralysisisflaccid(andothersigns,suchaspriapism,maybeabsentinthis'spinalshock'phase)becomesspasticafterafewweeks.Bowelandbladderfunctionislost.
LesionsaboveT10willresultinimpairedcoughintheinitialstageastheabdominalwallisunabletocontract(intercostalmusclefunctionmaybeimpairedaswell,butthisisoflessimportanceclinically).
CentralCordSyndrome
Centralcordsyndromeresultsinaflacidparalysisandlossofsensationoftheupperlimbsgreaterthanthelowerlimbs.
AnteriorCordSyndrome
Anteriorcordsyndromesparesthedorsalcolumnsonly,thereforemotorfunctionandpainandtemperaturesensationareaffectedbelowthelevelofthelesion.
Brown-SequardSyndrome
Hemisectionofthecordresultsin:
IpsilaterallossofmotorfunctionbelowthelevelofthelesionIpsilaterallossoflighttouchandproprioceptionbelowthelevelofthelesionContralaterallossofpainandtemperaturesensationbelowthelevelofthelesionIpsilaterallossofpainandtemperaturesensationatthelevelofthelesion
SpinalCordAnatomy
323
![Page 324: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/324.jpg)
CaudaEquina
CaudaEquinasyndromeresultsfromcompressionoflumbosacralnerverootsbelowtheleveloftheconusmedullaris.ItmayproduceacombinationofUMNandLMNsigns:
RadiculopathySacralsensorylossAsymmetricLMNweaknessandatrophyErectiledysfunctionandinabilitytoejaculateUrinaryretentionandoverflowincontinenceConstipationandoverflowincontinence
References1. GoldberS.ClinicalNeuroanatomyMadeRidiculouslySimple.3rdEd.Medmaster.2005.2. McMinn,RMH.Last'sAnatomy:RegionalandApplied.9thEd.Elsevier.2003.
Lastupdated2017-09-22
SpinalCordAnatomy
324
![Page 325: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/325.jpg)
IntracranialPressureExplainthecontrolofintra-cranialpressure
NormalICPis
P1isthefirstpeak,andrepresentsarterialpulsationP2isthesecondpeak,andrepresentsintracranialcomplianceIfP2>P1,thisissuggestiveofpoorintracranialcomplianceP3isthethirdpeak,andisadicroticwaverepresentingvalveclosure
Inaddition,asecondsetofLundbergwavesaredescribed:
Awavesarepathological,andconsistofsquare-waveplateausupto50mmHglasting5-20minutes.Theyaresuggestiveofherniation,andarealwayspathological.BwavesarevariablespikesinICPat30-120secondintervals,suggestiveofcerebralvasospasmCwavesareoscillationsthatoccur4-8timesperminute,andareabenignphenomenaoccurringwithrespiratoryandbloodpressurevariations
RaisedintracranialpressuremaycausefocalischaemiawhenICP>20mmHg,andglobalischaemiawhentheICP>50mmHg:
MonroeKellieDoctrine
Thisstatesthat:
Theskullisarigidcontainerofafixedvolume,containingapproximately8partsbrain,1partblood,and1partCSFAsithasnegligibleelastance,anyincreaseinvolumeofonesubstancemustbemetwithadecreaseinvolumeofanotherorariseinICP
ElastanceistechnicallycorrectaswearediscussingachangeinpressureforagivenchangeinvolumeComplianceisachangeinvolumeforagivenchangeinpressure.
PhysiologicalResponsestoanIncreaseinICP
DisplacementofCSFintothespinalsubarachnoidspaceCompressionofvascularbedIncreasedCSFreabsorption
TheCushingreflexmayoccurinbrainstemherniationThisisatriadofhypertension,bradycardia,andirregularrespirationsecondarytoSNSactivation,andisareflexiveresponsetomedullaryischaemia.
Hypertension
IntracranialPressure
325
![Page 326: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/326.jpg)
ToimproveCPP.BradycardiaDuetoabaroreceptorresponse.IrregularrespirationDuetorespiratorycentredysfunction.
PhysiologicalBasisofTreatment
TreatmentcanbeclassifiedaspertheMonroeKelliedoctrine:
Brain
OsmoticagentssuchasmannitolandhypertonicsalineIncreaseplasmaosmolalityandexpandbloodvolume,creatinganosmoticgradientbetweenbrainparenchymaandbloodwitharesultingreductioninbrainoedemaandICP.Timelyevacuationofmasslesionsandintracranialhaemorrhage
CSF
ExternalVentricularDrainFacilitatesremovalofCSF.
Blood
ReducingcerebralmetabolicrateResultsinreducedbloodflowduetoflow-metabolismcoupling.Maybeachievedwith:
CNSdepressantssuchaspropofol,benzodiazepines,orbarbituratesHaveseveralbeneficialeffects:DepresscerebralmetabolismwhichreducesoxygenrequirementsReduceseizurerisk,whichisdetrimentalbecauseitgreatlyincreasescerebralO demandandimpairsvenousreturnImprovesventilatordyssynchrony,limitingcoughingandbearingdown,andsubsequentrisesinICPHypothermiaCausesareductionincerebralmetabolismandriskofseizures.PreventionofhypoxiaorhypercapneaHypoxiaandhypercapneabothcausevasodilatation,withasubsequentincreaseincerebralbloodvolume,bloodflow,andICP.
InducedhypocarbiaCausesvasoconstrictionandasubsequentreductionincerebralbloodflowandbloodvolume.Thisleadsto:
ReductioninICPReductionincerebraloxygendeliveryConsequently,alow-normalETCO targetisusedtoavoidtissuehypoxia.
References1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. CrossME,PlunkettEVE.Physics,Pharmacology,andPhysiologyforAnaesthetists:KeyConceptsfortheFRCA.2ndEd.
CambridgeUniversityPress.2014.3. StocchettiN,MaasAI.Traumaticintracranialhypertension.NEnglJMed.2014May29;370(22):2121-30.
2
2
IntracranialPressure
326
![Page 327: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/327.jpg)
4. BarrettKE,BarmanSM,BoitanoS,BrooksHL.Ganong'sReviewofMedicalPhysiology.24thEd.McGrawHill.2012.
Lastupdated2019-07-18
IntracranialPressure
327
![Page 328: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/328.jpg)
IntraocularPressureNormalintraocularpressureis~15mmHg,witharangeof12-20mmHg.Regulationofintraocularpressureisimportantfor:
VisionSustainedhigh(>25mmHg)canleadtoblindnessduetocompressionofaxonsoftheopticnerveandtheopticarteryattheopticdisc.
DeterminantsofIntraocularPressure
Astheglobehastypicallypoorcompliance,asmallincreaseinvolumecancausealargeincreaseinintraocularpressure.Factorsaffectingvolumeinclude:
VolumeofaqueoushumorAqueoushumorisaclearfluidthatfillstheanteriorandposteriorchambersoftheeye,andprovidesavasculartissueswithnutrientsandoxygenwhilststillallowinglighttopassfreelybetweenthelensandretina.Volumeofaqueoushumorisafunctionof:
ProductionAqueoushumorisproducedbysecretionandfiltrationfromcapillariesintheciliarybodyintheposteriorchamber,andcirculatesthroughintotheanteriorchamber.
Productionisacceleratedbyβ2 agonismProductionisinhibitedbyα agonismCarbonicanhydraseinhibitorsdecreaseaqueoushumorproductionprobablybydecreasingsodiumsecretionintotheeye
ReabsorptionAqueoushumorisreabsorbedintovenousbloodinthecanalofSchlemm.
ThetrabeculaemeshworkisthemainsourceofresistancetoreabsorptionIfthisisblocked,asignificantreductioninreabsorptioncanoccurandIOPwillincrease.Reabsorptionisaffectedby:
HaemorrhageBlockstrabecularmeshwork.MuscarinicantagonismDilatespupil,whichbringstheirisclosertocanalanddecreasesabsorption.α agonismDilatesthepupil,decreasingabsorption.PGFRelaxesciliarymuscle,increasingabsorption.
VolumeofbloodwithintheglobeAffectedby:
MAPVenousobstruction
ExternalfactorsOtherfactorsaffectingvolumeorcomplianceoftheglobe:
ExtraocularmuscletensionExtraocularcompression
22
1
2α
IntraocularPressure
328
![Page 329: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/329.jpg)
References
1. ANZCAJuly/August20002. Hall,JE,andGuytonAC.GuytonandHallTextbookofMedicalPhysiology.11thEdition.Philadelphia,PA:Saunders
Elsevier.2011.3. GoelM,PiccianiRG,LeeRK,BhattacharyaSK.AqueousHumorDynamics:AReview.TheOpenOphthalmologyJournal.
2010;4:52-59.
Lastupdated2019-07-18
IntraocularPressure
329
![Page 330: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/330.jpg)
SleepDescribethephysiologyofsleep
Sleepisanaturallyoccurringstateofunconsciousnessfromwhichonecanbearousedbyanexternalstimuli.
Sleepisimportantin:
HomeostasisofmanyorgansystemsMemoryformationPreservationofcognitivefunction
StagesofSleep
StagesofsleepareclassifiedbasedonEEGchanges:
REMsleepCharacterisedbyEEGactivityresemblingthatofawakeindividuals.REMsleep:
Lastsfor5-30minutesEventfrequencydecreaseswithage.InREMsleep:
IrregulareyemovementsDreamingoccursIrregularHRandRRMusclecontractionoccurs(butmuscletoneisdecreased)
Non-REMsleepDeepsleep,characterisedbydepressionofHR,SVR,BP,RR,andmetabolicrate(~0.9METs)ItisdividedintofourstagesonEEG:
Stage1:4-6Hzθwavesreplaceα-wavesDosing,easilyroused.Stage2:Similartostage1withoccasionalhighfrequency50μVbursts(sleepspindles)Stage3:1-2Hzhigh-voltageδwavesappearStage4:LargeδwavesbecomesynchronisedDeepsleep.
PeriodsofREMsleepalternatewithnon-REMsleepduringthenight,withanaverageof4-5cyclesofREMsleeppernight.
RespiratoryEffects
GABAergicneuronsdepresstherespiratorycentre,leadingtorespiratorydepression:
DecreasedMVDecreasedVGreatestdecreaseoccursduringREMsleep,whereitfallsby~25%.UnchangedRR
IncreasedPaCODecreasedPOMorepronouncedinelderly.
Collapseofairwaysofttissue
T
22
Sleep
330
![Page 331: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/331.jpg)
Duetoreducedtonicactivityofpharyngealmuscles.
References1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. LeslieRA,JohnsonEK,GoodwinAPL.DrPodcastScriptsforthePrimaryFRCA.CambridgeUniversityPress.2011.3. LumbA.Nunn'sAppliedRespiratoryPhysiology.7thEdition.Elsevier.2010.
Lastupdated2019-07-18
Sleep
331
![Page 332: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/332.jpg)
PainDescribethephysiologyofpain,includingthepathwaysandmediators
Keydefinitions:
PainPainisan"unpleasantsensoryoremotionalexperienceassociatedwithactualorpotentialtissuedamage,ordescribedinsuchterms."Paincanbebroadlyclassifiedby:
AetiologyNociceptivepainStimulationofnociceptorsbynoxiousstimuli.VisceralpainNeuropathicpainNervoussystemdysfunction.
DurationAcutepainPainduetosymptomsofcurrentpathology.ChronicpainPainoccurringafterthepathologicalprocesshasresolved.
HyperalgesiaIncreasedresponsetoanormallypainfulstimulus.
PrimaryhyperalgesiaLocalreductioninpainthreshold.SecondaryhyperalgesiaHyperalgesiaawayfromthesiteofinjuryduetoalterationinspinalcordsignaling.
AllodyniaPainfulresponsetoanormallypainlessstimuli.Occursduetopathologicalsynapsebetweensecond-orderneuronesinthespinalcord.
AnaesthesiadolorosaPaininanareawhichisanaesthetised.
PeripheralNociception
Nociceptorsarereceptorswhichrespondtoanoxiousstimulus.Nociceptors:
Canbestimulatedorsensitisedby:ChemicalsignalsSeetable.Mechanicalsignals
ShearstressThermalsignals
Hotnociceptorsactivateabove43°CColdnociceptorsactivatebelow26°C
StimulationinitiatesanervousimpulseSensitisationincreasesareceptorssensitivitytoastimulatingmediator
Keychemicalstimulatingandsensitisingmediatorsinclude:
Pain
332
![Page 333: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/333.jpg)
StimulatingMediators SensitisingMediators
H Prostaglandins
K Leukotrienes
ACh SubstanceP
Histamine NeurokininA
5-HT CalcitoninGRP
Bradykinin
Nociceptors
Impulsesareconductedbytwotypesofprimaryafferentfibres:
Aδfibres:Small(~2-5μmdiameter)MyelinatedConductsharppainatupto40m.sMediateinitialreflexresponsestoacutepainSynapseinlaminaeIinthedorsalhornSubstancePistheneurotransmitterattheNK1receptor.
Cfibres:<2μmdiameterUnmyelinatedConductdullpainat2m.sSynapseinlaminaeIIinthedorsalhornSubstancePistheneurotransmitterattheNK1receptor.
PainPathwayandSiteofActionofAnalgesicsTheresponsetoapainfulstimulusrequiresacascadeofprocesses:
ActivationofnociceptorsMembranedepolarisationinresponsetostimulus.Ifthestimulusisgreatenoughtoreachthethresholdpotential,anactionpotentialisgenerated.
NSAIDSreducenociceptormediatedinflammationOpiatesactonperipheralMOPreceptorsLocalanaestheticspreventsignalpropagation
SynapseinthedorsalhornInputfrombothAδandCfibres,anddescendinginterneurons.
DescendinginhibitoryinputreducesnociceptivetransmissionBasisof"gatecontrol"theory.Descendinginputincreasedwith:
TouchAβ'touch'fibresstimulateinhibitoryinterneuronsinthedorsalhorn,'closingthegate'byincreasingdescendinginhibitionandpreventsignalsfromperipheralCfibresfromrisingtothethalamus.ArousalOpioidreceptorsParticularlyMOP(pre-andpost-synaptically).
Opioidsactpre-synapticallytoreduceSubstancePandglutaminerelease.α receptors
+
+
-1
-1
2
Pain
333
![Page 334: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/334.jpg)
Clonidine,tricyclicantidepressants,noradrenaline-reuptakeinhibitors,andendogenouscatecholamines.Gabapentinandpregabalininhibitpresynapticneurotransmitterrelease
WidedynamicrangeneuronesReceiveafferentinputfromchemical,thermal,andmechanoreceptors.
TypicallymoredifficulttostimulateImportantinwind-upMediatedbyNMDAagonism.
KetaminereduceswindupandcentralsensitisationLeadtosecondaryhyperalgesiaLeadtoallodyniaViaadditionalsynapsestosensoryneuronesinlaminaIIIandIV.Interneuronsynapseswithasecond-orderneuronesfibreThesesecondaryafferents:
Crosswithin1-2vertebralsegmentsandascendsinthespinothalamictractReceivesinputfromdescendingfibresOpioidsactpost-synapticallytohyperpolarisesecond-orderneurones
Reflexarc
HighercentresPainperceptionoccursinthesomatosensorycortex.
NeuropathicPainPainduetoalesionofthesomatosensorysystem,ratherthanastimulusitself.Neuropathicpainisdividedinto:
CentralneuropathicpainFromCNSinjury,e.g.spinalcordinjury,CVA,multiplesclerosis.PeripheralneuropathicpainDamagefrom:
DiabetesIschaemiaofSchwanncellscausesdemyelination,causingtheexposedaxontogenerateactionpotentialsinappropriately.TraumaTransectedaxonsmayregrowwithendingsthatspontaneouslyfireorthathavealteredthresholdpotentials.
MechanismsofNeuropathicPain
NeuromaHealingofdamagednervesleadstoneuromaformation.Neuromas:
AremoresensitivetopainfulstimuliCausespontaneouspainMaysproutandinnervatelocaltissuesMovementofthesetissuesmayleadtopain.
WindupPhantomlimbpainNeuronsdamagedinremovalofalimbdevelopadditionalsynapses,leadingtophantomsensations.
FeaturesofNeuropathicPain
Neuropathicpainisassociatedwith:
Pain
334
![Page 335: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/335.jpg)
InjuryordiseasethatcausesnerveinjuryBurningorelectricalqualityReducedorabsentsensationPoorresponsetotypicalanalgesia
ChronicRegionalPainSyndrome
DamagetotheSNScanleadtoabnormalitiesinautonomicfunction:
ChangeintemperatureduetovasomotordysfunctionAlteredsweatingReducedhairgrowthOsteoporosisHyperalgesiaandallodynia
PainintheElderly
NervousSystemChanges:
PeripheralNervousSystemNervedeteriorationDecreasedmyelinationDecreasedconductionvelocityReducedrangeandspeedofANSresponsesIncreasedrestingsympathetictone
CentralNervousSystemDecreasedpainperceptionIncreasedsensitivitytoanaestheticandanalgesicsReachceilingeffectsmorerapidly.DegenerationofmyelinSubsequentcognitivedysfunctionduetoneuronalcircuitdysfunction.GeneralisedatrophyDecreasedneurotransmitterproduction
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. SchugSA,PalmerGM,ScottDA,HalliwellR,TrincaJ.AcutePainManagement:ScientificEvidence.4thEd.2015.
AustralianandNewZealandCollegeofAnaesthetistsandFacultyofPainMedicine.3. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.4. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.5. MerskeyH,BogdukN.ClassificationofChronicPain.2ndEd.1994.IASPTaskForceonTaxonomy.IASPPress,Seattle.6. HalaszynskiT.InfluencesoftheAgingProcessonAcutePerioperativePainManagementinElderlyandCognitively
ImpairedPatients.TheOchsnerJournal.2013;13(2):228-247.7. MelzackR,WallPD.Painmechanisms:anewtheory.Science.1965.19;150(3699):971-9.8. GibsonS.PathophysiologyofPain.
Lastupdated2019-07-18
Pain
335
![Page 336: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/336.jpg)
Pain
336
![Page 337: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/337.jpg)
AutonomicNervousSystemDescribetheautonomicnervoussystem,includinganatomy,receptors,subtypesandtransmitters(includingtheirsynthesis,releaseandfate)
TheANSisthesectionofthenervoussystemwhichregulatesinvoluntaryandvisceralfunctions.Theseinclude:
HaemodynamicsDigestionUrinationanddefecationThermoregulationSexualfunction
Theautonomicnervoussystemcanbedividedinto
CentralANSControloccursinthehypothalamus,brainstem,andspinalcord.PeripheralANSDividedanatomicallyandfunctionallyintothe:
SympatheticnervoussystemParasympatheticnervoussystem
GRAPHFROMPAGE258ofGANONG
CentralControl
Thehypothalamuscontrolsautonomicfunctionsbyneuralandendocrinemechanisms.Itissubdividedanatomicallyintofourregions:
AnteriorhypothalamusControlsthePNSandthermoregulation.ItalsoreleasesADHinresponsetoincreasedplasmaosmolality,andoxytocin.MedialhypothalamusInhibitsappetiteinresponsetoincreaseinbloodglucose.LateralhypothalamusContainsthethirstcentreanddrivetoseekfood.PosteriorhypothalamusControlsvasomotorcentres,modulatingsympatheticvasoconstriction,aswellaspositiveandnegativeinotropyandchronotropy.Alsomodulateswakefulnessinresponsetosympatheticstimuli.
Signalsfromthehypothalamushaveatonicoutputto:
AllsmoothmuscleHeartExocrineorgansEndocrineorgansGITGU
CentralAnatomy
AutonomicNervousSystem
337
![Page 338: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/338.jpg)
Inthegreymatterofthespinalcord,efferentnervessynapsewithtwoothernervesconnectedinseries.Thismaintainstonicautonomicoutflow.
FIGUREFROMPAGE67-POWERANDKAM
Efferentnervesexitthespinalrootanteriorly,andformtheventralroot.
Conversely,afferentnervesexitposteriorly,formingthedorsalrootandthendorsalrootganglion,beforesynapsinginthespinalcord.
SympatheticNervousSystem
Thesympatheticnervoussystemoptimisesthebodyforshort-termsurvival.
Sympatheticinnervationisfromthesympathetictrunks.These:
AreapairedbundleofsympatheticneuronswhichrunlateraltothevertebralbodiesfromT1toL2Thetrunkissubdividedintofourparts:
Thecervicalpartinnervatesthehead,neck,andpartofthethoraxThethoracicpartisfurthersubdividedinto:
UpperthoracicfromT1-T5,whichinnervatestheaorta,heart,andlungsLowerthoracicfromT6-T12,whichinnervatestheforegutandmidgut
ThelumbarpartformsthecoeliacplexusThepelvicpartinnervatethepelvicvisceralandlowerlimbvasculature
Containthesympatheticganglion,whichisasynapsebetweenthe:Shortpre-ganglionicfibreCellbodyislocatedinthelateralhornofthespinalcord,andconnectstothesympatheticganglion.
ReleasesAChtostimulatethepost-ganglionicfibre.Longpost-ganglionicfibreCellbodyislocatedinthesympatheticganglion,andstimulatestheeffectsite.
HasanicotinicAChreceptorReleasesNAattheeffectsiteSensitivity(forACh)andactivity(forNArelease)ismodulatedbyanumberofothersubstances:
EnkephalinNeuropeptideYDopamineAdrenalineProstaglandinGABANeurotensin
Therearethreeexceptionstotheabovestructure:
Theadrenalglandisamodifiedsympatheticganglion.Itis:DirectlyinnervatedbypreganglionicneuronsreleasingACh
Sweatglandshavemuscarinicreceptors,andarestimulatedbyAChratherthannoradrenalineSkeletalmusclearteriolesalsohavemuscarinicAChreceptors,andarestimulatedbyACh
Effect
Sympatheticstimulationhasanumberofeffectsbyeitherdirectneuralinnervationoradrenalinerelease.Theyareconsistentwitha'fightorflight'response,andoptimisethebodyforshort-termstressconditions.
Effector Sympathetic Response
AutonomicNervousSystem
338
![Page 339: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/339.jpg)
Organ Innervation Response
Eye Cervical Pupillarydilatation
Lungs Thoracic Bronchodilation
Heart Thoracic ↑↑↑Chronotropy,↑↑↑inotropy,↑↑↑lusitropy,↑↑dromotropy
Vasculature Sacral Constriction
MSK Sacral Sweating,contraction,lipolysis
Endocrine Lowerthoracic Adrenalineandnoradrenalinerelease
GIT Thoracic,lumbar DecreasedsalivationandGITmotility,increasedsphinctertone,gluconeogenesis
GU Pelvic Detrusorrelaxation,sphinctercontraction,↑uterinetone
ParasympatheticNervousSystem
Parasympatheticinnervationarisesfromthe:
CranialnervesFromCNIII,VII,IX,and(mostly)X.
Thevagusisthemajorcranialparasympathetic,innervatingthe:Heartviathecardiacplexus
TheSAnodeisinnervatedbytherightvagusTheAVnodeisinnervatedbytheleftvagusTheventriclesarealsosparselyinnervatedfromtheleftvagus.
LungsviathepulmonaryplexusStomach,liver,spleen,andpancreas,andgutproximaltothesplenicflexureviathegastricplexus.
HypogastricplexusArisesfromS2-S4,andinnervatesthebladder,uterus,andgutdistaltothesplenicflexure.
Theparasympatheticnervoussystemgangliasiteclosetothetargetorgan.Thismeansthatthe:
Pre-ganglionicfibreislongPreganglioniccellbodysitswithinthebrainstem(cranialnerves)orsacralgreymatter(hypogastricplexus)ReleasesAChtostimulatethepost-ganglionicneuroneatanicotinicAChreceptor
Post-ganglionicfibreisshortReleasesAChtostimulatethetargetorganatamuscarinicAChreceptor
Effect
EffectorOrgan ParasympatheticInnervation Response
CNS CNIIIviatheEdinger-Westphalnucleus,CNVII Pupillaryconstriction(CNIII),lacrimation(CNVII)
Lungs CNX Bronchoconstriction,increasedmucousproduction
Heart CNX
↓↓↓Chronotropy,↓↓↓dromotropy,↓inotropy,↓lusitropy(↓ininotropyandlusitropyisgreaterintheatriathantheventricles)
CNVII(submaxillaryandmandibularsalivaryglands),CNIX
AutonomicNervousSystem
339
![Page 340: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/340.jpg)
GIT (parotidgland),CNX(stomachtoproximaltwo-thirdsofthetransversecolon),hypogastricplexus(distalone-thirdofthetransversecolontorectum)
Salivation,decreasedsphinctertone,increasedmotility
GU Hypogastricplexus Detrusorcontraction,erection
GanglionBlockadeBlockadeoftheganglion(atthenicotinicAChreceptor)blockstransmissionandreducessympatheticandparasympatheticimpulsetransmission.ClinicaleffectofganglionblockadedependsonwhichpartoftheANSisdominantinthatorgansystem:
SNSdominantorgansystemsEffectivesympatholysis:
VasculatureVasodilation,hypotension.SweatglandsAnhydrosis.
PNSdominantorgansystemsEffectiveparasympatholysis:
HeartTachycardia.IrisMydriasis.GITDecreasedton.BladderUrinaryretention.SalivaryReducedsecretions.
EntericPlexus
TheentericplexusisasystemofautonomicnervesintheGITwhichisfreeofCNScontrol.Itconsistsofsensoryandintegrativeneuronsaswellasexcitatoryandinhibitorymotorneuronswhichgeneratecoordinatedmuscularactivity.
References1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. BarrettKE,BarmanSM,BoitanoS,BrooksHL.Ganong'sReviewofMedicalPhysiology.24thEd.McGrawHill.2012.3. Klabunde,RE.NeuralActivationoftheHeartandBloodVessels.Accessed2016.
Lastupdated2019-07-20
AutonomicNervousSystem
340
![Page 341: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/341.jpg)
AnticonvulsantsAnunderstandingofthepharmacologyofanti-depressant,anti-psychotic,anti-convulsant,andanti-Parkinsonianmedication
Anticonvulsantsworkviaanumberofdifferentmechanisms:
SodiumChannelBlockers
Sodiumchannelblockers:
Stabilisetheinactivestateofthechannel,preventingreturntotheactivestateandpreventgenerationoffurtheractionpotentialsThishaltspost-tetanicpotentiationandlimitsthedevelopmentofseizureactivity.MayalsohaveClassIantiarrhythmicpropertiesDuetoNa blockingeffects.Include:
PhenytoinCarbamazepineLamotrigine
GABAMediatorsGABAisthekeyinhibitoryneurotransmitterintheCNS.GABAmediators:
EnhancetheeffectofGABAMultiplepotentialmechanisms:
DirectGABA-receptoragonistse.g.Benzodiazepinesandphenobarbital.Positiveallostericmodulatione.g.Propofolandthiopentone.GABAreuptakeinhibitione.g.Tiagabine.GABAtransaminaseinhibitione.g.Vigabatrin.IncreaseGABAsynthesise.g.SodiumValproate.
GlutamateBlockers
GlutamateisanimportantCNSexcitatoryneurotransmitter.Glutamateantagonists:
Aregenerallyavoidedduetotheirsideeffectprofile,whichincludespsychosisandhallucinationsIncludetopiramate
OtherAgentsGabapentinandpregabalin:
+
Neuropharmacology
341
![Page 342: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/342.jpg)
DonotappeartomediateGABAInhibitofexcitatoryα δvoltage-gatedcalciumchannelsintheCNSThisgivesthemanticonvulsantproperties.
References1. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.2. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.3. Medscape-AntiepilepticDrugs.AccessedDecember2015.
Lastupdated2017-08-11
2
Neuropharmacology
342
![Page 343: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/343.jpg)
NeurotransmittersDescribethemajorneurotransmittersandtheirphysiologicalrole,withparticularreferencetoGABA,excitatoryandinhibitoryaminoacids,acetylcholine,noradrenaline,dopamineandserotoninandNMDAreceptor
GABA
GammaaminobutyricacidisthemajorinhibitoryCNSneurotransmitter.GABAreceptorshavethreesubtypes:
GABAInotropicreceptorimportantfortheactionofmanydrugs.
Pentamericstructure2αBindGABA.2β1γ
Affectedbymanydifferentdrugs:BenzodiazepinesPositiveallostericmodulationatattheα/γinterface.GeneralanaestheticagentsIncludingpropofol,barbiturates,halogenatedvolatiles,andetomidate.
ActattheβsubunitCauseaconformationalchangewhichincreasesCl openingtime,hyperpolarisingthecell.
GABAMetabotropicreceptor.GABAInotropicreceptorlocatedonlyintheretina.
NMDA
N-methylD-aspartatereceptorisaninotropicreceptorthatis:
AgonisedbyglutamateGlycineisco-agonist
VoltagedependentCentralporeusuallyblockedbyanMg ionBecomesunblockedwhenpartiallydepolarised
ImportantintheactionofdrugswhichdonotactattheGABA receptorAntagonisedby:
KetamineXenonN O
References1. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.
A
-
B
C
2+
A
2
Neurotransmitters
343
![Page 344: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/344.jpg)
Lastupdated2019-07-18
Neurotransmitters
344
![Page 345: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/345.jpg)
LocalAnaestheticsUnderstandingofthepharmacologyoflocalanaestheticdrugs,includingtheirtoxicity
Localanaestheticdrugscreateause-dependenttemporaryblockadeofneuronaltransmissionbyblockingthevoltage-gatedsodiumchannelinthecellmembrane,preventingdepolarisation.
MechanismofAction
Actionisdependentonblockadeofthesodiumchannel.Twotheoriesexist:
Unioniseddrugpassesthroughthecellmembrane,andthenbecomesionisedintracellularlyTheioniseddrugisthenabletobindtotheopensodiumchannel,andpreventconductionofsodiumandthereforegenerationofanactionpotential
LocalanaestheticsalsodisplayreducedaffinityforK andL-typeCa channelsThistheoryexplainsuse-dependentblockade,assodiumchannelscanonlybeblockedintheiropenstate
Analternativesuggestedmechanismofactionisthedrugentersthecellmembraneandmechanicallydistortsthechannel,renderingitineffective
OnsetisinverselyproportionaltothesizeofthefibreFromfastesttoslowest:
PainTemperatureTouchDeeppressureMotor
ChemicalStructureofLocalAnaestheticsAlllocalanaestheticsareweakbasesconsistingof:
AhydrophiliccomponentAlipophilicaromaticringAnamideoresterlinkconnectingthetwo
Chemicalstructureinfluencespharmacologicalbehaviour:
HydrophilicportionTypicallythetertiaryamine.
Determinesionisation3bonds:Lipidsoluble4bonds:Watersoluble
LipophilicportionTypicallyaromaticring.
Determineslipidsolubility,andthereforepotency,toxicity,anddurationofactionEstervs.amide
AmidesHepaticallymetabolised(hydroxylationandN-de-alkylation)Thisisslower,thereforethereisagreaterriskofsystemictoxicity.Stableinsolution
+ 2+
LocalAnaesthetics
345
![Page 346: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/346.jpg)
EstersHeat-sensitiveCannotbeautoclaved.RapidlyhydrolysedinplasmaOrganindependentelimination.HaveagreaterincidenceofallergyDuetotheinactivemetabolitePABA.
AminegrouplengthPotencyandtoxicityincreaseascarbon-chainincreasesToxicity(butnotpotency)continuestoincreasebeyond10carbons
IsomerismAltersbehaviour:
LevobupivacaineislesstoxicR-ropivacaineislesspotentandmoretoxic
KeyCharacteristicsofLocalAnaesthetics
Characteristicsarerelatedtochemicalstructure.Theseinclude:
PotencyPotencyisexpressedwiththeminimumeffectiveconcentrationoflocalanaesthetic(C )ThisistheconcentrationofLAthatresultsincompleteblockofanervefibrein50%ofsubjectsinstandardconditions.MorepotentagentshavealowerC .Potencyisafunctionof:
LipidsolubilityPotency(andalsotoxicity)increaseswithgreaterlipidsolubility.VasodilatorpropertiesIngeneral,localanaestheticscausevasodilationinlowconcentrations,andvasoconstrictionathighconcentrations(exceptcocaine,whichcausesvasoconstrictionatallconcentrations).
DurationofactionDurationofactionisafunctionof:
DrugfactorsVasodilatorpropertiesVasoconstrictionincreasesthedurationofblock.UseofadditivesAdditionofadrenalinetolignocaineincreasesdurationofblock.LipidsolubilityIncreasedlipidsolubilityincreasesdurationofaction,asagentremainsinthenerveforlonger.
PotencythereforehasapositivecorrelationwithdurationofactionDurationofactionisincreasedwhenpHincreases,astheionisedportionfalls
ProteinbindingHighlyproteinboundagentshaveanincreaseddurationofactionduetoincreasedtissuebinding.
ProteinbindingdecreaseswithdecreasingpH,increasingthefractionofunbounddrugThisiswhyagentssuchasbupivacainearemorecardiotoxicinacidoticpatients.Localanaestheticsarepredominantlyboundtoα-1-acidglycoprotein(AAG)AAGisreducedinpregnancy,increasingthefreedrugfractionandthereforereducingthetoxicdoseofLAinpregnantpatients.
PatientfactorsTissuepHDecreaseddurationofblockwhentissuepHislow.
m
m
LocalAnaesthetics
346
![Page 347: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/347.jpg)
MetabolicimpairmentHepaticfailureincreasesdurationofactionofaminosteroidsButylcholinesterasedeficiencyincreasesdurationofesterlocalanaesthetics
SiteofadministrationWellvascularisedtissue(e.g.intercostalarea)willhavegreatersystemicuptakeofdrugthanvesselpoortissue.
OnsetSpeedofonsetisrelatedto:
DrugfactorsDoseIncreasingthedoseincreasesthespeedofonset,asperFick'sLaw.
IncreasedconcentrationwillincreasespeedofonsetandblockdensityIncreasedvolume(withoutincreasingdose,resultingindecreasedconcentration)willdecreasespeedofonset
LipidsolubilityAnincreasedlipidsolubilityincreasesthespeedatwhichthelocalanaestheticentersthenerve.However:
LipidsolubilityalsocorrelateswithpotencyTherefore,inpractice,morelipidsolubleagentsareadministeredinlowerdoses,andsohaveareducedspeedofonsetThisisknownasBowman'sPrinciple.
IonisedportionOnlyunioniseddrugcancrosscellmembranes.Ionisationisafunctionof:
pKaTissuepH
Thisisalsowhyanaestheticsareineffectiveinanaesthetisinginfectedtissue,asthelowpHmakesthemajorityoftheLAionisedandunabletocrossthecellmembrane.
PatientfactorsNerveactivityLocalanaestheticsproduceafrequencydependentblockade,meaningnervesfiringfrequentlywillbeblockedmorerapidlythanquiescentnervesNervefibresizeLargernervesrequireanincreasedconcentrationoflocalanaesthetictoachieveblockadethansmallernerves.NervetypeDifferentnervefibresareaffectedatdifferentspeeds,whichismostly(thoughnotentirely)afunctionofcriticallength.
Aγ(proprioceptive)areaffectedfirstSmallmyelinatedAδ(sharppain,cold)fibresareaffectedsecondLargemyelinatednervesareaffectedthirdTheseincludeAα(motor)andAβ(touch)fibres.UnmyelinatednervesareaffectedlastTheseincludeC(dullpain,heat)fibres.
HyperkalaemiaReducesonsetofaction.
Toxicity
Localanaestheticsare:
ToxictoboththeCNSandCVSToxicityoccurswhenthereisanexcessplasmaconcentrationThisoccurswhentherateofdrugenteringthesystemiccirculationisgreaterthanthedrugleavingthesystemiccirculationduetoredistributionandmetabolism.
Toxicityisrelatedtothe:
LocalAnaesthetics
347
![Page 348: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/348.jpg)
DrugfactorsDrugusedAgentsarecomparedusingtheCC/CNSratio,whichistheratioofthedoseofdrugrequiredtocausecardiovascularcollapse(CC)comparedtothedoserequiredtocauseseizure.Itisacrudealternativetothetherapeuticindex.DoseusedContinuousinfusionsaremorelikelytocauseadelayedonsetoflocalanaesthetictoxicity.
BlockfactorsSiteofadministrationThisaffectstherateofuptakeintothesystemiccirculation,andthelikelihoodofinadvertentintravascularinjection.Ranked(fromhighesttolowest):
Intravascular(obviously)ThisisthemostcommoncauseofLAtoxicity.
Siteisalsorelevanthere:aninjectionintothecarotidarterywillcausetoxicityatalowerdosethanifinjectedintoaperipheralvein.
IntercostalCaudalEpiduralBrachialplexusSubcutaneous
UseofadjunctsAdrenalineVasoconstrictorpropertiesreducesystemicabsorptionofLA.
TechniqueFrequentaspirationTestdoseUseofultrasound
PatientfactorsAnythingthatincreasespeak[plasma]canleadtoanincreasedriskofLAtoxicity.
Bloodflowtoaffectedareaα1-acidglycoproteinLowlevelsofthisproteinincreasefreedrugfraction.
NeonatesandinfantshavehalfthelevelofAAGthanadults.HepaticdiseaseReducesclearanceofamides,whichmaycausetoxicitywithrepeateddosesoruseofinfusions.AgeOrganbloodflow(andthereforeclearance),aswellaspharmacokineticinteractionsmayaffectclearanceofLA.BothchildrenandtheelderlyhavereducedclearanceofLA.AcidosisIncreasesunionisedportion.HypercarbiaIncreasescerebralbloodflow.
CardiacToxicity
Cardiactoxicityoccursdueto:
BlockingofthecardiacNa channel(K andCa channelsmayalsobeinvolved)Severityoftoxicitywillvarydependingonhowlongtheagentbindstothechannel,withlesstoxicitycausedbyagentsspendinglesstimebound:
Lignocaine
+ + 2+
LocalAnaesthetics
348
![Page 349: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/349.jpg)
Spendstheshortesttimeboundtothechannel,socausestheleastamountoftoxicity.Thisisalsowhylignocainecanbeusedasanantiarrhythmic,butotheragentscannot.BupivacaineTakes10xaslongtodissociateaslignocaine.Thiscanleadtore-entrantarrhythmias,andthenVF.Theriskofthisisincreasedintachycardiaduetouse-dependentblockade.RopivacaineDissociatesmorerapidlyfromcardiacchannelsthanbupivacaine.
DirectmyocardialdepressanteffectsReducescAMPlevelsbydisruptingmetabotropicreceptors.
Cardiactoxicityistriphasic:
InitialphaseHypertensionTachycardia
Intermediatephase:HypotensionMyocardialdepression
Terminalphase:SeverehypotensionVasodilationVariousarrhythmias
SinusbradycardiaVariabledegreeheartblockVTVFAsystole
CNSToxicity
LocalanaestheticsintheirunionisedstatecancrosstheBBBandinterferewithCNSconduction.CNStoxicityisbiphasic:
Initially,inhibitoryinterneuronsareblockedThiscausesexcitatoryeffects:
PerioraltinglingSlurredspeechVisualdisturbancesTremulousnessDizzinessConfusionConvulsionsTypicallysignifiestheendoftheexcitatoryphase.
Secondly,thereisageneraldepressionofallCNSneuronsThiscausesinhibitoryeffects:
ComaApnoea
Treatment
ToxicityismanagedwithanABCapproach,thoughdefinitivemanagementusesIntralipidemulsion:
Intralipidisanemulsionofsoyaoil,glycerol,andeggphospholipids.Mechanismofactioninuncertain,buttheoriesinclude:
LocalAnaesthetics
349
![Page 350: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/350.jpg)
LipidsinkILEbindsunionisedLA,causingittodistributeoffreceptorsites.FattyacidmetabolismCardiacfattyacidmetabolismisinterruptedbyLA.ILEprovidesasourceoffattyacidstoallowmetabolismtocontinue.CompetitiveantagonismILEmaydirectlyinhibitLAbinding.
DosingofIntralipid20%:Bolusof1.5ml.kg over1minuteInfusionat15ml.kg .hr
ComplicationsincludepancreatitisNotethatILEinterfereswithamylaseandlipaseassays,andsothesewillbeunreliable.
Notethatwhilstpropofolcanbeusedtotreatseizures,theamountoflipidcontainedinpropofolisinadequatetobindLA
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. ChristieLE,PicardJ,WeinbergGL.Localanaestheticsystemictoxicity.ContinuingEducationinAnaesthesiaCriticalCare
&Pain,Volume15,Issue3,1June2015,Pages136–142.3. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.4. BeckerDE,ReedKL.EssentialsofLocalAnestheticPharmacology.AnesthesiaProgress.2006;53(3):98-109.
Lastupdated2019-07-18
-1-1 -1
LocalAnaesthetics
350
![Page 351: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/351.jpg)
NeuraxialBlockadeDescribethephysiologicalconsequencesofacentralneuraxialblock
Centralneuraxialblockadereferstoblockadeoffibresinthespinalcordbyadministrationofintrathecalorepidurallocalanaesthetic.
RespiratoryResponses
Anincreasinglevelofblockwillleadtogreatereffects:
ThoracicImpedimenttoactiveexpirationandexpectorationduetoblockadeofintercostalsandabdominalwallmusculatureLossofvitalcapacityLossofsomeaccessorymuscleuse
CervicalImpedimentduetodiaphragmaticblockade.
CardiovascularResponsesOccurduetoblockadeofsympatheticchainfibresinthethoracolumbarregion.
Anincreasinglevelofblockwillleadtogreatereffects:
SacralParasympatheticblockadeonly.MinimalCVSeffects.Lowerthoracic/lumbarArteriolarandvenousvasodilationinlowerabdomenandlowerlimbs,causingafallinSVR,BP,andGFR.UpperthoracicLossofcardioacceleratorfibresaboveT5,causingareductioninheartrateandcontractility,compoundinghypotensionduetofallinSVR.CranialNervesVagalblockadewillreducePNStoneandattenuatesomeofthelossofSNStone.BrainstemInhibitionofvasomotorcentrewithprofoundfallinCVSparameters.
CNSResponsesAnincreasinglevelofblockwillleadtogreatereffects:
CervicalHorner'ssyndrome(miosis,anhydrosis,ptosis)duetolossofsympathetictrunks.CranialnervePupillarydilationduetoCNIIIblockade.BrainstemandCerebralCortexAnaesthesiaduetoblockadeofthereticularactivatingsystemandthalamus.
References
NeuraxialBlockade
351
![Page 352: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/352.jpg)
1. Diaz,A.CardiovascularResponsetoCentralNeuraxialBlockade.PrimarySAQs.2. ANZCAJuly/August2007
Lastupdated2019-07-20
NeuraxialBlockade
352
![Page 353: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/353.jpg)
AcetylcholineReceptorsUnderstandingofthepharmacologyofanticholinesterasedrugs.
Describetheadverseeffectsofanticholinesteraseagents.
ThiscoversthepharmacologyofacetylcholinereceptorsandtheproductionandmetabolismofACh.Detailedinformationonspecificagentsisinthepharmacopeia.
Acetylcholineisaneurotransmittervitalfornormalfunctionof:
CNSANSMusclecontraction
Synthesis,Release,andMetabolismAChisproducedisthenervecytoplasmbyacetyltransferasefrom:
CholineFromdietandrecycledACh.Acetyl-coenzymeAProducedintheinnermitochondrialmatrix.
Oncesynthesised,AChisthenpackagedintovesicles(eachcontaining~10,000AChmolecules),whicharereleasedinresponsetocalciuminfluxoccurringattheculminationofanactionpotential.
Acetylcholineismetabolisedbyacetylcholinesteraseonthepost-junctionalmembrane.AChE:
Hastwobindingsites:AnionicbindingsiteBindsthepositivelychargedquaternaryammoniummoiety.EsteraticbindingsiteBindstheestergroupofACh.
Oncebound,AChisacetylatedAcetylated-AChisthenhydrolysedtoproduceaceticacid
AChReceptorSubtypes
TherearetwotypesofAChreceptor:
NicotinicAChreceptorsInotropicLinkedtoanionchannel.
Non-specific-mayallowNa ,K ,orCa tocrossConsistsoffivesubunits:
TwoαBindACh.OneβOneδOneγ
Locatedin:
+ + 2+
AcetylcholineReceptors
353
![Page 354: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/354.jpg)
Post-synapticNMJPreganglionicautonomicnervoussystemAntagonismcausesganglionblockade.Brain
KnownasnicotinicbecausenicotineagonisesthisreceptorActivation:
2AChmoleculesmustbindtoactivatethereceptorOncebound,receptorundergoesaconformationalchangewhichopensthecentralionporePermeabilitytoNa (andtoalesserextent,K andCa )increases,leadingtodepolarisation
MuscarinicAChreceptorsMetabotropicG-proteincoupled.KnownasmuscarinicbecausemuscarinealsoagonisesthisreceptorSubdividedinto:
M (Gq)SecretoryglandsandCNS.M (Gi)Heart.M GqBronchialandarteriolarsmoothmuscle.M (Gi)andM (Gq)CNS.
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.
Lastupdated2019-07-18
+ + 2+
1
2
3
4 5
AcetylcholineReceptors
354
![Page 355: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/355.jpg)
OpioidsKeydefinitions:
Opiatesareallnaturally-occurringsubstanceswithmorphine-likepropertiesOpioidsisageneraltermforsubstanceswithanaffinityforopioidreceptorsOpiumisamixtureofalkaloidsfromthepoppyplant
ClassificationofOpioids
NaturallyoccurringEndogenousopioids
EndorphinsEnkephalinsDynorphins
OpiumderivativesPhenanthrenes
MorphineCodeine
SemisyntheticSimplemodificationstomorphine.
DiacetylmorphineBuprenorphineOxycodone
SyntheticPhenylpiperidines
FentanylAlfentanilRemifentanilPethidine
DiphenylpropylaminesMethadone
OpioidReceptorClassification
AllopioidreceptorsareGireceptors.Activation:
Inhibitsadenylylcyclase,reducingcAMPPre-synapticallyinhibitsvoltage-gatedCa channels
DecreasesCa influxReducesneurotransmitterrelease
Post-synapticallystimulatesactivatesK channelsCausesK effluxLeadstomembranehyperpolarisation
Receptor Actions NotableProperties
MOPAnalgesia(spinalandbrain),euphoria,meiosis(viastimulationoftheEdinger-Westphalnucleus),nauseaandvomiting(viaCTZ),sedation,bradycardia,inhibition
Onlyopioidreceptortocause
2+2+
++
Opioids
355
![Page 356: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/356.jpg)
ofgutmotility,urinaryretention,physicaldependence nausea/vomiting
KOP Analgesia(predominantlyspinal),sedation,meiosis,dysphoria Lessrespiratorydepression
DOP Analgesia,respiratorydepression,urinaryretention,physicaldependence Minimalconstipation
NOP Anxiety,depression,changeinappetite
Hyperalgesiaatlowdoses,analgesicathighdoses
Mechanismofeffects:
RespiratorydepressionDecreasescentralchemoreceptorsensitivitytoCO .ConstipationStimulationofopioidreceptorsinthegut.
Normallyactivatedbylocalendogenousopioids(usedasneurotransmitters)Agonismofthesereceptors(µ,k,andtoasmallerextent,δ)reducesGITsecretionsandperistalsis
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. KatzungBG,TrevorAJ.BasicandClinicalPharmacology.13thEd.McGraw-HillEducationEurope.2015.3. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.
Lastupdated2019-07-18
2
Opioids
356
![Page 357: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/357.jpg)
InhalationalAnaestheticsStructure-activityrelationshipsofinhalationalagents
Describetheuptake,distributionandeliminationofinhalationalanaestheticagentsandthefactorswhichinfluenceinductionandrecoveryfrominhalationalanaesthesiaincludingthe:-Conceptsofpartitioncoefficients,concentrationeffectandsecondgaseffect-Relationshipsbetweeninhaledandalveolarconcentration-Significanceofthedistributionofcardiacoutputandtissuepartitioncoefficientsonuptakeanddistributionofvolatileagents
DescribetheconceptandclinicalapplicationofMACinrelationtoinhaledanaestheticagents
Describehowthepharmacokineticsofdrugscommonlyusedinanaesthesiainneonatesandchildrendifferfromadultsandtheimplicationsforanaesthesia
Propertiesofanidealinhalationalanaestheticagent
Inhaledanaestheticsarechemicalswithgeneralanaestheticpropertiesthatcanbedeliveredbyinhalation.Theycanbedividedinto:
VolatileanaestheticagentsVolatilityreferstothetendencyofaliquidtovapourise.Volatileagentsinclude:
SevofluraneIsofluraneDesfluraneMethoxyfluraneEnfluraneHalothaneEther
AnaestheticgasesNitrousoxideXenon
KeyPrinciplesofInhalationalAgents
Keyprinciples:
TheclinicaleffectofaninhalationalagentisdependentonitspartialpressurewithintheCNSAtequilibrium,thepartialpressureintheCNS(P )equalsthepartialpressureinblood(P ),andinthealveoli(P )Reachingequilibriumisrarelyachievedinpracticeasittakesmanyhours.Rateofonsetandoffsetofaninhalationalagentaredependentonbothphysiologicalandpharmacologicalfactorsaffectingthetransferofagent:
IntothealveoliFromthealveoliintobloodFrombloodintotheCNS
MinimumAlveolarConcentration(MAC)
MACisdefinedastheminimumalveolarconcentrationatsteadystatewhichpreventsamovementresponsetoastandardsurgicalstimulus(1cmforearmincision)in50%ofapopulation.
B a A
InhalationalAnaesthetics
357
![Page 358: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/358.jpg)
Notethatthisdefinition:
DoesnotreflectlackofawarenessDoesreflecttheactionofanagentonspinalcordreflexesThisiswhy1MACisadequateforthemajorityofpatients,asawarenessandrecallaresuppressedatlowerMACvaluesthanarerequiredforimmobility.ConsciousnessisbetterestimatedbyMAC-awakeEnd-tidalconcentrationofagentthatpreventsappropriateresponsestoaverbalcommandin50%ofapopulation.
Notethatthistechnicallymeasuresawarenessratherthanmemory.MAC-awakeistypicallyone-thirdofMACforcommonly-usedagents
Isonlyvalidatsea-levelTheclinicaleffectofanagentisdependentonitspartialpressurenotconcentration.
At1atm,thesearealmostthesame1atm≃100kPa;therefore2%sevofluraneis≃2kPaAsaltitudeincreases,theactualpartialpressurewillfallforanygivenconcentrationi.e.2%sevofluraneat0.5atmis≃1kPaofsevoflurane.
MACis:
Ameasureofpotency(i.e.theEC oftheagent,wheretheoutcomeismovement)TheMACofanagentisinverselyproportionaltopotency;i.e.morepotentagentsrequiresmalleralveolarconcentrationstoproduceanaesthesia.
ThisgivesrisetotheMeyer-Overtonhypothesis,whichsuggeststhatanaesthesiarequiresasufficientnumberofmoleculestodissolveintotheneuronalcellmembrane.
Ifthiswastrue,theproductoftheoil:gaspartitioncoefficientandMACwouldbeconstant,whichisnotthecase.AdditiveTheMACsofdifferentagentsusedsimultaneouslyareadditive.Normally-distributedNotallpatientswillbeunresponsiveat1MAC.
Thestandarddeviationis0.1,so95%ofpatientswillnotmoveinresponsetoastimulusat1.2MACEstimatedclinicallyusingend-tidalgasmeasurementMACisnotbasedonarterialpartialpressure(F )ofagent.
Thisisanimportantdifference,becauseevenatsteady-state,F ≠FThisoccursdueto:
V/QmismatchShuntedalveoliwillnotabsorbanaestheticagent,andunperfusedalveoliwillcontainagentthatisnotbeingabsorbed.
ThisisworsenedbytheeffectsofanaesthesiaVolatileagentsareheavyandhavefinitediffusibility
However,thedifferencebetweenF andF foranyagentisthesameatsteadystate(andinabsenceofnitrousoxide)Thismeansthat,atsteady-state,MACwillbeproportionalto,andanaccuratemeasureof,P .
Oneofseveralrelatedterms:MACawakeConcentrationrequiredtopreventresponsetoaverbalstimuliinabsenceofnoxiousstimuli.
Typically~1/3 ofMACformostagents(sevoflurane,isoflurane,desflurane)Notablyhigherfornitrousoxide(MAC-awake~2/3 ofMAC)MAC-awakeistypicallylessthanMAC-asleepas:
HysteresisbetweenalveolarandeffectsiteconcentrationsDuringinduction,alveolarconcentrationishigherthaneffectsiteconcentration,andsooverestimateseffect.Duringwashout,alveolarconcentrationislessthaneffectsiteconcentration,andthereverseeffectoccurs."Neuralinertia"Intrinsicresistanceofnervecellstoachangeintheirstate.
50
aa A
a Aa
rdrds
InhalationalAnaesthetics
358
![Page 359: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/359.jpg)
MAC-BARMinimumalveolarconcentrationrequiredtoblockadrenergicresponse,i.e.topreventariseinHRorBPfollowingskinincision.MACTheMACrequiredtopreventamovementresponsetoastandardsurgicalstimulusin95%ofthepopulation.MAC.hrTheamountoftimeapatientisexposedto1MACofanagent.Usedtocomparedifferentagents.
FactorsAffectingMAC
DecreasesMAC IncreasesMAC
Age(~6%/10years↑)andneonates Youth
Hypothermia Hyperthermia
Hypocapnea Hypercapnea
Hyponatraemia Hypernatraemia
Hypothyroidism Hyperthyroidism
AcutealcoholandotherCNSdepressantintoxication ChronicETOHandCNSdepressantabuse
Chronicamphetamineintake Acuteamphetamineintake
Hypovolaemia/Hypotension
Lithium
Hypoxia
Anaemia
Pregnancy
SNSactivationandanxiety
IncreasedP
Notethatadditionofotheragents(e.g.opioids)willaffectdifferentMACsubtypes(e.g.MAC vsMAC )differently.
PartitionCoefficients
Apartitioncoefficientdescribestherelativeaffinityofanagentfortwophases,andisdefinedastheratiooftheconcentrationofagentineachphase,whenbothphasesareofequalvolumeandthepartialpressuresareinequilibriumatSTP.
Theblood:gaspartitioncoefficientdescribesthesolubilityoftheagentinbloodrelativetoair,whenthetwophasesareofequalvolumeandinequilibriumatSTPAlowblood:gaspartitioncoefficientindicatesarapidonsetandoffset.Thisisbecause:
PoorlysolubleagentsgenerateahighP ,whichcreatesasteepgradientbetweenP andP ,givingarapidonsetofactionConversely,solubleagentsdissolveeasilyintopulmonarybloodwithoutsubstantiallyincreasingPThiscausesleadstoaslowonsetdueto:
AlargefallinP astheagentleavesthealveolus,decreasingthegradientforfurtherdiffusionAsmallgradientbetweenP andP
Theoil:gaspartitioncoefficientdescribesthesolubilityoftheagentinfatrelativetoair,whenbothphasesareofequalvolumeandinequilibriumatSTPAhighoil:gaspartitioncoefficientindicatesagreaterpotency,andthereforealowMAC.
95
-1
atm
50 BAR
a a B
a
Aa B
InhalationalAnaesthetics
359
![Page 360: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/360.jpg)
PharmacokineticsofInhalationalAgents
AchievingtherequiredP requiresmaintainingP atahighenoughlevel.ByincreasingP ,thepressuregradientfordiffusionintoblood,andthereforeCNS,isincreased.
Asdiscussedabove,rateofonsetofaninhalationalagentisdependentonrateofuptake:
IntothealveoliFromthealveoliintobloodFrombloodintotheCNS
Factorsaffectingalveolarconcentrationofagent:
InspiredconcentrationAhighinspiredconcentration(F )willincreasetherateofincreaseofalveolarconcentration(F ).Inspiredconcentrationisdependenton:
DeliveredconcentrationinfreshgasFreshgasflowIncreasingFGF(andtheconcentrationofagentintheaddedgas)increasesF .VolumeofthebreathingsystemAlowercircuitvolumewillincreasetherateatwhichthepatientreachesequilibriumwiththecircuit,andthereforeincreaseF .CircuitabsorptionAbsorptionofagentbythecircuitwilldecreaseF .
VIncreasedalveolarventilationincreasesF ,asitreplenishesagentthathasbeentakenupintothevasculature.
Similarly,increaseddeadspacewillprolonginduction,asanaestheticgaswillbedeliveredtonon-perfusedalveoliFRCAlargeFRCwilldilutetheamountofagentinspiredwitheachbreath,andsoreduceF .
ThisismeasuredwiththeV /FRCratioIncreasedratioincreasesspeedofonset.
Normalinadults:1.5:1Normalinneonates:5:1
SecondgaseffectUseofN OwithanotheragentwillincreasetheP ofthatagent.Thisisbecause:
N Ois20xassolubleinbloodaseitherbloodornitrogen,andisadministeredinhighconcentrations,soitisrapidlyabsorbedfromalveoliIfnitrousoxideisdeliveredathighconcentrations,it'srapidabsorptionmeansthatalveoliwillshrink,causing:
AnincreaseinthefractionalconcentrationofallothergasesThisisknownastheconcentrationeffect,andincreasesthepressuregradientdrivingdiffusionintoblood,increasingspeedofonset.
TheconcentrationeffectisthecauseofthesecondgaseffectTheconcentrationeffectismorepronouncedasFiN OincreasesTheconcentrationeffectismoreprofoundinlungunitswithmoderatelylowV/Qratios,causinginalargeincreaseinFThisresultsinalargervalueofF foranygivenF ,evenatsteadystate.
AugmentedventilationasmoreinhalationalagentisdrawninthealveolifromdeadspacegasThesecondgaseffectalsocausesdiffusionhypoxiaWheninspiredN Oisreduced,N Owillleavebloodandenterthealveolus,displacingothergasesinthealveolus.
ThiscancauseareductioninPAO ,andthereforehypoxaemiaDiffusionhypoxiaisavoidedbydelivering100%oxygen,whichmaintainsanadequatePAO asN Oisremoved
B A A
i A
i
i
iA
i
iA
2 A2
2
aa A
2 22
2 2
InhalationalAnaesthetics
360
![Page 361: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/361.jpg)
NotethatN Oreachesahigherratiofasterthandesflurane,despiteitslowerblood:gaspartitioncoefficient,duetotheconcentrationeffect
Factorsaffectingdruguptakefromthelungs:
Blood:gaspartitioncoefficient
Agentswithalowblood:gaspartitioncoefficientreach equilibriummorerapidly.Theblood:gascoefficientisaffectedby:
TemperatureBlood:gaspartitioncoefficientsdecreaseastemperatureincreases.HaematocritVariableeffect,whichdependsontheparticularagentsaffinityforredcellsorplasma(andserumconstituents,e.g.albumin).
Anagentthatislesssolubleinredcells(e.g.isoflurane)willhaveadecreasedblood-gaspartitioncoefficientinanaemia.
FatBlood:gaspartitioncoefficientincreasesfollowingfatingestion.
AlveolarbloodflowIncreasedalveolarbloodflowincreasesuptakeanddeliverytotissues,includingtheCNS.
However,theincreaseduptakecausesareductioninPTherefore,rateofonsetisreducedwhenalveolarbloodflowishigh.
Thiseffectismorepronouncedwithagentswithahighblood:gaspartitioncoefficientAlveolarbloodflowisafunctionof:
CardiacoutputShunt
Alveolar-VenouspartialpressuregradientThedifferenceinpartialpressureofagentinthealveolusandvenousbloodisduetotheuptakeofdrugintissues.Tissueuptakeisdependenton:
TissuebloodflowAstheCNShasahighbloodflow,itwillequilibratemorequickly.Blood:tissuesolubilitycoefficients
Musclehassimilaraffinitytoblood,butequilibratesmoreslowlythantheCNSduetolowerbloodflowFathasamuchhigheraffinityforanaestheticthanmuscle,butequilibratesveryslowlyduetotheverylowbloodflowThisisofgreaterimportanceintheobese,especiallyduringprolongedanaesthesia,astheyhavealongerequilibrationtimeandthereforeprolongedemergence.
Wash-outofInhalationalAgents
2
A
InhalationalAnaesthetics
361
![Page 362: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/362.jpg)
Recoveryisdependentonhowquicklyaninhalationalagentcanbeeliminatedfromtheeffectsite,andcanbegraphedbytheF /F ratioovertime:
Washoutcanbedividedinto:
RapidwashoutOfagentincircuitandFRC.
Thetimeconstantforremovalofagentfromthecircuitisafunctionofcircuitvolumeandfreshgasflow,i.e.
SlowwashoutOfagentinpatient.
ThetimeconstantforremovalofagentfromthepatientisafunctionofFRCandminuteventilation,i.e.
Factorsaffectingvolatilewashout:
Brain-BloodandTissue-BloodTissue:BloodcoefficientofagentDurationanddepthofanaesthesiaImportantforhighlysolubleagentsusedinlongcases.
Blood-AlveolusBlood:gascoefficientofagentHighlysolubleagentswillhaveanincreasedamountofdrugdissolvedintissue,soalargereservoirofdrugexiststhatwillhavetoberemoved.AlveolarCardiacoutputDecreasedcardiacoutputincreaseselimination.
ShuntDecreaseselimination.
Alveolus-AirMV /FRCIncreasedalveolarventilationincreaseselimination.
OtherfactorsMetabolismofagentAgentsundergoingmetabolismareeliminatedmorerapidly.AbsorptionofagentintocircuitPercutaneousloss
A A0
A
InhalationalAnaesthetics
362
![Page 363: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/363.jpg)
Lossofagentbydiffusionfromtissuesintoexternalenvironment.
AlterationtoPharmacokinetics
Increasedrateofinductioninchildrendueto:
IncreasedV /FRCratioIncreasesP .LoweralbuminandcholesterolReducedblood-gassolubilitycoefficientsforsomeagents.
Increasedrateofinductioninelderlydueto:
LowerMACrequirementLoweralbuminReducesblood-gassolubilitycoefficientsforsomeagents.LowercardiacoutputP andthereforeP isestablishedmorerapidly.
Alteredrateofinductioninpregnancydueto:
IncreasedV /FRCratioIncreasedminuteventilationThisisofgreaterimportanceinspontaneousventilation,asthisiscontrolledbytheanaesthetistduringcontrolledventilation.DecreasedFRCIncreasesP ,increasingP andspeedofonset.
LoweralbuminReducesblood-gassolubilitycoefficientsforsomeagents.IncreasedCOReducesrateofriseofP ,reducingP andthereforespeedofonset.ReducedMACrequirementProgesteronehassomesedativeproperties.
AlterationtoPharmacokineticswithSpecialMethodsofAdministration
Intarget-controlledanaesthesia,FGFandagentF arecontrolledbythemachinetoreachthetargetF rapidlyatlowconcentrations.Thiscauses:
Aninitialover-pressureofF ,inordertofilltheFRCandreachthedesiredFAmorerapidinduction,asthetargetF isreachedmorerapidly
Inliquidinjection,anaestheticagentisinjectedintothebreathingsystem.Thiscauses:
AverylargedegreeofoverpressureInthiscircumstance,therateofriseofend-expiredagentconcentrationisidenticalfordifferentagents.
i.e.Onsetisindependentoftheblood:gascoefficient
MechanismofActionofInhaledAnaestheticAgents
Mechanismsofactioncanbedividedinto:
MacroscopicAtthelevelofthebrainandspinalcord.
Inthespineby:
AA
a B
A
A B
A B
I A
I Aa
InhalationalAnaesthetics
363
![Page 364: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/364.jpg)
DecreasingtransmissionofnoxiousafferentsignalsatthethalamusInhibitionofspinalefferents,decreasingmotorresponses
Inthebrainby:GlobaldepressionofCBFandglucosemetabolism
MicroscopicSynapsesandaxonsby:
Inhibitingpre-synapticexcitatoryactivity:ACh5-HTGlutamine
Augmentingpost-synapticinhibitoryactivity:GABA
MolecularAnaestheticagentsmayalterthefunctionofmoleculeswithintheCNS.Theseinclude:
Alterationofα-subunitsoftheGABA receptorThisprolongsthetimeitspendsopenonceactivated,prolongingtheinhibitoryCl currentandincreasingthedegreeofhyperpolarisation.Enhancetheactivityoftwo-poreK channelsIncreasestherestingmembranepotentialofbothpre-synapticandpost-synapticCNSneurons.
IncompleteTheoriesoftheMechanismofActionofGeneralAnaestheticAgents
Meyer-OvertonHypothesis:
PotencyofanaestheticsrelatestotheirlipidsolubilityAnaestheticmoleculesdissolveintoCNSmembranes,disruptingtheireffectFlaws:
NotalllipidsolubledrugshavegeneralanaestheticaffectsOtherfactorsdisruptcellmembraneswithoutcausinganaesthesia
VolumeExpansion,PressureReversal(Mullin'sCriticalVolumeHypothesis):
CNScellmembranesexpandwithgeneralanaestheticagentsThisdistortschannelsresponsibleformaintainingmembranepotentialandgeneratingactionpotentials.IncreasedambientpressurereversesgeneralanaesthesiaFlaws:
Doesnotaccountforstero-selectivityofdrug-receptorinteractionsI.e.receptorsselectforonestereoisomeroverothers.
Structure-ActivityRelationshipsofInhaledAnaesthetics
Chemicalstructuresofdifferentvolatileanaestheticsarecoveredinthepharmacopeia.
Differentchemicalandphysicalpropertiesaltertheeffectofinhalationalagents:
PhysicalMolecularweightAdecreaseinmolecularweightdecreasesboilingpointandthereforeincreasesSVP.
ChemicalH contentGreaterhydrogencontent:
IncreasesflammabilityIncreasespotency
A
A-
+
+
-
InhalationalAnaesthetics
364
![Page 365: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/365.jpg)
F contentGreaterfluoridecontent:
DecreasesflammabilityDecreasesoxidativemetabolismThisdecreasestoxicity.Decreasespotency
Cl contentIncreasedchlorideincreasespotency.-CHF (Di-fluor-methylgroup)
ProducesCOinthepresenceofdrysodalime
TheIdealInhaledAnaestheticAgent
Fromthepropertiesdiscussedabove,wecanconstructthefollowingidealagent:
PhysicochemicalLiquidatroomtemperatureHighSVPLowspecificheatcapacityLongshelf-lifeLightstableHeatstableDoesnotreactwiththecomponentsinthebreathingcircuit
RubberMetalPlasticSodalime
Notflammable/explosiveSmellsnicePreservativefreeEnvironmentallyfriendlyCheap
PharmacokineticHighoil:gaspartitioncoefficientLowMAC.Lowblood:gaspartitioncoefficientRapidonsetandoffset.NotmetabolisedNon-toxic
PharmacodynamicDoesnotcauselaryngospasmorairwayhyperreactivityNoeffectonHDxparametersAnalgesicHypnoticAmnesticAnti-epilepticNoincreaseinICPSkeletalmusclerelaxationAnti-emeticNotocolyticeffects
-
-
2
InhalationalAnaesthetics
365
![Page 366: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/366.jpg)
NotteratogenicorotherwisetoxicNodruginteractions
References1. KhanKS,HayesI,BuggyDJ.PharmacologyofanaestheticagentsII:inhalationanaestheticagents.ContinuingEducationin
AnaesthesiaCriticalCare&Pain,Volume14,Issue3,1June2014,Pages106–111.2. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.3. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.4. LeslieRA,JohnsonEK,GoodwinAPL.DrPodcastScriptsforthePrimaryFRCA.CambridgeUniversityPress.2011.5. MillerRD,ErikssonLI,FleisherLA,Weiner-KronishJP,CohenNH,YoungWL.Miller'sAnaesthesia.8thEd(Revised).
ElsevierHealthSciences.6. ZhouJX,LiuJ.Theeffectoftemperatureonsolubilityofvolatileanestheticsinhumantissues.AnesthAnalg.2001
Jul;93(1):234-8.7. HendrickxJ,PeytonP,CaretteR,DeWolfA.Inhaledanaestheticsandnitrousoxide:Complexitiesoverlooked:thingsmay
notbewhattheyseem.EurJAnaesthesiol.2016Sep;33(9):611-9.8. AranakeA,MashourGA,AvidanMS.Minimumalveolarconcentration:ongoingrelevanceandclinicalutility.Anaesthesia.
2013May;68(5):512-22.doi:10.1111/anae.12168.9. LermanJ,GregoryGA,WillisMM,EgerEI2nd.Ageandsolubilityofvolatileanestheticsinblood.Anesthesiology.1984
Aug;61(2):139-43.
Lastupdated2019-11-08
InhalationalAnaesthetics
366
![Page 367: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/367.jpg)
HormonesAhormoneisachemicalmessengerproducedbyaductlessglandwhichhasitsactionatadistanttargetcellviaaspecificreceptor.
Lipidhormones,dividedinto:SteroidsSteroidsaresynthesisedfromcholesterol,andarereleasedastheyareproduced(theyarenotstored).Theyarehighlylipidsolubleandactoncytoplasmicandintra-nucleicreceptors.
AldosteroneTestosteroneOestrogenCortisol
EicosanoidsEicosanoidsareformedfromcellmembranephospholipid.
ProstaglandinsThromboxanesLeukotrienes
PeptidehormonesPeptidehormonesarestoreingranulesandreleasedbyexocytosis.Theyaredividedinto:
Short-chainInsulinADHOxytocinACTH
Long-chainGHProlactin
GlycopeptidesProteinswithcarbohydrategroups.
LHFSHTSH
MonoaminederivativesDerivedfromasingleaminoacid.
CatecholaminesStoredingranulesandactatmembranereceptors.
AdrenalineNoradrenaline
SerotoninThyroxine
References
1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2017-09-17
Endocrine
367
![Page 368: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/368.jpg)
Endocrine
368
![Page 369: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/369.jpg)
Insulin,Glucagon,andSomatostatinDescribethephysiologyofinsulin,glucagonandsomatostatin.
Insulin
Insulinisapolypeptidehormone,andis:
SynthesisedfromproinsulinintheroughendoplasmicreticulumofBcellsintheIsletsofLangerhansExcretedviaexocytosisinresponsetoanincreaseinintracellularCaMinimallyproteinboundwithatinyvolumeofdistributionV 0.075L.kg ,increasedto0.146L.kg indiabetics.Metabolisedinliver,muscle,andkidneybyglutathioneinsulintranshydrogenase,withrenaleliminationofinactivemetabolitesCirculatoryhalf-lifeof~5min.
ActionsofInsulin
Insulinbindstoaspecificinsulinreceptor(amembrane-spanningproteincomposedofαandβsubunits)onthecellmembrane.Thecomplexisinternalised,anditseffectsaremediatedbytyrosinekinase.
Seconds Minutes Hours
Muscle Increasedglucose,aminoacid,ketone,andK uptake Increasedanabolism,decreasedcatabolism
Fat Increasedglucose(viaGLUT4),aminoacid,andK uptake Increasedglycerolphosphatesynthesis Increasedfatty
acidsynthesis
Liver
Decreased:gluconeogenesis,ketogenesis.
Increased:glycogensynthesis,glycolysis,proteinsynthesis,lipidsynthesis
General Increasedcellgrowth
GlucoseTolerance
Hyperglycaemiaoccursindiabetesduetodecreasedperipheralutilisationasglucoseuptakeisreducedduetoabsenceoforresistancetoinsulin.Inaddition,thesuppressiveeffectofinsulinonhepaticgluconeogenesisisabsentorreduced.
GlucagonGlucagonisapolypeptidehormone,andis:
SynthesisedintheAcellsofthepancreasHasacirculatinghalf-lifeof~5minMetabolisedpredominantlyintheliverSecreteddirectlyintotheportalvein,andundergoesfirst-passmetabolismresultinginlowcirculatinglevels.
System Effect
2+
D-1 -1
+
+
Insulin,Glucagon,andSomatostatin
369
![Page 370: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/370.jpg)
Liver Glycogenolysis,gluconeogenesis,glucoserelease,ketoneformation
CVS Inotropy
Fat Lipolysis
Metabolic Increasedmetabolicrate,GHrelease,somatostatinrelease,insulinrelease
Secretionofglucagonisinfluencedbyanumberoffactors:
StimulateRelease InhibitRelease
Hypoglycaemiaandstarvation Somatostatin
Aminoacids Secretin
Physiologicalstress:Exercise,infection FreeFattyAcids
β-agonists α-agonists
Cortisol Insulin
ACh Ketones
Theophylline GABA
SomatostatinSomatostatinisapolypeptidehormonethat:
Inhibitssecretionofotherhormonesincluding:GlucagonInsulinOtherpancreaticpeptides
MayfunctionasaneurotransmitterintheCNS
References
1. BarrettKE,BarmanSM,BoitanoS,BrooksHL.Ganong'sReviewofMedicalPhysiology.24thEd.McGrawHill.2012.2. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.
Lastupdated2019-07-18
Insulin,Glucagon,andSomatostatin
370
![Page 371: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/371.jpg)
ControlofBloodGlucoseExplainthecontrolofbloodglucose
Normalbloodglucoseinthenon-diabeticis4-6mmol.L ,thoughwillriseafterconsumptionofcarbohydrate.Glucoseregulationcanbedividedinto:
Short-termRegulationviasecretionorinhibitionofinsulinandglucagonfromthepancreaticislets.Long-termRegulationviabothneuronal(SNSactivation)andhormonal(cortisol,GH)mechanisms.
HormonalMechanisms
ShortTerm
GlucoselevelsaresenseddirectlyinthepancreasandwillresultininsulinreleasewhentheBGLis>5.6mmol.L .PancreaticBcellsresponddirectlytoglucosebysecretinginsulininabiphasicfashion:
Aninitial,rapidincreaseinreleaseGlucoseentersviatheGLUT-2transporter,andisconvertedtopyruvatewhichentersthecitricacidcycleandproducesATPATPinhibitsATP-sensitiveK channels,reducingK effluxandcausingdepolarisationDepolarisationcausesCa release,resultinginexocytosisofinsulingranules
Aprolonged,slowincreaseinreleaseGlutamateisproducedasaby-productofthecitricacidcycleGlutamatestimulatesmaturationofotherinsulingranulesReleaseofthesegranulescausesthesecondphaseofinsulinrelease
Conversely,alowglucoselevelstimulatessecretionofglucagon.Thisistypicallylessimportantthantheeffectofinsulinunlessinsituationsofstarvationorseverephysiologicalstress.
LongTerm
Sustainedhypoglycaemiaincreasesfatutilisationanddecreasesglucoseutilisation(limitingfurtherdropsinbloodglucose),viastimulatingreleaseof:
GHCortisol
NeuronalMechanismsHypoglycaemiadirectlystimulatesthehypothalamus,causing:
IncreasedSNStoneAdrenalinereleaseinturnstimulateshepaticglucoserelease.
OrganEffects
Glucoselevelsareinfluencedbythe:
-1
-1
+ +2+
ControlofBloodGlucose
371
![Page 372: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/372.jpg)
LiverInsulinandglucagonactonthelivertocontinuallyadjusttherelativeratesofglycogenolysisandglycogenesis,allowingittofunctionasaneffectivebufferofbloodglucose.
Hepaticdiseasesignificantlylimitstheefficacyofthissystem,andresultsinawidely-fluctuatingbloodglucoselevelKidney
Atransientglycosuriamaybeseenashyperglycaemiadecreasesrenalabsorptionofglucose
PhysiologicalResponsestoHypoglycaemia
BSL(mmol.L ) Symptoms EndocrineResponse
4.6 Insulinsecretioninhibited
3.8 Autonomicdysfunction Glucagon,adrenaline,andGHsecretion
2.8 CNSdysfunction
2.2 Lethargy,Coma
1.7 Convulsions
0.6 Permanentbraindamage,Death
References1. BarrettKE,BarmanSM,BoitanoS,BrooksHL.Ganong'sReviewofMedicalPhysiology.24thEd.McGrawHill.2012.2. Hall,JE,andGuytonAC.GuytonandHallTextbookofMedicalPhysiology.11thEdition.Philadelphia,PA:Saunders
Elsevier.2011.
Lastupdated2019-07-18
-1
ControlofBloodGlucose
372
![Page 373: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/373.jpg)
HypothalamusandPituitaryDescribethecontrol,secretionsandfunctionsofthepituitaryandthehypothalamus
Hypothalamus
Thehypothalamusisacircumventricularorganthatregulatesalargenumberofautonomicprocesses:
ThermoregulatoryIntegratesthermoreceptorinputandcontrolsactivityofheatlossandheatgainmechanisms.SatietyFeelingsofhungeraremodulatedbyglucose,CCK,glucagon,andleptin.Waterbalance
ContainsosmoreceptorswhichcontrolADHreleasefromtheposteriorpituitaryAngiotensinIIstimulatesthirstandADHreleaseviathesubfornicalorganandorganumvasculosum
CircadianrhythmsBalancebetweenanteriorandposteriorhypothalamicstimulationcontrolssleep-wakecycle.Pituitarycontrol
Anteriorpituitarybyhormonesecretionintothelongportalvein.Secretedhormonesinclude:GnRH,stimulatesFSHandLHreleaseCRH,stimulatesACTHreleaseGHRH,stimulatesGHreleaseTRH,stimulatesTSHreleaseSomatostatin,inhibitsGHandTSHreleaseDopamine,inhibitsprolactinrelease
PosteriorpituitarybyneuronalinnervationBehaviourPunishmentandrewardcentres.Sexualfunction
Pituitary
Thehypothalamic-pituitaryaxisdescribesthecomplexfeedbackloopsbetweentheseendocrineorgans:
Short-loopfeedbackdescribesnegativefeedbackfromthepituitaryonthehypothalamus,e.g.GHinhibitingGHRHreleaseLong-loopfeedbackdescribesnegativefeedbackfromapituitarytargetgland(i.e.thyroid,adrenal,gonads)onthehypothalamus,e.g.cortisolinhibitingCRH(aswellasACTH)release.
Theseaxesarealsonamedwithtargetgland,e.g.hypothalamic-pituitary-adrenalaxis
PituitaryHormones
Thepituitaryglandsecreteseighthormonesfromtwolobes:
AnteriorPituitarySecretessixhormonesinresponsetohypothalamicendocrinestimulus.Theseareclassifiedas:
Stimulatinghormones,whichactatanothergland:ACTHShort-chainpeptidethatstimulatescortisolreleasefromthezonafasciculata.ReleaseisstimulatedbyCRH,andinhibitedbycortisol.
HypothalamusandPituitary
373
![Page 374: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/374.jpg)
TSHGlycoproteinthatstimulatessynthesisandreleaseofT andT .ReleaseisstimulatedbyTRH,andinhibitedbyT .FSHGlycoproteingonadotropin.ReleaseisstimulatedbyGnRH,andinhibitedbycirculatingsexsteroids.Hasdifferenteffectsdependingonsex:
Females:Stimulatesoestrogensynthesisandovarianfollicledevelopment.Males:Stimulatesspermmaturation.
LHGlycoproteingonadotropinwithdifferenteffectsdependingonsex:
Females:Rapidincreasestimulatesovulationandcorpusluteumdevelopment.Males:Stimulatestestosteronesynthesis.
Directactinghormones:GHLong-chainpeptidereleasedinapulsatilefashion.ReleaseisstimulatedbyGHRHandistypicallyhighwithexercise,hypoglycaemia,andstress.ReleaseisinhibitedbysomatostatinandIGF-1.GHhasgenerallyanaboliceffects:
Directlystimulateslipolysis,increasingcirculatingFFAIndirectlystimulatesIGF-1release,promotingcellgrowthanddevelopment
ProlactinLong-chainpeptidewhichpromotesbreastdevelopmentduringgestation,andlactationafterdelivery.
PosteriorpituitarySecretestwohormones:
ADHShort-chainpeptidewhichis:
ReleasedinresponsetoosmoreceptorsinthecircumventricularorgansdetectingachangeinosmolalityADHreleaseis:
Reducedwhenosmolalityis<275mosm.l-1</sup>Increasedwhenosmolalityis>290mOsm.L
Effectiveat:V receptorsinvascularsmoothmuscle,causingvasoconstrictionV receptorsinkidneycollectingductstoincreasewaterreabsorption,andonendotheliumtoincreasevWFandfactorVIIIreleaseV receptorsinthepituitarytostimulateACTHrelease
OxytocinShort-chainpeptide,structurallysimilartoADH,whichcauses:
UterinecontractionLet-downreflexStimulatesmilkreleaseonsuckling.PsychologicalPairbonding.
References
1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.2. Nickson,C.Vasopressin.LITFL.
Lastupdated2019-07-18
3 43
-1
12
3
HypothalamusandPituitary
374
![Page 375: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/375.jpg)
HypothalamusandPituitary
375
![Page 376: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/376.jpg)
ThyroidDescribethecontrol,secretionsandfunctionsofthethyroid.
Thethyroidgland:
ProducesandsecretestwohormonesinresponsetoTSH:T (thyroxine,93%)T (tri-iodothyronine,7%)
Secretionsarecontrolledviaanegative-feedbacklooponthehypothalamic-pituitary-thyroidaxisIncreasedTSHresultsin:
IncreasediodineuptakeIncreasediodinationtoformT andTIncreasedproteolysisofthyroglobulin,whichreleasesT andT
SecretionsaredecreasedwithdecreasediodineuptakePerchlorateBlocksNa /I symporter.Wolff-ChaikoffeffectAreductioninthyroidhormoneproductionduetoahighcirculating[iodide].
SynthesisThyroidhormonesare:
SynthesisedinfolliclesAfollicleisformedofasinglelayerofcuboidalepitheliumaroundacentrallumen(follicularcavity)containingthyroglobulin.
IodideistransportedintofollicularcellsviaasecondaryactivetransportmechanismNa /I co-transporter.IodideisthenoxidisedtoiodineThyroglobulinissynthesisedintheendoplasmicreticulumofthefollicularcellandexcretedintothefollicularcavityIodineisexcretedintothefollicularcavityusingachlorideexchangepumpInthefollicularcavity:
Thyroidperoxidasecatalysestheiodinationofthyroglobulin,formingmono-iodotyrosineanddi-iodotyrosineThesearesubsequentlyoxidised,formingT andT respectively
Insummary:
Iodideistakenintothethyroidfolliclesbysecondaryactivetransport,andoxidisedtoiodineThyroglobulinissynthesisedinthefollicle,andexcretedintothefollicularcavityIodineissecretedintothefollicularcavity,whereitcombineswiththyroglobulintoproduceT andT
SecretionandMetabolism
Thyroidhormonesare:
SecretedinvesiclesviaendocytosisintothesurroundingcapillariesColloidentersthyroidcellviapinocytosisattheapicalmembraneVesiclesthenfusewithlysosomes
43
4 34 3
+ -
+ -
3 4
4 3
Thyroid
376
![Page 377: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/377.jpg)
ThyroidhormonecleavedfromthyroglobulinbyproteasesFreeT andT diffusethroughthebaseofthethyroidcellintosurroundingcapillaries
Highlyproteinboundtoalbuminandthyroxine-bindingglobulinT hasat of7daysT hasat of24hoursBotharedeiodinatedintheliver,kidney,andmuscle
55%ofT willbefirstdeiodinatedtoT
PhysiologicalEffects
Thyroidhormones:
ActonthyroidreceptorsinthecellnucleusIncreasinggenetranscription,proteinsynthesis,andmitochondriasizeandnumber.T is3-5xmoreactivethanT
Effectsofthyroidhormonearepredominantlymetabolic:
System Effect
Resp ↑MVdueto↑CO production
CVS ↑HR,↑inotropy,↑CO,↓SVR,↓DBP
CNS ↑Excitability:Seizures,tremor
MSK ↑Osteoblasticactivity
GU Impotence(men),oligomenorrhoea(women)
GIT ↑GITmotility
Metabolic↑BMRupto100%,↑carbohydratemetabolism(↑glucoseuptake,↑glycolysis,↑gluconeogenesis),↑fatmetabolism(↑lipolysis,↑non-shiveringthermogenesis,↓plasmacholesterol,↓plasmaphospholipids,↓triglycerides),↑proteinmetabolism(↑anabolismatphysiologicallevels,↑catabolismathighlevels)
References
1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. CICMSeptember/November2008
Lastupdated2019-07-18
3 4
4 1/23 1/2
4 3
3 4
2
Thyroid
377
![Page 378: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/378.jpg)
AdrenalHormonesDescribethecontrol,secretionsandfunctionsofrenalandadrenalhormones
Thiscoverstheproductionofadrenalhormones.Informationspecifictocatecholaminesreceptorfunctioncanbefoundunderadrenoreceptors,whilstdetailedinformationonspecificagents,includingstructure-activityrelationships,isinthepharmacopeia.
Theadrenalglandsarepairedtriangularglandsatthesuperiorpoleofthekidney.Theglandcanbedividedinto:
AdrenalcortexConsistsofthreelayerswhichproducesteroidhormones(AgoodmnemonicisGFRforthelayers,andACT(H)forhormones)
ZonaGlomerulosaPredominantlyproducesmineralocorticoids(aldosterone).ZonaFasciculataPredominantlyproducesglucocorticoids(cortisol).ZonaReticularisPredominantlyproducessexsteroids(testosterone).
AdrenalmedullaProducescatecholamines.
SteroidHormones
Mineralocorticoids
Aldosteroneisthekeymineralocorticoidhormone,accountingfor95%ofmineralocorticoidactivity:
Releaseisstimulatedby:IncreasedserumKIncreasedAngiotensinII
HypovolaemiaDecreasedosmolarity
IncreasedACTHDecreasedserumpH
Actstoincreasesodiumandwaterretention(andremovalofpotassium),via:IncreasedexpressionandactivationofNa /K pumpsonthebasolateralmembraneofDCTandCTcells,causingincreasedNa (andwater)reabsorptionandK eliminationStimulationoftheNa /H pumpinintercalatedcellsontheDCT
Glucocorticoids
Cortisol(hydrocortisone)istheprimaryglucocorticoidinthebody,accountingfor95%ofendogenousglucocorticoideffect.Cortisolis:
Producedat~15-30mg.dayReleasedinresponsetoACTHACTHisreleasedinresponsetoCRH,whichis:
ReleasedinresponsetostressModulatedbycircadianrhythms,anddemonstratesdiurnalvariation:
CRHpeaksjustbeforewakingCRHtroughsduringsleep
+
+ ++ +
+ +
-1
AdrenalHormones
378
![Page 379: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/379.jpg)
Cortisolhaseffectsonmanyorgansystems,andinphysiologicalamountscause:
CVSIncreasedsensitivitytocatecholaminesIncreasesfluidretention
Metabolic(Essentiallyanti-insulineffects):
GluconeogenesisToprovidesubstrates,italsostimulates:
ProteolysisLipolysis
Decreasedglucoseuptake
Catecholamines
Naturallyoccurringcatecholaminesinclude:
AdrenalineNoradrenalineDopamine
Synthesisofcatecholaminesoccursintheadrenalmedulla,whichisamodifiedsympatheticganglioncomposedofchromaffincells.
SynthesisandreleaseisdependentonAChreleasebythepresynapticneuronUnlikemanyotherhormones,catecholaminesecretionisnotanegative-feedbackloop.
Processofcatecholaminesynthesis:
TyrosineisconcentratedintheadrenalmedullaTyrosineishydroxylatedtoDOPAbytyrosinehydroxylaseThisistherate-limitingstep,andisprobablythebestenzymetoremember.DOPAisdecarboxylatedtodopamineDopamineisconvertedtonoradrenalineNoradrenalineisconvertedtoadrenalinebyPNMT(PhenylethanolamineN-methyltransferase)Thismayonlyoccurintheadrenalmedulla.
Plasmahalf-livesofnoradrenalineandadrenalinearesmallasaconsequenceoftheirmetabolismandelimination.
Extraneuronaluptakeinthelungs,liver,kidney,andGITNeuronaluptakebysympatheticnerveendingsInactivationbyMAOinnervecytoplasmInactivationbyCOMTintheliverandkidney
References
1. BrandisK.ThePhysiologyViva:Questions&Answers.2003.2. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2018-06-25
AdrenalHormones
379
![Page 380: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/380.jpg)
AdrenalHormones
380
![Page 381: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/381.jpg)
CalciumHomeostasisDescribethefunction,distribution,regulationandphysiologicalimportanceofsodium,chloride,potassium,magnesium,calciumandphosphateions
Describethecontrolofplasmacalcium.
Calciumisabivalentcation.Almostall(99%)ofcalciumislocatedinbone,withtheremainderinplasmaandsofttissues.Normalplasmalevelsare2.2-2.55mmol.L ,which(inplasma)maybe:
Ionised(free)calcium(50%)Normalrange1.1to1.3mmol .Boundtoalbumin(40%)Ascalciumcompounds(10%)
FunctionsofCalcium
CellSignalingCalciumhasanumberofrolesincellsignaling:
AffectscellsodiumpermeabilityandthereforetheRMPofexcitablecellsCalciumtriggersexocytosisofneurotransmittervesiclesCalciumisanimportantsecondmessengerforsomeGproteins
BoneCalciumhastwofunctionsinbone:
PhysicalstructureAlkalireserveCalciumphosphatecanbemobilisedtobufferacidosis.
EnzymaticcofactorCalciumisanimportantcofactorinenzymaticpathways,includingthecoagulationcascade.Clinicalhypocalcaemiadoesnotcausecoagulopathyhowever,ascalciumlevelslowenoughtopreventcoagulationarenotcompatiblewithlife.
RegulationofCalcium
Calciumisregulatedtomaintainastableionisedcalciumlevel.Threehormonesareinvolvedintheregulationofcalcium:
ParathyroidHormoneProteinhormonesecretedbythefourparathyroidglands,locatedontheposteriorsurfaceofthethyroid,inresponsetoafalliniCa levels,andactstoincreaseplasmacalcium:
IncreasecalciumreabsorptioninthePCTandlateDCTIncreaseosteoclasticactivityinboneIncreasevitaminDactivationintheintestine,whichinturnincreasesintestinalabsorptionofdietarycalcium
VitaminD/CalcitriolOnceconvertedtocalcitriolinthekidney(viastimulationfromPTH),vitaminDactsto:
IncreasecalciumreabsorptionfromkidneyandgutIncreasebonecalcification
CalcitoninPeptidehormonesecretedbytheCcellsofthethyroidgland,inresponsetoariseiniCa greaterthan2.4mmol.L .
-1
-1
2+
2+ -1
CalciumHomeostasis
381
![Page 382: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/382.jpg)
Calcitoninactsto:DecreaseabsorptionofcalciumfromgutandkidneyDecreaseosteoclasticactivityofbone
References1. BrandisK.ThePhysiologyViva:Questions&Answers.2003.2. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2017-09-08
CalciumHomeostasis
382
![Page 383: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/383.jpg)
HistamineDescribethephysiologyofhistamineandserotonin
Histamineisanendogenousamineproducedbydecarboxylationofhistidine.Histamineis:
PresentinalltissuesParticularlyabundantinthoseexposedtotheoutsideenvironment:
LungsGutSkin(lungs,gut,skin)
Producedinandreleasedby:MastcellsReleasedbyexocytosisduringinflammatoryandallergicreactions.BasophilsHistaminocytesinthestomachHistaminergicneuronsintheCNS
Metabolisedby:HistaminaseImidazoleN-methyltransferase
HistamineReceptorsandEffectsHistamineactson:
H receptorsGqreceptorinvolvedbroadlyininflammationandvasodilation.H receptorsGsreceptorinvolvedingastricacidsecretion.H receptorsGipresynapticreceptorintheCNS.H receptorsGireceptorlocatedinbonemarrowandothersolidhaematologicalorgans(spleen,liver,thymus).
System H H H H
Resp Bronchoconstriction Bronchodilation
CVS↑Vasodilation(endothelialeffect),coronaryvasoconstriction,↓AVnodalconduction
↑HR,↑inotropy,coronaryvasodilation,↑capillarypermeability
CNSPresynapticinhibitionofneurotransmission
MSK Wealduetolocalvasodilation,itch,↑nociception
GIT ↑Peristalsis ↑Gastricacidsecretion
HaemeAlterIL-16release
1
23
4
1 2 3 4
Histamine
383
![Page 384: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/384.jpg)
References
1. ParsonsME,GanellinCR.Histamineanditsreceptors.BritishJournalofPharmacology.2006;147(Suppl1):S127-S135.doi:10.1038/sj.bjp.0706440.
2. RangHP,DaleMM,RitterJM,FlowerRJ.RangandDale'sPharmacology.6thEd.ChurchillLivingstone.3. BowenR.Histamine.Vivo.ColoradoState.
Lastupdated2017-09-17
Histamine
384
![Page 385: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/385.jpg)
ProstanoidsProstanoidsareadiversefamilyofeicosanoids(20-carbonmolecules),producedfromarachidonicacid,andinclude:
ThromboxaneProstacyclinProstaglandins
Synthesis
Arachidonicacidisconvertedinto:
LeukotrienesbyLOXCyclicendoperoxidasesbyCOXenzymesTheseundergofurthermetabolismtoproduce:
ThromboxanesThromboxaneA
ProstacyclinsPGI
ProstaglandinsPGE
EPEPEP
PGFPGD
Effects
Receptor Receptor Respiratory Vascular GIT GU Other
ThromboxaneA Gq Vasoconstriction Platelet
aggregation
PGI Gs BronchodilationVasodilation(renalandpulmonary)
PGE EP Gq Bronchoconstriction Increasedcontraction
Renalvasodilation
PGE EP Gs BronchodilationClosureofductusarteriosus
Decreasedcontraction
Renalvasodilation
2
2
2123
2α2
2
2
2 1
2 2
Prostanoids
385
![Page 386: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/386.jpg)
PGE EP Gi
Gastricmucousproduction,GITcontraction
Uterinecontraction
PGF Gq Bronchoconstriction Vasoconstriction Uterinecontraction
PGD Gs Renalvasodilation
Promotessleep
References
1. RicciottiE,FitzGeraldGA.ProstaglandinsandInflammation.Arteriosclerosis,thrombosis,andvascularbiology.2011;31(5):986-1000.doi:10.1161/ATVBAHA.110.207449.
Lastupdated2019-07-18
2 3
2α
2
Prostanoids
386
![Page 387: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/387.jpg)
SkeletalMuscleDescribetheanatomyandphysiologyofskeletal,smooth,andcardiacmuscle
Describethemechanismofexcitation-contractioncoupling
Skeletalmusclehasanumberoffunctions:
FacilitatemovementPostureViatoniccontractionofantagonisticmusclegroups.SofttissuesupportAbdominalwallandpelvicfloorsupportviscera.VoluntarysphinctercontrolHeatproduction
StructureandContents
Skeletalmuscleconsistsoflongtubularcells,knownasmusclefibres,whichrunthelengthofthemuscle.Skeletalmusclecells:
Areundervoluntarycontrolfromthesomaticnervoussystemviaα-motorfibresα-motorfibresmaycontrolmultiplemyofibres,formingamotorunit.Are10-100μmindiameterContainseveralhundredperipheralnucleiContainmultiplemitochondria
Slowoxidativefibres(redfibres)Containmultiplemitochondria,producesustainedcontraction,andareresistanttofatigue.Fastglycolyticfibres(whitefibres)Containlownumbersofmitochondriaandlargeamountsofglycogen,andproducestrongcontractionsbutaremoreeasilyfatigued.
ContainsarcoplasmicreticulumContainlargeamountsofglycogen~200gtotal.ContainmyoglobinAppearstriatedmicroscopicallyduetothearrangementofmyofibrils
MyofibrilsaremultiplemyofilamentsarrangedinparallelMyofilamentsareformedfrommultiplesarcomeresarrangedinseriesAsarcomereisthefunctionalunitofmuscle
Musclefibresaresurroundedbylayersofconnectivetissue:
EndomysiumThinlayerwhichsurroundseachmusclefibre.PerimysiumSurroundsbundlesofmusclefibres.EpimysiumThicklayerwhichsurroundsanentiremuscle.
Theselayersofconnectivetissuejoinattheendofamuscletoformatendonoraponeurosis.
Sarcomere
MusculoskeletalSystem
387
![Page 388: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/388.jpg)
Thesarcomereisthefunctionalcontractileunitofmuscle.Averagesarcomerelengthis2.5μm.
Thesarcomerecontainstwomainproteins:
Myosin(thick)filamentsMyosinisalargeproteinwithtwoheads,whichbindactinandATP.Themyosinheadflexesonitsneckduringcontraction.Actin(thin)filamentsActinisasmallerproteinthanmyosin,andpotentiatestheATPaseofmyosin.Actinfilamentshaveagroovewhichcontainsanotherproteincalledtropomyosin,towhichtroponinattachesto.
Troponinhasthreesubunits:TroponinT-bindstroponintotropomyosinTroponinI-preventsmyosinbindingtoactinbyphysicallyobstructingthebindingsiteTroponinC-BindsCa whichinitiatescontraction
Theseproteinsarearrangedtoformthreebandsandtwolines:
A-bandThemyosinfilaments.H-bandThesectionofmyosinfilamentsnotoverlappingwithactinfilaments.I-bandThesectionofactinfilamentsnotoverlappingwithmyosinfilaments.Z-lineEachendofthesarcomere.ActinfromadjacentsarcomeresareconnectedattheZline.M-lineBandofconnectionsbetweenmyosinfilaments.
Excitation-ContractionCoupling
Musclecontractionnormallyrequiresthecoordinationofelectrical(signaling)eventswithmechanicalevents.
InresponsetoAChstimulatingnicotinicreceptors,theNa andK conductanceoftheend-plateincreasesandanend-platepotentialisgeneratedMusclefibresundergosuccessivedepolarisationandanactionpotentialisgeneratedalongTtubulesThesedelivertheAPdeepintothecell,andclosetothesarcoplasmicreticulum.Ca isreleasedfromsarcoplasmicreticulumThisprocessinvolves:
DihydropyridineReceptorSpecialisedvoltage-gatedL-typeCa channel,activatedbyT-tubulardepolarisation.ResponsibleforasmallamountofCa transport.RyanodineReceptor
2+
+ +
2+
2+2+
2+
MusculoskeletalSystem
388
![Page 389: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/389.jpg)
AsecondCa channelwhichisattachedto,andactivatedby,thedihydropyridinereceptor,causingamuchlargerreleaseofCa .
Ca isreleasedfromtheSR(increasingintracellularCa 2000x)andbindstotroponinC,weakeningthetroponinI-actinlinkanduncoveringmyosin-bindingsitesonactinCross-linkagesformbetweenactinandmyosin,whichreleasesADPThereleaseofADPtriggersapowerstroke,whichisaprocessofattachment,pulling,anddetachmentEachcycleshortensthesarcomereby~10nm:
Themyosinheadrotatesonits'neck',movingtoanewactinbindingsiteATPbindstothe(nowfree)bindingsiteonthemyosinATPishydrolysedtoADP,intheprocess"re-cocking"themyosinheadThisprocesscausesthethickandthinkfilamentstoslideoneachother,withthemyosinheadspullingtheactinfilamentstothecentreofthesarcomere.Therefore,overthecourseofapowerstroke:
TheA-bandisunchangedTheH-bandshortensTheI-bandshortens
PowerstrokescontinueaslongasthereisATPandCa available
Inrelaxation:
Ca ispumpedbackintothesarcoplasmicreticulumThisisanATP-dependentprocess,andiswhymusclerelaxationisactive.TroponinreleasesCaBindingsitesareoccludedbytroponin,andnofurthercontractionoccurs
References
1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. BarrettKE,BarmanSM,BoitanoS,BrooksHL.Ganong'sReviewofMedicalPhysiology.24thEd.McGrawHill.2012.3. Slomianka,L.Muscle.UniversityofWesternAustralia-SchoolofAnatomyandHumanBiology.
Lastupdated2019-07-18
2+2+
2+ 2+
2+
2+
2+
MusculoskeletalSystem
389
![Page 390: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/390.jpg)
SkeletalMuscleInnervationExplaintheconceptofmotorunits
Describetherelationshipbetweenmusclelengthandtension
Describethemonosynapticstretchreflex,singletwitch,tetanusandtheTreppeeffect
MotorUnitsAmotorunitconsistsofanα-motorneuronandthegroupofmusclecellsthatitinnervates
AnactionpotentialinthisneuronwillcausecontractionofallthemyocytesintheunitLargemuscleshavemanymyocytesperunitSmall,precisemuscles(e.g.extraocular)havefewmyocytesperunit
ForceofContractionMuscletensionisdependentonthreefactors:
InitialmyocytefibrelengthOptimalstretchmaximisesthenumberofoverlappingactinandmyosinfilaments.NumberofcontractingmyocytesRecruitmentofadditionalmotorunitsincreasestheforceofcontraction.FrequencyofActionPotentialsHighfrequencyactionpotentialscauseaccumulationofcalciuminthecytoplasm(theBowditchorTreppeeffect),increasingforceofcontraction.
Astheabsoluterefractoryperiodofskeletalmuscleisshorterthancardiacmuscle,tetany,orsustainedmusclecontraction,canoccur
Proprioception
Proprioceptionistheabilityofthebodytodetermineit'spositioninspace.Therearetwokeyproprioceptivesensors:
MusclespindlesGolgitendonorgans
MuscleSpindles
Musclespindlessensechangesinmusclelength.They:
Areaspecialisedmusclefibre,knownasintrafusalfibresRunparalleltomyocytes(alsoknownasextrafusalfibres)Consistoftwoelements:
Central,non-contractileportionwhichsensestensionContractileendsThisallowsthemusclespindletoadjustitslengthwithitsmuscle,sothataconstanttensioninthenon-contractileportioncanbemaintainedoverarangeofmusclelengths.
Musclespindleshavebothafferentandefferentinnervation:
SkeletalMuscleInnervation
390
![Page 391: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/391.jpg)
AfferenttypeIafibresadjusttheirelectricaloutputtosignalbothcurrentfibrelengthandrateofchangeAfferenttypeIIfibresonlysignalfibrelengthEfferentγneuronsinnervatethecontractileelements
Voluntarymusclecontractionresultsincontractionofbothmotorunits(α1neurons)andintrafusalfibres(γ-motorneurons).
Tonicinnervationofγ-motorneuronsincreasesmuscletonebystretchingthenon-contractileportions,increasingIafiringandsubsequentα-motorunitfiring.
GolgiTendonOrgans
Golgitendonorgansarestretchreceptorslocatedbetweenmuscleandtendon.They:
RuninseriestomyocytesSensestretchCausereflexivemusclerelaxation,intendedtopreventmuscledamage
Reflexes
Areflexisaninvoluntary,predictablemovementinresponsetoastimulus.Therearetwotypes:
Monosynaptic:MotorneuronsynapsesdirectlywiththesensoryneuronMonosynapticreflexesarerapid,butonlygeneratesimpleresponses.Therearefivecomponentstoamonosynapticreflex:
SensoryreceptorTypicallymusclespindles.AfferentneuronTypeIaafferentsrelaysignalfrommusclespindletoventralhornviathedorsalroot.SynapsebetweenafferentandefferentneuronIntheventralhornEfferentneuronα-motorneurontravelsfromtheventralhornandinnervatesthemotorunit.EffectormuscleInnervatedmotorunitcontractsinresponse.
Polysynaptic:MotorneuronisseparatedfromthesensoryneuronbyoneormoreinterneuronsinthedorsalhornThisallowsmodulationofsignal.Responsesareslowerbutmorecomplex,e.g.withdrawalofalimbfromahotobject.
TwitchandTetany
Atwitchistheresponseofamuscletoasinglestimulus(actionpotential)Atetaniccontractiondescribesthesustainedcontractionproducedbyrepetitivestimulationbeforerelaxationcanoccur
Thisstimulationmustbecausingaboveacriticalfrequency,whichisdependentontheactionpotentialdurationforacellRepetitivestimulationcausesrepeatedSRdepolarisation,leadingtosustainedhighintracellularCa levelsasCaentryexceedsCa exitForcefromtetaniccontractionisupto4xgreaterthanthatofatwitch
References1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.2. ANZCAMarch/April2000
2+ 2+2+
SkeletalMuscleInnervation
391
![Page 392: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/392.jpg)
Lastupdated2019-07-18
SkeletalMuscleInnervation
392
![Page 393: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/393.jpg)
NeuromuscularBlockersUnderstandingofthepharmacologyofneuromuscularblockingdrugs
Theneuromuscularjunctionisachemicalcommunicationbetweenthemotorneuronandthemusclecell.VesiclescontainingACharereleasedwhenactivatedbyCa ,andinfluxofwhichoccurswhentheactionpotentialreachesthenerveterminal.
NicotinicAChreceptorssitontheshouldersofjunctionalfoldsofmusclecells,whilstacetylcholinesteraseisburiedintheclefts.
FactorsAffectingNeuromuscularBlockade
PatientFactors
Factor Effect Mechanism
HepaticDisease Prolongeddurationofaminosteroidsandsuxamethonium
Decreasedmetabolism,decreasedproductionofpseudocholinesteraseinseveredisease
Pseudocholinesterasedeficiency Prolongeddurationofsuxamethonium Decreasedmetabolism
Age Increasedsensitivityinneonates,particularlyprematureinfants IncompletematurationofNMJ
Hypokalaemia Potentiatesnon-depolarisingblockade,reducesdepolarisingblockade
Increasesmagnitudeofstimulusrequiredtodepolarisecell
Hyperkalaemia Potentiatedepolarisingblockade,reducenon-depolarisingblockade
Decreasesmagnitudeofstimulusrequiredtodepolarisecell
Hypermagnesaemia Potentiatesblockade DecreasesAChrelease,decreasessensitivityofpost-synapticmembrane
Hypocalcaemia Potentiatesblockade DecreasespresynapticACHrelease,decreasessensitivityofpost-synapticmembrane
Respiratoryacidosis Potentiatesblockade EnhanceseffectofNMBagents
Hypothermia Potentiatesblockade Reduceshepaticmetabolism,renalelimination,Hoffmandegradation
Hypovolaemia Slowsrateofonsetandenhancesduration Prolongedcirculationtime
MyastheniaGravis Increasedsensitivitytonon-depolarisingagents
Autoimmuneblockadeofreceptorsgivespre-existinglevelofblock
Eaton-LambertSyndrome IncreasedsensitivitytoallNMBs Autoimmunedestructionofvoltage-gatedCa
channelspreventAChvesicleexocytosis
DrugFactors
Drugs Effect Mechanism
FrusemidePotentiatesblockadeatlowdose,reducesblockadeathighdose
Inhibitsproteinkinases(reducingAMP/ATPsynthesis)atlowdose,inhibitsPDEathighdoseswhichincreasesAChrelease
Inhalationalanaesthetics Potentiatesblockade
Stabilisepost-junctionalmembrane,blockadeofpresynapticAChreceptors
2+
2+
NeuromuscularBlockers
393
![Page 394: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/394.jpg)
Antibiotics Potentiateblockade Variable.Aminoglycosidesandtetracyclinesprolongblockade
Localanaesthetics Potentiateblockade ReduceAChreleaseandstabilisepost-junctionalmembrane
Anticholinesterases Reducesblockade IncreaseACHlevelsattheNMJbydecreasingbreakdown
OCP Potentiatesdepolarisingblockade Competesforbindingsitesonplasmacholinesterases
Ca -channelblockers Potentiateblockade InhibitCa dependentAChrelease
Lithium Potentiatesblockade AugmentsactionofNMBs
AdditionalFactorsAffectingOnsetofNeuromuscularBlockade
MostofthesecanberelatedtoFick'sLaw:
Factor Effect Mechanism
Potency
Lowpotencydecreasestimetoonset
Bowman'sprinciple:Lesspotentdrugsmustbeadministeredinhigherdoses,andsohaveagreaterconcentrationgradientdrivingdiffusiontotheeffectsite
Dose
Increaseddosedecreasestimetoonset
Greaterconcentrationgradient
CardiacOutput
Highoutputdecreasestimetoonset
Increaseddrugdelivery
Musclegroupflow
Highmuscularflowdecreasestimetoonset
Increaseddrugdelivery
PrimingPrinciple
(May)decreasetimetoonset
A'priming'doseofnon-depolarisingblockeristoanawakepatientgivenpriortoinduction.Thisoccupieslessthan70%ofreceptors,sodoesnotcausesignificantneuromuscularblockade.Afterinduction,aseconddoseisgiventooccupytheremainingreceptorsandcompleteblockade.
References1. SterlingE,WinsteadPS,FahyBG.GuidetoNeuromuscularBlockingAgents.2007.AnesthesiologyNews.2. ICUAdelaide.NeuromuscularBlockers.3. PinoRM.RevisitingthePrimingPrincipleforNeuromuscularBlockers:UsefulnessforRapidSequenceInductions.AustinJ
AnesthesiaandAnalgesia.2014;2(5):1030.4. ANZCAFebruary/April2011
Lastupdated2019-07-18
2+ 2+
NeuromuscularBlockers
394
![Page 395: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/395.jpg)
NeuromuscularBlockers
395
![Page 396: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/396.jpg)
BasalMetabolicRateDescribebasalmetabolicrateanditsmeasurement
Outlinethefactorsthatinfluencemetabolicrate
BasalMetabolicRateistheenergyoutputrequiredtosustainlifeatrest.
'Resting'isdefinedasanindividualwhois:Fastedfor12hoursInacomfortableexternalenvironmentAtmentalandphysicalrest
Normalvaluesare:100W.day70kcal.hr
Metabolicrateistheactualenergyconsumptionofanindividual,andisgreaterthanBMRduetoanumberoffactors.
FactorsAffectingMetabolicRateMetabolicRateisaffectedby:
AgeBMRdecreasesasageincreases.
NeonateshaveaBMRtwicethatofanadultChildrenhaveanincreasedBMRrelativetothatofanadultBMRdeclinesby2%foreachdecadeoflife
BodyCompositionLeanmusclehasagreaterenergyrequirementthanfat.
HigherbodyfatpercentageresultsinalowerBMRFemaleshavealowerBMRforthisreason-whenadjustedforleanmassthereisnodifference
DietDigestionincreasesBMRby~10%duetotheenergyrequiredtoassimilatenutrientsThisisknownasthespecificdynamicactionoffood.
Protein>carbohydrate>fatNotethattheSpecificDynamicActionforeachmacromoleculeisnotrelatedtotherespiratoryquotientforthatfoodtype.
StarvationdecreasestheBMRExercise
SkeletalmuscleisthelargestandmostvariablesourceofenergyconsumptionEnvironment
CoolerenvironmentsincreaseBMRTemperateenvironmentsdecreaseBMRupto10%
PhysiologicalstatesPregnancyincreasesBMRupto20%in2ndand3rdtrimesterLactationincreasesBMRCatecholaminesincreaseBMRCorticosteroidsincreaseBMR
DiseasestatesMalignancyincreasesBMR
-1-1
Nutrition&Metabolism
396
![Page 397: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/397.jpg)
SepsisincreasesBMRHyperthyroidismincreasesBMR
MeasurementofBMRusingIndirectCalorimetry
BMRismeasuredusingindirectcalorimetry,whichcalculatesheatproductionviameasurementofVO andVCO .Anumberofmethodsexistsdependingonwhetherthepatientisintubatedornot,orwhethertheyarerequiringsupplementaryoxygen.
Ingeneral:
PatientsshouldberelaxedandfastedFiO needstobecalculated(ortakenfromtheventilatorsettings),andE CO andE O mustbemeasuredSteady-stateshouldbeachievedacrossafiveminuteperiod
TheaverageMVO andMVCO changesby<10%
Therespiratoryquotient( )changeby<5%Thisratiowillvarydependingonthesubstancesmetabolised:
Carbohydrates=1Protein≈0.8Fat≈0.7
RestingEnergyExpenditureisgivenbytheabbreviatedWeirequation:
inWattsperunittimeofmeasurement.
ErrorsinIndirectCalorimetry
AirleaksandmeasurementerrorsMeasuresconsumption(ratherthanrequirements)Pointestimateofadynamicprocess
Footnotes
Therespiratoryquotientisthevalueof atsteady-state,whilsttherespiratoryexchangeratioisaffectedbymetabolicrate.
References
1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. ANZCAFeb/April20063. LITFL-IndirectCalorimetry
Lastupdated2019-07-18
2 2
2 T 2 T 2
2 2
Nutrition&Metabolism
397
![Page 398: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/398.jpg)
FatMetabolismDescribethephysiologyandbiochemistryoffat,carbohydrateandproteinmetabolism
Digestion
Triglyceridesarethemainconstituentofbodyfatinanimalsandvegetables,andthereforeindietaryfat.Theyconsistofthreefattyacidmoleculesjoinedbyaglycerolmolecule.
Asfatsarenotwatersoluble,theytendtoclumptogetherinchymeandarehardtodigestduetothelowsurfacearea:volumeratio.Emulsificationspeedsupthedigestiveprocess,andoccursviatheactionof:
BilesaltsManybilesaltshaveahydrophobicandahydrophilicend,whichgiveadetergentaction.Bilesaltsboundtofattyacidsformamixedmicellewhichcanbefurtherdigestedbyenzymesordirectlyabsorbed.PartiallydigestedfatsMechanicalactionofthestomach
Onceemulsified,triglyceridescanbehydrolysedbylipaseintofattyacidsandmonoacylglycerol.
Absorption
Absorptionoccursinanumberofstages:
Mixedmicelles,freefattyacids,monoacylglycerol,andcholesterolsareabsorbedviafacilitateddiffusionintotheenterocyteFromtheenterocyte:
Short-chainfattyacids(thosewith<12carbonatoms)entertheportalveinandtraveldirectlytotheliverLong-chainfattyacidsarere-esterifiedandpackagedwithalayerofproteinandcholesteroltoformachylomicronRe-esterificationmaintainstheconcentrationgradientfordiffusionoffattyacids,allowingfurtheruptaketooccur.
ChylomicronsareejectedfromthecellintothelymphaticsandtraveltothesystemiccirculationChylomicronsareremovedfromcirculationbylipoproteinlipaseLipoproteinlipaseisfoundoncapillaryendotheliumandboundtoalbumin.LipoproteinlipasebreaksdowntriglycerideinchylomicronsandVLDLtofreefattyacidsandglycerolThisreactionusesheparinasacofactor.Freefattyacidsandglycerolarethenfreetoenteradiposetissue
StorageFatisstoredastriglycerides,andformsthebulkofenergystorageofthebody.
Triglyceridesaresynthesisedbytheliver:
OccurswheninsulinlevelsarehighandglycogenstoresarefullFromexcesscarbohydrateandaminoacidsTheseareconvertedtofattyacidsandglycerol,andthenesterifiedtoformtriglyceride.Thisisknownaslipogenesis.
Metabolism
FatMetabolism
398
![Page 399: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/399.jpg)
Freefattyacidscanbeabsorbedbyadipocytesforstorage,orbeβ-oxidisedtoacetylCoAintheliver,whichcanenterthecitricacidcycletoproduceATP.
References1. ChaneyS.OverviewofLipidMetabolism.UniversityofNorthCarolinaSchoolofMedicine.2005.2. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.3. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2019-07-18
FatMetabolism
399
![Page 400: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/400.jpg)
CarbohydrateMetabolismDescribethephysiologyandbiochemistryoffat,carbohydrateandproteinmetabolism
Storage
Carbohydratesarestoredinliverandmuscleasglucosepolymersknownasglycogen.
Thelivercontains~100gofglycogenThiscanmaintainplasmaglucosefor~24hours.Skeletalmusclecontains~200gofglycogenThiscannotbereleasedintocirculation,andisforuseonlybythemuscle.
Productionofglycogenisstimulatedbyinsulin,whichisreleasedasplasmaglucoselevelsrisefollowingcarbohydrateingestion.Whenplasmaglucoselevelsfall,thereleaseofglucagonandadrenalinestimulatesglycogenolysis.
GlycolysisGlycolysis:
DescribestheprocessofconvertingglucoseintopyruvateThisisknownastheEmbden-Meyerhofpathway.OccursinthecytoplasmDoesnotconsumeoxygenorproducecarbondioxideProduces2ATPGlycolysisallowsproductionofATPinanaerobicconditions.
Gluconeogenesis
Gluconeogenesisistheproductionofglucosefromothermolecules.Gluconeogenesis:
RequiresATPtoperformSomeorgans(heart,brain)relyonglucoseforATPHasmanypotentialsubstrates:
LactatePyruvateGlycerolAminoacidsCAC-intermediates
IsstimulatedbyglucagonIsinhibitedbybiguanides(metformin)
References1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2019-07-18
CarbohydrateMetabolism
400
![Page 401: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/401.jpg)
CarbohydrateMetabolism
401
![Page 402: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/402.jpg)
ProteinMetabolismDescribethephysiologyandbiochemistryoffat,carbohydrateandproteinmetabolism
Essentialaminoacidscannotbeproducedbytransamination-theymustbesuppliedinthediet.
Metabolism
Proteincatabolisminvolvesthedeaminationofaminoacids.Deaminationcanoccurinoneoftwoways:
OxidativedeaminationHepaticdeamination,removingtheaminogrouptocreateaketoacidandammonia.Ammoniaproducedintheliverenterstheureacycleandbecomesurea,whichrequires3ATP.TransaminationAminogroupistransferredbyaminotransferasestoanotheraminoacidoraketoacidtoproduce:
Ketoacids,which:EnterthecitricacidcycleandproduceATPGetconvertedtoglucoseorfattyacids
AminogroupsEntertheureacycleandbecomeurea
FootnotesAmmoniacanalsobeproducedinthekidneybythedeaminationofglutamateinthekidney.Inthisinstance:
ItiseliminateddirectlyinurineasammoniumDoesnotentertheureacycle
--
References
1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2019-07-18
ProteinMetabolism
402
![Page 403: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/403.jpg)
RequirementsandStarvationDescribethenormalnutritionalrequirements
Fasting
Fastingisthemetabolicstateachievedaftercompletedigestionandabsorptionofameal.
Fastingcanbedividedinto:
EarlyfastingLessthan24hours.
PlasmaglucosefallsduetoconsumptionLeadstohormonalchanges:
Insulinreleasedecreases,causing:Liver
DecreasedglycogenesisIncreasedgluconeogenesis
MuscleDecreasedglucoseutilisationDecreasedglycogenesisDecreasedproteinsynthesis
FatDecreasedlipogenesisDueto:
DecreasedglucoseuptakeDecreasedTGuptake
IncreasedlipolysisAdrenalinereleaseincreases,causing:
DecreasedinsulinreleaseIncreasedlipolysisIncreasedmuscleFFAuseIncreasedhepaticglycogenolysisandgluconeogenesis
GlucagonreleaseincreasesCellularmetabolismalters:
Decreasedglucoseuptakebynon-obligateglucoseconsumerse.g.Muscle.IncreasedFFAandketonebodyuseβ-oxidationofFFAstomeetATPrequirements,leadingtoformationofketonebody.
SustainedfastingGreaterthan24hours.Seestarvationbelow.
Starvation
Starvationisthefailuretoabsorbsufficientcaloriestosustainnormalbodyfunction,requiringthebodytosurviveonendogenousstores.
Days:
RequirementsandStarvation
403
![Page 404: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/404.jpg)
EnergyisconservedthroughreductioninmovementHormonalchanges
Increasedgluconeogenesis,usingglycerol,lactate,andaminoacidsInsulinconcentrationsfallfurtherCortisollevelsincreaseGlucagonlevelspeakat4days
MetabolicchangesGlucoseusecontinuestofall,andFFAuseincreasesFurtherfallinmuscleproteinsynthesis
Weeks:Tissuesadapttometaboliseketones(withplasmalevelsrisingupto7mmol.L ,andgluconeogenesisfalls
Thebrainstillrequires100gofglucoseperdayBMRfallsAllbutlife-savingmovementceasesDeathtypicallyoccursafter30-60days,whenmusclecatabolismweakenstherespiratorymusclessuchthatsecretionscannolongerbecleared,andpneumoniaoccurs
RefeedingSyndrome
Refeedingsyndromeisaderangedmetabolicstatethatoccurswithfeedingafteraperiodofprolongedfasting,typically>5days.
Therearethreepathogenicmechanisms:
Alargespikeininsulincausesincreasedcellularuptake(andlowplasmalevels)of:GlucoseMagnesiumPhosphatePotassium
Sodiumandwaterretentionoccurs,whichmayprecipitatecardiacfailureIncreasedcarbondioxideproductionincreasesminuteventilationandworkofexhaustedrespiratorymuscles
Managementisbyslowinstitutionoffeedingandaggressiveelectrolytemanagement.
References
1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.2. ANZCAAugust/September2001
Lastupdated2019-07-18
-1
RequirementsandStarvation
404
![Page 405: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/405.jpg)
AnaerobicMetabolismDescribetheconsequencesofanaerobicmetabolismandketoneproduction
Lactate
TheEmbden-Meyerhofpathway:
Describestheconversionofglucosetopyruvate(andtwoATP)DoesnotconsumeO orproduceCOThereforeitoccursinbothanaerobicandaerobicconditions.ConsumestwoNAD andproducestwoNADH
Inanaerobicconditions(intheerythrocyte,andinthesettingofcellularhypoxia):
ThereisnooxygenavailabletoallowfurtherATPproductionviatheelectrontransportchainThereisalsonoregenerationofNAD intheETC.Inorderforglycolysistocontinue,NAD isregeneratedviaproductionoflactate
About1400mmoloflactateisproducedperday.Lactateiseither:
OxidisedinthecellThisrequiresrestorationofNAD ,e.g.resolutionofcellularhypoxia.CirculatedtotheliverLactateisthen:
OxidisedtopyruvateConvertedtoglucoseThisprocessisknownastheCoricycle.
Ketones
Ketones:
β-oxidationoffattyacidsintheliverproducesacetyl-CoAAcetyl-CoAusuallyentersthecitricacidcycletoproduceATPWhenlargeamountsofacetylCoAareproduced,theymayinsteadcondensetoformacetoacetate,whichcanthenbereducedtoβ-hydroxybutyrateThesesubstancesareknownasketones
Ketonescanonlybeproducedbytheliver,andonlyusedasasubstratebythekidney,aswellasskeletalandcardiacmuscle
Productionofketonesisacceleratedbyglucagonandadrenaline
References
1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. ANZCAAugust/September2011
2 2
+
++
+
AnaerobicMetabolism
405
![Page 406: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/406.jpg)
Lastupdated2017-07-27
AnaerobicMetabolism
406
![Page 407: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/407.jpg)
RegulationofBodyTemperatureOutlinethemechanismsforheattransferbetweenthebodyanditsenvironment.
Definethethermoneutralzone,anddescribethemechanismsbywhichnormalbodytemperatureismaintained.
Regulationofbodytemperatureisdonebybalancingheatlossandheatproduction,predominantlythroughbehaviouralmechanismsandskinThebodyisabletomaintainarelativelyconstantcoretemperatureunderawiderangeofenvironmentalconditions
Thethermoneutralzoneistherangeacrosswhichthebasalrateheatproduction(andoxygenconsumption)isbalancedbytherateofheatloss
Foranadultitistypically27-31°CInneonatesitishigher,typically32-34°C.
PrinciplesNetfluxofheatisdeterminedbythebalanceofmetabolicheatproductionandthecontributionoffourmechanismsofheatloss:
RadiationConductionConvectionEvaporation
Radiative
Radiativeheatexchange:
DescribesthelossofheatthroughEMRbyallobjectsabove0°KRadiativeheatlossisproportionaltotemperatureRadiativeheatlossdoesnotrequireatransfermedium
Makesup~45%ofheatlossunderthermoneutralconditions.Dependsonthetemperaturedifferentialbetweenanindividualandtheirenvironment
Acoldenvironment(e.g.operatingtheatre)causesalargeradiantheatlossTheheatlossfromthepatientisgreaterthantheheatgainfromthesurroundingenvironment.
Conduction
Conductionisthetransferofheat(askineticenergy)bydirectcontactfromahighertemperatureobjecttothelowertemperatureone.Conduction:
RequiresphysicalcontactbetweenbodiestoconductheatSolidsconductheatbetterthangasesThereisnoconductioninavacuum
HeatlossviaconductionisminimalinairbutisamajorcauseofheatlossinimmersionAsarteriesandveinstypicallyrunnexttoeachother,arterialheattendstobetransferredtothe(cooler)veins,limitingfurtherheatlossThisissimilartocounter-currentexchangeinthekidney.
Asfatisapoorerconductorofheatthanmuscle,increasedbodyfatwillslowheatlossbyconduction
Convection
Thermoregulation
407
![Page 408: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/408.jpg)
Convectionislossofheatbyconductionbyamovingobject.Convectionis:
ThepredominantmechanismofheatlossinthenakedhumanEffectsaregreatereffectsathigherwindspeeds.
Evaporation
Evaporativelossesdescribethelossofheatenergyduetothelatentheatofvapourisationofwater.Evaporationof100mlofwaterwillreducebodytemperatureby~1°C.
TemperatureSensationandRegulation
Temperaturesensorsarecentralandperipheral,whilstregulationoccurscentrally.
CentralSensation
Centraltemperaturesensorsexistinthe:
AbdominalvisceraSpinalcordHypothalamusAnteriorhypothalamusisthemostimportantcentralthermoreceptor,andrespondstobothincreasedanddecreasedtemperaturesbyalteringtheirrateofdepolarisation,elicitinganarrayofneuronalandhormonalresponses.Brainstem
Theinter-thresholdrangeistherangeofcoretemperaturesnottriggeringaresponse.
Normalis0.2to0.4°C.Widensunderanaesthesiato~4°C
PeripheralSensation
Peripheraltemperaturesensorsare:
FreenerveendingsExtremelysensitiveAltertheirratesoffiringbyordersofmagnitudeinresponsetotemperaturechange.Dividedinto:
ColdreceptorsLiebeneaththeepidermis,andareexcitedbycooling(inhibitedbywarming),activefrom10-40°C,withastaticmaximaat25°C.WarmreceptorsLiedeeptothedermis,areexcitedbywarming(andinhibitedbycooling),activefrom30-50°C,withastaticmaximaat44°C.
Regulation
Temperaturesensationrunsfromcutaneousreceptorsviathespinothalamictractsandmedullatothehypothalamus.Corticalinputisreceivedviathethalamocorticalrelay,whilstprimitiveresponsesareeffectedviathemidbrain.
EffectorResponses
Thermoregulation
408
![Page 409: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/409.jpg)
Increaseheatloss Reduceheatloss/Increaseheatgain
CNS Removeclothing,sprawl,reduceactivity. Huddle,seekshelter,addclothing
Cardiovascular IncreaseperipheralvasodilationandAVshunting,andcardiacoutputtoimproveflowtocutaneoustissues
Vasoconstriction,peripheralcirculatoryshutdown
Musculocutaneous Sweating Piloerection,Shivering
Metabolic IncreasedBMR,non-shiveringthermogenesis
Vascularchangesaretheleastmetabolicallycostlyandcanresultindramaticincreases(upto60%ofcardiacoutput)inskinbloodflowWhenenvironmentaltemperatureexceedsbodytemperature,conductionandconvectionresultinheatgain-evaporativecoolingviasweatingistheonlywaytoreducebodytemperatureEfficacyofsweatingisrelatedtorelativehumidity
Piloerection(hairstandingonend)trapsalayerofwarmairclosetothebodytoactasaninsulatorThisisofmoreimportanceinotherprimatesthaninman,astheyhaveenoughbodyhairtomakeiteffective.
Increasingbasalmetabolicrateand'waste'heatproductionisessentialtomaintaintemperatureincoldenvironments.Thiscanbethrough:
ShiveringThesimultaneouscontractionofagonisticandantagonisticmuscles.Non-shiveringthermogenesis:
HormonalLevelsofthyroidhormoneandadrenalineincrease,raisingmetabolicrateinallcellsBrownfatBrownfatproducesheatthroughuncoupledoxidativephosphorylation,whichusestheelectrontransportchaintoproduceheatratherthanATP.Brownfatis:
Avitalmechanismforheatproductionintheneonate(theyhaveanimmatureshiveringresponse),andforms~5%ofneonatalmassLocatedin:
NeckSupraclavicularInterscapularSuprarenal
SympatheticallyinnervatedContainslargenumbersofβ receptors
EffectofAnaesthesia
Generalanaesthesiacausesa1-3°Cdropincorebodytemperature,whichoccursinthreephases:
RapidreductionCoretemperaturefallsby1-1.5°Cinthefirst30minutes.
Predominantlyduetovasodilation,whichisdueto:ReductioninSVR,withgeneralisedvasodilationandincreasedskinbloodflowHeatredistributionisthemajorinitialfactor(ratherthanheatloss),asvasodilationleadstoincreasedheatcontentofperipheries.ImpairsthermoregulatoryvasoconstrictiveresponsesInter-thresholdrangeiswidenedto4°C(upfrom0.4°C)
3
Thermoregulation
409
![Page 410: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/410.jpg)
GradualreductionFurtherdropincoretemperatureof1°Coverfollowing2-3hours.
DuetoheatlossexceedingheatproductionNon-shiveringthermogenesisistheonlyresponseavailabletoparalysed,anaesthetisedpatient.
PlateauOncecorebodytemperaturefallsfarenough,thermoregulatoryresponsesareactivatedandfurtherheatlossisattenuatedbyincreasedmetabolicheatproduction.
Neuraxialanaesthesia:
HypothermiaislessextremeasthermoregulationisonlyaffectedinareascoveredbytheblockadePlateaudoesnotoccurasvasoconstrictiveresponsesareinhibitedbytheblockade
References
1. Auerbach.WildernessMedicine.SixthEdition.Chapter4:Thermoregulation.2. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.3. DiazA.Define"thermoneutralzone".Brieflyexplainhowthebodyregulatestemperaturewhentheambienttemperature
exceedsthethermoneutralzone.PrimarySAQs.4. BuggyDJ,CrossleyAW.Thermoregulation,mildperioperativehypothermiaandpostanaestheticshivering.BrJAnaesth.
2000May;84(5):615-28.
Lastupdated2019-07-18
Thermoregulation
410
![Page 411: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/411.jpg)
InflammationDescribethefactorsinvolvedintheprocessofinflammationandtheimmuneresponse,includinginnateandacquiredimmunity
Inflammationisanon-specificresponsetriggeredbyapathogenortissueinjury,whichaimstolimitfurthertissuedamage.
Inflammationisclassicallycharacterisedby:
PainHeatRednessSwellingLossoffunction
Thisisaconsequenceof:
VasodilationIncreasesbloodflowtoarea,whichincreasessupplyofimmunecellsandresourcesforcellularrepair.IncreasedvascularpermeabilityIncreasesextravasationofproteinandimmunecells.MigrationofphagocytesRemovepathogensandcellulardebris.
ProcessofInflammation
TissuedamageTraumacausesmechanicaldisruptionofvasculatureandmastcelldegranulation,causinglocalinflammationandactivationofhaemostaticmechanismsInfectionstimulatesdegranulationoflocalmacrophages,releasinginflammatorycytokinesandtriggeringmastcelldegranulation
LocalinflammatoryresponseHistaminecausesarteriolarandpost-capillaryvenuledilatationandsubsequentextravasationReleaseofchemotacticmoleculesattractscirculatinginflammatorycells
SystemicinflammatoryresponseSevereinflammationmayleadtocytokinesinthesystemiccirculation,causing:
FeverNeutrophilrecruitmentfrombonemarrowReleaseofacute-phaseproteinsfromliver
References1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2018-09-21
Immunology
411
![Page 412: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/412.jpg)
Immunology
412
![Page 413: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/413.jpg)
InnateImmunityDescribethefactorsinvolvedintheprocessofinflammationandtheimmuneresponse,includinginnateandacquiredimmunity
Theinnateimmunesystemconsistsofprotectivemechanismswhicharepresentlife-long,andtypicallyformsthefirstlineofdefenceagainstpathogens.
Keyfeaturesofinnateimmunityinclude:
ImmediacyNon-specificresponseNotmodifiedbyrepeatexposures
Theinnateimmunesystemconsistsofthreecomponents:
PhysicochemicalbarriersHumoralmechanismsCellularMechanisms
PhysicochemicalBarriers
Theseinclude:
SkinMucousmembranes
MucousMucociliaryelevator
GastricacidUrinationOptimisedbyhighflowratesandlowresidualbladdervolumes.
InnateHumoralMechanisms
Humoralmechanismsdescribestheroleofinflammatoryproteinsininnateimmunity:
ComplementThecomplementsystemisacomplexgroupofabout25plasmaproteinsimportantinbothinnateandadaptiveimmunity.
Thecomplementsystemisactivatedby:Antigen-antibodycomplexesThe'classicalpathway.'SubstancesinthebacteriacellwallThe'alternativepathway.'
Complementhasanumberofinflammatoryfunctions:DestructionofbacteriaSeveralcomplementproteinscometogethertoformamembraneattackcomplex,whichcreateslargeporesincellmembranes,causingwatertodiffuseinandbacteriatoburst.OpsonisationofbacteriaBoundcomplementactsasabindingsiteforphagocytes.ActivationofmonocytesandphagocytesChemotaxis
InnateImmunity
413
![Page 414: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/414.jpg)
Attractsleucocytes.MastcelldegranulationAugmentsinflammation.
Acute-PhaseProteinsInflammatoryproteinswithanumberofeffects:
OpsonisationInflammatorymediatorsIncreasebloodflowanddeliveryofinflammatorycellsviathreemechanisms:
DilatationandincreasedcapillarypermeabilityEndothelialactivationincreasingleukocyteadhesionAttractionofneutrophilsandmonocytes
ProteolyticenzymesBactericidalenzymeslocatedinsaliva,tears,respiratorymucous,andneutrophils.
InnateCellularMechanismsCellularcomponentsoftheinnateimmunesysteminclude:
MastcellsExistinlooseconnectivetissueandmucosa,andcontainmanyintracellulargranulesofheparinandhistamine.
LeukocytesNeutrophils(60%ofallleukocytes)Phagocytosebacteriaandfungi(15-20perneutrophil).Thisprocessconsistsofanumberofsteps:
ExitcirculationbymarginatingalongcapillaryborderwhenactivatedMigrateviachemotaxistowardsthetissueinsultPhagocytoseopsonisedbacteriaandfungiKillorganismswitharespiratoryburst:Agranulecontaininghydrogenperoxide,hydroxylandoxygenradicalsfuseswiththetargetcellmembrane,destroyingboththetargetandtheneutrophil.
MonocytesBecomemacrophageswhentheyleavecirculationandentertissue.Macrophageshavealifespanof2-4months,andcanphagocytoseupto100bacteriabeforeitdies.Functionsinclude:
PhagocytosisanddestructionofpathogenEspeciallyintracellularpathogens(listeria,mycobacteria),parasites,andfungi.BreakdownofdamagedbodycellsPresentantigentoT-helpercellsSecretionofinflammatorymediators
EosinophilsKillmulticellularparasites.BasophilsContainheparinandhistamine.LymphocyteSubtypeofleukocyteimportantinadaptiveimmunity.Include:
NaturalKillercellsActiveagainstviralandtumourcells.BcellsTcells
InnateImmunity
414
![Page 415: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/415.jpg)
References
1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.
Lastupdated2019-07-18
InnateImmunity
415
![Page 416: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/416.jpg)
AdaptiveImmunityDescribethefactorsinvolvedintheprocessofinflammationandtheimmuneresponse,includinginnateandacquiredimmunity
Theadaptiveimmunesystemrespondstoanexposure,demonstratingspecificityandmemory,withimprovedefficacyonrepeatexposure.
Adaptiveimmunitymaybe:
ActivePrimaryimmuneresponsegeneratedbyexposuretoantigen.
InfectionVaccinationAninactive(butstillforeignandthereforeantigenic)proteincomponentofapathogenisgiventothepatient,resultinginanimmuneresponse.Subsequentexposuretothewholepathogentriggersasecondaryimmuneresponse.
PassivePreformedantibodyisgiventothepatient.Thiswillprovidetreatment/coverageforthelifeoftheantibody,butimmunitywillbelostwhentheantibodybreaksdownorsuppliesareexhausted.
TransplacentalColostrumAdministrationofserum
Componentsoftheactiveimmunesysteminclude:
CellularPredominantlyTlymphocytesHumoralIncludingcomplementandantibody.
AdaptiveCellularImmunity
Lymphocytesaredividedintotwotypes:
BlymphocytesAreproducedinthebonemarrow,andmigratetolymphoid(nodes,spleen,MALT)wheretheyarerenamedplasmacellsandproduceantibody.Functionsinclude:
ProductionofantibodyagainstspecificantigensPresentationofantigentoT-cellstoactivethemProliferationtoformmemorycells
TlymphocytesAreproducedinthebonemarrowandmigratetothethymuswheretheymature.Tcellswhichexpressantibodytohostproteinapoptose,resultinginonly2%ofimmatureTcellssurviving.MatureTcellsthenspreadtolymphoidtissue.TherearefivetypesofTcells,ofwhichtwoaremostimportant:
HelperT-cells2/3 ofT-cellsarehelpercells,areareidentifiedbytheirCD4membraneprotein.Functionsinclude:
CytokineproductionBlymphocytestimulationMacrophageactivation
CytotoxicT-cells
rds
AdaptiveImmunity
416
![Page 417: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/417.jpg)
AreidentifiedbytheirCD8membraneprotein.Functionsinclude:DestructionofvirallyinfectedandtumourcellsAllcellsexpressproteinsthattheyareproducingonmembraneMHCImolecules,forinspectionbyimmunecells.Infectedortumourcellswillexpressforeignproteins,andcauseactivationofcytotoxicTcells:
InduceapoptosisinthetargetcellRapiddivisionofcytotoxicTcell,whichtheninspectsothercellsforinfection
Transformationtomemorycells
AdaptiveHumoralImmunity
AntibodiesY-shapedimmunoglobulinswhich:
AreproducedinresponsetoapathogenArespecifictothatpathogen
Antibodyfunctionsinclude:
OpsonisationAgglutinationEachantibodycanbindmultiplepathogens,increasingtargetsizeforleukocytes.InactivationofpathogenAntibodybindingmaydisablethepathogen.ActivationofcomplementAntibody-antigencomplexescausecomplementactivation.
PrimaryImmuneResponse
Theprocessofinvasionofanewpathogentoantibodyproductiontakes~5days,andoccursinanumberofsteps:
APCphagocytoseapathogenAPCsincludemacrophagesanddendriticcells.APCexpressantigen(bitsofpathogen)oncellsurfaceAPCtraveltolymphoidtissueandpresentittoBandTcellsWhenanAPCfindsaBandTcellwithareciprocalantibody:
ThelpercellbecomesactivatedbyAPCThelpercellrapidlyproliferates('clonalexpansion')
ProportionbecomememorycellsBcellsareactivatedbyboththeAPCandaT-helpercell(requiresboth)Bcellsrapidlyproliferate
ProportionbecomememorycellsProportionbecomeplasmacells
Plasmacellsproduceantibodyatarateof2000moleculespersecond,whichoverridesnormalcellularhomeostasis,causingdeathwithinaweek.AntibodyproducedinaprimaryimmuneresponseisIgM,withsomeIgGproducedlateron.
SecondaryImmuneResponse
Repeatinvasionbythesamepathogenismetwithamuchmorerapidandaggressiveimmuneresponse:
APCsphagocytoseapathogenAPCsexpressandpresentantigenMemoryTandMemoryBcellsformedduringtheprimaryresponseareactivated,andbeginrapidlydividingandproducingantibody
AdaptiveImmunity
417
![Page 418: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/418.jpg)
References
1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2019-07-18
AdaptiveImmunity
418
![Page 419: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/419.jpg)
HypersensitivityExplaintheimmunologicalbasisandpathophysiologicaleffectsofhypersensitivity,includinganaphylaxis.
Understandthepharmacologyofthedrugsusedinthetreatmentofanaphylaxis.
Hypersensitivityreactionsareexaggeratedimmuneresponsesthatcausehostinjury.
ClassificationofHypersensitivityReactionsTheGelandCoombssystemclassifieshypersensitivityreactionsbythemechanism.Itiscommonlyusedbutfailstoclassifymorecomplexdiseases.
Type Timing Mediator Pathophysiology Diseaseexample(s)
TypeI-Immediatehypersensitivity
Secondstominutes
IgE BasophilandmastcelldegranulationAnaphylaxis(systemic),Atopy(local)
TypeII-Cellularhypersensitivity
5-8hours IgM,IgG
Antibodybindingtocellsurfaceantigen,resultingincelldeathviacomplementmembraneattackcomplexes,orphagocytosisbymacrophages
Transfusionreactions,hyperacuteallograftrejection
TypeIII-Immune-complexdeposition
2-8hours
IgM,IgG,IgA
TissuedepositionofAb-Agcomplexes.AccumulationofPMNs,macrophages,andcomplement.
SLE,necrotisingvasculitis,post-StrepGN
TypeIV-Delayedhypersensitivity
24-72hours T-cell T-cellinducedmononuclearcellaccumulation.
Releaseofmonokinesandlymphokines.
TB,Wegener'sGranulomatosis,Granulomatousvasculitis
TypeIHypersensitivity
AntigensimulatesaBlymphocytetoproduceaspecificIgEagainstitThisIgEthenbindstoFcreceptorsonmastcells,sensitisingthemtothisexposureOnre-exposuretheantigenbinds(cross-links)IgEonmastcells,causingdegranulation:
Histamine,leukotrienes,andprostaglandinsarereleasedThismaycauselocalorsystemiceffects,dependingonmethodofexposure:
Asystemicreactioniscalledanaphylaxis,andmanifestsasacombinationof:HypotensionBronchospasmLaryngealoedemaRashes
Localreactionsdependontherouteofexposure,andincludeAsthmaInhaled.AllergicrhinitisNasopharyngealmucosa.
Non-immuneanaphylaxis(alsoknownasanaphylactoid)reactionsarecharacterisedbyaimmediategeneralisedreactionclinicallyindistinguishablefromtrueanaphylaxis,buttheimmunenatureisunknown,ornotduetoatypeIhypersensitivity
Hypersensitivity
419
![Page 420: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/420.jpg)
reaction
ManagementofAnaphylaxis
Adrenalineisthedrugofchoice,asittreatscardiovascularcollapse,bronchospasm,anddecreasesoedemaformation.Inadults,0.3-0.5mgIMQ5-15minInchildren,0.01mg/kgIMQ5-15min
Glucagonmaybeusedinβ-blockedpatientsresistanttoadrenaline.Inadults,1-5mgIVover5minutes,followedbyinfusionat5-15microg/minInchildren,20-30mcg/kgupto1mgover5minutes
Non-pharmacologicalmanagementincludesearlyintubationtoprotectagainstairwayobstructionduetoangioedema.Adjunctsincludeantihistaminesandsteroids.Theyaresecondlineastheydonotattenuatecardiovascularcollapse,resolveairwayobstruction,orhavestrongevidencebehindtheiruse.Theyinclude:
Diphenhydramine25-50mgIV(Children:1mg/kgupto40mg)upto200mgin24/24Salbutamol,forbronchodilationMethylprednisolone1-2mg/kg,ostensiblytoprotectagainstreboundanaphylaxis(thoughthereisminimalevidence)
TypeIIHypersensitivity
AntibodiesbindtocellsurfaceantigenAntibody-AntigencomplexactivatescomplementComplementgeneratesaninflammatoryresponseCelldeathoccursvia:
ComplementmembraneattackcomplexPhagocytosis
Clinicalpicturedependsonaffectedorgans.Examplesinclude:
HyperacuteallograftrejectionTransfusionreactionsandhaemolyticdiseaseofthenewbornGoodpasture'ssyndromeAutoimmunecytopaeniasMyastheniaGravis
TypeIIIHypersensitivity
Immune-complexreactionwhereAb-AgcomplexesareformedanddepositedintissuesSubsequentcomplementactivationcausesinflammationandneutrophilsactivation,leadingtotissuedamageTherearetwosubtypesoftypeIIIreactions:
Formationofcomplexesincirculationandsubsequentdepositionintissuese.g.Serumsickness
FormationofcomplexesintissuesSmallamountsaretypicallyremovedbythereticuloendothelialsystem,butinthiscasetherearetoomany,ortheyaretoosmall,tobeclearedeffectively.
e.g.TheArthusreaction(alocalisedvasculitis,whichmaybenecrotising)
TypeIVHypersensitivity
AntigenispresentedtoTlymphocyteswhichproliferateandbecomesensitisedT-cellsthenreleasecytokines,attractingmacrophagesandleadingtolocalinflammationDuringprolongedexposure,macrophagesmayfusetoformgiantcellsandformagranuloma.Examplesinclude:TB
Hypersensitivity
420
![Page 421: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/421.jpg)
Granulomatousvasculitis
References
1. CICMJuly/September20072. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.
Lastupdated2019-07-18
Hypersensitivity
421
![Page 422: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/422.jpg)
ClassificationofMicroorganismsDescribetheclassificationofmicro-organisms,includingviruses,bacteria,protozoaandfungi
Microorganismscanbeclassifiedasprokaryotes(bacteria),viruses,oreukaryotes(whichincludefungi,helminths,andprotozoa).
Bacteria
BacteriaareprokaryoticorganismsMostclinicallyrelevantbacteriacanbeclassifiedbyGramstainandshape
GramstainseparatesbacteriaaccordingtotheircellwallcompositionItcannotbeusedonorganismsthatlackacellwall,suchasmycoplasma.
Acrystalvioletfollowedbyaniodinesolutionisappliedtotheslide,whichisthenwashedwithasolventGram+veorganismswillretainthestainduetotheirthickpeptidoglycancellwall,whilstgramnegativeorganismsbecomecolourless
Asafraninpinkstainisthenapplied,whichstainsthegram-vebacteriapinkBacteriacanalsobeclassifiedbyshapeinto:
CocciAppearroundonmicroscopy.Rods
Combiningofthesetwosystemsclassifiesalargeproportionofmicrobes:
Examples: GramPositive GramNegative
Cocci StaphylococcusAureus,StreptococcusPneumoniae N.Meningitidis,N.Gonorrhoea
Rods Listeria,Clostridiumdifficile EscherichiaColi,Pseudomonasaeruginosa
BacterialSubclassification
Additionaltestingcanbedonetofurtherclassifybacteria:
CatalasetestingisperformedonGrampositivecocciHydrogenperoxideisaddedtoabacterialsample,andinthepresenceofcatalasewillproduceoxygen.
CatalasepositiveindicatesStaphylococciCatalasenegativeindicatesStreptococci(andenterococci)
CoagulasetestingisperformedonStaphylococcalspeciesCoagulaseisanenzymewhichcleavesfibrinogentofibrin.Thestaphylococcalcolonyisaddedtorabbitplasmaandincubated.Inthepresenceofcoagulase,fibrinisformed.
CoagulasepositivestronglysuggestsS.AureusCoagulasenegativeexamplesincludeS.epidermidisorS.saprophyticus
HaemolytictestingisperformedonStreptococcalspeciesBacterialcoloniesareaddedtobloodagar,andthecolourchange(duetohaemolysis)isnoted.
αhaemolyticorganismsproducedarkgreenagar,asmethaemoglobinisproducedbyhydrogenperoxideproducedbytheseorganisms.Examplesinclude:
Strep.pneumoniaeStrep.viridans
β-haemolyticorganismsproduceyellowagarfromcompletehaemolysis.Examplesinclude:
1
Microbiology
422
![Page 423: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/423.jpg)
Strep.pyogenesStrep.agalactiae
γ-haemolyticorganismsleavetheagarunchanged.Examplesinclude:E.faecalisE.faecium
Additionally,gramnegativerodsshouldbefurtherclassifiedintopseudomonalandnon-pseudomonalorganisms
Viruses
VirusesconsistofmoleculesofeitherDNAorRNAshieldedinaproteincoat.Theyrequiretheuseofhostcellstructuresforreproductionandarethereforeobligateintracellularparasites.Theycanbeclassifiedbyfiveproperties:
1. DNA/RNADNAvirusesreplicateinthecellnucleususingahostpolymerase.
2. Double-strandedorsingle-strandedi. MostDNAvirusesaredouble-stranded(dsDNA)ii. MostRNAvirusesaresingle-stranded(ssRNA)
3. Negative-senseorpositive-sense(RNAvirusesonly)i. Positive-sensegenomesmaybetranslateddirectlyintomRNAii. Negative-sensegenomesrequireanRNA-dependentRNApolymerasetotranslatethemtoapositive-sensestrandprior
totranslation.4. CapsidSymmetry
Theproteincoatmaybeeithericosahedralorhelical5. Envelopedornon-enveloped
Inadditiontoaproteincoat,virusesmayhavealipidmembrane(acquiredfromthehostcell)aroundtheirproteincoat.
EukaryoticOrganismsEukaryoticorganismsincludefungi,protozoa,andhelminths,aswellasplantsandanimals.Theydifferfromprokaryoticorganismsinanumberofways:
Property Prokaryotes Eukaryotes
Chromosomes Single,circular Multiple
NucleusandOrganelles None Membraneboundnucleusandorganelles
Cellwall Usually Inplants
Ribosome 70S 80Sincell,70Sinorganelles
Size 0.2-2mm 10-100mmm
Fungitypicallyfeedondead/decomposing/theimmunocompromisedandproducespores.Theyaresubclassifiedinto:YeastsYeastsareunicellular.Theyaredividedinto:
CandidaAlbicansNon-albicansMoredifficulttotreat.
CryptococcusMouldsMouldsarearefilamentous.
Aspergillus
Microbiology
423
![Page 424: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/424.jpg)
PenicilliumDimorphousHavecharacteristicsofbothyeastsandmoulds.
Histoplasma
Protozoaareparasiticsingle-celledeukaryotes.Theycanbeintracellularorextracellular.
Helminthsareparasiticmulti-celledeukaryotes.Theycanbeintracellularorextracellular.Theyaresubdividedintotapeworms(cestodes),flukes(trematodes),androundworms(nematodes).
Footnotes.Thisclassificationdoesnotcapturespirochetes,mycoplasmas,chlamydias,andotherlesscommonlyencounteredorganisms.Amorecompleteclassificationusessixproperties:↩
1. CellWallStructurei. Flexible(e.g.Spirochetes)ii. Rigidiii. Non-existent(e.g.Mycoplasmaspp.)
2. Morphologyi. Unicellularii. Filamentous
3. GrowthLocationi. Extracellularii. Obligateintracellularparasites(e.g.Chlamydiaspp.)
4. GramStaini. Grampositiveii. Gramnegative
5. Shapei. Cocciii. Rods
6. O tolerancei. Aerobesii. Anaerobes(e.g.Clostridiumspp.)
References1. HarveyRA,CornelissenCN,FisherBD.LippincottIllustratedReviews:Microbiology(LippincottIllustratedReviews
Series).3rdEd.LWW.2. CICMSeptember/November2008
Lastupdated2019-07-20
1
2
Microbiology
424
![Page 425: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/425.jpg)
AntimicrobialResistanceDescribetheprinciplesofanti-microbialresistance
Resistanceoccurswhenthemaximalleveloftheagenttoleratedisinsufficienttoinhibitgrowth.
Resistancecanoccurbroadlyviatwomechanisms:
GeneticAlterationSpontaneously,throughmutationandsubsequentnaturalselectionofresistantorganismsTransferalofresistancegenesfromorganismtoorganismviaplasmids
ProteinExpressionIncreasingordecreasingexpressionofproteinswithsubsequentchangeinefficacyofantimicrobials.
MechanismsSpecificmechanismsofresistance(whichmaybegeneticalterationsorchangesinproteinexpression)include:
PreventaccesstotargetDecreasepermeability
Narrowingofporinchannelse.g.StreptococcalresistancetopenicillinstypicallyoccursbyreducingaccesstoPBPs.Lossofnon-essentialtransporterchannelse.g.Anaerobeshavenooxygen-transportchannelwhichpreventspenetrationbyaminoglycosides.
ActiveeffluxofagentIncreasedefficiencyorexpressionofeffluxpumps.Canbe:
RemovedfromcellTrappedbetweencellwalllayerse.g.GlycopeptideresistanceinVRSA.
AlterantibiotictargetsiteChangesinbindingsiteproteinwillincreaseresistancetoagentswithlowaffinityOver-expressionoftargetproteinSynthesisoftarget-protectingproteins
ModificationorInactivationofDrugMetabolismofdruge.g.β-lactamaseshydrolyseβ-lactamrings
ModificationofMetabolicPathwaysDevelopmentofmetabolicpathwaystobypasssiteofactionofantibiotice.g.ResistancetoTrimethoprim-Sulfamethoxazolebyallowingbacteriatosynthesisorabsorbfolicacid.
References
1. HarveyRA,CornelissenCN,FisherBD.LippincottIllustratedReviews:Microbiology(LippincottIllustratedReviewsSeries).3rdEd.LWW.
2. CICMSeptember/November20083. BlairJM,WebberMA,BaylayAJ,OgboluDO,PiddockLJ.Molecularmechanismsofantibioticresistance.NatRev
AntimicrobialResistance
425
![Page 426: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/426.jpg)
Microbiol.2015Jan;13(1):42-51.doi:10.1038/nrmicro3380.4. Microrao-MechanismsofAntimicrobialResistance
Lastupdated2019-07-18
AntimicrobialResistance
426
![Page 427: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/427.jpg)
AntisepticsOutlinethepharmacologyofantisepticsanddisinfectants
KeyDefinitions
Relevantdefinitionsforantisepticsinclude:
CleaningPhysicalremovalofforeignmaterial.
Usedfornon-criticalitems,whichcomeintocontactwithhealthyskinbutnotmucousmembranes(e.g.bloodpressurecuff)
DecontaminationDestructionofcontaminantssuchthattheycannotreachasusceptiblesiteinsufficientnumbertocauseharm.DisinfectionEliminationofallpathologicalorganisms,excludingspores.
Usedforsemi-criticalitems,whicharethosethatcontactmucousmembranesbutdonotbreakthebloodbarrier(e.g.endoscopes,laryngoscopes)
SterilisationEliminationofallformsofmicrobiallife,includingspores.
Usedforcriticalitems,whicharethosethatentersterileorvasculartissueandposeahighriskofinfection(e.g.surgicalinstruments,vascularandurinarycatheters)
AntisepticAgents
Drug IsopropylAlcohol Chlorhexidine Povidoneiodine
PharmaceuticsTypically60-90%-requiressomewatertodenatureprotein.Flammable.
Maybeaqueousorcombinedwithisopropylalcohol.
Iodinecombinedwithapolymer(povidone)toenhancewatersolubility
AntiviralProperties Poorantiviral Poorantiviral Goodantiviral
AntibacterialProperties Broadspectrumantibacterial
Broadspectrumantibacterialandantifungal
Broadspectrumincludingfungi,spores(unlikeiodine),andtuberculosis
Toxic Irritantonmucousmembranesandopenwounds Hypersensitivity Hypersensitivity
Other Persistentantisepticeffect
Requirescontinualreleaseofiodinetoachieveeffect.Inactivatedbyorganicsubstances.Stains.
References
1. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.2. SabirN,RamachandraV.Decontaminationofanaestheticequipment.ContinuingEducationinAnaesthesia,CriticalCareand
Pain.(2004).4(4),103–106.
Antiseptics
427
![Page 428: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/428.jpg)
Lastupdated2017-08-11
Antiseptics
428
![Page 429: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/429.jpg)
RespiratoryChangesofPregnancyExplainthephysiologicalchangesduringpregnancy,andparturition
Respiratorychangesinpregnancyareafunctionoftwothings:
AnatomicalcompressionofthechestIncreasedVO andVCO
AnatomicalChangesDiaphragmpushedupwardsby~4cmIncreasedAPandtransversediameterofthechestwall(~2-3cm)Largeairwaydilation,reducingairwayresistanceby~35%
VolumesandCapacitiesFromconceptionuntilterm:
V increasesby40%Inspiratorycapacityincreasesby10%Expiratorycapacitydecreasesby30%Totallungcapacitydecreasesby5%Vitalcapacityisunchanged
From~20weeksuntilterm:
ERVdecreasesRVdecreasesFRCdecreases
By20%erectBy30%supine
Ventilation
Progesteronestimulatesrespiratorycentres,shiftingtheO andCO responsecurvestotheleftwhichcauseshyperventilationandarespiratoryalkalosis.Fromconceptionuntilterm:
MVincreasesby50%10%increaseinRR40%increaseinV
PCO fallsto~26-32mmHg,withacompensatorydropinplasma[HCO ]to18-21mmol.L
LabourandPostpartumDuringlabour:
MVincreases70%duetopainandincreasedoxygendemandThiscauseshypocapnea,socessationofuterinecontractions(andtheassociatedpainandoxygendemand)arefollowedbya
2 2
T
2 2
T2 3
- -1
Obstetrics&Neonates
429
![Page 430: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/430.jpg)
hypoventilatoryperiodproducingdesaturation
FRCandRVreturntonormalwithin48hoursofdelivery.
References
1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.
Lastupdated2019-07-18
Obstetrics&Neonates
430
![Page 431: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/431.jpg)
CardiovascularChangesofPregnancyExplainthephysiologicalchangesduringpregnancy,andparturition
Physiologicalconsequencesofchangesinpostureduringpregnancy
Pregnancyisatimeofincreasedmetabolicdemand,whichcardiovascularchangesreflect.Thesechangesinclude:
IncreasedintravascularvolumeOccursviatwomechanisms:Increasedoestrogencausesanincreasedplasmavolume
Thisdecreasescapillaryoncoticpressure,predisposingtooedemaThismaybeexacerbatedbythegraviduteruscompressingtheIVC,especiallynear-term
IncreasedEPOcausesanincreasedredcellvolumeIncreasedvenousreturnDuetoincreasedintravascularvolumeandMSFP.
ThegraviduterusmaycompresstheIVCandimpairVR,hencepregnantwomenarepositionedwithaleftlateraltilttodisplacetheuterusofftheIVC
IncreasedVRcausesanincreaseinCO(withbothanincreaseinHRandSV,aswelladecreaseinSVR)DecreasedSVRresultsinSBP,DBPandMAPdropping(despitetheincreaseinCO)
MagnitudeofChangesbyTrimester
Parameter Direction FirstTrimester
SecondTrimester
ThirdTrimester Notes
Plasmavolume ↑ 35% 45% 50% Peaksbetween32-36 week,decreases
slightlythereafter
Bloodvolume ↑ 5% 15% 20% Increaseslessthanplasmavolume,
resultinginthefallinhaematocritto33%
HR ↑ 15% 18% 25% Increasesprogressivelythroughout
SV ↑ 20% 25% 30% Increasesprogressivelythroughout
CO ↑ 20% 40% 45% Increasesthroughoutanddramaticallyinlabour
ChangesDuringLabour
Uterinecontractionboluses~300mlofbloodintothematernalcirculationCausesanincreaseinCObyupto30%duringtheactivephaseand45%duringejection.
AssociatedwithcorrespondingincreaseinSBPandDBPby10-20mmHg
Post-partumCOisupto80%ofpre-labourvaluesduetoautotransfusion,andreturnstonormalwithin2weeksofdelivery
References
1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.
Lastupdated2018-03-04
th
CardiovascularChanges
431
![Page 432: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/432.jpg)
CardiovascularChanges
432
![Page 433: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/433.jpg)
FoetalCirculationExplainthephysiologicalchangesduringpregnancy,andparturition
InUtero
Thefoetalcirculationhasanumberofstructuraldifferences:
TwoumbilicalarteriesTheumbilicalarteryreturnsdeoxygenatedbloodtotheplacenta.
PO of18mmhg(SpO 45%)Over50%ofthecombinedoutputofbothfoetalventriclesenterstheplacenta
OneumbilicalveinTheumbilicalveinsuppliesoxygenatedbloodtothefoetus.
HasaPaO of28mmHg(SpO 70%)60%ofbloodfromtheumbilicalveinenterstheIVC40%ofbloodenterstheliver
Twoducts:DuctusvenosusShuntsbloodfromtheumbilicalveintotheIVC.DuctusarteriosusShuntsbloodfromthepulmonarytrunktothedescendingaorta.
AforamenovaleShuntsbloodfromtherightatriumtotheleftatrium.ImmaturemyocardiumFoetalmyocardiumdoesnotobeyStarlingsLaw,anddoesnotadjustcontractilityforanygivenpreload.Therefore:
SVisfixedCOisHRdependentNormalHRattermis110-160bpm.
Thesestructuraldifferencealterthepathwayofbloodcirculation:
Oxygenatedbloodreturnsviatheumbilicalvein40%flowstotheliver60%isreturnedtotheIVC
OxygenatedbloodintheIVCisdirectedviatheEustachianvalvethroughtheforamenovaleBloodreturningfromtheSVCisdirectedintotheRV,andthenintothedescendingaortabytheductusarteriosus
~10%ofRVoutputflowsthroughthepulmonarycirculation
Thisarrangementhasseveralfeatures:
BloodwiththemostoxygenisdeliveredtothearchvesselstosupplythebrainBloodwiththeleastoxygenisdeliveredtotheumbilicalarteriesforgasexchangeBoththeRVandtheLVejectintosystemiccirculations,andareofsimilarsizeandwallthickness
ChangesatBirth
Severalchangeshappenatbirth:
Placentalcirculationislost
2 2
2 2
FoetalCirculation
433
![Page 434: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/434.jpg)
Thereisatransitionfromcirculationinparalleltocirculationinseries.AnFRCisestablishedReversalofhypoxicpulmonaryvasoconstrictionresultsinarapiddropinPVR.ThecordisclampedThesystemicvascularbedvolumefalls,andSVRincreasesduetothelossofthelow-resistanceplacentalcirculation.
ThefallinPVRlowersRVafterloadRAPfallsduetothelossofhypoxicpulmonaryvasoconstriction.
TheriseinSVRincreasesLVafterloadLAPrisesastheLVmovesuptheStarlingcurve.WhenLAPexceedsRAP,theforamenovaleclosesAdegree(~10%)ofresidualshuntremains.Shuntis:
BidirectionalLeft-to-rightshuntisunconcerningRight-to-leftshunthasusuallyonlyminoreffectsonsystemicSpOWillbeincreasedwith↑PaCO ,excessivePEEP,↓pH.
BewareembolicmaterialDon'tforgetthebubbles.
IncreasedleftsidedafterloadcausesflowreversalintheductusarteriosusThereisprogressiveclosureoftheductusoverhourstodays,undertheinfluenceofprostaglandinsandoxygenatedbloodflowingthroughtheduct.
Theductusvenosusprogressivelyfibrosesoveraperiodofdaystoweeks
References
1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.3. BrandisK.ThePhysiologyViva:Questions&Answers.2003.
Lastupdated2019-06-14
22
FoetalCirculation
434
![Page 435: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/435.jpg)
ThePlacentaOutlinethefunctionsoftheplacenta,anddeterminantsofplacentalbloodflow.
Theplacentaisanorganofmaternalandfoetaloriginwhichsupportsthedevelopingfoetus.
PhysiologicalProperties
Theplacentahasthreebroadfunctions:
InterfacebetweenfoetusandmotherfornutrientexchangeImmunologicalbarrierEndocrine
NutrientandWasteExchangeFunctions
Theprimarypurposeoftheplacentaisdiffusionofnutrientsandoxygen,andremovalofwaste.
Aswiththelung,diffusionisdependentonFick'sPrinciple,i.e.:
,where:
=Flowofsubstanceacrossthemembrane
=Areaofthemembrane
=Diffusionconstantforthesubstance,whereMolecules<600Dainsizemorereadilydiffusedownconcentrationgradients
=ConcentrationdifferenceacrossthemembraneMaternalplacentalflowis~600mL.min atterm-doublethatoffoetalflow-whichimprovesdiffusionbyincreasingtheconcentrationgradientforsolutes
=Thicknessofthemembrane
O Diffusion
Attheendofpregnancy,PO forfoetalblood:
Enteringtheplacentaviatheumbilicalarteryis18mmHg(SpO245%)Leavingtheplacentaviaumbilicalveinis28mmHg(SpO270%)
ThefoetusisabletohaveadequatedeliveryofO despitethelowPO forfourreasons:
HighCardiacIndexIncreasedcardiacoutputincreasesDO .
FoetalHbContainstwogammasubunitsinsteadofbetasubunits.Thesepreventthebindingof2,3-DPG,whichresultinaleft-shiftedOxy-Haemoglobindissociationcurve,favouringoxygenloadingatalowPaO .
Foetal[Hb]is50%greaterthanmaternal[Hb]
TheDoubleBohreffect:
-1
2
2
2 2
2
2
ThePlacenta
435
![Page 436: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/436.jpg)
TheBohreffectstatesthatanincreaseinPaCO right-shiftstheoxyhaemoglobindissociationcurve.Conversely,theaffinityofHbforO increasesinalkalaemia.ThedoubleBohreffectdescribesthishappeninginoppositedirectionsinthefoetalandmaternalcirculations,favouringtransferofO tothefoetus:
Intheplacenta,foetalCO diffusesintomaternalblooddownitsconcentrationgradientThismakesfoetalbloodrelativelyalkaline,andmaternalbloodrelativelyacidic.Therefore:
O unloadingofmaternalbloodisfavouredO loadingoffoetalbloodisfavoured
CO Diffusion
CO isextremelylipidsoluble,andsopasseseasilyacrossmembranes.FoetalPaCO is~50mmHg,andintervillousPCO is~37mmHg.CO offloadingisfavouredinthefoetusby:
AhighFoetal[Hb]increasestheamountofCO thatcanbecarriedascarbaminohaemoglobinTheDoubleHaldaneeffect:TheHaldaneeffectstatesthatdeoxygenatedHbbindsCO withmoreaffinitythanoxygenatedHb.ThedoubleHaldaneeffectdescribesthishappeninginoppositedirectionsinthematernalandfoetalcirculations,favouringCO transfertothemother:
AsmaternalbloodreleasesO ,thisfavoursmaternalloadingofCO withoutanincreaseinmaternalPCO (Haldaneeffect)ThereleaseofCO fromthefoetalHbfavoursO loading,whichinturnfavoursfurthermaternalO release.
NutrientDiffusion
Inlatepregnancy,foetalcaloricrequirementsarehigh(approximatelythesameasthemother).Facilitateddiffusionofglucoseviacarriermoleculesoccursintrophoblasts.
Activetransportoccursforaminoacids,Ca ,Fe,folate,andvitaminsAandC.Othertransportersactivelyremovesubstancesfromfoetalcirculation.
ImmunologicalFunction
TheplacentaisselectivelypermeabletoIgGviapinocytosis,whichallowsmaternalantibodiestoprovidepassiveimmunitytothefoetus.
EndocrineFunction
Synthesises:
βHCGhPLOestriol
22
2
2
22
2
2 2 22
2
22
2 2 2
2 2 2
2+
ThePlacenta
436
![Page 437: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/437.jpg)
Progesterone
Development
Theplacentadevelopssimultaneouslyfromfoetusandmother:
Fromtheuterinewall,themotherproducesbloodsinusesaroundthetrophoblasticcordsTheseinturnsendoutplacentalvilli
Thiscreatesasinusofmaternalbloodinvaginatedbymultiplefoetalvilli
Foetalvilliaresuppliedbytwoumbilicalarteriesandasingleumbilicalvein
MaternalsinusesarefilledfromtheuterinearteriesThematernalsinusesaresuppliedbyspiralarteries
PropertiesoftheDevelopingPlacenta
Thick(er)membraneimpairspermeabilityPlacentalmembranepermeabilityissmallinearly-to-midpregnancy,reachingmaximumat~34weeksSmallersurfacearea
PropertiesoftheMaturePlacenta
Thickmembrane-improvedpermeabilitySurfaceareaof14mWeightof~500gBloodflowof600mL.min attermFlowisreducedduringcontractionsduetoincreaseduterinepressureandalsowithα-adrenergicstimulation.
References
1. Hall,JE,andGuytonAC.GuytonandHallTextbookofMedicalPhysiology.11thEdition.Philadelphia,PA:SaundersElsevier.2011.
2. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.
Lastupdated2019-07-18
2
-1
ThePlacenta
437
![Page 438: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/438.jpg)
GastricSecretionsDescribethecomposition,volumesandregulationofgastrointestinalsecretions
TheGITproducesaanumberofsubstanceswhichcanbeclassifiedbyregionandfunction:
SalivaH O(98%)Digestiveproteins
AmylaseLipaseMucinHaptocorrinBindsVitaminB12.
ImmunologicalproteinsLysozymeLactoferrinIgA
GastricDigestive
HClGastrinPepsinIntrinsicFactor
MucosalProtectionMucousHCO
SmallBowelDigestive
PancreaticLipaseAmylaseTrypsinogen
EndocrineSecretinSomatostatin
ControlofSecretionsSecretionoccursinthreephases:
CephalicThought/sight/taste/smelloffood,resultinginvagal-mediatedstimulustoreleasegastrin.Accountsfor~30%ofproduction.GastricStretchofthestomachstimulatesHClsecretionandgastrinrelease.Accountsfor~50%ofproduction.IntestinalAdropinpHoftheproximalduodenumreleasessecretintostimulatetheexocrinepancreas.
2
3-
GastrointestinalSystem
438
![Page 439: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/439.jpg)
SalivarySecretions
Approximately1Lofsalivaisproducedbytheparotid,submandibular,andsublingualglandseachday.
Salivahasfourmainfunctions:
LubricationMucin
DigestionAmylaseLipaseParticularlyimportantinneonateswhoproducelittlepancreaticlipase.
NeutralisationofacidForprotectionpriortovomiting.Antibacterial
GastricSecretions
Thestomachproduces~2Lofsecretionsperday:
AcidsecretionParietalcellscontainanH -K exchangepump.
H isproducedbycarbonicanhydraseonCO andwater,with'waste'HCO removedfromthecellinexchangeforCl .
HighlevelsofacidproductionresultinlargeamountsofbicarbonatebeingsecretedintobloodThiscreatesanalkalinetideasportalvenouspHincreasesdramaticallyRespiratoryquotientofthestomachmaybecomenegativeduetoconsumptionofCO
ThispumpisactivatedinresponsetoincreasedlevelsofintracellularCa fromstimulationby:AChHistamine(H )Gastrin
Inhibitedby:LowgastricpHSomatostatin
GastricGastinisapeptidefamilysecretedfromantralGcells.
Secretionisstimulatedby:Neural(vagal)stimulationinthecephalicphaseofdigestionMainmechanism.ProteinandaminoacidsinthestomachDrugs
AlcoholCaffeine
Secretionisinhibitedby:LowpHSecretinGlucagon
Gastrinhasanumberofpro-digestiveeffects:StimulatesgastricacidsecretionStimulatespancreaticsecretion
+ ++
2 3-
-
22+
2
GastrointestinalSystem
439
![Page 440: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/440.jpg)
StimulatesbiliarysecretionIncreasesgastricandintestinalmotility
PepsinogensChiefcellssecretepepsinogenIandisreleasedbyAChorβstimulation.Pepsinogeniscleavedtopepsininthegastriclumen,andbreaksdownprotein.
IntrinsicFactorParietalcellsproduceintrinsicfactor,whichformsacomplexwithB whichfacilitatesitslaterabsorptionintheterminalileum.
MucousNeckcellsproducemucopolysaccharide,glycoprotein,andHCO inresponsetostimulusbyprostaglandins,whichprotectsmucosaandlubricatesfood.
PancreaticSecretionsExocrinepancreaticsecretionsareproducedbytheacinarandductalcells,attherateof1.5Lperday.
Releaseisstimulatedby:CCKSecretinAChViavagalstimulation.
Consistof:HCOToalkalinisegastriccontents.
PancreaticbicarbonateproductionlowersvenouspH,andneutralise'sthealkalinetideofthestomach.WaterEnzymes
TrypsinogenProteolysis.AmylaseHydrolysisofglycogen,starch,andcomplexcarbohydrate.LipaseHydrolysisofdietarytriglycerides.
EndocrineFunctionCholecystokinin(CCK)isapeptidefamilysecretedbyintestinalenteroendocrinecells(Icells)inthemucosaoftheduodenumandjejunum.Cholecystokinin:
RegulatessatietyRegulatesleptinreleasefromfatStimulatessecretionsfromthegallbladderandduodenum
Secretinstimulatespancreaticrelease.Secretinis:ReleasedbytheproximalduodenuminresponsetolowpH
Motilinstimulatesthemigratingmotorcomplex.Motilinis:ReleasedcyclicallyfromMcellsinthesmallbowel
References
1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.
12
3-
3-
GastrointestinalSystem
440
![Page 441: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/441.jpg)
Lastupdated2019-07-18
GastrointestinalSystem
441
![Page 442: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/442.jpg)
OesophagusDescribethecontrolofgastrointestinalmotility,includingsphincterfunction.
Theoesophagusisamusculartubeconnectingthepharynxtothestomach.Theoesophagushas:
SkeletalmuscleinitsupperthirdSmoothmuscleinitslowerthird
LowerOesophagealSphincterTheLoSis:
Themostdistal2-4cmoftheoesophagusMacroscopicallyindistinguishablefromtherestoftheoesophagus
HoweverithasahigherconcentrationofnervecellsandisabletoconstrictatahigherpressureTonicallyinnervatedbythevagusImportantinthepreventionofrefluxCompetencyoftheLoSisrequiredtopreventreflux
Barrierpressureisthepressuredifferencebetweenthepressureattheloweroesophagealsphincterandthepressureinthestomach,andistypically~15-25mmHgBarrierpressureisaffectedby:
ChangesinloweroesophagealsphincterpressureSwallowingBarrierpressuredecreasesduringswallowing,andtransientlyincreasesimmediatelyafterwards.Anatomical
AgeSphinctertoneisdecreasedinneonatesandtheelderly.DiaphragmAnexternalsphincterisformedbythediaphragmaticcrura,andexertsapinch-cockactionontheoesophagus.StomachAfoldinthestomachwalljustdistaltotheGOJcreatesaflapvalve,whichoccludestheGOJwhengastricpressurerises.OesophagusTheoesophagusentersthestomachatanobliqueangle,limitingretrogradeflow.
HormonalGastrin,motilin,α-agonismincreaseLoStoneProgesterone,glucagon,vasoactiveintestinalpeptide(VIP)decreaseLoStone
DrugsETOH,IVandvolatileanaestheticagents,andanticholinergicsdecreaseLoStoneSuxamethonium,metoclopramide,andanticholinesterasesincreaseLoStone
ChangesingastricpressureRaisedintraabdominalpressure
ObesityPregnancy
DiseaseHiatusherniaGOJmovesintothethorax,causing:
Oesophagus
442
![Page 443: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/443.jpg)
Lossofpinch-cockactionNegativeintrathoracicpressurereducesLoSpressureandthereforebarrierpressure
--
References
1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.2. ANZCAJuly/August19993. KahrilasPJ,PandolfinoJE.Hiatushernia.GIMotilityonline.2006.4. ANZCAAugust/September2015
Lastupdated2019-07-18
Oesophagus
443
![Page 444: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/444.jpg)
ControlofGastricEmptyingDescribethecontrolofgastrointestinalmotility,includingsphincterfunction.
Gastricemptyingisaneurallyandhormonallymediatedprocesswhichaimstopresentfoodtothesmallbowelinacontrolledmanner.Differentdrugs,hormones,andphysiologicalstatescaneitherencourageorinhibitgastricemptying.
DeterminantsofGastricEmptying
Rateofgastricemptyingisafunctionof:
AntralpressureMaindeterminantaspyloricresistancetendstobelow,andisaffectedby:
StomachDuodenumSystemicfactorsDrugs
Pyloricresistance
Stomach
GastricdistensionVagalexcitationfromgastricstretchcausesreleaseofgastrin,increasingperistalticfrequency.Compositionofchyme:
LiquidsemptyfasterthansolidsLiquidshaveahalf-timeof~20minutes,andemptyinanexponentialfashionSolidshaveahalf-timeof~2hours,withadwelltimeof~30minutes,andemptyinalinearfashion
Proteinindependentlystimulatesgastrinrelease
Duodenum
Theduodenumhashormonalmechanismswhichhaveanegativefeedbackongastricemptying.Theseinclude:
DuodenaldistensionHypoosmolarandhyperosmolarchymeAcidicchymeInresponsetoacidtheduodenumreleasessecretinandsomatostatin:
SecretindirectlyinhibitsgastricsmoothmuscleSomatostatininhibitsgastrinrelease
FatandproteinFatandproteinbreakdownproductsstimulatereleaseofcholecystokinin,whichinhibitsgastrin.
Carbohydrate-richmealsemptyfasterthanprotein,whichemptyfasterthanfat.
Systemic
Motilinreleasedbythesmallbowelenhancesthestrengthofthemigratingmotorcomplex,aperistalticwaveofcontractionthroughthewholeGITwhichoccursevery60-90minutesSympatheticinputfromthecoeliacplexusinhibitsgastricemptyingPregnancyhasanumberofeffectsongastricemptying:
ProgesteronerelaxessmoothmuscleandinhibitsgastricsmoothmuscleresponsetoAChandgastrin,aswellascreating
ControlofGastricEmptying
444
![Page 445: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/445.jpg)
incompetenceoftheLoSleadingtoGORDGastrinproductionincreasesSomegastrinisproducedbytheplacenta.Gastricacidproductionisincreasedduringthethethirdtrimester
Parasympatheticinputenhancesgastricmotility
Effectofdrugs
Drugswhichincreasegastricemptyinginclude:
MetoclopramideErythromycin
Drugswhichinhibitgastricemptyinginclude:
OpioidsAlcoholAnticholinergicagents
References
1. CICMJuly/September20072. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.
Lastupdated2019-07-18
ControlofGastricEmptying
445
![Page 446: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/446.jpg)
SwallowingDescribethecontrolofgastrointestinalmotility,includingsphincterfunction
Swallowingisdividedintothreephases:
OralPhaseVoluntaryFoodispushedagainsthardpalatebytongue
PharyngealPhaseInvoluntaryCoordinatedbymedulla.ClosureofnasopharynxAdductionofvocalcordsHyoidelevationanddeflectionofepiglottisPharyngealcontractionPropelsfoodbolustowardsoesophagus
OesophagealphaseInvoluntaryClosureofUoSRestingbarrierpressure100mmHg.RelaxationofLoSRestingbarrierpressure20mmHg,whichisabalancebetween:
LoSpressure(30mmHg)Antralpressure(10mmHg)
Oesophagealperistalsis
Impairmentofanyoftheseprocessesincreasesriskofaspiration:
ObtundationReducedcoughreflex.MuscularweaknessImpairedmedullarycoordination
References
1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2019-07-18
Swallowing
446
![Page 447: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/447.jpg)
PhysiologyofVomitingDescribethecontrolofgastrointestinalmotility,includingsphincterfunction
Vomitingistheactive,forcefulexpulsionofgastriccontentsfromthestomach.Itisdifferentfromregurgitationwhichisapassiveprocess.
ItisamechanismtoexpeltoxicsubstancesfromtheGIT.
StimulationStimulantstovomitingcanactcentrally,ordirectlyinthebowel:
CentralstimulationCentralstimulimayactdirectlyonthevomitingcentre.OthersactviatheCTZ,whichispartoftheareapostremalocatedoutsideoftheblood-brainbarrier,andsoitcanbestimulatedbycirculatingsubstances.Centralvomitingstimuliinclude:
Direct:EmotionPainOlfactoryVisual
ViatheCTZ:Vestibularactingon:
HACh
Drugs/Toxinsactingon:5-HTDμ-opioidreceptors
GITstimulationGITstimulitravelSNSandPNSafferentstothevomitingcentre.TheCTZisnotinvolvedandsoanti-emeticswhichactherearenotusefulinthistypeofvomiting.
GITvomitingstimuliincludedistensionandtoxins.Neurotransmittersinclude:
5-HT inmucosalstretchreceptorsAChinNTSafferentsH inNTSafferents
PostoperativeNauseaandVomiting
Centralstructuresinvolvedinclude:
ChemoreceptortriggerzoneNTSMultiplepathwaysexist(similartothosedescribedabove),andneurotransmittersinvolvedinclude:
5-HTDNKHmACh
1
32
3
1
321
1
PhysiologyofVomiting
447
![Page 448: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/448.jpg)
RiskfactorsPatientfactors
FemaleNon-SmokerYoungageHistoryofPONVormotionsickness
AnaestheticfactorsVolatileuseNitrousoxideuseRelativeriskof1.4.OpioiduseAnaesthesiaduration
SurgicalfactorsGynaecologicalsurgeryLikelynotanindependentriskfactor,andsimplyconfoundedbyfemalegender.Strabismussurgeryinchildren
Processofvomiting
Vomitingconsistsofasetofprocessescoordinatedbythevomitcentreinthemedullaoblongata,andisdividedintothreephases:
Pre-ejectionphaseProdromalnauseaSalivationRetrogradeintestinalcontractionwhichforcesintestinalcontentsintothestomach
RetchingPhaseDeepinspirationandbreath-holdingtosplintthechestEpiglotticclosureElevationofthesoftpalate(preventsnasalsoiling)
ExpulsivephaseRelaxationofoesophagealsphinctersPyloriccontractionViolentcontractionofthediaphragmandabdominalmuscles
References
1. BrandisK.ThePhysiologyViva:Questions&Answers.2003.2. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.3. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.4. PierreS,WhelanR.Nauseaandvomitingaftersurgery.ContinuingEducationinAnaesthesiaCriticalCare&Pain,Volume
13,Issue1,1February2013,Pages28–32.
Lastupdated2019-07-18
PhysiologyofVomiting
448
![Page 449: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/449.jpg)
FunctionsoftheLiverDescribethestorage,synthetic,metabolicandexcretoryfunctionsoftheliver
Storage
Theliverisimportantinstorageandreleaseof:
CarbohydratesasglycogenTheadultliverstores~100gofglycogen.FatastriglyceridesAllfat-solublevitamins(A,D,E,K)ManywatersolublevitaminsincludingfolicacidandBIronCopper
Synthetic
Syntheticfunctionsinclude:
BileproductionPlasmaproteinsincluding:
ClottingfactorsAlbuminproduction120-300mg.kg ofalbuminisproducedperday,dependentonnutritionalstatus,plasmaoncoticpressure,andendocrinefunction.
MetabolicMetabolicfunctionsinclude:
CarbohydrateFatProteinBilirubinmetabolismDrugsandToxins
Carbohydrates
MonosaccharidesanddisaccharidespassivelydiffuseintohepatocytesGradientismaintainedbyconvertingglucosetoglucose-6-phosphatewhichisusedtoproduceglycogen.Thismaintainsthegradientfordiffusion.Glycogeniseithersynthesised(glycogenesis)orbrokendown(glycogenolysis)dependingonplasmaglucoseandinsulin:
Increasedbloodglucosestimulatesinsulinrelease,increasingtheformationofglycogenthroughactivationofglycogensynthetaseDecreasedbloodglucosestimulatesglycogenolysisandgluconeogenesisfromaminoacids.
Lipids
12
-1
LiverPhysiology
449
![Page 450: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/450.jpg)
Fatcanbe:StoredastriglyceridesHydrolysedtoglycerolandfattyacids,whichisusedforATPproduction
ProteinsandUrea
Aminoacidsareabsorbedfrombloodtobeusedforgluconeogenesisandforproteinsynthesis.InordertoproducesubstratesfortheCAC,Aminoacidsmaybe:
TransaminatedDeaminatedDecarboxylated
Thenitrogenousscrapofthesereactionsisurea,whichisproducedinseveralstages:
AvarietyofmetabolicprocessesconvertaminoacidstoglutamateGlutamateisconvertedtoammoniabyglutamatedehydrogenaseAmmoniathenenterstheureacycletoproduce(surprisingly)urea,atthecostof3ATP
Anormaldietof100gproteinperdayproduces~30gofurea,and1000mmolofhydrogenions
Endocrine
ProducesangiotensinogenProducesIGF-1ConvertsT4toT3
Immunoprotective
KupffercellsTissuemacrophagesofthehepaticreticuloendothelialsystem.Theyphagocytoseharmfulsubstancesincluding:
EndotoxinsBacteriaVirusesImmunecomplexesThrombinFibrincomplexesTumourcells
Acid-BaseBalance
Mayproduceorconsumelargenumbersofhydrogenions:
CarbondioxideproductionMetabolismoforganicacidanions
LactateKetonesAminoacids
AmmoniumProductionofplasmaproteinsNotablyalbumin
LiverPhysiology
450
![Page 451: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/451.jpg)
References1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.3. BrandisK.ThePhysiologyViva:Questions&Answers.2003.
Lastupdated2019-07-18
LiverPhysiology
451
![Page 452: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/452.jpg)
LaboratoryAssessmentofLiverFunctionDescribethelaboratoryassessmentofliverfunction
SyntheticFunction
Measuresofsyntheticfunctioninclude:
AlbuminMainplasmaprotein.
Normalrange28-58g.LHalf-life~20daysImportantin:
MaintenanceofplasmaoncoticpressureBinding
CalciumDrugs
Decreasedinliverdysfunctionandmalnutrition
CoagulationAssaysClottingfactorsareproducedbytheliver.Hepaticimpairmentmayresultinreducedproductionandabnormalityofclottingassays,althoughfunctionalclottingfunctionmaybenormal(aspro-coagulantproteinsareaffectedtoasimilarextent).
INRTestoftheextrinsicpathway.APTTTestofintrinsicpathway.
MetabolicFunctionTransaminasesarereleasedwhenliverparenchymaisdamaged,andareusedtoevaluatemetabolicfunction:
ALTNormalrange<54U.L .ASTNormalrange<35U.L .
ObstructiveTests
ALP(AlkalinePhosphatase)Enzymeinvolvedindephosphorylationofmanycompounds.ALPisfoundinallcells,butparticularlyintheliver,bileduct,bone,kidney,andplacenta.
Normalrangeis30-120U.LGGTEnzymefoundinbiliaryduct.
Normalrange:Males:11-50U.LFemales:7-30U.L
Bilirubin
-1
-1
-1
-1
-1-1
LaboratoryAssessmentofLiverFunction
452
![Page 453: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/453.jpg)
Byproductofhaemoglobinmetabolism.Maybemeasuredastotal,orasconjugatedandunconjugatedbilirubin.
References1. Diaz,A.Outlinetheclinicallaboratoryassessmentofliverfunction.PrimarySAQs.
Lastupdated2019-07-18
LaboratoryAssessmentofLiverFunction
453
![Page 454: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/454.jpg)
BileDescribethephysiologyofbileanditsmetabolism
Bileisadarkgreensolutionproducedbythelivertofacilitateabsorptionoffatandfat-solublevitamins(ADEK)throughemulsification.Bileis:
Producedbytheliverattherateof1LperdayConcentratedinthegallbladderImportantintheabsorbanceoflipidandfat-solublevitaminsFormedfrom:
WaterProteinBilirubinBilesaltsThesodiumandpotassiumsaltsofbileacids.Bileacids:
AreareproducedfromcholesterolAreamphipathic,andactasemulsifiersoflipidBreakuplargefatglobulesintosmallermicelles,whichcanthenbeabsorbed.Majorbileacidsinclude:
CholicacidChenodeoxycholicacid
Areabsorbedintheterminalileum,andrecycledbytheportalcirculationLipidsElectrolytes
References1. Hall,JE,andGuytonAC.GuytonandHallTextbookofMedicalPhysiology.11thEdition.Philadelphia,PA:Saunders
Elsevier.2011.2. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.
Lastupdated2019-07-18
Bile
454
![Page 455: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/455.jpg)
ErythrocytesOutlinethephysiologicalproductionofbloodanditsconstituents
Erythrocytes:
Are7.5μmindiameterAre2umthickHavealifespanof120daysHave:
NonucleusMaximisescellvolumeavailableforHb.NomitochondriaCannotperformaerobicmetabolism-allATPisgeneratedviaglycolysis.NoribosomesIncapableofproducingprotein
HaveabiconcavediscshapeThismaximisessurfacearea(optimisinggastransfer)andmakesthecellsflexibleenoughtopassthroughcapillarybeds(whicharenarrowerthanthecell).Areimportantin:
DeliveringO tothetissuesanddeliveringCO tothelungsAcid-BasebalanceMetabolismofsomedrugs
Carry~29pgofhaemoglobinComprise40-50%ofbloodvolume
ProductionErythrocyteshaveamyeloidprogenitorwhichdifferentiatesintothemyeloidline.EPO(seeendocrinefunctionsofthekidneystimulatesmyeloidprogenitorcellsto:
DifferentiateProliferate
ProerythroblastsbeginsynthesisofHb,withongoingproductionoccurringuntilthecellismatureFurtherdifferentiationresultsinsuccessivelossoforganelles,increasingHbcontentThelossofribosomesandnucleusofthereticulocytearethefinalstageoferythropoiesisTheentireprocesstakes~7-10days
FunctionGasCarriageAcid-BaseBuffering
ProductionofHCOBindingofH toHb
MetabolismEsterases(andother-ases)inerythrocytesmetabolisemanydrugs,including:
RemifentanilSNP(reactswithHbtoformNO,CN,andMet-Hb)Esmolol
2 2
3-
+
Haematology
455
![Page 456: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/456.jpg)
Elimination
Oldredcellsareremovedfromcirculationvia:
Phagocytosisbymacrophagesin:SpleenMajormechanism.LiverBonemarrow
Haemolysis~10%ofredcellbreakdownoccursincirculation,wheretheHbdimersarethenboundtohaptoglobinbyhaemopexin.
Thisisimportanttopreventglomerularfiltrationofhaeme,andlossofiron
HaemoglobinMetabolism
Haemoglobinisbrokendowninto:
GlobinBrokendownintoconstituentaminoacids.IronRe-entershaemoglobinsyntheticpathway.HaemeComplexmetabolicpathway,notableasitistheonlymetabolicprocessthatproducescarbonmonoxide:
MetabolisedtobiliverdinbysplenicmacrophagesinthereticuloendothelialsystemofthespleenCirculatingerythrocytesarephagocytosedbysplenicmacrophagesHaptoglobinbindscirculatingHb,theHb-Haptoglobincomplexisthenphagocytosedbysplenicmacrophages
BiliverdinisreducedtounconjugatedbilirubinThisisfatsoluble,andbindstoalbumin.UnconjugatedbilirubinisconjugatedinthelivertoconjugatedbilirubinConjugatedbilirubinissecretedinbilebyactivetransportThisisimpairedduringhepaticdisease,leadingtoincreasedbilirubinlevelsinplasma.SecretedconjugatedbilirubinismetabolisedtourobilinogenbygutbacteriaUrobilinogenmayhaveanumberoffates:
Enterohepaticrecirculationandeliminationinbile(again)FurthermetabolismbygutbacteriatostercobilinogenandthentostercobilinEnterohepaticrecirculationandurinaryexcretion,whereitisoxidisedtourobilin
InDisease
Blood Urine Faeces
Prehepaticdisease ↑Unconjugatedbilirubin ↑Urobilinogen,
bilirubinnotpresent Normal
Intrahepaticdisease
↑Conjugatedbilirubin,↑Unconjugatedbilirubin Bilirubinpresent Maybepaleduetodecreased
urobilinogenexcretedinbile
Posthepaticdisease ↑Conjugatedbilirubin ↓Urobilinogen,
bilirubinpresent Pale
References
Haematology
456
![Page 457: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/457.jpg)
1. BarrettKE,BarmanSM,BoitanoS,BrooksHL.Ganong'sReviewofMedicalPhysiology.24thEd.McGrawHill.2012.
Lastupdated2019-07-18
Haematology
457
![Page 458: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/458.jpg)
IronHomeostasisDescribethenormalnutritionalrequirements
Approximately3-5gofironisfoundinthebodyas:
Oxygen-carryingglobinmoleculesHaemoglobin(~70%)andmyoglobin(~5%).Catalystforbiologicalreactions(~25%)Catalase,peroxidase,andcytochromesallrequireiron.
AbsorptionDietaryironcomesintwoforms:
HaemegroupsDirectlyabsorbedviaspecialisedtransportproteins.Dietaryironsalts
Ferrous(Fe )ironissoluble,andisabsorbedviafacilitateddiffusionacrosstheenterocytemembraneReducedacidityofthestomachwillreducetheabsorptionofferrousiron
Ferric(Fe )ironprecipitateswhenpH>3,andsocannotbeabsorbedindependentlybythesmallbowel.Apathwaymayexistforabsorptionofferricironfromsolublechelates
Onceintheenterocyte,ironcanbe:Stored,boundtoferritinTransportedviaferroportinoutoftheenterocyte,whereitisthenoxidisedtoferrousironandboundtotransferrin
RegulationExcretionisuncontrolledRegulationofironlevelsisonlybyabsorptionHepcidinisaliverproteinwhichinhibitstheactionofferroportin
HighhepcidinpreventsirontransportfromtheenterocyteHepcidinisdeficientinhaemochromatosis
References
1. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2017-09-23
2+
3+
IronHomeostasis
458
![Page 459: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/459.jpg)
PlateletsOutlinethephysiologicalproductionofbloodanditsconstituents
Describetheprocessandregulationofhaemostasis,coagulationandfibrinolysis
Plateletsaresmallcellfragmentswhicharevitalinhaemostasisviaformingaplateletplug.They:
Havealifespanof7-10daysAreremovedbythereticuloendothelialsysteminthespleenandliver
Production
Plateletsare:
Anuclearcirculatingcellbodies,whichbudfrommegakaryocytesAsthemegakaryocytecellvolumeincreases,thecellmembraneinvaginatesandsmallplateletsbudoff.
Thetimefromstemcelltoplateletis~10days,andisstimulatedbythrombopoietinNewplateletsareheldinthespleenfor36hoursuntiltheymature
Contentsα-granulesContainfibronectin,fibrinogen,vWF,PDGF,andThrombospondin,plateletfactor4.δ-granulesContain5-HT,ATP,ADP,andCa .ContractileproteinsFacilitateplateletdeformationwhenactivated.
ActivationPlateletsareactivatedby:
CollagenExposedbydamagedendothelium.AdrenalineADPThrombin
Activationresultsinseveralevents:ExocytosisofgranulesActivationofmembranephospholipaseA toformthromboxaneADeformationfromadisctoaspherewithlongprojectionsPromotionofthecoagulationcascadeChangeinglycoprotein(GP)expressionbytheactionofADP:ADPantagonists(e.g.clopidogrel)preventexpressionoftheGPIIb/IIIacomplex.
GPIb/IIb/IIIafacilitateplateletattachmenttovWFvWFalsobindstosub-endothelialconnectivetissue.GPIIb/IIIaarealsoreceptorsforfibrinogen,whichencouragesplateletaggregation
2+
2 2
Platelets
459
![Page 460: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/460.jpg)
References
1. KamP,PowerI.PrinciplesofPhysiologyfortheAnaesthetist.3rdEd.HodderEducation.2012.2. KraftsK.ClotorBleed:APainlessGuideforPeopleWhoHateCoag.PathologyStudent.
Lastupdated2019-07-18
Platelets
460
![Page 461: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/461.jpg)
TransfusionUnderstandingtheadverseconsequencesofbloodtransfusion,includingthatofmassivebloodtransfusion
ProductionandStorageofBloodProducts
Redcells,platelets,andFFPhavedifferentstoragerequirements.
RedBloodCells
Storedblooddecaysovertime-thisisknownasastoragelesionPreservativesareusedtoextendthetimebloodcanbestored:
Keptat~4°C(balancebetweenfreezingandbeingtoowarm)ReducescellularmetabolicrequirementInhibitsbacterialgrowth
CollectedinanasepticfashionStoredinspecialsolutions:
SAGMiscurrentlyusedbytheAustralianRedCross:SalineAdenineSubstrateforATPsynthesisGlucoseSubstrateforRBCglycolysisMannitol
CPDA1(citrate-phosphate-dextrose-adenine)wastraditionallyusedCitratebindscalcium,preventingclottingPhosphateactsasabufferandphosphatesourceformetabolismDextroseAdenine
Astoragelesiondescribesthechangesthatoccurinstoredblood:Lossof2,3DPGLessofafactorinCPDA1blood.HaemolysisHyperkalaemiaTypicallynotclinicallyrelevantaspotassiumistakenupintoredcellswhenmetabolismresumes.AcidaemiaHyponatraemiaNotclinicallysignificant.
Bloodcanbestoredforupto35days,whichcorrespondsto70%survival
Platelets
Plateletsrequireparticularstorageconditionstoremainfunctional:
Temperature~22°CBelowthis,plateletsdeformandbecomenon-functionalGasexchangePlateletsarestoredinabagwhichallowsgasexchangetooccur,minimisinglacticacidandcarbondioxideproduction
Transfusion
461
![Page 462: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/462.jpg)
AgitationPlateletsarestoredonanagitatorwhichpreventsclottingandensurestheplateletsarewellmixed,whichmaximisesthediffusiongradientforgasexchangepHcontrolpHiskeptbetween6.2to7.8topreventdegranulation.
Asplateletsdonotcontainantigen,thereisnotastrictrequirementforplateletstobetypematched.However:
Rh(+)plateletsshouldbeavoidedinRh(-)patientsThesmallamountofcontaminatingredcellsmayprecipitaterhesusdisease.Plasmaincompatibilityshouldbeavoidedasthismayleadtohaemolysisofrecipientredcells
Childrenareatgreaterriskduetotheirproportionallysmallerbloodvolume
FreshFrozenPlasma
FreshFrozenPlasmais:
Preparedeithervia:SeparationfromwholebloodApheresisRemovalofalargevolume(typically800ml)ofplasmafromasinglepatient,withreturnofredcellstothedonor.
Oncecollected,itisfrozenandre-thawedinawaterbathpriortouse
Cryoprecipitate
CryoprecipitateispreparedbyremovingtheprecipitatefromFFPwhichformsat1–6°C.Cryoprecipitatecontainspredominantly:
FibrinogenFibronectinvWFFactorVIIIFactorXIII
WholeBlood
Wholebloodundergoesadditionalchanges:
Whitecellsbecomenonfunctionalwithin4-6hoursofcollection,thoughantigenicpropertiesremainPlateletsbecomenon-functionalwithin48hoursofstorageat4°CFactorlevelsdecreasesignificantlyafter21days
BloodGroups
Bloodgroupsrefertotheexpressionofsurfaceantigensbyredbloodcells,aswellasanyantibodyinplasma.Bloodgroupscanbedividedintothreetypes:
ABORhesusOtherantibodiesTheseareadditionalantibodiesthatapatientmayexpressinplasma,andincludeKell,Lewis,Duffy,etc.
ABO
TheABObloodgroupis:
Transfusion
462
![Page 463: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/463.jpg)
Acomplexcarbohydrate-basedantigensseriesThesemaybeeitherAorBantigen,andpatientsmayexpressone,both,orneither,givingfourbloodgroups(A,B,AB,O).ExpressedontheH-antigenstemofRBCs,andonthesurfaceoftissuecells.
TheBombayBloodGroup(orhhorOhgroup)describesindividualswhodonotexpresstheHantigenTheseindividuals:
Don'texpressA-orB-antigen(asthereisnoH-antigenstem)andare'universaldonors'ExpressH-antibodyCanonlyreceivebloodfromotherindividualswiththeBombayphenotype
IndividualsexpressIgMantibodytoforeignbloodgroupsThisdevelopswithin6monthsofbirth,likelyduetoenvironmentalexposuretosimilarantigens.AssociatedwithaseverehypersensitivityreactionifanABO-mismatchoccurs
Group RBC Plasma
A A-antigen B-antibody
B B-antigen A-antibody
O - A-antibodyB-antibody
AB A-antigenB-antigen -
Rhesus
TheRhesusbloodgroupisthenextmostimportantgroupafterABO.TheRhesussystem:
Consistsof~50differentantigens,themostimportantofwhichisDRhesusstatusisthereforeexpressedaspositive(D-85%ofthepopulation)ornegative(anything-but-D).RhesusantibodydoesnotnaturallyoccurinRh(-)individuals
ThisisrelevantinRhesusdiseaseARh(-)motherexposedtoRh(+)bloodwilldevelopAnti-Dantibody,whichcancrossplacentaandinduceabortioninafutureRh(+)foetus.Thiscanoccurwith:
IncompatibletransfusionFoetal-maternalhaemorrhage
CompatibilityTestingDonorbloodmustbetestedwithrecipientbloodtoavoidatransfusionreaction.Thisinvolvesthreeprocesses:
BloodTyping(ABO/Rh)Bloodistypedbymixingitinvitrowithplasma(andplasmawitherythrocytes)ofknowngroups(containingIgMantibody(Anti-A,Anti-B,Anti-AB)),andobservingforagglutination.AntibodyScreenForotherantibodies.
TestingissimilartoABOscreening,exceptplasmaismixedwithredcellscontainingknownantigen(e.g.Kell,Duffy),andmonitoredforagglutination.
Cross-matchInvolvestwoprocesses:
SalinetestErythrocytesaresuspendedinsalineandmixedwithantibodiesatroomtemperature,monitoringforagglutination.
ThisconfirmsABOtypeIndirectCoombs'test
Transfusion
463
![Page 464: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/464.jpg)
IdentifiesIgGantibodyinhostplasmawhichwouldcausehaemolysisoftransfusedredcells.Thisistypicallynolongerdone,asitoffersnegligibleextrasafetyovertheaboveprocesses.Doingitinvolves:
IncubatingBindsIgGAbtoantigenonRBCmembrane.WashingRemovesserumandunboundIgG.TestingwithanantibodytoIgG,knownasantiglobulinserum.
Apositivetestwillcauseclumpingofredcells,aseachantiglobulinserumwillbindtwoIgGmolecules,whichhaveinturnbeenboundtoredcellsAnegativetestwillcausenoagglutination,astheIgGhasnotbeenboundtoredcells
Ifnegative,theantiglobulinserumisre-usedonacontrolsampletoensurethatitisnotafalsenegative
TransfusionReactions
Transfusionreactionscanbeclassifiedaseitheracute(<24hours)ordelayed(>24hours),andasimmunologicalornon-immunological.
ImmunologicalAcuteReactions
Reaction Incidence Mechanism
ABOMismatch 1:40,000 ABOincompatibilitycausingrapidintravascularhaemolysis,whichmaycausechest
pain,jaundice,shock,andDIC.RhD-reactionstendtocauseextravascularhaemolysis.
Haemolytic(acute)
1:76,000(1:1.8millionfatal)
Immunologicaldestructionoftransfusedcells(TypeIIhypersensitivity).Presentswithfever,tachycardia,pain,progressingtodistributiveshock
Febrile,non-haemolytic
~1:100Cytokinereleasefromstoredcellscausingamildinflammatoryreaction,withtemperaturerisingto≥38ºCor≥1ºCabovebaseline(if>37ºC).Benign-butrequiresexclusionofahaemolyticreaction.
Urticaria 1:100 Hypersensitivitytoplasmaproteinsinthetransfusedunit
Anaphylaxis 1:20,000 TypeIhypersensitivityreactiontoplasmaproteinintransfusedunit
TRALI Variable DonorplasmaHLAactivatesrecipientpulmonaryneutrophils,causingfever,shock,andnon-cardiogenicpulmonaryoedema
Non-ImmunologicalAcuteReactions
Reaction Incidence Mechanism
MassiveTransfusionComplications Variable Seebelow
Non-immunemediatedhaemolysis Rare DuetophysicochemicaldamagetoRBCs(freezing,devicemalfunction).
Mayleadtohaemoglobinuria,haemoglobinaemia,tachycardiaandfevers.
Sepsis
1:75,000(platelets),1:500,000(RBC)
Contaminationduringcollectionorprocessing.Mostcommonorganismsarethosewhichuseironasanutrientandreproduceatlowtemperatures,e.g.YersiniaPestis.
TransfusionRelatedCirculatoryOverload(TACO)
<1:100Rapidincreaseinintracellularvolumeinpatientswithpoorcirculatorycomplianceorchronicanaemia.MayresultinpulmonaryoedemaandbeconfusedwithTRALI.
Transfusion
464
![Page 465: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/465.jpg)
DelayedImmunologicalReaction
Reaction Incidence Mechanism
Delayedhaemolytictransfusionreaction 1:2,500 Developmentofsensitisationwiththereactionoccurring2-14days
afterasingleexposure.TypicallyKidd,Duffy,Kellantibodies.
Post-transfusionPurpura Rare AlloimmunisationtoHumanPlateletAntigencausingsuddenself-
limitingthrombocytopenia
TA-GVHD Rare TransfusedlymphocytesrecognisehostHLAaspositivecausingmarrowaplasia,withmortality>90%
Alloimmunisation1:100(RBCantigens),1:10(HLAantigens)
Previoussensitisationleadingtoantibodyproductiononre-exposure.
Transfusion-relatedImmuneModulation
Notknown Transientimmunosuppressionfollowingtransfusionpotentiallyduetocytokinereleasefromleukocytes
DelayedNon-ImmunologicalReaction
Reaction Incidence Mechanism
IronOverload
Chelationafter10-20units,organdysfunction50-100units
EachunitofPRBCcontains~250mgofiron,whilstaverageexcretionis1mg.day .
ComplicationsofMassiveTransfusion
Amassivetransfusionisonewhere:
Greaterthanone-halfofcirculatingvolumein4hoursWholecirculatingvolumein24hours
Riskofcomplicationfromamassivetransfusionisinfluencedby:
NumberofunitsRateoftransfusionPatientfactors
Complication Mechanism
Airembolism Inadvertentinfusion
Hypothermia Cooledproducts
Hypocalcaemia Consumptionwithcoagulopathyandboundtocitrateaddedtotransfusedunits
Hypomagnesaemia Boundtocitrateintransfusedunits
Citratetoxicity Citrateisaddedtostoredunitsasananticoagulant
Lacticacidosis Hyperlactataemiaduetoanaerobicmetabolisminstoredunits
Hyperkalaemia Potassiummigratesfromstorederythrocytesintoplasmawhilstinstorage
References
-1
Transfusion
465
![Page 466: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/466.jpg)
1. BloodService.Classification&IncidenceofAdverseEvents.AustralianRedCross.2. NationalBloodAuthority.PatientBloodManagementGuidelines.AustralianRedCross.3. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.
Lastupdated2019-07-18
Transfusion
466
![Page 467: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/467.jpg)
HaemostasisDescribetheprocessandregulationofhaemostasis,coagulationandfibrinolysis
Haemostasisdescribesthephysiologicalprocessesthatoccurtostopbleeding.Itinvolvesthreeprocesses:
VesselconstrictionDecreasesflow,whichlimitsfurtherhaemorrhageandreducestheshearstresseswhichbreakupformingclotPlateletplugformationorPrimaryHaemostasisPlateletsadheretothedamagedvesselwallandaggregateFibrinformationorSecondaryHaemostasisFibrinisformedfromfibrinogen(viathecoagulationcascade),whichstabilisestheplateletplug
PrimaryHaemostasisFollowingavascularinjury,theexposureofsubendothelialproteinsstimulatesplateletstoformanocclusiveplugviaseveralprocesses:
AdhesionExposedcollagenbindstoGPIareceptoronplatelets.vWFalsobindstoplatelets.
ActivationMetabolicactivation,increasingPhospholipaseA andPhospholipaseC,increasingplateletintracellularCa andinitiatingatransformationfromadisctoaspherewithlongprojections.
Metabolicactivationisstimulatedby:CollagenAdrenalineADPThrombin
Additionally,plateletsreleaseADPandthromboxaneA fromtheiralphagranulesanddensebodies,amplifyingfurtherplateletaggregationandadhesion
AggregationWithotherplatelets-heldtogetherbyfibrin-formingaplug.
ContractionAftersometimeplateletscontract,retractingtheclotandsealingthewall.
SecondaryHaemostasis
Thecoagulationcascadeisanamplificationmechanismwhichactivatesclottingfactorsinordertoproducefibrin.
22+
2
Haemostasis
467
![Page 468: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/468.jpg)
Participatingfactorsinthecoagulationcascadecanbeeitherenzymesorcofactors:
Enzymescirculateintheirinactiveform,andbecomeactive(e.g.VII⇒VIIa)whenhydrolysedbytheirprecursorfactorCofactorsamplifythecascade
Pathways
Thecascadeisdividedintotheintrinsicpathwayandextrinsicpathway,whichjointoformthecommonpathway.Invitro,theintrinsicandextrinsicpathwaysoperateseparately.Thisisanartifactoflabmeasurement-invivothepathwaysareco-dependent.
ExtrinsicPathway
Theextrinsicpathwaycontainstwofactors,andtheprocessofactivationoccursinseconds:
TissueFactorMembraneproteinonsub-endothelialcells,whichisexposedwhenthevesselisdamaged(itisfoundinafewotherplacesaswell).ItbindstofactorVIItoformVIIa,andthusactivatestheextrinsicpathway.FactorVII
IntrinsicPathway
Theintrinsicpathwayisactivatedoverminutes,andcontains:
ContactfactorsOnlyimportantinvitrowhenconductinglabtesting-deficiencyofthesefactorsdoesnotcauseacoagulopathy.
Haemostasis
468
![Page 469: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/469.jpg)
HMWKHMWKactivatesfactorXII.FactorXIIFactorXIIaactivatesfactorIX,asdoesthrombin.
FactorXIFactorIXFactorVIIIFactorVIIIcirculatesinacomplexwithvWF,preventingitfromdegradation.Whenactivatedbythrombin,itactsasacofactorforfactorIXatoactivatefactorX.
Theintrinsicpathwayisactivatedby:
ThrombinMainactivatoroftheintrinsicpathwayinvivo.CollagenGlassInvitro.
CommonPathway
Thecommonpathwaycontains:
FactorXFactorVCofactor(similartofactorVIII),whichwhenactivatedbythrombinallowsfactorXatoconvertprothrombinintothrombin.FactorII(prothrombin)Hasseveralkeyroles:
CleavesfibrinogentofibrinActivatesfactorXIIIFactorXIIIastabilisesclotbyformingcross-bridgesbetweenfibrininaplateletplug.AmplificationoftheclottingcascadebyactivatingfactorsVandVIIIActivatesproteinCThrombinbindswiththrombomodulintoformacomplexwhichinhibitscoagulation.
FactorI(fibrinogen)
TheCell-BasedModelofCoagulation
Thecascademodel(above)accuratelydescribestheprocessofclottinginvitro,butnotinvivoThecell-basedmodelhasseveralchanges,notingthecentralroleoftheplatelet:
InitiationphaseCoagulationbeginswithtissuefactorbeingexposed,whichalsoactivatesplatelets.AmplificationphaseApositivefeedbackloopoccurs:
ProductionofXacausesproductionofthrombin(IIa),primingthesystemThrombinthenactivatesfactorsV,VIII,andIX,acceleratingXaproductionandfurtherthrombingeneration
PropagationphasePlateletsbindactivatedclottingfactors,causinghighratesofthrombinformationaroundthem.
References
Haemostasis
469
![Page 470: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/470.jpg)
1. KraftsK.ClotorBleed:APainlessGuideforPeopleWhoHateCoag.PathologyStudent.2. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.3. ClottingCascade22/4/2007.(Image).ByJoeD(Ownwork).CCBY3.0,viaWikimediaCommons.
Lastupdated2019-07-18
Haemostasis
470
![Page 471: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/471.jpg)
HaemostaticRegulationDescribethemechanismsofpreventingthrombosisincludingendothelialfactorsandnaturalanticoagulants
Haemostasismustbecontrolledtopreventrampantclottingofthevasculartree.Thisinvolvesbothendothelialfactorsandproteins.
EndothelialRegulation
Intactendotheliumandtheglycocalyxpreventclottinginanumberofways:
MinimisestasisHighbloodflowEspeciallywhereflowisturbulent(largearteries).MaximiselaminarflowGlycocalyxsmoothsflow.
InhibitionofplateletadhesionandactivationNO,prostacyclin,andectonucleotidases(whichdegradeADP)inhibitplateletactivation.
Membrane-boundanticoagulantproteinsHeparan(notheparin)ActivatesantithrombinIII.ThrombomodulinBindsthrombin,preventingcleavageoffibrinogentofibrin.Thethrombin-thrombomodulincomplexactivatesproteinC(whichinturninactivatesfactorsVaandVIIIa).
PreventexposureofprocoagulantproteinCollagenvWFTissueFactor
tPAsecretion(see'ClotLysis')
ClotRegulation
EffectofbloodflowDilutesclottingfactorsActivatedclottingfactorsarewashedawayandmetabolisedbytheRES.LaminarflowCausesaxialstreamingofplatelets,minimisingendothelialcontactandchanceofactivation.fa
ActivationofanticoagulantfactorsTissueFactorPathwayInhibitorInhibitsVIIa,antagonisingtheactionoftissuefactorAntithrombinIIIInhibitstheserineproteases,i.e.thenon-cofactorfactorsinallthreepathways-IIa,VIIa,IXa,Xa,XIa,XIIa.ProteinCInactivatesproteinVaandVIIIa,andisactivatedbythrombin.ProteinSCofactorwhichhelpsproteinC.
HaemostaticRegulation
471
![Page 472: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/472.jpg)
ClotLysis
Clotbreakdownisperformedby:
TissuePlasminogenActivator(tPA)Bindstofibrin,andthencleavesplasminogentoplasmin.Thiskeepstheplasminformationinthevicinityoftheclot,limitingitssystemicspreadof.
PlasmincleavesfibrinintofibrindegradationproductsFDPsconvenientlyinhibitfurtherthrombinandfibrinformation.
References
1. KraftsK.ClotorBleed:APainlessGuideforPeopleWhoHateCoag.PathologyStudent.2. VanHinsberghVWM.Endothelium—roleinregulationofcoagulationandinflammation.SeminarsinImmunopathology.
2012;34(1):93-106.
Lastupdated2019-07-18
HaemostaticRegulation
472
![Page 473: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/473.jpg)
CoagulopathyTestingOutlinethemethodsforassessingcoagulation,plateletfunctionandfibrinolysis
CoagulationFactors
Allthesetestsmeasurehowlongittakestomakefibrin.Theyevaluatedifferentpartsofthecoagulationcascade,whichhelplocalisewhereacoagulopathymaybeoccurring.
Inthesetests:
CitrateisaddedtobloodBindscalciumandpreventsclotting.SampleiscentrifugedPlasmadecantedCalcium(toreplacethecalciumlostbybindingtocitrate)andareagentisaddedTimetakentoclotmeasured
ProthrombinTime/INR
Theprothrombintimemeasurestheextrinsicpathway.Tissuefactorhastobeaddedtothesampleinorderstartclotting-thisiswhyitisknownastheextrinsicpathwayasasubstanceextrinsictothesamplemustbeadded.AsthePTvariessignificantlybetweendifferentlabs,theINRisusedtoallowvaluestobecompared.
AnydisorderoftheextrinsicorcommonpathwayswillprolongthePT,i.e.deficiencyorinhibitionof:
FactorVIIFactorXFactorII(prothrombin)FactorVFactorI(fibrinogen)
Althoughwarfarinaffectsfactorsinallthreepathways,itsclinicaleffectsaremeasuredusingINR.Thisisbecause:
FactorVIIhastheshortesthalf-lifeoftheclottingfactorsaffectedbywarfarinThereforesoitslevelswillfallthequickest.ThereforeafallinFactorVIIlevelsistheearliestindicationofchangesincoagulationstatusduetowarfarinAsfactorVIIisonlyintheextrinsicpathway,thePT/INRaretheonlytestswhichcanevaluateitsfunction
(Activated)PartialThromboplastinTime
Thepartialthromboplastintimemeasurestheintrinsicpathway,whichbeginsproducefibrinwhenactivatedbytheadditionofphospholipidtothesample(phospholipidiscontainedinplatelets,andsoisnottechnically"extrinsic").Theactivatedpartialthromboplastintimeisthesametest,exceptanactivatingagentisaddedtospeedupthereaction.
AnydisorderoftheintrinsicorcommonpathwayswillprolongtheAPTT,i.e.deficiencyorinhibitionof:
FactorXIFactorIXFactorVIIIFactorXFactorV
CoagulopathyTesting
473
![Page 474: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/474.jpg)
FactorII(prothrombin)FactorI(fibrinogen)
Heparinaffectsbothsidesofthepathway(IIa,IXa,Xa,XIa)howevertypicallyaffectsintrinsicfactorsmorethanextrinsic.
Inaddition,anti-phospholipidantibodieswillalsoprolongtheAPTTbybindingtheaddedphospholipid.
ActivatedClottingTime
ActivatedClottingTimeisusedtoforthedosingandreversalofheparinincardiopulmonarybypassandotherextracorporealcircuits.
Freshwholebloodisaddedtoatubewithanactivator(e.g.glassbeads)tostimulatetheintrinsicpathway.Thetimeuntilclotformationismeasuredinseconds.Differentactivatorswillhavedifferentnormalranges,andtargetrangesforthecircuitinuse.
PlateletFunction
EvaluatehowwellplateletsaggregateinresponsetofactorslikeADP,collagen,arachidonicacid,andadrenaline(i.e.,endogenousstimulatorsofplateletaggregation).
Inthistest,theaggregatingagentisaddedtoatubeofplatelets,andthechangeinturbiditymeasured.Differentpatternsofresponse(ornon-response)canbediagnosticofdifferentplateletfunctiondisorders.
PointofCareTestingPointofcarecoagulationtesting:
InvolvestestingofwholebloodTraditionaltestingusesplasmaonly.
Thereforeincludesthecell-basedmodelofcoagulationMaybetterrepresentactualclottingfunctioncomparedwithtraditionalcoagulationfactortesting.
Providesinformationonallphasesofclotting
ViscoelasticMethods
Include:
Thromboelastography(TEG)Continuousmeasurementanddisplayofviscoelasticpropertiesofabloodsamplefrominitialfibrinformationtoclotretraction,andultimatelyfibrinolysis.Involves:
Aknownvolume(typically0.36ml)ofwholebloodaddedtoactivatorsintwodisposablecuvettes(cups)heatedto37°CContactactivators(suchaskaolin)areaddedtothebloodtoaccelerateclottingAheparinasecuvetteisalsocommonlyusedsoclottingfunctioncanbemeasuredduringfullanticoagulation(e.g.CPB)
PinattachedtotorsionwireimmersedintobloodTorsiononthepinisconverted(byatransducer)intoaTEGtracing.Cuvetterotatesthrough4°45′inalternatedirectionsEachrotationtakes10s.Pininitiallyremainsstationaryasitrotatesthroughtheun-clottedbloodThisisrepresentedbyastraightlineonthetracing.Asbloodclots,cuprotationexertstorqueonthepinThestrongerthebloodclot,thegreaterthetorqueexertedonthepin
RotationalThromboelastometry(ROTEM)
CoagulopathyTesting
474
![Page 475: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/475.jpg)
ModifiedversionofTEG:ApinfixedtoasteelaxisisrotatedinbloodviamovementofaspringThecuvetteremainsstationary.Twosamplesareused:
Tissuefactorisaddedtomeasuretheextrinsicpathway(knownastheENTEMcuvette)Contactactivatorisaddedtomeasuretheintrinsicpathway(INTEMcuvette)
Impedancetorotationisdetectedbyanopticalsystem:LEDMirroronthesteelaxisElectroniccamera
UsesdifferentreferencerangesandnomenclaturetoTEG
AdvantagesandDisadvantagesofTEG/ROTEM
Advantages Disadvantages
Rapidcomparedwithtraditionaltesting Stillmeasurescoagulationinartificialconditions
Useswholeblood,providingamorecompletepictureofplasma-RBC-plateletinteraction
Doesnotmeasurecontributionofendotheliumandthereforeconditionsaffectingplateletadhesion(e.g.vonWillebrand'sdisease)
Real-timedisplayofclotevolution HardertoinstituteQAoutsideoflaboratory
Reducesnon-evidence-basedtransfusion Measurementmethodologyisnotyetstandardisedbetweeninstitutions
Predictiveofpost-operativehypercoagulablestates Baselinemeasurementdoesnotpredictpost-operativebleeding
Verysensitivetoheparineffect Doesnotmeasureeffectofhypothermia
Requirestrainingandcompetencyofnon-labstaff
Moreexpensivethantraditionaltesting
InterpretingTEG/ROTEM
Notethatreferencerangesarenotincludedhere,andwillvarydependingonthe:
Technique(TEG/ROTEM)usedActivatorusedAdjuvantsaddede.g.Citratedvs.recalcifiedsamples.
Parameter(TEG)
Parameter(ROTEM) Definition Relevance
CoagulopathyTesting
475
![Page 476: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/476.jpg)
R(reaction)time
CT(clottingtime)
Timeuntil2mmamplitude
Timeuntilinitialfibrinformation,dependentonplasmaconcentrationofclottingfactors
KtimeCFT(clotformationtime)
Timeforamplitudetoincreasefrom2-20mm
Measurementofclotkinetics(clotamplification),dependentonfibrinogen
αangle αangle
Anglebetweenthetangenttothetracingat2mmandthemidline
Rapidityoffibrinformationandcross-linking.Alternatemeasureofclotkinetics,dependentonfibrinogen
MA(maximumamplitude)
MCF(maximumclotthickness)
GreatestamplitudeIndicatespointofmaximalclotstrength,dependentpredominantlyonplatelets(80%)andfibrinogen(20%),bindingviaGPIIb/IIIa.TreatmentwithplateletsorDDAVP.
CL30(clotlysis30)
LY30Percentdecreaseinamplitude30minutesafterMA
Clotstability,dependentonfibrinolysis.ReducedCL30canbetreatedwithanantifibrinolytic,suchasTXA
References
1. KraftsK.ClotorBleed:APainlessGuideforPeopleWhoHateCoag.PathologyStudent.2. ActivatedClottingTime-PracticalHaemostasis.3. SrivastavaA,KelleherA.Point-of-carecoagulationtesting.ContinEducAnaesthCritCarePain.2013;13(1):12-16.
Lastupdated2019-07-18
CoagulopathyTesting
476
![Page 477: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/477.jpg)
SIUnitsTheInternationalSystemofUnits(SI,orSystèmeInternationald'Unités),isasetofmeasurementstandardswhichdefines(almost)allstandardsintermsofuniformnaturalphenomena,andformthebaseofthemetricsystem.
BaseSIUnits
TherearesevenbaseSIunits,withmanyderivedunitsmadefromcombinationsofthese.BaseSIunitsaremutuallyindependent.Theyconsistof:
Quantity Unit Abbreviation Definition
Time Second sDurationof9,192,631,770periodsoftheradiationcorrespondingtothetransitionbetweentwohyperfinelevelsofthegroundstateofanatomofCs-133
Length Metre m Distancethatlighttravelsinavacuumin1/299,792,458 ofasecond
Current Ampere ATheconstantcurrentthatwouldproduceaforceof2x10 Newtonbetweentwoconductorsofinfinitelengthandnegligiblecrosssectioninavacuum
Temperature Kelvin °K1/273.16 ofthetriplepointofwater.Thetriplepointisthetemperatureatwhichasubstanceexistsinequilibriuminallthreephases(solid,liquid,gas).
Amount Mole mol Theamountofsubstancewhichcontainsasmanyelementaryentitiesasin0.012kgofCarbon12
LuminousIntensity Candella cd Luminousintensityofasourcewhichemitsmonochromaticradiation
at540x10 Hzatradiantintensityof1/683wattspersteradian
Mass Kilogram kg WeightoftheInternationalPrototypeKilogram(IPK)
DerivedUnits
Quantity Unit Abbreviation ConversiontoBaseSIUnits Definition
Area Squaremetre m
Velocity MetreperSecond m.s
Acceleration MetreperSecondperSecond m.s
Force Newton N Forcerequiredtoaccelerate1kgat1m.s
Pressure Pascal Pa Forceperarea
Energy/Work/QuantityofHeat Joule J Energyconvertedwhen1Nis
appliedto1kgover1m
DoseEquivalence Sievert Sv Radiationdosepermass
th
-7
th
12
2
-1
-2
-2
EquipmentandMeasurement
477
![Page 478: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/478.jpg)
Power Watt W second
ElectromotiveForce Volt V Measureofelectricalpotentialenergy
References
1. PhysicalMeasurementLaboratory.NationalInstituteofStandardsandTechnology.Andvarioussubpages
Lastupdated2017-09-22
EquipmentandMeasurement
478
![Page 479: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/479.jpg)
ElectricalSafetyUnderstandtheconceptsofpatientsafetyasitappliestomonitoringinvolvingelectricaldevices
ElectricalPrinciples
ChargeisthepropertyofasubatomicparticlewhichcausesittoexperienceaforcewhenclosetootherchargedparticlesChargeismeasuredincoulombs(C).
CurrentistheflowofelectronsthroughaconductorCurrentismeasuredinamps(A).
VoltageisthestrengthoftheforcethatcausesmovementofelectronsBytradition,voltagesarequotedrelativetoground(orearth).Ifapotentialdifferenceexists,acurrentwillflowfromthatobjecttotheearthviathepathofleastresistance.Ifthispathcontainsaperson,anelectricalinjurymayresult.
ResistancedescribestowhatextentasubstancereducestheflowofelectronsthroughitResistanceismeasuredinohms(Ω).
SubstanceswithhighresistanceareinsulatorsSubstanceswithlowresistanceareconductors
Inductanceisthepropertyofaconductorbywhichachangeincurrentinducesanelectromotiveforceintheconductor,andanynearbyconductors
CapacitanceistheabilityofanobjecttostoreelectricalchargeMeasuredinFarads(F),whereonefaradiswhenonevoltacrossthecapacitorstoresonecoulombofcharge.
Acapacitorisanelectricalcomponentconsistingoftwoconductorsseparatedbyaninsulator(calledadielectric)Whenadirectcurrentflows,electrons(anegativecharge)buildupononeoftheseconductors(calledaplate),whilstanelectrondeficit(positivecharge)occursontheotherplate
CurrentwillflowuntilthebuildupofchargeisequaltothevoltageofthepowersourceCurrentcanberapidlydischargedwhenthecircuitischanged
Analternatingcurrentcanflowfreelyacrossacapacitor,andcausesnobuildupofcharge
ImpedancedescribestowhatextenttheflowofalternatingcurrentisreducedwhenpassingthroughasubstanceImpedancecanbethoughtofas'resistanceforACcircuits',andisacombinationofresistanceandreactance.
Reactanceisafunctionoftwothings:InductionofvoltageinconductorsbythealternatingmagneticfieldofACflowCapacitanceinducedbyvoltagesbetweentheseconductors
ElectricalInjury
Potentialelectricalinjuriescanbedividedinto:
VentricularFibrillationLikelihoodisafunctionof:
CurrentdensityFrequencyLowestcurrentdensityrequiredisat50Hz.
BurnsFunctionofcurrentdensity.Burnstypicallyoccurattheentryandexitpointasthisiswherecurrentdensityishighest.
ElectricalSafety
479
![Page 480: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/480.jpg)
TetanicContractionFlexorsarestrongerthanextensors,whichmaymaintaingriponlivewire.DeathmayresultfromeitherVForasphyxiationfromsustainedrespiratorymusclecontraction.
ElectricalShock
Electricalshocksaredividedintotwotypes,basedontheirabilitytoinduceVF:
MicroshockCurrentrequiredtoinduceVFwhenapplieddirectlytomyocardium.
Typicalcurrentis0.05-0.1mAThisrequiresskinbreachPotentialcauses:
GuidewirePacingleadColumnofconductingfluidCVCPICC
MacroshockCurrentrequiredtoinduceVFfromsurfacecontact.
Typicalcurrentis100mAThisismuchhigherbecausemostofthiscurrentisnotgoingtotheventricle,andsothetotalcurrentmustbegreatertoachievesufficientcurrentdensityinthemyocardiumtoinduceVF
Otherdetrimentaleffectsseenatlowercurrentsinclude:
Current(mA) Effect
1 Tingling
5 Pain
8 Burns
15 Skeletalmuscletetany
50 Skeletalmuscleparalysis&respiratoryarrest
PrinciplesofElectricalSafety
Powerpointscontainthreewires:
Active240V.MeasuringvoltageforACcurrentisnotintuitive,asthevoltagewillbenegativehalfthetime.Therootmeansquare(RMS)isusedinstead-eachvalueforthevoltageissquared(givingapositivenumber),andthendividedbythenumberofsamplestogiveanaverage.Neutral0V,relativetoground.EarthDirectpathwayintoground.
Anelectricalcircuitiscompletedbetweenanapplianceandthepowerstationbyreturningcurrenttothestationviatheearth.Thisisanearthreferencedpowersupply.
ElectricalDangers
ElectricalSafety
480
![Page 481: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/481.jpg)
ActivewireshortstoequipmentcasingPrincipleofearthwire,whichprovidespathofleastresistanceforcurrenttotravelifanindividualtouchesthecase
HighcurrentdrainthroughawiregeneratesheatandstartsafirePrincipleoffuseswhichtriggerwhencurrentdrainis>15A
MethodsofElectricalSafety
InsulationConductorsarecoatedbyahigh-resistancesubstance,preventingcurrentflowingwhereitshouldn't.
FusesSafetydeviceswhichceaseallcurrentflowwhencurrentexceedsacertainthreshold(typically20A).Ifthereisafaultwhichgreatlylowersresistance(i.e.insulationbreaks,causingadevicetobecomeliveanddrainviatheearthwire),ahighcurrentwillflowandthefusewillbetriggered.
Afaultrequires:AfaultthatcausesahighcurrentflowThefusetoworkcorrectly
ResidualCurrentDevicesAnRCDmeasuresthecurrentdifferencebetweentheactiveandneutrallines.
Inannon-faultsituation,thesewillbeequalInafaultsituation,currentwillbebeingdeliveredbytheactivelinebutnotreturnedviatheneutralCurrentwillinsteadflowtogroundviafaultyequipment/throughthepatient.
TheRCDwilldetectifthereisa>10mAdifferencebetweentheactiveandneutrallines,anddisconnectpowerwithin10msifitdoesso
Afaultrequires:CurrenttoflowAsinglefaultwillturnoffthecircuit
Pros:SafeCons:Willshutoffpowertothedevice,whichisbadforECMO/CPB/ventilatorswithoutbatterybackup
LineIsolationSupply,withalineisolationmonitorAlineisolatedsupplyisa'transformer'withanequalnumberofwindings,suchthatthevoltageproducedisthesameoneachside.However,thepowerpointisnotphysicallyconnectedtothesupply,creatinganearth-referencedfloatingsupply.
Afaultrequires:TwofaultsThismakesafailurewithpotentialforshockmuchlesslikely.
ActivewiremustbeconnectedtogroundNeutralwiremustbeconnectedtogroundAcircuitthenexists:activewire-ground-neutralwire,andacurrentcouldflow
AlineisolatedsupplyispairedwithalineisolationmonitorThismonitorstateshowmuchcurrentcouldflow,ifasecondfaultcompletedthecircuit.
ThisiscalledaprospectivehazardcurrentThelineisolationmonitorcontinuouslychecksthehazardcurrentbyevaluatingtheimpedancebetweentheactivewireandground,andtheneutralwireandground
Inano-faultsituation,bothimpedancesshouldbethesameandclosetoinfinite(Impedancewon'tbeabsolutelyinfiniteastherewillalwaysbeasmallcurrentleakfromdevices).Inasingle-faultsituation,thecalculatedimpedancefortheaffectedlinewillbesignificantlylower,andthereforetheprospectivehazardcurrentwillincrease
Analarmwillsoundwhentheprospectivehazardcurrentexceeds20mAPros:Asinglefaultisnotdangerousandwillnotresultinapowerloss(importantforvitalequipment)
ElectricalSafety
481
![Page 482: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/482.jpg)
Cons:Twoormorefaultsaredangerous,andwillstillnotresultinapowerloss
EquipotentialearthingThisistheonlymethodwhichpreventsmicroshock.
Ultra-lowresistanceearthcablesareattachedtoelectricaldevicesandthepatientsbedThesecablesarethenattachedtospecialwallearthconnectorsThisensuresallequipmentisreferencedtoacommonground,minimisingtheriskofleakagecurrentsbetweendevicesandthepatient
ClassificationofElectricallySafeEquipment
Theseclassificationsaredesignedtolimitmacroshock:
ClassI:EarthedAnypartthatcancontacttheuserisearthedtoground.
Ifafaultdevelopssuchthatpartsofthedevicethattheusercantoucharelive,thenthereisariskofshockIfthecaseisearthed,thepathofleastresistanceshouldbeviatheearthwireThiswillcausealargecurrenttoflow,andshouldblowafuse,ceasingcurrentflow.
ClassII:Double-insulatedAllpartsofthedevicethattheusercantouchhavetwolayersofinsulationaroundthem,reducingthechanceofthedevicebecominglive.
ClassIII:Low-voltageDeviceoperatesatlessthan40VDC/24VAC,limitingtheseverityofshockadevicecandeliver.
ClassificationofElectricallySafeAreas
Bareas:ProtectionagainstmacroshockResidualCurrentDevicesLineIsolationSupply
BFareas:Cardiac(microshock)protectionEquipotentialEarthingAlldevices,andthepatient,areearthedtoeachotherbythickcopper(i.e.low-resistance),suchthatanypotentialdifferencebetweendeviceswillbeequalisedviathepathofleastresistance(thewire,notthepatient).
Zareas:Noparticularprotections
ElectricalDeviceswhichAttachtoPatients
DevicessuchasECGandBISrequireanelectricalconnectiontothepatient.Riskofelectrocutionbythesedevicesisreducedby:
Highresistancewires
References1. ElectricityandElectricalHazards.2. AlfredAnaesthesiaPrimaryExamTutorialProgram3. AstonD,RiversA,DharmadasaA.EquipmentinAnaesthesiaandIntensiveCare:AcompleteguidefortheFRCA.Scion
PublishingLtd.2014.
Lastupdated2019-07-18
ElectricalSafety
482
![Page 483: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/483.jpg)
ElectricalSafety
483
![Page 484: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/484.jpg)
WheatstoneBridgeTheWheatstonebridgeisanelectricaldeviceusedtoaccuratelymeasureverysmallchangesinelectricalresistance.TheWheatstonebridgeis:
Usedinmanyothermedicaldevices(e.g.invasivepressuremonitoring)AdevicewithinfinitegainAnulldeflectiongalvanometerNotanamplifierAsitdoesnotincreasecurrentamplitude.
Mechanism
TheWheatstonebridgeconsistsof:
BatteryFourresistors
and areknownandfixed
isknownandadjustable
isunknownGalvanometer
TheWheatstonebridgereliesontheratioofresistancesbetweentheknown( )andunknown( )legs:
When )equalcurrentflowsdowneitherlimbandthereisnocurrentflowacrossthegalvanometerAtthispointthebridgeissaidtobebalanced.
Theequationcanthenbere-arrangedtosolvefor :
Verysmallchangesin leadtoacurrentflowacrossthebridge
canthenbeadjusteduntilthebridgeisbalanced,andthevalueof calculated
References
WheatstoneBridge
484
![Page 485: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/485.jpg)
1. AlfredAnaestheticDepartmentPrimaryExamTutorialSeries
Lastupdated2017-10-02
WheatstoneBridge
485
![Page 486: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/486.jpg)
NeuromuscularMonitoringDescribetheconceptofdepthofneuromuscularblockadeandexplaintheuseofneuromuscularmonitoring
Describetheclinicalfeaturesandmanagementofinadequatereversalofneuromuscularblockade
Thedegreeofneuromuscularblockadecanbeassessed:
ClinicallyCrudecomparedtoelectricalassessment.Testsinclude:
Sustainedheadlift>5secondsSuggests<30%blockade.V >10ml.kgTongueprotrusion
ElectricallyUsinganervestimulator.Canbe:
Visual/tactileMonitoringoftwitchheightbyanaesthetist.ElectricalMonitoringoftwitchheightbyadevice:
Accelerometer
Accelerationisproportionaltoforceforanygivenmass( ),thereforeanaccelerometertapedtothethumbcanbeusedtoassessforceofcontraction.MechanicalforcetransducersMuscletensionismeasuredusingastraingauge.Requirescontrolpriortoadministration.ElectromyographyEMGresponseismeasuredusingelectrodesoverthemuscle.TheAUCoftheresponsecurvecanbeusedtocalculatedegreeofblockade.
NerveStimulator
Anervestimulator:
Consistsoftwoelectrodes,apowersupply,andsomebuttonsforcontrolProducesamonophasic,squarewaveatconstantcurrent,lastingnomorethan0.3msGeneratesasupra-maximalstimulusEnsureseverynervefibreisdepolarised,whichmeansaconsistentlyreproducibleresponsewillbegenerated.Asupra-maximalstimulusis25%greaterthanthemaximumrequiredtodepolariseallnervefibres.AllowsassessmentofdifferentmusclegroupsNotallmusclegroupsareaffectedequallybyneuromuscularblockade.
TypicallysmallermusclegroupsaremoresensitiveThepositive(red)leadisplacedproximalUlnarnerveElectrodesareplacedalongtheulnarborderofthewristattheflexorcrease,andthumbadductionisassessed.FacialnerveThepositiveelectrodeisplacedattheoutercanthus,andthenegativeelectrodeisplacedanteriortothetragus.Eyebrowtwitchingisassessed.PosteriortibialnerveElectrodesareplacedposteriortothemedialmalleolus,andplantarflexionisassessed.
T-1
NeuromuscularMonitoring
486
![Page 487: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/487.jpg)
StimulationPatterns
Therearefivecommonstimulationpatterns:
TrainofFourFoursingletwitches(0.1ms)deliveredat2Hz(i.e.1.5sforall4).
NumberofobservedtwitchesgivesanindicationofreceptoroccupancyWithincreasingblockade,theamplitudeandnumberofobservedtwitchesdecreases.
FadeisthereductionoftwitchheightwithrepeatedstimuliduringapartialneuromuscularblockOccursduetotheeffectofnon-depolarisingagentsonthepresynapticmembrane,reducingAChproduction.Numberofobservedtwitchesdependsonthedegreeofblockade:
Notwitches≈100%blockadeOnetwitch≈90%blockadeTwotwitches≈80%blockadeThreetwitches≈75%blockadeReversalagentsshouldnotbegivenwithaToFcount<3.Fourtwitches≈<75%blockade
TheratiooftheamplitudeofT toT (ToFratio)canalsobeusedasameasureofblockade:ToFratio>90%isadequateforextubationToFratio>70%suggestsadequaterespiratoryfunction
Shouldnotberepeatedfasterthanevery10s
TetanicstimulationHighfrequency(50-200Hz)supramaximalstimulusfor5seconds.
NormalmusclewillexhibittetaniccontractionPartiallyparalysedmuscleexhibitsfadeDegreeoffadeisproportionaltodegreeofblockade,andisverysensitive.
Post-tetaniccount(PTC)UsedindeepblockadewhenthereisnoresponsetoToF.Atetanicstimulusisgiven,followed3slaterbysingletwitchesat1Hz.
NoresponsemaybeseeninverydeepblockadeHowever,twitchesmaybeseenpriortothereturnofaToFresponse.Thisiscalledpost-tetanicfacilitation,andoccursduetothetetanicstimulusmobilisingAChvesiclesintothepre-junctionalarea.
Typically,aToFof1willoccurwhenthePTC≈9Shouldnotberepeatedfasterthanevery6minutesDuetoresidualpost-tetanicpotentiation.
DoubleburstTwo0.2ms50Hz(tetanic)stimuliareapplied750msapart.
TwoidenticalcontractionsoccurinnormalmuscleAmplitudeofthesecondburstisreducedinpartiallyparalysedmuscleDBratioissimilartotheToFratio,butiseasiertoassessclinically.Aratio>0.9isrequiredforadequatereversal
SingletwitchAsinglestimuluslasting~0.2msisapplied.
>75%blockadecausesadepressedresponseAtwitchmustbeassessedpriortoblockadesoabaselinecanbeestablished
1 4
NeuromuscularMonitoring
487
![Page 488: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/488.jpg)
References
1. LeslieRA,JohnsonEK,GoodwinAPL.DrPodcastScriptsforthePrimaryFRCA.CambridgeUniversityPress.2011.2. Saenz,AD.PeripheralNerveStimulator-TrainofFourMonitoring.2015.Medscape.3. McGrathCD,HunterJM.Monitoringofneuromuscularblock.ContinuingEducationinAnaesthesiaCriticalCare&Pain,
Volume6,Issue1,1February2006,Pages7–12.
Lastupdated2019-07-18
NeuromuscularMonitoring
488
![Page 489: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/489.jpg)
PressureTransductionDescribetheprinciplesofmeasurement,limitations,andpotentialsourcesoferrorforpressuretransducers,andtheircalibration
Describetheinvasiveandnon-invasivemeasurementofbloodpressureandcardiacoutputincludingcalibration,sourcesoferrorsandlimitations
Atransducerconvertsoneformofenergytoanother.Pressuretransducersconvertsapressuresignaltoanelectricalsignal,andrequireseveralcomponents:
CatheterTubingStopcockFlushTransducer
Thissystemmustbecalibratedintwoways:
StaticcalibrationCalibratestoaknownzero.DynamiccalibrationAccuraterepresentationofchangesinthesystem.
StaticCalibration
Staticcalibrationinvolves:
Levelingthetransducer(typicallytothelevelofthephlebostaticaxisattherightatrium,ortheexternalauditorymeatus)Achangeintransducerlevelwillchangethebloodpressureduetothechangeinhydrostaticpressure(incmH O).Zeroingthetransducer
OpeningthetransducertoairZeroingthetransduceronthemonitorAchangeinmeasuredpressurewhenthetransducerisopentoairisduetodrift,anartifactualmeasurementerrorduetodamagetothecable,transducer,ormonitor.
DynamicCalibration
Dynamiccalibrationensurestheoperatingcharacteristicsofthesystem(ordynamicresponse)areaccurate.Dynamicresponseisafunctionof:
DampingHowrapidlyanoscillatingsystemwillcometorest.
DampingisquantifiedbythedampingcoefficientordampingratioDescribestowhatextentthemagnitudeofanoscillationfallswitheachsuccessiveoscillationCalculatedfromtheratiooftheamplitudesofsuccessiveoscillationsinaconvolutedfashion:
,where:
2
PressureTransduction
489
![Page 490: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/490.jpg)
ResonantFrequencyHowrapidlyasystemwilloscillatewhendisturbedandleftalone.
Whendampingislow,itwillbeclosetothenaturalfrequency(orundampedresonantfrequency)
Dampingandnaturalfrequencyareused(ratherthanthephysicalcharacteristics)astheyarebotheasilymeasuredandaccurateindescribingthedynamicresponseThesepropertiesareactuallydeterminedbythesystemselasticity,mass,andfriction,butitisconceptuallyandmathematicallyeasiertousedampingandresonance
PressureWaveformsandDynamicResponse
ThedynamicresponserequiredisdependentonthenatureofthepressurewavetobemeasuredAccuratelyreproducinganarterialwaveformrequiresasystemwithagreaterdynamicresponsecomparedtoavenouswaveform
Anarterialpressurewaveformisaperiodic(repeating)complexwave,thatcanberepresentedmathematicallybyFourieranalysisFourieranalysisinvolvesexpressingacomplex(arterial)waveasthesumofmanysimplesinewavesofvaryingfrequenciesandamplitudes
Thefrequencyofthearterialwave(i.e.,thepulserate)isknownasthefundamentalfrequencyThesinewavesusedtoreproduceitmusthaveafrequencythatisamultiple(orharmonic)ofthefundamentalfrequency
Increasingthenumberofharmonicsallowsbetterreproductionofhigh-frequencycomponents,suchasasteepsystolicupstroke
Accuratereproductionofanarterialwaveformrequiresupto10harmonics-or10timesthepulserateAnarterialpressuretransducershouldthereforehaveadynamicresponseof30Hz
Thisallowsaccuratereproductionofbloodpressureinheartratesupto180bpm(180bpm=3Hz,3Hzx10=30Hz)
Resonance
Ifhighfrequencycomponentsofthepressurewaveformapproachthenaturalfrequencyofthesystem,thenthesystemwillresonateThisresultsinadistortedoutputsignalandasmallovershootinsystolicpressure.
Damping
Apressuretransductionsystemshouldbeadequatelydamped:
Anoptimallydampedwaveformhasadampingof0.64.Itdemonstrates:Arapidreturntobaselinefollowingastep-change,withoneovershootandoneundershoot
Acriticallydampedwaveformhasadampingcoefficientof1.Itdemonstrates:
PressureTransduction
490
![Page 491: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/491.jpg)
Themostrapidreturntobaselinepossiblefollowingastep-changewithoutovershootingAnover-dampedwaveformhasadampingcoefficientof>1.Itdemonstrates:
Aslowreturntobaselinefollowingastep-changewithnooscillationsSlurredupstrokeAbsentdicroticnotchLossoffinedetail
Anunder-dampedwaveformhasadampingcoefficientcloseto0(e.g.0.03).Itdemonstrates:Averyrapidreturntobaselinefollowingastep-changewithseveraloscillationsSystolicpressureovershootArtifactualbumps
Optimallydampedwaveformsareaccurateforthewidestrangeoffrequencyresponses:
TestingDynamicResponse
Dynamicresponsecanbetestedbyinducingastep-changeinthesystem,whichallowscalculationofboththenaturalfrequencyandthedampingcoefficient.Clinically,thisisperformedbydoingafast-flushtest.
Fastflushvalveisopenedduringdiastolicrunoffperiod(minimisessystemicinterference)Thepressurewaveproducedindicatesthenaturalfrequencyanddampingcoefficientofthesystem:
ThedistancebetweensuccessiveoscillationsshouldbeidenticalandequaltothenaturalfrequencyofthesystemTheratioofamplitudesofsuccessiveoscillationsgivesthedampingcoefficient
OptimisingDynamicResponse
Thelowerthenaturalfrequencyofamonitoringsystem,thesmallertherangeofdampingcoefficientswhichcanaccuratelyreproduceameasuredpressurewave.Therefore,theoptimaldynamicresponseisseenwhenthenaturalfrequencyisashighaspossible.Thisisachievedwhenthetubingis:
ShortWideStiffFreeofairIntroducinganairbubblewillincreasedamping(generallygood,sincemostsystemsareunder-damped),howeveritwilllowerthenaturalfrequencyandisdetrimentaloverall.
Footnotes
FundamentalsofPressureMeasurement
PressureTransduction
491
![Page 492: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/492.jpg)
Pressureexertedbyastaticfluidisduetotheweightofthefluid,andisafunctionof:
Fluiddensity(inkg.L )Acceleration(effectofgravity,inm.s )Heightofthefluidcolumn
Thiscanbederivedasfollows:
,thereforeCombiningtheaboveequations:
Thisisusuallyexpressedas:
NotethatthisexpressiondoesnotrequirethemassorvolumeoftheliquidtobeknownThisiswhypressureisoftenmeasuredinheight-substanceunits(e.g.mmHg,cmH O)
References
1. BrandisK.ThePhysiologyViva:Questions&Answers.2003.2. AlfredAnaestheticDepartmentPrimaryExamProgram3. Miller,RD.ClinicalMeasurementofNaturalFrequencyandDampingCoefficient.In:Anesthesia.5thEd.Churchill
Livingstone.
Lastupdated2019-07-18
-1-2
2
PressureTransduction
492
![Page 493: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/493.jpg)
PressureWaveformAnalysisDescribetheinvasiveandnon-invasivemeasurementofbloodpressureandcardiacoutputincludingcalibration,sourcesoferrorsandlimitations
Analysisofarterialpulsecontouris:
Real-timeandcontinuousUsedtoestimatecardiacoutputLessaccuratebutalsolessinvasive(e.g.thermodilution)ortechnicallydemanding(e.g.echocardiography)thanothermethods.
Thereforealsocalculate(andoftendisplay)strokevolumevariationandpulsepressurevariation
PrinciplesAllmodelsrecognisethattheamplitudeofthesystolicupstrokeis:
DirectlyproportionaltostrokevolumeInverselyproportionaltoarterialcompliance
Otherprinciplesusedbysome(butnotall)devicesinclude:
Three-elementWindkesselmodelCharacterisesthearterialtreeashavingthreemajorfeatures:
AorticImpedanceArterialCompliancePredictedusingpatientcharacteristics.SystemicVascularResistance
ConservationofMass
Devices
Devicescanbeclassifiedbasedonwhethertheyare:
Calibrated/UncalibratedCalibratedInitialestimationisrefinedusingadilutiontechnique.
Dilutionsmaybeby:Thermodilution
ColdsalineinjectedintoSVCUsinganIJVorSCVCVC.Temperaturechangedmeasuredatthefemoralartery
LithiumdilutionSmallamountsoflithiumchlorideinjectedintoacentralveinChangeinlithiumconcentrationmeasuredinradialarteryCObycalculatedStewart-Hamiltonequation
PeriodicallyrecalibratedtocorrectfordriftUncalibratedNotcorrectedforameasured'true'cardiacoutput.
Inaccurateforshorttermchangesinarterialproperties
PressureWaveformAnalysis
493
![Page 494: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/494.jpg)
Notvalidatedin:ShockARDSHepaticsurgeryDuetochangesinarterialtone.Cardiacsurgery
Invasive/Non-invasiveInvasiveRelyona(usuallyfemoral)arterialcatheter.Non-invasiveRelyonthevolumeclampmethod:
InflatablecuffwrappedaroundfingerPlethysmographestimatesbloodvolumeinthedigitalarteriesCuffinflatesanddeflatesthroughoutthecardiaccycle,keepingthevolumeofthearteriesconstantArterialpressureisproportionaltocuffpressure.Inaccuratein:
PeripheraloedemaVasoconstrictedstates
CommonDevicesinUse
PiCCO/VolumeView/FloTracCalibratedInvasive3-elementWindkesselMechanism:
CalculatesareaundersystolicpartofthearterialcurveDividescalculatedareabyaorticcomplianceComplianceestimatedbyproprietaryalgorithmeachtimethedeviceiscalibrated.
SVRiscontinuouslyestimatedfromcalculatedCOandmeasuredBPLiDCO
CalibratedInvasiveConservationofmassComplianceinferredfrombiometricdata
Clearsight/CNAPUncalibratedNon-invasive
T-LineCalibratedProprietary,non-validatedauto-calibratingalgorithm.Non-invasiveUsesradialapplanationtonometry
References1. JozwiakM,MonnetX,TeboulJ-L.PressureWaveformAnalysis.AnesthAnalg.2017.2. Francis,SE.ContinuousEstimationofCardiacOutputandArterialResistancefromArterialBloodPressureusingaThird-
OrderWindkesselModel.MIT.2007.
PressureWaveformAnalysis
494
![Page 495: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/495.jpg)
Lastupdated2019-07-18
PressureWaveformAnalysis
495
![Page 496: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/496.jpg)
Non-InvasiveBloodPressureDescribetheinvasiveandnon-invasivemeasurementofbloodpressureandcardiacoutputincludingcalibration,sourcesoferrorsandlimitations
Non-invasivebloodpressuremeasurementsisperformedwitheithera:
DeviceforIndirectNon-invasiveAutomaticMeanArterialPressure(DINAMAP)Automaticbloodpressurecuff.VonRecklinghausen'soscillotonometer"Manual"bloodpressurecuff.
Usestwocuffs,andthereforetwotubes
DINAMAPComponents:
OnecuffPerformsbotharterialocclusionandmeasurement.TubingDeviceforinflatingtheocclusivecuffandgraduallydeflatingitPressuretransducerDisplay
Method:
CuffisinflatedaboveSBPCuffdeflatesatarateof2-3mmHg.sWhencuffpressureequals:
SBPTurbulentflowoccurspastthecuff,creatingpressureoscillations.ThepressureatwhichthesearefirstdetectedistheSBP.MAPThepressureatwhichamplitudeofoscillationsismaximal.
DBPiscalculatedfromMAPandSBP
Cons
RequiresanappropriatelysizedcuffCuffshouldbe~20%greaterthanarmdiameter.
Cuffsthataretoosmallwillover-readCuffsthataretoowidewillunder-read
RequiresaregularrhythmInaccurateatextremesofbloodpressureInaccuratewhenusedmorefrequentlythanonceperminuteInaccuratewhenthevesselisincompressible
HeavilycalcifiedvesselsWhenappliedtoforearm/foreleg
Maycauseneuropraxia
-1
Non-InvasiveBloodPressure
496
![Page 497: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/497.jpg)
VonRecklinghausen'sOscillotonometer
Components:
TwocuffsOcclusivecuffMeasurementcuff
TubingDeviceforinflatingtheocclusivecuffandgraduallydeflatingitAneroidbarometerfortransducingpressureDisplay
Process:
CuffisinflateduntiltheradialpressureisnolongerpalpableThisisapproximatesSBP.Cuffisdeflated,andre-inflatedto20mmHgabovetheestimatedSBPCuffisdeflatedatarateof2-3mmHg.s whilstauscultatingthebrachialarteryWhencuffpressureequals:
SBPTurbulentflowoccurspastthecuff,turbulentflowcausesthefirstoftheKorotkoffsounds(cleartappingpulsations)tobeheard.DBPThecuffnolongercompressesthevesselatall,sonoturbulentflowoccursandnothingisauscultated.
References
1. ANZCAJuly/August20002. AstonD,RiversA,DharmadasaA.EquipmentinAnaesthesiaandIntensiveCare:AcompleteguidefortheFRCA.Scion
PublishingLtd.2014.3. LeslieRA,JohnsonEK,GoodwinAPL.DrPodcastScriptsforthePrimaryFRCA.CambridgeUniversityPress.2011.
Lastupdated2019-07-18
-1
Non-InvasiveBloodPressure
497
![Page 498: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/498.jpg)
CardiacOutputMeasurementDescribetheinvasiveandnon-invasivemeasurementofbloodpressureandcardiacoutputincludingcalibration,sourcesoferrorsandlimitations
Explainthederivedvaluesfromcommonmethodsofmeasurementofcardiacoutput(i.e.measuresofvascularresistance)
Cardiacoutputmeasurementcanbeperformed:
InvasivelyPulmonaryArteryCatheter
ThermodilutionFickPrinciple
TOEArterialwaveformanalysis
PiCCOVigileo
Non-invasivelyTTEMRIThoracicimpedance
Thermodilution
Thermodilutionremainsthegoldstandardofcardiacoutputmeasurement.
Thistechnique:
RequiresapulmonaryarterycatheterVariousdifferentdesignsexist.ForCOmeasurement,theyrequire:
AproximalportattheRA/SVCAtemperatureprobeatthetipTypicallyasiliconoxidethermistor.AballoonatthetipTofloatitintoposition.Adistal(PA)portisrequiredformeasuringPAPandthePCWP,butisnotrequiredforCOcalculation
MethodforIntermittentCardiacOutputMeasurementbyThermodilution
Aknownvolumeof(typicallydextrose)ataknowntemperature(classicallycooled,butthisisnotrequired)isinjectedintotheproximalportThetemperatureofbloodismeasuredatthetipThisproducesatemperature-timecurve.Theareaunderthecurvecanbeusedtocalculatecardiacoutput,asperthemodifiedStewart-HamiltonEquation:
,where:
=Cardiacoutput
=Volumeofinjectate
=Temperatureofblood
CardiacOutputMeasurement
498
![Page 499: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/499.jpg)
=Temperatureofinjectate
=DensityconstantRelatestothespecificheatandspecificgravityofbothinjectateandblood.
=ComputationconstantAccountsforcatheterdeadspaceandheatexchangeduringinjection.
=Areaunderthechangeintemperature-timecurve
ErrorsinThermodilution
NaturalvariabilityCardiacoutputvariesupto10%withchangesinintrathoracicpressureduringrespiration.Therefore:
Ameanof3-5measurementsshouldbetakenMeasurementsshouldbetakenatend-expiration
IncorrectvolumeofinjectateToomuchunderestimatesCOToolittleoverestimatesCO
WarmfluidThecloserthetemperatureofinjectateistoblood,thegreaterdegreeoferrorintroducedtothemeasurement.
Colderinjectateismoreaccurate,butcarriestheriskofinducingbradyarrhythmiasPoorlypositionedPACThePACmustbepositionedinWest'sZone3forbloodflowtooccurpastthetip,andforthemeasuredtemperaturetobeaccurate.TricuspidregurgitationResultsinretrogradeejectionofinjectatebackpastthevalve.Arrhythmia
FickPrinciple
CardiacOutputcanalsobemeasuredusingtheFickPrinciple.Thistechnique:
UsestheFickPrincipleTheflowofbloodtoanorganisequaltotheuptakeofatracersubstancedividedbythearterio-venousconcentrationdifference.
Inthiscase,thetracersubstanceisoxygenThe'organ'isthewholebody
Thisproducestheequation: ,where:
isCardiacOutput
isthepatientsoxygenconsumptionTypicallyestimatedas3.5ml.kg .min
isarterialoxygencontent
ismixedvenousoxygencontentReliesonmixedvenousbloodsampledfromthepulmonaryartery,andarterialbloodsampledfromaperipheralarterialline
References
-1 -1
CardiacOutputMeasurement
499
![Page 500: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/500.jpg)
1. Moise,S.F.,Sinclair,C.J.andScott,D.H.T.(2002),Pulmonaryarterybloodtemperatureandthemeasurementofcardiacoutputbythermodilution.Anaesthesia,57:562–566.
2. Nishikawa,T.&Dohi,S.Errorsinthemeasurementofcardiacoutputbythermodilution.CanJAnaesth(1993)40:142.
Lastupdated2019-07-18
CardiacOutputMeasurement
500
![Page 501: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/501.jpg)
PulseOximetryDescribetheprinciplesofpulseandtissueoximetry,co-oximetryandcapnography,includingcalibration,sourcesoferrorsandlimitations
Pulseoximetryreliesonseveralprinciples:
OxygenatedanddeoxygenatedhaemoglobinabsorblightofdifferentwavelengthstodifferentextentsLightof660nmand940nmisused.
Deoxyhaemoglobinhasagreaterabsorbanceofred(660nm)lightthanoxyhaemoglobinOxyhaemoglobinhasagreaterabsorbanceofinfrared(940nm)lightthandeoxyhaemoglobinTherelativeabsorbanceofeachallowsdeterminationoftheproportionsofoxygenatedanddeoxygenatedhaemoglobin
TheBeer-LambertLaw(s):Absorptionoflightpassingthroughasubstanceisdirectlyproportionaltoboththedistanceittravelsthroughthesubstanceandtheconcentrationofattenuatingspecieswithinthesubstance.Itisacompositeof:
Beer'sLawAbsorptionoflightisproportionaltotheconcentrationof"attenuatingspecies"Lambert'sLawAbsorptionisproportionaltothethicknessofthesolution,ormoreprecisely,thateachlayerofequalthicknessabsorbsanequalproportionofradiationthatpassesthroughit
Bloodflowispulsatile
Method
Apulseoximeterconsistsof:
TwodiodesofthedesiredwavelengthsPhotocellMicroprocessor
Duringpulsatileflow,theexpansionandcontractionofthebloodvesselsaltersthedistanceandhaemoglobinconcentrations,changingtheabsorptionspectraofblood(aspertheBeer-LambertLaw).
Non-pulsatileelementsareduetotissuesandvenousblood
Thesearesubtractedfromthetotal,leavingthepulsatileelementwhichrepresentsthearterialcomponentTheratioofabsorbanceofthepulsatileelementsandthenon-pulsatileelementsiscalledR,andiscalculatedas:
RiscomparedwithasetofstandardisedvaluestodeliveracalculatedSpO
AnRof1givesanSpO of85%AnRof0.4givesanSpO of100%AnRof2givesanSpO of50%
TheIsobesticPoint
TheisobesticpointisthewavelengthatwhichlightisabsorbedequallybybothhaemoglobinspeciesLightabsorptionisthereforeindependentofsaturation,andisinsteadafunctionofhaemoglobinconcentrationThiscanbeusedtocorrectforhaemoglobinconcentrationTherearetwoisobesticpointsforoxygenatedanddeoxygenatedhaemoglobin,at590nmand805nm
222
2
PulseOximetry
501
![Page 502: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/502.jpg)
Limitations
RequiresdetectablepulsatileflowLimitedbypoorperipheralperfusion(shock,hypotension,hypothermia)andnon-pulsatileflow(ECMO,CPB)Bodymovementsconfoundreadings(shivering,seizing)
LowsaturationsInaccuratebelow70%,andcompletelyunreliablebelow50%.
VenouspulsationDetectedaspulsatileflow,anderroneouslyinterpretedbythemicroprocessorasarterialflow.
ConfoundedbyambientlightThediodesarecycledatseveralhundredtimespersecondwhichallowsthedetectortocompensatefortheeffectofambientlight(thevalueswhenthediodesareoffgivetheeffectofambientlight).
Absorptionspectraconfoundedby:Haemoglobinopathies
Carboxyhaemoglobincausesthepulseoximetertoreadartificiallyhighduetoasitalsoabsorbs660nmlightMethaemoglobinaemiacausestheSpO totrendtowards85%,asthoughitabsorbs660nmlightisalsoabsorbs940nmlighttoagreaterdegree
DyesMethylenebluewillcausetheSpO toread<65%forseveralminutesIndocyaninegreenwillalsocauseadecreasedSpO
References1. DavisPD,KennyD.BasicPhysicsandMeasurementinAnaesthesia.5thEd.Elsevier.2003.2. MardirossianG,SchneiderRE.LimitationsofPulseOximetry.AnesthProg39:194-1961992.3. CICMMarch/May20144. TremperKK,BarkerSJ.Pulseoximetry.Anesthesiology.1989Jan;70(1):98-108.5. WilliamsGW,WilliamsES.BasicAnaesthesiologyExaminationReview.OxfordUniversityPress.2016.
Lastupdated2019-07-18
2
22
PulseOximetry
502
![Page 503: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/503.jpg)
OxygenAnalysisDescribetheprinciplesofmeasuringoxygenconcentration
Asoxygenisamoleculecontainingtwosimilaratoms,itspartialpressurecannotbedeterminedusinginfraredtechniques(unlikeCO ).Oxygencontentofagasisinsteaddeterminedusing:
ParamagneticanalysesFuelCells
ParamagneticAnalysisPrinciplesofparamagneticanalysis:
OxygenisparamagneticThismeansitisattractedbymagneticfields,butdoesnotpropagatethefield.
Thisisbecauseitstwounpairedvalentelectronshavethesamespin.Manyothergasesweaklyrepelledbymagneticfields(diamagnetic)
Theattractionofagasmixturetoamagneticfieldisthereforeproportionaltoitsoxygencontent
Manydifferentmethodsexistwhichusethispropertytodetermineoxygencontent
PressureMethod
GastestedflowsintoatubeAreferencegasflowsintoaparalleltubeBothgasesthenpassthrough:
FlowrestrictorsMagneticfieldThisisbeingturnedonandoffat~100Hz.
ThegasescombineinthemagneticfieldThegreatertheoxygencontentofthegas,themoreitwillmoveintothemagneticfieldThismovementcreatesanegativepressurebehindthegas.Thepressuredifferencebetweenthetestedgasandthereferencegasisproportionaltotheoxygencontentofthetestgas.
TemperatureMethod
Usedinmanymoderndevices.
Gasflowsthroughamagneticfield,causingtheparticlestoalignThischangesthethermalconductivityoftheoxygenmolecules.ThechangeinthermalconductivityofthegasmixtureisproportionaltotheoxygencontentThisisdetectedbymeasuringcurrentpassingthroughaheatedwire
Pros
AccurateRapidresponsetimeModernanalyserscanidentifybreath-to-breathvariationinFiO .Don'trequireregularcalibration
2
2
OxygenAnalysis
503
![Page 504: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/504.jpg)
Cons
WatervapourreducesaccuracyInterferencefromotherparamagneticgases
NitricoxideEffectisminimalasnitricisdeliveredinfarsmallervolumesthanoxygen,andisonlyweaklyparamagnetic.
FuelCells
Fuelcellsrelyonreductionofoxygentomeasureoxygenpartialpressure.Theyconsistof:
OxygenpermeablemembraneKOHsolutionThiscontains:
LeadanodeLeadisconsumedasthefuelcelloperates.Goldcathode
Method
OxygendiffusesacrossthemembraneintothepotassiumhydroxidesolutionAtthecathode:
Attheanode:
Theoxygenconsumptionisproportionaltothecurrentgenerated,whichismeasuredwithanammeter
Pros
NopowerrequiredSmallAccurate
Cons
WillaccumulatenitrogeninthepresenceofN OResultsinanunder-readingofPO .Mustbereplacedafter6-12monthsRequiresregulartwo-pointcalibration21%and100%oxygenareused.Relativelyslowresponsetimecomparedtoparamagneticanalysers~20s.
References1. AstonD,RiversA,DharmadasaA.EquipmentinAnaesthesiaandIntensiveCare:AcompleteguidefortheFRCA.Scion
PublishingLtd.2014.
Lastupdated2019-07-18
22
OxygenAnalysis
504
![Page 505: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/505.jpg)
OxygenAnalysis
505
![Page 506: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/506.jpg)
End-TidalGasAnalysisDescribetheprinciplesofpulseandtissueoximetry,co-oximetryandcapnography,includingcalibration,sourcesoferrorsandlimitations
Principles
SeveralmechanismsforE CO measurementexist:
InfraredSpectroscopyColourimetricMethodsRaymanScatteringGasChromatography
InfraredSpectroscopy
Infraredspectroscopyreliesonthefactthat:
GaseswithtwoormoredifferentatomswillabsorbinfraredradiationDifferentgasesabsorbingdifferentwavelengthstodifferentdegreesMeasuringtheabsorbedwavelengthsandcomparingwiththelikelycompositionofamixture,asystemcanbedesignedusingaspecificwavelengthtomeasuregasconcentrationsandavoidinterference
End-tidalgasanalysisusinginfraredlightisusedinthemeasurementof:
COCapnographyisthecontinuousmeasurementandgraphicaldisplayofthepartialpressureofCO inexpiredgas.ThisisthemostcommonmethodtomeasureE CO .Anaestheticagents
MeasurementofCOComponents:
SapphiresamplingchambercontaininggassampleCO absorbsinfraredradiationatapeakwavelengthof4.28μmThesapphirelensonlyallows4.28μmlightthrough
EmitterDetectorMicroprocessorDisplay
Method:
LightisemittedandpassesthroughthesamplingchamberAlensisusedtofocusemittedlight.LevelsofradiationaremeasuredontheothersideofthechamberLevelscorrespondtotheamountofgaspresentinthesampleThelessradiationthatreachesthedetector,themoregasthereisinthesampleabsorbingit
T 2
22
T 2
2
2
End-TidalGasAnalysis
506
![Page 507: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/507.jpg)
EquipmentErrors
Errorscanbeclassifiedinto:
SpecifictotechniqueThecollisionbroadeningeffectIntermolecularforcesvarydependingontheirproximitytoothermoleculesinthegasmixture.Achangeinintermolecularforcesmayaltertheirbond-energyandthefrequenciesatwhichtheyabsorbradiation.Itcanbeovercomeby:
CorrectingforthepresenceofothergasesManuallyadjustingtheobtainedvalues
CrossoverwithothergasmixturesCO andN Ohavesimilarabsorbancespectra,andmayleadtoerrorwhenadeviceisnotdesignedtomeasurebothwavelengths.
FailureofequipmentThesecanbeovercomebyuseofdouble-beamcapnometer.ThisusesareferencechamberwhichcontainsCO -freeair,andthesameemitter-detectorsystem.Allabsorptionfromthissystemmustoccurduetoartifact(asnoCO ispresent).Theartifactualcomponentisthensubtractedfromthevaluedetectedinthemainchamber.Thiscorrectsfor:
VariableamountofinfraredradiationreleasedVariablesensitivityofthedetectorVariableefficacyofthecrystalwindowandlenssystem
RelatingtotypeofcapnometerusedE CO maybeeitherside-streamorin-line.
Side-streamCO involvesalengthofnarrowtubingdrawinggasfromtheexpiratorylimbofthebreathingcircuit(typicallyfromtheHMEfilter)tothecapnograph
Side-streamrequiresaflowof150ml.minHasa(prettyinsignificant)delay(<1s)inmeasurementMaybeblockedbywatervapour,andrequireuseofawatertraptoremovecondensation
In-linesystemshaveasamplingchamberattachedin-linewiththeETTThesamplingchamberslightlyincreasesthedead-spaceofthecircuitMayberelevantinchildrenorverydifficulttoventilatepatients.AddsweighttopatientendofthebreathingcircuitRequireheatingto41°Ctoavoidcondensation
NormalE CO Waveform
Thenormaltraceconsistsoffourcomponents:
1. ThebaselineThisconsistsof:
Inspiratorytime
2 2
22
T 22
-1
T 2
End-TidalGasAnalysis
507
![Page 508: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/508.jpg)
Earlydead-spaceexhalationThisistheperiodimmediatelybeforephase2,wheresomegaswithaPCO of0isexhaled.
2. Alveolarexhalation,wherePCO risesrapidly3. Alveolarplateau,wherePCO flattens
Thehighest-pointofthiscurveislabeledE CO .4. Inspiration,wherePCO returnsto0
E CO WaveformVariations
Airwayobstruction:
Occursduetounevenemptyingofalveoliwithdifferenttime-constants
Hyperventilation:
LowerE CO withshorterbaselinePlateauphasemaynotoccuratveryhighrespiratoryrates
Rebreathing:
BaselineincreasesasinspiredCO ismeasuredfromgasanalyser
ChangesinE CO
NormalE CO is32-42mmHg,whilstnormalPaCO is35-45mmHg.
22
2T 2
2
T 2
T 2
2
T 2
T 2 2
End-TidalGasAnalysis
508
![Page 509: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/509.jpg)
HighE CO
Thismaybefrom:
DecreasedventilationDecreasedRRDecreasedVIncreasedV andthereforeagreaterV :V ratio
IncreasedproductionofCOIncreasedmetabolicrate
SepsisTourniquetreleaseROSCfollowingarrest
IncreasedinspiredRebreathing(i.e.equipment/ventilatormalfunction)ExternalsourceofaddedCO
LowE CO
RapidLossofE CO
FailureofventilationCircuitdisconnectAirwayobstructionBronchospasm
FailureofcirculationCardiacarrestShock
GradualLossofE CO
IncreasedV (i.e.increasedMV)DecreasedCO production
HypometabolicstateHypothermia
IncreasedV ,i.e.V/QmismatchIncreasedWestZoneIphysiology:
HypotensionIncreasedRVAfterload:
PEHighPEEP
SamplingerrorAirentrainmentintothesamplechamberInadequateV
DiscrepancybetweenE CO ,PACO ,andPaCO
ThenormalgradientbetweenPaCO andE CO is0-5mmHg.Healthyandawakeindividualsshouldhaveessentiallyno(<1ml)alveolardeadspace,andsoessentiallynogradient.Thisgradientisincreasedinpatientswith:
V/QmismatchE CO willunderestimatearterialCO asgasfromun-perfusedalveoli(withnegligibleCO )willdiluteCO expiredgas
T 2
TD D T
2
2
T 2
T 2
T 2
A2
D
T
T 2 2 2
2 T 2
T 2 2 2 2
End-TidalGasAnalysis
509
![Page 510: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/510.jpg)
ColourimetricMethods
Litmuspaperwhichchangescolourwhenexposedtohydrogenions(producedbyCO )canbeusedtoconfirmendo-trachealintubation,thoughtheymaygeneratefalse-positiveresultsduetogastricpH.
References
1. CrossME,PlunkettEVE.Physics,Pharmacology,andPhysiologyforAnaesthetists:KeyConceptsfortheFRCA.2ndEd.CambridgeUniversityPress.2014.
2. DavisPD,KennyD.BasicPhysicsandMeasurementinAnaesthesia.5thEd.Elsevier.2003.3. LeslieRA,JohnsonEK,GoodwinAPL.DrPodcastScriptsforthePrimaryFRCA.CambridgeUniversityPress.2011.
Lastupdated2019-07-18
2
End-TidalGasAnalysis
510
![Page 511: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/511.jpg)
BloodGasAnalysisDescribethemethodsofmeasurementofoxygenandcarbondioxidetensioninbloodandbloodpH
Bloodgasmachinesdirectlymeasurethreevariablesandcalculatetheremainder.Measuredvariablesare:
POCOpH
Calculatedvariablesinclude:
BicarbonateUsingthepH,CO andtheHenderson-Hasselbalchequation.BaseExcessCalculatedusingtheHenderson-HasselbalchandSiggaard-Andersonequation.Canbeexpressedintwoways:
BaseExcessTheamountofalkalithatmustbeaddedtothesampletoreturnittoanormalpH,atatemperatureof37°CandaPaCO of40mmHg.StandardisedBaseExcessAsbaseexcess,butcalculatedforbloodwithaHbconcentrationof50g.L .ThisisthoughttobetterrepresenttheECFasawhole.
OxygenTensionOxygentensionismeasuredwithaClarkeelectrode.Thisconsistsof:
AchamberforthebloodsampleAchambercontainingapotassiumchloridesolution,which:
Isseparatedfromthebloodchamberbyanoxygen-permeablemembraneThispreventsbloodbeingindirectcontactwiththecathode,whichwouldleadtoproteindepositiononthecathodeandincorrectmeasurement.ContainsaplatinumcathodeContainsasilver/silverChlorideanode
Abatteryapplying0.6Vacrosstheelectrodes
Method
Avoltageof0.6Visappliedacrosstheelectrodes,causingthesilvertoreactivewithchlorideinthesolutiontoproduceelectrons:
22
2
2
-1
BloodGasAnalysis
511
![Page 512: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/512.jpg)
Thispotentialdifferenceisrequiredtostartthereaction0.6Vischosenbecauseitisenoughtostartthereactionbutwillhaveminimaleffectonmeasuredcurrentflow
Atthecathode,oxygencombineswithelectronsandwatertoproducehydroxylions:
Foreachoxygenmoleculepresentatthecathode,fourelectronscanbeconsumedIncreasingtheoxygenavailableatthecathodeincreasesthenumberofelectronsconsumed,andthereforeincreasescurrentflow
OxygenwillmovefromthesamplechambertothemeasuringchamberaccordingtoitspartialpressureMeasuredcurrentflowisthereforeproportionaltooxygentensioninblood
Calibration,Limitations,andAccuracy
CalibrationisperformedwithstandardgasmixturesRequiresregulartwo-pointcalibration.CathodemustbekeptcleanfromproteinandnotdamagedCathodemustbekeptat37°CMayreadfalselyhighwithhalothane
pHMeasurement
pHisameasureofthehydrogenionconcentration insolution,andisdefinedasthenegativelogarithmtothebase10ofthe[H ]:
ApHof7.4isa[H ]of40nmol.L at37°CAchangeinapHunitof1isequivalenttoa10-foldchangeinthe[H ]AchangeinpHof0.3isequaltodoublingorhalvingthe[H ]
ThepHelectrodeconsistsof:
AchamberforthebloodsampleAmeasuringchamber,separatedfromthesamplebyH -permeableglass,whichcontains:
AbuffersolutionAsilver/silverchloridemeasuringelectrode
Areferencechamber,alsoseparatedfromthechamberbyH -permeableglass,whichcontains:AKClsolutionHasnobufferingproperties.
1+
+ -1+
+
+
+
BloodGasAnalysis
512
![Page 513: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/513.jpg)
Amercury/mercurychloridereferenceelectrode
Method
ReliesontheprinciplethattwosolutionswithdifferentH activitieswilldevelopapotentialdifferencebetweenthem(proportionaltotheconcentrationgradient)H passesthroughtheglassalongaconcentrationgradient:
Avariablepotentialdifferenceisgeneratedinthemeasuringchamber,asH ionsarebufferedandtheconcentrationgradientismaintainedAconstantpotentialdifferenceisgeneratedinthereferencechamber,asthereisnobufferofH ionsintheKClsolution
OnceH hasequilibratedbetweenbloodandtheKClsolution,thepotentialdifferencebetweenthemeasuringandreferenceelectrodesisproportionaltotheH concentrationinblood
Calibration,Limitations,andAccuracy
Calibrationisperformedwithtwophosphatebuffersolutionscontainingtwodifferent(known)[H ]Mustbekeptat37°CHypothermiaincreasessolubilityofCO andthereforelowersPaCOAreducedpartialpressureofCO isrequiredtokeepthesamenumberofmoleculesdissolved(asperHenry'sLaw)
Therefore,asbloodcoolsitspHwillincreaseElectrodesmustbekeptcleanfromproteinandnotdamaged
CarbonDioxideTension
CarbondioxidetensionismeasuredwithaSeveringhauselectrode,whichisbasedonthepHelectrode,asPaCO2isrelatedto[H ].TheSeveringhauselectrodeconsistsof:
Achamberforthebloodsample,separatedfromthebicarbonatechamberbyaCO permeablemembraneAchambercontainingbicarbonatesolutioninanylonmesh,andseparatedfromboththemeasuringandreferencechambersbyH -permeableglassAmeasuringchambercontaining:
AbuffersolutionAsilver/silverchloridemeasuringelectrode
Areferencechambercontaining:AKClsolutionAmercury/mercurychloridereferenceelectrode
+
++
++
+
+
2 22
+
2
+
BloodGasAnalysis
513
![Page 514: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/514.jpg)
Method
CO diffusesfrombloodintothebicarbonatechamberCO reactswithwaterinthebicarbonatechambertoproduceH ionsFromhere,theprocessisidenticaltothepHelectrode,exceptbicarbonatetakestheplaceofblood:
H ionsdiffuseintothereferencechamberuntiltheH ionconcentrationhasequilibratedH ionscontinuallydiffuseintothemeasuringchamber(astheyarebuffered)
ThisestablishesaconstantpHgradientThisgradientisproportionaltheH ionconcentrationinthebicarbonatechamber,whichisproportionaltotheCO contentofblood.
Calibration,Limitations,andAccuracy
CalibrationisperformedwithsolutionsofknownCO concentrationMustbekeptat37°CHypothermiadecreasessolubilityofCO andthereforedecreasespHElectrodesmustbekeptcleanfromproteinandnotdamagedSlowresponsetimerelativetopHelectrodeduetotimetakenforCO todiffuseandreactThiscanbeacceleratedwithcarbonicanhydrase
Footnotes
.TechnicallypHisdefinedastheactivityofH inasolution.Clinically,activityisidenticaltoconcentration,soinmedicinethesedefinitionsarefunctionallythesame.↩
References1. LeslieRA,JohnsonEK,GoodwinAPL.DrPodcastScriptsforthePrimaryFRCA.CambridgeUniversityPress.2011.
22
+
+ ++
+
2
2
2
2
1 +
BloodGasAnalysis
514
![Page 515: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/515.jpg)
2. (FRCA-MeasurementofpO2,pCO2,pH,pulseoximetryandcapnography)[http://www.frca.co.uk/article.aspx?articleid=100389]
3. AstonD,RiversA,DharmadasaA.EquipmentinAnaesthesiaandIntensiveCare:AcompleteguidefortheFRCA.ScionPublishingLtd.2014.
Lastupdated2018-09-21
BloodGasAnalysis
515
![Page 516: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/516.jpg)
GasFlowDescribethemeasurementofflow,pressureandvolumeofgases
TypesofFlow:
LaminarflowFluidmovinginasteadymannerwithoutturbulence.TurbulentflowIrregularfluidmovementinradial,axial,andcircumferentialaxes.
Laminarflowismoreefficientthanturbulentflow,asitrequiresasmallerpressuregradienttogeneratethesameflowFortwofluidsmovingatthesamespeed,thevelocityofindividualparticlesinlaminarflowwillbebothhigherandlower
TransitionalflowMixtureoflaminarandturbulentflow.Flowistypicallyturbulentinthecentre,andlaminarattheedges.
Devicesusedtomeasuregasflowinclude:
Variable-OrificeFlowmetersFixed-OrificeFlowmetersPneumotachograph.Hotwireflowmeter
NoteorificebasedflowmetersrelyontheHagan-PoiseuilleEquation:
Viscosity( )andlength( )arefixedbybothdevicesFixedorificeflowmetersalsofixradius( ),suchthatthechangeinpressuremustthereforebeproportionaltoflow:
,where isaconstant
Variableorificeflowmetersalsofixpressure( ),suchthatflowcanbecalculatedfromtheradius:
Flowmeters
Constantpressure,variableorificeflowmetersarefoundonwallandcylindergases.Theyconsistof:
Aninverseconicaltube(i.e.narroweratthebottom,andwideratthetop)AneedlevalveAbobbinMayhaveagroovewhichcausesthebobbintospin,confirmingitisnotstuck.
Method:
GasflowsfromthebottomtothetopofthetubeThebobbinobstructsflowThereforethereisapressuredifferenceacrossit.
Remember:
Atequilibrium,thepressureexertedbythebobbinontheflowofgas( )
GasFlow
516
![Page 517: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/517.jpg)
isequaltothepressureexertedbythegasonthebobbin
Asflowisincreased,thebobbinispushedfurtheruptheflowmeterduetotheincreasedpressureThebobbinwillreachanewequilibriumpositionwhentheorificeoftheflowmeterhasbecomewideenoughforthepressureonthebobbintoequalthepressureofgravity
Flowmetersarecalibratedforindividualgasesas:
Laminar(typicallylowflows)flowisproportionaltoviscosityTurbulent(typicallyhighflows)flowisproportionaltodensity
Pros
CheapNoadditionalpowersupplyrequiredAccurateReadingsmaybealteredby:
ChangeintemperatureaffectsviscosityanddensityofgasChangeinpressureaffectsdensityofgas
Cons
MustbeverticalBobbinscanbecomestuck
PneumotachographsConstantorifice,variablepressureflowmeter.Severaldifferentdesignsexist,andinclude:
FleischpneumotachographConsistsofseveralfineboreparalleltubesplacedinthegascircuitDecreasedradiusandincreasedresistancereducesgasflowvelocity,improvinglaminarflow.AdifferentialpressuretransducerisplacedateitherendofthetubesThepressuredropacrossthetubingisdirectlyproportionaltoflow
PitottubesConsistsoftwotubesplacedintothegascircuit:
OnefacesintothegasflowTheotherfacesawayfromthegasflow
Thepressuredifferencebetweentubesisproportionaltoflow
Pros
AccurateContinualmeasurementAllowcalculationofvolumes
Cons
IncreasedresistanceIncreaseddeadspaceRequirelaminarflow
GasFlow
517
![Page 518: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/518.jpg)
Inaccuratewhen:FlowsarehigherthanwhatthesystemisdesignedforAlterationingasdensity
ChangeingasmixtureAlterationingastemperature
HotWireFlowmeter
Components:
TwofineplatinumwiresinthegascircuitOneheatedto180°CatOL.minOneat0°C
Ammeter
Method:
Asgasflows,thewirecoolsRateofheatdissipationisproportionaltogasflowTheamountofcurrentrequiredtoreturnthewireto180ismeasured,andisproportionaltoflow
Pros
AccurateFast
Cons
Fragile
References
1. AstonD,RiversA,DharmadasaA.EquipmentinAnaesthesiaandIntensiveCare:AcompleteguidefortheFRCA.ScionPublishingLtd.2014.
Lastupdated2019-07-18
-1
GasFlow
518
![Page 519: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/519.jpg)
PrinciplesofUltrasoundDescribethephysicalprinciplesofultrasoundandtheDopplerEffect.
Ultrasoundisanimagingtechniquewherehigh-frequencysoundwaves(2-15MHz)areusedtogenerateanimage.Anultrasoundwaveisproducedbyaprobeusingthepiezoelectriceffect:
CertaincrystallinestructureswillvibrateataparticularfrequencywhenacertainvoltageisappliedacrossthemTheconversionofelectricalenergytokineticenergyishowtheultrasoundprobecreatesanultrasoundwave.Similarly,theycangenerateavoltagewhenavibrationisinducedinthemThisishowtheprobeinterpretsreflectedwaves.
BasicPrinciplesSpatialresolutionHowclosetwoseparateobjectscanbetoeachotherandstillbedistinguishable.Itisdividedinto:
Axialresolution,howfaraparttwoobjectscanbewhenoneisabovetheother(inthedirectionofthebeam)Lateralresolution,howfaraparttwoobjectscanbewhensideside-by-side
Contrastresolutionishowsimilartwoobjectscanappear(inechogenicappearance)andstillbedistinguishable
Higherfrequencysettingsoffergreaterspatialresolutionbutdecreasedpenetration
LowerfrequencysettingsofferreducedspatialresolutionbutincreasedpenetrationTheyareusedforvisualisingdeepstructures.
AffectofTissuesonUltrasoundAttissueinterfaces,thewavemaybe:
AbsorbedSoundislostasheat,andincreaseswithdecreasedwatercontentoftissues.ReflectedSoundbouncesbackfromthetissueinterface,andreturnstotheprobe.
Reflectionisdependentonthe:DifferenceinsoundconductionbetweenthetwotissuesAngleofincidence(closeto90°improvesreflection)Smoothnessofthetissueplane
Theamplitudeofsoundreturningtotheprobedeterminesechogenicity,orhowwhitetheobjectwillbedisplayedThetimetakenforthesoundtoreturndeterminesdepth
Thetimetakenforawavetoreturnisproportionaltotwicethedistanceoftheobjectfromtheprobe
Depthcanbecalculatedusing ,where:
isDepthisthespeedofsoundintissue,andisassumedtobe1540ms
tisTimeTransmittedSoundpassesthroughthetissue,andmaybereflectedorabsorbedatdeepertissues.ScatteredSoundisreflectedfromtissuebutisnotreceivedbytheprobe.
Attenuated
-1
PrinciplesofUltrasound
519
![Page 520: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/520.jpg)
Attenuationdescribesthelossofsoundwavewithincreasingdepth,andisafunctionoftheabovefactors.AttenuationismanagedbyincreasingthegainGainreferstoamplificationofreturnedsignal.Time-gaincompensationreferstoamplificationofsignalswhichhavetakenlongertoreturn,whichamplifiessignalsreturnedfromdeeptissues
Modes
Ultrasoundmodesinclude:
B-Mode(brightnessmode)Thestandard2Dultrasoundmode,andplotsthemeasuredamplitudeofreflectedultrasoundwavesbythecalculateddepthfromwhichtheywerereflected.M-Mode(movementmode)Selectsasingleverticalsectionoftheimageanddisplayschangesovertime(i.e.depthonthey-axis,andtimeonthex-axis).
DopplerEffect
Thedopplereffectisthechangeinobservedfrequencywhenawaveisreflectedoff(oremittedfrom)amovingobject,relativetothepositionofthereceiver.Inmedicalultrasound,thisisthechangeinfrequencyofsoundreflectedfromamovingtissue(e.g.anerythrocyte).Itisgivenbytheequation:
where:
=Velocityofobject
=Frequencyshift=Speedofsound(inblood)
=Frequencyoftheemittedsound
=Anglebetweenthesoundwaveandtheobject
Reflectedfrequenciesarehighertowardstheprobeandloweraway.
CalculationofCardiacOutput
Remember, .
HeartrateismeasuredStrokevolumeiscalculatedby:
Measuringthecross-sectionalareaoftheleftventricularoutflowtractObtainedbymeasuringthediameterusingultrasound.MeasuringthestrokedistanceObtainedviaintegratingthevelocity-timewaveformfortimeacrosstheleftventricularoutflowtract(LVOTVTI).
Theintegralofflow(m.s andtime(s))fortime(s),producesadistance(m)MultiplyingtheLVOTcross-sectionalarea(m )bythestrokedistance(m),producesavolume(m )Thisisthestrokevolume.
References
-12 3
PrinciplesofUltrasound
520
![Page 521: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/521.jpg)
1. CrossME,PlunkettEVE.Physics,Pharmacology,andPhysiologyforAnaesthetists:KeyConceptsfortheFRCA.2ndEd.CambridgeUniversityPress.2014.
2. CICMJuly/September2007.
Lastupdated2019-07-18
PrinciplesofUltrasound
521
![Page 522: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/522.jpg)
TemperatureandHumidityDescribethemeasurementoftemperatureandhumidity
Temperatureisthetendencyofabodytotransferheatenergytoanotherbody,andismeasuredindegrees.Itisdistinctfromheat,whichisthekineticenergycontentofabody,andismeasuredinJoules.Thetwoarerelatedbythespecificheatcapacity,whichdescribeshowmuchenergy(J)mustbeappliedtoabodytoraiseitstemperaturefrom14°Cto15°C,withoutachangeinstate.
Humiditymaybeeitherabsoluteorrelative:
AbsoluteHumidityisthemassofwatervapourinavolumeofairRelativeHumiditymeasuresthepercentagesaturationofairatcurrenttemperature,ormoreformally:
MeasurementofTemperature
Temperatureismeasuredbyanumberofmethods:
LiquidExpansionThermometry
Thisisusedinmercurythermometers.Theseconsistof:
Agraduatedevacuatedcapillaryofnegligiblevolume,attachedtoAmercuryreservoir,ofmuchgreatervolume,separatedbyAconstrictionringPreventstravelofmercuryupthecapillarybygravity.
Mechanism:
Whenheated,thekineticenergyofthemercuryincreasesanditexpands,forcingitupthecapillaryAsthethermalexpansioncoefficientforallliquidsisverysmall,thecapillarymustbeofaverysmallvolumetocreateausabledevice.Thespeedthatthisoccursisrelatedtothetime-constantofthesystemThisistypically30seconds.Measurementthereforetakes~4time-constants,or2minutes.
Pros
EasytouseAccurateReusableSterilisableCheap
Cons
SlowresponseOnlyaccurateonceithasreachedthermalequilibrium.GlasscanbreakMaycausereleaseofmercuryoralcohol.Inaccurateat:
TemperatureandHumidity
522
![Page 523: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/523.jpg)
LowtemperatureswithmercuryFreezesat-38.8°C.HightemperatureswithalcoholBoilsat78.5°C.
Electrical
Electricalmethodsinclude:
ResistancethermometerPlatinumwireincreaseselectricalresistancewithincreasingtemperature.
ThereforethevoltagedropacrossthewirewillcorrespondtothetemperatureofthewireChangeinresistanceislinearacrossthetemperaturerangeHowever,theseareexpensive.
ThermistorMetal(e.g.SiO )semiconductorwhichchangesitsresistanceinapredictablynon-linearfashion(run-awayexponent)withtemperature.
CanbemanufacturedsothatchangeislinearovertheclinicalrangeMuchcheaperthanwireresistancemethodsThedegreeofvoltagedropisusuallyverysmall,howeverthiscanbeamplifiedusingaWheatstonebridge
ThermocoupleAtthejunctionoftwodissimilarmetals,apotentialdifferencewillbeproducedproportionaltotheirtemperature.ThisisknownastheSeebeckeffect.
Non-linear(washinexponent)Degradeovertime
MeasurementofHumidity
Humiditycanbemeasuredbyanumberofmethods:
HairHygrometerHair(actualhair)changeselasticitydependingonthehumidityofair.Changesinelasticitycanberelatedtochangesinhumidity.
WetandDryBulbThissystemmeasuresbothtemperatureandrelativehumidity.
TwothermometersareusedOneiswrappedinawick,whichisattachedtoawaterreservoirThisisthewetthermometer.Thedrythermometergivesameasurementofsurroundingairtemperature
ThewetthermometeriscooledduetoevaporativecoolingfromthewickHighenergywatermoleculesbecomevapour,leavingonlylowenergymoleculesbehind.Thetemperaturedifferencebetweenthethermometersisafunctionof:
LatentheatofvapourisationofwaterHowmuchevaporativecoolingisoccurringThisisfunctionofhumidity.
At100%relativehumidity,noevaporativecoolingwilltakeplaceandthetemperatureswillbeequalAshumiditydecreases,evaporativecoolingwillcoolthewetthermometer,andthetemperaturedifferenceallowshumiditytobedetermined
2
TemperatureandHumidity
523
![Page 524: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/524.jpg)
References
1. AstonD,RiversA,DharmadasaA.EquipmentinAnaesthesiaandIntensiveCare:AcompleteguidefortheFRCA.ScionPublishingLtd.2014.
2. AlfredAnaestheticDepartmentPrimaryExamTutorialSeries
Lastupdated2019-07-18
TemperatureandHumidity
524
![Page 525: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/525.jpg)
ElectrocardiographyDescribetheprinciplesbehindtheECG
TheECGisagraphicalrepresentationoftheelectricalactivityoftheheart,asmeasuredbythesumofelectricalvectorsatthepatientsskin.
Components
AnECGconsistsof:
ElectrodesDisposable,stickycomponentswhichactasconductorsduetoasilver/silverchloridecoating.Toreduceelectrodeimpedance,skinshouldbe:
HairlessDryClean
CablesShieldedtopreventcurrentsbeinginducedandelectrocutingthepatient.ProcessorMonitor
ECGLeads
ECGleadsarecreatedbytakingthepotentialdifferencebetweentwoelectrodes,whichvariesby0.5-2mVthroughthecardiaccycleasmyocardiumdepolarises.ECGleadsaredividedinto:
LimbleadsPotentialdifferencebetweenlimbelectrodes:
I:RAtoLAII:RAtoLLIII:LAtoLL
AugmentedleadsPotentialdifferencebetweentheaverageofthelimbleads(calledtheindifferentelectrode)andeachindividuallimblead.
AugmentedleadsareofmuchlowervoltageandmustbeamplifiedThreeaugmentedleadsexist(oneforeachlimbelectrode)
PrecordialleadsPotentialdifferencebetweentheindifferentelectrodeandoneofthesixadditionalelectrodesplacedonthechestwall.
TherelationshipbetweenelectrodesandleadsisdescribedwithEinthoven'sTriangle:
Electrocardiography
525
![Page 526: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/526.jpg)
Method
Asthemyocardialmembranepotentialchangesacrossthecardiaccycle,apotentialdifferencecanbemeasuredattheskin.Adepolarisationwavetravelingtowardsthepositiveelectrode(orarepolarisationwavetravelingaway)willcauseanupwarddeflectionintheECG
Thesepotentialdifferencesareverysmall,andthereforeneedtobe:DistinguishedfrombackgroundinterferenceSeveraltechniquesexist:
CommonmoderejectionIdenticalelectricalactivityoccurringinmultipleelectrodesislikelyduetointerferenceratherthancardiacactivity,andisremovedfromthemeasuredsignal.
AgroundelectrodeistypicallyusedforthispurposeECGmodesECGscanbesettovaryinglevelsofsensitivity.
DiagnosticmodeRespondstohigherrangeoffrequencies,butisatgreaterriskofinterference.MonitormodeECGrespondstoalowerrangeoffrequencies,reducinginterferencebutalsoresolution.Thisiscommonon3-leadECG.
HighinputimpedanceMinimisessignalloss.
AmplifiedFrequenciesinthedesiredsignalrangeareamplified.
SourcesofError
ImprovesignaldetectionGoodadherenceOptimalskincontactEnsuredryandhairless.
MinimiseexternalelectrostaticforcesEarthedDiathermyShivering
Electrocardiography
526
![Page 527: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/527.jpg)
Risks
ECGelectrodescanactasanexitelectrodeforsurgicaldiathermy
References
1. AstonD,RiversA,DharmadasaA.EquipmentinAnaesthesiaandIntensiveCare:AcompleteguidefortheFRCA.ScionPublishingLtd.2014.
2. CICMFebruary/April2016
Lastupdated2019-07-18
Electrocardiography
527
![Page 528: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/528.jpg)
HumidifiersHumidifiersaddwatervapourtoinspiredgas,takingtheplaceofnormalbodymechanismswhicharebypassedorimpededbyinvasiveandnon-invasiveventilation.Maintainingadequatehumidityofinspiredgasisimportantin:
ReducingmetabolicloadHumidificationofinspiredgasaccountsfor~15%ofbasalheatexpenditure.MaintainingfunctionofthemucociliaryelevatorInspirationofdrygasincreasesviscosityofmucous.ReducingwaterlossWaterwillbeabsorbedfrommucosatohumidifygas.
Humidifierscanbeclassifiedintoactiveorpassive.
PassiveHumidifiersPassivehumidifiers:
DonotrequirepowerDonotrequirewater
TheHeatandMoistureExchange(HME)filteristheclassicpassivehumidifier:
PlacedbetweenthepatientandthepatientY-pieceConsistsof:
AmoistureexchangelayerPleated,hygroscopicallycoatedfoamorpaper.
Expiredgascoolsasitpasses,condensingontothefoam,withcondensationpromotedbyhygroscopiccoating(usuallythisisNaCl)Thelatentheatofvapourisationresultsinadecreasedtemperatureofexpiredgas
AfilterlayerTypicallyaelectrostaticorhydrophobicmaterial.
ExpiredgasiscooledanddriedInspiredgasisthenheatedandhumidifiedAnHMEtakesupto20minutestobefullyeffective,andcanachievearelativehumidityupto70%Efficacydependsuponthepatient'scoretemperatureandtheconditionoftheairway
Pros
CheapLightweightStraightforwardMaycontainanti-bacterialfilter
Cons
MaybeblockedwithvomitandsecretionsIncreaseairwayresistanceIncreasedeadspaceNotaseffectiveaspoweredactivesystemsOnlylast24hours
Humidifiers
528
![Page 529: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/529.jpg)
Takes15-20minutestobecomefullyeffective
ActiveHumidifiers
ActiveHumidifiers:
Requireeither:PowerUnpoweredhumidifiersaretypicallylesseffective,andonlyoperatewellatlowerflowrates.Water(Orboth)
Consistof:AwaterbathTypicallysterilewater.AheatingelementToheatthewaterbath.AgaspipeInspiredgasesarebubbledthroughthewaterbathtohumidifythem.AwatertrapTotrapcondensedwater.Shouldbechangedregularlytominimiseinfectionrisk.
Pros
GreaterhumidificationAppropriateforlong-termventilation
Cons
BulkyExpensiveRequirepowerInfectionriskfromwaterbath
References
1. McNultyG,EyreL.Humidificationinanaesthesiaandcriticalcare.ContinuingEducationinAnaesthesiaCriticalCare&Pain,Volume15,Issue3,1June2015
Lastupdated2019-07-18
Humidifiers
529
![Page 530: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/530.jpg)
SupplementalOxygenDescribedifferentsystemstodeliversupplementaloxygenandtheadvantagesanddisadvantagesofthesesystems
Devicesfordeliveryofoxygencanbeclassifiedinto:
VariableperformancedevicesFixedperformancedevices
VariablePerformanceDevicesVariableperformancedevices:
DonotdeliverafixedFiOThisisbecauserespiratoryflowisnon-uniformAlthoughminuteventilationmaybe5-6L.min ,peakinspiratoryflowsaresubstantiallyhigher.DeliveredFiO isdependentonoxygenflowandinspiratoryflow
IncreasingoxygenflowratewillincreaseFiO ,buttheeffectwillvarydependingonthedevice(volume,seal)andthepatient
Include:NasalCannulaeProngsdeliveringgasat1-4L.min .
Higherflowsmaydrymucosa,andleadtoepistaxisNasopharynxactsasanoxygenreservoir,somewhatincreasingFiOWelltolerated
Alloweating,drinking,andtalkingHudsonMaskSimpleunsealedmask,allowinggasflowupto15L.min .
CheapLesswelltoleratedRebreathingmayoccur
Non-RebreatherMaskModifiedversionoftheHudsonmask,containingareservoirbag.
ReservoirbagisfilledduringexpirationGasisdrawnfromthereservoirbagduringinspiration,increasingFiOSomeairisentrainedfromaroundthemaskandsoFiO is<1.
FixedPerformanceDevices
Fixedperformancedevices:
TheoreticallydeliverafixedFiOTheseareusuallyflowlimitedaswell,andsoFiO maydecreaseathigherinspiratoryflows.Include:
VenturiConsistsofaconethroughwhichoxygenflows.Aperturesonthesideoftheconeentrainroomair.
Airisentrainedvia:FrictionaldragofmoleculesTheventurieffect(thoughthisiscontroversial)
2
-1
22
-1
2
-1
22
22
SupplementalOxygen
530
![Page 531: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/531.jpg)
Thewideningoftheconeleadstoanincreaseinfluidvelocityandthereforeadecreaseinpressure,asperthe
Bernoulliprinciple.Entrainedairisproportionaltoflowrate,sotheratioofoxygentoairisconstantforanygivenaperturesizeThisisknownastheentrainmentratio.WilldeliverthespecifiedFiO providedoxygenflowisabovetheminimumrateThereforebecomevariableperformancedeviceswheninspiratoryflowgreatlyexceedsoxygenflow.
References1. AstonD,RiversA,DharmadasaA.EquipmentinAnaesthesiaandIntensiveCare:AcompleteguidefortheFRCA.Scion
PublishingLtd.2014.
Lastupdated2019-07-18
2
SupplementalOxygen
531
![Page 532: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/532.jpg)
BispectralIndexDescribetheprinciplesbehindtheBIS
BispectralIndex(BIS)isaproprietarysignal-processedEMGandEEGmonitorusedtoestimatedepthofanaesthesia.
TheBISoutputsfourvalues:
BISDimensionlessindexbetween0and100where:
0representscorticalelectricalsilence85-100representsnormalawakecorticalactivity40-60isconsistentwithgeneralanaesthesia
SignalQualityIndex(SQI)Dimensionlessindexbetween0and100whichgivesanindicationoftheaccuracyoftheBISvalue.ElectromyographyGivesanindicationoftheinfluenceofmuscleactivityonBISvalues.SuppressionRatio(SR)Percentageofprevious63secondswhereEEGisisoelectric.
Method
Proprietary,butinvolves:
MultivariatelogisticregressionofEEGfeaturesthatcorrelatewithclinicallevelsofsedationInitialvalidationonacohortofhealthyvolunteers,notundergoingsurgeryUseoffourfrontotemporalEEGmonitors
Analytictechniques:
CompressedSpectralArrayThesignaloverashortperiod(e.g.5-10seconds)ofEEGrecordingsareanalysedtogetherEachperiodisknownasanepoch.AFouriertransformationisperformedThisbreakstheEEGsignaldownintothesinewavesusedtoproduceit.AhistogramofeachfrequencyisplottedAsanaesthesiadeepens,lowerfrequenciesbegintodominateThespectraledgefrequencyisthefrequencygreaterthan95%ofthefrequenciesinthecompressedspectralarrayItisanindicatorofanaestheticdepth,butnotofdrugconcentration.
CoherenceUnderanaesthesia,theelectricalactivityindifferentsectionsofthebrainfallsoutofphase.
Pros
ReducedanaestheticawarenessinhighriskpatientgroupsTrauma,GAcaesariansection,cardiacsurgery.Non-invasiveUseappearstoresultinreducedanaestheticuseandmorerapidemergence
BispectralIndex
532
![Page 533: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/533.jpg)
Cons
ProprietaryalgorithmExpensiveMaybeinaccuratewith:
HypothermiaHypercarbiaHypoxiaMusclerelaxantsBISmayfallinappropriately.Non-GABAergicagents(e.g.ketamine,nitrousoxide)Maynotfallappropriately.
References
1. AstonD,RiversA,DharmadasaA.EquipmentinAnaesthesiaandIntensiveCare:AcompleteguidefortheFRCA.ScionPublishingLtd.2014.
Lastupdated2019-07-18
BispectralIndex
533
![Page 534: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/534.jpg)
MedicalGasSupplyDescribethesupplyofmedicalgases(bulksupplyandcylinder)andfeaturestoensuresupplysafetyincludingpressurevalvesandregulatorsandconnectionsystems
Production
FractionalDistillation
Oxygenisproducedontheindustrialscalebyfractionaldistillationofatmosphericair.Thisprocess:
ReliesonthefactthatdifferentgaseshavedifferentboilingpointsByliquefyingairandthenheatingitgradually,eachgascanberemovedseparatelyasitboils.Occursinstages:
AtmosphericairisfilteredRemovesdustandothercontaminants.Airiscompressedto6atmandthencooledtobelowambienttemperatureWatervapourcondensesandisremoved.CompressedairpassedthroughazeolitesievewhichremovesCOCompressedairisallowedtore-expandAsitdoessoitlosesheatenergyasperGay-Lussac'sLaw,andliquefies.
AirmustbecooledbelowtheboilingpointofthedesiredgasesThisrequiresgettinggasesverycold,andsotheprocessmaybemechanicallyassistedusingaturbine,and/oraheatexchanger.Keyboilingpoints(at1atm):
Nitrogen:77°KOxygen:90°KHelium:4°KHeliumcanbeproducedbyfractionaldistillation,butliquefyingitisunderstandablydifficultgiventhevery,verylowboilingpoint.Heliumcanalsobemined,asheliumproducedbyalphadecayofradioactivematerialsmaybetrappedingaspocketsundertheearth.
LiquidairisthenfractionallydistilledTemperatureofliquidairisraisedslowly.
Astheboilingpointofeachgasisreached(e.g.77°Kfornitrogen),thatgaswillbegintovapourisefromtheliquid,andcanbecollectedTheremainingliquidcanthenbefurtherheated,untiltheboilingpointforthenextgasisreachedThisprocesscanberepeateduntilallthedesiredgaseshavebeenseparated
OxygenConcentrator
Oxygenconcentrators:
Produceupto95%oxygenfromairbyremovingnitrogenBuiltusingtwozeolitelattices
PressurisedairisfilteredthroughonelatticeNitrogenandwatervapourareretainedinthelatticeOxygenandargonareconcentratedProducesa95%oxygen/5%argonmixture.
Theunusedcolumnisheatedtoreleasetheboundnitrogenandwater
2
MedicalGasSupply
534
![Page 535: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/535.jpg)
Pros
CheapReliableAvoidneedforoxygendelivery
Cons
ResultinanaccumulationofargonwhenusedatlowflowsonacirclesystemRequirecontinuouspowerFireandexplosionrisk
Storage
MedicalGasCylinders
Gascylindersare:
MadefromchromiummolybdenumoraluminiumUsedas:
BackupforapipedsupplyWhenapipedsupplyisnotavailable(transports)Whenthegasisuncommonlyused(e.g.nitricoxide)
ThecommoncylinderusedinhospitalisCDThiscontains460Lofoxygenat15°Cand137bar.
Cylindersarenotcompletelyfilled,toreduceriskofoverpressureandexplosionsifthetemperaturerisesThefillingratioistheweightofliquidinafullcylindercomparedtotheweightofwaterthatwouldcompletelyfillthecylinder
Incoolclimates,thefillingratiois~0.75Inwarmerclimates,thefillingratioisreducedto~0.67
Cylindersaretestedforsafetyevery5-10yearsTestsinclude:
EndoscopicexaminationTensiletests1%ofcylindersaredestroyedtoperformtestingonthemetal.
Pros
PortableReusable
Cons
HeavyLimitedsupply
CylinderManifolds
Cylindermanifoldsareformedofsetsoflargegascylindersusedinparallel.
Allcylindersinagroupareusedtogether
MedicalGasSupply
535
![Page 536: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/536.jpg)
Whenthepressurefallsbelowasetlevel,apressurevalvewillswitchandgaswillbedrawnfromanothercylindergroupThefirst(nowempty)cylindergroupisexchangedforfullcylinders
Pros
CheapUsefulasabackupsupply
Cons
LesscapacitythanaVIEFireandexplosionrisk
VacuumInsulatedEvaporator
TheVIE:
StoresliquidoxygenItisvacuuminsulatedasitmustkeepoxygenbelowitscriticaltemperature(-119°C).TheVIEtypicallystoresoxygenbetween-160°Cand-180°C,andat700kPa.
ThegasisstoredbelowitscriticaltemperatureandaboveitsboilingpointTheamountofoxygenremainingiscalculatedfromitsmass
DoesnotrequireactivecoolingInsteaditiscooledby:
InsulationEvaporationHeatenteringtheVIEcausesliquidoxygentoevaporate.OxygenvapourisdrawnofftheVIEtothepipelinesupply,sotheVIEremainscoolandatasteadypressureprovidedoxygenisbeingdrawnfromit.
HasapressurereliefvalvetopreventexplosionsifoxygenisnotbeingusedHasanevaporatortoevaporatelargevolumesofoxygenrapidlyifdemandishigh
Thisissimplyanuninsulatedpipeexposedtotheoutsidetemperature
Pros
CheapestoptionforoxygendeliveryandstorageStoringoxygenasaliquidismuchmoreefficientthanasagasDoesnotrequirepower
Cons
Set-upcostsareexpensiveRequiresaback-upsetupWillwastelargevolumesofoxygenifnotbeingusedcontinuouslyFireandexplosionrisk
SafetyinMedicalGasSupply
Manysystemsexisttoensuresafety:
ColourcodingofcylindersandhosesOxygeniswhiteNitrogenisblack
MedicalGasSupply
536
![Page 537: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/537.jpg)
AirisblackwithwhiteshouldersNitrousoxideisblueHeliumisbrown
HelioxisbrownwithwhiteshouldersCarbondioxideisgrey-green
LabelingofconnectionsThepinindexsystemUsedtopreventthewronggasyokebeingconnectedtoacylinder.
PinsprotrudefromthebackoftheyokeHolesexistonthevalveblockPinsandholesmustlineupforthecylindertobeconnectedTherearesixpositions,dividedintotwogroupsofthreeCommoncombinationsinclude:
Oxygen:2-5Air:1-5Nitrousoxide:3-5
SleeveIndexSystemUsedinAustraliawhenconnectingpipelinegases.
WallblockcontainsasleevewhenpreventsfittingtheincorrectgashosetothewallScrewthreadisidenticalinallcases
Non-InterchangeableScrewThread(NIST)Used(butnotinAustralia)whenconnectingpipelinegases.
NISTconnectorshaveaprobeandanutProbediameterisgas-specific,preventingthewronggasfrombeingconnected
TestingMustdemonstrate
CorrectoxygenconcentrationsAbsenceofcontaminationDeliveryofadequatepressurewhenseveralothersystemsonthesamepipelineareinuse
Testingmustbeperformedtwiceonanewinstallation:FirstbyengineersSecondbyamedicalofficerIntheatres,thisshouldbethedirectoroftheanaestheticdepartmentortheirdelegate,whoshouldholdfellowshipofANZCA.
References
1. AstonD,RiversA,DharmadasaA.EquipmentinAnaesthesiaandIntensiveCare:AcompleteguidefortheFRCA.ScionPublishingLtd.2014.
2. ANZCAAugust/September20163. TheEssentialChemicalIndustryOnline-Oxygen,Nitrogen,andtheraregases.4. Thompson,C.TheAnaestheticMachine-GasSupplies.UniversityofSydney.
Lastupdated2019-07-18
MedicalGasSupply
537
![Page 538: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/538.jpg)
MedicalGasSupply
538
![Page 539: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/539.jpg)
VapourisersDescribetheprinciplesandsafeoperationofvapourisers
Deliveryofgasthatisfullysaturatedwithanaestheticagentwouldresultinlethaldosesbeingadministered.Theuseofavapouriserallowsasafedoseofanaestheticagenttobegiven.Vapouriserscanbedividedinto:
VariablebypassvapourisersAirthatisfullysaturatedwithgasismixedwitha'bypass'streamofgas,dilutingthedeliveredconcentration.Furthersubdividedinto:
PlenumRequiressupra-atmosphericpressuretooperate.
MoreaccurateDraw-overDrivenbythepatientsinspiratoryeffort.
Portable
VariableBypassVapouriserVariablebypassvapourisersaimtodeliverthesameconcentrationofanaestheticagentoverarangeofflows.Theyachievethisby:
FlowmanagementBafflesandwicksincreasethesurfaceareaoftheliquid/gasinterface,increasingtherateofvapourisation.
ExcessivelyhighflowratesmayresultingasnotbeingfullysaturatedwithagentwhenitexitsthevapouriserstreamThesearelesseffectiveindraw-overvapourisers,asresistancemustbeminimised
TemperaturemanagementTheSVPofvolatileagentsincreasesnon-linearlyastemperatureincreases.Temperaturechanges:
Occurthrough:ChangesinambienttemperatureLossthroughlatentheatofvapourisationLiquidagentfromthevapouriserwillcooloverthecourseofananaesthetic.
Aremanagedwith:TemperaturestabilisationUseofmaterialswithbothahighthermalconductivityandspecificheatcapacity,allowingthevapourisingchambertobufferchangesinsurroundingtemperature.TemperaturecompensationAdjustsflowintoeitherthevapourisingchamberorbypasschambertoaccountforchangesinenvironmentaltemperature.Methodsinclude:
BimetallicstripMetalstripwhichbendsinresponsetoenvironmentaltemperature,adjustingtheamountofgasenteringthevapourisingchamber.AneroidbellowsConnecttoaconeintheopeningofthebypasschamber.Astemperaturedecreases,thebellowscontractandtheconepartiallyobstructsthebypasschannel.
DifferenceBetweenPlenumandDraw-OverVapourisers
Plenumvapourisersare:
Vapourisers
539
![Page 540: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/540.jpg)
MoreaccurateDesignedtodeliveraccurateagentconcentrationsoverawiderange(0.25-15L.min )offlowrates
Below250ml.min theresistanceoftheflowsplittingvalvebecomesmoresignificant,causingtheamountofgasinthebypassstreamtobehigherthanintendedAbove15L.min gasmaynotbefullysaturated
HeavierTypicallybuiltofmetalssuchascoppertomaximisethermalstability.Highinternalresistance
Mustbeusedout-of-circleMustbeusedwithpositive-pressure
Draw-OverVapourisersare:
LessaccurateLessuseofbafflesandwickstominimiseinspiratoryresistance
LessthermallystableOxfordMinatureVapouriserdoesnothaveabimetallicstripOxfordMinatureVapouriserusesglycolasathermalbuffer
MeasuredFlowVapourisersMeasuredflowvapourisershaveaseparatestreamofagent-saturatedgasthatisaddedtothegasflow.Thisrequiresthedeviceto:
MeasurefreshgasflowrateAdjustvapour-gasflowratesothedesiredconcentrationisdelivered
Thissystemisusedforthedeliveryofdesflurane,asdesflurane:
HasaveryhighSVPRequireshighbypassflowratetodilutetoaclinicallyusefulconcentration.HasalowboilingpointIntermittentlyboilsatroomtemperature,whichwillcauselargefluctuationsindelivery:
ExcessiveagentdeliveryduringboilingThiswillleadtocoolingduetothelatentheatofvapourisation.CooleddesfluranewillhaveamuchlowersaturatedvapourpressureSignificantunder-deliverywillthenoccur.
TheTec6vapouriser:
Heatsdesfluraneto39°CSVPofdesfluraneatthistemperatureis1500mmHg.GaseousdesfluraneisthenaddedtothefreshgasflowTheamountaddeddependson:
DesiredconcentrationFreshgasflowrateAsflowincreasestheresistancetoflowofdesfluranevapourdecreases.
GeneralSafetyFeaturesofVapourisersAgentspecificity:
KeyindexedfillingPinindexedsafetysystemconnectors
-1-1
-1
Vapourisers
540
![Page 541: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/541.jpg)
Colourcodingofunitandagentcontainers
Singleagentadministration:
InterlockmechanismPreventsmultiplevapourisersbeingturnedon.Singlecartridgeslot(Aladdinsystem)
Tippingandoverfilling:
LongvapourisationchamberinflowHeavyconstructionTransportmodesSidefillingandoverflowports
Anti-pumping:
Checkvalvesandlongvapourisationchamberinflowprevententrainmentofvapourisergasintheinflowofthebypasschannel
Agentdepletion:
FillinggaugesLowpressurealarms(Tec6)
OtherFactorsAffectingVapourisers
CarrierGasComposition:
NitrousoxideandairaremoreviscousthanoxygenThisleadstodecreasedflowthroughthevapourisingchamberwhenFiO islowThiseffectisnotclinicallysignificant.
Altitude:
ClinicaleffectofvolatileagentisafunctionoftheirpartialpressureintissuesAsSVPisindependentofatmosphericpressure,thisisunchangedataltitudeAvapourisersetat2%willdeliver4%gasat0.5atmpressure,howeverastheatmosphericpressureisreducedthesamepartialpressureofvapourisdelivered
Thedeliveredconcentrationofanagentataltitudeisgivenbytheequation:
,where:
istheconcentrationofagentinthegasdeliveredtothepatientThismustbemultipliedbytheatmosphericpressuretofindthepartialpressureofagentdeliveredtothepatient.
istheconcentrationdialeduponthevapouriser
istheatmosphericpressurewherethevapouriserwascalibrated
istheatmosphericpressurewherethevapouriserisbeingused
References
1. MillerRD,ErikssonLI,FleisherLA,Weiner-KronishJP,CohenNH,YoungWL.Miller'sAnaesthesia.8thEd(Revised).
2
Vapourisers
541
![Page 542: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/542.jpg)
ElsevierHealthSciences.2. BoumphreyS,MarshallN.Understandingvapourizers.ContinuingEducationinAnaesthesiaCriticalCare&Pain.Volume
11,Issue6,1December2011,Pages199–203,
Lastupdated2019-07-18
Vapourisers
542
![Page 543: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/543.jpg)
BreathingSystemsThisprovidesageneraloverviewofanaestheticbreathingsystems.Thecirclesysteminparticulariscoveredelsewhere.
Classifications:
OpenAnaestheticgasesnotconfinedtothecircuit.
LimitedcurrentpracticalapplicationExpensive,environmentalcontamination.e.g.Ethermasks
Non-rebreathingNoexpiredgasisre-inspired;requiresaone-wayvalve.
LimitedpracticalapplicationRequiresalow-resistancedraw-overvapourisere.g.Tri-serviceapparatus
RobustInexpensive
RebreathingsystemsExpiredgasisre-inspired.
AbsorptionsystemsRequiresmethodforCO absorption.
CircleCommonanaestheticcircuit,coveredindetailunder.Canbe:
VapouriserOut-of-CircuitCommonsystem,coveredindetailundercirclesystem.
Vapouriserin-circuitUncommonsystem.
Inaspontaneousventilationmode,thepatientwillincreaseagentconcentrationasminuteventilation↑Thismeansthatassurgicalstimulus↑,depthofanaesthesiaalso↑.
WatersMaplesonBorCwithaCO absorptioncanisterbetweenbagandFGF.
Non-absorptionRebreathingexpiredgasispartofcircuitdesign.MaplesonSystems
MaplesonSystemProperties:
RebreathingofexpiredgasdoesnotnecessarilyequatetoCO retention,providedtheFGFisaboveacertainmultiple(circuitdependent)ofthepatientsMV
PaCO isafunctionofFGFandCO productiononlyIncreasingMVwithoutincreasingFGFwillresultinre-breathingofCO andunchangedPaCO .
Inanyspontaneousventilationmode,patientswillhyperventilateifFGFisinadequate
Types:
2
2
2
2 22 2
BreathingSystems
543
![Page 544: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/544.jpg)
MaplesonASetup
APLvalveclosetomaskTubingbetweenbagandmaskFGFclosetobag
Flowrequirements
Spontaneousventilation:APLvalveissetlow.Initialexhalation(whichismostlydeadspace,andnotcontainingCO )willfillbaguntilbagpressureexceedsAPLvalveopeningpressure.ProvidedtheAPLvalveissetlow,themajorityofCOcontainingexhalationwillexitthroughtheAPLvalve,andFGFrequiredtoclearCO fromthecircuitislow.
Controlledventilation:APLvalveissethigh.Moreoftheexhalationwillfillthebag,andsoagreaterFGFisrequiredtopreventre-breathing.
MaplesonB&CSetupAPLvalveandFGFaresituatedclosetothemask.
MaplesonBhaslongtubingbetweenthemaskandbagMaplesonChasshorttubingbetweenthemaskandbag
Flowrequirements
Spontaneousandcontrolledventilationaresimilar,at .MaplesonD
SetupFGFisisclosetomaskValveisclosetobagTubingbetweenFGFandAPLvalveCo-axialversionsexist,butarefunctionallysimilar.
FlowrequirementsOverall,generallythebestcircuittomaximiseefficiencyacrossbothspontaneousandcontrolledventilation.
Spontaneousventilation:
Controlledventilation:Bestcircuitforcontrolledventilation.
MaplesonE/Ayre'sT-pieceSetup
T-shapedcircuitwithnovalveorbagMaplesonF/Jackson-ReesmodificationtotheAyre'sT-piece
SetupBag(withhole)addedtothestemoftheTofaMaplesonEAllowsmonitoringofventilation,andoccludingtheholeofthebagallowscontrolledventilation.FunctionallyidenticaltoaMaplesonD,withanoperator-controlledAPLvalve
FlowrequirementsAsperMaplesonD.
Spontaneousventilation:
Controlledventilation:
References1. Westhorpe,R.PaediatricBreathingSystems.RCHAnaestheticTutorialProgram.2019.
22
2
BreathingSystems
544
![Page 545: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/545.jpg)
Lastupdated2019-07-20
BreathingSystems
545
![Page 546: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/546.jpg)
CircleSystemThiscoversthecirclebreathingsystem.Ageneraloverviewofanaestheticbreathingsystemsiscoveredunderanaestheticcircuits.
Thecirclebreathingsystemisahighlyefficientsystemwhich:
HasseveralkeyadvantagesPreservesanaestheticgasesmakingvolatileanaesthesiacost-effectivePreservesmedicalgases(oxygen)whichisusefulinresource-limitedsettings(e.g.prehospital)PreservesheatandmoistureReducesfireriskParticularlywitholderagents.
Requiresre-breathingofexpiredgasesCO isactivelyremoved.Isaclosed-circuitsystem
Theonlygaseswhichmustbereplacedarethose:Consumedbythepatient
OxygenAbsorbedandmetabolisedvolatileagents
Lostvialeak
PrinciplesAcirclecircuitconsistsof:
AY-piece,connectingthecircuittothepatientExpiratoryandinspiratoryvalves,ensuringunidirectionalflowAmeansofgeneratingpressureInmostsystemsthisconsistsofbothaventilatorandareservoirbagwithAPLvalveattached,withabag/ventswitchtoswapbetweencircuits.
ThesearetypicallyplacedontheexpiratorylimbsothatgascanberemovedviascavengingpriortopassagethroughsodalimeThisreducessodalimeconsumption,assomeCO willbescavenged.
SodalimeToabsorbCO .Freshgasflow
Includesoxygen,airandnitrousoxideOxygenenterstheback-barlastWhenthevapouriserisout-of-circuit,allfreshgasflowwillpassthroughthevapouriserpriortoenteringthecircle
Aseparatehigh-pressurehigh-flowoxygenflush,whichbypassesthevapouriser
SodaLime
Sodalime:
Consistsofgranulesof:81%Ca(OH)4%NaOH15%H OSilicates
2
2
2
2
2
CircleSystem
546
![Page 547: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/547.jpg)
Hardensgranules.
pHindicatorVisualrepresentationofuptakeofCO bysoda-lime.
PhenolphthaleinRedtowhite.EthylvioletWhitetopurple.
Granulesare4-8meshinsizeWillpassthroughameshwith4holespersquareinch,butnot8Balancebetweensurfacearea(speed/efficacyofreaction)andresistancetoflow
AbsorbsCO byfollowingreaction:
ThisincreasesthepHofthesodalime,causingthepHindicatortochangecolour100gofsodalimecanabsorb~26LofCO
Pros
CheapertooperateConservesgases,heat,andmoistureLowdeadspaceReducedgreenhouseeffects
Cons
GasmixturesettingsarenotdeliveredtothepatientSettingsaffectthefreshgasflowmixture,whilstthepatientrespiresgasfromthecircuit.Thesearenotidentical,especiallyatlowflows.Nitrogenmaybuildupinthecircuitduringlow-flowanaesthesia,andpotentiallyleadtodeliveryofahypoxicgasmixtureLessportablethanopen-circuitsystemsIncreasedcircuitresistanceRequiressodalime,whichcanbetoxic
ProducesCompoundA-EfromsevofluraneProducescarbonmonoxidefromdesflurane,isoflurane,andenfluraneDangerousifaspirated
References
1. AstonD,RiversA,DharmadasaA.EquipmentinAnaesthesiaandIntensiveCare:AcompleteguidefortheFRCA.ScionPublishingLtd.2014.
Lastupdated2019-07-18
2
2
2
CircleSystem
547
![Page 548: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/548.jpg)
ScavengingDescribethehazardsofanaestheticgaspollutionandthemethodsofscavenginganaestheticgases
Scavengingistheremovalandsafedisposalofwasteanaesthesiagasesfromthebreathingcircuittoavoidcontaminationofthetheatreenvironment.Thisisimportantascontinuousexposureofstafftoanaestheticgaseshasbeenimplicatedin:
CognitiveimpairmentSpontaneousabortionInfertilityHaematologicalmalignancy
MethodsofScavengingAscavengingsystemconsistsof:
GascollectionassemblyConnectstotheAPLvalveandventilatorreliefvalveCollectsgasventedfromthecircuit.Usesa30mmconnectorPreventsaccidentalconnectiontothebreathingsystem.
TransfertubingScavenginginterfaceThestructureofthescavenginginterfacedependsonthetypeofscavengingsystem.
OpeninterfaceActivescavengingsystemsuseapumptogenerateapressuregradientdrawinggastothedisposalassembly.Thescavenginginterfaceisopentoairtopreventthenegativepressurebeingtransmittedtothepatient.ClosedinterfacePassivescavengingsystemsuseaseriesofpositiveandnegativepressurereliefvalves.
Whengaspressureinthecollectionassemblyexceeds5cmH O,thepositivereliefvalveopensandgasentersareservoirbagWhengaspressureinthedisposalassemblyfallsbelow0.5cmH O,thenegativereliefvalveopensandgasentersthedisposalassembly
MoretransfertubingDisposalassembly
References
1. AstonD,RiversA,DharmadasaA.EquipmentinAnaesthesiaandIntensiveCare:AcompleteguidefortheFRCA.ScionPublishingLtd.2014.
Lastupdated2019-07-18
2
2
Scavenging
548
![Page 549: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/549.jpg)
DiathermyDiscusstheprinciplesofsurgicaldiathermy,itssafeuseandthepotentialhazards
Diathermyistheuseofanelectricalcurrenttocuttissueandcoagulatebloodvialocalisedheating.Diathermy:
Useshighfrequency,alternatingcurrentpassingbetweentwoelectrodesFrequenciesbetween300kHzand2MHzareused,whichhaveanegligibleriskofinducingarrhythmia.
Heatenergyproducedisproportionaltoelectricalpowerdissipated( )Reliesontheprincipleofcurrentdensity
AhighcurrentdensityattheelectrodecausestissuedamageAlowcurrentdensity(e.g.attheplateofaunipolarelectrode)causesheatingwithoutdamage
DiathermyTypesDiathermycanbeeither:
UnipolarConsistsofaprobecontainingoneelectrode,andalargeplate(placedelsewhereonthepatient)containingtheotherprobe.BipolarConsistsofapairofforcepswitheachpointcontainingaseparateelectrode.Minimisesthecurrentpassingbetweenprobes,andisusedwhenusingdiathermyonelectricallysensitivetissues(e.g.brain).
DiathermyModes
Diathermymodesinclude:
CuttingLow-voltagemodeproducingahighcurrentintheshapeofacontinuoussinewave.CoagulateHigh-voltagemodeproducingadampedsinewaveresponse.BlendedMixtureofcuttingandcoagulateondifferenttissues.
RisksBurnsFromincorrectlyappliedunipolarplate.ElectrocutionMayinjurepatient,staff,ordamageequipmentandimplants.ElectricalInterferenceMayinhibitpacingincertainpacemakers,ortriggerICDs.SmokeproductionRespiratoryirritant,disseminationofviralparticles,andmaybecarcinogenic.TissuedisseminationPotentialsourceofmetastaticseeding.
Diathermy
549
![Page 550: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/550.jpg)
References1. AstonD,RiversA,DharmadasaA.EquipmentinAnaesthesiaandIntensiveCare:AcompleteguidefortheFRCA.Scion
PublishingLtd.2014.
Lastupdated2017-09-16
Diathermy
550
![Page 551: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/551.jpg)
LasersDescribetheprinciplesofsurgicallasers,theirsafeuseandthepotentialhazards
Alaserisadeviceforlightamplificationbystimulatedemissionofradiation.Laserlightis:
Non-divegentAllphotonsmoveinparallel.CoherentAllphotonsareinphase.MonochromaticAllphotonshavethesamewavelength.
Lasersareusedclinicallyfor:
PreciseincisionsDestructionofcellsbylocalisedvapourisationofwater.DestructionofchemicalsTattoos,oncologicaldrugs.TissuedestructionwithoutheatingOpthalmology.
PrinciplesMethod:
Anenergysourceispassedthroughalasingmedium,housedinaresonatormadeofmirrorsAsthelasingmediumisexcited,electronsenterahigherenergylevelWhenmorethan50%ofelectronsareatahigherenergylevel,populationinversionhasoccurred.Aselectronsfallbacktotheirrestingstate,theyreleaseaphoton
AspontaneousemissionoccurswhenanelectronentersitsrestingstatespontaneouslyAstimulatedemissionoccurswhenanelectronentersitsrestingstateafterbeingstruckbyaphotonreleasedfromaspontaneousemission
StimulatedemissionsresultinamplificationoflightreleaseThemirrorsintheresonatingchamberensuremostlightisreflectedbackintothechamber,causingmorestimulatedemissionsTheexitfromthechambercanbebeadjustedsoonlycertainpolaritiesoflightareemittedAlensmaybeusedtofocusthelaserbeam
Lasersmaybe:PulsewaveUsesshortburstsoflaserlighttominimisecollateraldamage.ContinuouswaveMayleadtoexcessiveheating.
Pros
Precisesurgeryandhaemostasis
Lasers
551
![Page 552: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/552.jpg)
Cons
RequiremultiplesafetyprecautionsLasersafetyofficerEyeprotectionWarningsignsondoorsCovertheatrewindowsNon-combustibledrapesMattefinishonequipmenttominimisechanceofreflection
AdditionalrisksinairwaysurgeryUselowestFiO possibleAvoidN OConsideruseofhelioxUsespecialisedlasertubesNormalPVCETTsarecombustible.
References
1. AstonD,RiversA,DharmadasaA.EquipmentinAnaesthesiaandIntensiveCare:AcompleteguidefortheFRCA.ScionPublishingLtd.2014.
Lastupdated2019-07-18
22
Lasers
552
![Page 553: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/553.jpg)
SubclavianVeinDescribetheanatomyrelevanttocentralvenousaccess(includingfemoral,internaljugular,externaljugular,subclavianandperipheralveins)
Thesubclavianvein:
IsacontinuationoftheaxillaryveinasitcrossestheuppersurfaceofthefirstribTravelsposteriortotheclavicle,separatedfromthesubclavianarterybytheanteriorscaleneJoinswiththeinternaljugularveintoformthebrachiocephalicvein
BordersAnteriorlybytheclavicle,subclaviusmuscle,andpectoralismajorPosteriorlybyanteriorscalenemuscleandsubclavianarteryInferiorlybyfirstribandlungapexSuperiorlybyskin,subcutaneoustissue,andplatysmaMediallybythebrachiocephalicveinLaterallybytheaxillaryvein
SurfaceAnatomyTheneedleisplacedinthedeltopectoralgroove,inferiorandlateraltothemiddlethirdoftheclavicle.Theneedleisinsertedatashallowangle,passingunderthemiddlethirdoftheclavicleaimingatthesternalnotch.
References1. McMinn,RMH.Last'sAnatomy:RegionalandApplied.9thEd.Elsevier.2003.
Lastupdated2019-07-18
ProceduralAnatomy
553
![Page 554: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/554.jpg)
InternalJugularVeinDescribetheanatomyrelevanttocentralvenousaccess(includingfemoral,internaljugular,externaljugular,subclavianandperipheralveins)
Theinternaljugularvein:
OriginatesatthejugularbulbThisisadilatationformedbytheconfluenceoftheinferiorpetrosalsinusandthesigmoidsinus.ExitstheskullviathejugularforamenDescendslaterallytotheinternalcarotid(andlaterthecommoncarotid)inthecarotidsheathTerminatesbehindthesternalendoftheclavicle,whereitjoinswiththesubclavianveintoformthebrachiocephalicvein
BordersAnteriorlybySCMPosteriorlybythelateralmassofC1,scalenemuscles,andlungpleuraMediallybytheinternalcarotid
RelationshipsVagusnerveliesbehind/betweenthecarotidandIJVCervicalsympatheticplexusliesposteriortothecarotidsheathDeepcervicallymphnodeslieclosetotheveinExternaljugularcrossesthesternomastoidbellyofSCM,runningposteriorlyandmoresuperficialtotheIJV,laterperforatingdeepfasciatodrainintothesubclavianveinPleurarisesabovetheclavicle,andisclosetotheveinatitsterminationThoracicductpasseslateraltotheconfluenceoftheleftIJVandSCV,andmaybeinjuredduringleftIJVcannulation
TherightlymphaticductmaybeinjuredduringrightIJVcannulation,butduetoitssmallersizethisislesscommon
SurfaceAnatomyIdentifythetriangleformedbythetwoheadsofSCMandtheclavicle.Palpatetheartery,andensurethesiteofentryislateraltothecarotid.Aim:
Caudally,ata30angletothefrontalplaneParalleltothesagittalplaneTowardstheipsilateralnipple
UltrasoundAnatomy
IdentifytheveindeeptoSCM,notingthatitis(unliketheadjacentICA):
Non-pulsatileThinwalledCompressible
InternalJugularVein
554
![Page 555: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/555.jpg)
Approaches
AnteriorAtthemedialborderofSCM,3-4cmabovetheclavicle.Requiresretractionofthecarotidmedially.CentralapproachAttheapexofthetriangleformedbyeachmusclebellyofSCMandtheclavicle.PosteriorapproachAttheposterioredgeofSCM,justsuperiortowheretheEJVcrossesthesternomastoid.
References
1. Lasts2. http://radiopaedia.org/articles/internal-jugular-vein3. http://www.frca.co.uk/article.aspx?articleid=1000304. Internaljugularveincatheterisation:PosteriorandCentralApproach
Lastupdated2019-07-18
InternalJugularVein
555
![Page 556: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/556.jpg)
IntercostalCatheterDescribetheanatomyrelevanttotheinsertionofanintercostalcatheter
Anintercostalcatheterdrainstheintrapleuralspace.
SurfaceAnatomy
AnICCshouldbeplacedinthesafetriangle:
Thisisbordered:
AnteriorlybypectoralismajorPosteriorlybylatissimusdorsiToofarposteriorwillinjurethelongthoracicnerve.SuperiorlybythebaseoftheaxillaInferiorlybythe5 intercostalspaceToofarinferiorlyrisksplacementintheliverorspleen.
LayersofDissectionSkinSubcutaneoustissueExternalintercostalInternalandinnermostintercostalmusclesNotetheneurovascularbundlewhichsitsontheinferioraspectoftheribs,thereforeaimtoplacetheICCatthebottomoftheintercostalspace-"abovetheribbelow".Parietalpleura
References
1. LITFL-ChestDrain
Lastupdated2017-09-18
th
IntercostalCatheter
556
![Page 557: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/557.jpg)
IntercostalCatheter
557
![Page 558: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/558.jpg)
AntecubitalFossaDescribetheanatomyrelevanttocentralvenousaccess(includingfemoral,internaljugular,externaljugular,subclavianandperipheralveins)
Theantecubitalfossaisatriangularspaceontheanterioraspectoftheforearm.
Borders
Thetriangularbordersareformed:
MediallybypronatorteresLaterallybybrachioradialisSuperiorlybyanimaginarylinebetweenthemedialandlateralepicondyles
Theroofofthefossaisformedbysubcutaneoustissue
Thefloorisformedbybrachialisandsupinator
ContentsFrommedialtolateral:
MediannerveBrachialarteryBicepstendonandaponeurosisRadialandposteriorinterosseousnervesVeins
BasilicveinCephalicveinVenousvariations:
AmediancubitalveinconnectingthebasilicandcephalicveinsAmedianveinoftheforearm,whichdividesintoamedianbasilicandmediancephalicveinwhichdrainintothebasilicandcubitalveins
References1. FRCA-TheCubitalFossa
Lastupdated2019-07-18
AntecubitalFossa
558
![Page 559: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/559.jpg)
TracheostomyDescribetheanatomyrelevanttotheperformanceofanaso,orendo,trachealintubation,acricothyroidotomyortracheostomy
Trachea
Thetracheaisfibrocartilagenoustubewhich:
ExtendsfromthelarynxsuperiorlytothePlaneofLouisinferiorlyTerminatesbydivisionintotherightandleftmainstembronchiRunsat15degreesparalleltothesurfaceoftheneck,suchthatthedistaltracheaisdeeperthantheproximaltracheaHasaD-shapedcrosssection
Anteriorwallisformedby18-22incompletecartilaginousringswhichmaintaintrachealpatencyPosteriorwallofthetracheaisspannedbylongitudinalsmoothmuscleknownastrachealis
Istypically:10cmlong2.3cmwide1.8cminAPdiameter
Relationships
Lateraltothetracheaarethe:CarotidsheathsContainsthecarotidartery,internaljugularvein,andvagalnerves.Thyroidlobes(andinferiorthyroidarteries)Recurrentlaryngealnerves.
InferiortothethyroidisthmusliesthethyroidveinsPosteriortothetracheaarethe:
OesophagusVertebralcolumn
SurfaceAnatomy
Midlineneckstructuresarerelevantsurfaceanatomy:
LaryngealstructuresIncluding:Hyoid,thyroidcartilage,cricothyroidmembrane,cricoidcartilage.SternalnotchThyroidlobesLielateraltotrachea.
LayersofDissectionSkinSubcutaneousfatSuperficialandDeepPretrachealfasciaTrachealwall
Tracheostomy
559
![Page 560: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/560.jpg)
Ideallybetween1stand2ndrings
References1. McMinn,RMH.Last'sAnatomy:RegionalandApplied.9thEd.Elsevier.2003.
Lastupdated2019-07-18
Tracheostomy
560
![Page 561: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/561.jpg)
ToxicAlcoholsAlcoholsinclude:
EthanolMethanolEthyleneGlycol
Intoxicity:
AllpresentwithsymptomsofalcoholintoxicationAllcontributetotheosmolargapDifferenttoxicitiesoccurduetothedifferentmetabolites
Ethanol
Ethanolisaweakalcoholwithacomplicatedmechanismofactionsimilartovolatileanaestheticagents:
EnhancedGABA-mediatedinhibitionThisisreversiblewithflumazenil.InhibitionofCa entryInhibitionofNMDAfunctionInhibitionofadenosinetransport
Property Drug
Dosing Oneunitis~8g/10mlofpureethanol
Absorption RapidPOabsorption
Metabolism
Saturatablekineticsat>4mmol.L duetohighdosesrequiringextensiveNAD foroxidation,limitingmetabolismto~1unitperhour.Low(0.2)extractionratio,sohighportalveinconcentrationsfromrapidabsorption(e.g.shots)causesagreaterpharmacologicaleffect.Ethanolismetabolisedbyalcoholdehydrogenasetoacetylaldehyde,whichismetabolisedbyaldehydedehydrogenasetoacetylCoA.
Elimination 10%eliminatedunchangedinairandurine
Resp Respiratorydepression
CVS Vasodilatationincreasingheatloss,reducedcardiovasculardiseasemortalityduetoincreasedHDLandinhibitionofplatelets.Alcoholiccardiomyopathyinabuse.
CNS Slurredspeech,intellectualimpediment,motorimpediment,euphoria,dysphoria,increasedconfidence.Dementia,encephalopathy,peripheralneuropathy,andcerebellaratrophywithchronicuse.
Endocrine StimulatesACTHreleaseand'pseudo-Cushing'ssyndrome'.Inhibitstestosteronerelease.Maycauselacticacidosisandhypoglycaemiaintoxicity.
Renal InhibitionofADHrelease,causingdiuresis.Ethanolisosmoticallyactiveandcontributestotheosmolargap.
GIT Gastritis.Fattyliver,progressingtohepatitis,necrosis,fibrosisandcirrhosis
GU Tocolyticeffect
Haeme Inhibitionofplateletaggregation
Metabolic Highenergycontentcomparablewithfat(29kJ.g )
Other SynergisticwithotherCNSdepressants.Metabolicinteractionswithwarfarin,phenobarbitone,andsteroids
2+
-1 +
-1
Toxicology
561
![Page 562: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/562.jpg)
Methanol
MetabolisedbyalcoholdehydrogenasetoformaldehydeandthenformicacidFormicacidisneurotoxicDamagesretinaandtheopticnerve.
EthyleneGlycol
Metabolisedbyalcoholdehydrogenasetoglycoaldehyde,and(viaseveralintermediatesteps)tooxalicacidOxalicacidbindscalcium,whichcauses:
HypocalcaemiaLongQT
Acuterenalfailure
References
1. RangHP,DaleMM,RitterJM,FlowerRJ.RangandDale'sPharmacology.6thEd.ChurchillLivingstone.2. HolfordNH.Clinicalpharmacokineticsofethanol.ClinPharmacokinet.1987Nov;13(5):273-92.3. LITFL-ToxicAlcoholIngestion
Lastupdated2019-07-18
Toxicology
562
![Page 563: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/563.jpg)
NaloxonePureMOPantagonistusedfor:
TreatmentofopioidoverdoseReducingconstipationIncombinationwithPOoxycodone.
Property Drug
Class μ-selectiveopioidreceptorcompetitiveantagonist
Uses Opioidoverdose,neuraxialopioidsideeffects(e.g.pruritus),preventionofconstipationincombinationwithoralopioids
Presentation Clear,colourlesssolutionat400mcg.ml
RouteofAdministration IV,IM,PO
Dosing 0.1-0.4mgQ5min,0.5mg.kg .hr byinfusion
Absorption Veryhighfirstpassmetabolismleadingto~2%PObioavailability
Distribution 50%proteinbound.V 2L.kg ,highlylipidsoluble.
Metabolism Rapidhepaticglucuronidation
Elimination Renalelimination
Resp Reversalofopioid-inducedrespiratorydepression(↑RR,↑V )
CVS ↑SVR&↑BP,arrhythmiadue↑inSNStone
CNS ↓Analgesia,↓sedation,↓miosis.Antanalgesicinopioidnaivepatients.Precipitationofopioidwithdrawal.
Otherconsiderations
Durationofactionis~30-40minutesisshorterthansomeopioids,whichmayleadtore-narcosisifnotgivensubsequentdosesorbyinfusion
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.
Lastupdated2019-07-18
-1
-1 -1
D-1
T
Antidotes
563
![Page 564: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/564.jpg)
FlumazenilCompetitiveantagonistandinverseagonistofthebenzodiazepinereceptor.
Property Action
Class Imidazo-benzodiazepine
Uses ReversalofBZD
RouteofAdministration IV
Dosing 0.1mgbolusesupto2mg
Onset Within2minutes
Distribution Moderatelipidsolubility,50%proteinbound.t β<1hour-mayrequireinfusion.
Metabolism Hepatictoinactivemetabolites
Elimination Renalofmetabolites
CNS MayprecipitateseizuresorBDZwithdrawalduetoinverseagonisteffect
GIT N/V
References
1. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.
Lastupdated2017-09-17
1/2
Flumazenil
564
![Page 565: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/565.jpg)
Oxygen
Property Action
Class Naturallyoccurringgas
Uses ImproveFiO ,COpoisoning,hyperbaricO therapy
Pharmaceutics Clear,colourless,odourlessgasatSTP.Criticaltemperature-119°C,manufacturedbyfractionaldistillation.Highlyflammable.
RouteofAdministration Inhaled
Dosing 0.21-1.0FiO
Absorption Diffusionacrossthealveolarcapillarymembraneinproportiontomembraneareaandpartialpressuregradient,andinverselyproportionaltomembranethickness
Distribution BoundtoplasmaHb,anddissolvedinplasma
Metabolism MetabolisedinmitochondriaofcellsduringthecitricacidcycletoproduceATP,creatingCO
Elimination ExhalationasCO ,orcombinedwithH OtoproduceHCO andeliminatedinurine
Resp↓Respiratorydriveinallindividuals.Mayresultinafatal↓inthosedependentonhypoxicdrive.PulmonarytoxicityduetofreeradialformationwhenPiO >0.6bar-pneumonitis/ARDSduetolipidperoxidationofthealveolar-capillarymembrane.Absorptionatelectasis.
CVS ImprovementinallCVSparametersinthesettingofhypoxia.However,hyperoxia↓CO,↓PVR,↓PAP,andcausescoronaryvasoconstrictionwithprolongedadministration
CNSCNSO toxicity,typicallyatpressures>1.6barthoughthisisvariable.Presentswithavarietyofneurologicalsymptoms,progressingtodisorientationandseizure.RetrolentalfibroplasiainneonatesexposedtohighFiO .
Other Firerisk
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. RAHAdvancedDivingMedicineCourseNotes:Chapter6OxygenandCarbonDioxideToxicity
Lastupdated2019-07-18
2 2
2
2
2 2 3-
2
2
2
Respiratory
565
![Page 566: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/566.jpg)
HeliumHeliumisaninertgaswhichisusedtoreducethespecificgravityofinhaledgasmixtures.Itistypicallyprovidedasa0.79/0.21Helium-Oxygen(Heliox)mixture(thoughotherdilutionsexist).
Helium Heliox(0.79/0.21) Oxygen
SpecificGravity(ascomparedtoair) 0.18 0.34 1.09
ReducedspecificgravityresultsinaproportionalreductioninReynoldsNumber,improvinglaminarflowwithintheairways.
Property Action
Class InertGas
Uses Obstructivelungdisease,deepwaterdiving
Presentation Clear,colourlesssolution
RouteofAdministration Inhaled
Dosing TypicallyasHeliox:79%He/21%O
Absorption Diffusionacrossthealveolarcapillarymembraneinproportiontomembraneareaandpartialpressuregradient,andinverselyproportionaltomembranethickness
Distribution Distributesproportionallytosolubilityandtissuepartialpressures
Metabolism Notmetabolised
Elimination Respiratoryexhalationalongapressuregradient
Resp Significantlydecreasesthespecificgravityofinhaledgasmixtures
ToxicEffects HighPressureNeurologicSyndromeat>16atm
References
1. RAHAdvancedDivingMedicineCourseNotes:Chapter6OxygenandCarbonDioxideToxicity
Lastupdated2017-12-22
2
Helium
566
![Page 567: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/567.jpg)
BetaAgonistsThiscoverstheinhaledβ-agonistsusedforbronchodilation.Informationoncatecholaminesandsympathomimeticswithactivityonβ-receptorsiscoveredunderadrenergicvasoactives.
CommonFeatures
PharmacodynamicEffects β-agonists
Resp Bronchodilatation,↓HPVcausing↑shuntandpotential↓PaO ifO isnotco-administered.
CVS ↑HR(β withhigherdoses),↓BP(β withlowerdoses)
GU Tocolytic.
Metabolic Hypokalaemiafromβ stimulationofNa /K ATPase,hyperglycaemia.
Other Potentiatesnon-depolarisingmusclerelaxants
Differences
Property Salbutamol Salmeterol
Class Syntheticsympathomimeticamine Syntheticsympathomimeticamine
Uses Acuteasthma/bronchospasm,hyperkalaemia Nocturnalandexercise-inducedasthma
Presentation MDI(100µg),solutionat2.5-5mg.ml fornebulisation MDI
RouteofAdministration Inhaled,IV Inhaled
Dosing 1-2puffsviaMDI,5mgnebulised.0.5mcg.kg .min asIVinfusion.
Onset Rapid Slow
Distribution Lowproteinbinding
Metabolism Highfirstpasshepatictoinactivemetabolites,t β6hours. ExtensivehepaticviaCYP3A4
Elimination Urinaryeliminationofactive(30%)drugandinactivemetabolites Renalofmetabolites
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.
Lastupdated2017-09-07
2 2
1 2
2+ +
-1
-1 -1
1/2
Bronchodilators
567
![Page 568: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/568.jpg)
Bronchodilators
568
![Page 569: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/569.jpg)
Antimuscarinics(Respiratory)AntimuscarinicswithpredominantlycardiaceffectsarecoveredatAntimuscarinics(Cardiac),whilstatropineiscoveredseparately.
TheseagentscompetitivelyantagoniseAChatM receptorsinbronchialsmoothmuscle,preventingparasympatheticmediatedbronchoconstriction.
Property Ipratropium Tiotropium
Class Muscarinicantagonist Muscarinicantagonist
Uses Bronchodilatation Bronchodilatation
Presentation MDIorsolutionfornebulisation MDI
RouteofAdministration Inhaled Inhaled
Dosing 18mcgMDI,500µgnebuliser
Absorption 5%bioavailabilityviainhaledroute
Metabolism Hepatictoinactivemetabolites
Elimination Equalrenalandfaecalelimination
Resp Bronchodilation Bronchodilation
GIT DecreasedGIsecretionsinlargedoses DecreasedGIsecretionsinlargedoses
CNS Mydriasisifdepositedineye Mydriasisifdepositedineye
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.
Lastupdated2017-08-02
3
Antimuscarinics
569
![Page 570: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/570.jpg)
PhosphodiesteraseInhibitors/MethylxanthinesMethylxanthinesnon-selectivelyinhibitphosphodiesterase,whichresultsinreducedlevelsofcAMPhydrolysisandthereforeincreasedintracellularcAMP,andsubsequentsmoothmusclerelaxation.Thiseffectissynergisticwithβ agonists,whichalsoincreasecAMPbyincreasingproduction.
Property Theophylline
Class Methylxanthine/Non-selectivephosphodiesteraseinhibitor
Uses AsthmaandCOAD
RouteofAdministration IVorPO
Dosing 4-6mg.kg IVload,thenat0.4mg.kg .hr targetingserumconcentrationof10mcg.ml
Absorption Highoralbioavailability
Distribution V 0.5L.kg ,40%proteinbinding.
Metabolism HepaticviaCYP450toactivemetabolites(caffeineand3-methylxanthine),lowhepaticextractionratio
Elimination Highlyvariableeliminationaffectedbyage,renaldisease,hepaticdisease
Resp Bronchodilation,↑Diaphragmaticcontractility
CVS ↑Inotropy,↑chronotropy.Narrowtherapeuticrangeduetoarrhythmogenic(VF)properties
CNS ↓Seizurethreshold
Renal Natriuresisandhypokalaemia
ToxicEffects Lowtherapeuticindex,withtoxicitymanifestedastachyarrhythmiasincludingVF,tremor,insomniaandseizures
References
1. Lexicomp.Theophylline:DrugInformation.In:UpToDate,Post,TW(Ed),UpToDate,Waltham,MA,2017.2. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.3. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.
Lastupdated2019-07-18
2
-1 -1 -1 -1
D-1
PhosphodiesteraseInhibitors
570
![Page 571: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/571.jpg)
LeukotrieneAntagonistsSelectivelyinhibitthecysteinylleukotrienereceptor,increasedactivityofwhichisinvolvedinairwayoedemaandbronchialsmoothmuscleconstriction.
Property Montelukast
Class LeukotrieneAntagonist
Uses Asthma,allergicrhinitis
RouteofAdministration PO
Dosing 10mgdaily
Absorption 64%PObioavailability
Distribution t 5hours,>99%proteinbound
Metabolism HepaticbyCYP3A4
Elimination Predominantlyfaecal
Resp Bronchodilatation
References
1. .Lexicomp.Montelukast:Druginformation.In:UpToDate,Post,TW(Ed),UpToDate,Waltham,MA,2017.
Lastupdated2017-09-20
0.5
LeukotrieneAntagonists
571
![Page 572: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/572.jpg)
CorticosteroidsGlucocorticoidsareendogenous(hydrocortisone)andsynthetic(prednisolone,methylprednisolone,dexamethasone)steroidhormoneswithmetabolic,anti-inflammatory,andimmunosuppressiveeffects.Theybindtospecificintracellularreceptorsandtranslocateintothenucleus,wheretheyregulategeneexpressioninatissue-specificmanner.
Corticosteroidshavemultipleindicationsincluding:
Replacementinadrenalsuppressionorothercortisol-deficientstatesAutoimmunedisordersAnaphylaxisandatopicdisorders,includingasthmaHypercalcaemiaChemotherapyImmunosuppressionfollowingtransplantation
CommonFeatures
System Effect
Resp ↑Bronchialsmoothmuscleresponsetocirculatingcatecholamines,↓airwayoedema
CVS ↑Inotropy,↑vascularsmoothmuscleresponsetocirculatingcatecholamines(↑receptorexpression),↑BPsecondarytomineralocorticoideffects
CNS Moodchanges,sleepdisturbance,psychosis
MSK Atrophy,thinningofskin
Renal Glycosuria,Na andfluidretention(mineralocorticoideffect),hypokalaemia
GIT Gastriculceration
Metabolic ↑Gluconeogenesis,diabetes,↑proteincatabolism,fatredistribution,adrenalsuppression(negativefeedbackonACTH),↑lipolyticresponsetocirculatingcatecholamines
Immune ↓Transudateproduction,↓productionofinflammatorymediators,↓macrophagefunction,↓transportoflymphocytes,↓T-cellfunction,↓antibodyproduction,↑susceptibilitytoinfection,
ToxicEffects Relativesteroiddeficiencyinadrenalsuppressedindividualswithinfectionorsurgery
ComparisonofCorticosteroids
Property Hydrocortisone Prednisolone Methylprednisolone Dexamethasone
RouteofAdministration IV/PO PO PO/IV/IM IV
RelativeDoseEquivalents 100mg 25mg 20mg 4mg
Absorption 50%PObioavailability
100%PObioavailability
60%PObioavailability
Distribution
Variableproteinbindingdependingonconcentration,V 0.5L.kg
Variableproteinbindingdependingonconcentration,V0.5L.kg
V 1L.kg
+
D-1 D-1D
-1
Corticosteroids
572
![Page 573: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/573.jpg)
Metabolism Hepatic Hepatic Hepatic Hepatic
Elimination Eliminationt is2hours
Eliminationt is3hours
Eliminationt is3hours
Eliminationtis4hours
Relativemineralocorticoideffect
+++ ++ + +
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.3. NiemanLK,LacroixA,MartinKA.Pharmacologicuseofglucocorticoids.In:UpToDate,Post,TW(Ed),UpToDate,
Waltham,MA,2017.4. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.
Lastupdated2019-07-18
0.5 0.5 0.5 0.5
Corticosteroids
573
![Page 574: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/574.jpg)
PulmonaryVasodilators
Property NitricOxide Iloprost Sildenafil
Class Inorganicgas Syntheticeicosanoidwithprostacyclinactivity
Uses ARDS,RVF,PHTN PHTNPHTN,erectiledysfunction
Presentation Aluminiumcylinderswith100/800ppmNO/N Syntheticanalogofepoprostenol
RouteofAdministration Inhaled Inhaled PO
Dosing 1-40ppm,viainspiratorylimbofventilator 20mgTDS
Absorption 40%PObioavailability
Distribution AvidlyboundtoHb95%proteinbound,V of100L
MetabolismMetabolisedtomethaemoglobinandnitritepriortoreachingsystemiccirculation-tof<5s
HepaticbyCYP450
Elimination Faecal
MechanismofAction
StimulatescGMPwhichreducesintracellularCa
StimulatescAMPwhichreducesintracellularCa andsmoothmusclegrowth
InhibitscGMP
Resp InhibitsHPV,improvesV/Qmatching
CVS↓vascularresistance,↓PVRinventilatedalveoliandimprovingV/Qmatching.↑Capillarypermeability.
↓BPwithcompensatory↑HR ↓PVR
CNS ↑CBF
Haeme Inhibitsplateletaggregation.MetHb Inhibitsplateletaggregation
Other ReboundpulmonaryHTNonabruptcessation
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.
Lastupdated2019-07-18
2
D
1/2
2+ 2++
PulmonaryVasodilators
574
![Page 575: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/575.jpg)
PulmonaryVasodilators
575
![Page 576: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/576.jpg)
AdrenergicVasoactivesThiscoversthepharmacologyofspecificcatecholaminesandsympathomimetics.Thesynthesisofendogenouscatecholaminesiscoveredunderadrenalhormones,whilstspecificsofcatecholaminereceptorfunctioniscoveredunderadrenoreceptors.
Adrenergicdrugs:
Actvia:Dopamine(D)Adrenoreceptors(αandβ)
Canbe:Direct-actingStimulatethereceptor.Indirect-actingStimulatethereleaseofnoradrenalinetocauseeffects.
Classifiedaseither:Naturally-occurringcatecholaminesSyntheticcatecholaminesSyntheticsympathomimeticsDrugswhichactonadrenoreceptorsbutarenotclassifiedascatecholaminesduetotheirchemicalstructure.
ComparisonofCommonlyUsedAdrenergicAgents
Properties Noradrenaline Adrenaline Phenylephrine Metaraminol Ephedrine
Class NaturalCatecholamine
NaturalCatecholamine
Sympathomimeticphenylethylaminederivative
Syntheticsympathomimetic
Syntheticsympathomimetic
Uses ↑SVR
Cardiacarrest,anaphylaxis,inotropy,chronotropy,adjunctinlocalanaesthetics
↑SVR ↑SVR ↑SVRwithout↓inHR
Dosing Startat0.05µg/kg/min
Infusionstartsat:0.01µg/kg/min
Bolusstartat50-100mcg Bolus0.5-2mg 3-6mgbolus
Route IV IV/IM/ETT/SC IV/IM/SC IV IV
Presentation
Clear,colourless,light-sensitivesolution.Sodiummetabisulfiteasexcipient.
Aclear,colourlesssolutiontypicallyat0.1-1mg/ml
Clear,colourlesssolutionat100mcg/ml
Clear,colourlesssolutioninampouleat10mg/ml,typicallyreconstitutedto0.5mg/ml
Clear,colourlesssolutionin30mg/mlampoule
Absorption IVonlyVariableETTandSCabsorption
IMonset15minutes,durationupto1hour
IVonly IVorIM
t 2min.MetabolisedbymitochondrialMAOand
t 2min.MetabolisedbymitochondrialMAOand Someuptakeinto
Hepatic(notmetabolisedbyMAOandCOMT),givinga
1/2 1/2
CardiovascularPharmacology
576
![Page 577: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/577.jpg)
Metabolism COMTinliver,kidney,andbloodtoVMAandmetadrenaline.
COMTwithinliver,kidney,andbloodtoVMAandmetadrenaline.
HepaticbyMAO adrenergicnerveendings
longer(10-60minute)durationofactionandat βof3-6hours
Elimination
Pulmonaryuptakeofupto25%.Urinaryexcretionofmetabolites
Urinaryexcretionofmetabolites
Renalofmetabolites,t β2-3hours
50%unchangedinurine
Mechanismofaction α>>β
β>αatlowerdoses.Athighdosesα effectsdominate.
Directα
Directandindirect(via↑NArelease)αagonism
↑NArelease(indirectα )anddirectαandβagonism
Respiratory ↑MV,bronchodilation
↑MV,bronchodilation Bronchodilation
CVS
↑SVR,↑MyocardialOconsumption,↑Coronaryflow.
↑Inotropy,↑HR,↑SVRandPVR,↑BP,↑CO,↑myocardialOconsumption.Coronaryvasodilation.Arrhythmogenic.
↑SVRandBP,potentialreflexbradycardia.Notarrhythmogenic.
↑SVR/PVR,reflexbradycardia.Indirect↑incoronaryflow.
Directandindirect(viaNArelease)↑inHR,BP,andCO.Arrhythmogenic.
CNS ↑Painthreshold,↑MAC
↑MAC,mydriasis.
MSK Necrosiswithextravasation
Necrosiswithextravasation
Renal ↓RBF ↓RBFand↑insphinctertone ↓RBF ↓RBF ↓RBF
Metabolic
↑BMR,↑lipolysis,↑gluconeogenesisandBSL,↑Lactate.Initially↑insulinsecretion(β),then↓(α)
GU↓Uterinebloodflowandfoetalbradycardia
↓Uterinebloodflow
↓Uterinebloodflow
ComparisonofLessCommonAdrenergicAgents
Properties Dopamine Isoprenaline Dobutamine
Class NaturalCatecholamine SyntheticCatecholamine SyntheticCatecholamine
Uses Haemodynamicsupport Severebradycardia Stresstesting,increasingCO
Dosing Start1µg/kg/min Infusionfrom0.5-10µg/min 0.5-20µg/kg/min
Route IV IV IV
1/2
1/2
1 1 11
2 2
CardiovascularPharmacology
577
![Page 578: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/578.jpg)
Presentation Clear,colourlesssolutionwith200mgor800mginwater
Clearsolutionat1mg/ml
250mgdobutaminein20mlwater
Metabolismt 3min.25%ofdoseconvertedtonoradrenaline.RemainderismetabolisedbyMAOandCOMTsimilartonor/adrenaline.
HepaticbyCOMT t 2min.COMTtoinactivemetabolites.
Elimination Renal,t β3minutesUrinaryexcretionofunchangeddrugandmetabolites
Mechanismofaction D ,D ;β>αatlowerdose β >β β >>β ,D
Respiratory Potentbronchodilation Bronchodilation
CVS ↑Inotropy,↑HR,↑CO,coronaryvasodilation.Athighdoses,↑SVRandPVR,↑VR.
↑SVR,potentialreflexbradycardia.Notarrhythmogenic.
↑HR,CO,contractility,andautomaticity.Βeffectsmay↓SVRandBP.
CNS Inhibitsprolactin.Nausea. Stimulant Tremor
MSK Necrosiswithextravasation
Renal
↑RBFand↑urinaryoutputwithnoimprovementinrenalfunction
GIT Mesentericvasodilation
Structure-ActivityRelationshipsofSympathomimetics
Catecholaminesconsistof:
AcatecholringAbenzeneringwithtwohydroxylgroupsinthe3and4position.
LosingonehydroxylgroupIncreaseslipidsolubilityanddecreasesthepotency10-fold
1/2 1/2
1/2
1 2 1 2 1 2 2
2
CardiovascularPharmacology
578
![Page 579: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/579.jpg)
PreventsmetabolismbyCOMT,prolongingdurationofactionLosingbothhydroxylgroupsdecreasesthepotency100-fold
Changingthehydroxylgroupstothe3and5positionincreasesbeta-2selectivitywhenthereisalsoalargesubstitutionpresentontheaminegroup
AnethylaminetailConsistsof:
BetacarbonThefirstcarbon.
AddingahydroxylgroupdecreaseslipidsolubilityandCNSpenetrationAddinganygroupincreasesalphaandbetaselectivity
AlphacarbonThesecondcarbon.
AddingagrouppreventsmetabolismbyMAO,prolongingdurationofactionMethylationincreasesindirectactivity
AminegroupTheterminalnitrogen.
AdditionofamethylgroupgenerallyincreasesbetaselectivityAsthechainlengthincreases,sodoesthebetaselectivity.
Dopamine
Dopamineistheprototypicalcatecholamine,towhichothersarecompared
Noradrenaline
CardiovascularPharmacology
579
![Page 580: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/580.jpg)
Noradrenalinehasahydroxylgroupaddedtothebetacarbon,increasingitsalphaselectivity
Adrenaline
AdrenalineissimilartonoradrenalinewithanadditionalhydroxylgrouponthebetacarbonAdrenalinealsohasamethylgroupaddedtotheterminalamine,increasingbetaselectivity
Metaraminol
CardiovascularPharmacology
580
![Page 581: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/581.jpg)
MetaraminolhasanadditionalhydroxylgrouponthebetacarbonMetaraminolhasonlyonehydroxylgrouponthephenolring,so:
ItisnolongerclassifiedasacatecholamineItisnotmetabolisedbyCOMT,prolongingitsdurationofactionIthasreducedpotency,requiringadministrationinhigherdoses
Metaraminolhasanadditionalmethylgrouponthealphacarbon,preventingmetabolismbyMAOandfurtherprolongingitsdurationofaction
Ephedrine
Likemetaraminol,ephedrinehasahydroxylgrouponthebetacarbonandamethylgrouponthealphacarbonEphedrinehasnohydroxylgroupsonthephenolring,furtherreducingitspotencyandincreasingitseliminationhalf-lifeEphedrinehasamethylgroupontheamine,increasingitsbetaselectivity
References1. BrandisK.ThePhysiologyViva:Questions&Answers.2003.2. ChambersD,HuangC,MatthewsG.BasicPhysiologyforAnaesthetists.CambridgeUniversityPress.2015.3. YartsevA.DerangedPhysiology-StructureofSyntheticCatecholamines4. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.
Lastupdated2019-07-18
CardiovascularPharmacology
581
![Page 582: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/582.jpg)
CardiovascularPharmacology
582
![Page 583: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/583.jpg)
Non-AdrenergicVasoactivesKeynon-adrenergiccardiovasculardrugsincludevasopressin(anditsanalogues,terlipressinandornipressin),phosphodiesteraseIIIinhibitorssuchasmilrinone,andcalciumsensitiserssuchaslevosimendan.
Property Vasopressin(ADH) Milrinone Levosimendan
Class Naturalnonapeptide PhosphodiesteraseIIIinhibitor
Calciumsensitiserandphosphodiesteraseinhibitor
UsesHaemorrhage,DI,catecholamine-sparingvasopressor
RefractoryCCFandlowCOstates Severeacuteheartfailure
Dosing 5-10unitsIVbolus,upto4U/hrinfusion
Load12-24mcg/kgover10min,theninfusionat0.05-2mcg/kg/min
Route IV/SC/IM IV IV
Presentation Clearsolution Yellowsolutionat1mg/ml 2.5mg/mLin5ml&10mlvials
Distribution 70%proteinbound Veryhighproteinbinding>90%
Metabolismt 10minutes.Metabolisedbytissuepeptidasesandrenalelimination.
t 1-2.5hourst 1hour.Hepatictoactivemetabolitewithat~70hours
Elimination 80%ofdrugisexcretedunchanged
Mechanismofaction
V receptors(kidney,platelets)areadenylatecyclasemediated.V (vascularsmoothmuscle)andV receptors(pituitary)arephospholipaseC/inositoltriphosphatemediated
InhibitsphosphodiesterasebreakdownofcAMP,increasingintracellularCalevels.AlsoincreasesspeedofCa uptakeintocardiacmuscle,increasinglusitropy.
BindstotroponinCincreasingmyofilamentCa sensitivity.AlsoopensK channelscausingvasodilation.ItmayalsohavesomePDIIIinhibitioneffect.
CVS ↑SVRthroughvasoconstriction
Increasedinotropy,increasedlusitropy,decreasedSVRandPVR(PVRdecreasesmorethanSVR).Increaseddysrhythmias.
IncreasedCOwithoutincreasedO demand,vasodilation,prolongedQTcwithriskofarrhythmia
GIT GITsmoothmusclecontraction
Renal
↑Aquaporininsertionintotheapicalmembraneofcollectingductswhich↑waterreabsorption
Haematological↑Coagulationfactormobilisationand↑plateletaggregation
Metabolic Hyponatraemia
References
1/21/2
1/21/2
2
13
2+
2+
2++
2
Non-adrenergicVasoactives
583
![Page 584: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/584.jpg)
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.3. BruntonL,ChabnerBA,KnollmanB.GoodmanandGilman'sThePharmacologicalBasisofTherapeutics.12thEd.
McGraw-HillEducation-Europe.2011.
Lastupdated2019-07-18
Non-adrenergicVasoactives
584
![Page 585: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/585.jpg)
CentrallyActingAnti-Hypertensives
Property Clonidine Methyldopa
Class Centralα -agonist(200:1α :α ) Phenylalaninederivative
Uses Analgesia,sedation,anti-hypertensive Antihypertensive(especiallyinpregnancy)
Presentation Clearcolourlesssolutionat150μg.mlTablets-notappropriateforurgentbloodpressurereduction
RouteofAdministration
PO/IVat10-200mcguptoQID.Canbeaddedtoneuraxialblockadeat1-2mcg.kg todecreaseopioidrequirement. PO/IV.
Dosing 50-200μgQID. 250-500mgPOBD/TDS.
Absorption 100%PObioavailabilitywithrapidabsorption HighlyvariablePObioavailability
Distribution 20%bound,V 2L.kg 50%proteinbound,V0.3L.kg
Metabolism 50%hepatictoinactivemetabolites,t β9-18hours Intestinalandhepatic
Elimination 50%renaleliminationunchanged 40%renaleliminationunchanged
MechanismofAction
Agonistofcentralα2receptor,↓SNStoneviadecreasedNAreleasefromperipheralnerveterminals.
Metabolisedtoα-methyl-noradrenalineintheCNS,whichagonisescentralα2receptors.
CVS
Initial↑inBPduetoα stimulation,evidentwithbolusdosing.Followedbyprolonged↓inBP,↑PR,↓AVconduction,↑baroreceptorsensitisation(lowerHRforagivenincreaseinBP).CessationmaycausereboundHTN.
↓SVRwithunchangedHRorCO
CNSSedation,analgesiadueto↓NAreleasewhich↓opioidrequirement.Adjunctinchronicpainandinopioidwithdrawal.Anxiolysisatlowdoses.Centralantiemeticeffect.
May↓MAC
Metabolic Stressresponsetosurgicalstimulusisinhibited
Renal DiuresissecondarytoinhibitionofADH
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.
Lastupdated2017-09-12
2 2 1
-1
-1
D-1 D-1
1/2
1
Antihypertensives
585
![Page 586: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/586.jpg)
CalciumChannelBlockersCa -channelblockers:
HaveaffinityforL-typecalciumchannelsL-typechannelsexistinmyocardium,nodal,andvascularsmoothmuscle.
Variableaffinityforeachcausesapreferenceforeithernodalandinotropic,orvasculareffectsPreventCa entryintocellsinause-dependentfashion
Class ChemicalStructure Drugs
ClassI Phenylalkylamines Verapamil
ClassII Dihydropyridines Nifedipine,amlodipine,nimodipine
ClassIII Benzothiazepines Diltiazem
ComparisonofCalciumChannelBlockers
Property Verapamil Amlodipine Diltiazem
Class Phenylalkylamine Dihydropyridine Benzothiazepine
Uses SVT,excludingAFwithWPW HTN,AnginaAngina,HTN,SVT,Raynaud's,migraine,oesophagealdysmotility
Presentation 20-240mgtablet,POsolution,IVat2.5mg.ml Tablet Tablet
IsomerismRacemicpreparation.TheD-isomeralsohassomelocalanaestheticactivity
RouteofAdministration PO/IV PO PO
Dosing 80-160mgBD/TDS 2.5-10mgdaily 30-120mgTDS
Absorption 20%bioavailability 60%bioavailability 40%bioavailability
Distribution 90%proteinbound 90%proteinbound,lipidinsoluble. 80%proteinbound
Metabolism Hepatictoactivenorverapamil Hepatictoinactivemetabolites Hepatictoactivemetabolites
Elimination Renaleliminationofactivemetabolites
Renalofinactivemetabolites
Renalofactivemetabolites.t2-7hours
CVS↓HRvia↓SAand↓AVnodalconduction,↓inotropy,↓SVR,↓BP,arrhythmiaincludingHB
↓SVR,↓BP,withreflexive↑HR,↑inotropy,↑CO
↓AVnodalconductionbuttypicallystableHR,↓SVR,↓CVR,↓MVO ,↑CO
CNS ↓Cerebralvascularresistance↓Cerebralvascularresistancewithnimodipine
GIT ↓LOStone
InteractionsContraindicatedwithconcurrentβ-blockeruseduetoprofound↓HR,↓
Contraindicatedwithconcurrentβ-blockeruseduetoprofound↓
2+
2+
-1
1/2
2
CalciumChannelBlockers
586
![Page 587: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/587.jpg)
inotropy HR,↓inotropy
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.3. RangHP,DaleMM,RitterJM,FlowerRJ.RangandDale'sPharmacology.6thEd.ChurchillLivingstone.
Lastupdated2019-07-18
CalciumChannelBlockers
587
![Page 588: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/588.jpg)
DirectVasodilatorsDirectvasodilatorsinclude:
Ca channelblockers(seeCalciumChannelBlockers)NitratesIncreaseproductionofNO:
NOactivatesguanylatecyclase,increasingcGMPcGMPinhibitsCa uptakeintosmoothmuscleandenhancesitssequestrationintosmoothendoplasmicreticulumThedecreaseincytoplasmic[Ca ]causessmoothmusclerelaxationandvasodilation
HydralazineMultimodalmechanismofaction,including:
OpensK channels,hyperpolarisingvascularsmoothmuscleDecreasesintracellularCa invascularsmoothmuscleActivationofguanylatecyclase
Property SodiumNitroprusside GTN Hydralazine
Class InorganicNitrate OrganicNitrate Directvasodilator
Uses Afterload(withsomepreload)reduction Afterload&preloadreduction,angina HTN
Presentation Solutionat10mg.ml ,mustbeprotectedfromlight
Spray,tablets,patch,IVsolutionwhichisabsorbedintoPVC-requiresapolyethyleneadministrationset
20mgampouleorpowder.Shouldnotbereconstitutedwithdextrose.
RouteofAdministration IVonly IV,topical,sublingual PO,IV
Dosing 0.5-6µg.kg .min 10-200µg.min 5-20mgIV
Absorption <5%PObioavailability
30%bioavailabilityduetohighfirstpassmetabolism
Metabolism
Prodrug.ReactswithOxy-HbinRBCtoform1xNO,5xCN ,andMetHb.MetHbreactswithCNtoformcyanomethaemoglobin.CNismetabolisedintheliverandkidneytoformSCN,themajorityofwhichisexcretedinurine(thoughmaybere-convertedtoCN).
CNmayalsocombinewithhydroxocobalamin(vitaminB )toformcyanocobalamin,whichiseliminatedinurine.
Prodrug.MetabolisedtoNOandglyceroldinitrate(whichisthenalsoconvertedtoNO)intheliver.
N-acetylatedingutandliver
EliminationRenaleliminationofSCNandcyanocobalamin.ImpairedinrenalfailurewhichmayworsenCNtoxicity.t forSCNis2-7days
t 1-4mins.Urinaryexcretion
Dependentonacetylationrates
Resp Inhibithypoxicpulmonaryvasoconstrictionleadingto↑shunt Bronchodilation
Vasodilationpredominantlyof
Arteriolarvasodilation
2+
2+2+
+2+
-1
-1 -1 -1
-
12
1/2
1/2
DirectVasodilators
588
![Page 589: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/589.jpg)
CVS ↓SVR>venodilation.↓SBPand↓preload,↑HRmaintainsCO,↓MVO
capacitancevessels,↓preload,↓VR,↓EDP,↓walltensionimprovingsubendocardialbloodflow,↓MVO
withcompensatorytachycardiaandincreasedCO
CNS ↑CBFfollowingcerebralvasodilatation↑CBFfollowingcerebralvasodilatation,whichmaycauseheadache
IncreasedCBF
Haematological Methaemoglobinemia Methanoglobinaemia
ToxicEffects Threemechanisms:hypotension,thiocyanatetoxicity,CNtoxicity.
MethaemoglobinaemiacanoccurwithGTN
GTNpatchesmayexplodeifleftonduringDCcardioversion.
NitrateToxicityNitratetoxicitycanberelatedto:
CyanideThiocyanateMethaemoglobinaemia
CyanideToxicity
CyanidetoxicityoccursonlywithSNP,asCN isproducedasabyproductofmetabolism.
KineticsRapidcellularuptakeSmallVHepaticallymetabolisedtothiocyanate,usingthiosulfateasasubstrate
MechanismCN bindstocytochromeoxidase,preventingoxidativephosphorylation.Thiscauseshistotoxichypoxia,andischaracterisedby:
RapidlossofconsciousnessandseizuresMetabolicacidosisLactataemiaArrhythmiaIncreasedMVOHypertensionDuetotachyphylaxistoSNP.
RiskofcyanidetoxicityfromSNPisrelatedto:InfusionrateInfusionduration
ManagementSupportivecare,includinginotropesCyanidechelatorsBindCN,removingitfromthecirculation.Include:
DicobaltedetateHydroxycobalamin(VitaminB )Sulfurdonors
2
2
-
D
-
2
12
-
DirectVasodilators
589
![Page 590: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/590.jpg)
Provideadditionalsulfhydrylgroups,allowingfurtherhepaticmetabolismofCN toSCN.Include:
ThiosulfateNitritesConvertsOxy-HbtoMet-Hb,whichhasahigheraffinityforCN thancytochromeoxidase.Include:
SodiumnitriteAmylnitrite
ThiocyanateToxicity
ThiocyanteisproducedwithhepaticmetabolismofCN .Toxicityoccurswhenthiocyanateaccumulates,whichoccursin:
LongdurationSNPinfusions7-14days.PatientswithrenalfailureReducedclearance,mayoccurin3-6days.PatientsgiventhiosulfateformanagementofCN toxicity.
EffectsMultisystemic,including:
RashAbdominalpainWeaknessCNSdisturbance
TreatmentDialysis
Methaemoglobinaemia
MethaemoglobinaemiaoccurswhentheFe (ferrous)ioninhaemoglobinisoxidisedtotheFe (ferric)form,whichisunabletobindoxygen.
Duetothehighconcentrationofoxygeninerythrocytes,methaemoglobiniscontinuallybeingformedSeveralendogenousreductionsystemsexisttokeepMetHblevelsstableat~1%
Predominantlycytochrome-b reductaseNADPH-MHbreductaseThisreducesmethaemoglobinaemiainthepresenceofareducingagent,classicallymethyleneblue.ReducedglutathioneMoreimportantinpreventingoxidativestressinothercellsthantheRBC.
Diseaseoccursduetothelossinoxygen-carryingcapacityfromthelossofeffectivehaemoglobine.g.a20%MetHblevelgivesatheoreticaloxygencarryingcapacityof80%oftheactualhaemoglobinThereisinfactaslightleftshiftoftheoxyhaemoglobindissociationcurve,asoxygenbindsmoretightlytothepartially-oxidisedhaemoglobin.
References
1. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.2. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.3. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.4. CICMSeptember/November20085. LITFL-CyanidePoisoning
-
-
-
-
2+ 3+
5
DirectVasodilators
590
![Page 591: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/591.jpg)
6. ThomasC,LumbA.Physiologyofhaemoglobin.ContinuingEducationinAnaesthesiaCriticalCare&Pain,Volume12,Issue5,1October2012,Pages251–256.
7. WrightRO,LewanderWJ,WoolfAD.Methemoglobinemia:Etiology,Pharmacology,andClinicalManagement.AnnalsofEmergencyMedicine,Volume34,Issue5,1999,Pages646-656.
8. RusswurmM,KoeslingD.NOactivationofguanylylcyclase.TheEMBOJournal.2004;23(22):4443-4450.
Lastupdated2019-07-18
DirectVasodilators
591
![Page 592: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/592.jpg)
AngiotensinConvertingEnzymeInhibitorsACEinhibitorspreventtheconversionofangiotensinItoangiotensinIIbyangiotensinconvertingenzyme(ACE)inthelungs,inturnreducingeffectsofangiotensinII.Theseeffectsinclude:
VasoconstrictionNoradrenalinereuptakeinhibitionThirstADHreleaseACTHreleaseAldosteronereleaseReducesKf,reducingGFR
Indications
HypertensionParticularlyininsulindependentdiabeteswithdiabeticnephropathyLesseffectiveforthisindicationintheblackpopulationContributetopost-operativehypertensionandmaybewithheldperioperatively
CardiacfailureAllgrades.
MIwithLVdysfunctionImprovedprognosis.
Classification
Canbedividedintothreegroupsbasedonpharmacokinetics:
ActivedrugwithactivemetabolitesCaptopril.ProdrugRamipril.NotmetabolisedandexcretedunchangedinurineLisinopril.
CommonFeaturesofACEInhibitors
Property Drug
Resp Bradykinincough
CVS ↓SVRandBP.UnaffectedHRandbaroreceptorresponse.
Endocrine Hypoglycaemiaindiabetics
Renal Withanormalrenalperfusionpressure,natriuresisresults.However,afallinrenalperfusionpressuremaycausepre-renalfailure(e.g.renalarterystenosis).
Haeme Agranulocytosis,thrombocytopenia
ACEInhibitors
592
![Page 593: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/593.jpg)
Immune Angioedema
Metabolic ↑Reninrelease.
Interactions ↓Aldosteronerelease,which↑theefficacyofspironolactoneandmayprecipitatehyperkalaemia.PharmacodynamicinteractionwithNSAIDstodroprenalperfusionpressure.
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.
Lastupdated2019-11-02
ACEInhibitors
593
![Page 594: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/594.jpg)
AngiotensinReceptorBlockersAngiotensinreceptorantagonistsareverysimilartoACEinhibitors,except:
BradykinindoesnotaccumulateasitisstillbrokendownbyACEThereforethereisnocoughandpatientcomplianceisimproved.TheAT receptorincardiactissueismorecomprehensivelyblockedwhichmayimprovecardiacoutcomesTheAT receptorisnotblocked,whichmayalsoimprovecardiacoutcomes
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.
Lastupdated2017-07-27
12
AngiotensinReceptorBlockers
594
![Page 595: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/595.jpg)
PotassiumChannelActivatorsPotassiumchannelactivatorsstimulateATPsensitiveK channels,causinganincreaseinintracellularcGMPandsubsequentrelaxationofsmoothmuscleinthe:
HeartVenouscapacitancevesselsArterioles
Property Nicorandil
Uses HTN,angina,CHF
RouteofAdministration PO
Dosing 10-30mgBD
Absorption 80%PObioavailability
Distribution Negligibleproteinbinding
Metabolism Hepaticdenitration
Elimination Renaleliminationofactivedrugandmetabolites
CVS ↓Preload,↓afterload,↓BP,↑coronaryflow
CNS Headache,improveswithongoinguse
Haeme Inhibitionofplateletaggregation
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.
Lastupdated2017-09-22
+
PotassiumChannelActivators
595
![Page 596: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/596.jpg)
SodiumChannelBlockersSodiumchannelblockersinclude:
ClassIa:ProcainamideQuinidineDisopyramide
ClassIb:LignocaineMexiletine(lignocaineanalogue)
ClassIc:Flecainide
Ingeneral:
IVpreparationsaregivenforVTGoodPObioavailabilityandlowproteinbindingMetabolitesarerenallycleared
Property Procainamide Lignocaine Flecainide
Class ClassIaamide ClassIbamidelocalanaesthetic ClassIcamidelocalanaesthetic
Uses SVT/VT VT SVT/VT
Presentation Clearsolutionat10-20mg.ml (1-2%)
RouteofAdministration PO/IV IV PO/IV
Dosing 100mgIVload,followedbyinfusionat2-6mg.ml
Loadat1mg.kgfollowedbyinfusionat1-3mg.min
2mg.kg (upto150mg)loadover10-30minutes,followedbyinfusionat1.5mg.kg .hr ,aimingforlevelsof<0.9mg/ml
Absorption 75%bioavailability IVonlyforarrhythmia 90%orallybioavailable
Distribution 33%unionised,70%proteinbound 50%proteinbound
MetabolismHepatictoactivemetabolitesviaacetylation-slowacetylatorsatincreasedriskofsideeffects
Hepaticamidasestoinactivemetabolites Hepatictoactivemetabolites
MechanismofAction
Reducestherateofriseofphase0,raisesthethresholdpotential,andprolongstherefractoryperiodwithoutprolongingtheactionpotential
Reducestherateofriseofphase0oftheactionpotential.Repolarisationphaseisshortened.
Reducestherateofriseofphase0oftheactionpotential.Repolarisationisunchanged.
CVS↓HR,↓SVR,↓BP,↓CO,heartblock,may↑HRwhenusedforSVT,↑QTwithriskofTDP
AVblock,myocardialdepressioncausingunresponsive↓BP
Precipitatepre-existingconductiondisorders,↓inotropy,↑pacinganddefibrillationthreshold
CNS
Circumoraltingling,dizziness,parasthesia,confusion,seizures,coma
Dizziness,parasthesia,headache
-1
-1
-1
-1
-1
-1 -1
Antiarrhythmics
596
![Page 597: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/597.jpg)
ImmuneLupoidsyndromein20-30%,reducesantimicrobialeffectofsulfonamides
InteractionsPharmacokineticinteractionswithdigoxin,propranolol,amiodarone
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.
Lastupdated2019-07-18
Antiarrhythmics
597
![Page 598: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/598.jpg)
Beta-Blockersβ-blockersarecompetitive(oftenhighlyselective)antagonistsofβ-adrenoreceptors.Theyaresub-classifiedintointoselectiveandnon-selectiveagents:
Selective(β antagonism)(BEAM)BisoprololEsmololAtenololMetoprolol
Non-selective(β andβ antagonism)PropranololSotalolTimolol
Non-selective(β&αantagonism)CarvedilolLabetalol
Indications
CardioAnginaArhythmia
Rate-controlinAFParoxysmalSVTSinustachycardiafrom↑catecholamines
CardiacFailureSecondarypreventionforMI
VascularHypertension(2 line)AlsousefulforaggressivecontrolofBP.HypotensiveanaesthesiaAttenuatehypertensiveresponsetolaryngoscopy
Non-CVSThyrotoxicosisGlaucoma(topically)AnxietyMigraineprophylaxis
CommonFeatures
Property Action
KineticsVariabilityprimarilyduetolipidsolubility.Poorlipidsolubilityconferspoorgutabsorptionandminimisesneedforhepaticmetabolism.LipidsolubleagentswillhaveCNSeffectsandbeexcretedinbreastmilk.
Respiratory Bronchospasm.
1
1 2
nd
Beta-Blockers
598
![Page 599: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/599.jpg)
CVS ↓Inotropy,↓HR,↓MVO ,↓BP,↑SVR(β effect),worsenarrhythmia.
CNS Tiredness,nightmares,andsleepdisturbancewithlipidsolubleagents.↓IOP.
Metabolic ↓Insulinreleaseandbluntedhypoglycaemicresponse(β effect).
Interactions ContraindicatedwithcardioselectiveCa channelblockers.duetoextreme↓HR&↓inotropy.
ComparisonofBetaBlockers
Property Esmolol Metoprolol Atenolol Propranolol Labetalol
Class Cardioselective Cardioselective Cardioselective βnon-selective
Non-selectiveβ&selectiveα Ratioofβ:αantagonismis3:1afterPOand7:1afterIVadministration
Uses
Short-termtreatmentoftachyarrhythmiaandHTN
MI,HTN,migraine,thyrotoxicosis
HTN,angina,tachyarrhythmias,acuteMI
HTN,Angina,dysrhythmia,essentialtremor,anxietyHOCM,phaeochromocytoma,migraine,oesophagealvarices
HTN,MI
Presentation Clear,colourlesssolution
Clear,colourlesssolution,50mgTablet.
25/50/100mgtablets,syrup,colourlesssolution.
Tabletsandsolutionat1mg.ml
Tabletsandsolutionat5mg.ml
RouteofAdministration IV PO/IV PO/IV PO/IV PO/IV
Dosing 50-200μg.kg.min
IV:1mgbolusesPO:12.5-100mgBD
PO:50-100mgdailyIV:2.5mgIVupto10mg
PO:10-100mgBD/TDSIV:1mgbolusestitratedtoresponse
PO:100-800mgBDIV:10-20mgIVbolus,followedby20-80mgQ30minupto300mg.Alternativelybyinfusionat1-2mg.min
Absorption IVonly
50%bioavailability,improveswithregularuse
45%PObioavailability 30%bioavailability
Highlyvariablebioavailability:10-80%
Distribution 60%proteinbound
20%proteinbound.Lipidsoluble
5%proteinbound 95%proteinbound 50%proteinbound
Metabolism
RBCesterasestoaninactivemetaboliteandmethylalcohol.t of10minutes
Hepaticwithgeneticvariabilityint ofactivemetabolites
Minimalmetabolism-dosereduceinrenalfailure
Hepatictoactiveandinactivemetabolites
Considerablehepaticfirstpassmetabolismwithinactivemetabolites
Renal
2 2
22+
1
-1 -1
-1 -1
1/21/2
Beta-Blockers
599
![Page 600: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/600.jpg)
Elimination Renaleliminationofactivedrug
Renaleliminationofmetabolites
eliminationofinactivemetabolites
CVS Venousirritant
↓SVR,↓BP.Doesnottendto↓HRor↓COwhengivenacutely.
CNS Orthostaticdizziness
References
1. LeslieRA,JohnsonEK,GoodwinAPL.DrPodcastScriptsforthePrimaryFRCA.CambridgeUniversityPress.2011.2. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.3. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.4. MacCarthyEP,BloomfieldSS.Labetalol:areviewofitspharmacology,pharmacokinetics,clinicalusesandadverseeffects.
Pharmacotherapy.1983.Jul-Aug;3(4):193-219.
Lastupdated2019-07-18
Beta-Blockers
600
![Page 601: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/601.jpg)
AmiodaroneAmiodaroneisanantiarrhythmicagentwithacomplexmechanismofactionandmanyeffects.
K channelblockadeincardiacmyocytes,inhibitingtheslowoutwardcurrentandslowingrepolarisation(ClassIII)β-blocker-likeactivityonSAandAVnodes,decreasingautomaticityandslowingnodalconduction(ClassII)Ca channelblocker-likeactivityonL-typeCa channels,decreasingtheslowinwardCa current,increasingdepolarisationtimeanddecreasingnodalconduction(ClassIV)α-blocker-likeactivity,decreasingSVR
Property Amiodarone
Class ClassIIIantiarrhythmic,thoughexhibitsactionfromall4classes.
Uses VT/VF,resistantarrhythmia,ALS.
Presentation 100/200mgtablets,IV:150mgampouletobereconstitutedinD5W.
RouteofAdministration IV/PO.
Dosing IV:Loadwith5mg.kg over1/24,withafurther15mg.kg overthefollowing24/24PO:200mgTDSfor1/52,200mgBDfor1/52,200mgODthereafter.
Absorption PoorPOabsorptionwithbioavailability~50%.
Distribution HighlyproteinboundwithveryhighV of~70L.kg sduetoaccumulationinfatandmuscle.
Metabolism HepaticmetabolismwithinhibitionofCYP3A4,totheactivedesmethylamiodarone.
Elimination Verylongt ofupto~55days.Biliary,skin,andlacrimalelimination,with<5%ofdrugeliminatedrenally.Notremovedbydialysis.
Resp 10%3-yearriskofpneumonitis,fibrosis,pleuritis.
CVS ↓HR,↓BP,↓SVR,↑QTwithoutriskofTDP.Irritanttoperipheralveins.
CNS Mildblurringofvisionfromcornealdeposition,sleepdisturbance,vividdreams,peripheralneuropathy.
MSK Photosensitivity,greyskin.
Endocrine Hyperthyroidism(1%)andhypothyroidism(6%).
GIT Nausea,vomiting,cirrhosis,hepatitis,andjaundice.
Other
AmiodaronehaspotentialtocauseanumberofdruginteractionsduetoitsinhibitionofCYP3A4anditshighproteinbinding.Aselectioninclude:Digoxin,statins,warfarin,phenytoin,andotherantiarrhythmics.Contraindicatedinporphyria.
AmnemonicforsomeoftherarereffectsisBITCH:
BlueskinInterstitiallungdiseaseThyroidCornealHepatic
+
2+ 2+ 2+
-1 -1
D-1
1/2
Amiodarone
601
![Page 602: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/602.jpg)
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.Peckandhill
2. RangHP,DaleMM,RitterJM,FlowerRJ.RangandDale'sPharmacology.6thEd.ChurchillLivingstone.
Lastupdated2019-07-18
Amiodarone
602
![Page 603: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/603.jpg)
SotalolTheD-isomerofsotalolisaclassIIIantiarrhythmic,whilsttheL-isomeralsohasclassIIactivity.
Property Action
Class ClassIIIantiarrhythmic
Uses Tachyarrhythmiaprophylaxis
Presentation Solutionat10mg.ml andtablets
Isomerism Racemicmixture
RouteofAdministration PO/IV
Dosing PO:40-160mgBDIV:50-100mgover20minutes
Absorption >90%bioavailability
Distribution Noproteinbinding
Metabolism Notmetabolised
Elimination Excretedunchangedinurine
Resp Bronchospasm
CVS Torsades(<2%)-morecommonwithhighdoses,longQT,andelectrolyteimbalances
CNS Maskingsymptomsofhypoglycaemia
GU Sexualdysfunction
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.
Lastupdated2019-07-18
-1
Sotalol
603
![Page 604: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/604.jpg)
DigoxinDigoxinisacardiacglycosideusedinthetreatofatrialarrhythmiasandincardiacfailureasapositiveinotrope.
Digoxinhasbothadirectandindirectmechanismofaction:
DirectInhibitscardiacNa /K ATPase,causing:
Increasingintracellular[Na ],increasingactivityoftheNa /Ca pumpIncreasedintracellularCa increasesinotropyDecreasedK resultsprolongsrefractoryperiodoftheAVnodeandbundleofHis
IndirectParasympathomimeticeffectsbyincreasingAChreleaseatcardiacmuscarinicreceptors.
SlowsAVnodalconductionandventricularresponseThisimprovescoronarybloodflow,increasingtimeforventricularfilling,andimprovingcardiacoutput.
Property Action
Class CardiacGlycoside
Uses Arrhythmia-particularlyAF/Flutter,andCCF
Presentation Tablets,elixir,clearcolourlesssolution
RouteofAdministration PO/IV
Dosing PO:62.5μg-250μg,IV:250-500μgload
Absorption >70%bioavailabilitythoughvarieswithformulation
Distribution 25%proteinbound.V 5-11L.kg ,dependentonleanmass
Metabolism Minimalhepaticmetabolism
Elimination Renaleliminationofactivemetabolitest 35hours-increasedinrenalfailure
CVS ↓HR,↑inotropy,arrhythmiasincluding;bigeminy,PVCs,1 /2 /3 degreeAVblock,SVT,VT
CNS Derangedred-greencolourperception,visualdisturbances,headache
Immune Eosinophiliaandrash
Metabolic Gynaecomastia
ToxicEffects NarrowTI.SeverearrhythmiawithDCcardioversion
Interactions
Interaction Drug
Increasedlevel Amiodarone,captopril,erythromycin,verapamil
Decreasedlevel Antacids,cholestyramine,phenytoin,metoclopramide
References
+ ++ + 2+
2++
D-1
1/2st nd rd
Digoxin
604
![Page 605: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/605.jpg)
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.
Lastupdated2018-09-21
Digoxin
605
![Page 606: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/606.jpg)
AdenosineAdenosineactsviaA adenosinereceptorsintheSAandAVnode,whichwhenstimulatedopenK channelscausinghyperpolarisationandareductioninCa current,withsubsequentblockadeofAVnodalconduction.
Property Action
Class Naturallyoccurringpurinenucleoside
Uses SVT
Presentation Colourlesssolutionat3mg.ml
RouteofAdministration IV
Dosing 3mg/6mg/12mginincreasingdoses
Metabolism Rapidlydeaminatedinplasma.t <10s
Resp Bronchospasm,↑RRandV
CVS ↓↓AVnodalconduction,maycauseAF/lutter
ToxicEffects Contraindicatedinsick-sinussyndrome,2 /3 degreeAVblock
Interactions
Interaction Drug
Increasedeffect Dipyridamole
Decreasedeffect Methylxanthines,suchasaminophyllineandcaffeine
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.
Lastupdated2017-07-27
1+
2+
-1
1/2
T
nd rd
Adenosine
606
![Page 607: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/607.jpg)
MagnesiumMg isacationthatisimportantforneurotransmissionandneuromuscularexcitability.Magnesium:
InhibitsAChreleaseattheNMJActsacofactorinmultipleenzymesystemsIsimportantintheproductionof:
ATPDNARNA
Property Action
Uses HypoMg,arrhythmia,eclampsia,tocolysis,bariumpoisoning,asthma,tetanus,autonomichyperreflexia
Presentation 2mmol.ml ,madeupinto10mmolin100mlforperipheraladministration
RouteofAdministration PO/IV
Dosing IV:10-20mmol
Distribution 30%proteinbound
Elimination Significanturinaryexcretion,evenwhendeficient
Resp Bronchodilation
CVS ↓SVR,hypotension,↓HR
CNS CNSdepression,anticonvulsant
GU ↓Uterinetoneandcontractility
ClinicalEffectsofMagnesium
[Plasma] Effect
<0.7mmol.L Arrhythmia
4-6mmol.L Nausea,hyporeflexia,speechimpairment
6-10mmol.L Weakness,respiratorydepression,bradycardia
>10mmol.L Cardiacarrest
References1. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.2. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.3. RangHP,DaleMM,RitterJM,FlowerRJ.RangandDale'sPharmacology.6thEd.ChurchillLivingstone.
Lastupdated2017-09-20
2+
-1
-1
-1
-1
-1
Magnesium
607
![Page 608: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/608.jpg)
Magnesium
608
![Page 609: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/609.jpg)
AtropineNaturallyoccurringtertiaryaminewhichcompetitivelyantagonisesAChatthemuscarinicreceptor,causingparasympatholyticeffects.
Property Atropine
Class Naturallyoccurringtertiaryamine.Muscarinicantagonist.
Uses Bradycardia,organophosphatepoisoning,antisialagogue,treatmentofPDPH
Presentation Clear,colourlesssolutionat600μg.ml .Racemicmixture,withonlytheL-isomeractive
RouteofAdministration IV
Dosing 600μg-3mg
Distribution 50%proteinbound,V 3L.kg .CrossesBBB.
Metabolism Extensivehepatichydrolysis
Elimination Renaleliminationofmetabolitesandunchangeddrug
Resp Bronchodilation,↓secretions
CVS ↑HRdueto↑AVnodalconduction,peakswithin2-4minutesandlasts2-3hours
CNS Centralanticholinergicsyndrome,confusion,↑IOP,↑CSFsecretioninchoroid,cerebralvasoconstriction
MSK Inhibitssweating
GIT ↓LoStone
References
1. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.2. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.3. Mahmoud,AhmedAbdelaalAhmed,AmrZakiMansour,HanyMahmoudYassin,HazemAbdelwahabHussein,Ahmed
MoustafaKamal,MohamedElayashy,MohamedFaridElemady,etal.‘AdditionofNeostigmineandAtropinetoConventionalManagementofPostduralPunctureHeadache:ARandomizedControlledTrial’127,no.6(2018):6.
Lastupdated2019-07-18
-1
D-1
Atropine
609
![Page 610: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/610.jpg)
DiureticsAnunderstandingofthepharmacologyofdiuretics.
Diureticsaredrugsthatactonthekidneytoincreaseurineproduction.Theycanbeclassifiedbytheirmechanismofactioninto:
ThiazidesLoopdiureticsPotassiumsparingAldosteroneantagonistsOsmoticCarbonicAnhydraseinhibitors
CommonFeaturesofDiuretics
Property Diuretics
Absorption Typicallypoorbioavailability(exception:acetazolamide)
Distribution Variableproteinbinding
Metabolism Generallynotmetabolised.Keyexceptions:Spironolactoneisextensivelymetabolisedwithactivemetabolites,andasmallamountoffrusemideismetabolisedtoglucuronide.
Elimination Renaleliminationofunchangeddrug
CVS Reducedintraandextravascularvolume
Renal
Anydiureticwhichinhibitssodiumreabsorptioncanprecipitatehypokalaemia(asagreaterintra-luminalconcentrationofsodiumresultsinexchangeofsodiumforpotassiumions),hyponatraemia(asthereisstillanetlossofsodium),andalkalosis(fromlossofhydrogenionsexchangedforsodium,ortheoverallraisedstrongiondifference).
ComparisonofDiuretics
Thiazides LoopDiuretics PotassiumSparing
Aldosteroneantagonists Osmotic
Example Hydrochlorothiazide Frusemide Amiloride Spironolactone Mannitol
Site Distaltubule LoopofHenle Distaltubule Distaltubule Glomerulus
Mechanismofaction
InhibitNa andClreabsorption,andincreaseCareabsorptionintheDCT
InhibitNKCC2,theNa /K /2.Cltransportproteininthethickascendinglimb,impedingthecounter-currentmultiplier.Thisreducesthehypertonicityofthemedulla,andsubsequentwaterreabsorptioninthecollectingsystem.
InhibitsNa /Kexchangepump.Weakeffect.
Competitivealdosteroneantagonist.AldosteronestimulatesNareabsorption,whichinturnstimulatesKsecretion.
Filteredattheglomerulusandnotreabsorbed,increasingfiltrateosmolarityandincreaseswaterexcretion.
+ -
2+
+ + -
+ ++
+
Renal
610
![Page 611: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/611.jpg)
Resp
Cardiac
AntihypertensiveduetoreducedplasmavolumeandSVR
Arteriolarvasodilation,reducingSVRandpreload
Increasesintravascularvolume,increasingpreload.MayincreaseCOorresultincardiacfailure.
CNS ↓ICP
Renal ReducedrenalbloodflowandGFR
IncreasedrenalbloodflowandGFR
Increasedrenalbloodflow
Metabolic
Hypokalaemic,hypochloraemicalkalosis.Hyperglycaemia.
Hypochloraemia,hyponatraemia,hypokalaemia,hypomagnesaemia.Occasionalhyperuricaemiaprecipitatinggout.
Hyperkalaemia. Hyperkalaemia,hyponatraemia.
Miscellaneous Blooddyscrasias
Deafness,typicallyfollowinglargedoses.Morecommoninkidneyimpairmentandwithaminoglycosideuse.
Gynaecomastiaandmenstrualirregularityduetoanti-androgynismfromaldosteroneantagonism
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. RangHP,DaleMM,RitterJM,FlowerRJ.RangandDale'sPharmacology.6thEd.ChurchillLivingstone.
Renal
611
![Page 612: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/612.jpg)
3. Auerbach.WildernessMedicine.SixthEdition.
Lastupdated2019-07-18
Renal
612
![Page 613: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/613.jpg)
IntravenousFluidsIntravenousfluidscanbeclassifiedinto:
CrystalloidsCanpassfreelythroughasemipermeablemembrane.Canbefurtherclassifiedinto:
ECFreplacementsolutionsHavea[Na ]similartoECF,suchthattheyareconfinedmostlytotheECF.MaintenancesolutionsDesignedtodistributethroughoutTBW.SpecialsolutionsThesesolutionsdon'tfitintotheabovetwocategories,andinclude:
HypertonicsalineMannitol8.4%SodiumBicarbonate
ColloidsSubstanceevenlydispersedthroughoutanothersolutioninwhichitisinsoluble.Canbeclassifiedinto:
NaturallyoccurringAlbuminHeat-treatedhumanalbumin.
ProducedatlowpHbutnottechnicallysterileUsewithin3hoursofopening.ContributestoplasmaoncoticpressureContributestodrugandendogenoussubstancebinding
SyntheticDextransHighmolecularweightsugarssynthesisedfromsucrosebybacteria.
InterferewithhaemostasisduetovWFinhibitionInterferewithbloodcrossmatchRiskofanaphylaxis
GelatinsHighmolecularweightproteinsproducedbycollagenhydrolysis.
GreatestanaphylaxisriskDonotinterferewithclotting
Hydroxyl-ethylstarchesRiskofanaphylaxisRiskofrenalimpairmentAccumulateinthereticuloendothelialsystem
ComparisonofCrystalloids
Contents(mmol.L ) 0.9%NaCl Hartmann's Plasmalyte
Na 154 130 140
Cl 154 109 98
K 4
Ca 3
+
-1
+
-
+
2+
2+
IntravenousFluids
613
![Page 614: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/614.jpg)
Mg 1.5
Lactate 28
Acetate 27
Gluconate 23
pH 5.0 6.5 5.5
References
http://www.anaesthesiamcq.com/FluidBook/fl7_2.php
Lastupdated2019-07-18
2+
IntravenousFluids
614
![Page 615: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/615.jpg)
PropofolPropofol(2-6di-isopropylphenol)isaphenolicderivativewitheffectsonmanyreceptorsincluding:
GABAPotentiatestheeffectofGABA,prolongingCl channelopeningandhyperpolarisingthecell.GlycineNicotinicAChD receptors
Property Action
Class Phenolicderivative
Uses Inductionofanaesthesia,sedation,TIVA
Presentation
Whiteoil-in-wateremulsionatapHof7-8.5containing:-10-20mg.ml propofol-10%Soybeanoil(solubilisingagent)-1.2%Purifiedeggphosphatide(emulsifier)-2.25%Glycerol(fortonicity)Bacteriostaticadditivesincluding:-Generics:Sodiummetabisulfite-Diprivan:Disodiumedetate(lessallergenic)Riskofbacterialcontaminationlimitsshelflife.Energycontentis1.1kcal.ml
pKa 11-almostallisunionised(andactive)atphysiologicpH
RouteofAdministration IVonly
Dosing Induction:1-2.5mg.kg Maintenance:4-12mg/kg/hr.Targetplasmaconcentrationof4-8μg.ml tomaintaingeneralanaesthesia
Distribution 98%proteinbound.VeryhighV at4L.kg .Rapidinitialdistribution:t α(fast)1-3minutes,intermediatedistributiont α(slow)30-70minutes.t
MetabolismHepaticandextra-hepaticmetabolismtoinactiveglucuronidesandsulphates;t β2-12hours.Clearanceof30-60ml.kg.min ,unaffectedbyrenalandhepaticdisease.Contextsensitivehalf-timepeaksat50minutesfollowinga9hourinfusion.
Elimination Tri-exponential.Renaleliminationofinactivemetabolites.
Resp Respiratorydepression,apnoea.Strongsuppressionoflaryngealreflexes.↓Responsetohypoxiaandhypercapnea.Bronchodilation.
CVS↓Arterialandvenousvasodilation(viastimulatingNOrelease)causing↓SVRand↓VR,with↓BP.↓Inotropyvia↓inSNStone,↓MVO .Depressesbaroreceptorreflex.Painoninjectionduetolipidemulsion.
CNSHypnosis.RapidLoC(within1arm-braincirculationtime).↓CMRO2,CBF,andICP.Anticonvulsant.↓IOP.Paradoxicalexcitatoryeffectsseenin~10%-dystonicmovementsofsubcorticalorigin.EEGdemonstratesnon-specificseizure-likeactivity.
MSK Painoninjectionintosmallveins
Renal Greenurine
GIT Anti-emetic.↓HepaticBloodFlow
Metabolic Fatoverloadsyndrome,lipaemiafollowingprolongedinfusion.Inhibitsmitochondrialfunction.
Propofolinfusionsyndrome:Acidosis,bradycardia,andMODSfollowingprolongedinfusion(>24
A-
2
-1
-1
-1 -1
D-1
1/21/2 1/2 </sub>of2.7min.ke0
1/2-1
2
-1 -1
Neuropharmacology
615
![Page 616: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/616.jpg)
mitochondrialdefects.Believedduetoinhibitionofmitochondrialfunction.
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. CICMJuly/September2007http://ceaccp.oxfordjournals.org/content/4/3/76.full.pdf
http://www2.pedsanesthesia.org/meetings/2007winter/pdfs/Morgan-Friday1130-1150am.pdf
Lastupdated2019-07-18
Neuropharmacology
616
![Page 617: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/617.jpg)
BarbituratesThiopentoneisapositiveallostericmodulatoratGABA receptors(ataseparatesitetobenzodiazepines)intheCNS.Barbituratescause:
DecreasedrateofdissociationofGABAIncreasesthedurationofchannelopening,causingeffectivehyperpolarisationduetoincreasedCl conductance.
Clinicaleffectsdifferfrombenzodiazepinesasbenzodiazepinesincreasefrequencyofopening,whilstbarbituratesincreaseduration
Directactivationofthechannelathigherdoses
Property Thiopentone
Class Barbiturate
Uses Inductionofanaesthesia,statusepilepticus,controlofICPrefractorytoothermeasures
Presentation500mgofyellowpowderwithNaCO forreconstitutionasa2.5%solution.Containerusesnitrogenasafillergas(topreventHCO formationwhenCO combineswithwaterduringreconstitution,which↓pHandthereforewatersolubility).pHof11whenreconstituted-bacteriostaticsolution.
Isomerism Tautomer.pKaof7.6,suchthat60%isunionisedatpH7.4(i.e.watersolubilitydecreasesonceinjected).
RouteofAdministration IV
Dosing 3-7mg.kg .Consider75mgboluses,assessinghaemodynamicandneuronaleffects.
Distribution65-85%proteinbound.HighlipidsolubilityandCBFgivesarapid,reliableonset.Rapidoffsetduetoredistribution,withafastt αof8minutes.Prolongedeliminationhalflife(11hours)contributestolongCSHT.Increasedunionisedportioninacidosis.t
Metabolism CapacitydependentCYP450metabolism-saturatesathighdoses(longCSHTwithinfusion).Metabolisedto(active)pentobarbital,whichalsoincreasesthedurationofitsclinicaleffects.
Elimination Renalofmetabolites,<1%excretedunchanged
Resp Respiratorydepression,bronchospasm,laryngospasm
CVS Vasodilationandvenodilation(↓MSFP),↓inotropy,withcompensatorytachycardia(baroreceptorresponsepreserved)
CNS
Hypnosisandanaesthesiawithin40secondsofinjection,withreliablelossoflashreflex.Anticonvulsant.Dose-dependentflatteningoftheEEG(βαθδburstsuppressionisoelectric),causingprogressive↓CMRO (55%ofmaximalduringburstsuppression),↓CBF,and↓ICP.
Resolutionofinductiondosein5-10minutesduetoredistribution.
Endocrine ↓RBFcausing↓UO
GIT Hepaticenzymeinduction
Immune Anaphylaxis~1;20,000
Metabolic Mayprecipitateacuteporphyriccrisesandiscontraindicatedinthesepatients
Other
IntraarterialinjectioncausesprecipitationaswatersolubilitydecreasesatbloodpH.Microembolisationandischaemiaresult,whichshouldbetreatedwithintraarteriallocalanaesthesia,analgesia,anticoagulation,andsympatheticblockadeofthelimb.
Tissuenecrosisonextravasation.
A
-
33-1
2
-1
1/21/2 of1.2minutes.ke0
2
Barbiturates
617
![Page 618: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/618.jpg)
References
1. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.2. LITFL-Thiopentone3. Hill,SA.Pharmacokineticsofdruginfusions.ContinuingEducationinAnaesthesia.2004.
Lastupdated2019-07-18
Barbiturates
618
![Page 619: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/619.jpg)
KetamineKetamineisaphencyclidinederivativeusedforinduction,sedation,analgesia,andasabronchodilatorinsevereasthma.
Ketamineactsvia:
Non-competitiveantagonistofNMDAandglutamatereceptorsintheCNSReducespresynapticglutamatereleaseSodiumchannelinhibitionLocalanaesthetic-likeeffect.Potentialmonoaminergic,muscarinic,andnicotinicantagonism
Property Action
Class Phencyclidinederivative
Uses Inductionofanaesthesia,sedation,analgesia,asthma
Presentation Clear,colourlesssolutionforminganacidicsolution(pH3.5-5.5)
Isomerism RacemicmixtureorthesingleS(+)enantiomer,whichis2-3xaspotentastheR(-)enantiomerbuthaslessbronchodilatoryproperties
RouteofAdministration IV,IM,PO,PR,PN,viaepidural(withpreservative-freesolution)
Dosing Induction:1-2mg.kg IV,5-10mg.kg IM,Sedation:0.2-0.5mg.kg IV
Distribution 25%proteinbound.t α10-15minutes
Metabolism HepaticmetabolismtoactivenorketaminebyCYP450andthentoinactivemetabolites,t β2-4hours
Elimination Renaleliminationofinactivemetabolites.Actionofnorketamineprolongedinrenalfailure.
Resp Bronchodilation,tachypnea,relativepreservationoflaryngealreflexes.Apnoeawithrapidinjection.PreservedcentralresponsetoCO .
CVS ↑Sympatheticoutflow:↑HR,↑BP,↑SVR,↑MVO .Actsdirectlyasamyocardialdepressant-bewaremaximallystimulatedpatient.Depressesbaroreceptorreflex.
CNS
Dissociation,analgesia,emergencephenomena(hallucinations,delirium)reducedbyconcurrentBDZadministration(increasingriskwithhigherdosesandrapidadministration).
Producesdissociativeanaesthesiawithin90secondsbydissociatingthalamocorticalandlimbicsystemsonEEG.Purposefulmovementsunrelatedtostimulusmayoccurevenduringsurgicalanaesthesia.
↑IOP.
Renal Cystitiswithlong-term,high-doseuse
GIT N/V
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.3. CICMJuly/Sept2007
-1 -1 -1
1/2
1/2
2
2
Ketamine
619
![Page 620: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/620.jpg)
4. LuptonT,PrattO.Intravenousdrugsusedfortheinductionofanaesthesia.
Lastupdated2019-07-18
Ketamine
620
![Page 621: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/621.jpg)
DexmedetomidineDexmedetomidineisacentralα -agonist(α :α activity1600:1)usedforitssedationandanalgesicproperties.
Property Action
Class Imidazolederivative
Pharmaceutics D-stereoisomerofmedetomidine(theL-stereoisomerisinactive)
Uses Sedationwithoutrespiratorydepression
Presentation Clearcolourlesssolutionat10µg.ml
RouteofAdministration IVonly
Dosing 0.2-0.7µg.kg .hr
Distribution 95%proteinbound
Metabolism Hepatictoinactivemetabolites
Elimination Renalofmetabolites,t βof2hours
CVSInitialtransient↑SVRandBPduetoα effects,followedby↓MAP,↓HR.
Rebound↑BPwhenabruptlyceased.
CNSSedation,anxiolysisatlowdose(anxiogenicathighdose),amnesia.↓MAC.
↓SNSoutflow.
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.3. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.
Lastupdated2017-09-16
2 2 1
-1
-1 -1
1/2
1
Dexmedetomidine
621
![Page 622: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/622.jpg)
LocalAnaestheticAgentsLocalanaestheticdrugsdeliverause-dependent,temporaryblockadeofneuronaltransmissionUnioniseddrugpassesthroughthecellmembrane,andthenbecomesionisedintracellularlyTheioniseddrugisthenabletobindtotheionchannel,andpreventconductionofsodiumandthereforegenerationofanactionpotential
Alllocalanaestheticsconsistof:AhydrophiliccomponentAlipophilicaromaticringAnamideoresterlinkconnectingthetwo
CommonFeaturesofLocalAnaesthetics
Property Action
Class Amide(-NHCO-)orEster(-COOH-)
Pharmaceutics Amidesarestableinsolution,estersareunstableinsolution.Allareformulatedasahydrochloridesalttoensurewatersolubility.
pKa Allareweakbases,andhaveapKa>7.4
Onset
Onsetisrelatedtodose(Fick'sLaw)andpKa,withalowpKagivingafasteronsetasthereismoreunioniseddrugpresentandthereforemoredrugabletocrossthecellmembrane.Thisiswhylocalanaestheticsarepooratanaesthetisinginfectedtissues,asthetissuepHislowresultinginagreaterproportionofioniseddrug,andlessdrugreachingtheeffectsite.
DurationofAction
Durationofactionisrelatedtoproteinbinding,withgreaterproteinbindinggivingalongerdurationofaction
Potency Potencyisrelatedtolipidsolubility(higherlipidsolubilityincreasespotency)andvasodilatorproperties(weakervasodilatorshavinggreaterpotency)
AbsorptionSystemicabsorptionvarieswithsiteofentry(fromhighestabsorptiontolowest:IV,intercostal,caudalepidural,lumbarepidural,brachialplexus,subcutaneous),dose,andpresenceofvasoconstrictors
Distribution Amidesareextensivelyproteinbound,estersareminimallybound
Metabolism Amidesarehepaticallymetabolised,estersarehydrolysedbyplasmacholinesterases(givingamuchshortert )
CVSVasodilatationatlowconcentrations,vasoconstrictionathighconcentrations.InhibitionofcardiacNachannels,inhibitingmaximumrateofriseofphase0ofthecardiacactionpotential.Negativeinotropyproportionaltopotency.
CNSDoes-dependentCNSeffects:circumoraltingling,visualdisturbances,tinnitus,tremors,dizziness,slurredspeech,convulsions,coma,apnoea.PotentiatedbyotherCNSdepressantsandhypercarbia(dueto↑CBFand↓seizurethreshold).
ToxicEffects Estershaveahigherincidenceofallergyduetotheirmetabolitepara-aminobenzoicacid(PABA).LocalanaesthetictoxicityispredominantlyCNSandCVS.
ComparisonofLocalAnaesthetics
Property Lignocaine Bupivacaine Ropivacaine Cocaine
1/2+
LocalAnaesthetics
622
![Page 623: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/623.jpg)
Class Amide Amide Amide Ester
Uses Local/regional/epidural,ventriculardysrhythmia Local/regional/epidural Local/regional/epidural
Topicalanaesthesiaandvasoconstriction
Presentation
Clear,colourlesssolutionat0.5/1/2%withorwithoutadrenaline.Spray.Ointment.4%solution.
Clear,colourlesssolutionat0.25/0.5%
Clear,colourlesssolution
1-4%solution,Moffat'ssolution(8%cocaine,1%NaCO ,1:2000adrenaline)
pKa 7.9 8.1 8.1 8.6
RouteofAdministration SC,epidural,IV SC,epidural SC,epidural Topical
Onset/Duration Rapidonset,shortduration
Intermediateonset,longduration
Intermediateonset,longduration 20-30minutes
MaximumDose
Analgesia:4mg.kgwithoutadrenaline,7mg.kg withadrenaline
2mg.kg 3mg.kg 3mg.kg
Distribution 70%proteinbound Highlyproteinbound
Lowerlipidsolubilityreducesmotorblockcomparedtobupivacaine
Highlyproteinbound
Metabolism Hepaticwithsomeactivemetabolites
Hepatictoinactivemetabolites
Hepatictoactivemetabolites
Plasmaesterases,somehepaticmetabolism(unlikeotheresters)
Elimination Reducedinhepaticorcardiacfailure
Eliminationofactivedrugandinactivemetabolites
CC/CNSratio 7 3 5
Other
MosttoxicofLAagentsasittakeslongertodissociatefromthemyocardialNa channel.Levobupivacaineislesscardiotoxictheracemicmixture,possiblyasithasmoreintrinsicvasoconstrictiveproperties.
Maycause↑BP,↑HR,coronaryvasoconstriction,myocardialdepression,VF,↑temperaturedueto↑serotonin,dopamine,andnoradrenalinereuptake
LignocaineToxicity
Serumconcentration(µg.ml ) Phase Effect
2 Safe Antiarrhythmic.Maybegintohavelightheadedness,circumoraltingling,numbness
5 Excitatory Dysarthria
8 Excitatory Visualchanges
3
-1
-1 -1 -1 -1
+
-1
LocalAnaesthetics
623
![Page 624: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/624.jpg)
10 Excitatory Seizures
12 Depressive Lossofconsciousness
20 Depressive Respiratorydepression
25 Depressive CVSdepression
PharmaceuticsofTopicalLocalAnaesthetics
EffectoftopicallocalanaestheticsisgovernedbyFick'sLaw.
Characteristic Effect
PharmaceuticFactors
Presentation Aerosolimprovesspeedofonsetbymoisturisingskin
Concentrationofactivecomponent Increasespeedofonset
Stability
pH ↑pHensuresmorelocalanaestheticisintheunionisedform,↑absorption.
Additives AffectpHandvasoconstrictoractivity
DrugFactors
Molecularweight Smallmoleculeswilldiffusemoreeasily
pKa Affectsionisationandthereforelipidsolubility
Lipidsolubility ↑lipidsolubilityimprovesspeedofonset.
Potency Determinesamountofdrugneededtoproduceaneffect
Vasoconstrictoractivity Willaffectbothspeedofonsetanddegreeofsystemicabsorption
PatientFactors
Site Degreeofvascularityofsite
Skin Skinthicknessandareawillaffectonset
References1. CICMMarch/May20092. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.3. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.4. OpenAnaesthesia.LocalAnaestheticsSystemicToxicity5. GadsdenJ.LocalAnaesthetics:ClinicalPharmacologyandRationalSelection.NYSORA.6. LeslieRA,JohnsonEK,GoodwinAPL.DrPodcastScriptsforthePrimaryFRCA.CambridgeUniversityPress.2011.7. ChristieLE,PicardJ,WeinbergGL.Localanaestheticsystemictoxicity.ContinuingEducationinAnaesthesiaCriticalCare
&Pain,Volume15,Issue3,1June2015,Pages136–142.
Lastupdated2017-09-20
LocalAnaesthetics
624
![Page 625: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/625.jpg)
LocalAnaesthetics
625
![Page 626: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/626.jpg)
BenzodiazepinesBenzodiazepinesaredouble-ringedpositiveallostericmodulatorsoftheGABAreceptorsintheCNS.They:
Bindtotheα/γinterfaceofthereceptor,increasingaffinityofthereceptorforGABAThisleadstohyperpolarisationofthecellmembranesanddecreasedneuronaltransmissionThemechanismvariesbetweenreceptors:
GABA isaligandgatedpost-synapticCl ionchannelActivationincreasesCl conductanceviaincreasingfrequencyofchannelopening.GABA isapre-andpost-synapticG-proteincoupledreceptorActivationincreasesK conductance.
CommonFeaturesofBenzodiazepines
Property Action
Uses Sedation,anxiolysis,hypnotic,anticonvulsants,amnestic,musclerelaxation
Absorption
Distribution Highlylipidsolubleandproteinbound,verylowV
Metabolism Generallyactivemetabolites.
Elimination Renaleliminationofactiveandinactivemetabolites.
Resp ↓V ,↑RR,apnoea.
CVS ↓SVR,↓SBP,↓DBP,↑HR.TypicallystableCO.
CNS Hypnosis,sedation,anterogradeamnesia,anticonvulsant,↓CBF.↓MAC.
MSK Skeletalmusclerelaxation.
Metabolic ↓Adrenergicstressresponse.
ComparisonofBenzodiazepines
Property Midazolam Diazepam Clonazepam
Physicochemical
pKa6.5.StructureisdependentonsurroundingpH-atapH<4itsringstructureopensanditbecomeswatersoluble.
40%propyleneglycol.
RouteofAdministration PO/IV/IM. PO/IV/IM. PO.
Absorption 50%PObioavailability. GoodPObioavailability.
Distribution V 1.5L.kg ,95%proteinbound. 95%proteinbound.
MetabolismPartiallymetabolisedtooxazepamand1-α-hydroxy-midazolam.Clearance~7ml.kg .min .
Hepatictoallactivemetabolitesincludingoxazepam,temazepam,anddes-methyl-diazepam(hast βupto100hours).
Hepatictoinactivemetabolites.
Eliminationt β2-4hours,prolongedwithcirrhosis,CHF,obesityandinthe t β20-45hours.
A-
-
B+
D
T
D-1
-1 -1 1/2
1/21/2
Benzodiazepines
626
![Page 627: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/627.jpg)
elderly.
References
1. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.2. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.3. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.4. RangHP,DaleMM,RitterJM,FlowerRJ.RangandDale'sPharmacology.6thEd.ChurchillLivingstone.
Lastupdated2019-07-18
1/2
Benzodiazepines
627
![Page 628: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/628.jpg)
AntidepressantsSymptomsandmanagementofTCAoverdoseiscoveredunderTricyclicAntidepressantOverdose.
Antidepressantdrugsinclude:
TricyclicAntidepressants(TCAs)Mechanismofactionbymultipleeffects,including:
CompetitivelyinhibitreuptakeofNAand5-HTMuscarinicantagonismLeadstoanticholinergicsideeffects(drymouth,blurredvision,constipation,urinaryretention).H andH antagonismα antagonismNMDAantagonism
SelectiveSerotoninReuptakeInhibitors(SSRIs)Inhibitneuralreuptakeof5-HTPreferredoverTCAsas:
SimilareffectivenessBettersideeffectprofile
MonoamineOxidaseInhibitors(MAO-Is)Inhibitmonoamineoxidaseonexternalmitochondrialmembrane,increasingthelevelofamineneurotransmittersintheCNSandPNSTwoenzymesexist:
MAO-ADominantenzymeinCNSActsonserotonin,noradrenaline,adrenaline
MAO-BDominantinGITandplateletsResponsiblefor75%ofMAOactivityPreferentialmetabolismofnon-polaramines
MAO-IsclassifiedbytheirmechanismandselectivityNon-selective,irreversibleBindcovalentlytotheenzyme,permanentlyinactivatingit.
MayleadtohypertensivecrisiswhencatecholaminelevelsincreasedTyramineinfoodMetabolisedbyMAO-B.IndirectlyactingsympathomimeticsAbsolutelycontraindicated.
RiskofserotoninsyndromewithserotoninreuptakeinhibitorsInclude:
PhenelzineIsocarboxazidTranylcypromine
Enzymelevelswilltake2-3weekstorecoverfollowingcessationMAO-Aselective,reversible
HypertensivecrisisislesscommonMAO-Bunaffected-tyramineismetabolisedShortactingEnzymelevelsnormaliseafter24hoursofcessation.
Include:
1 21
Antidepressants
628
![Page 629: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/629.jpg)
MoclobemideMAO-Bselective
MuchlowerriskofhypertensivecrisisInclude:
SelegilineDiscontinuationsyndromemayoccurifabruptlyceased
Property TricyclicAntidepressants SelectiveSerotoninReuptakeInhibitors
MonoamineOxidaseInhibitors
Example Amitriptyline Fluoxetine
Uses Depression,treatmentofchronicpainandtrigeminalneuralgia Depression,anxiety
Treatmentresistantdepression.Nowlargelysupersededduetoside-effectprofile
Absorption HighPObioavailability HighPObioavailability
DistributionHighlylipidsolublewithHighV .Veryhighlyproteinbound-leadstointeractionswithwarfarin,digoxin,andaspirin
Highlyproteinbound,highV
Metabolism Hepaticwithactivemetabolites.Largeinterpatientvariability
Hepaticwithnon-linearkinetics
VenlafaxinedoesnotaffectCYP450enzymes.
Elimination Unaffectedbyrenalimpairment
Resp Drymouth
CVS
Posturalhypotension,↑HR.QTprolongationandwideningQRSinoverdose,witharrhythmiamorelikelywhenQRSexceeds0.16s.
LesscardiotoxicthanTCAs,mayprecipitateserotoninsyndrome
CNSSedation,blurredvision,loweredseizurethreshold.Excitation,followedbyseizuresanddepressioninoverdose.
IdenticalantidepressanteffecttoTCAs.Lesssedation
Renal Urinaryretention
GU SexualdysfunctionGreaterincidenceofsexualdysfunctioncomparedwithTCAs
GIT ConstipationGreaterincidenceofN/VcomparedwithTCAs
Other
Multiplecomplexdruginteractions,includingarrhythmiasandvariableBPwithsympathomimetics,centralanticholinergicsyndrome,serotoninsyndrome,andseizures.
↑Sensitivitytocatecholamines-suggestavoiding:-Indirectlyactingsympathomimetics-Ketamine-Surgicalstress
Continueduringperioperativeperiodtoavoidriskofdiscontinuationsyndrome.
D
D
Antidepressants
629
![Page 630: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/630.jpg)
SerotoninSyndrome
SerotoninsyndromeisexcessiveserotoninintheCNS,typicallyasaconsequenceofdruginteractions.Thesyndromemaybemild,moderate,orsevere,andpresentswithsomeorallof:
AlteredmentalstateConfusion
MotorchangesMyoclonusHyperreflexiaTremor
AutonomicinstabilityDiaphoresisShiveringFever
Serotoninsyndromeistypicallyself-limitingandresolveswithcessationofthedrug.
References
1. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.2. AltamuraAC,MoroAR,PercudaniM.Clinicalpharmacokineticsoffluoxetine.1994Mar;26(3):201-14.3. BromheadH,FeeneyA.Anaesthesia&PsychiatricDrugs-Antidepressants.AnaesthesiaTutorialoftheWeek(164).2009.
Lastupdated2019-07-18
Antidepressants
630
![Page 631: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/631.jpg)
AntipsychoticsAntipsychoticsaredrugsusedforthemanagementofpsychosesandthoughtdisorders.Theyhaveacomplicatedmechanismofactionwitheffectsonmultiplereceptors:
Centraldopamine(typicallyD ,butvarieswithagent)antagonismResponsiblefortheantipsychoticproperties5-HT antagonism
Otherreceptorswhicharequantitativelylessimportant:H antagonismα antagonismMuscarinicAChantagonism
Basedontheiraffinitytovariousreceptors,theyare(loosely)classifiedaseither:
Typicalor1 generationantipsychoticsHigheraffinityforD receptors(subsequentlylessblockadeof5-HT ),causingagreatereffecton'positive'symptoms'andagreaterincidenceofextrapyramidalsideeffectsAtypicalor2 generation,whichtypicallyhavefewermotoreffectsHavegreatereffectonnegativesymptoms.
CommonFeaturesofAntipsychotics
Property Drug
Uses Behaviouralemergencies,schizophrenia/psychosis
CVS QTprolongation
CNS Apathy,↓initiative,↓responsetoexternalstimuli,↓aggression.Nolossofintellectualfunction.
Endocrine ↑Prolactin(typicalantipsychotics)
Haeme Leukopeniaandagranulocytosis(predominantlyclozapine,butcanbeall)
Metabolic Weightgain,diabetes,hypercholesterolaemia(allatypical>typical)
OtherToxicities Neurolepticmalignantsyndrome,EPSE
NeurolepticMalignantSyndrome
AntipsychoticMalignantSyndromeisrareandpresentssimilarlytoMH,witharapidriseinbodytemperatureandconfusion.Ithasahighmortality(upto20%).
Extra-PyramidalSideEffects
MotordisturbancesfromantipsychoticusearetermedEPSEs,andaredividedintotwomaintypes:
AcuteDystonicReactionsareinvoluntarymovementsandparkinsoniansymptoms.Theyare:
MorecommonwithtypicalagentsDeclinewithongoinguseReversiblewithcessationoftheagent
TardivedyskinesiaissimilartoADR,except:
2
2
11
st
2 2
nd
Antipsychotics
631
![Page 632: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/632.jpg)
InvoluntarymovementsaremorepronouncedanddisablingItoccurswithlongtermuse(10-20years)Theyareirreversible,andworsenwhentherapyisstopped
ComparisonofAntipsychotics
Property Haloperidol Olanzapine Clozapine
Class Typical Atypical Atypical("3 gen")
Uses BehaviouralEmergencies BehaviouralEmergencies,Psychosis/Schizophrenia Treatmentresistantschizophrenia
Presentation Tablets,syrup,clearsolutionforinjectionat5mg.ml
Tablets,solutionforinjection Yellowtablet
RouteofAdministration PO/IM/IV PO/IM PO
Dosing 1-5mgIV,2-30mgIM,1-15mgPO IM5-10mg,PO5-20mg Mustbeprescribedbya
psychiatrist
Absorption 50%PObioavailability 60%PObioavailability Rapidabsorption
Distribution 92%proteinbound 93%proteinbound,V~14L.kg V 2L.kg
Metabolism Hepatictolargelyinactivemetabolites
Hepatictoinactivemetabolites
Mayobeyzero-orderkineticsattheupperlimitofthedoserange
Elimination Renalofmetabolites Renalofinactivemetabolites
Renalofactivedrug(~25%)andinactivemetabolites
CVS Hypotension Myocarditis(potentiallyfatal)
CNS Seizures
GIT Antiemetic Hepatitis
Haeme Agranulocytosis,thromboembolicdisease
ReferencesRangandDaleSmith,Scarth,SasadaCriticalCareDrugsManualhttp://lifeinthefastlane.com/book/critical-care-drugs/https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=8248https://www.ncbi.nlm.nih.gov/pubmed/8453823
Lastupdated2019-07-18
rd
-1
D-1 D-1
Antipsychotics
632
![Page 633: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/633.jpg)
AnticonvulsantsIngeneral,anticonvulsantsare:
WellabsorbedorallyHighlyproteinboundHepaticallymetabolisedbyCYP450enzymes,andinducetheirownmetabolism(aswellasthatofotherdrugs)RenallyeliminatedInteractwitheachother
Property Phenytoin SodiumValproate Carbamazepine Levetiracetam
UsesGTCS,partialseizures,trigeminalneuralgia,ventriculararrhythmias
PartialseizuresAntiepileptic,trigeminalneuralgia
GTCS,partialseizures,myoclonicseizures,seizureprophylaxis
Presentation
Capsules,syrup,solution.IVformulationincompatiblewithdextrose.
Tablets,syrup,solution
Tablets,suppositories,syrup
Tablets,oralliquid,IVliquid
RouteofAdministration PO,IV,IM PO,IV PO PO,IV(over15
minutes)
Dosing15-20mg.kg load,aimingplasmalevels10-20mcg.ml
300-1250mgBD 50-800mgBD
Typically1gloading,then500mgBDincreasingupto1.5gBD.Doseadjustedinrenalimpairment.
MechanismofAction
StabilisesNa channelsintheirinactivestate,inhibitinggenerationoffurtheractionpotentials.
StabilisesNachannelsintheirinactivestateandGABAergicinhibition
StabilisesNachannelsintheirinactivestateandpotentiatesGABA
Unknown,butdifferenttootherantiepilepticsandmayberelatedtoinhibitionofN-typeCa currents
Absorption SlowPOabsorption.PObioavailability90%
PObioavailability100%
95%PObioavailability
Near100%PObioavailability
Distribution Highlyproteinbound Highlyproteinbound
Highlyproteinbound
Nilsignificantproteinbinding,V ~0.5L.kg
Metabolism
Hepatichydroxylationwithhighlyindividualvariationindosing.Obeysfirst-orderkineticsinthetherapeuticrange,andzero-orderkineticsjustabovethetherapeuticrange.MetabolisedbyCYP450.Induceswarfarin,benzodiazepines,OCPmetabolism.Inhibitedbymetronidazole,chloramphenicol,isoniazid.Geneticpolymorphismresultsin
Hepatictoinactiveandactivemetabolites
HepaticHepatichydrolysistoinactivemetabolites
-1
-1
+ + +
2+
D-1
Anticonvulsants
633
![Page 634: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/634.jpg)
reducedmetabolismin5-15%ofpatients.
EliminationRenaleliminationofinactivemetabolitesandactivedrug
Renaleliminationofmetabolitesandactivedrug
Renalelimination
Renalofactivedrug(majorroute)andmetabolite(minorroute)
CVS
↓BP,heartblock,andasystolewithrapidadministration,antiarrhythmicproperties
Antiarrhythmic
CNS
↑Seizurethreshold,paraesthesia,ataxia,nystagmus,slurredspeech,tremor,vertigo.
↑Seizurethreshold ↑Seizurethreshold
↑Seizurethreshold,anxiolytic.Minimal↓inseizurethresholdoncessation.
RenalWaterretentionfromADH-likeeffects
RarelyprecipitatesAKI
GITHepatotoxicity(idiosyncratic).Nauseaandvomiting.
Hepatotoxicity.
Haeme Aplasticanaemiaandotherblooddyscrasias
Thrombocytopenia,leukopenia(requiresregulartesting)
Thrombocytopenia
Immune Rash SJS
Metabolic Hyperammonaemia
Other
Requiresmonitoringduetonarrowtherapeuticwindowandsignificantpharmacokineticvariation.Gumhyperplasia.Teratogenic.Mayprecipitateporphyria.
Reducesefficacyofaminosteroids.Teratogenic.
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.3. CICMMarch/May20104. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.5. Levetiracetam-DrugInformation.FDA.2009.
Lastupdated2019-07-20
Anticonvulsants
634
![Page 635: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/635.jpg)
GABAAnaloguesGabapentinandpregabalin:
ArebothstructuralanaloguesofGABAHavenodirectactionontheGABA receptorActontheα δsubunitofvoltagegatedCa channelsintheCNS,inhibitingneurotransmitterreleaseMayhavesomeNMDAreceptoractivity
ComparisonofGABAAnalogues
Property Gabapentin Pregabalin
Uses Focalseizures,neuropathicpain Focalseizures,neuropathicpain,anxiety
RouteofAdministration PO
Dosing 100mgTDS,increasingupto1200mgTDS 50mgBD/TDS,upto600mgindivideddoses(BDorTDS)
Absorption PObioavailabilityof60%,decreaseswithincreasingdoseduetosaturationoftransporter
90%PObioavailability,delayedbyfoodbutunaffectedbydose
Distribution Minimallyproteinbound Minimallyproteinbound
Metabolism Notmetabolised Notmetabolised
Elimination Renaleliminationofactivedrug,t β6hours Renaleliminationofactivedrug,t β6hours
CNS Drowsiness,ataxia,psychiatricsymptoms Confusion,psychiatricsymptoms,drowsiness
GIT N/V
References
1. TaylorCP,AngelottiT,FaumanE.Pharmacologyandmechanismofactionofpregabalin:thecalciumchannelalpha2-delta(alpha2-delta)subunitasatargetforantiepilepticdrugdiscovery.EpilepsyRes.2007Feb;73(2):137-50.Epub2006Nov28.
2. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.
Lastupdated2019-07-18
A2
2+
1/2 1/2
GABAAnalogues
635
![Page 636: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/636.jpg)
InhalationalAnaestheticAgentsDescribetheeffectsofinhalationalagentsonthecardiovascular,respiratoryandcentralnervoussystems
Describethetoxicityofinhalationalagents
Describethecomparativepharmacologyofnitrousoxide,halothane,enflurane,isoflurane,desflurane,sevoflurane,xenonandether
Thissectioncoversfeaturesandstructuresofinhalationalanaesthetics.Structure-activityrelationshipsarecoveredunderinhalationalanaesthetics.
CommonFeaturesofInhalationalAgents
Property Action
MetabolismHepaticCYP450(CYP2E1)metabolisesC-halogenbondstoreleasehalogenions(F ,Cl ,Br ),whichcanbenephrotoxicandhepatotoxic.TheC-FbondisminimallymetabolisedcomparedtotheC-Cl,C-Br,andC-Ibonds.Allagentsundergohepaticoxidation,exceptforhalothanewhichisreduced.
RespAllhalogenatedagents↓V and↑RR,withanoverall↓inMVandthereforecausePaCO to↑;and↓sensitivityofcentralrespiratorycentrestoCO .ImpairmentofHPVmayworsenV/Qmatchingand↑shunt.
CVS ↓MAP(predominantlyby↓inSVRduetoNOreleaseandCa channelblockade),↓inotropyduetoCa channelblockade.
CNS
Hypnosis.↓CMRO .Above1MACthereisuncouplingoftheCBF-CMRO relationship,andCBF↑despite↓CMRO duetocerebralvasodilation.ICPmaymirrorCBFchanges.
Allexcepthalothanehavesomeanalgesiceffect.↓EEGfrequencysuchthatθ-andδ-wavedominatetheEEGasdepth↑.Maycauseburstsuppression.
MSK MusclerelaxationviablockadeofCa channels.AdditionalaugmentationoftheeffectsofNMBDduetoskeletalmusclevasodilation.MayprecipitateMH.
Renal
Dosedependent↓inRBF,GFR,andUOsecondaryto↓inMAPandCO.
FluorinatedethersproduceF ionswhenhepaticallymetabolised,whichmayproducehigh-outputrenalfailureatserumconcentrations>50μmol/L.Thisisprobablyonlyaconcernwithmethoxyflurane(asithassignificant(>70%)hepaticmetabolism)whenusedatanaestheticdoses.
GIT ↓Hepaticbloodflow.
GU Tocolysis.
ToxicEffects Decreasedfertilityandincreasedriskofspontaneousabortioninoperatingtheatrepersonnel.
ComparisonofCommonInhalationalAgents
Property Sevoflurane Isoflurane Desflurane
Pharmaceutics
Minimallysoluble,lightstable,notflammable.Formulatedwith300ppmofH OtopreventformationofHFacidbyLewisacidsinglass.
Solubleinrubber,lightstable,notflammable.
Lightsensitive,flammableat17%.
- - -
T 22
2+2+
2 22
2+
-
2
InhalationalAnaestheticAgents
636
![Page 637: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/637.jpg)
Structure
MolecularWeight 200.1 184.5 168.0
Boilingpoint 58.5°C 48.5°C 23.5°C
SVP(mmHg)at20°C 158 239 669
Blood:gascoefficient 0.7 1.4 0.42
Oil:gascoefficient 50 98 29
MAC 2 1.15 6.6
Metabolism
3-5%CYP2E1metabolismtohexafluoroisopropanolandinorganicF (whichmaybenephrotoxic)
0.2%hepatictonontoxicmetabolites
RespBronchodilation,↓MV.Smallest↓inV andthereforesmallest↑inPaCO
Bronchodilation,airwayirritability.↓MV(greaterthanhalothane)with↑inRR
Airwayirritabilitymanifestascoughingandbreath-holding,↑secretions
CVS
↑QT,↓SVRcausing↓MAPwithoutareflex↑HR.Inotropyunchanged.Smallest↓inBPofanyinhalationalagent.
Reflex↑HRdueto↓MAPfrom↓SVR.Small↓inotropyandCO,equivalenttosevofluranebutgreaterthandesflurane.Maycausecoronarysteal.
Minimal↓inotropy(leastofallinhalationalagents),butgreater↓inSVRandBPthansevoflurane.↑inHR,withabiggerincreaseat>1.5MAC.
Large↑inSNStonewithrapid↑indesfluraneconcentration.
CNS
↑Post-operativeagitationinchildrencomparedtohalothane.Smallest↑inCBFat>1.1MAC,withnoincreaseinICPupto1.5MAC.Cerebralautoregulationintactupto1.5MAC.
Bestbalanceof↓CMROfor↑inCBF.
ToxicEffects
SevofluraneinteractswithsodalimetoproduceCompoundA(aswellasBthroughE,whichareunimportant),whichisnephrotoxicinrats(butnot,itseems,inhumans).
-CHF groupmayreactwithdrysodalimetoproduceCO.
Desfluranehasmuchgreatergreenhousegaseffectsthansevofluraneorisoflurane.
ComparisonofUncommonInhalationalAgents
-
T2
2
2
InhalationalAnaestheticAgents
637
![Page 638: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/638.jpg)
Property Enflurane Halothane Xenon
Pharmaceutics
Structuralisomerofisofluranewithdifferentphysicalproperties
Lightunstable.Corrodessomemetalsanddissolvesintorubber.
Notflammable.Veryexpensivetoproduce.
Structure
MolecularWeight 184.5 197 131
Boilingpoint 56.5°C 50.2°C -108°C
SVP(mmHg)at20°C 175 243 -
Blood:gascoefficient 1.8 2.4 0.14
Oil:gascoefficient 98 224 1.9
MAC 1.7 0.75 71
Metabolism
~25%undergoesoxidativephosphorylationbyCYP450systems,producingtrifluoroaceticacid,whichbindstoproteinandcancauseaT-cellmediatedhepatitis,whichcanbefatalin~1/10,000anaesthetics.
Notmetabolised.
RespLargest↓inV ,thereforelargest↑inPaCO
↑InRR,↓inV withoverallunchangedPaCO
↓RR,↑inV suchthatMVisconstant.3xasdenseand1.5xasviscousasN O,whichincreaseseffectiveairwayresistance.Doesnotappeartocausediffusionhypoxia.
CVSGreatest↓ininotropy,HR,SVR,andMAP.Significant↑incatecholaminesensitivity.
MorestableMAP,↓HR
CNS
Produces3Hz"spikeandwave"EEGpatternathighconcentrations,resemblinggrandmalseizures
Greatest↑inCNSbloodflowat>1.1MAC Analgesic,↑PONV
MSK Musclerelaxationwhen>60%.DoesnottriggerMH.
Renal
Directnephrotoxicity,potentiallyrelatedtofluoride(thoughthisassociationisnotpresentwithotheranaestheticagents)
GU Leasttocolyticeffect
Toxiceffects ProducesF ions
Hepaticdamagemaybe:-Reversibletransaminitis-Fulminanthepaticnecrosis,witha
T
2
T2
T
2
-
InhalationalAnaestheticAgents
638
![Page 639: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/639.jpg)
mortalityof50-75%.
References
1. KhanKS,HayesI,BuggyDJ.PharmacologyofanaestheticagentsII:inhalationanaestheticagents.ContinuingEducationinAnaesthesiaCriticalCare&Pain,Volume14,Issue3,1June2014,Pages106–111.
2. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.3. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.4. MillerRD,ErikssonLI,FleisherLA,Weiner-KronishJP,CohenNH,YoungWL.Miller'sAnaesthesia.8thEd(Revised).
ElsevierHealthSciences.PeckandHill5. LeslieRA,JohnsonEK,GoodwinAPL.DrPodcastScriptsforthePrimaryFRCA.CambridgeUniversityPress.2011.6. LawLS,LoEA,GanTJ.XenonAnesthesia:ASystematicReviewandMeta-AnalysisofRandomizedControlledTrials.
AnesthAnalg.2016Mar;122(3):678-97.
Lastupdated2017-10-07
InhalationalAnaestheticAgents
639
![Page 640: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/640.jpg)
NitrousOxideDescribethepharmacologyofnitrousoxide
Describethecomparativepharmacologyofnitrousoxide,halothane,enflurane,isoflurane,desflurane,sevoflurane,xenonandether
Property NitrousOxide
Pharmaceutics
Non-flammablebutsupportscombustion.Producedbyheatingammoniumnitrateto250°C.PotentialcontaminantsincludeNH ,N ,NO ,andHNO .
Storedasaliquid,suchthatthegaugepressureisonlyaccuratewhenallremainingN Oisinthegaseousphase.
ThefillingratioisthemassofN Ointhecylindercomparedtothemassofwateritcouldhold,andis0.75intemperateregions,and0.67inwarmerregions.
MolecularWeight 44
Boilingpoint -88°C
CriticalTemperature/Pressure 36.5°C/72bar
SVP(at20°C) 39,000mmHg
Blood:gascoefficient 0.47
Oil:gascoefficient 1.4
MAC 105(MACawake68)
MechanismofAction
Severaldifferentmechanisms,including:-Stimulatesdynorphinrelease(actsatKOPreceptor)-PositiveallostericmodulatoratGABA receptor-NMDAantagonist
Metabolism <0.01%hepaticreduction.
Resp Diffusionhypoxiaduetosecondgaseffect.Small↓inV ,↑inRRsuchthatMVisunchanged.
CVS ↑SNStone,mildmyocardialdepression.↑PVR-bewareinpulmonaryhypertension.
CNS Powerfulanalgesicwhen>20%,viaendorphinandenkephalinmodulation,andonopioidreceptors.↑CBF.Lossofconsciousnesscommonat80%.1.4xrelativeriskofPONV
GU Nottocolytic-usefuladjuvantinGAcaesariansectiontoreducevolatileanaestheticuse
GIT Expansion
Metabolic ↑Homocysteine.
ToxicEffects
MoresolublethanN meansitwillrapidlydiffuseintoair-filledcavities,increasingthevolumeofcompliantcavities(PTHx,bowel),andincreasingthepressureofnon-compliantcavities(middleear).
Prolongeduse(>6hours)oxidatescobaltioninvitaminB ,preventingitsactionasacofactorformethioninesynthetase,preventingDNAsynthesis.Thisleadsto:-Megaloblasticchangesinbonemarrow-Agranulocytosis-Peripheralneuropathy-Possibleteratogenicity-avoidinearlypregnancy
Greenhousegas.
3 2 2 3
2
2
A
T
2
12
NitrousOxide
640
![Page 641: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/641.jpg)
EntonoxEntonoxisa50/50mixtureofnitrousoxideandoxygen,usedasanalgesiainlaborandminorprocedures.
Property Entonox(50%O ,50%N O)
Pharmaceutics Thegasesdissolveeachotherandbehavedifferentlythanwouldbeexpectedfromtheirindividualproperties.ThisisthePoyntingeffect.
CriticalTemperature/Pressure
Pseudocriticaltemperatureof-6°C,belowwhichitwillseparateintoliquid50%N O(withsomedissolvedO ),andgaseousO .Thisismostlikelytooccurat117bar,andcanleadtodeliveryofahypoxicmixture.
Deliveryofahypoxicmixispreventedby:-Storingcylindershorizontally(↑areafordiffusion)-Storingcylindersattemperatures>5°C-Usingadiptubesothatliquid50%N Oisusedbeforethegaseousmixture
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.3. ANZCAFebruary/April20064. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.5. EmmanouilDE,QuockRM.AdvancesinUnderstandingtheActionsofNitrousOxide.AnesthesiaProgress.2007;54(1):9-
18.doi:10.2344/0003-3006(2007)54[9:AIUTAO]2.0.CO;2.6. Hendrickx,J.,Peyton,P.,Carette,R.,&DeWolf,A.(2016).Inhaledanaestheticsandnitrousoxide.EuropeanJournalof
Anaesthesiology,33(9),611–619.7. BrownS,SneydJ.Nitrousoxideinmodernanaestheticpractice.2016.BJAEducation,16(3),87–91.
Lastupdated2019-07-18
2 2
22 2
2
NitrousOxide
641
![Page 642: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/642.jpg)
Opioids
CommonFeatures
Property Effect
Uses Analgesia,sedation,eliminationofsympatheticresponsetolaryngoscopy/surgicalstressresponse
Resp ↓CNSsensitivitytoCO causingrespiratorydepression(↓RR>↓V )-↑relianceonhypoxicdrive(thereforerespiratorydepressionmaybepotentiatedbyhighFiO )
CVS ↓HR.May↓BPduetohistaminerelease(lesswithsyntheticagents).↑PVR
CNS Sedation,euphoria.NauseaandvomitingduetoCTZstimulation.MeiosisduetostimulationoftheEdinger-Westphalnucleus.↓MACupto90%
Renal ↓RPF,↑ADH,↑uretericandsphinctertone
MSK Musclerigidity,pruritus(especiallywithintrathecaladministration)
Metabolic ↓ACTH,prolactin,gonadotrophichormonesecretion.↑ADHsecretion
GIT ↓PeristalsisandGITsecretionswithsubsequentconstipation
Immunological Impaired:chemotaxis,lymphocyteproliferation,andantibodyproduction
ComparisonofNaturallyOccurringOpioids
Property Morphine
Receptor MOP,KOP
RouteofAdministration SC/IM/IV/Intrathecal
pKa 8.0,23%unionisedatphysiologicpH.
Absorption Low(relative)lipidsolubility-sloweronsetandSCabsorption.POpreparationsabsorbedinsmallbowel,bioavailability30%-highfirstpassmetabolism.
Distribution ~35%proteinbinding.V 3.5L.kg
Clearance(ml.kg.min ) 15
Metabolism Hepaticglucuronidationto70%inactivemorphine-3-glucuronideand10%activemorphine-6-glucuronide,whichis13xaspotentasmorphine.t βof160minutes.
Elimination Renaleliminationofactivemetabolites-accumulationinrenalfailure
TimetoPeakEffect(IV) 10-30minutes
Duration(IV) 3-4hours
EquianalgesicDose(IV,to10mgIVmorphine) 10mg
ComparisonofSemisyntheticOpioids
2 T2
D-1
-1 -1
1/2
Analgesics
642
![Page 643: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/643.jpg)
Property Oxycodone Buprenorphine
Receptor MOP,KOP,DOPPartialMOPagonist,KOPantagonist(antanalgesiceffect)
RouteofAdministration PO/IV Topical
pKa 8.5,<10%isunionisedatphysiologicpH.
Absorption PObioavailability60-80% Significant1stpassmetabolism
DistributionAslipidsolubleasmorphine,45%proteinbound,V 3L.kg .MorerapidonsetthanmorphinedespitehigherpKapotentiallyduetoactiveCNSuptake
Clearance(ml.kg.min ) 13
MetabolismHepaticdemethylationtonoroxycodone(80%,viaCYP3A)andthemorepotentandactiveoxymorphone(20%,viaCYP2D6).t β200minutes.
Hepatictoactivenorbuprenorphine
Elimination Renaleliminationofactivedrugandmetabolites70%biliary,30%renalelimination,t β40hours
TimetoPeakEffect(IV) 5minutes
Duration(IV) 4hours
EquianalgesicDose(IV,to10mgIVmorphine)
10mg.Note10mgPOoxycodoneis≈15mgPOmorphineduetohigherfirstpassmetabolismofmorphine
ComparisonofSyntheticOpioids
Property Fentanyl Alfentanil Remifentanil
Receptor MOP MOP MOP
RouteofAdministration SC/IM/IV/Epidural/Intrathecal/Transdermal IV
IV(containsglycine,socannotbeadministeredintrathecally)
pKa 8.4,<10%unionisedatpH7.4 6.5,90%unionisedatpH7.4conferringrapidonset
7.3means58%unionisedatphysiologicpH.
AbsorptionRapidonsetofaction(<30s,peakat5min)duetolipidsolubility(600xthatofmorphine).
90xmorelipidsolublethanmorphine,butmorerapidonsetthanfentanyl.Thisisdueto:1.LowpKameansagreaterproportionisunionisedatphysiologicalpH.2.Lowerpotencyofalfentanilcomparedtofentanylmeansagreaterdoseisrequired(Bowman'sPrinciple)
20xmorelipidsolublethanmorphine.
D-1
-1 -1
1/2
1/2
Analgesics
643
![Page 644: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/644.jpg)
Distribution600xaslipidsolubleasmorphineconferringalargerV (4L.kg ).85%proteinbound.
90xaslipidsolubleasmorphine,smallV of0.6L.kg .90%proteinbound
20xaslipidsolubleasmorphine,verysmallV of0.4L.kg .70%proteinbound.CSHTisconstantduetorapidmetabolism.
Clearance(ml.kg .min ) 13 6 40
Metabolism
Significantfirstpasspulmonaryendothelialuptake.Hepaticdemethylationtoinactivenorfentanyl.t βof190minutes,longerthanmorphineduetohigherlipidsolubilityandV .
Shortereliminationt βthanfentanyl(100minutes)despitelowerclearanceduetolowerV .ProlongedwithadministrationofmidazolamduetoCYP3A3/4competition.
Rapidmetabolismbyplasmaandtissueesterases-t β10minutes
Elimination Renaleliminationofinactivemetabolites Renaleliminationofmetabolites
Renalofinactivemetabolites
TimetoPeakEffect(IV) 5minutes 90seconds 1-3minutes
Duration(IV)
Variabledependingondoseanddistribution.Withdoses>3μg.kg tissuesbecomesaturatedandthedurationofactionissignificantlyprolonged
5-10minutesOffset5-10minutesfromceasinginfusion
EquianalgesicDose(IV,to10mgIVmorphine)
150mcg 1mg 50mcg
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.3. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.4. ANZCAJuly/September20105. SchugSA,PalmerGM,ScottDA,HalliwellR,TrincaJ.AcutePainManagement:ScientificEvidence.4thEd.2015.
AustralianandNewZealandCollegeofAnaesthetistsandFacultyofPainMedicine.
Lastupdated2019-07-18
D-1 D-1
D-1
-1 -1
1/2
D
1/2
D
1/2
-1
Analgesics
644
![Page 645: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/645.jpg)
COXInhibitorsCyclo-oxygenaseinhibitorsaretypicallyusedtotreatmildtomoderatepain.OralCOXinhibitorstypicallyhave:
RapidabsorptionHighproteinbindingLowV
MechanismofAction
Therearetwo(ish)isoenzymesofCOX:
COX-1Importantforhomeostaticfunction.COX-2Inducedwithtissuedamageandcontributestoinflammation.COX-2:
Existsinthevascularendotheliumwhereitsynthesisesprostacyclin(whichopposestheactionofthromboxanes)Inhibitionmayresultinarelativeabundanceofthromboxane,causingplateletaggregationandvasoconstriction
COX-3VariantofCOX-1whichexistscentrallyandmediatestheanalgesicandantipyreticeffectsofparacetamol.
Effectsoccurdueto:
DecreaseinendoperoxidasesInhibitedbyCOX.Increaseinotherarachidonic-acidderivedfactorsDuetothediversionofarachidonicaciddownotherpathways.
COXinhibitionhasdifferenteffectsindifferenttissues:
PreventssubsequentconversionofprostaglandinstothromboxaneA andPGIPeripherally,inhibitionofprostaglandinsynthesisisanti-inflammatoryCentrally,itisanti-pyreticInthestomach,itdecreasesmucousproductionandleadstomucosalulceration
Aspirin(anon-specificCOXinhibitor),preventsproductionofboththromboxaneA andPGIAsplateletshavenonucleus,theCOXinhibitionremainsfortheentiretyoftheplateletlifespanEndothelialcellswillproducenewCOXwithinhours,andsoitsanti-inflammatoryeffectsaretemporary
AdverseEffects
Asthma/BronchospasmSecondarytoincreasedleukotrienesynthesisduetoincreasedarachidonicacidlevels.Occursin20%ofasthmaticswithNSAIDuse.
PlateletdysfunctionAconsequenceofCOX-1inhibitiononly,andmayresultinincreasedperioperativebleedingrisk(thoughdecreasedAMIandCVArisk).
Thromboticevents,includingMIandCVARiskisgreaterwithCOX-2inhibitors,duetoselectiveinhibitionofprostacyclin.withNNHfornon-fatalMIbeing500patient-years,andNNHforfatalMIbeing1000patient-years.
D
2 2
2 2
COXInhibitors
645
![Page 646: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/646.jpg)
ImpairedGFROccursasaconsequenceofuninhibitedafferentarteriolarconstriction.Worsewithconcurrenthypovolaemia,renalarterystenosis,orconcurrentACE-Iuse.
GastricerosionAconsequenceofimpairedmucosalsecretionthroughCOX-1inhibition.Thiscanresultinpain,anaemia,orfatalbleed.Ingeneral,riskofgastricerosionis(fromhighesttolowestrisk):
KetorolacDiclofenac/naproxenIbuprofen(<1.2g/day)COX-2Inhibitors
TransaminitismayoccurfollowingNSAIDuse
ComparisonofCOXInhibitors
Characteristic Aspirin Diclofenac Ketorolac Ibuprofen Celecoxib Parecoxib
MechanismofAction
Irreversibleinhibitionofplateletthromboxaneproduction.Asplateletsareanucleate,theyareunabletoregeneratethromboxane.
Non-selectiveCOXinhibitor
Non-selectiveCOXinhibition
Non-selectiveCOX-inhibition
COX-2inhibitor(30:1infavourofCOX-2)
COXinhibitor(61:1infavourofCOX
Uses
Preventionofarterialthromboembolism,MI,CVA,migraine,analgesia,others(e.g.Still'sdisease)
Mild-to-moderatepain
Potentanti-analgesic,minimalanti-inflammatoryproperties
Mild-to-moderatepain
Analgesia,particularchronicarthriticpain
Acuteinflammatorypain
Distribution
85%proteinbound.WeakacidwithapKaof3,unionisedinthestomachandionisedatphysiologicalpH
97%proteinbound
AbsorptionGastricabsorption(pKa3)leadstorapidonset.
Metabolism
Hepaticmetabolismtosalicyluricacidandglucuronides.Mayhavezero-ordereliminationinoverdose.
CYPtoinactivemetabolites
CYP2C9toinactivemetabolites
CYP2C9toinactivemetabolites
Elimination
Renal.Eliminationmaybeincreasedwithurinaryalkalinisation.
Low-dose(100mg
COXInhibitors
646
![Page 647: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/647.jpg)
Dose
daily)selectivelyinhibitsplateletCOX,whilstpreservingendothelialCOX,resultingindecreasedplateletaggregationwhilstmaintainingvasodilation.300-900mgforanalgesia/migraine.
50mgBD/TDS
15-30mgIM/IVQ6H
400-800mgTDS,or10mg/kg
100-200mgBD 20-40mgBD
Route PO PO/PR/IM/IVIM/IV(off-labelinAustralia)
PO/PR PO IV
Respiratory
Aspirinuncouplesoxidativephosphorylation,increasingOconsumptionandCO production.Italsomaystimulate,and(athigherdoses)depresstherespiratorycentre.Inoverdose,thesearesignificant,andmayresultinamixedrespiratoryandmetabolicacidosis.
CVSMIandCVAriskreduction.Increasedbleeding.
RiskofMIsimilartoCOX-2inhibitors.LocalthrombuswithIVinjection.
Lowerdosenotassociatedwithprothromboticevents.
UncleareffectonCVAandMI,butrecommendedtoavoiduseinIHD/CVD
UncleareffectonCVAandMI,butrecommendedtoavoiduseinIHD/CVD
Metabolic
Reye'ssyndromeismitochondrialdamage,hepaticfailure,andcerebraloedema(andencephalopathy)inchildren<12.Mortality40%.
References
PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.
Lastupdated2019-07-18
2
2
COXInhibitors
647
![Page 648: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/648.jpg)
TramadolTramadolisananalgesicagentwithacomplicatedmechanismofaction:
Actionatallopioidreceptors,butparticularlyMOP,causinganalgesiaaswellasnauseaandvomitingInhibits5-HTreuptakewhichprovidesdescendinginhibitoryanalgesiaInhibitsNAreuptakedescendinginhibitoryanalgesiaNMDAreceptorantagonist
Properties Tramadol
Class Cyclohexanolderivative.Racemicmixtureof(+)TramadolwhichhasgreaterMOPand5HTreuptakeeffects,and(-)Tramadol,whichmediatesNAreuptakeinhibition
Uses Analgesia
Presentation Racemicmixture-eachisomerhascomplementaryeffects.IVsolutionisclearat50mg.ml
RouteofAdministration PO/IV/Topical
Dosing 50-100mgQID.Potency1/5 thatofmorphine.
Absorption Bioavailability70%
Distribution V 4L.kg
Metabolism Hepatictoactiveandinactivemetabolites
Excretion Urinaryofpredominantlyinactivemetabolites,t β300minutes
Respiratory Minimalrespiratorydepression
CVS AvoidconcomitantMAO-IusegivenNAreuptakeinhibition
CNS IncreasedseizureriskinthosewithepilepsyorconcurrentSSRI/SNRI/TCAuse.Minimaladdictionpotential
GIT N/V
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.
Lastupdated2019-07-18
-1
th
D-1
1/2
Tramadol
648
![Page 649: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/649.jpg)
ParacetamolParacetamolananalgesicandantipyreticwhichistypicallyclassedasanNSAID,thoughitisuniqueandimportantenoughtogetitsownpage.Ithasanumberofmechanismsofaction:
Non-selectiveCOXinhibition,includingCOX-3ThisconferssomeoftheanalgesicpropertiesInhibitionofcentralprostaglandinsynthesisThisconferstheantipyreticeffectbyinhibitingprostaglandinEsynthesisintheanteriorhypothalamusinresponsetopyrogensSerotonergicinhibitionProvidessomeadditionalanalgesicactionCannabinoidinhibitionProvidessomeadditionalanalgesicactionviaendocannabinoidreuptakeinhibition.
Property Effect
Class NSAID,acetanilidederivative
Uses Analgesia,antipyretic
Presentation Tablets,capsules,syrup,clearcolourlesssolutionforIVadministration
RouteofAdministration PO/PR/IV
Dosing 10-15mg.kg Q4Hupto90mg.kg .day
Onset IV:5mins,peakat40minsPO/PR:40mins,peakat1hour
Absorption Rapidabsorption(viasmallbowel,thereforeproportionaltogastricemptying),variablebioavailability(upto90%)-greaterbyPRroute
Distribution 10%proteinbound,smallV :0.5-1L.kg (thoughlargerthanotherNSAIDs)
Metabolism Predominantlyhepaticglucuronidation.However,10%ismetabolisedtoNAPQIbyCYP2E1whichishepatotoxic.
Elimination Activesecretionintorenaltubules-considerdosereductioninrenalimpairment
Resp Mayexacerbateanalgesicasthmaduetoglutathionedepletion
CNS Excellentanalgesia.Synergisticwithotheranalgesics,resultinginagent-sparingeffectandreducedsideeffects
Metabolic Antipyretic
Haeme Cytopaenias(rare)
ToxicityParacetamolispartiallymetabolisedtothetoxicN-acetyl-p-amino-benzoquinoneimine(NAPQI)
InnormalcircumstancesthisrapidlyconjugatedwithglutathioneIntoxicity,glutathioneisexhaustedNAPQIthencovalentlybindstocriticalproteinsinhepatocytes,causingcentrilobularhepaticnecrosisandcelldeath
-1 -1 -1
D-1
Paracetamol
649
![Page 650: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/650.jpg)
Toxicdoses:>200mg.kg inasingleingestionRepeatedingestionof>150mg.kg .day fortwodays>100mg.kg .day forthreedays
Riskfactorsfortoxicity:Glutathionedeficiency
ExtremesofageMalnutritionHepaticdysfunction
Enzymeinducers:Anti-epileptics
CarbamazepinePhenytoinPhenobarbitone
RifampicinETOHOCP
FeaturesofOverdose
ConsciousNausea,vomiting,andepigastricpainHaemolyticanaemiaDistributiveshockHyperglycaemiaLate(>48hours)hepaticfailureLater(3-5days)coagulopathyFulminanthepaticfailure(3-7days)
TreatmentofOverdose
Activatedcharcoalwithtabletingestionifseenwithin1hourofingestion.
SerumparacetamolleveltodeterminerequirementforNAC(N-acetylcysteine)basedonthenomogramIVNACisusedasitisaglutathioneprecursor,replenishingdepletedglutathioneandfacilitatingfurtherconjugationofNAPQI
References1. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.2. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.3. ParacetamolPoisoning.RoyalChildren'sHospital.4. HinsonJA,RobertsDW,JamesLP.MechanismsofAcetaminophen-InducedLiverNecrosis.Handbookofexperimental
pharmacology.2010;(196):369-405.
Lastupdated2019-07-18
-1-1 -1
-1 -1
Paracetamol
650
![Page 651: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/651.jpg)
Paracetamol
651
![Page 652: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/652.jpg)
Antimuscarinics(Cardiac)AntimuscarinicsusedforbronchodilationarecoveredunderAntimuscarinics(Respiratory),whilstatropineiscoveredseparately.
Antimuscarinicsareascompetitive,reversibleantagonistsofAChatthemuscarinicreceptor.Theyaredividedinto:
NaturallyoccurringtertiaryaminesThesecancrosstheblood-brainbarrier,andhavecentraleffects.
AtropineHyoscine
SyntheticquaternaryaminesDonotcrosstheblood-brainbarrier.
Glycopyrrolate
Property Glycopyrrolate Hyoscine
Class Quaternaryamine.Muscarinicantagonist Tertiaryamine
Uses Bradycardia,antisialagogue Antisialagogue,motionsickness
Presentation Clear,colourlesssolutionat200μg.ml .Incompatiblewithdiazepamandthiopentone.
Racemic,onlyL-isomeractive
RouteofAdministration IV/IM PO,SC,IV/IM
Dosing 200-400μg 20-40mgIVslowpushorIM
Absorption MinimalPOabsorption-notusedviathisroute. <50%PObioavailability
Distribution CrossesplacentabutnotBBB,V 0.5L.kg V 2L.kg
Metabolism Minimalhepatichydrolysis Extensivemetabolismbyhepaticesterases
Elimination Renalof85%unchangeddrug Renalofmetabolites
Resp Bronchodilation,antisialagogue Bronchodilation,greatestantisialagogueeffect
CVSInitialbradycardiaduetopartialagonisteffect.Reversesvagalcausesofbradycardia,maycausetachycardiaindoses>200μg.HRpeaksat3-9minutesfollowingadministration.
Leastlikelyanticholinergictocausetachycardia
CNSMostlikelyanticholinergictocausecentralanticholinergicsyndrome
MSK Anhydrosis
GIT Reducedoralandgastricsecretions,andgastricmotility
Reducedoralandgastricsecretions,andgastricmotility.Increasesbiliaryperistalsis
GU Difficultmicturition
References
-1
D-1
D-1
Autonomic
652
![Page 653: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/653.jpg)
1. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.2. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.
Lastupdated2018-07-29
Autonomic
653
![Page 654: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/654.jpg)
AnticholinesterasesAnticholinesterasesantagoniseAChE,decreasingthebreakdownofAChandthereforeincreasingitsavailabilityatthe:
NicotinicreceptorIncreasesmusclestrength.
Reversalofnon-depolarisingneuromuscularblockadeMuscarinicreceptorIncreasesparasympathetictone.
Anticholinesterasescanbe:
ReversibleFormacarbamylatedenzymecomplexIrreversible
Property Neostigmine Organophosphates
Class Quaternaryamine,formscarbamylatedenzymecomplex Irreversibleanticholinesterase
Uses Reversalofnon-depolarisingNMB,myastheniagravis,analgesia Insecticides,pesticides,chemicalweapons
Presentation Clear,colourless,lightstablesolutionat2.5mg.ml
RouteofAdministration PO,IV,intrathecal Topical
Dosing 0.05mg.kg forreversal,15-30mgPOforMG
Absorption LowPObioavailability Rapidtopicalabsorptionduetohighlipidsolubility
Distribution DoesnotcrossBBB,V 0.7L.kg CrossesBBB
Metabolism Majoritybyplasmaesterasestoquaternaryalcohol,withsomehepaticmetabolism Notmetabolised
Elimination 55%unchangedinurine t αofweeks
Duration 50minutes UntilnewAChEissynthesised
Resp Bronchospasm,↑secretion Bronchospasm,↑secretion
CVS ↓HR(maybeprofound),↓CO ↓HR,↓CO
CNS N/Vandanalgesicwhenadministeredintrathecally,cerebralvasoconstriction Centralcholinergicsyndrome
MSK ReversalofNMB,↑fasciculations,↑sweating,maycauseparalysis Paralysis
GIT ↑Peristalsis,↑LoStone,N/V ↑Peristalsis,↑LoStone,N/V
Other Muscarinicreceptorsaffectedatlowdose,nicotinicreceptorsathighdose
Maybereversedininitialstages(beforeorganophosphate-AChEcomplexhas'aged')withpralidoxime
-1
-1
D-1
1/2
Anticholinesterases
654
![Page 655: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/655.jpg)
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. ANZCA2007Feb/April3. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.4. Mahmoud,AhmedAbdelaalAhmed,AmrZakiMansour,HanyMahmoudYassin,HazemAbdelwahabHussein,Ahmed
MoustafaKamal,MohamedElayashy,MohamedFaridElemady,etal.‘AdditionofNeostigmineandAtropinetoConventionalManagementofPostduralPunctureHeadache:ARandomizedControlledTrial’127,no.6(2018):6.
Lastupdated2019-07-18
Anticholinesterases
655
![Page 656: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/656.jpg)
DepolarisingNMBsSuccinylcholinebindstothenicotinicAChreceptorcausingdepolarisation.ItcannotbehydrolysedbyacetylcholinesteraseintheNMJ,andsoremainsboundtothereceptor.This:
Producesasustaineddepolarisationwhichkeepsvoltage-gatedsodiumchannelsintheirinactivestatePreventsthepost-junctionalmembranefromrespondingtofurtherAChrelease
Property Succinylcholine
Class Depolarisingmusclerelaxant.
Uses Facilitatetrachealintubation.
Presentation ColourlesssolutionofpH3,at50mg.ml .Structurally,itistwoAChgroupsjoinedattheacetylgroups.
RouteofAdministration IV,IM.
Dosing 1-2mg.kg IV,3-4mg.kg IMupto150mg.
OnsetandDuration
IVonsetin30sto1minute,lasting2-3minutes,withoffsettypicallywithin10minutes.OffsetoccursduetodissociationofdrugoutofNMJintoplasma,asaconcentrationgradientisestablishedbydrugbreakdowninplasma.Prolongeddurationinpatientswithpseudocholinesterasedeficiency.IMonsetin2-3minutes.
Distribution 30%proteinbound.Nildistributionduetorapidmetabolism-V 0.25L.kg .Crossesplacentainverysmallamounts.
Metabolism Rapidhydrolysisbyplasmacholinesterasessuchthatonly20%ofadministereddosereachestheNMJ.
Elimination Minimalrenaleliminationduetorapidmetabolism.
Resp Apnoea,andsuxamethoniumapnoea.Maycausemasseterspasm.↑Salivationduetomuscariniceffects.
CVS ArrhythmiaduetoSAnodestimulation,aswellassecondarytohyperkalaemia.Bradycardia(duetomuscariniceffectswithsecond/largedoses,orinchildren).
CNS ↑ICP(duetocontraction),↑IOP(by10mmHg-thisissignificant)suchthatitiscontraindicatedinglobeperforation.
Metabolic MalignantHyperthermia.
MSK Myalgiaspostdepolarisation,particularlyinyoungfemales.Prolongedblockadewithpseudocholinesterasedeficiency.
RenalandElectrolyte
Hyperkalaemia(K ↑by~0.5mmol.L )duetodepolarisationcausingK efflux,↑inburns(>10%),paraplegia(first6months)andneuromusculardisordersincludingmusculardystrophyandmyopathies(includingcriticalillnessmyopathy).
GIT Intragastricpressure↑by10cmH O,matchedby↑inLoSpressure.
Immunological Anaphylaxis-highestriskofallNMBsat~11/100,000
AdverseEffectsTheadverseeffectsofsuxamethoniumcanberememberedasthreemajor,threeminor,andthreepressures:
Major
-1
-1 -1
D-1
+ -1 +
2
Neuromuscular
656
![Page 657: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/657.jpg)
AnaphylaxisSuxamethoniumApnoeaMalignanthyperthermia
MinorHyperkalaemiaMyalgiasBradycardia
PressureIOPICPIntragastricpressure
PhaseIandPhaseIIBlockade
InitialblockadeistermedPhaseI,whichisapartialdepolarisingblock.SustaineduseofsuxamethoniummaycausesaPhaseIIblockwhich:
Appearssimilartoanon-depolarisingblockMaybedueto:
PresynapticinhibitionofAChsynthesisandreleaseDesensitisationofthepost-junctionalreceptor
Keydifferencesinclude:
Property PhaseIBlock PhaseIIBlock
BlockAmplitude Reduced Reduced
Train-of-fourratio >0.7 <0.7
Post-tetanicpotentiation No Yes
Effectofanticholinesterases Blockaugmented Blockinhibited
MalignantHyperthermia
RareautosomaldominantgeneticconditionTriggeredbysuxamethoniumandvolatileanaestheticagentsMutationoftheryanodinereceptorcausesexcessiveamountsofcalciumtoleavethesarcoplasmicreticulum,causingcontinualmusclecontraction
Resultsingreatlyincreasedcarbondioxide,lactate,andheatproductionCelllysiswithmyoglobulinaemiaandhyperkalaemiaresults
SuxamethoniumApnoea
AdeficiencyofbutylcholinesterasecausessuxamethoniumtonotbemetabolisedMaybecongenital(genetic)oracquired(hepaticfailure)Canbetreatedwithfreshfrozenplasma
References
Neuromuscular
657
![Page 658: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/658.jpg)
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. SuxamethoniumChlorideInjectionBPPRODUCTINFORMATION3. Appiah-AnkamJ,HunterJM.Pharmacologyofneuromuscularblockingdrugs.ContinuingEducationinAnaesthesiaCritical
Care&Pain,Volume4,Issue1,1February2004,Pages2–7.4. CookT,HarperN.Anaesthesia,Surgery,andLife-ThreateningAllergicReactions:ReportandfindingsoftheRoyalCollege
ofAnaesthetists'6thNationalAuditProject:PerioperativeAnaphylaxis.RoyalCollegeofAnaesthetists'.2018.
Lastupdated2019-07-18
Neuromuscular
658
![Page 659: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/659.jpg)
Non-DepolarisingNeuromuscularBlockersNon-depolarisingNMBsaremusclerelaxantsusedto:
FacilitatelaryngoscopyandtrachealintubationControlICPImproverespiratorysystemcomplianceImprovepatientsafetyontransportation
MechanismofactionisbycompetitiveantagonismofAChattheNMJ,preventinggenerationofend-platepotentials.Effectivepharmacodynamicresponserequires>70%receptoroccupation.
CommonFeaturesofNeuromuscularBlockers
Property Action
RouteofAdministration IV/IM
Distribution SmallV astheyarepolarandunabletocrosslipidmembranes
Elimination Reducedurinaryclearancewhichprolongsthemechanismofactionofaminosteroidsinrenalfailure
Resp Apnoea
MSK ↑Durationinhypothermia
Renal ↑Durationinacidosis,↑durationinhypokalaemia,↓durationinhyperkalaemia,↑durationinhypermagnesaemia
Metabolic CriticalIllnessMyopathyinpatientswithlong-termrelaxantuse
TheED is:
Thedoseofaneuromuscularblockingdrugrequiredtoproducea95%reductionintwitchheightin50%ofthepopulationAcommonly-usedtherapeuticend-pointforneuromuscularblockingdrugsTypically,inductiondosesusedare2-5xtheED .
ComparisonofNeuromuscularBlockers
Property Rocuronium Vecuronium Pancuronium Atracurium Cisatracurium
Class Aminosteroid AminosteroidBis-quaternaryaminosteroid
Benzylisoquinoliniumderivative
Benzylisoquinoliniumderivative
Presentation
Clear,colourlesssolutionat10mg.ml
10mgpowderforreconstitutioninwater.ContainsmannitolandNaOH.
Colourlesssolutionat2mg.ml ,whichmustbestoredat4°C
Colourlesssolutionat10mg.ml ,whichshouldbestoredat4°C.Mixtureofalltenextantdiastereoisomers.
R-Cis,R'-Cisisomerofatracurium,whichis15%ofatracuriumbyweightbutprovides50%ofitsNMBDaction.
Colourlesssolutionat2-5mg.ml ,whichshouldbestoredat4°C
D
95
95
-1
-1
1
-1
Non-DepolarisingNMBs
659
![Page 660: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/660.jpg)
IntubatingDose
0.6-1.2mg.kg 0.1mg.kg 0.05-0.1
mg.kg 0.5mg.kg 0.15-0.2mg.kg
ED 0.3mg.kg 0.05mg.kg 0.07mg.kg 0.25mg.kg 0.05mg.kg
Onset 45-90s 90-120s 90-150s 90-120s 60-180s
Duration
~30minuteswithnormalrenalfunction,repeatdosesmaybemoreunpredictable
45-65minutes
60-100minutes 15-35minutes 25-30minutes
Metabolism
<5%hepaticdeacetylationtoinactivemetabolites
20%hepaticdeacetylationwithweaklyactivemetabolites
20%hepaticdeacetylationwithweaklyactivemetabolites
60%byesterhydrolysis,withremainderbyHofmannelimination.
Metabolisedtolaudanosine,whichcausesseizuresinhighconcentrations(relevantwhenadministeredbylonginfusion)
Hofmannelimination
Elimination
60%biliary,40%urinary.Prolongeddurationinhepaticandrenalfailure
70%biliary,30%urinary
80%biliary,20%urinary
RespSlightriskofbronchospasmwithrapidinjection
Slightriskofbronchospasmwithrapidinjection
CVS ↑HRathighdoses No↑HR
↑HRandMAPduetomuscarinicantagonism
Riskof↓BPwithrapidinjection
Riskof↓BPwithrapidinjection
Immune
Higherriskofanaphylaxis,~6/100,000.Anaphylaxisriskassociatedwithuseofpholcodineintheprevious3years.
NotablynoanaphylaxisrecordedinNAP6
Anaphylaxis~4/100,000.
OtherReversiblewithsugammadex
Reversiblewithsugammadex
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.3. CrillyH,RoseM.Anaphylaxisandanaesthesia–cantreatingacoughkill?.AustPrescr.2014;37:74-6.
-1 -1 -1 -1 -1
95-1 -1 -1 -1 -1
Non-DepolarisingNMBs
660
![Page 661: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/661.jpg)
4. Lexicomp.Rocuronium:Druginformation.In:UpToDate,Post,TW(Ed),UpToDate,Waltham,MA,2017.5. Lexicomp.Vecuronium:Druginformation.In:UpToDate,Post,TW(Ed),UpToDate,Waltham,MA,2017.6. Lexicomp.Pancuronium:Druginformation.In:UpToDate,Post,TW(Ed),UpToDate,Waltham,MA,2017.7. Lexicomp.Atracurium:Druginformation.In:UpToDate,Post,TW(Ed),UpToDate,Waltham,MA,2017.8. Lexicomp.Cisatracurium:Druginformation.In:UpToDate,Post,TW(Ed),UpToDate,Waltham,MA,2017.9. CookT,HarperN.Anaesthesia,Surgery,andLife-ThreateningAllergicReactions:ReportandfindingsoftheRoyalCollege
ofAnaesthetists'6thNationalAuditProject:PerioperativeAnaphylaxis.RoyalCollegeofAnaesthetists'.2018.
Lastupdated2019-07-20
Non-DepolarisingNMBs
661
![Page 662: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/662.jpg)
DantroleneDantroleneisaryanodine(RYR1)receptorantagonist,whichpreventsreleaseofCa fromthesarcoplasmicreticulum,uncouplingtheprocessofexcitation-contraction.
Property Dantrolene
Uses MH,NMS,ecstasyintoxication,chronicmusclespasticity
Presentation Vialsoforangepowdercontaining20mgdantroleneand3gmannitol,reconstitutedwith60mlofH Otoformanalkalinesolution.
Dosing 2.5mg.kg IVevery10-15minutes,upto10mg.kg .Onceresolved,continuegiving1mg.kg every4-6hoursfor24hours.
Absorption IVonly,maycauseskinnecrosisifextravasates.
Distribution 85%proteinbound
Metabolism Hepaticmetabolismtoactive5-hydroxy-dantrolene
Elimination Renalofmetabolites,t βof12hours
Resp Respiratoryfailureduetoskeletalmuscleweakness
CVS Volumeoverloadduetolargevolumegivenwithadministration
MSK Skeletalmusclerelaxation
Renal Diuresis
GIT Hepaticfailure
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.3. ANZCAAugust/September2011
Lastupdated2017-09-16
2+
2
-1 -1 -1
1/2
Dantrolene
662
![Page 663: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/663.jpg)
Sugammadex
Property Sugammadex
Class Gammacyclodextrin.
Uses Reversalofneuromuscularblockinducedbyrocuroniumandvecuronium.
Presentation Clearcolourlesssolutionat100mg.ml .
Pharmaceutics Storebelow30°C.
RouteofAdministration IVonly.
Dosing2mg.kg ifToF>2.4mg.kg ifPTC>2.16mg.kg forreversalfollowingRSIdose.
Distribution V of11-14L.kg .
Metabolism Notmetabolised.
Elimination Renaleliminationofactivedrugandcomplex.
MechanismofAction Formsacomplexwithrocuroniumandvecuronium,causingreversalofneuromuscularblockade.
CVS Rarelymayprecipitatebradycardia-canresultincardiacarrest.
Immune Anaphylaxis.
Other
InteractswithOCP-treatasmissedpillShorteneddurationofrocuroniumandvecuroniumwhenusedwithin24hoursofsugammadexadministration.Onsetisdelayedupto5minutes,anddurationshortenedby10-15minutes.Thisperiodmaybeextendedinrenalfailure.
References1. SugammadexFullPrescribingInformation.FDA.
Lastupdated2019-07-20
-1
-1-1-1
D-1
Sugammadex
663
![Page 664: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/664.jpg)
Anticoagulants
Property Warfarin Heparin Enoxaparin
Uses AF,DVT/PE,ProstheticValves AF,DVT/PE,Extra-corporealCircuitAnticoagulation DVTProphylaxis
Pharmaceutics
Marevanandcoumadinmaypotentiallyhavedifferentbioavailabilities(ithasnotbeenassessed)andsoshouldnotbesubstituted
Mucopolysaccharideorganicacidwhichoccursnaturallyintheliverandinmastcells,withahighlyvariablemolecularweight(between5,000and25,000Da)
Smallerfragmentsofheparin(preparedfromUFH),withameanmolecularweightof5,000Da
MechanismofAction
PreventsthereturnofvitaminKtoitsreducedform,andthereforethegamma-carboxylationofvitamin-Kdependentclottingfactors(II,VII,IX,X),aswellasProteinCandProteinS).
PotentiatestheeffectofATIII,rapidlyincreasingitsanti-IIaandanti-Xaeffect(1:1effect).
InhigherconcentrationsalsoinhibitsIXa,XIa,XIIa,andplateletaggregation.
PotentiatestheactionofATIII,increasinginhibitionofXaandIIa,but(unlikeUFH)ina4:1ratio.
MorepredictableeffectonXastandardisesdosingandjustifieslackofmonitoringrequirement.
Onset
8-12hours.Peakat72hoursduetothehalf-lifeofexistingclottingfactors,andthetotalbodystoresofvitaminK
ImmediateIVonset
Absorption 100%bioavailability IV,SC SConly
Distribution 99%proteinbound Lowlipidsolubility,highlyproteinbound
Doesnotbindtoheparin-bindingproteins
Metabolism
Completehepaticmetabolism.Significantpharmacokineticinteractionwithenzymeinducersandinhibitors.
Hepaticinteractionsduetoenzymaticinduction(ETOH,amiodarone,salicylates,NSAIDs)andinhibition(OCP,barbiturates,carbamazepine)
Renaleliminationofmetabolites
Elimination Faecalandrenaleliminationofmetabolites,t βof40hours Renalofinactivemetabolites
Renalofactivedrugandinactivemetabolites
CVS Microthrombi HypotensionwithrapidIVadministration
Metabolic Lessosteoporosisduetolessprotein(andthereforetissue)binding Osteoporosis
Renal Inhibitsaldosteronesecretion
GIT N/V
Haeme Haemorrhage Haemorrhage,HITTs
Haemorrhage,lowerriskofHITTsthanUFH.Lessthrombocytopaenia.
Immune Hypersensitivityreactions
1/2
Haematological
664
![Page 665: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/665.jpg)
Reversal-Waiting-VitaminK-FFP-Prothrombinex
Reversedwithprotamine(1mgper100U).
Incompletereversalwithprotamineasonlytheanti-IIaeffectisinhibited.
OtherTeratogenic.ComplicatedpharmacokineticsrequiringmonitoringusingINR.
RequiresmonitoringwithAPTTorATIIIlevels.LargeinterpatientvariabilityduetovariableamountsofATIII.
1unitistheamountofheparinrequiredtoprvent1mlofbloodclottingfor24hoursat0°C
Nomonitoringrequired.
HITTs
Heparin-InducedThromboticThrombocytopeniacomesintwoflavours:
TypeI:Isnon-immunemediatedOccurswithin4daysofanticoagulantdosesIsanisolatedthrombocytopeniawithoutclinicalsignificance
TypeII:IsimmunemediatedOccurswithin4-14daysIsassociatedwithseriousthrombosisandhighmortality(typicallyfromPE)andmorbidity(fromCVAandlimbischaemia)
Protamine
Protamineis:
Abasiccationicproteinderivedfromsalmonspermwhichcombineswiththeacidicanionicheparintoformastable,inactivesaltinsolutionClearedmorerapidlythanheparinReboundanticoagulationmayoccur.
Adverseeffectsfromprotamineinclude:
HistaminereleaseBronchospasmHypotension
PulmonaryhypertensionThiscanbeprofoundandresultinadramaticincreaseinRVafterloadandEDV,withacorrespondingfallinLVpreload(interventricularinterdependence),leadingtodramatichypotensionandarrest.
MediatedbythromboxanesDuetoprotamine-heparincomplexes,ratherthanprotaminealoneAdministrationofprotamineinabsenceofheparindoesnotleadtopulmonaryhypertension.
AnticoagulationWhengiveninexcess.
References
Haematological
665
![Page 666: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/666.jpg)
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.3. ANZCAAugust/September20114. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.
Lastupdated2019-07-18
Haematological
666
![Page 667: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/667.jpg)
DirectThrombinInhibitorsDirectthrombininhibitorspreventcleavageoffibrinogentofibrin,andarethereforeveryeffectiveanticoagulants.
Property Dabigatran
Class NOAC
Uses VTEprophylaxis,AF
Presentation 75/110mgCapsules
RouteofAdministration PO
Dosing VTE:220mgdaily,AF:150mgBD
Absorption 6.5%bioavailability
Distribution 35%proteinbound
Metabolism Prodrug-activatedbyplasmaandhepaticesterases
Elimination Renaleliminationofactivedrug
Haeme Haemorrhage
Immune Allergy
Other Significantinteractionswithamiodarone,quinidine,St.John'sWort,aswellasotheranticoagulantandantiplateletagents.Dialysable.Potentiallyreversiblewithidarucizumab.
References
1. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.2. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.
Lastupdated2019-07-18
DirectThrombinInhibitors
667
![Page 668: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/668.jpg)
AntifibrinolyticsAntifibrinolyticsincludeaprotinin,aminocaproicacid,andtranexamicacid.Allpreventthebreakdownoffibrin(!)byvariousmechanisms.TXAcompetitivelyinhibitsplasminogenactivator,reducingrateoffibrinolysis.
Property TranexamicAcid(TXA)
Class Antifibrinolytic
Uses Trauma(within3hours),cardiacsurgery,obstetricsurgery,andmenorrhagia
Presentation Tablets,syrup,clearcolourlesssolutionforinjection
RouteofAdministration IV,PO
Dosing 1gslowIV,whichmaybefollowedbyinfusionof1gover8hours
Absorption 50%bioavailability
Distribution Lowplasmaproteinbinding,V 9-12litres
Metabolism Minimalhepaticmetabolism
Elimination Renalofactivedrug-dosereduceinrenalimpairment
GIT Nausea,vomiting
Haematological Reducesfibrinolysis,possibleincreaseinDVT/PE
Immunological Allergicdermatitis
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. LITFL-TranexamicAcid
Lastupdated2019-07-18
D
Antifibrinolytics
668
![Page 669: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/669.jpg)
AntiplateletsNoteaspirinisincludedunderCOXinhibitors.
ClassificationofAntiplateletAgents
Antiplateletagentscanbeclassifiedbywhichstageofplateletfunctiontheyaffect:
AdhesionvWFinhibitorse.g.Dextran70.
ActivationProstacyclinse.g.Epoprostenol.Phosphodiesteraseinhibitione.g.Dipyridamole.COXinhibitorsPreventthromboxaneA2production,e.g.aspirin.
AggregationADPreceptorantagonistsPreventactivationofGPIIb/IIIareceptors,e.g.clopidogrel.GPIIb/IIIareceptorantagonistsPreventplateletaggregationviafibrinlinkagesbetweenGPIIb/IIIareceptors,e.g.tirofiban.
ComparisonofCommonAntiplateletAgents
Property Clopidogrel Dipyridamole Tirofiban
Class ADPantagonist Phosphodiesteraseinhibitor GPIIb/IIaantagonists
Uses PVD,STEMI,NSTEMI,stentprophylaxis CVA UA,NSTEMI
RouteofAdministration POonly PO/IV IVonly
MechanismofAction
IrreversiblypreventsADPfrombindingtoitsreceptorontheplatelet,preventingactivationoftheIIb/IIIareceptor
Inhibitsplateletadhesiontowalls,potentiatesprostacyclinactivityandincreasesplateletcAMP,↓Ca andinhibitingplateletaggregationanddeformation.Alsoactsasacoronaryvasodilator.
ReversibleantagonismofIIb/IIIareceptor,preventingplateletaggregation
Dosing 300mgload,75mgdailythereafter 200mgBDforCVA
Load25mcg.kg ,maintenance15mcg.kg
Absorption Rapidabsorptionandonsetwithin2hours VariabledependingonoralintakeIVonly.Onsetwithin10minutes
Distribution Highlyprotein-bounddrugandmetabolites Highlyproteinbound 65%protein
bound
2+
-1
-1
Antiplatelets
669
![Page 670: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/670.jpg)
Metabolism
Prodrug.Majorityhydrolysedbyesterasestoinactivedrug,withasmallproportionhepaticallymetabolisedbyCYP450toactiveform.ProlongeddurationofactionduetoirreversibleADPblockaderatherthanlongeliminationhalf-life.
Partialhepatictoinactivemetabolites
Notmetabolised.
Elimination Urinaryandfaecal Renalandfaecal
Urinaryasunchangeddrug.Plateletaggregationreturnstobaselinewithin4-8hours
CVS VasodilatationmaydropCPPinASandrecentMI
Coronaryarterydissection
GIT Mucosalirritation
Haeme Haemorrhage Thrombocytopaeniaandhaemorrhage Haemorrhage
Other
Manypharmacokineticinteractions,includinggeneticvariability.Previouslythoughttokineticallyinteractwithomeprazole-morerecentlydisproved.
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. RangHP,DaleMM,RitterJM,FlowerRJ.RangandDale'sPharmacology.6thEd.ChurchillLivingstone.
Lastupdated2019-07-18
Antiplatelets
670
![Page 671: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/671.jpg)
PenicillinsPenicillinsarebactericidalantibioticsthatpreventcell-wallsynthesisbypreventingcross-linkingofpeptidoglycansbyreplacingthenaturalsubstratewiththeirβ-lactamringPenicillinsbindtopenicillinbindingproteins(PBPs)inthebacterialwallPenicillinsonlyrarelyachievecompleteeradicationofsensitiveorganismswithoutadditionofasynergisticantibiotic(suchasgentamicin)
CommonFeatures
Property Effect
Absorption Typicallywellabsorbedorally.IMdosingtendtocauselocalisedpainandirritation.
Distribution Typicallyhavegoodtissuepenetration.Onlycrosstheblood-brainbarrierandenterboneifitisinflamed.Typicallylowproteinbinding(exceptionisflucloxacillin,whichis95%proteinbound).
Metabolism Typicallysmallproportionishepaticallymetabolised.
Elimination Majority(60-90%)iseliminatedunchangedinurinepredominantlybyactivetubularsecretion,withrenalclearanceproportionaltototalrenalplasmaflow.Asmallquantityissecretedinbile.
MechanismsofResistance
AlterationorprotectionofPBPsGramnegativebacteriamayhavealteredpermeabilityofporinsintheiroutermembrane,whichprotectsthePDP
Hydrolysisbyβ-lactamase-producingbacteriaClavulanicacidandtazobactaminhibitβ-lactamase,whichcanrenderotherwiseresistantbacteriasensitiveNotably,flucloxacillinhasamodifiedbeta-lactamringthatisnotsensitivetoβ-lactamases
ComparisonofPenicillins
Narrowspectrum,naturallyoccurring
Narrowspectrum,synthetic
Extended-spectrum Antipseudomonal
Examples Benzylpenicillin,phenoxymethylpenicillin Flucloxacillin Ampicillin,
amoxacillinPiperacillin,ticarcillin
Indications
Grampositivesandanaerobes,particularlystreptococciandmeningococci.Alsolisteria,Clostridia,andTreponema.
Grampositivecocci,particularlystaphylococcibutalsostreptococci.
Grampositive,particularlyenterococci.Somegramnegative.
Grampositive,gramnegativeincludingpseudomonas.
Otherbits Highlybactericidal
Lessactivethanbenzylpenicillinonorganismssensitivetoboth.
Canpenetratesomegram-negatives.
Gramnegativecover.
References
Antimicrobials
671
![Page 672: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/672.jpg)
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. BarzaM,WeinsteinL.Pharmacokineticsofthepenicillinsinman.ClinPharmacokinet.1976;1(4):297-308.3. BruntonL,ChabnerBA,KnollmanB.GoodmanandGilman'sThePharmacologicalBasisofTherapeutics.12thEd.
McGraw-HillEducation-Europe.2011.4. CICMJuly/September2007
Lastupdated2019-07-18
Antimicrobials
672
![Page 673: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/673.jpg)
GlycopeptidesNon-β-lactamagentsthatinhibitcellwallsynthesis.Theyare:
Activeagainstgram-positiveanaerobesandaerobesBacteriostaticagainstenterococciandstreptococciBacteriocidalagainststaphylococci
Property Vancomycin
Uses MRSA,C.difficile
Presentation Powderforreconstitution
RouteofAdministration PO,IV,Intrathecal
Dosing Peaklevelsdeterminedbydose,troughlevelsbydoseandinterval
Absorption Nooralbioavailability.PoorCSFpenetration
Distribution V 0.4-1L.kg .PoorCSFpenetrationevenwithinflamedmeninges-higherlevelsarerequiredforCNSpenetration.~50%proteinbound.
Metabolism Minimalhepaticmetabolism
Elimination 90%secretedunchangedinurine-significantlyprolongedinrenalimpairment
CVS Phlebitis,redmansyndrome(profoundnon-anaphylactichistaminereleasewithrapidinjection)
CNS Ototoxicity
Renal Nephrotoxicity,typicallytemporaryandresolvesoncessation
Haematological Thrombocytopenia
Immunological 'Redmansyndrome'duetohistaminereleasewithrapidinjection,withaccompanying↑HR↓BP.Neutropenia.
Other Synergisticactionwithcephalosporins,aminoglycosides,andrifampicin
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. WellingtonICUDrugManual3. RybakMJ.Thepharmacokineticandpharmacodynamicpropertiesofvancomycin.ClinInfectDis.2006Jan1;42Suppl
1:S35-9.
Lastupdated2019-07-18
D-1
Glycopeptides
673
![Page 674: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/674.jpg)
AminoglycosidesBactericidalantimicrobialsthatpreventproteinsynthesisbyirreversiblebindingtothe30Sribosomalsubunit,preventingmRNAtranscription.
Astheyarelarge,polarmolecules,theymustbeactivelytransportedintothecellThisoccurswithanoxygendependenttransporterThereforetheyarenoteffectiveagainstanaerobes.
TransportisinhibitedbyincreasedCa ,Mg ,lowpH,andlowOAminoglycosidekillingisdependentonthepeakconcentrationoverMICTypicallypeakconcentrationmustbe8-10xMIC.
Exposuretoaminoglycosidescausesbacteriatodown-regulateaminoglycosideuptake,andthereforeincreasesMICThiseffectdisappearsafter~24hours,andisonejustificationfordailydosingofaminoglycosides.Additionaljustificationsinclude:
Allowslargersingledosestobeused,increasingbactericidaleffectAminoglycosidesexhibitapost-antibioticeffectOngoingbactericidalactivityevenafterconcentrationfalls.
Property Gentamicin
Uses/Spectrum Gramnegativeincludingpseudomonas,limitedgrampositive(staph,limitedstrep),synergisticeffectswithβ-lactamsandvancomycin.
RouteofAdministration IVonly.
Dosing 4-7mg.kg .
Distribution 70%proteinbound.VerysmallV of0.2L.kg ,whichmayresultinsignificantpharmacokineticchangeswithoedema.
Metabolism Notmetabolised.
Elimination Eliminatedunchanged,eliminationt prolongedupto70hoursinrenalimpairment.
CNS Ototoxicityduetoaccumulationinperilymph,andisusuallypermanent.Increasedriskwithconcomitantfrusemideuse.
MSK Muscleweakness.
Renal Nephrotoxicityduetoaccumulationintherenalcortex,typicallyreversible.
ToxicEffects Narrowtherapeuticindex,requiresmonitoringanddosereductioninrenalimpairment.
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. StubbingsW,BostockJ,InghamE,ChopraIMechanismsofthepost-antibioticeffectsinducedbyrifampicinandgentamicin
inEscherichiacoli.JAntimicrobChemother.2006Aug;58(2):444-8.3. DerangedPhysiology-KillCharacteristicsofAntibioticAgents
Lastupdated2017-08-12
2+ 2+2
-1
D-1
1/2
Aminoglycosides
674
![Page 675: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/675.jpg)
Aminoglycosides
675
![Page 676: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/676.jpg)
LincosamidesInhibitproteinsynthesisbydisruptingthe50Sribosomalsubunit.Maybebacteriostaticorbacteriocidal,dependingontheconcentrationandtheparticularorganism.
Property Clindamycin
SpectrumofActivity
Grampositivecocci,anaerobes.Littleactionagainstgramnegativeaerobes.Alsoactiveagainstsomeprotozoa,suchasP.falciparum.
RouteofAdministration PO/IV
Dosing 150-300mgQ6H
Absorption 90%PObioavailability
Distribution Excellentbonypenetration
Metabolism Hepatictoactiveandinactivemetabolites
Elimination Renaleliminationofallmetabolites
MSK Maycauseneuromuscularblockadeinoverdose
GIT ReasonableincidenceofGITupset,withfatalpseudomembranouscolitisreported.DerangedLFTs
Immune Atopy,eosinophilia,DRESS
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. Lexicomp.Clindamycin(systemic):DrugInformation.In:UpToDate,Post,TW(Ed),UpToDate,Waltham,MA,2017.
Lastupdated2019-07-18
Lincosamides
676
![Page 677: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/677.jpg)
MetronidazoleMetronidazoleinterruptscellularmetabolismbypreferentialreduction,capturingelectronsthatwouldbeusuallytransferredtoothermolecules.Thisleadstoabuildupofcytotoxicintermediatemetaboliccompoundsandfreeradicals,thatresultinDNAbreakageandsubsequentcelldeath.
Property Drug
Class Nitroimidazole
Uses Anaerobesandprotozoa
RouteofAdministration PO/IV
Dosing 500mgBD
Absorption 100%bioavailability
Distribution CrossesBBB
Metabolism Hepatictoactivemetabolites
Elimination Renalofactivemetabolites
Metabolic Significantrash,nausea,vomiting,headache,flushing
GIT Nausea,vomiting,metallictaste
Immunological Hypersensitivityreactions
Interactions Disulfiram-likereactionwithETOH
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. Lexicomp.Metronidazole(systemic):Druginformation.In:UpToDate,Post,TW(Ed),UpToDate,Waltham,MA,2017.
Lastupdated2019-07-18
Metronidazole
677
![Page 678: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/678.jpg)
AntifungalsAntimicrobialagentstargetingeukaryoticandheterotrophicmicrobes.Canbedividedbyclassinto:
AzolesInhibitergosterolsynthesis.Subdividedinto:
TriazolesFluconazoleItraconazoleVoriconazolePosaconazole
ImidazolesKetoconazole
EchinocandinsInhibitglucansynthesis.
CaspofunginMicafunginAnidulafungin
PolyenesDisruptcellmembrane.
AmphotericinBNystatin
CommonFeatures
MechanismsofAntifungalResistance
Threebroadmechanisms:
IncreasedeffluxIncreasedexpressionoftransportproteinsremovingdrugfromcell.AlterationoftargetenzymeChangestoproteintargetpreventdrugbindingorinactivation.
TypicallyonlyrequireschangesinafewaminoacidsAlterationofdrugmetabolismReducedenzymeactivitypreventsaccumulationoftoxicproduct.
Amphotericinresistanceisrareinvivo,andistypicallyviadifferentmechanisms:
DecreasedergosterolcontentAlteredsterol:phospholipidratio
ComparisonofAntifungals
Drug Fluconazole Voriconazole Caspofungin AmphotericinB
Class Azole AzoleEchinocandins Polyenes
Candida(includingazoleresistant
Antifungals
678
![Page 679: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/679.jpg)
SpectrumofActivity
Candidaalbicans(mostotherspecies,especiallyC.glabrataandtoalesserextentC.kruseiareresistant),asresistancerapidlydevelops),cryptococcus,coccidioides,histoplasma,blastomyces,andsomeaspergillus(resistancemayalsodeveloprapidly).Atleastasgoodasamphotericininsusceptibleorganisms.
Asfluconazole,butbroaderspectrumofactivity
C.glabrataandC.kruseiandCandidabiofilms),aspergillus.Notablynoactivityagainstcryptococcus,fusarium,andtrichosporon.
Additionally,echinocandinstypicallyhavenocross-resistancewithotherantifungals
Effectiveagainstmanyfungi,withnotableexceptionsbeingChromoblastomycosis,Aspergillusterreus,Candidalusitaniae,Scedosporium,andsomeFusarium.
Pharmaceutics Poorwatersolubility Poorwatersolubility
Poorwatersolubility
Fourdifferentformulations,mostcommonisamphotericinBcolloidaldispersion(ABCD)
Dosing 100-800mgOD,adjustinrenalfailure
Typically70mgloadingdose,followedby50mgdaily;dosereducedinhepaticimpairment
Loadwith0.25-0.5kg.kg ,followedby0.25-1.5mg.day ,reducedinsevererenalimpairment
RouteofAdministration IVorPO IVonly(high
MW)IVforsystemicindications
Absorption
HighPObioavailability,POabsorptionatlowpH(interactionwithantacids,vitaminsupplements)
<5%PObioavailability
DistributionCrossesBBB-goodCSFpenetration.Verylowproteinbinding(~10%)
Notdialysableduetoveryhighproteinbinding,V .Goodtissuepenetration.
EssentiallynoCSFpenetration,97%proteinboundinserum
Rapiduptakebyreticuloendothelialsystem.Bindstoorganicaniontransportingpeptides(importantinhepatocytedrugbinding),importantinkeydruginteractions(suchastacrolimus)
Metabolism
MetabolisedbyandcausereversibleinhibitionofmultiplehepaticCYP450enzymes(including3A4,2C19,2C9),leadingtoincreasedconcentrationsofmanydrugs/metabolites
Asfluconazole
ExtensivehydrolysisandN-acetylationtoinactivemetabolites
Minimalmetabolism
Elimination 80%offluconazolerenallyeliminatedunchanged
Mostlyclearedvialiver.
Renalofmetabolites
Renalandfaecaleliminationofunchangeddrug
MechanismofInhibitergosterolsynthesis
Preventcellwallsynthesis Bindssterols,
disruptingosmotic
-1-1
D
Antifungals
679
![Page 680: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/680.jpg)
Action byinhibitingCYP450enzyme
Asfluconazole byblockingproductionofbeta-glucan
integrityofthecellmembrane
CVS HTN LongQT Histaminerelease
CNS Headache,visualdisturbances
Hallucinations,psychosis
Renal
AKIviaafferentarteriolarconstrictionanddirecttubulartoxicity,hypokalaemia,renaltubularacidosis
GIT HepatotoxicityMildhepatotoxicityinupto~15%
Haeme Thrombophlebitis,normocyticanaemia
References
1. AndersonJB.Evolutionofantifungal-drugresistance:mechanismsandpathogenfitness.NatRevMicrobiol.2005Jul;3(7):547-56.
2. DrewRH.PharmacologyofAmphotericinB.In:UpToDate,Post,TW(Ed),UpToDate,Waltham,MA,2018.3. AshleyED,PerfectJR.Pharmacologyofazoles.In:UpToDate,Post,TW(Ed),UpToDate,Waltham,MA,2018.4. LewisRE.Pharmacologyofechinocandins.In:UpToDate,Post,TW(Ed),UpToDate,Waltham,MA,2018.5. BekerskyI,FieldingRM,DresslerDE,LeeJW,BuellDN,WalshTJ.Pharmacokinetics,excretion,andmassbalanceof
liposomalamphotericinB(AmBisome)andamphotericinBdeoxycholateinhumans.AntimicrobAgentsChemother.2002Mar;46(3):828-33.
Lastupdated2019-07-18
Antifungals
680
![Page 681: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/681.jpg)
InsulinsInsulinsaresyntheticpolypeptidehormones.They:
HaveasimilarmechanismofactionandpharmacodynamicsofendogenousinsulinOneunitofinsulinisdefinedastheamountrequiredtomakeapreviouslyhealthy2kgrabbithypoglycaemic
TypesofInsulin
Differentinsulinsarecategorisedbytheirtimeofonset,peak,andduration,andareclassifiedaseither:
FastactingIntermediateactingLongacting
FastActing
FastactinginsulinsareusedforcontrollingBSLspikespostmeals,andforcontrolofhyperglycaemia.Administeredsubcutaneouslytheyhavehavean:
Onsetof5-15minutesPeakat1-2hoursLast4-6hours.
Fastactinginsulinsinclude:
InsulinAspart(Novorapid)InsulinLispro(Humalog)
IntermediateActing
Endocrine
681
![Page 682: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/682.jpg)
IntermediateactinginsulinsareusedforcontrolofBSLbetweenmealsasapseudo-basalbolus.Administeredsubcutaneouslytheyhavean:
Onsetof1-2hoursPeakat4-6hoursLast>12hours
Intermediateactinginsulinsinclude:
NPHProtophane
LongActing
Longactinginsulinsareusedforcreatingabaselineinsulinlevel.Administeredsubcutaneouslytheyhavean:
Onsetof1-1.5hoursPeakat5hoursLast24hours
Long-actinginsulinsinclude:
Insulinglargine(Lantus)Insulindetemir(Levemir)
PharmacokineticsofExogenousInsulinPreparations
Property Drug
Class Syntheticpolypeptidehormones
Uses Diabetes,hyperglycaemia,hyperkalaemia,β-blockertoxicity,Ca -blockertoxicity
Presentation Clearcolourlesssolutiontypicallyat100IU.ml
RouteofAdministration SC,IM,IV
Absorption Variable,asdescribedabove.Insuliniscomplexedwithdifferentsubstances(e.g.protamine,zinc),whichalteritsrateofabsorption
Distribution MinimalproteinbindingandminimalredistributionoutofECF-V 0.075L.kg
Metabolism Glutathioneinsulintranshydrogenase.Metabolismisconstant-durationofactionisentirelyduetodifferentratesofsubcutaneousabsorption.
Elimination Renalofinactivemetabolites
References
1. DiabetesEducationOnline.TypesofInsulin.UCSF.AccessedJanuary2016.2. Graphofinsulinactivityprofilesfrom:DiabetesEducationOnline.TypesofInsulin.UCSF.AccessedJanuary2016.3. MudaliarS,MohideenP,DeutschR,CiaraldiTP,ArmstrongD,KimB,ShaX,HenryRR.Intravenousglargineandregular
insulinhavesimilareffectsonendogenousglucoseoutputandperipheralactivation/deactivationkineticprofiles.DiabetesCare.2002Sep;25(9):1597-602.
4. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.
2+
-1
D-1
Endocrine
682
![Page 683: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/683.jpg)
Lastupdated2017-09-18
Endocrine
683
![Page 684: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/684.jpg)
OralHypoglycaemics
Class Biguanides Sulfonylureas Glitazones Gliflozins
Example Metformin Gliclazide Pioglitazone Dapagliflozin
Uses T2DM T2DM T2DM T2DM
MechanismofAction
Delayglucoseabsorption,increaseperipheralinsulinsensitivity,inhibithepaticgluconeogenesis
Increaseinsulinsecretionfrompancreaticβ-cells.Mayincreaseinsulinsensitivity
ActivatestheintranuclearPPARγreceptor,affectinggenetranslationandincreasinginsulinsensitivity
InhibitsglucosereabsorptionbytheS-GLUT co-transporterinthekidney,increasingglucoseeliminationinurine
Dosing 500mg-2gBD 40-160mgBD 15-30mgdaily 5-10mgdaily
Absorption Bioavailability60%
Bioavailability80%
Highbioavailability.DelayedonsetandlatepeakeffectgivenMoA
Bioavailability>75%
Distribution Minimallyproteinbound
Extensivelyboundtoalbuminbynon-ionicforces,suchthattheydonottendtodisplaceotherhighlyproteinbounddrugs
LowV(0.6L.kg )
Metabolism NotmetabolisedPartialhepatictoinactivemetabolites
ExtensivehepaticphaseItoinactiveandactivemetabolites
Extensivehepatictoinactivemetabolites
EliminationRenaleliminationofactivedrug
Renaleliminationofactivedrugandinactivemetabolites
RenalandGIeliminationofactiveandinactivemetabolites
Renalofinactivedrug
CVSMayprecipitatefluidretention
Renal
Contraindicatedinrenalimpairmentduetoincreasedriskoflacticacidosis
Contraindicatedinrenalimpairment(<60ml.min )asithasnobenefit
MSK Photosensitivity
Metabolic
↑Appetite,weightgain.Hypoglycaemia
Weightloss,reducedinsulinrequirements
2
D-1
-1
OralHypoglycaemics
684
![Page 685: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/685.jpg)
infasting.
Renal IncreasedUTIandthrushrisk
GIT Nausea,Diarrhoea Cholestasis
Toxic
Severelacticacidosissecondarytoinhibitionofoxidativeglucosemetabolism,especiallyinrenalfailureandalcoholics
Crossplacenta,causingfoetalhypoglycaemia.
Mayleadtoeuglycaemicdiabeticketoacidosisduetobluntedinsulinproductioninthefaceofstresshormones.ConsiderinpatientswithDKAsymptoms(drowsiness,abdominalpain,nausea/vomiting),elevatedketones,andmetabolicacidosisinthesettingofanormalBSL.
References1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.3. DapaglifozinforType2Diabetes.2013.AustPrescr2013;36:174-9.4. KilovG,LeowS,ThomasM.SGLT2inhibitionwithdapagliflozin:Anovelapproachforthemanagementoftype2diabetes.
AmericanFamilyPhysician.Volume42,No.10,October2013Pages706-710.5. ANZCA.SevereEuglycaemicKetoacidosiswithSGLT2InhibitorUseinthePerioperativePeriod.2018.
Lastupdated2019-07-18
OralHypoglycaemics
685
![Page 686: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/686.jpg)
OxytocicsOxytocicsareagentswhichincreasetheforceofuterinecontraction.
Property Oxytocin Ergometrine PGF(Dinoprost) Carboprost
Class
Endogenous(typicallysyntheticversionused)posteriorpituitaryhormone
Ergotalkaloid Prostaglandin
UsesAugmentationoflabour,increaseuterinetone(PPH)
PPH SeverePPH SeverePPH
Presentation Clearliquidat5-10U.mlClearliquidat250μg.ml ,upto8doses(2mg)
RouteofAdministration IV IV,IM Intramyometrial
injection,IM Intramyometrial,IM
Dosing 1.5-12mU.min250μgIM(IVinemergencyviaslowpush)
500μgIM
Metabolism Oxytocinasesinliverandkidney
MechanismofAction
OxytocinGPCRintheuterus,increaseCainflux.StructurallysimilartoADH.
Actsonαand5HT receptorsonuterineandvascularsmoothmuscle
Resp Bronchospasm(maybesevere)
Bronchospasm(severeifIVsothisrouteiscontraindicated)
Bronchospasm,APOdueto↑PVRwithsubsequenthypoxia
CVS ↑HR,↓BPfollowingboluses
↑SVR,↑BP(maycause,↓HR)coronaryvasoconstriction
↑SVR,↑BP ↑SVR,↑BP(usuallytransient)
CNS Headache,nausea,vomiting Headache,nausea Nausea,
vomiting Headache
Renal↓UOduetoADH-likeeffectswithprolongedinfusions
GU
↑Uterinetone(↑frequencyatlowdose,tetaniccontractionathighdose),foetaldistress,lactation
↑Uterinecontractionfrequencyandtone
↑Uterinecontractionfrequencyandtone
↑Uterinecontractionfrequencyandtone,contraindicatedinpelvicinflammatorydisease
Other
Maybemetabolisedbyoxytocinasesinbloodproductsifco-administeredonthesameline
Contraindicatedinpre-eclampsiaduetoHTN
Deprecatedbycarboprost,increasedbodytemperature
2α
-1 -1
-1
2+ 2
Obstetric
686
![Page 687: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/687.jpg)
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.3. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.4. RoyalWomen'sHospita.PostpartumHaemorrhage-Carboprost.2017.
Lastupdated2019-07-18
Obstetric
687
![Page 688: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/688.jpg)
TocolyticsTocolyticsareagentswhichdecreaseuterinetone.Tocolyticsinclude:
β -agonistsCa -channelantagonistsCOXInhibitorsMgSONitratesVolatileanaestheticagents
Alltocolyticsarediscussedinmoredetailelsewhere-thiscoversjustthemechanismofactionoftheiruterineeffects.
Drug β -agonists Ca -channelantagonists COXInhibitors
Example Salbutamol,Terbutaline Nifedipine Indomethacin
MechanismofAction
ActivateGPCR,↑cAMP,whichactivatesproteinkinaseAandleadstoinhibitionofmyosinlightchainkinaseandrelaxation
BlockL-typeCa channels,causingrelaxation
Inhibitprostaglandinsynthesis,whicharevitalforuterinecontraction
References
1. Diaz,A.Describethemechanismofactionandsideeffectsofthreeclassesofdrugsthatareusedtoincreaseuterinetone,andthreeclassesofdrugsusedtodecreaseuterinetone.PrimarySAQs.
Lastupdated2019-07-18
22+
4
22+
2+
Tocolytics
688
![Page 689: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/689.jpg)
AcidSuppression
PropertyNon-
ParticulateAntacids
ParticulateAntacids ProtonPumpInhibitors H receptorantagonists
Example Sodiumcitrate
AluminiumHydroxide/Calciumcarbonate
Omeprazole Ranitidine
Uses Aspirationprophylaxis
Aspirationprophylaxis
Aspirationprophylaxis,GORD,pepticulceration
Aspirationprophylaxis,GORD,pepticulceration
Absorption
Rapidabsorptionduetohighwatersolubility
Lowerwatersolubilityresultsinslowerabsorptionandonsetbutnoriskofalkalosis
Absorbedinsmallbowel,highPObioavailability 50%PObioavailability
Distribution LowV of0.3L.kg 15%proteinbound
Metabolism
Prodrug,activatedwithinparietalcell.CYP450metabolised,inhibitsCYP2C19(reducing,amongotherthings,theantiplateleteffectofclopidogrel)
PartialhepaticbyCYP450
Elimination Renalofmetabolitesandactivedrug
Renalofmetabolitesandactivedrug
MechanismofAction
Basereactswithgastricacidtoproducesaltandwater
Basereactswithgastricacidtoproducesaltandwater
IrreversibleantagonismoftheparietalH /K ATPase
Competitiveantagonismofthe(Gs)H receptor,which↓cAMPproduction,↓intracellularCa ,and↓activityoftheH /K ATPase
Resp
Lowerriskofpneumonitisifaspirated
Greaterriskofpneumonitisifaspirated
Potentiallyincreasedseverityofpneumoniaifaspirationoccurs(riskwithmicro-aspirationinlong-termintubatedpatients)
Pneumonitis/pneumoniaasperPPI
CVS↓HR,↓BP,andarrhythmogenicwithrapidIVadministration
RenalPotentialmetabolicalkalosis
Noriskofalkalosis Interstitialnephritis
GIT ↑GastricpH ↑GastricpH ↑GastricpH(pH↑by~1),↓
volumeofsecretions
Other Tastebad
References1. PetkovV.EssentialPharmacologyForTheANZCAPrimaryExamination.VesselinPetkov.2012.2. ANZCAFeb/April2012
2
D-1
+ +2
2++ +
Gastrointestinal
689
![Page 690: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/690.jpg)
3. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.OxfordUniversityPress.4thEd.2011.
Lastupdated2019-07-18
Gastrointestinal
690
![Page 691: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/691.jpg)
AntiemeticsAntiemeticdrugscanbeclassifiedbytheirmechanismofaction:
SerotoninantagonistsOndansetron
CorticosteroidsDexamethasoneHasadditionaleffectsonpostsurgicalpainandfatigue.
DopamineantagonistsPhenothiazines
ChlorpromazineProchlorperazine
ButyrophenonesDroperidol
BenzamidesMetoclopramide
AnticholinergicsHyoscineAtropine
AntihistaminesCyclizine
NK antagonistsAprepitant
OthersBenzodiazepinesCannabinoidsPropofol
ComparisonofAntiemeticDrugs
Property Ondansetron Droperidol Metoclopramide Cyclizine
Class SerotoninantagonistBenzamidedopamineantagonist
DopamineantagonistPiperazinederivative/Hantagonist
Uses
Nausea.Ineffectiveforvomitingduetomotionsicknessordopamineagonism
Antiemetic,sedation,behaviouralcontrol
Prokinetic,antiemetic
Antiemetic(includingmotionsicknessandradiationsickness)
PresentationTablet,wafer,clearsolutionforinjectionat4mg.ml
Clearsolutioninbrownglass,incompatiblewiththiopentoneandmethohexital
Clearsolutioninplastic
50mgtabletsor50mg.mllight-sensitivesolution
RouteofAdministration PO/SL/IV IV IV/PO PO/IV/IM
Dosing4-8mgTDSGiveoninductionfor
IVGiveatendofsurgeryfor
25-50mgIV(note10mghasnoantiemeticproperties
1mg.kg upto150mgperday
1
1
-1
-1
-1
Antiemetics
691
![Page 692: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/692.jpg)
PONV PONV
Absorption PObioavailability60% PObioavailability30-90%
PObioavailability80%
Distribution 75%proteinbound90%proteinbound,V2L.kg
Minimalproteinbinding,V ~3L.kg
Metabolism
Hepatictoinactivemetabolites.Dosereductioninhepaticimpairment.t3/24.
Extensivehepaticmetabolism Hepaticmetabolism
Hepatictoinactivemetabolites
Elimination Renaleliminationofinactivemetabolites
Renalandhepaticofdrugandmetabolites
Renalof20%unchangeddrugandremainderasmetabolites
Renalofmetabolites
MechanismofAction
Centralandperipheralantagonismof5-HTreceptors,reducinginputtothevomitingcentre
CentralDblockadeandpost-synapticGABAantagonism
AntiemeticactivityviacentralD antagonism,prokineticactivityviamuscarinicagonism,peripheralD antagonism
CompetitiveHantagonistandanticholinergicatM ,M ,Mreceptors
CVS
BradycardiawithrapidIVadministration,QTprolongation
QTprolongation,hypotensionsecondarytoαantagonism
↑/↓HR,↑/↓BP↑HRand↓BPduetoαantagonism
CNS Headache
Sedation(neurolepsis),extrapyramidalsymptomsin~1%
Extrapyramidalsymptoms,neurolepticmalignantsyndrome
Sedation
GIT Constipation Antiemetic Antiemetic,prokinetic IncreasedLoStone
Endocrine Hyperprolactinaemia
References
1. PeckTE,HillSA.PharmacologyforAnaesthesiaandIntensiveCare.4thEd.CambridgeUniversityPress.2014.2. SébastienPierre,MD,RachelWhelan.NauseaandVomitingAfterSurgery.ContinEducAnaesthCritCarePain2013;13
(1):28-32.doi:10.1093/bjaceaccp/mks0463. SmithS,ScarthE,SasadaM.DrugsinAnaesthesiaandIntensiveCare.4thEd.OxfordUniversityPress.2011.
Lastupdated2017-08-01
D-1 D-1
1/2
3
22
2
1
1 2 3
Antiemetics
692
![Page 693: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/693.jpg)
IntravenousContrast
Intravenouscontrastmaybedividedinto:
X-rayContrastTheseagentsareallbasedonatri-iodinatedbenzenering,whichabsorbsx-rayradiation.Alterationstothisringaltertoxicity,lipophilicity,andelimination.
Agentsareclassifiedbythesestructuraldifferencesinto:IonicIonicsubstancesarestrongacidsandarewatersolubleduetoionisation.Theyarefurtherdividedinto:
MonomersTypicallyhighmolecularweight.Dimers
Non-IonicWatersolubleduetohydrophilicsidechains.Lowermolecularweightthanioniccontrastagents.
MonomerAgentofchoiceforangiography.
EasytoinjectWatersolubleatphysiologicpH
DimerHardertoinjectthanmonomersduetohigherviscosity.Typicallyusedforurography.
Allarerenallyeliminated,andmayberetainedinrenaldysfunctionGadoliniumContrastGd ,duetoitssevenunpairedelectrons,isparamagneticandwillaltersthemagneticfieldofanMRImachine.
FreegadoliniumisnephrotoxicandmustbechelatedThisincreasesitssolubilityandallowsittoberenallyeliminatedGadoliniumalsoattenuatesx-rays,butisnotusedasx-raycontrastasdosesrequiredwouldbetoxic
AdverseReactions
Adversereactionstolow-osmolarityagentsareuncommon(3%),withseverereactionsbeingveryrare(0.04%)andfatalreactionsbeingextremelyrare(1:170,000).
GeneralAdverseReactions
Adversereactionsinclude:
ChemotoxicityPlateletinhibitionIncreasedvagaltone
NegativeinotropyNegativechronotropy
IonictoxicityCellularmembranedysfunctionMayworsenmyastheniagravis.
OsmotoxicityPainEmesisIncreasedPAP
3+
OtherDrugs
693
![Page 694: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/694.jpg)
DecreasedPVRHypersensitivityreactionTypicallyoccurwithin20minutesofinjection.
Riskfactorsinclude:
AsthmaoratopyCriticallyillCardiacdiseaseRenaldisease
ContrastNephropathy
Definedasanincreaseincreatinineby25%abovebaselinewithinthreedaysofIVcontrastadministration.
Itistheorisedthatosmoticstressanddirecttubulartoxiceffectsleadtorenaltubularinjury,andmaycauseacutetubularnecrosisTypicallyisbenign,withcreatininereturningtobaselinewithin10-14daysSignificantuncertaintyastowhethercontrastmediadocauseacutekidneyinjuryIFthisriskispresent,itisprobablyonlyrelevantinpatientswhohave:
ImpairedrenalfunctionArterialcontrast
Rehydrationandvolumecorrectionareeffectiveinpreventingariseincreatinine
References
1. DickinsonMC,KamPC.Intravasculariodinatedcontrastmediaandtheanaesthetist.Anaesthesia.2008Jun;63(6):626-34.2. TheRoyalAustralianandNewZealandCollegeofRadiologists.IodinatedContrastMediaGuideline.Sydney:RANZCR;
2016.
Lastupdated2019-07-18
OtherDrugs
694
![Page 695: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/695.jpg)
DefinitionsThisappendixisalistofkeydefinitionsthatarecommontomanytopics.
A
AbsoluteHumidityMassofwatervapourinagivenvolumeofair.Measuredinmg.L .
AbsorptionTherateatwhichadrugleavesitssiteofadministrationandtheextenttowhichthisoccurs.
AccuracyTheabilityofameasuringdevicetomatchtheactualvalueofthequantitybeingmeasured.
AcidAprotondonor.
AcidaemiaArterialbloodpH<7.35.
AcidosisAprocesswhichleadstoanexcessofhydrogenions,andmayleadtoacidaemiaifthereisinadequatecompensation.Canbesubdividedinto:
Respiratoryacidosis:PaCO >45Metabolicacidosis:HCO <22
ActivityTheeffectiveconcentrationofasubstanceinareactingsystem.
AcutePainDefinedaspainof:
RecentonsetLimitedprobabledurationIdentifiablecausalandtemporalrelationshiptoinjuryordisease
AdiabaticAprocessthatoccurswithouttransferofheatormatter.Forexample,gasesheatupwhencompressed(greaterthantheenergyusedtocompressthem),andcoolwhenallowedtoexpand(adiabaticcooling).
AffinityAbilityofadrugtobindtoareceptor.
AfterloadSumofforces,bothelasticandkinetic,opposingventricularejection.
AgingNaturallyoccurring,physiologicaldeclineinthestructureandfunctionalreserveofallorgansystems.
AgonistDrugwhichproducesamaximalresponseatreceptorsite.
AlkalaemiaArterialbloodpH>7.45.
-1
23-
Definitions
695
![Page 696: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/696.jpg)
AlkalosisAprocesswhichleadstoadeficitofhydrogenions,andmayleadtoalkalaemiaifthereisinadequatecompensation.Canbesubdividedinto:
Respiratoryalkalosis:PaCO <35Metabolicalkalosis:HCO >26
AllodyniaPaincausedbyapreviouslynon-painfulstimulus.
AllostericModulatorSubstancewhichbindsareceptordistanttotheligand-bindingsite,andmodifies(positivelyornegatively)theeffectoftheligand.Hasnoactivityinabsenceofaligand.
AnaesthesiaWithoutsensation.
AnalogueSignalWheretheoutputofthetransducervarieswiththeinputsignal.
AnionNegativelychargedion.
AnodeTheelectrodewhichconventionalcurrentflowsinto.
AnrepeffectMethodofmyocardialautoregulationinwhichanincreaseinafterloadcausesanincreaseincontractility.
AntagonistDrugwhichproducesnoresponseatthereceptor,butpreventsotherligandsbinding.
AutoregulationAbilityofanorgantomaintainhomeostasisinthepresenceofdynamicphysiologicalconditions.
AzeotropeAmixtureoftwosubstancesthatcannotbeseparatedbyfractionaldistillation,aseachcomponentsharessameboilingpoint.Thisistypicallytemperaturedependent.
B
BaseProtonacceptor.
BaseExcessAmountofacidthatmustbeaddedtoasolutiontoloweritspHto7.4,at37°CandwithaPaCO of40mmHg.
BathmotropyDegreeofmyocardialexcitability.Usedwitheitherpositiveornegativebathmotropy.
Bell-MagendieLawTheprinciplethatinthespinalcordthedorsalrootsaresensoryandtheventralrootsaremotor.
BiasThesystematicdistortionoftheestimatedinterventioneffectawayfromthe“truth”,causedbyinadequaciesinthedesign,conduct,oranalysisofatrial.
23-
2
Definitions
696
![Page 697: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/697.jpg)
Black-bodyradiationElectromagneticradiationgivenoffbyallbodiesatgreaterthan0°K.Wavelengthofradiationemitteddependsonthetemperatureofthebody.
BohrEffectAnincreasein[H ]orPaCO decreasesHbaffinityforO2.
BoilingPointThetemperatureatwhichthevapourpressureofaliquidequalstheenvironmentalpressuresurroundingtheliquid.
Thereforeboilingpointdecreasesasenvironmentalpressurefalls,asthereislessexternalpressurekeepingmoleculesintheirliquidstateBoilingdiffersfromevaporationasmoleculesanywhereintheliquidmayenterthegaseousphase,whilstevaporationoccursonlyatthesurface
BowditchEffectIncreaseincontractilityseenwithanincreaseinHR.AlsoknownastheTreppeeffect.
Boyle'sLawPressureofagasisinverselyproportionaltovolume.
BufferSolutioncontainingaweakacidanditsconjugatebaseandwillresistachangeinpHwhenastrongeracidofbaseisadded.
C
CalibrationAprocessofcheckingamonitoringdeviceforlinearityofcorrelationbetweenactualandmeasuredvaluesoveragivenmeasurementrange.
CapacitanceAbilityofasystemtostoreelectricalcharge.MeasuredinFarads.
CentralBloodVolumeVolumeofbloodinheartandlungs.
CentralSensitisationIncreasedresponsivenessofnociceptiveneuronsinthecentralnervoussystem(i.e.,post-synaptic)totheirnormalorsubthresholdafferentinput.
ChemotaxisMovementofcellsalongagradientofincreasingconcentrationofanattractingmolecule.
ChronicPainPainthat:
PersistsbeyondthetimeoftissuehealingFrequentlyhasnoclearlyidentifiablecause
ClearanceVolumeofplasmacompletelyclearedofasubstanceperunittime.
CoronaryBloodFlowAtrestis~5%ofCO,or225ml.min ,andmayincrease3-4xduringexercise.
ColloidSubstanceevenlydispersedthroughoutanothersolutioninwhichitisinsoluble.
ColligativeProperties
+2
-1
Definitions
697
![Page 698: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/698.jpg)
Thepropertiesofasolutionthatdependontheratioofsolutetosolvent,andnotonthetypeofmoleculespresent.These
include:VapourpressureBoilingpointFreezingpointOsmoticpressure
ComplianceDistensibilityofasystem.Expressedasthechangeinvolumeforagivenchangeinpressure.
ConcentrationEffectDescribesthedisproportionatelyrapidriseinFi/FAratioofnitrousoxide,asitsrapiddiffusionacrossthealveolarmembraneincreasestheconcentrationofalveolargas,andalsoaugmentsrespirationbydrawingindeadspacegas.
Context-SensitiveHalf-TimeTimetakenforplasmadrugconcentrationtofallto50%ofitsstartingvalueaftercessationofadruginfusionaimedtomaintainaconstantplasmaconcentration.Varieswiththecontext,orduration,ofdruginfusion.
ContractilityFactorsaffectingmyocardialperformance,independentofpreloadandafterload.
CriticalLengthThelengthofaxonwhichmustbeblockedinordertopreventactionpotentialtransmission.Itisdependentonmyelinationandfibrediameter.
CriticalPointThepointonaphasediagramwheretheliquidandgasphasesofasubstancehavethesamedensity,andarethereforeindistinguishable.
Thispointiswhereasubstanceisatbothitscriticaltemperatureandcriticalpressure
CriticalPressurePressurerequiredtoliquefyavapouratitscriticaltemperature.
CriticalTemperatureTemperatureabovewhichasubstancecannotbeliquified,irrespectiveofhowmuchpressureisapplied.
CriticalVolumeThevolumeoccupiedbyagivenamountofsubstanceatitscriticalpoint.
DDaltonUnitofmassequalto1/12 ofthemassofCarbon-12.
Dalton'sLawThepartialpressureofagasinamixtureisequaltothepressurethatgaswouldexertifitoccupiedthevolumealone.
DeadSpaceInspiredgasnotparticipatingingasexchange.Includes:
ApparatusdeadspaceGasintheventilatororbreathingcircuit.AnatomicaldeadspaceGasintheconductingzoneofthelung.AlveolardeadspaceAlveolargasnotparticipatingingasexchange.AlsoknownasWestZone1.
th
Definitions
698
![Page 699: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/699.jpg)
PhysiologicaldeadspaceSumofalveolarandanatomicaldeadspace.
DensityMassperunitofvolume.
DependenceWhenacharacteristicwithdrawalsyndromeoccurswhenadrugiswithdrawn,oranantagonistadministered.
DiffusionPassivemovementofasubstancedownanactivitygradientbyBrownianmotion.
DiffusionHypoxiaFallinalveolarPAO duetodilutionofalveolargasbyN Odiffusingfrombloodtoalveoli.
DigestionProcessofbreakingdownmacromoleculesintoreadilyabsorbedcompounds.
DopplerEffectAlterationinfrequencyofasignalduetoarelativedifferenceinvelocitybetweentheemitterandobserver.Detectedfrequencieswillbe:
HigheriftheemitterismovingtowardtheobserverLoweriftheemitterismovingawayfromtheobserver
DownregulationDecreaseinreceptornumberduetochronicagonistexposure.
DriftAfixeddeviationfromthetruevalueatallpointsinthemeasuredrange.
DrugSubstanceadministeredtocauseachangeinaphysiologicalsystem.
DuplicatePublicationWherethesamesetofresultsarepublishedinmultiplejournals.Academicallyunethical,andwillcauseasystematicbiasinameta-analysesasthesamesetofpatientsareincludedtwice.
DyneForcerequiredtoaccelerate1gby1cm.sec .
E
EfficacyMaximaleffectproducedbyadrug.Analogoustointrinsicactivity.
ElectrocardiogramGraphicalrecordingofthevectorsumofcardiacelectricalactivity,asmeasuredbyelectrodesontheskin.
EmulsionAfinedispersionofminutedropletsofoneliquidinanotherinwhichitisnotsolubleormiscible.
EnzymeBiologicalcatalyst.
EutecticAmixtureofsubstanceswiththelowestpossiblemeltingpointthananyothermixtureofthesamesubstances(andlowerthanthatofeithersubstance).
2 2
-2
Definitions
699
![Page 700: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/700.jpg)
ExcitabilityHowrapidlyanexcitablecelldepolarises.Givenbythegradientofphase0oftheactionpotential,andisdependentonthefunctionofvoltage-gatedsodiumchannels.
ExponentialFunctionMathematicalfunctionwheretherateofchangeisproportionaltothecurrentvalue.
ExternalValidityHowwellfindingsfromonesettingcanbeappliedtoanother.
FFahraeus-LindqvisteffectDecreaseinapparentviscositythatoccurswhenasuspension(e.g.blood)flowsthroughatubeofsmallerdiameter.
FastingMetabolicstateachievedaftercompletedigestionandabsorptionofamealpriortotheonsetofstarvation.
FickPrincipleBloodflowtoanorganequalstheuptakeofatracersubstancebythatorgan,dividedbythearterio-venousconcentrationdifference.
FlowQuantityoffluidpassingapointperunittime.
FourierAnalysisDeconstructionofacomplexwaveformbyseparatingitintoitsconstituentsinewaves.Theslowestcomponentisknownasthefundamentalfrequency.
FreeradicalExtremelyreactivemolecularconstituentcarryinganunpairedelectron.
FreezingpointTemperatureatwhichmolecularmovementbegins.
FunctionalResidualCapacityVolumeofgasinthelungsattheendofanormaltidalexpiration,whentherecoilpressureofthelungsequalstheexpansilepressureofthechestwall.
GGalvanometerDevicetomeasureelectricalcurrent,usuallyviadeflectionofawireinamagneticfield.
GasSubstanceaboveitscriticaltemperature.
GeneralanaesthesiaDruginduced,controlled,andreversibleproductionofunconsciousness.
Gibbs-DonnanEffectDescribesthetendencyofdiffusableionstodistributethemselvessuchthattheratiosoftheconcentrationsareequalwhentheyareinthepresenceofnon-diffusableions.
GrahamsLawThespeedofdiffusionofagasthroughamembraneisinverselyproportionaltothesquarerootofthemolecularweight.
Definitions
700
![Page 701: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/701.jpg)
H
HaldaneeffectDeoxygenatedbloodformscarbaminocompoundsandbuffersH betterthanoxygenatedblood.
Half-LifeTimetakenfordrugconcentration(typicallyinplasma)tofallbyhalf.
HeatKineticenergycontentofabody,asmeasuredinjoules.
Henry'sLawAmountofgasdissolvedinasubstanceisdirectlyproportionaltothepartialpressureofgasatthegas-liquidinterface.
HeterometricautoregulationChangeinventricularfunctionbasedonmyocardialfibrelength.AlsoknownasStarling'sLaw.
HomeometricautoregulationMechanismswhichaltermyocardialperformanceindependentoffibrelength.
HormoneChemicalmessengersecretedbyaductlessglandandhasactiononadistanttargetcell.
HyperalgesiaGreaterthannormalamountofpainfromanoxiousstimulus.Maybe:
PrimaryOccurringintheregionoftissuedamage,e.g.inaninflamedareaaroundawound.SecondaryExtendingbeyondtheregionoftissuedamage.
HypoxaemiaWhenPaO islessthan60mmHg.
HypoxiaThepointatwhichinadequateoxygenationoftissuesresultsinanaerobicmetabolism.
HysteresisWhenthefuturestateofasystemdependsnotonlyonitscurrentstate,butonthestatesprecedingit.
I
IdealGasAgaswhichwillobeytheidealgaslaw.Anidealgasmusthave:
NegligibleintermolecularattractionAsmallmolecularvolumecomparedtothespacebetweenthemolecules
IdiosyncrasyAneffectofadrugaffectingonlyasmallnumberofpatients,typicallyduetotheactionofaparticularmetabolite.
InductancePropertyofaconductorbywhichachangeincurrentinducesanelectromotiveforceintheconductorandanynearbyconductors.
InotropeDrugwhichaltersmyocardialcontractility.
+
2
Definitions
701
![Page 702: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/702.jpg)
IntrinsicActivityMaximaleffectproducedbyadrug.Analogoustoefficacy.
ImpedanceResistancetoalternatingcurrent.
InternalValidityWhereacausalrelationshipbetweenvariableshasbeenproperlydemonstrated,i.e.alackofbias.
IrritabilityHoweasilyanexcitablecellcanbestimulated.Givenbyhowclosetherestingmembranepotentialistothresholdpotential.
IsomerCompoundwiththesamechemicalformula,butdifferentchemicalstructureorarrangementofatoms.
IsothermLineofconstanttemperaturedrawnonapressure-volumegraphforagas,whichdescribestherelationshipbetweenpressure,temperature,andvolumeforaparticulargas.
J
JouleEnergytransferedtoanobjectwhenitisactedonby1Nfor1m.
L
LaminarFlowFlowoccurringsmoothlyandwithoutturbulence.
LocalAnaestheticDrugwhichreversiblypreventstheconductionofthenerveimpulseintheregiontowhichitisapplied,withoutaffectingconsciousness.
M
MACTheminimalalveolarconcentration(measuredin%of1atm)atsteadystatewhichpreventsamovementresponsetoastandardsurgicalstimulus(midlineincision)in50%ofapopulation.
ManometerDevicewhichmeasuresgaspressure.
MeanSystemicFillingPressureThepressuremeasuredanywhereinthesystemiccirculationwhenallflowofbloodisstopped.
MixedVenousBloodBloodfromtheIVC,SVCandcoronarysinus,whichhasbeenmixedbythepumpingactionoftheRVandistypicallysampledfromthepulmonaryartery.
MoleAmountofasubstancewhichcontainsasmanyrepresentativeparticlesasthereareatomsin12gofcarbon-12.
MolalityNumberofmolesofsoluteperkgofsolvent.
Definitions
702
![Page 703: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/703.jpg)
MolarityNumberofmolesofsoluteperLofsolvent.Varieswith:
TemperatureSolventdensitySolutevolume
N
NaturalFrequencyFrequencyatwhichasystemwilloscillateatifdisturbedandleftalone.
NauseaUnpleasantsubjectivesensationassociatedwithurgetovomit.
NeuropathicPainPaincausedbyalesionordiseaseofthesomatosensorynervoussystem.
NociceptionNeuralprocessofencodinganoxiousstimulus.
O
OddsRatioEstimateofrisk,wheretheORistheratioofoddsofanoutcomeinthosetreatedvs.thosenottreated.OR=1suggestsnoeffect,≤1suggestsreducedrisk>1suggestsincreasedrisk.
OhmResistancewhichwillallowoneampereofcurrenttoflowpervoltofpotentialdifference.
OpiateNaturallyoccurringsubstancewithmorphine-likeproperties.
OncoticPressureProportionofosmoticpressureduetocolloid.
OpioidDescribesanysubstancewithactivityatopioidreceptors,andwhichcanbereversedbynaloxone.
OsmosisMovementofasolventacrossasemipermeablemembranetoanareaofgreatersoluteconcentration.
OsmoticPressurePressurethatmustbeappliedtoasolutiontopreventthemovementofasolventfromenteringasolutionwithhigherosmolality.
OxygenFluxVolumeofoxygendeliveredtothetissuesperminute.
P
p50Thepartialpressureatwhichanoxygen-carryingproteinis50%saturated.
Definitions
703
![Page 704: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/704.jpg)
PainUnpleasantsensoryandemotionalexperienceassociatedwithactualorpotentialtissuedamage,orexpressedintermsofsuchdamage.
PartitionCoefficientDescribetherelativeaffinityofanagentfortwophases.Itisdefinedastheratiooftheconcentrationofagentineachphase,whenbothphasesareofequalvolumeandthepartialpressuresareinequilibriumatSTP.
PasteurPointPO atwhichoxidativephosphorylationceases.
PEEPSupra-atmosphericairwaypressureattheendofexpiration.
pHThepowerofhydrogen.Describestheactivityofhydrogenionsinasolution,andisexpressedas
.
PreloadLoadimposedonamusclebeforecontraction,andmeasuredastheaveragemyocardialfibrelengthattheonsetofsystole.MaybeapproximatedclinicallyusingEDV.
PrecisionTheabilityofameasurementdevicetoprovidereproducibleresultsuponrepeatedmeasurement.
Pseudo-criticaltemperatureTemperatureatwhichagasmixturewillseparateintoitsconstituentcomponents.
RRadiationTransferofenergyviaelectromagneticradiation.
ReceptorComponentofacellwhichbindstoaligandandresultsinachangeinfunction.
ReductionReactionwhichresultsinagainofanelectron.
ReflexUnconscious,predictableresponsetoastimulus.
RegurgitationPassivepassageofgastriccontentsintothemouth.
RelativeHumidityRatioofmassofwatervapourinagivenvolumeofair,tothemassrequiredtosaturatethatvolumeatthattemperature.Expressedasapercentage.
RespiratoryExchangeRatioRatioofCO producedtoO consumedatanygivenpoint.
RespiratoryQuotientRatioofCO producedtoO consumedatsteady-state.
ReynoldsNumberDimensionlessindexwhichpredictsthelikelihoodofturbulentflow.
2
2 2
2 2
Definitions
704
![Page 705: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/705.jpg)
S
SaturatedVapourVapourwhichisinequilibriumwithitsownliquidstate,i.e.thereareasmanymoleculesenteringthevapourphaseastheretherearethosecondensingintotheliquidphase.
Asaturatedvapourcontainstheleastamountofenergypossiblewithoutcondensing
SaturatedVapourPressurePressureexertedbyavapourwhichisinequilibriumwithitsliquidstate.Increaseswithtemperature,sinceasthekineticenergy(heat)contentofmoleculesincrease,moreofthementerthevapourphase.
SecondGasEffectDisproportionatelyrapidriseinFA/Firatioseenwhenananaestheticagentisco-administeredwithnitrousoxide.
SeebeckeffectThegenerationofapotentialdifferenceatthejunctionoftwodissimilarmetals,withitsvaluedependentonthetemperatureofthejunction.
ShiveringInvoluntary,oscillatory,muscularactivitythataugmentsmetabolicheatproduction.
ShuntBloodenteringtheleftsideofthecirculationwithoutbeingoxygenatedviapassagethroughthelungs.
SpecificGravityDensityofaliquid,inmassperunitvolume.
SpecificHeatCapacityAmountofheatenergyrequiredtoraisethetemperatureof1kgofasubstanceby1°Kwithoutachangeinstate.
StandardBaseExcessThebaseexcesscalculatedforanHbof5g.L ,andwhichgivesabetterrepresentationofECFpH.
SurfaceTensionDescribesthetendencyofafluidtominimiseitssurfacearea.
SuspensionParticlesofanyphasedispersedinaliquid.
SynergismWhentwodrugsinteracttoproduceagreatereffectthanwouldbeexpected.
TTemperatureAbilityofabodytotransferheatenergytoanotherbody,asmeasuredindegrees.
ThirstConscioussensationofthephysiologicalurgetodrink.
TimeconstantTimeitwouldtakeforanexponentialfunctiontocompleteiftheinitialrateofchangecontinued.Aprocessis:
63%completeat1T86.5%completeat2T95%completeat3%
-1
Definitions
705
![Page 706: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/706.jpg)
TonicityEffectiveosmolalityofasolution.Givenbytheosmolality,minustheconcentrationoffreelydiffusableosmoles(inplasma,theseareureaandglucose).
TonometerDevicewhichmeasurespressureofliquid.
TransducerDevicewhichchangesasignalfromoneenergyformtoanother.
TreppeEffectIncreaseincontractilitywithanincreaseinHR.AlsoknownastheBowditcheffect.
TurbulentFlowIrregularmovementinradial,axial,andcircumferentialaxes.
VValsalvaManoeuvreForcedexpirationagainstaclosedglottis.
VapourSubstanceinagaseousphasebelowitscriticaltemperature.
VapourpressurePressureexpertedbyavapour.
VenousadmixtureAmountofmixedvenousbloodthatmustbeaddedtopulmonaryend-capillarybloodtogivetheobservedarterialoxygencontent.
ViscosityDescribesthetendencyofafluidtoresistflow.
VoltPotentialdifferencewhichdissipates1Wofenergyper1Aofcurrent.
VolumeofDistributionApparentvolumeintowhichadrugisdistributedtoproducetheidentifiedplasmaconcentration.
Lastupdated2019-07-20
Definitions
706
![Page 707: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/707.jpg)
KeyGraphsGraphs:
HelpyoutoconveyknowledgeandunderstandingefficientlyinthewrittenAreoftenafeatureofthevivaastheyallowexaminerstoassessdepthofunderstanding
Youwillbeaskedtodemonstratehowtheychangeunderdifferentphysiologicalstates
Itiseasytogetdistractedbythecurve,andforgetthebasics(especiallyinthewritten).Toavoidthis,approachtheminthesamewayeachtime:
AxisFirstdrawtheaxis.
Iftheaxisiscontinuous(e.g.PaO ),ensureyouplaceanarrowatthefarendIftheaxisendsatafixedpoint(e.g.SpO ),ensureyouplaceabarattheendtosignifyitdoesnotcontinueindefinitely
LabelsLabeleachaxiswithwhatitisrepresenting.UnitsGiveeachlabelappropriateunits.
Intheviva,youcanjustsaythisoutloudasyou'redrawingtheaxesCurveDrawthecurve.SpecialPointsIdentifythekeypointsofthecurveandlabelthesepoints.Theseinclude:
InterceptsInflectionpointsImportantvaluese.g.Themixedvenouspoint.
Pharmacology
Dose-Response:
Doseresponsecurveisawash-inexponentialDifficulttocomparedifferentdrugsusingthiscurve
Log -Response:
22
Dose
KeyGraphs
707
![Page 708: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/708.jpg)
Log-transformofdoseallowsdifferentdrugstobecomparedBothredandbluedrugsarefullagonists(astheybothreach100%response),howeverthebluedrugismorepotentasithasalowerE 50
Agonists:
Partialagonistsdonotreach100%responseInverseagonistshaveanegativeresponse
Antagonists:
Non-competitiveantagonistspreventmaximalresponsebeingreachedCompetitiveagonistsrightshiftthecurve,astheycanbeovercomewithincreasingdoseofagonist
TherapeuticIndex:
D
KeyGraphs
708
![Page 709: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/709.jpg)
CanbecalculatedfromtheratiooftheLD andED
Models
TheOne-CompartmentModel:
DrugisaddedtoandremovedfromthesinglecentralcompartmentThereisnodistributionpossible.V isequaltothevolumeofdistributionk istherateconstantforelimination
Three-CompartmentModel:
DrugisaddedtoandremovedfromthecentralcompartmentDrugwillalsodistributeto(andredistributefrom)theperipheralcompartmentsPlasmaconcentrationwilldependon:
RateofdrugdeliveryRateofdrugdistributionandredistribution
50 50
110
KeyGraphs
709
![Page 710: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/710.jpg)
Rateofdrugelimination
Effect-Site:
DrugdistributestotheeffectsitefromthecentralcompartmentEffectsitehasnovolume,butdoeshaverateconstantst ke0isgenerallydrawnwithdrugbeingeliminatedfromtheeffectsite,howeverinrealitythisdoesnotoccurasdrugshouldonlybeeliminatedfromthecentralcompartment
Pharmacokinetics
Zero-orderkinetics:
AconstantamountofdrugiseliminatedperunittimeHalf-lifeisnotaconstantvalueHalf-lifeprogressivelyshortens,asthetimetakentogofrom50%to25%ishalfthetimeittooktogofrom100%to50%.
First-OrderKinetics:
AconstantproportionofdrugiseliminatedperunittimeHalf-lifeisaconstantvalue
1/2
KeyGraphs
710
![Page 711: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/711.jpg)
Biexponentialelimination:
Notethatconcentrationhasbeenlog-transformedThisdescribestheeliminationofdrugfromatwocompartmentmodel
Pharmacodynamics
Isobologram:
Plotslinesofequalactivityversusconcentrationoftwodrugs
Plasma-SiteTargeting:
TCIgraphsareeasytodrawifyourememberthat:
Thepumpaimstoachievethetargetedconcentration:AsrapidlyaspossibleWithoutovershoot
KeyGraphs
711
![Page 712: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/712.jpg)
EffectsiteconcentrationsfallslowerthanplasmasiteconcentrationsDrugcanonlyredistributebacktoplasmawheneffectsiteconcentrationisgreaterthanplasmaconcentration.
Thereforeinplasmasitetargeting:
PlasmaconcentrationrisesrapidlywithinitialbolusdoseDoesnotovershootEffectsiteconcentrationrisesmoreslowly
Exponentialwashincurveastheconcentrationgradientbetweenplasmaandeffectsitefallsovertime
Effect-SiteTargeting:
Plasmaconcentrationovershootseffect-sitetargetandthendeclinesrapidlyEffectsiteconcentrationrisesrapidly,andisachievedmorequicklycomparedwithplasma-sitetargetedmodel
Statistics
Boxplot:
Boxisdefinedbythe25 and75 centilesLineinthemiddleoftheboxisthemedian("50 centile")"Whiskers"eithersideoftheboxdefinethe10 and90 centiles
Thesemayalsorefertothe5 and95 centilesResultsoutsideofwhiskersaredefinedasoutliers,andarerepresentedbysingledots
Respiratory
Oxygen
OxygenCascade:
th ththth th
th th
KeyGraphs
712
![Page 713: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/713.jpg)
GraphoflocationversusoxygenpartialpressureAtmospheric(dry)airhasaPO of160mmHgTracheal(humidified)gashasaPO of149mmHgReducedduetosaturatedvapourpressureofwater.AlveolargashasaPO of105mmHgReducedtothepresenceofCO ,asperthealveolargasequation.ArterialbloodhasaPO of~100mmHgReducedtotheAlveolar-arterialoxygengradient.TissueshaveaPO of~5mmHgMixedvenousbloodhasaPO of~40mmHgGreaterthantissuePO asnotalloxygeninblooddiffusesintoorisconsumedbytissues.
OxyhaemoglobinDissociationCurve:
GraphofPaO versusoxygensaturationNotethatPaO2 iscontinuous,andsoanarrowshouldbedrawnatthetipofthex-axis,whilstsaturationisfiniteandsothey-axisshouldbecappedat100%ThecurveisasigmoidshapeKeypoints:
At10mmHg,saturationis10%
22
22
2
22
2
22
KeyGraphs
713
![Page 714: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/714.jpg)
Thep50isat27mmHgThemixedvenouspointisat40mmHg,wherehaemoglobinis75%saturatedNotethatduetotheHaldaneeffect,themixedvenouspointdoesnottechnicallyexistonthearterialcurve.Thisisasmallpointandisignoredinmostgraphs(includingthisone),butmaybeworthstatingifyou'refeelingconfidentintheviva.The"ICUpoint"(theupperinflection)isat60mmHgwherehaemoglobinis93%saturatedThearterialpointis97%saturatedat100mmHg
Thecurvemayberight-shiftedby:IncreasedHIncreasedPaCOIncreasedtemperatureIncreased2-3DPG
Theseshiftsaredefinedbyamovementofthep50
Double-BohrEffect:
ThedoubleBohreffectcaneasilybecomeconfusing,especiallywhenyouareunderpressureandonlyallowedonecolour(asinthewrittenexam)Hereisastraightforwardmethodwhichminimisestheconfusion:1. Drawanadultcurvewithap50of27mmHg2. Drawafoetalcurvewithap50of17mmHg3. Drawaright-shiftedadultcurve4. Drawaleft-shiftedfoetalcurve
PaO andMinuteVentilation:
+
2
2
KeyGraphs
714
![Page 715: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/715.jpg)
ExponentialcurveMinuteventilationdoublesasPaO decreasesfrom100mmHgto60mmHgInflectionpointis~50-60mmHgBelowthisthereisalargeincreaseinventilation.HypercapnealeadstoagreaterminuteventilationforanygivenPaO
IsoshuntDiagram:
PlotstherelationshipbetweenPAO versusPaO fordifferent(fixed)shuntfractionsTheseareknownasisoshuntlinesKeyisoshuntlinesare:
At50%shunt,PaO2isessentiallyindependentofPAO2At30%shunt,PaO2willnotincreaseabove100mmHgon100%oxygenatatmosphericpressure
CarbonDioxide
CarbonDioxideDissociationCurve:
GraphofcarbondioxidecontentversuspartialpressureKeypointsonthiscurve:
2
2
2 2
-1
KeyGraphs
715
![Page 716: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/716.jpg)
ArterialCO contentis48mls.100ml ofbloodat40mmHgMixedvenousCO contentis52.mls.100ml ofbloodat46mmHg
Notethatthemixedvenouscurveisup-shiftedduetotheHaldaneeffectRememberthat50%ofthedifferenceinCO contentisduetotheHaldaneeffect.Therefore:
ThemixedvenouscurveshouldbedrawnsuchthatCO contentis50mls.100ml at40mmHgThearterialcurveshouldbedrawnsuchthatCO contentis50mls.100ml at46mmHg
PaCO andMinuteVentilation:
GraphsthechangeinminuteventilationforprimarychangeinPaCORememberthatminuteventilationincreasesby~3L.min forevery1mmHgincreaseinPaCOFromthis,therelationshiptootherstatescanbederived:
Minuteventilationisreducedduringsleep,butthecentralresponsetoCO isonlyminimallyaffectedThecentralresponsetoCO isheavilyaffectedduringanaesthesiaMinuteventilationisincreasedforanygivenPaCO inthesettingofacidosis
AlveolarVentilationandPaCO :
GraphsthechangeinPaCO foraprimarychangeinminuteventilationExponentialcurveasPaCO isinverselyproportionaltominuteventilationMinuteventilationisincreasedforanygivenPaCO duringexercise
AnatomicalandPhysiologicalInteractions
ClosingCapacityandAge:
2-1
2-1
22
-1
2-1
2
2-1
2
22
2
2
22
2
KeyGraphs
716
![Page 717: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/717.jpg)
NotethatalthoughFRCincreasesslightlywithage,thisisnotgenerallyshownonthisgraphClosingcapacityincreaseswithincreasingageKeyintersectionsare:
GreaterthanFRCwhensupineat44yearsofageGreaterthanFRCwhenerectat66yearsofage
DiffusionandPerfusionLimitation:
ClassicallydrawnaspartialpressureversusdistancealongthecapillaryTimealongcapillarymayalsobeused,howevernotethattotaltransittimewillchangewithcardiacoutput.Notethatatthebeginningofthecapillary,oxygenpartialpressurewillbeequaltothatofmixedvenousblood
Inperfusionlimitation,PaO willequalPAO beforetheendofthecapillaryIndiffusionlimitation,partialpressureswillnotbeequalattheendofthecapillaryInnormalcircumstances,PaO equalsPAO at~1/3 ofthedistancealongthecapillaryIftimeisbeinggraphedonthex-axis,thenthiswilloccurat~0.25s,astotalcapillarytransittimeis~0.75s.
Nitrousoxiderapidlydiffusesintobloodandisandnottypicallypresentinmixedvenousblood,sothiscurvebeginsattheoriginandPaN OwillrapidlyreachPAN O(inthisinstance100mmHg)CarbonmonoxidebindsavidlytohaemoglobinandsoPaCOincreasesslowly,resultingindiffusionlimitation
RegionalVentilationandPerfusion:
2 2
2 22
2 2
KeyGraphs
717
![Page 718: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/718.jpg)
GraphofalveolarventilationandalveolarbloodflowversusribnumberintheerectpersonBasalalveolarhavegreaterperfusionandventilationthanapicalalveoliNotetheperfusiongradientissteeperthantheventilationgradientNotethattheV/Qratiois:
~1atthe3 rib~3.3attheapex~0.63atthebase
AirwayResistanceandAirwayGeneration:
GraphofairwayresistanceversusairwaygenerationAirwaygenerationsarefrom1to23,andsothisgraphshouldnotextendoutsidethesevaluesAirwayresistanceismaximalatthe5 generationThishasthelowesttotalcross-sectionalarea.Airwayresistanceisnegligibleintherespiratoryzone,whichexistsafterthe15 generation
AirwayResistanceandLungVolume:
Airwayresistancedecreasesaslungvolumeincreasesasradialtensiondistendsairways,increasingtheircross-sectionalareaandloweringairwayresistance
rd
th
th
KeyGraphs
718
![Page 719: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/719.jpg)
PulmonaryVascularResistanceandPulmonaryArteryPressure:
PulmonaryvascularresistancedecreasesaspulmonaryarterypressureincreasesArterialpressurehasagreatereffectonPVRthanvenouspressure
LungandChestWallVolumeandPressureRelationships:
GraphoflungvolumeversusrecoilpressureExpressinglungvolumeasapercentageoftotallungcapacitymaymakeiteasiertorememberthekeypointsonthisgraphNotethatrecoilpressureisthepressuregeneratedbetweenthelungandthechestwallwhentheyaredistended,itisnotintrapleuralpressure
ThisgraphiscomplexanditiseasytodrawincorrectlyThisisanapproachtomakeitaseasyaspossible:1. Drawasigmoidgraphforthepressure-volumerelationshipoftherespiratorysystemasawhole
Asrecoilpressureis0atFRCthiswillbethey-interceptThegraphwillasymptoteatresidualvolume,asvolume(bydefinition)cannotbecomelowerthanthisvolume
2. Drawasteeprun-awayexponentialforthepressure-volumerelationshipofthechestwallRecoilpressureshouldbe~-5cmH OatFRCRecoilpressureshouldbe0cmH Oat~75%ofTLCRecoilpressureshouldnotexceed~5cmH OatTLC
3. Drawasteepwash-inexponentialforthepressure-volumerelationshipofthelungRememberlungvolumecannotfallbelowresidualvolumeRecoilpressureshouldbe~5cmH OatFRCThisshouldbeequalandoppositetotherecoilpressureforthechestwall,asthesumofthesemustbe0atFRC.Notethatthiscurveshouldslightlyexceedthecurvefortherespiratorysystemasrecoilpressureincreases
WorkofBreathing:
22
2
2
KeyGraphs
719
![Page 720: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/720.jpg)
Graphoflungvolume(aboveFRC)versusintrapleuralpressureNotethatintrapleuralpressurebecomesmorenegativealongthex-axis.Theareaunderdifferentsectionsofthiscurvegivetheworkofbreathing
ElasticinspiratoryworkofbreathingisgiventhebluetriangleResistiveworkofexpirationisgivenbytheredareaNotethatasthisisentirelycontainedwithintheareaofelasticinspiratorywork,expirationispassiveanddoesnotrequireadditionalenergyexpenditure.Resistiveworkofinspirationisgivenbythegreenarea
WorkofBreathing-ActiveExpiration:
Whenresistiveexpiratoryworkexceedselasticinspiratorywork,activeexpirationmustoccurInthisgraph,activeexpirationisgivenbytheredareanotcontainedwiththebluetriangle
NeonatalFirstBreath:
Thisgraphdescribesthepressure-volumechangesoftheneonateasittakesitsfirstbreathsandestablishesFRCThisgraphiseasytodrawprovidedyourememberthat:
Priortothefirstbreath,lungvolumeis0Asthelunginitiallyhasverypoorcompliance,theintrapleuralpressuremustbecomeverynegativemorelungvolume
KeyGraphs
720
![Page 721: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/721.jpg)
increasessubstantiallyAttheendofeachbreath,intrathoracicpressureiscloseto0Witheachsubsequentbreath:
LungcomplianceimprovesThereforethemagnitudeofpressureswingsisreduced.FRCincreasesLungvolumeatend-inspirationisincreased.
Spirometry
ForcedVitalCapacity:
Graphofexpiredvolume(vitalcapacity)overtime~80%oftotalvolumeisexpiredwithinthefirstsecond(FEV )TotalFVCis4.5Linthe70kgGuytonManThegradientofinitialexpirationisthepeakexpiratoryflowrate
Spirometry:
GraphoflungvolumeovertimeIncludesanormaltidalbreathandavitalcapacitybreath
Flow-VolumeLoops
Normalloop:
1
KeyGraphs
721
![Page 722: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/722.jpg)
Peakexpiratoryflowis~8L.sPeakinspiratoryflowis~6L.sEffortindependentexpirationoccursduringexpiration
ObstructiveDisease:
ResidualvolumeandtotallungcapacityareincreasedduetogastrappingPeakexpiratoryflowisreducedThereisscallopingoftheeffort-independentportionofthecurveAlsoknownasaconcavecurve.
RestrictiveDisease:
TotallungcapacityisreducedResidualvolumeisnormalPeakexpiratoryflowmaybereduced(asseenhere)HowevertheFEV :FVCratiowillbenormalinpurelyrestrictivelungdisease.Effort-independentexpirationislinearandwilljoinwiththenormalcurve
FixedUpperAirwayObstruction:
-1-1
1
KeyGraphs
722
![Page 723: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/723.jpg)
ObstructionthatdoesnotchangecalibrethroughouttherespiratorycyclePeakexpiratoryandinspiratoryflowratesarelimited
ExtrathoracicObstruction
Obstructionworsensduringinspirationasitis'pulledin'bynegativeintrathoracicpressure
IntrathoracicObstruction
Obstructionworsensduringexpirationasitiscompressedbydynamicairwayscompression
AnaestheticAgents
F /F :A I
KeyGraphs
723
![Page 724: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/724.jpg)
GraphofthealveolaroverinspiredagentfractionversustimeforvariousvolatileagentsIndicatestherelativespeedofonsetofdifferentagentsUptakeofagentisproportionaltosolubilityinblood,andthereforeisinorderoftheirblood:gascoefficients
Theexceptionisnitrousoxide,whichhasafasterrateofrisethandesfluranedespiteitsgreaterblood:gascoefficientduetotheconcentrationeffect
F /F :
GraphofalveolaragentfractionversustimeforavolatileagentNotethelogarithmicscaleonthey-axisExponentialwashoutcurveFunctionoftwoseparatewashoutcurves
RapidwashoutwithremovalofagentfromcircuitandFRCSlowwashoutduetodiffusionofagentfromtissuesintoblood,andthenalveolus
Cardiovascular
LeftVentricularCoronaryBloodFlow:
GraphofbloodflowtotheleftventricleovertimeSystoleshouldbeclearlyidentified.LeftventricularflowoccurspredominantlyindiastolePeakflowis~115ml.min .Thereisabriefperiodofflowreversalduringisovolumetriccontraction
RightVentricularCoronaryBloodFlow:
A A0
-1
KeyGraphs
724
![Page 725: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/725.jpg)
GraphofbloodflowtotherightventricleovertimeRightventricularflowoccursthroughoutthecardiaccycleThisisbecauseaorticrootpressureexceedscavitypressurethroughoutthecardiaccycle.Peakflowis~15ml.min
BaroreceptorResponse:
GraphofheartrateversussystolicbloodpressureNotethattheRRintervalisinverselyproportionaltoheartrate.Heartrateresponsesasymptoteatextremesofbloodpressure
StarlingCurve:
Typicallydrawnasagraphofstrokevolume(orcardiacoutput,assumingaconstantheartrate)versuspreload(typicallyestimatedasend-diastolicvolume,butmayalsobeend-diastolicpressure)GraphdoesnotcrosstheoriginasEDVisnever0ml
StarlingCurve-Failing:
-1
KeyGraphs
725
![Page 726: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/726.jpg)
Myocardiumthathasbeenoverloadedbyhighend-diastolicvolumesmayleadtoadecreaseintensiongeneratedbythemyocardium
VenousReturn:
GraphofvenousreturnversusrightatrialpressureThex-interceptisthepointofnoflowwithinthecirculation(asVR=CO),andthereforeisthemeansystemicfillingpressureThecurveflattenswhenRAPbecomesnegative,asexternaltissuesactasaStarlingresistorandpreventfurtherincreasesinflow
VenousReturn-ComplianceandVolume:
Decreasingvenouscomplianceorincreasingcirculatingvolumeresultsinanincreaseinmeansystemicfillingpressure(asforanygivencompliance,pressuremustincreaseifvolumeincreases)andanincreaseinvenousreturnforanygivenrightatrialpressureTheoppositeoccurswithadecreaseincirculatingvolumeoranincreaseinvenouscompliance
VenousReturn-ResistancetoVenousReturn:
KeyGraphs
726
![Page 727: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/727.jpg)
Alteringresistancetovenousreturn(e.g.duringpregnancy,orlaparoscopicsurgery)willaltervenousreturnwithoutchangingmeansystemicfillingpressure
CirculatoryFunctionCurve:
PlottingthevenousreturncurveandtheStarlingcurveonthesameaxesgeneratesthisgraphThisisonlyvalidatsteadystate,i.e.whenCO=VR
Notethatassteady-stateexistswhenCO=VR,theinterceptofthesetwocurvesistheoperatingpointofthecirculation
WiggersDiagram:
KeyGraphs
727
![Page 728: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/728.jpg)
WiggersdiagramisagraphicalrepresentationoftheeventsduringeachphaseofthecardiaccycleKeypointstonote:
AorticdiastolicpressureoccursjustpriortoaorticvalveopeningAcommonmistakeistolabeldiastolicpressureatthedicroticnotch.VentricularpressureexceedsaorticpressureduringejectionAorticpressurewillslightlyexceedventricularpressureduringthelastpartofejectionThisisduetotheinertiaofejectedbloodcausingongoingforwardflowdespitethepressuregradient.ThedicroticnotchoccursontheaorticpressurecurveAcommonmistakeistodrawthisontheventricularcurve.CVPslightlyexceedsventricularpressureduringventricularfillingTheCwaveoccursduringisovolumetriccontractionTheVwavebeginspriortotheTwave,butpeaksaftertheTwavehasfinishedElectricaleventsslightlyproceedventricularmechanicalevents
ActionPotentials
PacemakerPotential:
KeyGraphs
728
![Page 729: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/729.jpg)
Thepacemakerpotentialhasonlythreephases,andnotablyno'restingphase'Thisisduetothefunnycurrent.Maximaldiastolicpotentialis-65mVPeakmembranepotentialis~20mV
PacemakerPotential-IonFlux:
DemonstratesthetimingofelectrolytepassageacrossthecellmembraneFunnycurrentoccursthroughoutphase4andtheearlypartofphase0T-typecalciumcurrentbeginsinlatephase4andterminatespriortotheonsetofphase0L-typecalciumcurrentoverlapswiththeT-typecurrentandcontinuesthroughoutphase3Outwardrectifyingpotassiumcurrentbeginsduringphase3andcontinuesduringphase4,restoringmembranepotential
PacemakerPotential-AutonomicTone:
Alterationtoautonomictonealterstheslopeofthefunny-current(Somesourcesalsonoteachangetomaximaldiastolicpotential,althoughthisisnotshownhere).
VentricularActionPotential:
KeyGraphs
729
![Page 730: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/730.jpg)
Theventricularactionpotentialconsistsof5phases0:Rapiddepolarisation1:PartialrepolarisationDuetoinitialeffluxofpotassiumwithoutproportionalcalciuminflux.2:PlateauOutwardpotassiumcurrentismatchedbyinwardcalciumcurrent.3:RepolarisationNotethattheabsoluterefractoryperiodendswhenrestingmembranepotentialfallsbelow-50mV,whichtypicallyoccursat~250ms.4:RestingmembranepotentialNotethat:
RestingMembranePotentialistypically~-85mVTherelativerefractoryperiodendswhenthemembranepotentialisatitsrestingstate
VentricularActionPotential-Hyperkalaemia:
Inhyperkalaemia:Theventricleismoreirritableasrestingmembranepotentialislessnegative,bringingitclosertothresholdpotentialThedurationoftheactionpotentialisshorter,increasingthechanceforare-entrantarrhythmia
BasicPressure-VolumeLoops
Pressure-volumeloopsarecoveredindetailunderpressure-volumerelationships.
LeftVentricularP-VLoop:
KeyGraphs
730
![Page 731: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/731.jpg)
LeftVentricularP-VLoop-IncreasedPreload:
LeftVentricularP-VLoop-IncreasedAfterload:
LeftVentricularP-VLoop-IncreasedContractility:
Advanced-PressureVolumeLoops
KeyGraphs
731
![Page 732: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/732.jpg)
Whendrawingchangestomoreleft-fieldpressure-volumeloopswhichyoumaynothaveseenbeforeapproachtheminthefollowingway:
Howispreloadchanged?Howisafterloadchanged?Howiscontractilitychanged?Howareisovolumetriccontractionandisovolumetricrelaxationchanged?
Advancedpressure-volumeloopsarecoveredindetailunderpressure-volumerelationships.
RightVentricularP-VLoop:
LeftVentricularP-VLoop-AorticStenosis:
LeftVentricularP-VLoop-AorticRegurgitation:
LeftVentricularP-VLoop-MitralStenosis:
KeyGraphs
732
![Page 733: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/733.jpg)
LeftVentricularP-VLoop-MitralRegurgitation:
Antiarrhythmics
VentricularActionPotential-ClassIa:
Prolongtherateofriseofphase0Lengthenthemyocardialactionpotential
VentricularActionPotential-ClassIb:
KeyGraphs
733
![Page 734: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/734.jpg)
Prolongtherateofriseofphase0Shortenthemyocardialactionpotential
VentricularActionPotential-ClassIc:
Prolongtherateofriseofphase0Donotalterthelengthofthemyocardialactionpotential
PacemakerPotential-ClassII(Beta-Blockade):
Sympatholyticeffectreducesthemagnitudeofthefunnycurrent
VentricularActionPotential-ClassIII:
KeyGraphs
734
![Page 735: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/735.jpg)
Prolongdurationofphase3ofthemyocardialactionpotentialThisprolongstherefractoryperiodandreducesthechanceofare-entrycircuitoccurring,andthereforereducestachyarrhythmiasbutmayincreasetheriskoftorsadedepointesduetoanincreasedriskofafterdepolarisations.
PacemakerPotential-ClassIV(CalciumChannelBlockade):
Inthepacemakercell,reducethemagnitudeofT-typeandL-typecalciumcurrents,reducingtherateofriseofphase0ofthepacemakeractionpotential
CNSMonroe-KellieDoctrine:
Graphstheintracranialpressureversusthevolumeofacomponent(blood,brain,orCSF)inthecranialvaultNotethatoverallvolumeisnotcorrect,asthisisunchanged-ifoverallvolumeincreasedthepressurewouldreduce(e.g.suchasadecompressivecraniectomy).Notetheinitialperiodofcompensation,whichoccursduetodisplacementofCSFtothespinalsubarachnoid,decreasedcerebralbloodvolume,andadecreaseinCSFvolume.OncecompensatoryresponsesareexhaustedICPwillincreaserapidlyduetothepoorelastanceofthecranialvault
KeyGraphs
735
![Page 736: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/736.jpg)
FocalischaemiaoccurswhenICPexceeds20mmHgGlobalcerebralischaemiaoccurswhenICPexceeds50mmhg
CerebralBloodFlowandCerebralPerfusionPressure:
CerebralbloodflowisautoregulatedforaCPPof50-150mmHg(Notethatthisclassicrelationshipisprobablyincorrect,andthatCBFisprobablyonlyautoregulatedacrossanarrowrangeofbloodpressures).
CerebralBloodFlowandPaCO :
CBFincreasesby~3%forevery1mmHgincreaseinCOBelowaPaCO of20mmHg,CBFcannotdecreasefurtherasthereducedflowresultsintissuehypoxia,andmetabolicautoregulatoryresponsesAboveaPaCO of80mmHg,CBFcannotincreasefurtherasvesselsaremaximallydilated
CerebralBloodFlowandPaO :
AboveaPaO of60mmHg,CBFisessentiallyindependentofPaOBelowaPaO of60mmHg,CBFincreasesrapidly
CerebralBloodFlowandTemperature:
2
22
2
2
2 22
KeyGraphs
736
![Page 737: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/737.jpg)
Cerebralmetabolicratefallsby~6%per°CdecreaseintemperatureThisresultsinaconcomitantreductioninCBFThisisanalmostlinearresponse.
Renal&Acid-Base
IonisedpotentialvspH-Acids:
AcidsareionisedabovetheirpKa
IonisedpotentialvspH-Bases:
BasesareionisedbelowtheirpKa
GlomerularFiltrationandMeanArterialPressure:
KeyGraphs
737
![Page 738: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/738.jpg)
GFRisautoregulatedforaMAPbetween60and160mmHg
GlomerularFiltrationRateandSerumCreatinine:
Atsteady-state,GFRandserumcreatinineareinverselyproportionalFollowingastep-changeinGFR,itwilltake~48hoursbeforesteady-stateisachievedagainDuringthisperiod,estimatesofGFRusingserumcreatininewillbelessaccurate.
GlucoseFlux:
Asglucoseisfreelyfilteredattheglomerulus,filteredplasmaglucosewillbedirectlyproportionaltoserumglucoseThisrelationshipisgivenbythedottedblackline.Undernormalcircumstances,allfilteredglucosewillbereabsorbedThisrelationshipisgivenbytheoverlapoftheredanddottedblacklines.Whenglucosefiltrationexceedsglucosereabsorption,glucosewillbegintobeexcretedinurine.Thisisgivenbythedottedblueline.
Theserumconcentrationofasubstanceatwhichthisoccursisknownasthetransportmaximum,orTInreality,someglucosewillbefilteredbeforeT isreached.ThisisduetothedifferentaffinityofS-GLUTchannels,andisthecauseofthegentlecurvesseenontheplotsofreabsorptionandexcretion.
Theserumconcentrationatwhichglucosestartstoappearinurineisknownasthethresholdconcentration
maxmax
KeyGraphs
738
![Page 739: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/739.jpg)
ThedifferencebetweenthresholdconcentrationandT isknownassplay
Haematology
CoagulationCascade:
Thecoagulationcascadeiscoveredindetailunderclotting
Thromboelastography:
TEG/ROTEMcanbeusedtoguidecoagulopathytreatmentas:ProlongedRtimeIndicatesdecreasedclottingfactorconcentration;giveFFP.
max
KeyGraphs
739
![Page 740: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/740.jpg)
Decreasedα-angle/prolongedKtimeDecreasedrapidityoffibrinogencross-linking;givefibrinogen.DecreasedMA(maybeassociatedwithprolongedKtime)Decreasedmaximalclotstrength;giveplateletsorDDAVP.DecreasedCL30/CL60Fibrinolysis;giveantifibrinolytic.
Other
HeatLossUnderAnaesthesia:
Heatlossunderanaesthesiaoccursinthreephases:1. Rapidreduction:1-1.5°Cin30minutes2. Gradualreduction:1°Cover2-3hours3. Plateau:Furtherheatlossattenuatedbymetabolicheatreduction
Doesnotoccurinneuraxialanaesthesiaasvasoconstrictiveresponsesarepreventedbysympathectomy
Equipment&MeasurementEinthoven'sTriangle:
Einthoven'striangledemonstratestherelationshipbetweendifferentlimbleadsandaugmentedleadsontheECGUnderstandingthetrianglemeansonecanidentifymisplacedECGelectrodesbythechangesinECGmorphology
e.g.iftheRAandLAelectrodesareswitched:LeadIwillinvertitspolarity
KeyGraphs
740
![Page 741: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/741.jpg)
LeadIIandIIIwillbeswitchedLeadsaVLandaVRwillbeswitchedLeadaVFwillbeunchanged
DampingCoefficients:
Followingastep-change:Anoptimally-dampedwaveformwillreturntobaselinewithoneovershootandoneundershootAnunder-dampedwaveformreturnstobaselinerapidlybutovershootsandundershootsseveraltimesAcriticallydampedwaveformreturnstobaselineasfastaspossiblewithoutovershootingAnover-dampedwaveformreturnstobaselineslowerthanacriticallydampedwaveform,anddoesnotovershoot
WheatstoneBridge:
CoveredindetailunderWheatstonebridge
GasAnalysis
ClarkElectrode:
CoveredindetailunderOxygenTension
pHElectrode:
KeyGraphs
741
![Page 742: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/742.jpg)
CoveredindetailunderpHMeasurement
SeveringhausElectrode:
CoveredindetailunderCarbonDioxideTension
Capnography
Capnograph:
KeyGraphs
742
![Page 743: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/743.jpg)
Thecapnographwaveformconsistsoffourcomponents:1. Baseline
Inspirationandearlydead-spaceexpiration(containingnoCO ).2. Alveolarexhalation3. Alveolarplateau
HighestpointisdefinedasE CO .4. Inspiration
VariationsonthewaveformarecoveredunderE CO WaveformVariations
References
1. Wigger'sDiagram(withsomemodifications)fromWigger'sDiagram.21/3/2012.(Image).ByDanielChangMD(revisedoriginalworkofDestinyQx);RedrawnasSVGbyxavax.CCBY3.0,viaWikimediaCommons.
2. ClottingCascade22/4/2007.(Image).ByJoeD(Ownwork).CCBY3.0,viaWikimediaCommons.
Lastupdated2019-07-18
2
T 2
T 2
KeyGraphs
743
![Page 744: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/744.jpg)
LawsandEquationsThisappendixisalistofthekeylawsandequationscommontomanytopics:
GeneralLaws
Fick'sLawofDiffusionDiffusionofasubstanceacrossamembraneisgivenby:
,where:
=Areaofthesheet
=Diffusionconstant,whichisproportionaltothesolubilityofthegasandinverselyproportionaltothesquareroot
ofthemolecularweight,i.e.
=Thicknessofthesheet
Hagan-PoiseuilleEquationCalculatestheflowforagivenpressuredifferentofaparticularfluid.Mayalsoberearrangedtocalculatepressureorresistance.
Givenbytheequation:
,where:QistheflowPisthedrivingpressureηisthedynamicviscosityListhelengthoftubingristheradius
Hasseverallimitations:OnlymodelslaminarflowFluidmustbeincompressibleNottechnicallyvalidforair,butprovidesagoodapproximationwhenusedclinically.FluidmustbeNewtonianFluidmustbeinacylindricalpipeofuniformcross-section
ReynoldsNumberReynoldsNumberisadimensionlessindexusedtopredictthelikelihoodofturbulentflow.R<2000islikelytobelaminar,R>2000islikelytobeturbulent.Givenbytheequation:
,where:
visthelinearvelocityoffluidin
disthefluiddensityinristheradiusin
nistheviscosityin
CellPhysiology
LawsandEquations
744
![Page 745: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/745.jpg)
NernstEquationCalculatestheelectrochemicalequilibriumforagivenion:
,where:
istheequilibriumpotentialfortheion
isthegasconstant(8.314J.deg .mol )
isthetemperatureinKelvin
isFaraday'sConstantistheionicvalency(e.g.+2forMg ,-1forCl )
Goldman-Hodgkin-KatzEquationCalculatesthemembranepotentialforgivenvaluesofintracellularandextracellularionicconcentrations:
,where:
isthepermeabilityconstantfortheion,
Ifthemembraneisimpermeableto ,then .
Henderson-HasselbalchCalculatesthepHofabuffersolution:
,where:
isthepHofthesolution
isthepKaofthebuffer
istheconcentrationofbase
istheconcentrationofacid
RespiratoryLawsModifiedBohrEquationTheratioofdeadspacetotidalvolumeventilationequationsthearterial-mixed-expiredCO2difference,overthearterial
CO2.
LaPlace'sLawThelargerthevesselradius,thelargerthewalltensionrequiredtowithstandagiveninternalfluidpressure.Forathin-walled
sphere,WallTension(T)ishalftheproductofpressureandradius,i.e.
AlveolarGasEquationThealveolarPO2isequaltothePiO2minusthealveolarCO2/therespiratoryquotient,i.e.:
GasLawsBoyle'sLaw
,i.e.pressureandvolumeareinverselyrelatedatconstanttemperatureandpressure.
-1 -1
+2 -
LawsandEquations
745
![Page 746: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/746.jpg)
BoylesLawcanbeusedtoworkouthowmanylitresofgasareremainingingascylinder,e.g.:AstandardCcylinderis1.2LinsizeNormalcylinderpressureis~137bar,andatmosphericpressureis~1bar
Therefore,thecylindercontains~164LofoxygenThiscanbeusedtocalculatethevolumeofgasremaininginthecylinderduringuse,usingthevolumeofthecylinder(fixed)andthecurrentpressureasmeasuredattheregulator
Charle'sLaw
,i.e.volumeandtemperaturearelinearlyrelatedwhenpressureisconstant.
Gay-Lussac'sLaw/TheThirdGasLaw ,i.e.pressureandtemperaturearelinearlyrelatedwhenvolumeisconstant.
TheUniversalGasEquation
,i.e.combinationofBoyle's,Charle'slawcombiningeachvariableandtheuniversalgasconstant,R(8.13).
Henry'sLawThenumberofmoleculesofdissolvedgasisproportionaltothepartialpressureofthegasatthesurfaceoftheliquid
Graham'sLawofDiffusionDiffusionratesthroughorificesareinverselyproportionaltothesquarerootofthemolecularweight
Dalton'sLawofPartialPressuresInamixtureofgases,eachgasexertsthepressurethatitwouldexertifitoccupiedthevolumealone.
CardiovascularEquations
Fick'sPrincipleFlowofbloodthroughanorganequalstheuptakeofatracersubstancebytheorgandividedbytheconcentrationdifferenceofthesubstanceacrossit,i.e.:
Starling'sLawofFluidExchangeFlowoffluidacrossthecapillariesisproportionaltothehydrostaticpressuredifferenceandtheoncoticpressuredifference(timesthereflectioncoefficient),alltimesbythefiltraitoncoefficient,i.e.:
VenousAdmixtureCalculatestheshuntfractionbyidentifyinghowmuchmixedvenousbloodmustbeaddedtoidealpulmonarycapillaryblood
toproducetheidentifiedarterialoxygencontent.
Equipment
DopplerequationCalculatesthevelocityofanobjectbasedonthechangeinobservedfrequencywhenawaveisreflectedoff(oremittedfrom)
LawsandEquations
746
![Page 747: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/747.jpg)
theobject:
where:
=Velocityofobject
=Frequencyshift=Speedofsound(inblood)
=Frequencyoftheemittedsound
=Anglebetweenthesoundwaveandtheobject
References1. Davis&Kenny.BasicPhysicsandMeasurementinAnaesthesia,5thEdition.2. Gorman.RAHDivingandHyperbaricMedicine.Chapter3:Thephysicsofdiving.
Lastupdated2019-07-18
LawsandEquations
747
![Page 748: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/748.jpg)
StructuresforSAQsStructuredanswersarevital:
StructureaidsbothlearningandrecallofinformationAstructuredformatiseasytofollowlesslikelytoirritatethedrunk/tired/hungovermindoftheexaminerYoumaygetmarksforincompleteanswersifyourstructuredemonstratesyouhaveanunderstandingofthetopic,evenifthedetailsarenotfilledin
Somequestionslendthemselvesmoreeasilytoaparticularstructurethanothers,butallquestionscanbemadetofitevenabasicstructure.
RegulationofPhysiologicalResponsesSensorIntegrationEffector
ChangeinLevelofaSubstanceIntakeDistributionElimination
CompareandContrast(Drugs)ClassPharmaceutics
UsesChemicalPresentationHeat/lightstabilityRoutesofadministrationDoses
PharmacokineticsAbsorptionDistributionMetabolismElimination
PharmacodynamicsMainActionModeofActionEffects(Seethephysiologicalapproach)SideEffectsToxiceffects
AllergicDose-dependentIdiopathic
StructuresforSAQs
748
![Page 749: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/749.jpg)
Druginteractions
DescribeWhyTwoDrugsareUsedinCombination
DefinitionBrief,ofeachdrug.
ConsiderthecomponentsofanaesthesiathateachprovidesPharmacokinetics
InteractionsRelativeonsetMetabolism
Noeffect/Induces/InhibitsElimination
PharmacodynamicsIsobologramSynergistic/additive/antagonistic.Thenlisttheeffectsofeachdrug,andhowtheyaremodifiedbytheother
e.g.ifdrugsaresynergistic,thendecreaseddoseswillberequiredIncreasesbeneficialeffectsDecreasesadverseeffects
DescribethePhysiologyof...
RespiratoryBronchodilation/constrictionVasodilation/constrictionVRRSecretionLaryngealreflexes
CVSPreloadContractility/Pumpeffects
InotropyChronotropy/rhythmDromotropyLusitropyBathmotropyNodaleffectsCoronaryBloodFlow
Afterload/PipeeffectsSBPDBPMAPSVRPVR
IntraarterialinjectionCNS
Sedation
T
StructuresforSAQs
749
![Page 750: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/750.jpg)
AnalgesiaPro/anticonvulsantAmnesticCerebralMetabolicRateCerebralBloodFlowICPIOP
MusculocutaneousBloodFlowNMJ
EndocrineGynaecomastiaHairBone
RenalandGURenalBloodFlowNephrotoxicityBladdertoneUterinetone
GITandHepaticHepatotoxicity/LFTsSecretionsGastricemptyingN/V/D/C
HaematologicalG6PDPorphyriasBonemarroweffects
ImmunologicalAnaphylaxisHistaminergicNeutrophilfunction
Metabolic
AnatomicalStructure
AnatomyofthestructureRelationshipsRelevantsurfaceanatomyLayersofdissection
PhysicsandMeasurement
DefinitionUsesPhysicalprinciplesComponentsCalibrationAdvantages/Disadvantages
StructuresforSAQs
750
![Page 751: Table of Contents - LITFL · Coronary Circulation Cardiac Cycle Electrical Properties Cardiac Action Potential Cardiac Output Determinants of Cardiac Output Venous Return Myocardial](https://reader033.fdocuments.us/reader033/viewer/2022052806/606030c5a7157561df6fafcb/html5/thumbnails/751.jpg)
References
Dr.PodcastWisdomfromdrunk,tired,and/orhungoverexaminers.
Lastupdated2019-07-18
StructuresforSAQs
751